# RGD-PIPELINE: ftp-file-extracts # MODULE: annotations-version-1.1.9 (Oct 10, 2019) # GENERATED-ON: 2025/07/19 # PURPOSE: annotations about active Pig objects extracted from RGD database # ONTOLOGY: ChEBI: ChEBI Ontology # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: multiple values in a single column are separated by '|' # #COLUMN INFORMATION: # #1 RGD_ID unique RGD_ID of the annotated object #2 OBJECT_SYMBOL official symbol of the annotated object #3 OBJECT_NAME official name of the annotated object #4 OBJECT_TYPE annotated object data type: one of ['gene','qtl','strain'] #5 TERM_ACC_ID ontology term accession id #6 TERM_NAME ontology term name #7 QUALIFIER optional qualifier #8 EVIDENCE evidence #9 WITH with info #10 ASPECT aspect #11 REFERENCES db references (Reference RGDID|PUBMED ID) #12 CREATED_DATE created date #13 ASSIGNED_BY assigned by #14 MESH_OMIM_ID MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only) #15 CURATION_NOTES curation notes provided by RGD curators #16 ORIGINAL_REFERENCE original reference RGD_ID OBJECT_SYMBOL OBJECT_NAME OBJECT_TYPE TERM_ACC_ID TERM_NAME QUALIFIER EVIDENCE WITH ASPECT REFERENCES CREATED_DATE ASSIGNED_BY MESH_OMIM_ID CURATION_NOTES ORIGINAL_REFERENCE 13842626 CXCR2 C-X-C motif chemokine receptor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CXCR2 mRNA PMID:35307453 13842626 CXCR2 C-X-C motif chemokine receptor 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CXCR2 mRNA; Zearalenone results in increased expression of CXCR2 protein PMID:29758222 13842626 CXCR2 C-X-C motif chemokine receptor 2 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CXCR2 mRNA PMID:21505051 13842626 CXCR2 C-X-C motif chemokine receptor 2 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 epostane promotes the reaction [Dinoprost results in increased expression of CXCR2 mRNA] PMID:21505051 13842693 IL1B2 interleukin 1, beta 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL1B2 mRNA PMID:27915442 13842693 IL1B2 interleukin 1, beta 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL1B2 mRNA]; nivalenol promotes the reaction [deoxynivalenol results in increased expression of IL1B2 mRNA] PMID:27915442 13842693 IL1B2 interleukin 1, beta 2 gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL1B2 mRNA PMID:27915442 13842693 IL1B2 interleukin 1, beta 2 gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL1B2 mRNA]; nivalenol promotes the reaction [deoxynivalenol results in increased expression of IL1B2 mRNA] PMID:27915442 13842714 PPWD1 peptidylprolyl isomerase domain and WD repeat containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPWD1 mRNA PMID:35307453 13842752 TINAG tubulointerstitial nephritis antigen gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TINAG mRNA PMID:35307453 13842914 AUTS2 activator of transcription and developmental regulator AUTS2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of AUTS2 mRNA PMID:34933075 13842957 EDAR ectodysplasin A receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EDAR mRNA PMID:35307453 13842986 TTC9 tetratricopeptide repeat domain 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTC9 mRNA PMID:35307453 13843161 CYB5A cytochrome b5 type A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYB5A mRNA PMID:35307453 13843179 PSMC4 proteasome 26S subunit, ATPase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMC4 mRNA PMID:35307453 13843210 LRRK2 leucine rich repeat kinase 2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of LRRK2 mRNA PMID:39151877 13843268 SST somatostatin gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in decreased expression of SST mRNA; Copper Sulfate results in decreased expression of SST protein PMID:21110139 13843302 RUNDC1 RUN domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUNDC1 mRNA PMID:35307453 13843313 C6H19orf81 chromosome 6 C19orf81 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C6H19ORF81 mRNA PMID:35307453 13843388 ULK4 unc-51 like kinase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ULK4 mRNA PMID:35307453 13843466 PRKCG protein kinase C gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRKCG mRNA PMID:35307453 13843581 RAC2 Rac family small GTPase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAC2 mRNA PMID:35307453 13843649 TRIM45 tripartite motif containing 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIM45 mRNA PMID:35307453 13843693 GPN1 GPN-loop GTPase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPN1 mRNA PMID:35307453 13843726 FMO3 flavin containing dimethylaniline monoxygenase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMO3 mRNA PMID:35307453 13843742 IGSF5 immunoglobulin superfamily member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGSF5 mRNA PMID:35307453 13843742 IGSF5 immunoglobulin superfamily member 5 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IGSF5 mRNA PMID:34933075 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDIT3 mRNA PMID:35307453 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of DDIT3 mRNA; deoxynivalenol results in increased expression of DDIT3 protein PMID:37442268|PMID:38608924 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 GSK2656157 inhibits the reaction [deoxynivalenol results in increased expression of DDIT3 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of DDIT3 protein] PMID:37442268 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:136004 linsidomine increases expression EXP E RGD:6480464 20191114 CTD MESH:C002385 linsidomine results in increased expression of DDIT3 mRNA PMID:18086661 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:139047 GSK2656157 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C000597302 GSK2656157 inhibits the reaction [deoxynivalenol results in increased expression of DDIT3 protein] PMID:37442268 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:146195 3-acetyldeoxynivalenol increases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased expression of DDIT3 protein PMID:37659622 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of DDIT3 protein] PMID:37659622 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of DDIT3 mRNA] PMID:36584959 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased expression of DDIT3 mRNA PMID:37207789 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 protein; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of DDIT3 mRNA] PMID:33891997|PMID:37207789 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of DDIT3 protein] PMID:37442268 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of DDIT3 mRNA PMID:36584959 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of DDIT3 mRNA] PMID:36584959 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] PMID:18086661 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of DDIT3 protein PMID:36754226 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of DDIT3 protein] PMID:36754226 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:3093 bifenthrin increases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased expression of DDIT3 protein PMID:33901951 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of DDIT3 mRNA; bisphenol A results in increased expression of DDIT3 protein PMID:37108405|PMID:38845341 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein]; ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of DDIT3 mRNA] PMID:37108405|PMID:38845341 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of DDIT3 mRNA PMID:17464326|PMID:18086661 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 protein; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA]; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] PMID:17464326|PMID:18086661|PMID:33891997 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of DDIT3 protein] PMID:37442268 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of DDIT3 protein] PMID:36754226 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein] PMID:37108405 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:49662 indometacin increases expression EXP E RGD:6480464 20191114 CTD MESH:D007213 Indomethacin results in increased expression of DDIT3 mRNA PMID:18799549 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in increased expression of DDIT3 protein PMID:38567716 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of DDIT3 mRNA] PMID:37207789|PMID:38845341 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of DDIT3 protein] PMID:37659622 13843780 DDIT3 DNA damage inducible transcript 3 gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in increased expression of DDIT3 protein PMID:34637808 13843890 PFDN2 prefoldin subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFDN2 mRNA PMID:35307453 13843986 IL17B interleukin 17B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL17B mRNA PMID:35307453 13844072 BPIFB6 BPI fold containing family B member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BPIFB6 mRNA PMID:35307453 13844322 NDST4 N-deacetylase and N-sulfotransferase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NDST4 mRNA PMID:35307453 13844364 DECR2 2,4-dienoyl-CoA reductase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DECR2 mRNA PMID:35307453 13844465 PSD2 pleckstrin and Sec7 domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSD2 mRNA PMID:35307453 13844546 PIGP phosphatidylinositol glycan anchor biosynthesis class P gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIGP mRNA PMID:35307453 13844646 SELENOP selenoprotein P gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SELENOP mRNA PMID:35307453 13844745 FMO5 flavin containing dimethylaniline monoxygenase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMO5 mRNA PMID:35307453 13844769 PDPK1 3-phosphoinositide dependent protein kinase 1 gene CHEBI:138236 oridonin decreases phosphorylation EXP E RGD:6480464 20250311 CTD MESH:C011959 oridonin results in decreased phosphorylation of PDPK1 protein PMID:38972361 13844769 PDPK1 3-phosphoinositide dependent protein kinase 1 gene CHEBI:34440 4-nonylphenol increases phosphorylation EXP E RGD:6480464 20240604 CTD MESH:C041594 4-nonylphenol results in increased phosphorylation of PDPK1 protein PMID:38246476 13844795 ABCA3 ATP binding cassette subfamily A member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCA3 mRNA PMID:35307453 13844870 PSCA prostate stem cell antigen gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSCA mRNA PMID:35307453 13844878 CHAD chondroadherin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHAD mRNA PMID:35307453 13844951 PGAP3 post-GPI attachment to proteins phospholipase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PGAP3 mRNA PMID:35307453 13844971 S100A5 S100 calcium binding protein A5 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of S100A5 mRNA PMID:39265697 13844982 LMNA lamin A/C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LMNA mRNA PMID:35307453 13845036 AMBP alpha-1-microglobulin/bikunin precursor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AMBP mRNA PMID:35307453 13845036 AMBP alpha-1-microglobulin/bikunin precursor gene CHEBI:2762 antimycin A decreases uptake EXP E RGD:6480464 20191114 CTD MESH:D000968 Antimycin A results in decreased uptake of AMBP protein PMID:9019736 13845036 AMBP alpha-1-microglobulin/bikunin precursor gene CHEBI:27882 (S)-colchicine decreases uptake EXP E RGD:6480464 20191114 CTD MESH:D003078 Colchicine results in decreased uptake of AMBP protein PMID:9019736 13845036 AMBP alpha-1-microglobulin/bikunin precursor gene CHEBI:42017 2,4-dinitrophenol decreases uptake EXP E RGD:6480464 20191114 CTD MESH:D019297 2,4-Dinitrophenol results in decreased uptake of AMBP protein PMID:9019736 13845129 CARD11 caspase recruitment domain family member 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CARD11 mRNA PMID:35307453 13845335 SCN5A sodium voltage-gated channel alpha subunit 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCN5A mRNA PMID:35307453 13845426 PHB2 prohibitin 2 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of PHB2 mRNA PMID:35839969 13845486 TNFAIP8 TNF alpha induced protein 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFAIP8 mRNA PMID:35307453 13845813 PAPPA2 pappalysin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAPPA2 mRNA PMID:35307453 13845844 PRR36 proline rich 36 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRR36 mRNA PMID:35307453 13845955 RAC1 Rac family small GTPase 1 gene CHEBI:4031 cyclosporin A affects localization EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine affects the localization of RAC1 protein PMID:12695417 13846042 SLC35E4 solute carrier family 35 member E4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC35E4 mRNA PMID:35307453 13846063 ZCCHC2 zinc finger CCHC-type containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZCCHC2 mRNA PMID:35307453 13846113 ENPP6 ectonucleotide pyrophosphatase/phosphodiesterase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENPP6 mRNA PMID:35307453 13846113 ENPP6 ectonucleotide pyrophosphatase/phosphodiesterase 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ENPP6 mRNA PMID:39265697 13846129 PLLP plasmolipin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLLP mRNA PMID:35307453 13846145 FYCO1 FYVE and coiled-coil domain autophagy adaptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FYCO1 mRNA PMID:35307453 13846242 R3HDM4 R3H domain containing 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of R3HDM4 mRNA PMID:35307453 13846278 MAP3K13 mitogen-activated protein kinase kinase kinase 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP3K13 mRNA PMID:35307453 13846278 MAP3K13 mitogen-activated protein kinase kinase kinase 13 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MAP3K13 mRNA PMID:39265697 13846426 PTPRD protein tyrosine phosphatase receptor type D gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPRD mRNA PMID:35307453 13846657 NEIL2 nei like DNA glycosylase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEIL2 mRNA PMID:35307453 13846747 SLC26A4 solute carrier family 26 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC26A4 mRNA PMID:35307453 13846798 UBAP1L ubiquitin associated protein 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBAP1L mRNA PMID:35307453 13846917 ASNS asparagine synthetase (glutamine-hydrolyzing) gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ASNS mRNA PMID:35307453 13846917 ASNS asparagine synthetase (glutamine-hydrolyzing) gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ASNS mRNA] PMID:21852083 13847160 TMEM232 transmembrane protein 232 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM232 mRNA PMID:35307453 13847227 KRT80 keratin 80 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of KRT80 mRNA PMID:39265697 13847461 HBEGF heparin binding EGF like growth factor gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of HBEGF mRNA PMID:27617619 13847461 HBEGF heparin binding EGF like growth factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of DTR mRNA PMID:21852083 13847461 HBEGF heparin binding EGF like growth factor gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of HBEGF protein PMID:39486568 13847461 HBEGF heparin binding EGF like growth factor gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of HBEGF protein PMID:39486568 13847474 PRKCI protein kinase C iota gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRKCI mRNA PMID:35307453 13847503 CFAP251 cilia and flagella associated protein 251 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP251 mRNA PMID:35307453 13847759 PCDH11X protocadherin 11 X-linked gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of PCDH11X mRNA PMID:25455459 13847800 CDS2 CDP-diacylglycerol synthase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDS2 protein PMID:37257635 13847825 ROPN1L rhophilin associated tail protein 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ROPN1L mRNA PMID:35307453 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLCO1A2 mRNA PMID:35307453 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:17474 estrone 3-sulfate increases uptake EXP E RGD:6480464 20191210 CTD MESH:C017296 SLCO1A2 protein results in increased uptake of estrone sulfate PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:17474 estrone 3-sulfate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C017296 Amoxicillin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; cefquinome inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Chlortetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Clarithromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Erythromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Penicillins inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; tilmicosin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Tylosin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:17658 tylosin multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D015645 Tylosin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Tylosin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:195409 tilmicosin multiple interactions EXP E RGD:6480464 20230808 CTD MESH:C052319 tilmicosin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; tilmicosin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:2676 amoxicillin increases uptake EXP E RGD:6480464 20191210 CTD MESH:D000658 SLCO1A2 protein results in increased uptake of Amoxicillin PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:2676 amoxicillin multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D000658 Amoxicillin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Amoxicillin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27644 chlortetracycline increases uptake EXP E RGD:6480464 20191210 CTD MESH:D002751 SLCO1A2 protein results in increased uptake of Chlortetracycline PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27644 chlortetracycline multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D002751 Chlortetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27701 oxytetracycline increases uptake EXP E RGD:6480464 20191210 CTD MESH:D010118 SLCO1A2 protein results in increased uptake of Oxytetracycline PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27701 oxytetracycline multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D010118 Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27902 tetracycline increases uptake EXP E RGD:6480464 20191210 CTD MESH:D013752 SLCO1A2 protein results in increased uptake of Tetracycline PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:27902 tetracycline multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D013752 Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D019833 Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Penicillins]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:28197 daidzein multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C004742 daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Penicillins]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:28819 naringin multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C005274 naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Penicillins]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:28865 taurocholic acid increases uptake EXP E RGD:6480464 20191210 CTD MESH:D013656 SLCO1A2 protein results in increased uptake of Taurocholic Acid PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:28865 taurocholic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D013656 Amoxicillin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; cefquinome inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Clarithromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Erythromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Penicillins inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; tilmicosin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid]; Tylosin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:3732 clarithromycin multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D017291 Clarithromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Clarithromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:42355 erythromycin A multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D004917 Erythromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Erythromycin inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Penicillins]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:50845 doxycycline increases uptake EXP E RGD:6480464 20191210 CTD MESH:D004318 SLCO1A2 protein results in increased uptake of Doxycycline PMID:31287969 13847854 SLCO1A2 solute carrier organic anion transporter family member 1A2 gene CHEBI:50845 doxycycline multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D004318 Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] PMID:31287969 13848022 LCP2 lymphocyte cytosolic protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LCP2 mRNA PMID:35307453 13848022 LCP2 lymphocyte cytosolic protein 2 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of LCP2 mRNA PMID:21391292 13848125 SLC47A1 solute carrier family 47 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC47A1 mRNA PMID:35307453 13848125 SLC47A1 solute carrier family 47 member 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SLC47A1 mRNA PMID:34389318 13848199 TP53BP2 tumor protein p53 binding protein 2 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in decreased expression of TP53BP2 mRNA PMID:22497863 13848245 TGFBI transforming growth factor beta induced gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGFBI mRNA PMID:35307453 13848418 KNG1 kininogen 1 gene CHEBI:16480 nitric oxide increases abundance EXP E RGD:6480464 20191114 CTD MESH:D009569 KNG1 protein results in increased abundance of Nitric Oxide PMID:12672649 13848418 KNG1 kininogen 1 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] PMID:12672649 13848418 KNG1 kininogen 1 gene CHEBI:3011 benazepril increases activity EXP E RGD:6480464 20191114 CTD MESH:C044946 benazepril results in increased activity of KNG1 protein modified form PMID:7890486 13848418 KNG1 kininogen 1 gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein] PMID:17105827 13848418 KNG1 kininogen 1 gene CHEBI:59877 enalaprilat dihydrate increases activity EXP E RGD:6480464 20191114 CTD MESH:D015773 Enalaprilat results in increased activity of KNG1 protein modified form PMID:7890486 13848418 KNG1 kininogen 1 gene CHEBI:68556 icatibant decreases activity EXP E RGD:6480464 20191114 CTD MESH:C065679 icatibant results in decreased activity of KNG1 protein modified form PMID:7890486 13848499 TSC22D1 TSC22 domain family member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSC22D1 mRNA PMID:35307453 13848499 TSC22D1 TSC22 domain family member 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of TSC22D1 mRNA PMID:39265697 13848571 IFIT3 interferon induced protein with tetratricopeptide repeats 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFIT1 mRNA PMID:35307453 13848571 IFIT3 interferon induced protein with tetratricopeptide repeats 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IFIT1 mRNA PMID:39265697 13848571 IFIT3 interferon induced protein with tetratricopeptide repeats 3 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IFIT1 mRNA] PMID:27079946 13848622 SPC25 SPC25 component of NDC80 kinetochore complex gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPC25 mRNA PMID:35307453 13848622 SPC25 SPC25 component of NDC80 kinetochore complex gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SPC25 mRNA PMID:21852083 13848724 ERMARD ER membrane associated RNA degradation gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERMARD mRNA PMID:35307453 13848995 ARMH1 armadillo like helical domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARMH1 mRNA PMID:35307453 13849118 TBX15 T-box transcription factor 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TBX15 mRNA PMID:35307453 13849155 RPL35 ribosomal protein L35 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL35 mRNA PMID:39265697 13849163 TLX3 T cell leukemia homeobox 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TLX3 mRNA PMID:35307453 13849218 AP3M2 adaptor related protein complex 3 subunit mu 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AP3M2 mRNA PMID:35307453 13849240 IL4R interleukin 4 receptor gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of IL4R mRNA PMID:34389318 13849240 IL4R interleukin 4 receptor gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of IL4R mRNA PMID:18988085 13849296 DKK3 dickkopf WNT signaling pathway inhibitor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DKK3 mRNA PMID:35307453 13849472 REEP6 receptor accessory protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of REEP6 mRNA PMID:35307453 13849493 PTI pancreatic trypsin inhibitor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTI mRNA PMID:35307453 13849560 CLDN10 claudin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLDN10 mRNA PMID:35307453 13849718 DNER delta/notch like EGF repeat containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNER mRNA PMID:35307453 13849794 TMEM270 transmembrane protein 270 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM270 mRNA PMID:35307453 13849860 ATF2 activating transcription factor 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide affects expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas affects the expression of ATF2 mRNA PMID:18988085 13849905 CLIC2 chloride intracellular channel 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLIC2 mRNA PMID:35307453 13849920 TRPM6 transient receptor potential cation channel subfamily M member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPM6 mRNA PMID:35307453 13850049 HOGA1 4-hydroxy-2-oxoglutarate aldolase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOGA1 mRNA PMID:35307453 13850107 ACSL5 acyl-CoA synthetase long chain family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACSL5 mRNA PMID:35307453 13850201 LNPEP leucyl and cystinyl aminopeptidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LNPEP mRNA PMID:35307453 13850246 NENF neudesin neurotrophic factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NENF mRNA PMID:35307453 13850292 GJC3 gap junction protein gamma 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GJC3 mRNA PMID:35307453 13850355 ASB1 ankyrin repeat and SOCS box containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB1 mRNA PMID:35307453 13850438 FAM149A family with sequence similarity 149 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM149A mRNA PMID:35307453 13850554 UQCRH ubiquinol-cytochrome c reductase hinge protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of UQCRH mRNA PMID:39265697 13850633 PYY peptide YY gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PYY mRNA PMID:35307453 13850697 ADAMTS18 ADAM metallopeptidase with thrombospondin type 1 motif 18 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADAMTS18 mRNA PMID:34933075 13850788 STARD13 StAR related lipid transfer domain containing 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STARD13 mRNA PMID:35307453 13850842 ALS2CL ALS2 C-terminal like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALS2CL mRNA PMID:35307453 13850979 TNPO3 transportin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNPO3 mRNA PMID:35307453 13851085 ALDH3A2 aldehyde dehydrogenase 3 family member A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH3A2 mRNA PMID:35307453 13851106 KCNIP3 potassium voltage-gated channel interacting protein 3 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of KCNIP3 mRNA PMID:35307453 13851160 GCG glucagon gene CHEBI:17489 3',5'-cyclic AMP affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D000242 Cyclic AMP affects the susceptibility to GCG protein PMID:6253273 13851160 GCG glucagon gene CHEBI:17489 3',5'-cyclic AMP increases abundance EXP E RGD:6480464 20191114 CTD MESH:D000242 GCG protein results in increased abundance of Cyclic AMP PMID:6253273 13851247 SCG2 secretogranin II gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SCG2 mRNA PMID:39265697 13851303 GLG1 golgi glycoprotein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLG1 mRNA; deoxynivalenol results in decreased expression of GLG1 protein PMID:38403181 13851397 ID3 inhibitor of DNA binding 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ID3 mRNA PMID:39265697 13851404 TSHR thyroid stimulating hormone receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSHR mRNA PMID:35307453 13851404 TSHR thyroid stimulating hormone receptor gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of TSHR mRNA PMID:16896063 13851573 FABP6 fatty acid binding protein 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FABP6 mRNA PMID:35307453 13851573 FABP6 fatty acid binding protein 6 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP6 mRNA] PMID:21852083 13851627 MYADM myeloid associated differentiation marker gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYADM mRNA PMID:35307453 13851760 MRI1 methylthioribose-1-phosphate isomerase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRI1 mRNA PMID:35307453 13851770 FOXO6 forkhead box O6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FOXO6 mRNA PMID:39265697 13851776 APLP1 amyloid beta precursor like protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APLP1 mRNA PMID:35307453 13851813 KRCC1 lysine rich coiled-coil 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KRCC1 mRNA PMID:35307453 13851888 SUGCT succinyl-CoA:glutarate-CoA transferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUGCT mRNA PMID:35307453 13852063 MTFMT mitochondrial methionyl-tRNA formyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTFMT mRNA; deoxynivalenol results in decreased expression of MTFMT protein PMID:38403181 13852091 NAA25 N-alpha-acetyltransferase 25, NatB auxiliary subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAA25 mRNA PMID:35307453 13852132 PSMB8 proteasome 20S subunit beta 8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of PSMB8 mRNA PMID:25455459 13852132 PSMB8 proteasome 20S subunit beta 8 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of PSMB8 mRNA PMID:22497863 13852148 SMAD9 SMAD family member 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMAD9 mRNA PMID:35307453 13852157 NAALADL1 N-acetylated alpha-linked acidic dipeptidase like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAALADL1 mRNA PMID:35307453 13852183 SLC17A3 solute carrier family 17 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC17A3 mRNA PMID:35307453 13852324 HDAC6 histone deacetylase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HDAC6 mRNA PMID:35307453 13852392 RPS24 ribosomal protein S24 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS24 mRNA PMID:39265697 13852486 P2RX6 purinergic receptor P2X 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P2RX6 mRNA PMID:35307453 13852736 STON2 stonin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STON2 mRNA PMID:35307453 13852780 PRPF3 pre-mRNA processing factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRPF3 mRNA PMID:35307453 13852888 IPCEF1 interaction protein for cytohesin exchange factors 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of IPCEF1 mRNA PMID:21852083 13852908 DRAXIN dorsal inhibitory axon guidance protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DRAXIN mRNA PMID:35307453 13852919 NPHP4 nephrocystin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPHP4 mRNA PMID:35307453 13852967 SLC4A2 solute carrier family 4 member 2 gene CHEBI:4286 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017878 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid promotes the reaction [SLC4A2 protein binds to SLC4A2 protein] PMID:10387099 13853019 MRPS10 mitochondrial ribosomal protein S10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS10 mRNA PMID:35307453 13853079 FOLR2 folate receptor 2 (fetal) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOLR2 mRNA PMID:35307453 13853131 CCT3 chaperonin containing TCP1 subunit 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT3 mRNA PMID:35307453 13853219 OSGIN1 oxidative stress induced growth inhibitor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OSGIN1 mRNA PMID:35307453 13853219 OSGIN1 oxidative stress induced growth inhibitor 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of OSGIN1 mRNA PMID:39265697 13853219 OSGIN1 oxidative stress induced growth inhibitor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of OSGIN1 mRNA PMID:27617619 13853231 NUP62CL nucleoporin 62 C-terminal like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUP62CL mRNA PMID:35307453 13853271 TFF1 trefoil factor 1 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol affects the expression of TFF1 mRNA PMID:30854615 13853271 TFF1 trefoil factor 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TFF1 mRNA PMID:39265697 13853395 RGN regucalcin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGN mRNA PMID:35307453 13853395 RGN regucalcin gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RGN mRNA PMID:34933075 13853427 ETS2 ETS proto-oncogene 2, transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ETS2 mRNA PMID:35307453 13853488 CLDN4 claudin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol analog results in decreased expression of CLDN4 protein; deoxynivalenol results in decreased expression of CLDN4 protein PMID:19289138|PMID:22859312|PMID:35307453|PMID:36596350 13853488 CLDN4 claudin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of CLDN4 protein PMID:37257635 13853488 CLDN4 claudin 4 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]; PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]; T 0070907 inhibits the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein] PMID:36596350 13853488 CLDN4 claudin 4 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of CLDN4 protein PMID:37659622 13853488 CLDN4 claudin 4 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of CLDN4 protein] PMID:37659622 13853488 CLDN4 claudin 4 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of CLDN4 mRNA PMID:28069986 13853488 CLDN4 claudin 4 gene CHEBI:33709 amino acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000596 Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN4 protein] PMID:26338884 13853488 CLDN4 claudin 4 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in decreased expression of CLDN4 protein PMID:26338884 13853488 CLDN4 claudin 4 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004178 Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN4 protein] PMID:26338884 13853488 CLDN4 claudin 4 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C060836 Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein] PMID:36596350 13853488 CLDN4 claudin 4 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of CLDN4 protein] PMID:37659622 13853488 CLDN4 claudin 4 gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in increased expression of CLDN4 mRNA; Troglitazone results in increased expression of CLDN4 protein PMID:36596350 13853488 CLDN4 claudin 4 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C057693 PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein] PMID:36596350 13853580 DIXDC1 DIX domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DIXDC1 mRNA PMID:35307453 13853711 LCAT lecithin-cholesterol acyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LCAT mRNA PMID:35307453 13853774 FSHR follicle stimulating hormone receptor gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of FSHR mRNA PMID:32423882 13853774 FSHR follicle stimulating hormone receptor gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of FSHR mRNA PMID:32423882 13853774 FSHR follicle stimulating hormone receptor gene CHEBI:31767 lead diacetate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of FSHR mRNA PMID:29273543 13853807 EXOC6 exocyst complex component 6 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20231003 CTD MESH:D005839 Gentamicins results in increased expression of EXOC6 mRNA PMID:28372472 13854017 TMSB15A thymosin beta 15A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMSB15A mRNA PMID:35307453 13854030 TNFAIP3 TNF alpha induced protein 3 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of TNFAIP3 mRNA PMID:37706587 13854030 TNFAIP3 TNF alpha induced protein 3 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of TNFAIP3 mRNA] PMID:37706587 13854030 TNFAIP3 TNF alpha induced protein 3 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of TNFAIP3 mRNA] PMID:37706587 13854198 ACTR3 actin related protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACTR3 mRNA PMID:35307453 13854230 TAGLN2 transgelin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TAGLN2 mRNA PMID:35307453 13854230 TAGLN2 transgelin 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TAGLN2 mRNA] PMID:21852083 13854413 WBP1 WW domain binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WBP1 mRNA PMID:35307453 13854425 IL1RN interleukin 1 receptor antagonist gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of IL1RN mRNA PMID:21391292 13854491 GDPD5 glycerophosphodiester phosphodiesterase domain containing 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GDPD5 mRNA PMID:35307453 13854624 ACOT8 acyl-CoA thioesterase 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACOT8 mRNA PMID:35307453 13854900 ZC3H8 zinc finger CCCH-type containing 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZC3H8 mRNA PMID:35307453 13854915 MOB3B MOB kinase activator 3B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MOB3B mRNA PMID:35307453 13854941 DUSP15 dual specificity phosphatase 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DUSP15 mRNA PMID:35307453 13855082 ITM2C integral membrane protein 2C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITM2C mRNA; deoxynivalenol results in decreased expression of ITM2C protein PMID:35307453|PMID:38403181 13855370 ANXA13 annexin A13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANXA13 mRNA PMID:35307453 13855422 HHIPL2 HHIP like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HHIPL2 mRNA PMID:35307453 13855446 C4H8orf34 chromosome 4 C8orf34 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C4H8ORF34 mRNA PMID:35307453 13855518 LOC100627422 ligand-dependent corepressor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LCOR mRNA PMID:35307453 13855628 CD40 CD40 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD40 mRNA PMID:35307453 13855628 CD40 CD40 molecule gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of CD40 protein PMID:15964915 13855685 RNF128 ring finger protein 128 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNF128 mRNA PMID:35307453 13855685 RNF128 ring finger protein 128 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RNF128 mRNA] PMID:21852083 13855699 QTRT1 queuine tRNA-ribosyltransferase catalytic subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of QTRT1 mRNA; deoxynivalenol results in increased expression of QTRT1 protein PMID:35307453|PMID:38403181 13855766 SCGN secretagogin, EF-hand calcium binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCGN mRNA PMID:35307453 13855785 KRAS KRAS proto-oncogene, GTPase gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of KRAS mRNA PMID:34389318 13855889 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein] PMID:28235547 13855889 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein] PMID:28235547 13855889 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein] PMID:28235547 13855889 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein] PMID:28235547 13855937 ANKS4B ankyrin repeat and sterile alpha motif domain containing 4B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKS4B mRNA PMID:35307453 13855968 MXD4 MAX dimerization protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MXD4 mRNA PMID:35307453 13855989 FGL2 fibrinogen like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGL2 mRNA PMID:35307453 13855995 C4BPA complement component 4 binding protein alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C4BPA mRNA PMID:35307453 13855995 C4BPA complement component 4 binding protein alpha gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220927 CTD MESH:D015025 Zearalenone results in decreased expression of C4BPA mRNA PMID:34933075 13856028 SLX4 SLX4 structure-specific endonuclease subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLX4 mRNA PMID:35307453 13856062 RASA2 RAS p21 protein activator 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RASA2 mRNA PMID:35307453 13856097 ATF1 activating transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATF1 mRNA PMID:35307453 13856097 ATF1 activating transcription factor 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of ATF1 mRNA] PMID:39151877 13856097 ATF1 activating transcription factor 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of ATF1 mRNA PMID:39151877 13856097 ATF1 activating transcription factor 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of ATF1 mRNA] PMID:39151877 13856136 PFDN4 prefoldin subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFDN4 mRNA PMID:35307453 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCARB1 mRNA PMID:35307453 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:34310 (24S)-24-hydroxycholesterol affects localization EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol affects the localization of SCARB1 protein PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:47612 bezafibrate affects localization EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate affects the localization of SCARB1 protein PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate results in increased expression of SCARB1 mRNA PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:5001 fenofibrate affects localization EXP E RGD:6480464 20191114 CTD MESH:D011345 Fenofibrate affects the localization of SCARB1 protein PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:8228 pioglitazone affects localization EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone affects the localization of SCARB1 protein PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:8228 pioglitazone increases expression EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone results in increased expression of SCARB1 mRNA PMID:16530456 13856190 SCARB1 scavenger receptor class B member 1 gene CHEBI:9753 troglitazone affects localization EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone affects the localization of SCARB1 protein PMID:16530456 13856369 NME3 NME/NM23 nucleoside diphosphate kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NME3 mRNA PMID:35307453 13856420 KNDC1 kinase non-catalytic C-lobe domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KNDC1 mRNA PMID:35307453 13856610 CAMK2A calcium/calmodulin dependent protein kinase II alpha gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CAMK2A mRNA PMID:39265697 13856706 NUP37 nucleoporin 37 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUP37 mRNA PMID:35307453 13856726 NFE2 nuclear factor, erythroid 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2 protein PMID:33592257 13856726 NFE2 nuclear factor, erythroid 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2 protein PMID:33592257 13856884 PUF60 poly(U) binding splicing factor 60 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PUF60 mRNA PMID:35307453 13856990 GRAMD1C GRAM domain containing 1C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRAMD1C mRNA PMID:35307453 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGS1 mRNA PMID:35307453 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PTGS1 mRNA PMID:39265697 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005998 [Folic Acid co-treated with Glycine] results in decreased expression of PTGS1 PMID:14662146 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:22977 cadmium atom decreases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in decreased expression of PTGS1 mRNA PMID:37207789 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D002104 ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTGS1 mRNA] PMID:37207789 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [Folic Acid co-treated with Glycine] results in decreased expression of PTGS1 PMID:14662146 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20241105 CTD MESH:C006780 bisphenol A results in decreased expression of PTGS1 mRNA PMID:38845341 13857165 PTGS1 prostaglandin-endoperoxide synthase 1 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTGS1 mRNA] PMID:37207789 13857230 DDX20 DEAD-box helicase 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX20 mRNA PMID:35307453 13857230 DDX20 DEAD-box helicase 20 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DDX20 mRNA PMID:34389318 13857255 PRDX1 peroxiredoxin 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PRDX1 mRNA] PMID:39151877 13857255 PRDX1 peroxiredoxin 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of PRDX1 mRNA PMID:39151877 13857255 PRDX1 peroxiredoxin 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PRDX1 mRNA] PMID:39151877 13857255 PRDX1 peroxiredoxin 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of PRDX1 mRNA PMID:14994279 13857275 LOC100523672 heat shock factor protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOL3 mRNA PMID:35307453 13857320 PLAT plasminogen activator, tissue type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLAT mRNA; deoxynivalenol results in decreased expression of PLAT protein PMID:38403181 13857320 PLAT plasminogen activator, tissue type gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PLAT mRNA PMID:39265697 13857356 UBAP2 ubiquitin associated protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBAP2 mRNA PMID:35307453 13857459 ETNK2 ethanolamine kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ETNK2 mRNA PMID:35307453 13857494 BOK BCL2 family apoptosis regulator BOK gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of BOK mRNA PMID:34933075 13857508 NALF2 NALCN channel auxiliary factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM155B mRNA PMID:35307453 13857576 HMOX2 heme oxygenase 2 gene CHEBI:3077 betamethasone increases expression EXP E RGD:6480464 20191114 CTD MESH:D001623 Betamethasone results in increased expression of HMOX2 protein PMID:11698254 13857697 MGLL monoglyceride lipase gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in increased expression of MGLL mRNA PMID:38848930 13857697 MGLL monoglyceride lipase gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of MGLL mRNA PMID:38848930 13857722 TACC2 transforming acidic coiled-coil containing protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TACC2 mRNA PMID:35307453 13857761 SLC34A3 solute carrier family 34 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC34A3 mRNA PMID:35307453 13857824 CX3CL1 C-X3-C motif chemokine ligand 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CX3CL1 mRNA PMID:35307453 13857824 CX3CL1 C-X3-C motif chemokine ligand 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CX3CL1 mRNA PMID:23326479 13857824 CX3CL1 C-X3-C motif chemokine ligand 1 gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of CX3CL1 mRNA PMID:33901951 13858001 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of YWHAZ mRNA PMID:34389318 13858001 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene CHEBI:28984 aluminium atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D000535 Aluminum binds to YWHAZ protein PMID:29385627 13858001 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene CHEBI:28984 aluminium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000535 [Aluminum binds to YWHAZ protein] inhibits the reaction [YWHAZ protein binds to MAPT protein]; Aluminum inhibits the reaction [MAPT protein binds to YWHAZ protein] PMID:29385627 13858001 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene CHEBI:33629 aluminium(0) affects binding EXP E RGD:6480464 20191114 CTD MESH:D000535 Aluminum binds to YWHAZ protein PMID:29385627 13858001 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene CHEBI:33629 aluminium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000535 [Aluminum binds to YWHAZ protein] inhibits the reaction [YWHAZ protein binds to MAPT protein]; Aluminum inhibits the reaction [MAPT protein binds to YWHAZ protein] PMID:29385627 13858094 PLEKHH2 pleckstrin homology, MyTH4 and FERM domain containing H2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHH2 mRNA PMID:35307453 13858149 SFRP4 secreted frizzled related protein 4 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SFRP4 mRNA PMID:34389318 13858159 DDAH1 dimethylarginine dimethylaminohydrolase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDAH1 mRNA PMID:35307453 13858247 IFRD1 interferon related developmental regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IFRD1 mRNA; deoxynivalenol results in increased expression of IFRD1 protein PMID:35307453|PMID:38403181 13858274 FGFRL1 fibroblast growth factor receptor like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGFRL1 mRNA PMID:35307453 13858345 DUSP23 dual specificity phosphatase 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DUSP23 mRNA PMID:35307453 13858574 SOBP sine oculis binding protein homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SOBP mRNA PMID:35307453 13858678 LOC102162486 putative RNA-binding protein Luc7-like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FMC1-LUC7L2 mRNA PMID:35307453 13858762 CA11 carbonic anhydrase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CA11 mRNA PMID:35307453 13858762 CA11 carbonic anhydrase 11 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CA11 mRNA PMID:34933075 13858942 ACAT1 acetyl-CoA acetyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACAT1 mRNA; deoxynivalenol results in decreased expression of ACAT1 protein PMID:35307453|PMID:38403181 13858987 DYNLT5 dynein light chain Tctex-type family member 5 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol affects the expression of DYNLT5 mRNA PMID:35307453 13859042 YPEL4 yippee like 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YPEL4 mRNA PMID:35307453 13859052 ANXA4 annexin A4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANXA4 mRNA PMID:35307453 13859052 ANXA4 annexin A4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ANXA4 mRNA PMID:39265697 13859175 CDH22 cadherin 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH22 mRNA PMID:35307453 13859191 CCDC170 coiled-coil domain containing 170 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC170 mRNA PMID:35307453 13859260 IQCC IQ motif containing C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IQCC mRNA PMID:35307453 13859274 PDCD1LG2 programmed cell death 1 ligand 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDCD1LG2 mRNA PMID:35307453 13859304 MARCHF8 membrane associated ring-CH-type finger 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MARCHF8 mRNA PMID:35307453 13859417 ITGAM integrin subunit alpha M gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGAM mRNA PMID:35307453 13859468 DCUN1D3 defective in cullin neddylation 1 domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCUN1D3 mRNA PMID:35307453 13859519 DPF3 double PHD fingers 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPF3 mRNA PMID:35307453 13859572 RIOX2 ribosomal oxygenase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIOX2 mRNA PMID:35307453 13859697 PSMB3 proteasome 20S subunit beta 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMB3 mRNA PMID:35307453 13859958 DNM1 dynamin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNM1 mRNA PMID:35307453 13859958 DNM1 dynamin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of DNM1 mRNA PMID:34933075 13860007 YPEL3 yippee like 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YPEL3 mRNA PMID:35307453 13860092 TST thiosulfate sulfurtransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TST mRNA PMID:35307453 13860209 TFG trafficking from ER to golgi regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TFG mRNA PMID:35307453 13860279 TMEM200A transmembrane protein 200A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM200A mRNA PMID:35307453 13860407 MRPS18C mitochondrial ribosomal protein S18C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS18C mRNA PMID:35307453 13860477 ACOX3 acyl-CoA oxidase 3, pristanoyl gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACOX3 mRNA PMID:35307453 13860522 RASL12 RAS like family 12 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of RASL12 mRNA PMID:34389318 13860584 ERCC6L ERCC excision repair 6 like, spindle assembly checkpoint helicase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ERCC6L mRNA PMID:35307453 13860595 PSMG3 proteasome assembly chaperone 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSMG3 mRNA PMID:35307453 13860671 FOXA1 forkhead box A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOXA1 mRNA PMID:35307453 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:223316 (+)-artemisinin increases expression EXP E RGD:6480464 20241001 CTD MESH:C031327 artemisinin results in increased expression of CYP1A2 mRNA PMID:24176340 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20241001 CTD MESH:D003907 Dexamethasone results in increased expression of CYP1A2 mRNA PMID:24176340 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:47318 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression EXP E RGD:6480464 20241001 CTD MESH:C475093 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP1A2 mRNA PMID:24176340 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:490095 esculetin increases expression EXP E RGD:6480464 20241001 CTD MESH:C007628 esculetin results in increased expression of CYP1A2 mRNA PMID:24176340 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20191114 CTD MESH:C014558 flunixin meglumine affects the expression of CYP1A2 mRNA PMID:26366864 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:77013 beta-naphthoflavone increases expression EXP E RGD:6480464 20191114 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA PMID:19464568|PMID:24176340 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20191114 CTD MESH:D005273 Fenbendazole affects the expression of CYP1A2 mRNA PMID:26366864 13860677 CYP1A2 cytochrome P450 family 1 subfamily A member 2 gene CHEBI:9055 scoparone increases expression EXP E RGD:6480464 20241001 CTD MESH:C018145 scoparone results in increased expression of CYP1A2 mRNA PMID:24176340 13860757 C7H6orf52 chromosome 7 C6orf52 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C7H6ORF52 mRNA PMID:35307453 13860810 CA8 carbonic anhydrase 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CA8 mRNA PMID:35307453 13860926 SLC2A2 solute carrier family 2 member 2 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in decreased expression of SLC2A2 mRNA PMID:33443779 13860940 CDC37 cell division cycle 37, HSP90 cochaperone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDC37 mRNA PMID:35307453 13861159 DIABLO diablo IAP-binding mitochondrial protein gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of DIABLO mRNA PMID:21645290 13861169 MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of MTRR mRNA PMID:34389318 13861283 RPP30 ribonuclease P/MRP subunit p30 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPP30 mRNA PMID:35307453 13861434 BPIFB3 BPI fold containing family B member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BPIFB3 mRNA PMID:35307453 13861452 ARHGEF16 Rho guanine nucleotide exchange factor 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF16 mRNA PMID:35307453 13861517 INHBE inhibin subunit beta E gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INHBE mRNA PMID:35307453 13861560 NOX4 NADPH oxidase 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NOX4 mRNA PMID:34933075 13861560 NOX4 NADPH oxidase 4 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of NOX4 mRNA PMID:39265697 13861603 PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PIP5K1A mRNA PMID:35307453 13861753 PRMT5 protein arginine methyltransferase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRMT5 mRNA PMID:35307453 13861787 MTHFD1L methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of MTHFD1L mRNA PMID:34389318 13861920 SLC40A1 solute carrier family 40 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC40A1 mRNA PMID:35307453 13861920 SLC40A1 solute carrier family 40 member 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SLC40A1 mRNA PMID:21852083 13861937 ABCD1 ATP binding cassette subfamily D member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCD1 mRNA PMID:35307453 13862084 CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHAC1 mRNA PMID:35307453 13862146 DEFB1 defensin beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of DEFB1 mRNA PMID:25701311 13862146 DEFB1 defensin beta 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of DEFB1 mRNA PMID:34933075 13862146 DEFB1 defensin beta 1 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of DEFB1 mRNA PMID:29421334 13862175 AKR1A1 aldo-keto reductase family 1 member A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKR1A1 mRNA PMID:35307453 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ICAM1 mRNA PMID:35307453 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20231003 CTD MESH:D005839 Gentamicins results in increased expression of ICAM1 mRNA PMID:28372472 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ICAM1 mRNA PMID:18988085 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of ICAM1 mRNA PMID:22533443 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:30187 aluminium oxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D000537 Aluminum Oxide results in increased expression of ICAM1 protein PMID:18456438 13862301 ICAM1 intercellular adhesion molecule 1 gene CHEBI:46680 serpentine asbestos increases expression EXP E RGD:6480464 20201006 CTD MESH:D017632 Asbestos, Serpentine results in increased expression of ICAM1 mRNA PMID:8685910 13862330 FLI1 Fli-1 proto-oncogene, ETS transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FLI1 mRNA PMID:35307453 13862359 NIFK nucleolar protein interacting with the FHA domain of MKI67 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NIFK mRNA PMID:35307453 13862455 CTXN1 cortexin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTXN1 mRNA PMID:35307453 13862455 CTXN1 cortexin 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CTXN1 mRNA PMID:39265697 13862598 RTP4 receptor transporter protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RTP4 mRNA PMID:35307453 13862616 RAB11FIP3 RAB11 family interacting protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB11FIP3 mRNA PMID:35307453 13862646 MYT1 myelin transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYT1 mRNA PMID:35307453 13862884 NCBP1 nuclear cap binding protein subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NCBP1 mRNA PMID:35307453 13863102 MRPL17 mitochondrial ribosomal protein L17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL17 mRNA PMID:35307453 13863116 NPAS1 neuronal PAS domain protein 1 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of NPAS1 mRNA PMID:35307453 13863158 GPRC5B G protein-coupled receptor class C group 5 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPRC5B mRNA PMID:35307453 13863313 SGSH N-sulfoglucosamine sulfohydrolase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SGSH mRNA PMID:35307453 13863439 POMGNT1 protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POMGNT1 mRNA PMID:35307453 13863478 DGKZ diacylglycerol kinase zeta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DGKZ mRNA PMID:35307453 13863602 DDX5 DEAD-box helicase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX5 mRNA PMID:35307453 13863670 EXO1 exonuclease 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXO1 mRNA PMID:35307453 13863864 RPLP1 ribosomal protein lateral stalk subunit P1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPLP1 mRNA PMID:39265697 13864007 TMEM209 transmembrane protein 209 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM209 mRNA PMID:35307453 13864051 WDR87 WD repeat domain 87 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR87 mRNA PMID:35307453 13864296 PLAC8 placenta associated 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLAC8 mRNA PMID:35307453 13864322 PEX11A peroxisomal biogenesis factor 11 alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PEX11A mRNA PMID:35307453 13864332 WASF1 WASP family member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WASF1 mRNA PMID:35307453 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FABP4 mRNA PMID:35307453 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] PMID:30481989 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA] PMID:21852083 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] PMID:30481989 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] PMID:30481989 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] PMID:30481989 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:75261 arotinoid acid decreases expression EXP E RGD:6480464 20191114 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of FABP4 mRNA PMID:15583048 13864371 FABP4 fatty acid binding protein 4 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] PMID:30481989 13864417 GPRIN1 G protein regulated inducer of neurite outgrowth 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPRIN1 mRNA PMID:35307453 13864470 SLC7A11 solute carrier family 7 member 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC7A11 mRNA PMID:35307453 13864470 SLC7A11 solute carrier family 7 member 11 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SLC7A11 mRNA] PMID:39151877 13864470 SLC7A11 solute carrier family 7 member 11 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SLC7A11 mRNA PMID:39151877 13864470 SLC7A11 solute carrier family 7 member 11 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SLC7A11 mRNA] PMID:39151877 13864515 ASH2L ASH2 like, histone lysine methyltransferase complex subunit gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Dietary Fats promotes the reaction [Resveratrol results in decreased expression of ASH2L mRNA] PMID:21852083 13864577 FFAR2 free fatty acid receptor 2 gene CHEBI:64243 monosodium L-glutamate affects expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate affects the expression of FFAR2 mRNA PMID:31360149 13864577 FFAR2 free fatty acid receptor 2 gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR2 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR2 mRNA] PMID:31360149 13864596 GPX6 glutathione peroxidase 6 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of GPX6 mRNA PMID:25455459 13864596 GPX6 glutathione peroxidase 6 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of GPX6 mRNA PMID:28069986 13864596 GPX6 glutathione peroxidase 6 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of GPX6 mRNA PMID:31535366 13864626 ZAR1L zygote arrest 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZAR1L mRNA PMID:35307453 13864764 VIM vimentin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of VIM mRNA PMID:25701311 13864764 VIM vimentin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VIM mRNA PMID:35307453 13864764 VIM vimentin gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of VIM mRNA PMID:39265697 13864764 VIM vimentin gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of and results in increased phosphorylation of VIM protein; [Melatonin co-treated with bisphenol A] results in decreased expression of VIM protein PMID:38848930 13864764 VIM vimentin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of and results in increased phosphorylation of VIM protein PMID:38848930 13864764 VIM vimentin gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of VIM protein PMID:38848930 13864764 VIM vimentin gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of and results in increased phosphorylation of VIM protein; [Melatonin co-treated with bisphenol A] results in decreased expression of VIM protein PMID:38848930 13864870 ABHD4 abhydrolase domain containing 4, N-acyl phospholipase B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABHD4 mRNA PMID:35307453 13864901 TPD52 tumor protein D52 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPD52 mRNA PMID:35307453 13865035 SMG1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMG1 mRNA PMID:35307453 13865222 IER5 immediate early response 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IER5 mRNA PMID:35307453 13865234 PBX1 PBX homeobox 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PBX1 mRNA PMID:35307453 13865310 SFR1 SWI5 dependent homologous recombination repair protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SFR1 mRNA; deoxynivalenol results in increased expression of SFR1 protein PMID:35307453|PMID:38403181 13865318 CXCL13 C-X-C motif chemokine ligand 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CXCL13 mRNA PMID:35307453 13865318 CXCL13 C-X-C motif chemokine ligand 13 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CXCL13 mRNA PMID:34933075 13865418 EPB41L1 erythrocyte membrane protein band 4.1 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPB41L1 mRNA PMID:35307453 13865626 GDI2 GDP dissociation inhibitor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GDI2 mRNA PMID:35307453 13865684 PNPT1 polyribonucleotide nucleotidyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PNPT1 mRNA PMID:35307453 13865724 OTULINL OTU deubiquitinase with linear linkage specificity like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OTULINL mRNA PMID:35307453 13865754 EPOR erythropoietin receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPOR mRNA PMID:35307453 13865940 KIFC1 kinesin family member C1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIFC1 mRNA PMID:35307453 13866169 PLPP1 phospholipid phosphatase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLPP1 mRNA PMID:35307453 13866267 ITGA5 integrin subunit alpha 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA5 mRNA; deoxynivalenol results in decreased expression of ITGA5 protein PMID:38403181 13866306 SEL1L3 SEL1L family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEL1L3 mRNA PMID:35307453 13866446 SCFD2 sec1 family domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCFD2 mRNA PMID:35307453 13866487 TXNDC17 thioredoxin domain containing 17 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TXNDC17 mRNA PMID:39265697 13866539 CCDC174 coiled-coil domain containing 174 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC174 mRNA PMID:35307453 13866554 CCNB3 cyclin B3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCNB3 mRNA PMID:35307453 13866712 HSPH1 heat shock protein family H (Hsp110) member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPH1 mRNA PMID:35307453 13866759 NAA35 N-alpha-acetyltransferase 35, NatC auxiliary subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAA35 mRNA PMID:35307453 13866895 CETN2 centrin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CETN2 mRNA PMID:35307453 13866926 ARNT aryl hydrocarbon receptor nuclear translocator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240430 CTD MESH:C007262 deoxynivalenol results in increased expression of ARNT mRNA PMID:35381244 13866926 ARNT aryl hydrocarbon receptor nuclear translocator gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C007262 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA] PMID:35381244 13866926 ARNT aryl hydrocarbon receptor nuclear translocator gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA] PMID:35381244 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FIS1 mRNA PMID:33592257 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of FIS1 mRNA PMID:39137830 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of FIS1 mRNA]; [Mycotoxins co-treated with 3,5-dicaffeoylquinic acid] results in decreased expression of FIS1 protein PMID:39137830 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:34905 paraquat affects expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat affects the expression of FIS1 protein PMID:34811946 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of FIS1 mRNA PMID:34811946 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]]; MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]; MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]] PMID:34811946 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FIS1 mRNA PMID:33592257 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]] PMID:34811946 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:47807 sulforaphane decreases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in decreased expression of FIS1 protein PMID:27993529 13867095 FIS1 fission, mitochondrial 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]] PMID:34811946 13867283 MAN2B1 mannosidase alpha class 2B member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAN2B1 mRNA PMID:35307453 13867386 KIF14 kinesin family member 14 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of KIF14 mRNA PMID:35307453 13867549 STARD6 StAR related lipid transfer domain containing 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of STARD6 mRNA PMID:39265697 13867843 SLC30A9 solute carrier family 30 member 9 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of SLC30A9 mRNA PMID:35839969 13867865 AURKA aurora kinase A gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of AURKA mRNA PMID:35839969 13867890 ARMC5 armadillo repeat containing 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARMC5 mRNA PMID:35307453 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol affects the expression of and affects the cleavage of PARP1 protein PMID:38104654 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:22977 cadmium atom increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased cleavage of PARP1 protein PMID:16785314 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 GLRX protein inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of PARP1 protein] PMID:16785314 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:27899 cisplatin increases activity EXP E RGD:6480464 20200211 CTD MESH:D002945 Cisplatin results in increased activity of PARP1 protein PMID:25806124 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20200211 CTD MESH:D002945 N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Cisplatin results in increased activity of PARP1 protein] PMID:25806124 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:30926 3-oxalomalic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C015407 oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of PARP1 protein] PMID:16785314 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of PARP1 protein PMID:34811946 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein]]; MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein] PMID:34811946 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:35456 cadmium dichloride increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased cleavage of PARP1 protein PMID:16785314 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 GLRX protein inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] PMID:16785314 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002738 Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein] PMID:30287338 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein]]; 3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein] PMID:30287338|PMID:34811946 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:7719 ochratoxin A increases cleavage EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased cleavage of PARP1 protein PMID:30287338 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in increased expression of PARP1 protein PMID:32454083 13868155 PARP1 poly(ADP-ribose) polymerase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein] PMID:30287338 13868222 ADAMTS17 ADAM metallopeptidase with thrombospondin type 1 motif 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTS17 mRNA PMID:35307453 13868380 SLC39A1 solute carrier family 39 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC39A1 mRNA PMID:35307453 13868408 HMCN2 hemicentin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HMCN2 mRNA PMID:35307453 13868750 ACP5 acid phosphatase 5, tartrate resistant gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACP5 mRNA PMID:35307453 13868771 ZNF507 zinc finger protein 507 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ZNF507 mRNA] PMID:21852083 13868829 SNX32 sorting nexin 32 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNX32 mRNA PMID:35307453 13868900 URAD ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of URAD mRNA PMID:35307453 13868978 CD99L2 CD99 molecule like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD99L2 mRNA PMID:35307453 13869005 PIF1 PIF1 5'-to-3' DNA helicase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PIF1 mRNA PMID:35307453 13869005 PIF1 PIF1 5'-to-3' DNA helicase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PIF1 mRNA] PMID:39151877 13869005 PIF1 PIF1 5'-to-3' DNA helicase gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of PIF1 mRNA PMID:39151877 13869005 PIF1 PIF1 5'-to-3' DNA helicase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PIF1 mRNA] PMID:39151877 13869115 TYRP1 tyrosinase related protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TYRP1 mRNA PMID:35307453 13869133 CREB5 cAMP responsive element binding protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CREB5 mRNA PMID:35307453 13869217 TMEM69 transmembrane protein 69 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM69 mRNA PMID:35307453 13869338 SPI1 Spi-1 proto-oncogene gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SPI1 mRNA PMID:39265697 13869374 CALU calumenin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CALU mRNA PMID:35307453 13869395 BMS1 BMS1 ribosome biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BMS1 mRNA PMID:35307453 13869453 ASAH2 N-acylsphingosine amidohydrolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASAH2 mRNA PMID:35307453 13869578 GPATCH2L G-patch domain containing 2 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPATCH2L mRNA PMID:35307453 13869738 PRKX protein kinase cAMP-dependent X-linked catalytic subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRKX mRNA PMID:35307453 13869753 ADGRF1 adhesion G protein-coupled receptor F1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRF1 mRNA PMID:35307453 13869816 DUSP12 dual specificity phosphatase 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP12 mRNA PMID:35307453 13869856 GPAT3 glycerol-3-phosphate acyltransferase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPAT3 mRNA PMID:35307453 13870155 TNFSF13B TNF superfamily member 13b gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFSF13B mRNA PMID:35307453 13870216 MRPL51 mitochondrial ribosomal protein L51 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL51 mRNA PMID:35307453 13870231 ANXA5 annexin A5 gene CHEBI:17351 linoleic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased activity of ANXA5 protein PMID:10617950 13870231 ANXA5 annexin A5 gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]; TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]] PMID:10617950 13870231 ANXA5 annexin A5 gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]] PMID:10617950 13870231 ANXA5 annexin A5 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of ANXA5 mRNA PMID:14994279 13870231 ANXA5 annexin A5 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]] PMID:10617950 13870334 PSMC5 proteasome 26S subunit, ATPase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMC5 mRNA PMID:35307453 13870378 CCNB1IP1 cyclin B1 interacting protein 1 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of CCNB1IP1 mRNA PMID:28069986 13870570 DGAT2 diacylglycerol O-acyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DGAT2 mRNA PMID:35307453 13870595 MISP mitotic spindle positioning gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MISP mRNA PMID:39265697 13870915 ANGEL1 angel homolog 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANGEL1 mRNA PMID:35307453 13871011 NR0B1 nuclear receptor subfamily 0 group B member 1 gene CHEBI:177470 Cloprostenol increases expression EXP E RGD:6480464 20210907 CTD MESH:D003008 Cloprostenol results in increased expression of NR0B1 mRNA PMID:15713365 13871094 RPS15A ribosomal protein S15a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS15A mRNA PMID:39265697 13871173 VTN vitronectin gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of VTN mRNA PMID:34389318 13871185 ARHGAP44 Rho GTPase activating protein 44 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGAP44 mRNA PMID:35307453 13871214 ERC1 ELKS/RAB6-interacting/CAST family member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ERC1 mRNA PMID:35307453 13871421 IL17C interleukin 17C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL17C mRNA PMID:35307453 13871550 CTNNA3 catenin alpha 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTNNA3 mRNA PMID:35307453 13871550 CTNNA3 catenin alpha 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of CTNNA3 mRNA PMID:18988085 13871614 GPR179 G protein-coupled receptor 179 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR179 mRNA PMID:35307453 13871645 POLQ DNA polymerase theta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POLQ mRNA PMID:35307453 13871732 POLR1G RNA polymerase I subunit G gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR1G mRNA PMID:35307453 13871792 H2BC11 H2B clustered histone 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of H2BC11 mRNA PMID:35307453 13871850 GSDMD gasdermin D gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein] PMID:36309173 13871850 GSDMD gasdermin D gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein] PMID:36281498 13871850 GSDMD gasdermin D gene CHEBI:188567 Belnacasan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C520022 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein] PMID:36309173 13871850 GSDMD gasdermin D gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein] PMID:36281498 13871850 GSDMD gasdermin D gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C056933 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein] PMID:36309173 13871850 GSDMD gasdermin D gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of GSDMD protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of GSDMD protein] PMID:39305878 13871850 GSDMD gasdermin D gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of GSDMD protein PMID:36281498 13871850 GSDMD gasdermin D gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein]; Taurine inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein] PMID:36281498 13871850 GSDMD gasdermin D gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of GSDMD protein PMID:39305878 13871850 GSDMD gasdermin D gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of GSDMD protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of GSDMD protein] PMID:39305878 13872031 LY6G6C lymphocyte antigen 6 family member G6C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LY6G6C mRNA PMID:35307453 13872031 LY6G6C lymphocyte antigen 6 family member G6C gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of LY6G6C mRNA PMID:39265697 13872038 SAA3 serum amyloid A-3 protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SAA3 mRNA PMID:39265697 13872060 MMP15 matrix metallopeptidase 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP15 mRNA PMID:35307453 13872130 TMEM116 transmembrane protein 116 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM116 mRNA PMID:35307453 13872202 TRIM13 tripartite motif containing 13 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TRIM13 mRNA] PMID:21852083 13872228 TRADD TNFRSF1A associated via death domain gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of TRADD mRNA PMID:32198028 13872249 PDX1 pancreatic and duodenal homeobox 1 gene CHEBI:9168 sirolimus decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus results in decreased expression of PDX1 mRNA PMID:20622751 13872256 DBNDD1 dysbindin domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DBNDD1 mRNA PMID:35307453 13872279 CAMKK2 calcium/calmodulin dependent protein kinase kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAMKK2 mRNA PMID:35307453 13872426 MNX1 motor neuron and pancreas homeobox 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MNX1 mRNA PMID:35307453 13872433 INTS13 integrator complex subunit 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INTS13 mRNA PMID:35307453 13872518 ALOX5AP arachidonate 5-lipoxygenase activating protein gene CHEBI:2825 aristolochic acid A increases expression EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in increased expression of ALOX5AP protein PMID:21658425 13872518 ALOX5AP arachidonate 5-lipoxygenase activating protein gene CHEBI:2825 aristolochic acid A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C000228 MK-886 inhibits the reaction [aristolochic acid I results in increased expression of ALOX5AP protein]; U 0126 inhibits the reaction [aristolochic acid I results in increased expression of ALOX5AP protein] PMID:21658425 13872518 ALOX5AP arachidonate 5-lipoxygenase activating protein gene CHEBI:75390 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060893 MK-886 inhibits the reaction [aristolochic acid I results in increased expression of ALOX5AP protein] PMID:21658425 13872538 LARS1 leucyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LARS1 mRNA PMID:35307453 13872621 CXXC5 CXXC finger protein 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CXXC5 mRNA; deoxynivalenol results in decreased expression of CXXC5 protein PMID:38403181 13872661 KIF5B kinesin family member 5B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIF5B mRNA PMID:35307453 13872721 MSN moesin gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MSN mRNA PMID:39265697 13873117 FAM151A family with sequence similarity 151 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM151A mRNA PMID:35307453 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACACA mRNA PMID:35307453 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:16469 17beta-estradiol increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased phosphorylation of ACACA protein PMID:15967841 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of ACACA mRNA PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA] PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of ACACA mRNA PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA] PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of ACACA mRNA PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA] PMID:25827716 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of ACACA mRNA PMID:31360149 13873255 ACACA acetyl-CoA carboxylase alpha gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of ACACA mRNA] PMID:31360149 13873510 CDHR2 cadherin related family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDHR2 mRNA PMID:35307453 13873652 ETFRF1 electron transfer flavoprotein regulatory factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ETFRF1 mRNA PMID:35307453 13873718 ARHGEF28 Rho guanine nucleotide exchange factor 28 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF28 mRNA PMID:35307453 13873807 CCKBR cholecystokinin B receptor gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CCKBR mRNA PMID:34933075 13873831 TTC36 tetratricopeptide repeat domain 36 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC36 mRNA PMID:35307453 13873846 SLC39A8 solute carrier family 39 member 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC39A8 mRNA PMID:35307453 13873942 RIPOR2 RHO family interacting cell polarization regulator 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIPOR2 mRNA PMID:35307453 13873942 RIPOR2 RHO family interacting cell polarization regulator 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RIPOR2 mRNA PMID:21852083 13874180 UBA7 ubiquitin like modifier activating enzyme 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBA7 mRNA PMID:35307453 13874250 BPIFB2 BPI fold containing family B member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BPIFB2 mRNA PMID:35307453 13874296 ENPP5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENPP5 mRNA PMID:35307453 13874309 CAV2 caveolin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CAV2 mRNA PMID:35307453 13874413 MRPS35 mitochondrial ribosomal protein S35 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS35 mRNA PMID:35307453 13874478 MTPAP mitochondrial poly(A) polymerase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTPAP mRNA PMID:35307453 13874602 RPRML reprimo like gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RPRML mRNA PMID:34933075 13874607 SGCA sarcoglycan alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SGCA mRNA PMID:35307453 13874704 DHFR dihydrofolate reductase gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of DHFR mRNA PMID:22497863 13874726 LHB luteinizing hormone subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LHB mRNA PMID:35307453 13874726 LHB luteinizing hormone subunit beta gene CHEBI:16422 androst-4-ene-3,17-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000735 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; [LHB protein co-treated with INS protein] results in increased abundance of Androstenedione; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione] PMID:11889176 13874726 LHB luteinizing hormone subunit beta gene CHEBI:16469 17beta-estradiol increases secretion EXP E RGD:6480464 20191114 CTD MESH:D004958 LHB protein results in increased secretion of Estradiol PMID:26055946 13874726 LHB luteinizing hormone subunit beta gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Biological Products inhibits the reaction [LHB protein results in increased secretion of Estradiol]; Cod Liver Oil inhibits the reaction [LHB protein results in increased secretion of Estradiol]; Industrial Waste inhibits the reaction [LHB protein results in increased secretion of Estradiol] PMID:26055946 13874726 LHB luteinizing hormone subunit beta gene CHEBI:17026 progesterone increases abundance EXP E RGD:6480464 20191114 CTD MESH:D011374 LHB protein results in increased abundance of Progesterone PMID:19617652|PMID:23375200 13874726 LHB luteinizing hormone subunit beta gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 daidzein inhibits the reaction [LHB protein results in increased abundance of Progesterone]; Lapatinib inhibits the reaction [LHB protein results in increased abundance of Progesterone] PMID:19617652|PMID:23375200 13874726 LHB luteinizing hormone subunit beta gene CHEBI:17347 testosterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D013739 LHB protein results in increased secretion of Testosterone PMID:26055946 13874726 LHB luteinizing hormone subunit beta gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013739 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; [LHB protein co-treated with INS protein] results in increased abundance of Testosterone; Biological Products inhibits the reaction [LHB protein results in increased secretion of Testosterone]; Cod Liver Oil inhibits the reaction [LHB protein results in increased secretion of Testosterone]; Industrial Waste inhibits the reaction [LHB protein results in increased secretion of Testosterone]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone] PMID:11889176|PMID:26055946 13874726 LHB luteinizing hormone subunit beta gene CHEBI:27485 prostaglandin J2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C037112 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA] PMID:11889176 13874726 LHB luteinizing hormone subunit beta gene CHEBI:27638 cobalt atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003035 [Cobalt binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:15833593 13874726 LHB luteinizing hormone subunit beta gene CHEBI:28112 nickel atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009532 [Nickel binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13874726 LHB luteinizing hormone subunit beta gene CHEBI:28197 daidzein multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C004742 daidzein inhibits the reaction [LHB protein results in increased abundance of Progesterone] PMID:19617652 13874726 LHB luteinizing hormone subunit beta gene CHEBI:28694 copper atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 [Copper binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13874726 LHB luteinizing hormone subunit beta gene CHEBI:30052 copper(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 [Copper binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13874726 LHB luteinizing hormone subunit beta gene CHEBI:49603 lapatinib decreases activity EXP E RGD:6480464 20191114 CTD MESH:C490728 Lapatinib results in decreased activity of LHB protein PMID:23375200 13874726 LHB luteinizing hormone subunit beta gene CHEBI:49603 lapatinib multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C490728 Lapatinib inhibits the reaction [LHB protein results in increased abundance of Progesterone] PMID:23375200 13874726 LHB luteinizing hormone subunit beta gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 protein modified form] PMID:11889176 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of ADIPOR1 protein PMID:28284726 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:17347 testosterone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013739 Testosterone results in decreased expression of ADIPOR1 protein PMID:28284726 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADIPOR1 protein PMID:28284726 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of ADIPOR1 protein PMID:28284726 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:5692 hexachlorobenzene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene results in decreased expression of ADIPOR1 protein PMID:28284726 13874758 ADIPOR1 adiponectin receptor 1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADIPOR1 protein PMID:28284726 13874801 TRPM2 transient receptor potential cation channel subfamily M member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRPM2 mRNA PMID:35307453 13874932 MXRA7 matrix remodeling associated 7 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of MXRA7 mRNA PMID:34933075 13874966 CAP2 cyclase associated actin cytoskeleton regulatory protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAP2 mRNA PMID:35307453 13875307 PFN1 profilin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFN1 mRNA PMID:35307453 13875358 ITGB2 integrin subunit beta 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGB2 mRNA PMID:35307453 13875358 ITGB2 integrin subunit beta 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ITGB2 mRNA PMID:18988085 13875358 ITGB2 integrin subunit beta 2 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of ITGB2 mRNA PMID:21391292 13875358 ITGB2 integrin subunit beta 2 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of ITGB2 mRNA PMID:22497863 13875629 ATR ATR serine/threonine kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATR mRNA PMID:35307453 13875629 ATR ATR serine/threonine kinase gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of ATR mRNA PMID:37706587 13875629 ATR ATR serine/threonine kinase gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATR mRNA] PMID:37706587 13875629 ATR ATR serine/threonine kinase gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATR mRNA] PMID:37706587 13875718 LOC102159820 cadherin EGF LAG seven-pass G-type receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CELSR1 mRNA PMID:35307453 13875814 CDKN2C cyclin dependent kinase inhibitor 2C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDKN2C mRNA PMID:35307453 13875882 CAV1 caveolin 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein; CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein] PMID:19608276|PMID:20406653 13875882 CAV1 caveolin 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein] PMID:19608276 13875882 CAV1 caveolin 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]; CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]; CAV1 mutant form promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 mRNA] PMID:19265715|PMID:20406653|PMID:24709675 13875882 CAV1 caveolin 1 gene CHEBI:8772 raloxifene increases expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in increased expression of CAV1 protein PMID:16680078 13875973 FAM72A family with sequence similarity 72 member A gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of FAM72A mRNA PMID:21852083 13876116 CCR2 C-C motif chemokine receptor 2 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCR2 mRNA PMID:21505051 13876116 CCR2 C-C motif chemokine receptor 2 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 epostane promotes the reaction [Dinoprost results in increased expression of CCR2 mRNA] PMID:21505051 13876116 CCR2 C-C motif chemokine receptor 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CCR2 mRNA PMID:34389318 13876116 CCR2 C-C motif chemokine receptor 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CCR2 mRNA PMID:21852083 13876254 CCDC60 coiled-coil domain containing 60 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC60 mRNA PMID:35307453 13876272 NFE2L3 NFE2 like bZIP transcription factor 3 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of NFE2L3 mRNA PMID:35307453 13876283 SLC38A3 solute carrier family 38 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC38A3 mRNA PMID:35307453 13876424 MGAT5 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MGAT5 mRNA PMID:35307453 13876473 PLA1A phospholipase A1 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLA1A mRNA PMID:35307453 13876491 LEFTY2 left-right determination factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LEFTY2 mRNA PMID:35307453 13876497 KRR1 KRR1 small subunit processome component homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KRR1 mRNA PMID:35307453 13876531 JUNB JunB proto-oncogene, AP-1 transcription factor subunit gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of JUNB mRNA PMID:39265697 13876531 JUNB JunB proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of JUNB mRNA PMID:37706587 13876531 JUNB JunB proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUNB mRNA] PMID:37706587 13876531 JUNB JunB proto-oncogene, AP-1 transcription factor subunit gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUNB mRNA] PMID:37706587 13876647 ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin inhibits the reaction [ABCB1 protein results in increased susceptibility to NSC73306] PMID:24800945 13876647 ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 gene CHEBI:3000 beauvericin decreases activity EXP E RGD:6480464 20191114 CTD MESH:C004456 beauvericin results in decreased activity of ABCB1 protein PMID:27474255 13876647 ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 gene CHEBI:3000 beauvericin increases expression EXP E RGD:6480464 20191114 CTD MESH:C004456 beauvericin results in increased expression of ABCB1 mRNA PMID:27474255 13876647 ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20191114 CTD MESH:C014558 flunixin meglumine affects the expression of ABCB1 mRNA PMID:26366864 13876647 ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20191114 CTD MESH:D005273 Fenbendazole affects the expression of ABCB1 mRNA PMID:26366864 13876703 IGFBP7 insulin like growth factor binding protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFBP7 mRNA; deoxynivalenol results in decreased expression of IGFBP7 protein PMID:35307453|PMID:38403181 13876712 BAG2 BAG cochaperone 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BAG2 mRNA PMID:35307453 13876750 RAB20 RAB20, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB20 mRNA PMID:35307453 13876750 RAB20 RAB20, member RAS oncogene family gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RAB20 mRNA PMID:39265697 13876756 FIGN fidgetin, microtubule severing factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FIGN mRNA PMID:35307453 13876767 CSAD cysteine sulfinic acid decarboxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSAD mRNA PMID:35307453 13876812 POLR1F RNA polymerase I subunit F gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR1F mRNA PMID:35307453 13876847 FASTKD5 FAST kinase domains 5 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of FASTKD5 mRNA] PMID:39151877 13876847 FASTKD5 FAST kinase domains 5 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of FASTKD5 mRNA PMID:39151877 13876847 FASTKD5 FAST kinase domains 5 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of FASTKD5 mRNA] PMID:39151877 13876947 ECHDC2 enoyl-CoA hydratase domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ECHDC2 mRNA PMID:35307453 13877087 RAPGEF5 Rap guanine nucleotide exchange factor 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAPGEF5 mRNA PMID:35307453 13877290 ODAPH odontogenesis associated phosphoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ODAPH mRNA PMID:35307453 13877290 ODAPH odontogenesis associated phosphoprotein gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ODAPH mRNA PMID:39265697 13877343 POGLUT2 protein O-glucosyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POGLUT2 mRNA PMID:35307453 13877475 NUCKS1 nuclear casein kinase and cyclin dependent kinase substrate 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUCKS1 mRNA PMID:35307453 13877651 DNAH3 dynein axonemal heavy chain 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH3 mRNA PMID:35307453 13877717 SIRT6 sirtuin 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SIRT6 mRNA PMID:35307453 13877839 ITFG1 integrin alpha FG-GAP repeat containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITFG1 mRNA PMID:35307453 13878136 TCEAL2 transcription elongation factor A like 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of TCEAL2 mRNA PMID:34389318 13878266 HNRNPLL heterogeneous nuclear ribonucleoprotein L like gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HNRNPLL mRNA] PMID:21852083 13878341 DDX18 DEAD-box helicase 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX18 mRNA PMID:35307453 13878399 EHHADH enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EHHADH mRNA PMID:35307453 13878411 NOP58 NOP58 ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOP58 mRNA PMID:35307453 13878472 TMEM92 transmembrane protein 92 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM92 mRNA PMID:35307453 13878540 HOXB5 homeobox B5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB5 mRNA PMID:35307453 13878573 ITGB1 integrin subunit beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGB1 protein PMID:38403181 13878573 ITGB1 integrin subunit beta 1 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of ITGB1 mRNA PMID:32423882 13878573 ITGB1 integrin subunit beta 1 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of ITGB1 mRNA PMID:32423882 13878778 MAMDC2 MAM domain containing 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of MAMDC2 mRNA PMID:21852083 13878797 CC2D2A coiled-coil and C2 domain containing 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CC2D2A mRNA PMID:35307453 13878953 MBOAT2 membrane bound O-acyltransferase domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MBOAT2 mRNA PMID:35307453 13878984 AMBRA1 autophagy and beclin 1 regulator 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of AMBRA1 mRNA PMID:35839969 13879055 POP1 POP1 homolog, ribonuclease P/MRP subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POP1 mRNA PMID:35307453 13879180 FAM120C family with sequence similarity 120 member C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM120C mRNA PMID:35307453 13879209 TNFSF11 TNF superfamily member 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNFSF11 mRNA PMID:35307453 13879275 SAFB2 scaffold attachment factor B2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SAFB2 mRNA PMID:35307453 13879342 MMP8 matrix metallopeptidase 8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of MMP8 mRNA PMID:34933075 13879478 KIAA1328 KIAA1328 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIAA1328 mRNA PMID:35307453 13879567 SASH3 SAM and SH3 domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SASH3 mRNA PMID:35307453 13879579 VAT1L vesicle amine transport 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VAT1L mRNA PMID:35307453 13879681 VTA1 vesicle trafficking 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VTA1 mRNA PMID:35307453 13879696 ATL2 atlastin GTPase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATL2 mRNA PMID:35307453 13879752 PPP1R15A protein phosphatase 1 regulatory subunit 15A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R15A mRNA PMID:35307453 13879767 THY1 Thy-1 cell surface antigen gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THY1 mRNA PMID:35307453 13879864 METTL21A methyltransferase 21A, HSPA lysine gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL21A mRNA PMID:35307453 13879893 TIMP4 TIMP metallopeptidase inhibitor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TIMP4 mRNA PMID:35307453 13879932 RSPH1 radial spoke head component 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RSPH1 mRNA PMID:35307453 13879997 ANAPC15 anaphase promoting complex subunit 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANAPC15 mRNA PMID:35307453 13880069 CFLAR CASP8 and FADD like apoptosis regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CFLAR mRNA PMID:35307453 13880069 CFLAR CASP8 and FADD like apoptosis regulator gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of CFLAR mRNA PMID:21645290 13880215 DENND11 DENN domain containing 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DENND11 mRNA PMID:35307453 13880264 HDGF heparin binding growth factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HDGF mRNA PMID:35307453 13880328 MIR331 microRNA mir-331 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20201006 CTD MESH:D015025 Zearalenone results in increased expression of MIR331 mRNA PMID:32439583 13880386 SARNP SAP domain containing ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SARNP mRNA PMID:35307453 13880401 MYH13 myosin heavy chain 13 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of MYH13 mRNA PMID:34933075 13880441 NUDT17 nudix hydrolase 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUDT17 mRNA PMID:35307453 13880462 RENBP renin binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RENBP mRNA PMID:35307453 13880501 PDIA2 protein disulfide isomerase family A member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDIA2 mRNA PMID:35307453 13880588 FAM89A family with sequence similarity 89 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM89A mRNA PMID:35307453 13880595 RRP15 ribosomal RNA processing 15 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRP15 mRNA PMID:35307453 13880637 ANKRD2 ankyrin repeat domain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKRD2 mRNA PMID:35307453 13880904 FTSJ1 FtsJ RNA 2'-O-methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FTSJ1 mRNA PMID:35307453 13880940 FUT11 fucosyltransferase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POFUT4 mRNA PMID:35307453 13881029 HDGFL3 HDGF like 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of HDGFL3 mRNA; deoxynivalenol results in increased expression of HDGFL3 protein PMID:38403181 13881131 TTC9C tetratricopeptide repeat domain 9C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTC9C mRNA PMID:35307453 13881388 SON SON DNA and RNA binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SON mRNA PMID:35307453 13881444 CFAP410 cilia and flagella associated protein 410 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP410 mRNA PMID:35307453 13881499 KIRREL3 kirre like nephrin family adhesion molecule 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIRREL3 mRNA PMID:35307453 13881562 MRPL15 mitochondrial ribosomal protein L15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL15 mRNA PMID:35307453 13881578 PPP1R13L protein phosphatase 1 regulatory subunit 13 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R13L mRNA PMID:35307453 13881653 SCP2 sterol carrier protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCP2 mRNA PMID:35307453 13881676 IFT74 intraflagellar transport 74 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IFT74 mRNA PMID:35307453 13881774 PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of PRKAA2 protein PMID:35307453 13881774 PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAA2 mRNA PMID:34416349 13881774 PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAA2 mRNA PMID:34416349 13881795 PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAFAH1B1 mRNA PMID:35307453 13881907 CYP2C42 cytochrome P450 C42 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP2C42 mRNA PMID:35307453 13881919 C5 complement C5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C5 mRNA PMID:35307453 13881919 C5 complement C5 gene CHEBI:8093 phenylephrine affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D010656 C5 protein affects the susceptibility to Phenylephrine PMID:10750764 13882026 PAQR8 progestin and adipoQ receptor family member 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAQR8 mRNA PMID:35307453 13882130 ZBBX zinc finger B-box domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBBX mRNA PMID:35307453 13882246 IL12A interleukin 12A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IL12A mRNA PMID:35307453 13882246 IL12A interleukin 12A gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of IL12A mRNA PMID:39265697 13882246 IL12A interleukin 12A gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL12A mRNA PMID:15998543 13882246 IL12A interleukin 12A gene CHEBI:28640 lipoteichoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C009900 lipoteichoic acid results in increased expression of IL12A mRNA PMID:15998543 13882274 UQCC2 ubiquinol-cytochrome c reductase complex assembly factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230606 CTD MESH:C007262 deoxynivalenol results in increased expression of UQCC2 mRNA PMID:35307453 13882282 DAPK2 death associated protein kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DAPK2 mRNA PMID:35307453 13882356 BTN2A2 butyrophilin subfamily 2 member A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BTN2A2 mRNA PMID:35307453 13882411 SLC25A10 solute carrier family 25 member 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A10 mRNA PMID:35307453 13882461 ARSG arylsulfatase G gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARSG mRNA PMID:35307453 13882461 ARSG arylsulfatase G gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of ARSG mRNA PMID:21852083 13882842 LETM1 leucine zipper and EF-hand containing transmembrane protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LETM1 mRNA PMID:35307453 13882958 EPRS1 glutamyl-prolyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EPRS1 mRNA PMID:35307453 13883032 CALD1 caldesmon 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALD1 mRNA; deoxynivalenol results in decreased expression of CALD1 protein PMID:38403181 13883032 CALD1 caldesmon 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CALD1 mRNA PMID:21852083 13883032 CALD1 caldesmon 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of CALD1 mRNA PMID:35839969 13883106 ATP5F1A ATP synthase F1 subunit alpha gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of ATP5F1A mRNA PMID:38432436 13883167 RPL39 ribosomal protein L39 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL39 mRNA PMID:39265697 13883184 BCL10 BCL10 immune signaling adaptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BCL10 mRNA PMID:35307453 13883407 VWDE von Willebrand factor D and EGF domains gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VWDE mRNA PMID:35307453 13883449 PDGFC platelet derived growth factor C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDGFC mRNA PMID:35307453 13883463 PLEKHG4B pleckstrin homology and RhoGEF domain containing G4B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHG4B mRNA PMID:35307453 13883498 SMURF1 SMAD specific E3 ubiquitin protein ligase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMURF1 mRNA PMID:35307453 13883558 CCDC107 coiled-coil domain containing 107 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC107 mRNA PMID:35307453 13883570 MACF1 microtubule actin crosslinking factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MACF1 mRNA PMID:35307453 13883674 UBA6 ubiquitin like modifier activating enzyme 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBA6 mRNA PMID:35307453 13883754 HS3ST2 heparan sulfate-glucosamine 3-sulfotransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HS3ST2 mRNA PMID:35307453 13883822 MAPT microtubule associated protein tau gene CHEBI:28984 aluminium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000535 [Aluminum binds to YWHAZ protein] inhibits the reaction [YWHAZ protein binds to MAPT protein]; Aluminum affects the expression of and affects the phosphorylation of and affects the localization of MAPT protein; Aluminum inhibits the reaction [MAPT protein binds to YWHAZ protein] PMID:29385627 13883822 MAPT microtubule associated protein tau gene CHEBI:33629 aluminium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000535 [Aluminum binds to YWHAZ protein] inhibits the reaction [YWHAZ protein binds to MAPT protein]; Aluminum affects the expression of and affects the phosphorylation of and affects the localization of MAPT protein; Aluminum inhibits the reaction [MAPT protein binds to YWHAZ protein] PMID:29385627 13883886 CASR calcium sensing receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CASR mRNA PMID:35307453 13884038 ATF4 activating transcription factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATF4 mRNA; deoxynivalenol results in increased expression of ATF4 protein PMID:35307453|PMID:37442268|PMID:38608924 13884038 ATF4 activating transcription factor 4 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 GSK2656157 inhibits the reaction [deoxynivalenol results in increased expression of ATF4 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ATF4 protein] PMID:37442268 13884038 ATF4 activating transcription factor 4 gene CHEBI:139047 GSK2656157 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C000597302 GSK2656157 inhibits the reaction [deoxynivalenol results in increased expression of ATF4 protein] PMID:37442268 13884038 ATF4 activating transcription factor 4 gene CHEBI:16170 mercury(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury results in increased expression of ATF4 protein PMID:16759985 13884038 ATF4 activating transcription factor 4 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 protein] PMID:36584959 13884038 ATF4 activating transcription factor 4 gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20210504 CTD MESH:C039060 artenimol results in increased expression of ATF4 mRNA; artenimol results in increased expression of ATF4 protein PMID:32721431 13884038 ATF4 activating transcription factor 4 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased expression of ATF4 mRNA; Cadmium results in increased expression of ATF4 protein PMID:16759985|PMID:37207789 13884038 ATF4 activating transcription factor 4 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 protein; Cycloheximide inhibits the reaction [Cadmium results in increased expression of ATF4 protein]; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of ATF4 mRNA] PMID:16759985|PMID:33891997|PMID:37207789 13884038 ATF4 activating transcription factor 4 gene CHEBI:25195 mercury atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury results in increased expression of ATF4 protein PMID:16759985 13884038 ATF4 activating transcription factor 4 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ATF4 protein] PMID:37442268 13884038 ATF4 activating transcription factor 4 gene CHEBI:27641 cycloheximide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of ATF4 protein]; Cycloheximide inhibits the reaction [Cadmium results in increased expression of ATF4 protein] PMID:16759985 13884038 ATF4 activating transcription factor 4 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of ATF4 mRNA; Glyphosate results in increased expression of ATF4 protein PMID:36584959 13884038 ATF4 activating transcription factor 4 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 protein] PMID:36584959 13884038 ATF4 activating transcription factor 4 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ATF4 protein PMID:36754226 13884038 ATF4 activating transcription factor 4 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of ATF4 protein] PMID:36754226 13884038 ATF4 activating transcription factor 4 gene CHEBI:31823 mercury dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased expression of ATF4 protein PMID:16759985 13884038 ATF4 activating transcription factor 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ATF4 mRNA; bisphenol A results in increased expression of ATF4 protein PMID:37108405|PMID:38845341 13884038 ATF4 activating transcription factor 4 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ATF4 protein]; ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of ATF4 mRNA] PMID:37108405|PMID:38845341 13884038 ATF4 activating transcription factor 4 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of ATF4; Cadmium Chloride results in increased expression of ATF4 mRNA; Cadmium Chloride results in increased expression of ATF4 protein PMID:16759985|PMID:20600546 13884038 ATF4 activating transcription factor 4 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 protein; Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of ATF4 protein] PMID:16759985|PMID:33891997 13884038 ATF4 activating transcription factor 4 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ATF4 protein] PMID:37442268 13884038 ATF4 activating transcription factor 4 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of ATF4 protein] PMID:36754226 13884038 ATF4 activating transcription factor 4 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ATF4 protein] PMID:37108405 13884038 ATF4 activating transcription factor 4 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of ATF4 mRNA]; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of ATF4 mRNA] PMID:37207789|PMID:38845341 13884038 ATF4 activating transcription factor 4 gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in increased expression of ATF4 protein PMID:34637808 13884051 DDX28 DEAD-box helicase 28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX28 mRNA PMID:35307453 13884057 PRR13 proline rich 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRR13 mRNA PMID:35307453 13884127 POLR1A RNA polymerase I subunit A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR1A mRNA PMID:35307453 13884179 KIAA1217 KIAA1217 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of KIAA1217 mRNA PMID:28069986 13884423 ACTN1 actinin alpha 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACTN1 mRNA PMID:35307453 13884463 POLR2M RNA polymerase II subunit M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR2M mRNA PMID:35307453 13884589 CA12 carbonic anhydrase 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CA12 mRNA PMID:35307453 13884589 CA12 carbonic anhydrase 12 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CA12 mRNA PMID:34389318 13884636 C2H11orf58 chromosome 2 C11orf58 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C2H11ORF58 mRNA PMID:35307453 13884645 GALNT5 polypeptide N-acetylgalactosaminyltransferase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT5 mRNA PMID:35307453 13884715 CCT4 chaperonin containing TCP1 subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT4 mRNA PMID:35307453 13884738 ACTG2 actin gamma 2, smooth muscle gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACTG2 mRNA; deoxynivalenol results in decreased expression of ACTG2 protein PMID:38403181 13884761 FCSK fucose kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FCSK mRNA PMID:35307453 13884830 UBE2M ubiquitin conjugating enzyme E2 M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBE2M mRNA PMID:35307453 13885110 HIRA histone cell cycle regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HIRA mRNA PMID:35307453 13885160 LRRC9 leucine rich repeat containing 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC9 mRNA PMID:35307453 13885278 CASP9 caspase 9 gene CHEBI:10022 deoxynivalenol increases cleavage EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased cleavage of CASP9 protein PMID:38104654 13885278 CASP9 caspase 9 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C007262 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CASP9 protein PMID:38763499 13885278 CASP9 caspase 9 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 protein] PMID:35665993 13885278 CASP9 caspase 9 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of CASP9 mRNA] PMID:36584959 13885278 CASP9 caspase 9 gene CHEBI:22977 cadmium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased activity of CASP9 protein PMID:19135140 13885278 CASP9 caspase 9 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP9 mRNA; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein]; Selenium inhibits the reaction [Cadmium results in increased activity of CASP9 protein] PMID:19135140|PMID:33493553|PMID:33891997 13885278 CASP9 caspase 9 gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CASP9 protein PMID:38763499 13885278 CASP9 caspase 9 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in increased activity of CASP9 protein] PMID:19135140 13885278 CASP9 caspase 9 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of CASP9 mRNA PMID:36584959 13885278 CASP9 caspase 9 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of CASP9 mRNA] PMID:36584959 13885278 CASP9 caspase 9 gene CHEBI:27899 cisplatin increases activity EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased activity of CASP9 protein PMID:20435919 13885278 CASP9 caspase 9 gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of CASP9 PMID:12712633 13885278 CASP9 caspase 9 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein] PMID:19135140|PMID:33905761 13885278 CASP9 caspase 9 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of CASP9 mRNA PMID:37108405 13885278 CASP9 caspase 9 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP9 mRNA] PMID:37108405 13885278 CASP9 caspase 9 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of CASP9 mRNA; tetrabromobisphenol A results in increased expression of CASP9 protein PMID:35665993 13885278 CASP9 caspase 9 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 protein] PMID:35665993 13885278 CASP9 caspase 9 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of CASP9 protein PMID:26607349 13885278 CASP9 caspase 9 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP9 mRNA; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] PMID:26607349|PMID:33493553|PMID:33891997 13885278 CASP9 caspase 9 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in increased activity of CASP9 protein] PMID:19135140 13885278 CASP9 caspase 9 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20211012 CTD MESH:C056933 fumonisin B1 results in increased expression of CASP9 mRNA; fumonisin B1 results in increased expression of CASP9 protein; fumonisin B1 results in increased expression of CASP9 protein modified form PMID:33905761|PMID:36397609 13885278 CASP9 caspase 9 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein] PMID:33905761|PMID:36397609 13885278 CASP9 caspase 9 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP9 mRNA]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP9 protein] PMID:26607349|PMID:37108405 13885278 CASP9 caspase 9 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20211012 CTD MESH:C025589 ochratoxin A results in increased expression of CASP9 mRNA; ochratoxin A results in increased expression of CASP9 protein; ochratoxin A results in increased expression of CASP9 protein modified form PMID:33905761|PMID:36397609 13885278 CASP9 caspase 9 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein] PMID:33905761|PMID:36397609 13885278 CASP9 caspase 9 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein] PMID:33905761 13885378 SHROOM1 shroom family member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SHROOM1 mRNA PMID:35307453 13885403 IGFBP5 insulin like growth factor binding protein 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFBP5 mRNA PMID:35307453 13885403 IGFBP5 insulin like growth factor binding protein 5 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IGFBP5 mRNA PMID:34933075 13885403 IGFBP5 insulin like growth factor binding protein 5 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of IGFBP5 mRNA PMID:18988085 13885403 IGFBP5 insulin like growth factor binding protein 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of IGFBP5 mRNA PMID:21852083 13885490 NPG4 protegrin 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CAMP mRNA] PMID:21852083 13885511 ABHD8 abhydrolase domain containing 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABHD8 mRNA PMID:35307453 13885545 MROH1 maestro heat like repeat family member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MROH1 mRNA PMID:35307453 13885616 SLC6A20 solute carrier family 6 member 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC6A20 mRNA PMID:35307453 13885640 RPL37A ribosomal protein L37a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL37A mRNA PMID:39265697 13885714 ARF2 ADP-ribosylation factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARF2 mRNA PMID:35307453 13885744 LOC110255234 liver carboxylesterase-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CES1 mRNA PMID:35307453 13885744 LOC110255234 liver carboxylesterase-like gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CES1 mRNA PMID:34933075 13885744 LOC110255234 liver carboxylesterase-like gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200901 CTD MESH:D012970 Sodium Glutamate inhibits the reaction [Dietary Fats results in decreased expression of CES1 mRNA] PMID:31360149 13885754 PET100 PET100 cytochrome c oxidase chaperone gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PET100 mRNA PMID:39265697 13885853 SP6 Sp6 transcription factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SP6 mRNA PMID:35307453 13885891 SCML2 Scm polycomb group protein like 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SCML2 mRNA PMID:21852083 13885919 ZBTB11 zinc finger and BTB domain containing 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBTB11 mRNA PMID:35307453 13886100 HOXB2 homeobox B2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB2 mRNA PMID:35307453 13886296 PRIMA1 proline rich membrane anchor 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PRIMA1 mRNA PMID:39265697 13886467 BCAS1 brain enriched myelin associated protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCAS1 mRNA PMID:35307453 13886467 BCAS1 brain enriched myelin associated protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BCAS1 mRNA PMID:39265697 13886538 GLYCTK glycerate kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLYCTK mRNA PMID:35307453 13886591 CYP17A1 cytochrome P450 family 17 subfamily A member 1 gene CHEBI:27485 prostaglandin J2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C037112 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA] PMID:11889176 13886591 CYP17A1 cytochrome P450 family 17 subfamily A member 1 gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20191114 CTD MESH:D003907 Dexamethasone results in increased expression of CYP17A1 PMID:19852296 13886591 CYP17A1 cytochrome P450 family 17 subfamily A member 1 gene CHEBI:47136 pentachlorobenzene increases expression EXP E RGD:6480464 20191114 CTD MESH:C003060 pentachlorobenzene results in increased expression of CYP17A1 protein PMID:21296658 13886591 CYP17A1 cytochrome P450 family 17 subfamily A member 1 gene CHEBI:5692 hexachlorobenzene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene results in decreased expression of CYP17A1 protein PMID:21296658 13886591 CYP17A1 cytochrome P450 family 17 subfamily A member 1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 protein modified form] PMID:11889176 13886729 RNF39 ring finger protein 39 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNF39 mRNA PMID:35307453 13886729 RNF39 ring finger protein 39 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RNF39 mRNA PMID:39265697 13886777 BPIFB4 BPI fold containing family B member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BPIFB4 mRNA PMID:35307453 13886816 LTF lactotransferrin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LTF mRNA PMID:35307453 13886816 LTF lactotransferrin gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PLF mRNA PMID:18988085 13886842 RIMKLA ribosomal modification protein rimK like family member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIMKLA mRNA PMID:35307453 13887025 PDP2 pyruvate dehydrogenase phosphatase catalytic subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDP2 mRNA PMID:35307453 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAPK3 mRNA; deoxynivalenol results in decreased expression of MAPK3 protein modified form PMID:26988607|PMID:35307453 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:10022 deoxynivalenol increases activity EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased activity of MAPK3 protein PMID:19674540 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol analog results in increased phosphorylation of MAPK3 protein; deoxynivalenol results in increased phosphorylation of MAPK3 protein PMID:22859312 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:135697 sarpogrelate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C064294 sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein] PMID:11426759 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of MAPK3 protein PMID:20406653 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of MAPK3 protein] PMID:20406653 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:16240 hydrogen peroxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein PMID:11325585|PMID:21798251 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] PMID:21798251 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:16412 lipopolysaccharide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased phosphorylation of MAPK3 protein PMID:28528741 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] PMID:28528741 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK3 mRNA PMID:32423882 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:17688 (S)-nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK3 protein PMID:32423882 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK3 mRNA PMID:32423882 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:18723 nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK3 protein PMID:32423882 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:207229 dihydroartemisinin decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C039060 artenimol results in decreased phosphorylation of MAPK3 protein PMID:29309768 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK3 protein PMID:10356984 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:27915 melamine increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in increased phosphorylation of MAPK3 protein PMID:30055240 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:2825 aristolochic acid A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in increased phosphorylation of and results in increased activity of MAPK3 protein; U 0126 inhibits the reaction [aristolochic acid I results in increased phosphorylation of and results in increased activity of MAPK3 protein] PMID:21658425 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:28790 serotonin increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D012701 Serotonin results in increased phosphorylation of MAPK3 protein PMID:11426759 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:28790 serotonin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012701 sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein] PMID:11426759 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:3093 bifenthrin increases phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased phosphorylation of MAPK3 protein PMID:33901951 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:32234 titanium dioxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased phosphorylation of MAPK3 protein PMID:23380242 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK3 protein PMID:20406653 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein PMID:11325585 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:38221 fumonisin B1 increases phosphorylation EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in increased phosphorylation of MAPK3 protein PMID:31557363 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:39329 etoxazole increases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased phosphorylation of MAPK3 protein PMID:31744678 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with etoxazole] results in increased phosphorylation of MAPK3 protein; [pyrazolanthrone co-treated with etoxazole] results in increased phosphorylation of MAPK3 protein; SB 203580 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK3 protein] PMID:31744678 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:48843 disodium selenite increases expression EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite results in increased expression of MAPK3 protein PMID:17342738 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:5078 flavonol increases expression EXP E RGD:6480464 20191114 CTD MESH:C041477 3-hydroxyflavone results in increased expression of MAPK3 protein PMID:21126572 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of MAPK3 protein PMID:38432436 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of MAPK3 protein]; U 0126 promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK3 protein] PMID:31400776 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C085911 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with etoxazole] results in increased phosphorylation of MAPK3 protein PMID:31744678 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:68889 hydroxytyrosol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C005975 3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] PMID:21798251 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:7719 ochratoxin A increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased phosphorylation of MAPK3 protein PMID:28699257 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] PMID:28528741 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK3 protein] PMID:17065204 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 [pyrazolanthrone co-treated with etoxazole] results in increased phosphorylation of MAPK3 protein; pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of MAPK3 protein] PMID:31400776|PMID:31744678 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 SB 203580 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK3 protein] PMID:31744678 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:9753 troglitazone increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in increased phosphorylation of MAPK3 protein PMID:17065204 13887126 MAPK3 mitogen-activated protein kinase 3 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK3 protein] PMID:17065204 13887195 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HMGCR mRNA PMID:35307453 13887195 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase gene CHEBI:49040 ezetimibe increases expression EXP E RGD:6480464 20191114 CTD MESH:D000069438 Ezetimibe results in increased expression of HMGCR mRNA PMID:17130282 13887195 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase gene CHEBI:49040 ezetimibe multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000069438 Simvastatin promotes the reaction [Ezetimibe results in increased expression of HMGCR mRNA] PMID:17130282 13887195 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase gene CHEBI:9150 simvastatin decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin results in decreased expression of HMGCR mRNA PMID:19343539 13887195 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase gene CHEBI:9150 simvastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin promotes the reaction [Ezetimibe results in increased expression of HMGCR mRNA] PMID:17130282 13887235 PARM1 prostate androgen-regulated mucin-like protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PARM1 mRNA PMID:35307453 13887243 TGFBR1 transforming growth factor beta receptor 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of TGFBR1 mRNA PMID:33626375 13887525 COLGALT2 collagen beta(1-O)galactosyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COLGALT2 mRNA PMID:35307453 13887525 COLGALT2 collagen beta(1-O)galactosyltransferase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of COLGALT2 mRNA PMID:34933075 13887576 EHD3 EH domain containing 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of EHD3 mRNA PMID:39265697 13887600 UBXN11 UBX domain protein 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBXN11 mRNA PMID:35307453 13887719 CYP39A1 cytochrome P450 family 39 subfamily A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP39A1 mRNA PMID:35307453 13887811 MOBKL3 MOB family member 4, phocein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MOBKL3 mRNA PMID:35307453 13887878 MMP12 matrix metallopeptidase 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MMP12 mRNA PMID:35307453 13887971 ADIG adipogenin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADIG mRNA PMID:35307453 13888401 DNAH7 dynein axonemal heavy chain 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH7 mRNA PMID:35307453 13888510 CHDH choline dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHDH mRNA PMID:35307453 13888563 PUM3 pumilio RNA binding family member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PUM3 mRNA PMID:35307453 13888629 THOP1 thimet oligopeptidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THOP1 mRNA PMID:35307453 13888669 PRSS56 serine protease 56 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS56 mRNA PMID:35307453 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NQO1 mRNA PMID:35307453 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone affects the expression of NQO1 mRNA; Zearalenone affects the expression of NQO1 protein PMID:31760079 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20221206 CTD MESH:D015025 Zearalenone results in decreased expression of NQO1 mRNA; Zearalenone results in decreased expression of NQO1 protein PMID:35489465 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D015025 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein] PMID:35489465 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 [Quercetin co-treated with Copper Sulfate] results in increased expression of NQO1 mRNA; Quercetin inhibits the reaction [Copper Sulfate results in increased expression of NQO1 mRNA] PMID:39151877 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of NQO1 mRNA] PMID:36584959 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NQO1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NQO1 mRNA PMID:33493553|PMID:34416349 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of NQO1 mRNA PMID:39151877 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 [Quercetin co-treated with Copper Sulfate] results in increased expression of NQO1 mRNA; Quercetin inhibits the reaction [Copper Sulfate results in increased expression of NQO1 mRNA] PMID:39151877 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:26267 proanthocyanidin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D044945 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein] PMID:35489465 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of NQO1 mRNA PMID:31677563|PMID:35388968|PMID:36584959 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of NQO1 mRNA] PMID:36584959 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of NQO1 mRNA; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NQO1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NQO1 protein] PMID:21852083|PMID:37955343 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Dicumarol inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein]]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein] PMID:20732396 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 mRNA PMID:24709675 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 [epigallocatechin gallate co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of NQO1 mRNA; CAV1 mutant form promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 mRNA] PMID:22521609|PMID:24709675 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of NQO1 mRNA PMID:33626375 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NQO1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NQO1 mRNA PMID:33493553|PMID:34416349 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240604 CTD MESH:C056933 fumonisin B1 results in decreased expression of NQO1 mRNA; fumonisin B1 results in decreased expression of NQO1 protein PMID:37955343 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NQO1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NQO1 protein] PMID:37955343 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:4513 dicoumarol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001728 Dicumarol inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein]] PMID:20732396 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:47807 sulforaphane increases activity EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased activity of NQO1 protein PMID:20732396 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of NQO1 protein PMID:28710020 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 Dicumarol inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein]]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of NQO1 protein]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein] PMID:20732396|PMID:28710020 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate increases expression EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in increased expression of NQO1 mRNA PMID:22521609 13888687 NQO1 NAD(P)H quinone dehydrogenase 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 [epigallocatechin gallate co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of NQO1 mRNA; NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of NQO1 mRNA] PMID:22521609 13889038 PACSIN1 protein kinase C and casein kinase substrate in neurons 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PACSIN1 mRNA PMID:35307453 13889180 ATG4A autophagy related 4A cysteine peptidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATG4A mRNA PMID:35307453 13889310 GNAO1 G protein subunit alpha o1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GNAO1 mRNA PMID:34933075 13889335 ACTRT3 actin related protein T3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACTRT3 mRNA PMID:35307453 13889467 INSYN1 inhibitory synaptic factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INSYN1 mRNA PMID:35307453 13889474 BST2 bone marrow stromal cell antigen 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BST2 mRNA PMID:35307453 13889480 CUL7 cullin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CUL7 mRNA PMID:35307453 13889669 HOXA9 homeobox A9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXA9 mRNA PMID:35307453 13889779 SLC4A11 solute carrier family 4 member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC4A11 mRNA PMID:35307453 13889863 COX10 cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COX10 mRNA PMID:35307453 13889931 HPS1 HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HPS1 mRNA PMID:35307453 13889984 SLC16A12 solute carrier family 16 member 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A12 mRNA PMID:35307453 13889984 SLC16A12 solute carrier family 16 member 12 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SLC16A12 mRNA PMID:34933075 13890082 NID2 nidogen 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NID2 mRNA PMID:35307453 13890243 HTRA1 HtrA serine peptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HTRA1 mRNA PMID:35307453 13890243 HTRA1 HtrA serine peptidase 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of HTRA1 mRNA PMID:28069986 13890451 CHEK1 checkpoint kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHEK1 mRNA PMID:35307453 13890601 MTMR2 myotubularin related protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTMR2 mRNA PMID:35307453 13890641 EIF4H eukaryotic translation initiation factor 4H gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4H mRNA PMID:35307453 13890653 DCAKD dephospho-CoA kinase domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DCAKD mRNA PMID:35307453 13890714 RRM2 ribonucleotide reductase regulatory subunit M2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RRM2 mRNA PMID:35307453 13890753 GJA4 gap junction protein alpha 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of GJA4 mRNA PMID:26386189 13890821 EEA1 early endosome antigen 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of EEA1 mRNA PMID:39265697 13890921 MESP2 mesoderm posterior bHLH transcription factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MESP2 mRNA PMID:35307453 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of SDHA mRNA] PMID:37999554 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of SDHA mRNA] PMID:36584959 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of SDHA mRNA PMID:36584959 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of SDHA mRNA] PMID:36584959 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of SDHA mRNA PMID:37999554 13890970 SDHA succinate dehydrogenase complex flavoprotein subunit A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of SDHA mRNA] PMID:37999554 13890998 SEC16A SEC16 homolog A, endoplasmic reticulum export factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC16A mRNA PMID:35307453 13891049 STAM2 signal transducing adaptor molecule 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STAM2 mRNA PMID:35307453 13891086 FGF21 fibroblast growth factor 21 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FGF21 mRNA PMID:39265697 13891116 FLNC filamin C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FLNC mRNA PMID:35307453 13891116 FLNC filamin C gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FLNC mRNA PMID:39265697 13891245 FGFR1 fibroblast growth factor receptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FGFR1 mRNA PMID:35307453 13891245 FGFR1 fibroblast growth factor receptor 1 gene CHEBI:17026 progesterone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in decreased expression of FGFR1 mRNA alternative form PMID:15120423 13891245 FGFR1 fibroblast growth factor receptor 1 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] PMID:15120423 13891276 GPX2 glutathione peroxidase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of GPX2 mRNA PMID:25701311|PMID:35307453 13891276 GPX2 glutathione peroxidase 2 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 [Betaine co-treated with Glyphosate] results in increased expression of GPX2 mRNA PMID:36584959 13891276 GPX2 glutathione peroxidase 2 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 [Betaine co-treated with Glyphosate] results in increased expression of GPX2 mRNA PMID:36584959 13891276 GPX2 glutathione peroxidase 2 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in decreased expression of GPX2 mRNA PMID:34399389|PMID:38565334 13891389 TMEM106B transmembrane protein 106B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM106B mRNA PMID:35307453 13891411 SLC26A11 solute carrier family 26 member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC26A11 mRNA PMID:35307453 13891432 PLAUR plasminogen activator, urokinase receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLAUR mRNA PMID:35307453 13891432 PLAUR plasminogen activator, urokinase receptor gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PLAUR mRNA PMID:18988085 13891432 PLAUR plasminogen activator, urokinase receptor gene CHEBI:46680 serpentine asbestos increases expression EXP E RGD:6480464 20201006 CTD MESH:D017632 Asbestos, Serpentine results in increased expression of PLAUR protein PMID:9853007 13891548 GPS2 G protein pathway suppressor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPS2 mRNA PMID:35307453 13891656 TJP2 tight junction protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TJP2 mRNA PMID:35307453 13891656 TJP2 tight junction protein 2 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of TJP2 protein PMID:37659622 13891656 TJP2 tight junction protein 2 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of TJP2 protein] PMID:37659622 13891656 TJP2 tight junction protein 2 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of TJP2 mRNA] PMID:37999554 13891656 TJP2 tight junction protein 2 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of TJP2 protein PMID:36754226 13891656 TJP2 tight junction protein 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of TJP2 mRNA PMID:37999554 13891656 TJP2 tight junction protein 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of TJP2 mRNA] PMID:37999554 13891656 TJP2 tight junction protein 2 gene CHEBI:33709 amino acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000596 Amino Acids inhibits the reaction [Diquat results in decreased expression of TJP2 protein] PMID:26338884 13891656 TJP2 tight junction protein 2 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in decreased expression of TJP2 protein PMID:26338884 13891656 TJP2 tight junction protein 2 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004178 Amino Acids inhibits the reaction [Diquat results in decreased expression of TJP2 protein] PMID:26338884 13891656 TJP2 tight junction protein 2 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of TJP2 protein] PMID:37659622 13891830 ALDH3B1 aldehyde dehydrogenase 3 family member B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH3B1 mRNA PMID:35307453 13891977 SPR sepiapterin reductase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPR mRNA PMID:35307453 13892007 NME1 NME/NM23 nucleoside diphosphate kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NME1 mRNA PMID:35307453 13892050 FAT1 FAT atypical cadherin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAT1 mRNA PMID:35307453 13892215 PTPN13 protein tyrosine phosphatase non-receptor type 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN13 mRNA; deoxynivalenol results in decreased expression of PTPN13 protein PMID:38403181 13892279 TREX1 three prime repair exonuclease 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TREX1 mRNA PMID:35307453 13892319 ENO3 enolase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENO3 mRNA PMID:35307453 13892392 UBA3 ubiquitin like modifier activating enzyme 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBA3 mRNA PMID:35307453 13892425 RASAL1 RAS protein activator like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASAL1 mRNA PMID:35307453 13892539 ACOT9 acyl-CoA thioesterase 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACOT9 mRNA PMID:35307453 13892586 C2CD4C C2 calcium dependent domain containing 4C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C2CD4C mRNA PMID:35307453 13892597 SLC22A2 solute carrier family 22 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC22A2 mRNA PMID:35307453 13892597 SLC22A2 solute carrier family 22 member 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] PMID:19605544 13892597 SLC22A2 solute carrier family 22 member 2 gene CHEBI:28527 rutin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012431 Rutin inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] PMID:19605544 13892597 SLC22A2 solute carrier family 22 member 2 gene CHEBI:44296 tetraethylammonium increases uptake EXP E RGD:6480464 20191114 CTD MESH:D019789 SLC22A2 protein results in increased uptake of Tetraethylammonium PMID:19605544 13892597 SLC22A2 solute carrier family 22 member 2 gene CHEBI:44296 tetraethylammonium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019789 Quercetin inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium]; Rutin inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] PMID:19605544 13892781 GJA10 gap junction protein alpha 10 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of GJA10 mRNA PMID:21852083 13892940 ARK2N arkadia (RNF111) N-terminal like PKA signaling regulator 2N gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of ARK2N mRNA PMID:35307453 13892987 DNPEP aspartyl aminopeptidase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNPEP mRNA PMID:35307453 13893144 TWNK twinkle mtDNA helicase gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TWNK mRNA PMID:33592257 13893144 TWNK twinkle mtDNA helicase gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TWNK mRNA PMID:33592257 13893267 SF3A3 splicing factor 3a subunit 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SF3A3 mRNA PMID:35307453 13893336 FAAH2 fatty acid amide hydrolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAAH2 mRNA PMID:35307453 13893425 CRY1 cryptochrome circadian regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRY1 mRNA PMID:35307453 13893471 ZIC2 Zic family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZIC2 mRNA PMID:35307453 13893559 OSER1 oxidative stress responsive serine rich 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OSER1 mRNA PMID:35307453 13893637 SYNE3 spectrin repeat containing nuclear envelope family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYNE3 mRNA PMID:35307453 13893660 ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTS9 mRNA PMID:35307453 13893735 L3MBTL2 L3MBTL histone methyl-lysine binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of L3MBTL2 mRNA PMID:35307453 13894014 WDR20 WD repeat domain 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR20 mRNA PMID:35307453 13894015 SLC26A6 solute carrier family 26 member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC26A6 mRNA PMID:35307453 13894361 GAB1 GRB2 associated binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAB1 mRNA PMID:35307453 13894533 B3GNT3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of B3GNT3 mRNA PMID:35307453 13894575 ZRSR2 zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZRSR2 mRNA PMID:35307453 13894618 MRPS5 mitochondrial ribosomal protein S5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS5 mRNA PMID:35307453 13894643 ADGRL3 adhesion G protein-coupled receptor L3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRL3 mRNA PMID:35307453 13894680 CARF calcium responsive transcription factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CARF mRNA PMID:35307453 13894734 ATRAID all-trans retinoic acid induced differentiation factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATRAID mRNA PMID:35307453 13894778 KIAA1143 KIAA1143 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIAA1143 mRNA PMID:35307453 13894899 MAFK MAF bZIP transcription factor K gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAFK mRNA PMID:35307453 13894955 PNPLA4 patatin like domain 4, phospholipase and triacylglycerol lipase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PNPLA4 mRNA PMID:35307453 13895075 ZNF529 zinc finger protein 529 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF461 mRNA PMID:35307453 13895089 MYH11 myosin heavy chain 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYH11 mRNA PMID:38403181 13895089 MYH11 myosin heavy chain 11 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of MYH11 mRNA PMID:34933075 13895135 ETV3 ETS variant transcription factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ETV3 mRNA PMID:35307453 13895162 EMG1 EMG1 N1-specific pseudouridine methyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EMG1 mRNA PMID:35307453 13895188 SEMA6D semaphorin 6D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA6D mRNA PMID:35307453 13895346 PCBP1 poly(rC) binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PCBP1 mRNA PMID:35307453 13895464 TDRD6 tudor domain containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TDRD6 mRNA PMID:35307453 13895940 MLXIP MLX interacting protein gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of MLXIP mRNA PMID:25827716 13895940 MLXIP MLX interacting protein gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose promotes the reaction [T0901317 results in increased expression of MLXIP mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 13895940 MLXIP MLX interacting protein gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of MLXIP mRNA PMID:25827716 13895940 MLXIP MLX interacting protein gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose promotes the reaction [T0901317 results in increased expression of MLXIP mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 13895940 MLXIP MLX interacting protein gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of MLXIP mRNA PMID:25827716 13895940 MLXIP MLX interacting protein gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose promotes the reaction [T0901317 results in increased expression of MLXIP mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 13895965 HPSE heparanase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HPSE mRNA PMID:35307453 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of LIF mRNA PMID:37706587 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of LIF mRNA] PMID:37706587 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LIF mRNA] PMID:21852083 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of LIF protein PMID:39486568 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of LIF mRNA] PMID:37706587 13895981 LIF LIF interleukin 6 family cytokine gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of LIF protein PMID:39486568 13896058 UMAD1 UBAP1-MVB12-associated (UMA) domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UMAD1 mRNA PMID:35307453 13896186 GRWD1 glutamate rich WD repeat containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GRWD1 mRNA; deoxynivalenol results in increased expression of GRWD1 protein PMID:35307453|PMID:38403181 13896282 POLR3G RNA polymerase III subunit G gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR3G mRNA PMID:35307453 13896305 PDE7B phosphodiesterase 7B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDE7B mRNA PMID:35307453 13896339 SC5D sterol-C5-desaturase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SC5D mRNA PMID:35307453 13896348 S100B S100 calcium binding protein B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100B mRNA PMID:35307453 13896446 HKDC1 hexokinase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HKDC1 mRNA PMID:35307453 13896446 HKDC1 hexokinase domain containing 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of HKDC1 mRNA] PMID:39151877 13896446 HKDC1 hexokinase domain containing 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of HKDC1 mRNA PMID:39151877 13896446 HKDC1 hexokinase domain containing 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of HKDC1 mRNA] PMID:39151877 13896824 CRYBG3 crystallin beta-gamma domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRYBG3 mRNA PMID:35307453 13896886 MICAL1 microtubule associated monooxygenase, calponin and LIM domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MICAL1 mRNA PMID:35307453 13896886 MICAL1 microtubule associated monooxygenase, calponin and LIM domain containing 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MICAL1 mRNA PMID:39265697 13896932 RRS1 ribosome biogenesis regulator 1 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRS1 mRNA PMID:35307453 13897010 IDUA alpha-L-iduronidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IDUA mRNA PMID:35307453 13897090 RPP38 ribonuclease P/MRP subunit p38 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of RPP38 mRNA PMID:32423882 13897090 RPP38 ribonuclease P/MRP subunit p38 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of RPP38 mRNA PMID:32423882 13897107 TSGA10 testis specific 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSGA10 mRNA PMID:35307453 13897192 SLC10A2 solute carrier family 10 member 2 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of SLC10A2 mRNA PMID:35307453 13897289 RXRB retinoid X receptor beta gene CHEBI:39329 etoxazole decreases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in decreased expression of RXRB mRNA PMID:31744678 13897403 SLC44A4 solute carrier family 44 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC44A4 mRNA PMID:35307453 13897440 PGAM1 phosphoglycerate mutase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGAM1 mRNA PMID:35307453 13897554 FAT2 FAT atypical cadherin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAT2 mRNA PMID:35307453 13897582 PMPCB peptidase, mitochondrial processing subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PMPCB mRNA PMID:35307453 13897648 MTURN maturin, neural progenitor differentiation regulator homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTURN mRNA PMID:35307453 13897661 MICAL2 microtubule associated monooxygenase, calponin and LIM domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MICAL2 mRNA PMID:35307453 13897714 BMX BMX non-receptor tyrosine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMX mRNA PMID:35307453 13897826 KLF4 KLF transcription factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLF4 mRNA PMID:35307453 13897877 RPUSD3 RNA pseudouridine synthase D3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPUSD3 mRNA PMID:35307453 13897897 DDX17 DEAD-box helicase 17 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of DDX17 mRNA; Resveratrol promotes the reaction [Dietary Fats results in decreased expression of DDX17 mRNA] PMID:21852083 13898049 NDUFB2 NADH:ubiquinone oxidoreductase subunit B2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDUFB2 mRNA PMID:39265697 13898115 UTP23 UTP23 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP23 mRNA PMID:35307453 13898182 VSTM2L V-set and transmembrane domain containing 2 like gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of VSTM2L mRNA PMID:34933075 13898190 BMP15 bone morphogenetic protein 15 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of BMP15 mRNA PMID:26386189 13898190 BMP15 bone morphogenetic protein 15 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of BMP15 mRNA] PMID:26386189 13898190 BMP15 bone morphogenetic protein 15 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of BMP15 mRNA] PMID:26386189 13898196 SCARF1 scavenger receptor class F member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCARF1 mRNA PMID:35307453 13898332 SELENOO selenoprotein O gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SELENOO mRNA PMID:35307453 13898374 DSTN destrin, actin depolymerizing factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of DSTN mRNA PMID:21852083 13898409 CLK3 CDC like kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CLK3 mRNA PMID:35307453 13898541 ACAP1 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACAP1 mRNA PMID:35307453 13898726 HPGD 15-hydroxyprostaglandin dehydrogenase gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of HPGD mRNA PMID:34389318 13898761 SMYD5 SMYD family member 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMYD5 mRNA PMID:35307453 13898851 PGM3 phosphoglucomutase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGM3 mRNA PMID:35307453 13898907 CYP4F22 cytochrome P450 family 4 subfamily F member 22 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CYP4F22 mRNA PMID:34933075 13898943 SLC13A4 solute carrier family 13 member 4 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SLC13A4 mRNA PMID:34389318 13898963 CD151 CD151 molecule gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CD151 mRNA PMID:39265697 13899026 C10H1orf115 chromosome 10 C1orf115 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C10H1ORF115 mRNA PMID:35307453 13899032 SMG9 SMG9 nonsense mediated mRNA decay factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMG9 mRNA; deoxynivalenol results in increased expression of SMG9 protein PMID:35307453|PMID:38403181 13899124 FBXO15 F-box protein 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXO15 mRNA PMID:35307453 13899188 TPRA1 transmembrane protein adipocyte associated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPRA1 mRNA PMID:35307453 13899246 NT5M 5',3'-nucleotidase, mitochondrial gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NT5M mRNA PMID:35307453 13899500 CLCN4 chloride voltage-gated channel 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLCN4 mRNA PMID:35307453 13899565 MTA2 metastasis associated 1 family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTA2 mRNA PMID:35307453 13899613 ROM1 retinal outer segment membrane protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ROM1 mRNA PMID:35307453 13899613 ROM1 retinal outer segment membrane protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ROM1 mRNA PMID:39265697 13899666 TXLNG taxilin gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TXLNG mRNA PMID:35307453 13900101 NAV2 neuron navigator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAV2 mRNA PMID:35307453 13900376 PEAK1 pseudopodium enriched atypical kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PEAK1 mRNA PMID:35307453 13900403 GLI2 GLI family zinc finger 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GLI2 mRNA PMID:34933075 13900403 GLI2 GLI family zinc finger 2 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of GLI2 mRNA PMID:21391292 13900528 FUZ fuzzy planar cell polarity protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FUZ mRNA PMID:35307453 13900548 EIF3A eukaryotic translation initiation factor 3 subunit A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF3A mRNA PMID:35307453 13900625 IL13 interleukin 13 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL13 mRNA PMID:15998543 13900625 IL13 interleukin 13 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL13 mRNA PMID:33891997 13900625 IL13 interleukin 13 gene CHEBI:28640 lipoteichoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C009900 lipoteichoic acid results in increased expression of IL13 mRNA PMID:15998543 13900625 IL13 interleukin 13 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL13 mRNA PMID:33891997 13900795 GNL2 G protein nucleolar 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GNL2 mRNA PMID:35307453 13900850 GSE1 Gse1 coiled-coil protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GSE1 mRNA PMID:35307453 13900905 EFNA3 ephrin A3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFNA3 mRNA PMID:35307453 13900905 EFNA3 ephrin A3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of EFNA3 mRNA PMID:39265697 13900973 RHOA ras homolog family member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHOA mRNA PMID:38403181 13901014 CHSY1 chondroitin sulfate synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHSY1 mRNA PMID:35307453 13901020 RAD54B RAD54 homolog B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAD54B mRNA PMID:35307453 13901047 ARHGAP45 Rho GTPase activating protein 45 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARHGAP45 mRNA PMID:35307453 13901113 ZNF432 zinc finger protein 432 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF432 mRNA PMID:35307453 13901221 DNMT3B DNA methyltransferase 3 beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNMT3B mRNA PMID:35307453 13901221 DNMT3B DNA methyltransferase 3 beta gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of DNMT3B mRNA PMID:28819136 13901287 SEC31A SEC31 homolog A, COPII coat complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC31A mRNA PMID:35307453 13901562 FRK fyn related Src family tyrosine kinase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FRK mRNA PMID:39265697 13901792 PTPN4 protein tyrosine phosphatase non-receptor type 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN4 mRNA PMID:35307453 13901832 DYNLRB2 dynein light chain roadblock-type 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNLRB2 mRNA PMID:35307453 13901861 OSBPL5 oxysterol binding protein like 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of OSBPL5 mRNA; deoxynivalenol results in decreased expression of OSBPL5 protein PMID:38403181 13901945 RIOK3 RIO kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIOK3 mRNA PMID:35307453 13901972 AQP9 aquaporin 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP9 mRNA PMID:35307453 13901972 AQP9 aquaporin 9 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A affects the expression of AQP9 mRNA PMID:32710935 13902102 NHSL2 NHS like 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NHSL2 mRNA PMID:34933075 13902114 SPATA6 spermatogenesis associated 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPATA6 mRNA PMID:35307453 13902300 COL7A1 collagen type VII alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL7A1 mRNA PMID:38403181 13902510 RADIL Rap associating with DIL domain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RADIL mRNA PMID:35307453 13902580 PDAP1 PDGFA associated protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDAP1 mRNA PMID:35307453 13902644 BEX3 brain expressed X-linked 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX3 mRNA] PMID:21852083 13902749 DHTKD1 dehydrogenase E1 and transketolase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DHTKD1 mRNA PMID:35307453 13902885 LEP leptin gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of LEP mRNA PMID:23153703 13902885 LEP leptin gene CHEBI:16469 17beta-estradiol increases secretion EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased secretion of LEP protein PMID:23153703 13902885 LEP leptin gene CHEBI:17026 progesterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased expression of LEP mRNA PMID:23153703 13902885 LEP leptin gene CHEBI:17026 progesterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased secretion of LEP protein PMID:23153703 13902885 LEP leptin gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 [TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone PMID:22151798 13902885 LEP leptin gene CHEBI:44658 okadaic acid affects expression EXP E RGD:6480464 20191114 CTD MESH:D019319 Okadaic Acid affects the expression of LEP mRNA PMID:10628429 13902912 COL18A1 collagen type XVIII alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL18A1 mRNA; deoxynivalenol results in decreased expression of COL18A1 protein PMID:38403181 13902999 IFT122 intraflagellar transport 122 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT122 mRNA PMID:35307453 13903100 COPB1 COPI coat complex subunit beta 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COPB1 mRNA PMID:35307453 13903246 NOTCH1 notch receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOTCH1 mRNA PMID:35307453 13903246 NOTCH1 notch receptor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NOTCH1 mRNA PMID:34933075 13903325 LOC110256483 carbonyl reductase [NADPH] 1-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBR1 mRNA PMID:35307453 13903325 LOC110256483 carbonyl reductase [NADPH] 1-like gene CHEBI:18009 NADP(+) affects binding EXP E RGD:6480464 20210803 CTD MESH:D009249 NADP binds to CBR1 protein PMID:15145449 13903325 LOC110256483 carbonyl reductase [NADPH] 1-like gene CHEBI:18009 NADP(+) multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D009249 NADP inhibits the reaction [4-hydroxymercuribenzoate results in decreased activity of CBR1 protein] PMID:15145449 13903325 LOC110256483 carbonyl reductase [NADPH] 1-like gene CHEBI:44409 NADP zwitterion affects binding EXP E RGD:6480464 20210803 CTD MESH:D009249 NADP binds to CBR1 protein PMID:15145449 13903325 LOC110256483 carbonyl reductase [NADPH] 1-like gene CHEBI:44409 NADP zwitterion multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D009249 NADP inhibits the reaction [4-hydroxymercuribenzoate results in decreased activity of CBR1 protein] PMID:15145449 13903400 ATP5IF1 ATP synthase inhibitory factor subunit 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATP5IF1 mRNA PMID:39265697 13903476 MBNL2 muscleblind like splicing regulator 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of MBNL2 mRNA PMID:34389318 13903538 SERPINE1 serpin family E member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERPINE1 mRNA PMID:35307453|PMID:37257635 13903538 SERPINE1 serpin family E member 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SERPINE1 mRNA PMID:39265697 13903538 SERPINE1 serpin family E member 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINE1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINE1 protein PMID:34416349 13903538 SERPINE1 serpin family E member 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SERPINE1 mRNA PMID:27617619 13903538 SERPINE1 serpin family E member 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SERPINE1 mRNA PMID:21852083 13903538 SERPINE1 serpin family E member 1 gene CHEBI:2814 arecoline increases expression EXP E RGD:6480464 20191114 CTD MESH:D001115 Arecoline results in increased expression of SERPINE1 protein PMID:26908192 13903538 SERPINE1 serpin family E member 1 gene CHEBI:2814 arecoline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001115 pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of SERPINE1 protein] PMID:26908192 13903538 SERPINE1 serpin family E member 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of SERPINE1 mRNA PMID:21391292 13903538 SERPINE1 serpin family E member 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINE1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINE1 protein PMID:34416349 13903538 SERPINE1 serpin family E member 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of SERPINE1 protein] PMID:26908192 13903685 ST14 ST14 transmembrane serine protease matriptase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST14 mRNA PMID:35307453 13903714 PGR progesterone receptor gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of PGR mRNA PMID:16431846 13903772 MYBBP1A MYB binding protein 1a gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYBBP1A mRNA PMID:35307453 13903772 MYBBP1A MYB binding protein 1a gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of MYBBP1A mRNA PMID:34389318 13903868 SLC31A2 solute carrier family 31 member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC31A2 mRNA PMID:35307453 13904010 SEMA3G semaphorin 3G gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA3G mRNA PMID:35307453 13904037 FBXO39 F-box protein 39 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXO39 mRNA PMID:35307453 13904100 LDHA lactate dehydrogenase A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LDHA mRNA PMID:35307453 13904100 LDHA lactate dehydrogenase A gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:16170 mercury(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury binds to and results in decreased folding of LDHA protein PMID:18501191 13904100 LDHA lactate dehydrogenase A gene CHEBI:16240 hydrogen peroxide increases activity EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in increased activity of LDHA protein PMID:38438008 13904100 LDHA lactate dehydrogenase A gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased activity of LDHA protein]; theanine inhibits the reaction [Hydrogen Peroxide results in increased activity of LDHA protein] PMID:38438008 13904100 LDHA lactate dehydrogenase A gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased activity of LDHA protein] PMID:38438008 13904100 LDHA lactate dehydrogenase A gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LDHA mRNA; Cadmium binds to and results in decreased folding of LDHA protein PMID:18501191|PMID:34416349 13904100 LDHA lactate dehydrogenase A gene CHEBI:25195 mercury atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury binds to and results in decreased folding of LDHA protein PMID:18501191 13904100 LDHA lactate dehydrogenase A gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of LDHA mRNA PMID:18988085 13904100 LDHA lactate dehydrogenase A gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:27889 lead(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D007854 Lead binds to and results in decreased folding of LDHA protein PMID:18501191 13904100 LDHA lactate dehydrogenase A gene CHEBI:33216 bisphenol A decreases methylation EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased methylation of LDHA promoter PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of LDHA mRNA PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter PMID:29065941 13904100 LDHA lactate dehydrogenase A gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LDHA mRNA PMID:34416349 13904100 LDHA lactate dehydrogenase A gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased activity of LDHA protein] PMID:38438008 13904255 SDHAF3 succinate dehydrogenase complex assembly factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDHAF3 mRNA PMID:35307453 13904265 UBE2D4 ubiquitin conjugating enzyme E2 D4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBE2D4 mRNA PMID:35307453 13904279 KCNK7 potassium two pore domain channel subfamily K member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNK7 mRNA PMID:35307453 13904434 AQP4 aquaporin 4 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in decreased expression of AQP4 mRNA PMID:32710935 13904475 PCSK4 proprotein convertase subtilisin/kexin type 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCSK4 mRNA PMID:35307453 13904501 CFAP119 cilia and flagella associated protein 119 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP119 mRNA PMID:35307453 13904674 AKAP12 A-kinase anchoring protein 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP12 mRNA PMID:35307453 13904918 RAPGEF4 Rap guanine nucleotide exchange factor 4 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of RAPGEF4 mRNA PMID:18988085 13904965 TMSB10 thymosin beta 10 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of TMSB10 mRNA PMID:21852083 13904972 DLX1 distal-less homeobox 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DLX1 mRNA PMID:35307453 13905099 SERBP1 SERPINE1 mRNA binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERBP1 mRNA PMID:35307453 13905134 SPEG striated muscle enriched protein kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPEG mRNA PMID:35307453 13905179 COPZ2 COPI coat complex subunit zeta 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COPZ2 mRNA PMID:35307453 13905267 ADCYAP1R1 ADCYAP receptor type I gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADCYAP1R1 mRNA PMID:34933075 13905267 ADCYAP1R1 ADCYAP receptor type I gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1R1 protein PMID:28506824 13905267 ADCYAP1R1 ADCYAP receptor type I gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1R1 protein PMID:28506824 13905267 ADCYAP1R1 ADCYAP receptor type I gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine results in decreased expression of ADCYAP1R1 protein PMID:28506824 13905267 ADCYAP1R1 ADCYAP receptor type I gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine results in decreased expression of ADCYAP1R1 protein PMID:28506824 13905467 BPIFC BPI fold containing family C gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of BPIFC mRNA PMID:34933075 13905556 SLC6A17 solute carrier family 6 member 17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC6A17 mRNA PMID:35307453 13905556 SLC6A17 solute carrier family 6 member 17 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SLC6A17 mRNA PMID:39265697 13905604 RPL34 ribosomal protein L34 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL34 mRNA PMID:39265697 13905671 IFN-ALPHA-15 interferon-alpha-15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFN-ALPHA-15 mRNA PMID:35307453 13905674 GTF3C4 general transcription factor IIIC subunit 4 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of GTF3C4 mRNA PMID:25455459 13905688 SLC27A4 solute carrier family 27 member 4 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in decreased expression of SLC27A4 mRNA PMID:33443779 13905803 GHRH growth hormone releasing hormone gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased expression of GHRH mRNA PMID:21110139 13905840 AP1M2 adaptor related protein complex 1 subunit mu 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AP1M2 mRNA PMID:35307453 13906019 COL16A1 collagen type XVI alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL16A1 mRNA PMID:38403181 13906139 CEP55 centrosomal protein 55 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEP55 mRNA PMID:35307453 13906171 TM7SF2 transmembrane 7 superfamily member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TM7SF2 mRNA PMID:35307453 13906185 IFI6 interferon alpha inducible protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFI6 mRNA PMID:35307453 13906359 ZMAT2 zinc finger matrin-type 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZMAT2 mRNA PMID:35307453 13906369 PDCD1 programmed cell death 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PDCD1 mRNA PMID:39265697 13906471 RBP4 retinol binding protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBP4 mRNA PMID:35307453 13906471 RBP4 retinol binding protein 4 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of RBP4 mRNA PMID:34389318 13906471 RBP4 retinol binding protein 4 gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone affects the expression of RBP4 protein PMID:11833939 13906471 RBP4 retinol binding protein 4 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of RBP4 protein PMID:21575630 13906471 RBP4 retinol binding protein 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RBP4 protein] PMID:21739664 13906680 ATRNL1 attractin like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATRNL1 mRNA PMID:35307453 13906810 STX8 syntaxin 8 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of STX8 mRNA] PMID:21852083 13906938 NAGLU N-acetyl-alpha-glucosaminidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAGLU mRNA PMID:35307453 13907018 WDR93 WD repeat domain 93 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR93 mRNA PMID:35307453 13907055 ANKRD65 ankyrin repeat domain 65 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKRD65 mRNA PMID:35307453 13907084 LRRFIP2 LRR binding FLII interacting protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRFIP2 mRNA PMID:35307453 13907175 PRSS55 serine protease 55 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS55 mRNA PMID:35307453 13907282 SLC15A3 solute carrier family 15 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC15A3 mRNA PMID:35307453 13907302 CXCR3 C-X-C motif chemokine receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CXCR3 mRNA PMID:35307453 13907326 LOC110256677 zinc finger protein 280A-like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF280B mRNA PMID:35307453 13907397 NAF1 nuclear assembly factor 1 ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAF1 mRNA PMID:35307453 13907768 JHY junctional cadherin complex regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JHY mRNA PMID:35307453 13907927 ENOSF1 enolase superfamily member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENOSF1 mRNA PMID:35307453 13907976 YAE1 YAE1 maturation factor of ABCE1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YAE1 mRNA PMID:35307453 13908045 PTBP1 polypyrimidine tract binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTBP1 mRNA PMID:35307453 13908104 ZBTB24 zinc finger and BTB domain containing 24 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBTB24 mRNA PMID:35307453 13908125 BCL2L14 BCL2 like 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCL2L14 mRNA PMID:35307453 13908150 RASSF2 Ras association domain family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASSF2 mRNA PMID:35307453 13908316 TNNT1 troponin T1, slow skeletal type gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNNT1 mRNA PMID:35307453 13908416 TCF12 transcription factor 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TCF12 mRNA PMID:35307453 13908478 OTUD4 OTU deubiquitinase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTUD4 mRNA PMID:35307453 13908559 CBLL1 Cbl proto-oncogene like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CBLL1 mRNA PMID:35307453 13908745 SLC16A9 solute carrier family 16 member 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A9 mRNA PMID:35307453 13908832 CDHR4 cadherin related family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDHR4 mRNA PMID:35307453 13909016 FAM187A family with sequence similarity 187 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM187A mRNA PMID:35307453 13909060 IL17RA interleukin 17 receptor A gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of IL17RA mRNA PMID:39265697 13909092 PDCD2L programmed cell death 2 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDCD2L mRNA PMID:35307453 13909112 TTC21A tetratricopeptide repeat domain 21A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC21A mRNA PMID:35307453 13909189 C6H1orf50 chromosome 6 C1orf50 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C6H1ORF50 mRNA PMID:35307453 13909234 FBLN2 fibulin 2 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of FBLN2 mRNA PMID:28069986 13909291 FASN fatty acid synthase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FASN mRNA PMID:35307453 13909291 FASN fatty acid synthase gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of FASN mRNA PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA] PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of FASN mRNA PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA] PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of FASN mRNA PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA] PMID:25827716 13909291 FASN fatty acid synthase gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of FASN mRNA PMID:31360149 13909291 FASN fatty acid synthase gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA] PMID:31360149 13909344 NSUN5 NOP2/Sun RNA methyltransferase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NSUN5 mRNA; deoxynivalenol results in increased expression of NSUN5 protein PMID:35307453|PMID:38403181 13909377 DCAF15 DDB1 and CUL4 associated factor 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCAF15 mRNA PMID:35307453 13909494 CCDC28A coiled-coil domain containing 28A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC28A mRNA PMID:35307453 13909504 ABLIM2 actin binding LIM protein family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABLIM2 mRNA PMID:35307453 13909504 ABLIM2 actin binding LIM protein family member 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ABLIM2 mRNA PMID:34933075 13909593 PDP1 pyruvate dehydrogenase phosphatase catalytic subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDP1 mRNA PMID:35307453 13909626 ZNF213 zinc finger protein 213 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF213 mRNA PMID:35307453 13909626 ZNF213 zinc finger protein 213 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ZNF213 mRNA PMID:39265697 13909639 SPEGNB SPEG neighbor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPEGNB mRNA PMID:35307453 13909710 NDRG2 NDRG family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NDRG2 mRNA PMID:35307453 13909768 RFX5 regulatory factor X5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RFX5 mRNA PMID:35307453 13909816 DDA1 DET1 and DDB1 associated 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDA1 mRNA PMID:35307453 13910089 EGFL7 EGF like domain multiple 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EGFL7 mRNA PMID:35307453 13910121 CD14 CD14 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD14 mRNA PMID:35307453 13910121 CD14 CD14 molecule gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of CD14 mRNA PMID:29421334 13910128 SYT12 synaptotagmin 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYT12 mRNA PMID:35307453 13910150 FUS FUS RNA binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FUS mRNA PMID:35307453 13910204 SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMARCA2 mRNA PMID:35307453 13910310 ECT2 epithelial cell transforming 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ECT2 mRNA] PMID:21852083 13910339 EDNRA endothelin receptor type A gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of EDNRA mRNA PMID:16364719 13910339 EDNRA endothelin receptor type A gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of EDNRA mRNA] PMID:39151877 13910339 EDNRA endothelin receptor type A gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of EDNRA mRNA PMID:39151877 13910339 EDNRA endothelin receptor type A gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of EDNRA mRNA] PMID:39151877 13910359 SYT2 synaptotagmin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYT2 mRNA PMID:35307453 13910410 KRT5 keratin 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KRT5 mRNA PMID:35307453 13910488 FAT4 FAT atypical cadherin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAT4 mRNA PMID:35307453 13910533 CYP46A1 cytochrome P450 family 46 subfamily A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP46A1 mRNA PMID:35307453 13910591 ABCF3 ATP binding cassette subfamily F member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABCF3 mRNA PMID:35307453 13910671 IL18BP interleukin 18 binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IL18BP mRNA PMID:35307453 13911021 SHARPIN SHANK associated RH domain interactor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SHARPIN mRNA PMID:35307453 13911119 PRPF6 pre-mRNA processing factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRPF6 mRNA PMID:35307453 13911160 TGM1 transglutaminase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGM1 mRNA PMID:35307453 13911413 NPM2 nucleophosmin/nucleoplasmin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NPM2 mRNA PMID:35307453 13911481 MRPS27 mitochondrial ribosomal protein S27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS27 mRNA PMID:35307453 13911559 MRPS28 mitochondrial ribosomal protein S28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS28 mRNA PMID:35307453 13911665 APOBR apolipoprotein B receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APOBR mRNA PMID:35307453 13911673 RHOG ras homolog family member G gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RHOG mRNA PMID:35307453 13911727 OAZ3 ornithine decarboxylase antizyme 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OAZ3 mRNA PMID:35307453 13911936 MATK megakaryocyte-associated tyrosine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MATK mRNA PMID:35307453 13912113 YPEL2 yippee like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YPEL2 mRNA PMID:35307453 13912134 PA2G4 proliferation-associated 2G4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PA2G4 mRNA PMID:35307453 13912305 EYA3 EYA transcriptional coactivator and phosphatase 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of EYA3 mRNA PMID:21852083 13912377 MPDU1 mannose-P-dolichol utilization defect 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPDU1 mRNA PMID:35307453 13912444 BAD BCL2 associated agonist of cell death gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of BAD mRNA; deoxynivalenol results in decreased expression of BAD protein PMID:38403181 13912455 PPP1R18 protein phosphatase 1 regulatory subunit 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R18 mRNA PMID:35307453 13912502 FBXO28 F-box protein 28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FBXO28 mRNA PMID:35307453 13912554 STARD4 StAR related lipid transfer domain containing 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STARD4 mRNA PMID:35307453 13912569 DNAL4 dynein axonemal light chain 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAL4 mRNA PMID:35307453 13912584 SERTM2 serine rich and transmembrane domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERTM2 mRNA PMID:35307453 13912712 AXIN2 axin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of AXIN2 protein PMID:30690062 13912745 KCNJ12 potassium inwardly rectifying channel subfamily J member 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in increased expression of KCNJ18 mRNA PMID:35307453 13912767 NHERF4 NHERF family PDZ scaffold protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in decreased expression of NHERF4 mRNA PMID:35307453 13912798 IFI44L interferon induced protein 44 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFI44L mRNA PMID:35307453 13912989 FIP1L1 factor interacting with PAPOLA and CPSF1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FIP1L1 mRNA PMID:35307453 13913077 LOC110255237 cytochrome P450 4F6-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP4F8 mRNA PMID:35307453 13913110 MT1A metallothionein 1A gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MT1A mRNA PMID:39265697 13913110 MT1A metallothionein 1A gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20200121 CTD MESH:D002104 Cadmium results in increased expression of MT1A protein PMID:12915104 13913110 MT1A metallothionein 1A gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20200121 CTD MESH:D019287 Zinc Sulfate results in increased expression of MT1A mRNA PMID:25895165 13913683 RDH10 retinol dehydrogenase 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RDH10 mRNA PMID:35307453 13913715 HSBP1L1 heat shock factor binding protein 1 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSBP1L1 mRNA PMID:35307453 13913859 PKP2 plakophilin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PKP2 mRNA PMID:35307453 13913912 DCN decorin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DCN mRNA] PMID:21852083 13914023 RIOK1 RIO kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIOK1 mRNA; deoxynivalenol results in increased expression of RIOK1 protein PMID:35307453|PMID:38403181 13914107 TRIM16 tripartite motif containing 16 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM16 mRNA PMID:35307453 13914117 PGAP2 post-GPI attachment to proteins 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PGAP2 mRNA PMID:35307453 13914229 VPS37C VPS37C subunit of ESCRT-I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VPS37C mRNA PMID:35307453 13914293 KDM1B lysine demethylase 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of KDM1B protein PMID:37257635 13914323 CSPG4 chondroitin sulfate proteoglycan 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSPG4 mRNA PMID:35307453 13914469 MRPL48 mitochondrial ribosomal protein L48 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL48 mRNA PMID:35307453 13914521 EDC3 enhancer of mRNA decapping 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EDC3 mRNA PMID:35307453 13914542 SLC26A5 solute carrier family 26 member 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC26A5 mRNA PMID:35307453 13914568 SLC35F1 solute carrier family 35 member F1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC35F1 mRNA PMID:35307453 13914755 XDH xanthine dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of XDH mRNA PMID:35307453 13914755 XDH xanthine dehydrogenase gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Hydrogen Peroxide PMID:21984542 13914755 XDH xanthine dehydrogenase gene CHEBI:17245 carbon monoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002248 [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide; CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; tempol inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] PMID:21984542 13914755 XDH xanthine dehydrogenase gene CHEBI:17368 hypoxanthine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019271 [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide; [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Hydrogen Peroxide; [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Superoxides; CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; CAT protein results in decreased activity of [Hypoxanthine co-treated with XDH protein]; tempol inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; tempol results in decreased activity of [Hypoxanthine co-treated with XDH protein] PMID:21984542 13914755 XDH xanthine dehydrogenase gene CHEBI:180664 4-hydroxy-TEMPO multiple interactions EXP E RGD:6480464 20211109 CTD MESH:C001803 tempol inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; tempol results in decreased activity of [Hypoxanthine co-treated with XDH protein] PMID:21984542 13914755 XDH xanthine dehydrogenase gene CHEBI:18421 superoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013481 [Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Superoxides PMID:21984542 13914844 C7 complement C7 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of C7 mRNA PMID:34389318 13914844 C7 complement C7 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of C7 mRNA PMID:18988085 13914872 GABARAPL1 GABA type A receptor associated protein like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GABARAPL1 mRNA PMID:35307453 13914872 GABARAPL1 GABA type A receptor associated protein like 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of GABARAPL1 mRNA PMID:35839969 13914915 FGR FGR proto-oncogene, Src family tyrosine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGR mRNA PMID:35307453 13914915 FGR FGR proto-oncogene, Src family tyrosine kinase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FGR mRNA PMID:39265697 13915052 STXBP2 syntaxin binding protein 2 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of STXBP2 mRNA PMID:28069986 13915103 YBEY ybeY metalloendoribonuclease gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YBEY mRNA PMID:35307453 13915225 CCNG1 cyclin G1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCNG1 mRNA PMID:35307453 13915272 FHAD1 forkhead associated phosphopeptide binding domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FHAD1 mRNA PMID:35307453 13915338 EDN1 endothelin 1 gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of EDN1 mRNA; ambrisentan results in decreased expression of EDN1 protein PMID:16364719 13915338 EDN1 endothelin 1 gene CHEBI:15551 prostaglandin E2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015232 [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid co-treated with EDN1 protein] results in decreased chemical synthesis of Dinoprostone PMID:16325014 13915338 EDN1 endothelin 1 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of EDN1 mRNA PMID:37706587 13915338 EDN1 endothelin 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA] PMID:37706587 13915338 EDN1 endothelin 1 gene CHEBI:16480 nitric oxide increases abundance EXP E RGD:6480464 20191114 CTD MESH:D009569 EDN1 protein results in increased abundance of Nitric Oxide PMID:12672649 13915338 EDN1 endothelin 1 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein] PMID:17105827 13915338 EDN1 endothelin 1 gene CHEBI:27958 cocaine increases expression EXP E RGD:6480464 20191114 CTD MESH:D003042 Cocaine results in increased expression of EDN1 protein PMID:9714087 13915338 EDN1 endothelin 1 gene CHEBI:27958 cocaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003042 1,3-ditolylguanidine inhibits the reaction [Cocaine results in increased expression of EDN1 protein]; Haloperidol inhibits the reaction [Cocaine results in increased expression of EDN1 protein] PMID:9714087 13915338 EDN1 endothelin 1 gene CHEBI:28158 6-oxoprostaglandin F1alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015121 [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid co-treated with EDN1 protein] results in decreased chemical synthesis of 6-Ketoprostaglandin F1 alpha PMID:16325014 13915338 EDN1 endothelin 1 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of EDN1 protein PMID:16625121 13915338 EDN1 endothelin 1 gene CHEBI:3441 carvedilol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in decreased expression of EDN1 protein PMID:18840580 13915338 EDN1 endothelin 1 gene CHEBI:3441 carvedilol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C043211 Glyburide inhibits the reaction [Carvedilol results in decreased expression of EDN1 protein] PMID:18840580 13915338 EDN1 endothelin 1 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of EDN1 protein PMID:17105827 13915338 EDN1 endothelin 1 gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein]; Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein] PMID:17105827 13915338 EDN1 endothelin 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases expression EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein PMID:17105827 13915338 EDN1 endothelin 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013755 Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein] PMID:17105827 13915338 EDN1 endothelin 1 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA] PMID:37706587 13915338 EDN1 endothelin 1 gene CHEBI:4031 cyclosporin A increases secretion EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in increased secretion of EDN1 protein PMID:16391421 13915338 EDN1 endothelin 1 gene CHEBI:5441 glyburide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005905 Glyburide inhibits the reaction [Carvedilol results in decreased expression of EDN1 protein] PMID:18840580 13915338 EDN1 endothelin 1 gene CHEBI:5613 haloperidol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006220 Haloperidol inhibits the reaction [Cocaine results in increased expression of EDN1 protein] PMID:9714087 13915435 S100A1 S100 calcium binding protein A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A1 mRNA PMID:35307453 13915452 KLHL29 kelch like family member 29 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of KLHL29 mRNA PMID:39265697 13915610 AUH AU RNA binding methylglutaconyl-CoA hydratase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AUH mRNA PMID:35307453 13915759 SLC25A45 solute carrier family 25 member 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A45 mRNA PMID:35307453 13915790 HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSD11B1 mRNA PMID:35307453 13915884 FOXD4 forkhead box D4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXD4 mRNA PMID:35307453 13915983 CAPN10 calpain 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPN10 mRNA PMID:35307453 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPER1 mRNA PMID:35307453 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in decreased expression of GPER1 protein PMID:31266599 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of GPER1 protein PMID:31266599 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [tetrabromobisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in decreased expression of GPER1 protein PMID:31266599 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:35004 Tetrachlorobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in decreased expression of GPER1 protein PMID:31266599 13916022 GPER1 G protein-coupled estrogen receptor 1 gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian inhibits the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of GPER1 protein] PMID:31266599 13916047 HFE homeostatic iron regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HFE mRNA PMID:35307453 13916068 PTPRZ1 protein tyrosine phosphatase receptor type Z1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPRZ1 mRNA PMID:35307453 13916117 EGF epidermal growth factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EGF mRNA PMID:35307453 13916290 CSTB cystatin B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSTB mRNA PMID:35307453 13916489 TPK1 thiamin pyrophosphokinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPK1 mRNA PMID:35307453 13916690 GDF9 growth differentiation factor 9 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of GDF9 mRNA PMID:25455459 13916694 CTNNBIP1 catenin beta interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTNNBIP1 mRNA PMID:35307453 13916721 CFAP52 cilia and flagella associated protein 52 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP52 mRNA PMID:35307453 13916750 PRSS23 serine protease 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS23 mRNA PMID:35307453 13916819 GALNT15 polypeptide N-acetylgalactosaminyltransferase 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GALNT15 mRNA PMID:35307453 13916843 CYB561 cytochrome b561 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYB561 mRNA PMID:35307453 13916843 CYB561 cytochrome b561 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CYB561 mRNA PMID:21852083 13916886 IFI44 interferon induced protein 44 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IFI44 mRNA PMID:39265697 13916938 GPD2 glycerol-3-phosphate dehydrogenase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of GPD2 mRNA PMID:21852083 13917103 OGFOD2 2-oxoglutarate and iron dependent oxygenase domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OGFOD2 mRNA PMID:35307453 13917174 APEH acylaminoacyl-peptide hydrolase gene CHEBI:17941 diisopropyl fluorophosphate decreases activity EXP E RGD:6480464 20191114 CTD MESH:D007531 Isoflurophate results in decreased activity of APEH protein PMID:10953051 13917174 APEH acylaminoacyl-peptide hydrolase gene CHEBI:34632 chlorpyrifos-methyl decreases activity EXP E RGD:6480464 20191114 CTD MESH:C007031 chlorpyrifos-methyl results in decreased activity of APEH protein PMID:10953051 13917174 APEH acylaminoacyl-peptide hydrolase gene CHEBI:34690 dichlorvos decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004006 Dichlorvos results in decreased activity of APEH protein PMID:10953051 13917312 SNAP47 synaptosome associated protein 47 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNAP47 mRNA PMID:35307453 13917448 ATP6V0D2 ATPase H+ transporting V0 subunit d2 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ATP6V0D2 mRNA PMID:28069986 13917471 NARS1 asparaginyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NARS1 mRNA PMID:35307453 13917513 LARP1B La ribonucleoprotein 1B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LARP1B mRNA PMID:35307453 13917706 FAM234A family with sequence similarity 234 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM234A mRNA PMID:35307453 13917774 TNFSF4 TNF superfamily member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFSF4 mRNA PMID:35307453 13917869 ACE2 angiotensin converting enzyme 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ACE2 mRNA PMID:34933075 13917908 SLIRP SRA stem-loop interacting RNA binding protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SLIRP mRNA PMID:39265697 13917926 PFDN6 prefoldin subunit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFDN6 mRNA PMID:35307453 13917926 PFDN6 prefoldin subunit 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PFDN6 mRNA PMID:39265697 13917973 LEF1 lymphoid enhancer binding factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LEF1 mRNA PMID:35307453 13918031 USHBP1 USH1 protein network component harmonin binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of USHBP1 mRNA PMID:35307453 13918047 ZHX3 zinc fingers and homeoboxes 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZHX3 mRNA PMID:35307453 13918183 MADCAM1 mucosal vascular addressin cell adhesion molecule 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MADCAM1 mRNA PMID:35307453 13918241 WT1 WT1 transcription factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WT1 mRNA PMID:35307453 13918339 MSC musculin gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MSC mRNA PMID:39265697 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in increased expression of AOC1 protein] PMID:36615853 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:17148 putrescine increases degradation EXP E RGD:6480464 20191114 CTD MESH:D011700 AOC1 protein results in increased degradation of Putrescine PMID:8144586 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of AOC1 protein PMID:36615853 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in increased expression of AOC1 protein] PMID:36615853 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:34919 Phenylamil affects binding EXP E RGD:6480464 20191114 CTD MESH:C047088 phenylamil binds to AOC1 protein PMID:8144586 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:35696 cobalt dichloride affects binding EXP E RGD:6480464 20191114 CTD MESH:C018021 cobaltous chloride binds to AOC1 protein PMID:16842785 13918368 AOC1 amine oxidase copper containing 1 gene CHEBI:49553 copper(II) chloride increases activity EXP E RGD:6480464 20191114 CTD MESH:C029892 cupric chloride results in increased activity of AOC1 protein PMID:16842785 13918601 NR1H4 nuclear receptor subfamily 1 group H member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NR1H4 mRNA PMID:35307453 13918649 SQSTM1 sequestosome 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in increased expression of SQSTM1 mRNA; deoxynivalenol results in increased expression of SQSTM1 protein PMID:32302720|PMID:38403181 13918649 SQSTM1 sequestosome 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SQSTM1 mRNA] PMID:39151877 13918649 SQSTM1 sequestosome 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SQSTM1 mRNA PMID:39151877 13918649 SQSTM1 sequestosome 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SQSTM1 mRNA] PMID:39151877 13918649 SQSTM1 sequestosome 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of SQSTM1 protein PMID:35388968 13918649 SQSTM1 sequestosome 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of SQSTM1 protein] PMID:35388968 13918649 SQSTM1 sequestosome 1 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of SQSTM1 protein] PMID:35388968 13918649 SQSTM1 sequestosome 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]] PMID:34811946 13918649 SQSTM1 sequestosome 1 gene CHEBI:35176 zinc sulfate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in decreased expression of SQSTM1 protein PMID:28803810 13918649 SQSTM1 sequestosome 1 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of SQSTM1 mRNA PMID:28803810 13918649 SQSTM1 sequestosome 1 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in decreased expression of SQSTM1 protein] PMID:28803810 13918649 SQSTM1 sequestosome 1 gene CHEBI:3638 chloroquine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002738 Chloroquine results in increased expression of SQSTM1 protein PMID:30287338 13918649 SQSTM1 sequestosome 1 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002738 Chloroquine inhibits the reaction [ochratoxin A results in decreased expression of SQSTM1 protein] PMID:30287338 13918649 SQSTM1 sequestosome 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of SQSTM1 mRNA; fumonisin B1 results in increased expression of SQSTM1 protein PMID:38705344 13918649 SQSTM1 sequestosome 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in decreased expression of SQSTM1 mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in decreased expression of SQSTM1 protein]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased lipidation of and results in increased localization of SQSTM1 protein] PMID:38705344 13918649 SQSTM1 sequestosome 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; 3-methyladenine inhibits the reaction [Zinc Sulfate results in decreased expression of SQSTM1 protein] PMID:28803810|PMID:34811946 13918649 SQSTM1 sequestosome 1 gene CHEBI:50842 norflurazon increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased phosphorylation of SQSTM1 protein PMID:38432436 13918649 SQSTM1 sequestosome 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of SQSTM1 protein PMID:30287338 13918649 SQSTM1 sequestosome 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Chloroquine inhibits the reaction [ochratoxin A results in decreased expression of SQSTM1 protein] PMID:30287338 13918649 SQSTM1 sequestosome 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]] PMID:34811946 13918796 PRR5L proline rich 5 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRR5L mRNA PMID:35307453 13918853 PLEKHB1 pleckstrin homology domain containing B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHB1 mRNA PMID:35307453 13918908 SLC27A3 solute carrier family 27 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC27A3 mRNA PMID:35307453 13919026 PRKN parkin RBR E3 ubiquitin protein ligase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRKN mRNA PMID:35307453 13919026 PRKN parkin RBR E3 ubiquitin protein ligase gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of PRKN mRNA; fumonisin B1 results in increased expression of PRKN protein PMID:38705344 13919026 PRKN parkin RBR E3 ubiquitin protein ligase gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of PRKN mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of PRKN protein] PMID:38705344 13919247 SELENOH selenoprotein H gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SELENOH mRNA PMID:39265697 13919563 GADD45GIP1 GADD45G interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GADD45GIP1 mRNA PMID:35307453 13919583 ATP5MC2 ATP synthase membrane subunit c locus 2 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of ATP5MC2 mRNA PMID:38432436 13919614 STMN1 stathmin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STMN1 mRNA PMID:35307453 13919641 JPT2 Jupiter microtubule associated homolog 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JPT2 mRNA PMID:35307453 13919687 LOC100512181 BTB/POZ domain-containing protein KCTD14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCTD14 mRNA PMID:35307453 13919688 TBL3 transducin beta like 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBL3 mRNA PMID:35307453 13919730 ARPC2 actin related protein 2/3 complex subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARPC2 mRNA PMID:35307453 13919745 ITPKB inositol-trisphosphate 3-kinase B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITPKB mRNA PMID:35307453 13919745 ITPKB inositol-trisphosphate 3-kinase B gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of ITPKB mRNA PMID:34389318 13919820 RAB17 RAB17, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB17 mRNA PMID:35307453 13919920 IGFBP6 insulin like growth factor binding protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFBP6 mRNA PMID:35307453 13919958 DOCK7 dedicator of cytokinesis 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DOCK7 mRNA PMID:35307453 13920049 N6AMT1 N-6 adenine-specific DNA methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of N6AMT1 mRNA PMID:35307453 13920321 PSMD14 proteasome 26S subunit, non-ATPase 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD14 mRNA PMID:35307453 13920321 PSMD14 proteasome 26S subunit, non-ATPase 14 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of PSMD14 mRNA PMID:35839969 13920360 TREM2 triggering receptor expressed on myeloid cells 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TREM2 mRNA PMID:34933075 13920427 ADRA1D adrenoceptor alpha 1D gene CHEBI:8093 phenylephrine increases activity EXP E RGD:6480464 20191114 CTD MESH:D010656 Phenylephrine results in increased activity of ADRA1D protein PMID:19376108 13920609 YRDC yrdC N6-threonylcarbamoyltransferase domain containing gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YRDC mRNA PMID:35307453 13920654 GALNT2 polypeptide N-acetylgalactosaminyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT2 mRNA PMID:35307453 13920729 NSUN7 NOP2/Sun RNA methyltransferase family member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NSUN7 mRNA PMID:35307453 13920774 MDH1 malate dehydrogenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MDH1 mRNA PMID:35307453 13920849 RPGR retinitis pigmentosa GTPase regulator gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of RPGR mRNA PMID:35307453 13920906 CNTROB centrobin, centriole duplication and spindle assembly protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNTROB mRNA PMID:35307453 13921181 KCNK3 potassium two pore domain channel subfamily K member 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of KCNK3 mRNA PMID:34933075 13921225 VTCN1 V-set domain containing T cell activation inhibitor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VTCN1 mRNA PMID:35307453 13921225 VTCN1 V-set domain containing T cell activation inhibitor 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of VTCN1 mRNA PMID:34933075 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOS mRNA PMID:35307453 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20221206 CTD MESH:C007262 deoxynivalenol results in increased expression of FOS mRNA PMID:35314294 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:135697 sarpogrelate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C064294 sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein] PMID:11426759 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:136004 linsidomine increases expression EXP E RGD:6480464 20191114 CTD MESH:C002385 linsidomine results in increased expression of FOS mRNA PMID:18086661 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FOS mRNA PMID:34389318 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of FOS mRNA PMID:18086661|PMID:37706587 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS mRNA] PMID:37706587 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of FOS mRNA PMID:18988085|PMID:27617619 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:27666 actinomycin D multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003609 Dactinomycin inhibits the reaction [Mercuric Chloride results in increased expression of FOS mRNA] PMID:9463523 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:28790 serotonin increases expression EXP E RGD:6480464 20191114 CTD MESH:D012701 Serotonin results in increased expression of FOS mRNA; Serotonin results in increased expression of FOS protein PMID:11426759 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:28790 serotonin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012701 sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein] PMID:11426759 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] PMID:18086661 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of FOS mRNA PMID:21391292 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of FOS mRNA PMID:22533443 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:31823 mercury dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased expression of FOS mRNA; Mercuric Chloride results in increased expression of FOS protein PMID:9463523 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:31823 mercury dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008627 Dactinomycin inhibits the reaction [Mercuric Chloride results in increased expression of FOS mRNA] PMID:9463523 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of FOS mRNA PMID:18086661|PMID:7564105 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] PMID:18086661|PMID:7564105 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS mRNA] PMID:37706587 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:43385 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019307 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] PMID:7564105 13921310 FOS Fos proto-oncogene, AP-1 transcription factor subunit gene CHEBI:83438 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019307 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] PMID:7564105 13921355 LOC100521518 uncharacterized LOC100521518 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TMA7 mRNA PMID:39265697 13921361 CDH17 cadherin 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH17 mRNA PMID:35307453 13921361 CDH17 cadherin 17 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone affects the expression of CDH17 mRNA PMID:34933075 13921415 PCMTD1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCMTD1 mRNA PMID:35307453 13921442 MEGF10 multiple EGF like domains 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEGF10 mRNA PMID:35307453 13921538 CLDN3 claudin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191224 CTD MESH:C007262 deoxynivalenol analog results in decreased expression of CLDN3 protein; deoxynivalenol results in decreased expression of CLDN3 mRNA; deoxynivalenol results in decreased expression of CLDN3 protein PMID:19289138|PMID:22859312|PMID:35307453|PMID:36596350 13921538 CLDN3 claudin 3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]; PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]; T 0070907 inhibits the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein] PMID:36596350 13921538 CLDN3 claudin 3 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of CLDN3 protein PMID:36754226 13921538 CLDN3 claudin 3 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of CLDN3 protein] PMID:36754226 13921538 CLDN3 claudin 3 gene CHEBI:33709 amino acid multiple interactions EXP E RGD:6480464 20191224 CTD MESH:D000596 Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN3 protein] PMID:26338884 13921538 CLDN3 claudin 3 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of CLDN3 protein] PMID:36754226 13921538 CLDN3 claudin 3 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191224 CTD MESH:D004178 Diquat results in decreased expression of CLDN3 protein PMID:26338884 13921538 CLDN3 claudin 3 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20191224 CTD MESH:D004178 Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN3 protein] PMID:26338884 13921538 CLDN3 claudin 3 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C060836 Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein] PMID:36596350 13921538 CLDN3 claudin 3 gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in increased expression of CLDN3 protein PMID:36596350 13921538 CLDN3 claudin 3 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C057693 PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein] PMID:36596350 13921649 IER5L immediate early response 5 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IER5L mRNA PMID:35307453 13921673 LAMA1 laminin subunit alpha 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LAMA1 mRNA PMID:35307453 13921745 PDGFB platelet derived growth factor subunit B gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the secretion of [PDGFB protein binds to PDGFB protein] PMID:15653758 13921745 PDGFB platelet derived growth factor subunit B gene CHEBI:8772 raloxifene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the secretion of [PDGFB protein binds to PDGFB protein] PMID:15653758 13921765 BAG5 BAG cochaperone 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BAG5 mRNA PMID:35307453 13921868 CA3 carbonic anhydrase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CA3 mRNA PMID:35307453 13921879 SLC16A14 solute carrier family 16 member 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A14 mRNA PMID:35307453 13921891 CACNA2D1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 gene CHEBI:42797 gabapentin affects binding EXP E RGD:6480464 20191114 CTD MESH:C040029 Gabapentin binds to CACNA2D1 protein PMID:11687876 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPX4 mRNA PMID:25701311|PMID:35307453 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in decreased expression of GPX4 mRNA] PMID:36281498 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:16112 chlorogenic acid multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D002726 Chlorogenic Acid inhibits the reaction [Mycotoxins results in decreased expression of GPX4 protein] PMID:39137830 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin results in increased expression of GPX4 mRNA PMID:31535366 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in increased expression of GPX4 mRNA PMID:36615853 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPX4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPX4 mRNA PMID:33493553|PMID:34416349 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:25442 mycotoxin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in decreased expression of GPX4 protein PMID:39137830 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of GPX4 protein]; 5'-O-caffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of GPX4 protein]; Chlorogenic Acid inhibits the reaction [Mycotoxins results in decreased expression of GPX4 protein] PMID:39137830 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of GPX4 mRNA] PMID:36281498 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:3259 CCCP multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D002258 Carbonyl Cyanide m-Chlorophenyl Hydrazone promotes the reaction [Diquat results in decreased expression of GPX4 mRNA] PMID:38567716 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of GPX4 mRNA PMID:36615853 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in increased expression of GPX4 mRNA PMID:36615853 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPX4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPX4 mRNA PMID:33493553|PMID:34416349 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:48843 disodium selenite increases activity EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite results in increased activity of GPX4 protein PMID:10998458 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in decreased expression of GPX4 mRNA PMID:38567716 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D004178 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Diquat results in decreased expression of GPX4 mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone promotes the reaction [Diquat results in decreased expression of GPX4 mRNA] PMID:38567716 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of GPX4 mRNA PMID:31535366 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in decreased expression of GPX4 mRNA PMID:36281498 13921981 GPX4 glutathione peroxidase 4 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of GPX4 mRNA]; Taurine inhibits the reaction [ochratoxin A results in decreased expression of GPX4 mRNA] PMID:36281498 13922132 MED6 mediator complex subunit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED6 mRNA PMID:35307453 13922187 ASB4 ankyrin repeat and SOCS box containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB4 mRNA PMID:35307453 13922261 SZT2 SZT2 subunit of KICSTOR complex gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SZT2 mRNA PMID:35307453 13922373 APCDD1 APC down-regulated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APCDD1 mRNA PMID:35307453 13922515 NXPE3 neurexophilin and PC-esterase domain family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NXPE3 mRNA PMID:35307453 13922546 GAL3ST1 galactose-3-O-sulfotransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAL3ST1 mRNA PMID:35307453 13922633 P3H2 prolyl 3-hydroxylase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P3H2 mRNA PMID:35307453 13922889 SPOUT1 SPOUT domain containing methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPOUT1 mRNA PMID:35307453 13922976 BCO1 beta-carotene oxygenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCO1 mRNA PMID:35307453 13922976 BCO1 beta-carotene oxygenase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BCO1 mRNA PMID:39265697 13923035 GNS glucosamine (N-acetyl)-6-sulfatase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNS mRNA PMID:35307453 13923158 CTSF cathepsin F gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSF mRNA PMID:35307453 13923228 ELN elastin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ELN mRNA PMID:35307453 13923306 ARB2A ARB2 cotranscriptional regulator A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARB2A mRNA PMID:37120089 13923306 ARB2A ARB2 cotranscriptional regulator A gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ARB2A mRNA] PMID:37120089 13923306 ARB2A ARB2 cotranscriptional regulator A gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ARB2A mRNA] PMID:37120089 13923397 GFAP glial fibrillary acidic protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GFAP mRNA PMID:35307453 13923609 ITGA8 integrin subunit alpha 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA8 mRNA; deoxynivalenol results in decreased expression of ITGA8 protein PMID:38403181 13923609 ITGA8 integrin subunit alpha 8 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in decreased expression of ITGA8 mRNA PMID:22497863 13923644 PRSS16 serine protease 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS16 mRNA PMID:35307453 13923644 PRSS16 serine protease 16 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PRSS16 mRNA PMID:39265697 13923644 PRSS16 serine protease 16 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PRSS16 mRNA] PMID:21852083 13923755 GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GCNT3 mRNA PMID:34933075 13923809 FN1 fibronectin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of FN1 protein PMID:38403181 13923809 FN1 fibronectin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FN1 mRNA PMID:35307453 13923809 FN1 fibronectin 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A] results in decreased expression of FN1 protein PMID:38848930 13923809 FN1 fibronectin 1 gene CHEBI:17224 4-methylumbelliferone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006923 Hymecromone results in decreased expression of FN1 mRNA; Hymecromone results in decreased expression of FN1 protein PMID:23139787 13923809 FN1 fibronectin 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN1 protein PMID:34416349 13923809 FN1 fibronectin 1 gene CHEBI:2814 arecoline increases expression EXP E RGD:6480464 20191114 CTD MESH:D001115 Arecoline results in increased expression of FN1 protein PMID:26908192 13923809 FN1 fibronectin 1 gene CHEBI:2814 arecoline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001115 pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of FN1 protein] PMID:26908192 13923809 FN1 fibronectin 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in increased expression of FN1 protein PMID:38848930 13923809 FN1 fibronectin 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A] results in decreased expression of FN1 protein PMID:38848930 13923809 FN1 fibronectin 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN1 protein PMID:34416349 13923809 FN1 fibronectin 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of FN1 protein] PMID:26908192 13923908 NIT2 nitrilase family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NIT2 mRNA PMID:35307453 13923958 GALNT6 polypeptide N-acetylgalactosaminyltransferase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT6 mRNA PMID:35307453 13923958 GALNT6 polypeptide N-acetylgalactosaminyltransferase 6 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of GALNT6 mRNA PMID:34933075 13923959 C6H16orf46 chromosome 6 C16orf46 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C6H16ORF46 mRNA PMID:35307453 13924005 JUND JunD proto-oncogene, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JUND mRNA PMID:35307453 13924063 C4H8orf33 chromosome 4 C8orf33 homolog gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol affects the expression of C4H8ORF33 mRNA PMID:35307453 13924387 NCOA1 nuclear receptor coactivator 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of NCOA1 mRNA PMID:34389318 13924523 IL15 interleukin 15 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of IL15 mRNA PMID:37706587 13924523 IL15 interleukin 15 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of IL15 mRNA] PMID:37706587 13924523 IL15 interleukin 15 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of IL15 mRNA] PMID:37706587 13924614 IL12B interleukin 12B gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IL12B mRNA] PMID:27079946 13924656 OTUB2 OTU deubiquitinase, ubiquitin aldehyde binding 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTUB2 mRNA PMID:35307453 13924666 LCA5 lebercilin LCA5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LCA5 mRNA PMID:35307453 13924688 TTC24 tetratricopeptide repeat domain 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC24 mRNA PMID:35307453 13924988 MMP25 matrix metallopeptidase 25 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MMP25 mRNA PMID:35307453 13925002 DPP3 dipeptidyl peptidase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DPP3 mRNA PMID:35307453 13925084 LOC100525249 endonuclease V gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENDOV mRNA PMID:35307453 13925085 HEPACAM2 HEPACAM family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HEPACAM2 mRNA PMID:35307453 13925142 HM13 histocompatibility minor 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HM13 mRNA PMID:35307453 13925273 FLNB filamin B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FLNB mRNA PMID:35307453 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol affects the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA] PMID:17656051 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA]; Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA]; Zearalenone promotes the reaction [FSHB protein results in increased abundance of Progesterone] PMID:17656051 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:16170 mercury(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008628 [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone PMID:20390873 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:16422 androst-4-ene-3,17-dione multiple interactions EXP E RGD:6480464 20211109 CTD MESH:D000735 [FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol; bisphenol AF inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol]; bisphenol S inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol] PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:16469 17beta-estradiol increases chemical synthesis EXP E RGD:6480464 20191114 CTD MESH:D004958 FSHB protein results in increased chemical synthesis of Estradiol PMID:29273543 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 [FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol; [FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol; bisphenol AF inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol]; bisphenol S inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol]; deoxynivalenol affects the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol]; lead acetate inhibits the reaction [FSHB protein results in increased chemical synthesis of Estradiol] PMID:17656051|PMID:29273543|PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:17026 progesterone increases abundance EXP E RGD:6480464 20191114 CTD MESH:D011374 FSHB protein results in increased abundance of Progesterone PMID:17656051|PMID:23375200 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:17026 progesterone increases chemical synthesis EXP E RGD:6480464 20191114 CTD MESH:D011374 FSHB protein results in increased chemical synthesis of Progesterone PMID:20965553 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 4,4'-bisphenol F inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; [FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone; bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol A promotes the reaction [fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; bisphenol AF inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol S inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; fisetin promotes the reaction [bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone; Lapatinib inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; Zearalenone promotes the reaction [FSHB protein results in increased abundance of Progesterone] PMID:17656051|PMID:20390873|PMID:23375200|PMID:29544186|PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:25195 mercury atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008628 [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone PMID:20390873 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:27889 lead(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D007854 [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone PMID:20390873 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:31767 lead diacetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate inhibits the reaction [FSHB protein results in increased chemical synthesis of Estradiol] PMID:29273543 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol A promotes the reaction [fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; fisetin promotes the reaction [bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]] PMID:29544186|PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20211109 CTD MESH:C543008 bisphenol S inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol]; bisphenol S inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone] PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20211109 CTD MESH:C008745 4,4'-bisphenol F inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone] PMID:34019995 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:42567 fisetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017875 bisphenol A promotes the reaction [fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; fisetin promotes the reaction [bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]] PMID:29544186 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:49603 lapatinib decreases activity EXP E RGD:6480464 20191114 CTD MESH:C490728 Lapatinib results in decreased activity of FSHB protein PMID:23375200 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:49603 lapatinib multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C490728 Lapatinib inhibits the reaction [FSHB protein results in increased abundance of Progesterone] PMID:23375200 13925527 FSHB follicle stimulating hormone subunit beta gene CHEBI:72754 bisphenol AF multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF inhibits the reaction [[FSHB protein co-treated with Androstenedione] results in increased chemical synthesis of and results in increased secretion of Estradiol]; bisphenol AF inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone] PMID:34019995 13925534 SUGT1 SGT1 homolog, MIS12 kinetochore complex assembly cochaperone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SUGT1 mRNA PMID:35307453 13925552 PPP4R2 protein phosphatase 4 regulatory subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP4R2 mRNA PMID:35307453 13925730 C2H11orf24 chromosome 2 C11orf24 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of C2H11ORF24 mRNA PMID:35307453 13925844 RALA RAS like proto-oncogene A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RALA mRNA PMID:35307453 13925899 SH3TC1 SH3 domain and tetratricopeptide repeats 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3TC1 mRNA PMID:35307453 13926035 BAIAP2L1 BAR/IMD domain containing adaptor protein 2 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BAIAP2L1 mRNA PMID:35307453 13926188 PMM1 phosphomannomutase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PMM1 mRNA PMID:35307453 13926238 SYT7 synaptotagmin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYT7 mRNA PMID:35307453 13926418 PRIM2 DNA primase subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRIM2 mRNA PMID:35307453 13926575 DPRX divergent-paired related homeobox gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPRX mRNA PMID:35307453 13926666 SNRPC small nuclear ribonucleoprotein polypeptide C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPC mRNA PMID:35307453 13926728 ADAMTS13 ADAM metallopeptidase with thrombospondin type 1 motif 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTS13 mRNA PMID:35307453 13926907 STK10 serine/threonine kinase 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STK10 mRNA PMID:35307453 13927045 MTARC1 mitochondrial amidoxime reducing component 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTARC1 mRNA PMID:35307453 13927088 ANKRD55 ankyrin repeat domain 55 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKRD55 mRNA PMID:35307453 13927251 ABI3BP ABI family member 3 binding protein gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of ABI3BP mRNA PMID:34389318 13927395 EFL1 elongation factor like GTPase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EFL1 mRNA PMID:35307453 13927430 H2AX H2A.X variant histone gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased expression of and results in increased phosphorylation of H2AX protein PMID:38104654 13927430 H2AX H2A.X variant histone gene CHEBI:146195 3-acetyldeoxynivalenol increases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased expression of H2AX protein PMID:37659622 13927430 H2AX H2A.X variant histone gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of H2AX protein] PMID:37659622 13927430 H2AX H2A.X variant histone gene CHEBI:15428 glycine decreases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in decreased expression of H2AX protein PMID:39127149 13927430 H2AX H2A.X variant histone gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of H2AX protein] PMID:39127149 13927430 H2AX H2A.X variant histone gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20230704 CTD MESH:D008070 Lipopolysaccharides results in increased expression of H2AX protein PMID:36549457 13927430 H2AX H2A.X variant histone gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D008070 Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of H2AX protein] PMID:36549457 13927430 H2AX H2A.X variant histone gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C059514 Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of H2AX protein] PMID:36549457 13927430 H2AX H2A.X variant histone gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of H2AX protein PMID:36754226 13927430 H2AX H2A.X variant histone gene CHEBI:4027 cyclophosphamide increases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in increased expression of H2AX protein PMID:37980972 13927430 H2AX H2A.X variant histone gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in increased expression of H2AX protein] PMID:37980972 13927430 H2AX H2A.X variant histone gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in increased expression of H2AX protein] PMID:30923867 13927430 H2AX H2A.X variant histone gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of H2AX protein PMID:30923867|PMID:32454083 13927430 H2AX H2A.X variant histone gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in increased expression of H2AX protein]; Decitabine inhibits the reaction [ochratoxin A results in increased expression of H2AX protein]; STAT3 protein affects the reaction [ochratoxin A results in increased expression of H2AX protein] PMID:30923867 13927430 H2AX H2A.X variant histone gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in increased expression of H2AX protein] PMID:37980972 13927430 H2AX H2A.X variant histone gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in increased expression of H2AX protein PMID:39127149 13927430 H2AX H2A.X variant histone gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of H2AX protein] PMID:39127149 13927430 H2AX H2A.X variant histone gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of H2AX protein] PMID:37659622 13927580 UBB ubiquitin B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBB mRNA PMID:35307453 13927639 SLC46A2 solute carrier family 46 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC46A2 mRNA PMID:35307453 13927650 PRKAB1 protein kinase AMP-activated non-catalytic subunit beta 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAB1 mRNA PMID:34416349 13927650 PRKAB1 protein kinase AMP-activated non-catalytic subunit beta 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAB1 mRNA PMID:34416349 13927680 SMU1 SMU1 DNA replication regulator and spliceosomal factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMU1 mRNA PMID:35307453 13927718 BBOX1 gamma-butyrobetaine hydroxylase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BBOX1 mRNA PMID:35307453 13927856 SMTNL2 smoothelin like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMTNL2 mRNA PMID:35307453|PMID:37257635 13927856 SMTNL2 smoothelin like 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SMTNL2 mRNA PMID:39265697 13927957 FARP1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FARP1 mRNA PMID:35307453 13928116 TTC17 tetratricopeptide repeat domain 17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTC17 mRNA PMID:35307453 13928153 SEMA6B semaphorin 6B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA6B mRNA PMID:35307453 13928301 IDH3B isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IDH3B mRNA PMID:35307453 13928330 RAMP1 receptor activity modifying protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAMP1 mRNA PMID:35307453 13928365 AXDND1 axonemal dynein light chain domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AXDND1 mRNA PMID:35307453 13928608 C2CD4B C2 calcium dependent domain containing 4B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of C2CD4B mRNA PMID:35307453 13928800 CHRM4 cholinergic receptor muscarinic 4 gene CHEBI:5720 himbacine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C048172 himbacine inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM4 protein] PMID:8744975 13928800 CHRM4 cholinergic receptor muscarinic 4 gene CHEBI:9757 Tropicamide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014331 Tropicamide inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM4 protein] PMID:8744975 13928806 S100A4 S100 calcium binding protein A4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A4 mRNA PMID:35307453 13928824 MPC1 mitochondrial pyruvate carrier 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MPC1 mRNA PMID:35307453 13929008 SHQ1 SHQ1, H/ACA ribonucleoprotein assembly factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SHQ1 mRNA PMID:35307453 13929027 LBP lipopolysaccharide binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LBP mRNA PMID:35307453 13929046 PLCH1 phospholipase C eta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLCH1 mRNA PMID:35307453 13929150 CYP11B2 cytochrome P450 family 11 subfamily B member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYP11B2 mRNA PMID:35307453 13929227 SLFN11 schlafen family member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLFN11 mRNA; deoxynivalenol results in decreased expression of SLFN11 protein PMID:38403181 13929241 C5H22orf23 chromosome 5 C22orf23 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C5H22ORF23 mRNA PMID:35307453 13929274 SLC4A4 solute carrier family 4 member 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SLC4A4 mRNA] PMID:21852083 13929361 MBTD1 mbt domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MBTD1 mRNA PMID:35307453 13929698 COPS5 COP9 signalosome subunit 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COPS5 mRNA PMID:35307453 13929728 GHSR growth hormone secretagogue receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GHSR mRNA PMID:35307453 13929825 SLC34A2 solute carrier family 34 member 2 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of SLC34A2 mRNA PMID:31535366 13929843 ID2 inhibitor of DNA binding 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ID2 mRNA PMID:35307453 13929843 ID2 inhibitor of DNA binding 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ID2 mRNA PMID:39265697 13929843 ID2 inhibitor of DNA binding 2 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of ID2 mRNA PMID:14994279 13930017 ZNF385B zinc finger protein 385B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF385B mRNA PMID:35307453 13930129 C1RL complement C1r subcomponent like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C1RL mRNA PMID:35307453 13930235 LOXL2 lysyl oxidase like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LOXL2 mRNA; deoxynivalenol results in decreased expression of LOXL2 protein PMID:38403181 13930294 DCLK3 doublecortin like kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DCLK3 mRNA PMID:35307453 13930320 MRPL42 mitochondrial ribosomal protein L42 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL42 mRNA PMID:35307453 13930334 PSMD8 proteasome 26S subunit, non-ATPase 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD8 mRNA PMID:35307453 13930373 TMF1 TATA element modulatory factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMF1 mRNA PMID:35307453 13930398 C8H4orf19 chromosome 8 C4orf19 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C8H4ORF19 mRNA PMID:35307453 13930455 WIPI1 WD repeat domain, phosphoinositide interacting 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WIPI1 mRNA PMID:35307453 13930669 NTRK1 neurotrophic receptor tyrosine kinase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NTRK1 mRNA PMID:39265697 13930669 NTRK1 neurotrophic receptor tyrosine kinase 1 gene CHEBI:64310 crizotinib decreases activity EXP E RGD:6480464 20191114 CTD MESH:C551994 Crizotinib results in decreased activity of NTRK1 protein PMID:21812414 13930697 AVP vasopressin gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of AVP mRNA PMID:34389318 13930729 REEP5 receptor accessory protein 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of REEP5 mRNA PMID:21852083 13930830 ZNF593 zinc finger protein 593 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF593 mRNA PMID:35307453 13930940 PFDN5 prefoldin subunit 5 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20250225 CTD MESH:C025589 ochratoxin A results in decreased expression of PFDN5 mRNA PMID:14994279 13930994 CCDC88C coiled-coil domain containing 88C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC88C mRNA PMID:35307453 13931032 JUP junction plakoglobin gene CHEBI:3441 carvedilol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in decreased expression of JUP mRNA PMID:16824628 13931032 JUP junction plakoglobin gene CHEBI:3441 carvedilol increases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in increased expression of JUP protein PMID:16824628 13931252 LAPTM4B lysosomal protein transmembrane 4 beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAPTM4B mRNA PMID:35307453 13931305 PPIL6 peptidylprolyl isomerase like 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPIL6 mRNA PMID:35307453 13931401 SCPEP1 serine carboxypeptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCPEP1 mRNA PMID:35307453 13931401 SCPEP1 serine carboxypeptidase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SCPEP1 mRNA PMID:21852083 13931460 DNAL1 dynein axonemal light chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAL1 mRNA PMID:35307453 13931505 THRSP thyroid hormone responsive gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THRSP mRNA PMID:35307453 13931656 SLC26A3 solute carrier family 26 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC26A3 mRNA PMID:35307453 13931769 ATP4A ATPase H+/K+ transporting subunit alpha gene CHEBI:30751 formic acid decreases expression EXP E RGD:6480464 20191114 CTD MESH:C030544 formic acid results in decreased expression of ATP4A mRNA PMID:16614409 13931769 ATP4A ATPase H+/K+ transporting subunit alpha gene CHEBI:77543 ebselen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C042986 ebselen results in decreased activity of [ATP4A protein binds to ATP4B protein] PMID:7590103 13931888 RPL7L1 ribosomal protein L7 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPL7L1 mRNA PMID:35307453 13931933 WDR19 WD repeat domain 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR19 mRNA; deoxynivalenol results in decreased expression of WDR19 protein PMID:35307453|PMID:38403181 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCL20 mRNA PMID:35307453 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CCL20 mRNA PMID:23326479|PMID:35314294 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA] PMID:30708112 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CCL20 mRNA PMID:25455459 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CCL20 mRNA PMID:39265697 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of CCL20 mRNA PMID:37706587 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL20 mRNA] PMID:37706587 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA] PMID:30708112 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL20 mRNA] PMID:37706587 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of CCL20 mRNA PMID:30708112 13932142 CCL20 C-C motif chemokine ligand 20 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA] PMID:30708112 13932207 IGSF3 immunoglobulin superfamily member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGSF3 mRNA PMID:35307453 13932207 IGSF3 immunoglobulin superfamily member 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IGSF3 mRNA PMID:34933075 13932224 TYR tyrosinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TYR mRNA PMID:35307453 13932283 RNASET2 ribonuclease T2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNASET2 mRNA PMID:35307453 13932374 TJP1 tight junction protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of TJP1 mRNA; deoxynivalenol results in decreased expression of TJP1 protein PMID:20937367|PMID:35307453|PMID:35381244|PMID:37120089|PMID:37442268 13932374 TJP1 tight junction protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of TJP1 mRNA PMID:26417708 13932374 TJP1 tight junction protein 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]]; Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein] PMID:32877744|PMID:35381244|PMID:37120089|PMID:37442268 13932374 TJP1 tight junction protein 1 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of TJP1 protein PMID:37659622 13932374 TJP1 tight junction protein 1 gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of TJP1 mRNA; Hydrogen Peroxide results in decreased expression of TJP1 protein PMID:38438008 13932374 TJP1 tight junction protein 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein] PMID:38438008 13932374 TJP1 tight junction protein 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of TJP1 mRNA; Lipopolysaccharides results in decreased expression of TJP1 protein PMID:32877744 13932374 TJP1 tight junction protein 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]] PMID:32877744 13932374 TJP1 tight junction protein 1 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin results in increased expression of TJP1 protein PMID:37120089 13932374 TJP1 tight junction protein 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein] PMID:37120089 13932374 TJP1 tight junction protein 1 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in decreased expression of TJP1 protein] PMID:36615853 13932374 TJP1 tight junction protein 1 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein] PMID:38438008 13932374 TJP1 tight junction protein 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein] PMID:37442268 13932374 TJP1 tight junction protein 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of TJP1 mRNA PMID:31677563 13932374 TJP1 tight junction protein 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of TJP1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of TJP1 protein] PMID:37955343 13932374 TJP1 tight junction protein 1 gene CHEBI:27915 melamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in decreased expression of TJP1 protein PMID:30055240 13932374 TJP1 tight junction protein 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein] PMID:35381244 13932374 TJP1 tight junction protein 1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of TJP1 protein PMID:36754226 13932374 TJP1 tight junction protein 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of TJP1 protein] PMID:36754226 13932374 TJP1 tight junction protein 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of TJP1 protein PMID:37108405 13932374 TJP1 tight junction protein 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of TJP1 protein] PMID:37108405 13932374 TJP1 tight junction protein 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in decreased expression of TJP1 protein PMID:36615853 13932374 TJP1 tight junction protein 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in decreased expression of TJP1 protein] PMID:36615853 13932374 TJP1 tight junction protein 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein] PMID:37442268 13932374 TJP1 tight junction protein 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in decreased expression of TJP1 mRNA; fumonisin B1 results in decreased expression of TJP1 protein PMID:31557363|PMID:37955343 13932374 TJP1 tight junction protein 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of TJP1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of TJP1 protein] PMID:37955343 13932374 TJP1 tight junction protein 1 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of TJP1 protein] PMID:36754226 13932374 TJP1 tight junction protein 1 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of TJP1 protein] PMID:37108405 13932374 TJP1 tight junction protein 1 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 protein] PMID:39305878 13932374 TJP1 tight junction protein 1 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in decreased expression of TJP1 protein PMID:26338884 13932374 TJP1 tight junction protein 1 gene CHEBI:7719 ochratoxin A affects localization EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A affects the localization of TJP1 protein PMID:14994279 13932374 TJP1 tight junction protein 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein] PMID:38438008 13932374 TJP1 tight junction protein 1 gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased expression of TJP1 mRNA; T-2 Toxin results in decreased expression of TJP1 protein PMID:39305878 13932374 TJP1 tight junction protein 1 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of TJP1 protein] PMID:39305878 13932437 IL1RL1 interleukin 1 receptor like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IL1RL1 mRNA PMID:35307453 13932478 FKBP9 FKBP prolyl isomerase 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FKBP9 mRNA PMID:35307453 13932580 S100A13 S100 calcium binding protein A13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A13 mRNA PMID:35307453 13932597 CKMT1A creatine kinase, mitochondrial 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CKMT1A mRNA PMID:35307453 13932919 LIPM lipase family member M gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LIPM mRNA PMID:35307453 13933026 FCER2 Fc epsilon receptor II gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FCER2 mRNA PMID:35307453 13933079 GHR growth hormone receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GHR mRNA PMID:35307453 13933124 PLAG1 PLAG1 zinc finger gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLAG1 mRNA PMID:35307453 13933449 TMED6 transmembrane p24 trafficking protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMED6 mRNA PMID:35307453 13933457 COL4A4 collagen type IV alpha 4 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL4A4 mRNA PMID:35307453 13933573 ACLY ATP citrate lyase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACLY mRNA PMID:35307453 13933642 CLRN3 clarin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLRN3 mRNA PMID:35307453 13933847 NPTX1 neuronal pentraxin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPTX1 mRNA PMID:35307453 13933881 ELAPOR1 endosome-lysosome associated apoptosis and autophagy regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ELAPOR1 mRNA PMID:35307453 13933927 PTGDR2 prostaglandin D2 receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGDR2 mRNA PMID:35307453 13933940 ACE angiotensin I converting enzyme gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACE mRNA PMID:35307453 13933940 ACE angiotensin I converting enzyme gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] PMID:12672649 13934087 RPL38 ribosomal protein L38 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL38 mRNA PMID:39265697 13934101 EBF2 EBF transcription factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EBF2 mRNA PMID:35307453 13934245 APOBEC1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of APOBEC1 mRNA PMID:35307453 13934399 SULT2B1 sulfotransferase family 2B member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULT2B1 mRNA PMID:35307453 13934417 IL2RG interleukin 2 receptor subunit gamma gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of IL2RG mRNA PMID:21391292 13934417 IL2RG interleukin 2 receptor subunit gamma gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of IL2RG mRNA PMID:22497863 13934436 IL2RB interleukin 2 receptor subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL2RB mRNA PMID:35307453 13934464 TIAM1 TIAM Rac1 associated GEF 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TIAM1 mRNA PMID:35307453 13934540 STRIP2 striatin interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STRIP2 mRNA PMID:35307453 13934540 STRIP2 striatin interacting protein 2 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of STRIP2 mRNA PMID:35839969 13934691 PRKG1 protein kinase cGMP-dependent 1 gene CHEBI:16356 3',5'-cyclic GMP increases activity EXP E RGD:6480464 20191114 CTD MESH:D006152 Cyclic GMP results in increased activity of PRKG1 protein PMID:18037907 13934691 PRKG1 protein kinase cGMP-dependent 1 gene CHEBI:18421 superoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013481 Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] PMID:18037907 13934691 PRKG1 protein kinase cGMP-dependent 1 gene CHEBI:28787 nitroglycerin affects expression EXP E RGD:6480464 20191114 CTD MESH:D005996 Nitroglycerin affects the expression of PRKG1 mRNA; Nitroglycerin affects the expression of PRKG1 protein PMID:18037907 13934691 PRKG1 protein kinase cGMP-dependent 1 gene CHEBI:28787 nitroglycerin increases activity EXP E RGD:6480464 20191114 CTD MESH:D005996 Nitroglycerin results in increased activity of PRKG1 protein PMID:18037907 13934691 PRKG1 protein kinase cGMP-dependent 1 gene CHEBI:28787 nitroglycerin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005996 Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] PMID:18037907 13934799 GABRB1 gamma-aminobutyric acid type A receptor subunit beta1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GABRB1 mRNA PMID:35307453 13934964 ISYNA1 inositol-3-phosphate synthase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ISYNA1 mRNA PMID:35307453 13934989 CLTRN collectrin, amino acid transport regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLTRN mRNA PMID:35307453 13935033 CFAP91 cilia and flagella associated protein 91 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP91 mRNA PMID:35307453 13935221 CACNA1D calcium voltage-gated channel subunit alpha1 D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CACNA1D mRNA PMID:35307453 13935427 CDC26 cell division cycle 26 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CDC26 mRNA] PMID:35839969 13935427 CDC26 cell division cycle 26 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of CDC26 mRNA PMID:35839969 13935427 CDC26 cell division cycle 26 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CDC26 mRNA] PMID:35839969 13935506 PROSER1 proline and serine rich 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PROSER1 mRNA PMID:35307453 13935604 MEX3A mex-3 RNA binding family member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MEX3A mRNA PMID:35307453 13935610 MAGOHB mago homolog B, exon junction complex subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAGOHB mRNA PMID:35307453 13935638 FAM167A family with sequence similarity 167 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM167A mRNA PMID:35307453 13935646 PCDH7 protocadherin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCDH7 mRNA PMID:35307453 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C007262 deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA] PMID:17656051 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20210803 CTD MESH:D015025 Zearalenone results in decreased expression of CYP19A1 protein PMID:29758222 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D015025 Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA] PMID:17656051 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D015237 [epostane co-treated with Dinoprost] results in increased expression of CYP19A1 mRNA PMID:20739670 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:16598 DDE increases activity EXP E RGD:6480464 20210803 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased activity of CYP19A1 protein PMID:18195494 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of CYP19A3 mRNA PMID:38848930 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D013739 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Testosterone] affects the activity of CYP19A1 protein; [3,4,5,3',4'-pentachlorobiphenyl co-treated with Testosterone] results in increased activity of CYP19A1 protein PMID:16151981 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20210803 CTD MESH:D009538 Nicotine results in decreased expression of CYP19A1 mRNA PMID:32423882 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20210803 CTD MESH:D009538 Nicotine results in decreased expression of CYP19A1 mRNA PMID:32423882 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D001564 Benzo(a)pyrene inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein] PMID:28284726 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20210803 CTD MESH:C006780 bisphenol A results in increased expression of CYP19A1 protein PMID:28284726 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C006780 bisphenol A inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein] PMID:28284726 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases activity EXP E RGD:6480464 20210803 CTD MESH:C016340 o,p'-DDT results in increased activity of CYP19A1 protein PMID:18195494 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl decreases activity EXP E RGD:6480464 20210803 CTD MESH:C014024 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CYP19A1 protein PMID:16151981 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C014024 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Testosterone] affects the activity of CYP19A1 protein PMID:16151981 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34211 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene increases activity EXP E RGD:6480464 20210803 CTD MESH:C054919 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased activity of CYP19A1 protein PMID:18195494 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases activity EXP E RGD:6480464 20210803 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP19A1 protein PMID:16151981 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C023035 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Testosterone] results in increased activity of CYP19A1 protein PMID:16151981 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34372 4,4'-sulfonyldiphenol affects expression EXP E RGD:6480464 20210803 CTD MESH:C543008 bisphenol S affects the expression of CYP19A1 protein PMID:28352085 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression EXP E RGD:6480464 20210803 CTD MESH:C543008 bisphenol S results in decreased expression of CYP19A1 mRNA PMID:28352085 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:47136 pentachlorobenzene increases expression EXP E RGD:6480464 20210803 CTD MESH:C003060 pentachlorobenzene results in increased expression of CYP19A1 protein PMID:21296658 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:5692 hexachlorobenzene decreases expression EXP E RGD:6480464 20210803 CTD MESH:D006581 Hexachlorobenzene results in decreased expression of CYP19A1 protein PMID:21296658 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20210803 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CYP19A1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP19A1 protein PMID:23146758|PMID:28284726 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of and results in increased activity of CYP19A1 protein; 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein]; Fadrozole inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of and results in increased activity of CYP19A1 protein] PMID:23146758|PMID:28284726 13935674 CYP19A3 cytochrome P450 19A3 gene CHEBI:94355 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D017316 Fadrozole inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of and results in increased activity of CYP19A1 protein] PMID:23146758 13935813 CDC42EP2 CDC42 effector protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDC42EP2 mRNA PMID:35307453 13935823 NNT nicotinamide nucleotide transhydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NNT mRNA; deoxynivalenol results in decreased expression of NNT protein PMID:35307453|PMID:38403181 13935931 PGF placental growth factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGF mRNA PMID:35307453 13935931 PGF placental growth factor gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of PGF mRNA PMID:21391292 13935945 IL19 interleukin 19 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IL19 mRNA PMID:39265697 13936028 LRIF1 ligand dependent nuclear receptor interacting factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRIF1 mRNA PMID:35307453 13936115 AMD1 adenosylmethionine decarboxylase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AMD1 mRNA PMID:35307453 13936139 NMT1 N-myristoyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NMT1 mRNA PMID:35307453 13936211 FKBP1A FKBP prolyl isomerase 1A gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of FKBP1A mRNA PMID:28069986 13936229 PLCXD3 phosphatidylinositol specific phospholipase C X domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLCXD3 mRNA PMID:35307453 13936343 CLGN calmegin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CLGN mRNA PMID:35307453 13936424 FBXO32 F-box protein 32 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FBXO32 mRNA PMID:35307453 13936424 FBXO32 F-box protein 32 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of FBXO32 mRNA PMID:27617619 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:15846 NAD(+) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009243 NAD promotes the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:16240 hydrogen peroxide decreases activity EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in decreased activity of ALDH7A1 protein PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein]; Mercaptoethanol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein]; NAD promotes the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:18320 1,4-dithiothreitol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:41218 mercaptoethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008623 Mercaptoethanol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:42106 L-1,4-dithiothreitol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936746 ALDH7A1 aldehyde dehydrogenase 7 family member A1 gene CHEBI:44215 NAD zwitterion multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009243 NAD promotes the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] PMID:21296058 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNM1L mRNA PMID:35307453 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNM1L mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNM1L protein PMID:33493553 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine results in increased expression of DNM1L protein] PMID:23347876 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of DNM1L mRNA; Paraquat results in increased expression of DNM1L protein PMID:34811946 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]]; MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]; MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]] PMID:34811946 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNM1L mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNM1L protein PMID:33493553 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of DNM1L mRNA PMID:38705344 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of DNM1L mRNA] PMID:38705344 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]] PMID:34811946 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:4031 cyclosporin A increases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in increased expression of DNM1L protein PMID:23347876 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine results in increased expression of DNM1L protein] PMID:23347876 13936768 FGD4 FYVE, RhoGEF and PH domain containing 4 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]] PMID:34811946 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of ADIPOR2 protein PMID:28284726 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:17347 testosterone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013739 Testosterone results in decreased expression of ADIPOR2 protein PMID:28284726 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADIPOR2 protein PMID:28284726 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of ADIPOR2 protein PMID:28284726 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:5692 hexachlorobenzene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene results in decreased expression of ADIPOR2 protein PMID:28284726 13936837 ADIPOR2 adiponectin receptor 2 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADIPOR2 protein PMID:28284726 13936954 HSP90AA1 heat shock protein 90 alpha family class A member 1 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in decreased expression of HSP90AA1 mRNA PMID:36615853 13936954 HSP90AA1 heat shock protein 90 alpha family class A member 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in decreased expression of HSP90AA1 mRNA PMID:36615853 13936964 PLD3 phospholipase D family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLD3 mRNA PMID:35307453 13937040 LYPD5 LY6/PLAUR domain containing 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LYPD5 mRNA PMID:35307453 13937049 SKP2 S-phase kinase associated protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SKP2 mRNA PMID:35307453 13937075 TOMT transmembrane O-methyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20241224 CTD MESH:C007262 deoxynivalenol results in decreased expression of TOMT mRNA PMID:35307453 13937083 PKD2 polycystin 2, transient receptor potential cation channel gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKD2 mRNA PMID:35307453 13937150 FBXO5 F-box protein 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of FBXO5 mRNA PMID:21852083 13937253 PTPN11 protein tyrosine phosphatase non-receptor type 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPN11 mRNA PMID:35307453 13937284 CCDC50 coiled-coil domain containing 50 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC50 mRNA PMID:35307453 13937543 PDE1A phosphodiesterase 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDE1A mRNA PMID:35307453 13937601 XRCC1 X-ray repair cross complementing 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in increased expression of XRCC1 protein PMID:32454083 13937721 IFT56 intraflagellar transport 56 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT56 mRNA PMID:35307453 13937758 CYP21A1 cytochrome P450 family 21 subfamily A member 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CYP21A1 mRNA PMID:34933075 13937928 STK33 serine/threonine kinase 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STK33 mRNA PMID:35307453 13938173 RFX2 regulatory factor X2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RFX2 mRNA; deoxynivalenol results in decreased expression of RFX2 protein PMID:35307453|PMID:38403181 13938213 S100A8 S100 calcium binding protein A8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A8 mRNA PMID:35307453 13938213 S100A8 S100 calcium binding protein A8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of S100A8 mRNA PMID:34933075 13938339 CMKLR2 chemerin chemokine-like receptor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CMKLR2 mRNA PMID:34933075 13938394 CALCB calcitonin-related polypeptide beta gene CHEBI:17489 3',5'-cyclic AMP increases abundance EXP E RGD:6480464 20191114 CTD MESH:D000242 CALCA protein results in increased abundance of Cyclic AMP PMID:18463244 13938394 CALCB calcitonin-related polypeptide beta gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020106 Acrylamide results in increased expression of CALCA protein PMID:30222996 13938412 E2F1 E2F transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of E2F1 mRNA PMID:35307453 13938614 NOP56 NOP56 ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOP56 mRNA PMID:35307453 13938670 ISG12(A) putative ISG12(a) protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ISG12(A) mRNA PMID:35307453 13938780 NUPR1 nuclear protein 1, transcriptional regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUPR1 mRNA PMID:35307453 13938806 TMEM53 transmembrane protein 53 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM53 mRNA PMID:35307453 13938817 PUS7 pseudouridine synthase 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PUS7 mRNA PMID:35307453 13938846 MAP2K6 mitogen-activated protein kinase kinase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP2K6 mRNA PMID:35307453 13938846 MAP2K6 mitogen-activated protein kinase kinase 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MAP2K6 mRNA PMID:39265697 13938894 TPO thyroid peroxidase gene CHEBI:132103 sodium perchlorate decreases activity EXP E RGD:6480464 20191114 CTD MESH:C031068 sodium perchlorate results in decreased activity of TPO protein PMID:23959146 13938894 TPO thyroid peroxidase gene CHEBI:28869 menadione decreases activity EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in decreased activity of TPO protein PMID:11815678 13938894 TPO thyroid peroxidase gene CHEBI:34292 1,3-benzothiazole-2-thiol decreases activity EXP E RGD:6480464 20191114 CTD MESH:C005563 captax results in decreased activity of TPO protein PMID:23959146|PMID:25953703 13938894 TPO thyroid peroxidase gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of TPO mRNA PMID:16896063 13938894 TPO thyroid peroxidase gene CHEBI:45993 benzothiazole decreases activity EXP E RGD:6480464 20191114 CTD MESH:C005465 benzothiazole results in decreased activity of TPO protein PMID:25953703 13938894 TPO thyroid peroxidase gene CHEBI:50673 methimazole decreases activity EXP E RGD:6480464 20191114 CTD MESH:D008713 Methimazole results in decreased activity of TPO protein PMID:23959146 13938894 TPO thyroid peroxidase gene CHEBI:64215 2,3-dimethoxynaphthalene-1,4-dione decreases activity EXP E RGD:6480464 20191114 CTD MESH:C063002 2,3-dimethoxy-1,4-naphthoquinone results in decreased activity of TPO protein PMID:11815678 13938894 TPO thyroid peroxidase gene CHEBI:8502 6-propyl-2-thiouracil decreases activity EXP E RGD:6480464 20191114 CTD MESH:D011441 Propylthiouracil results in decreased activity of TPO protein PMID:23959146 13939000 SPRYD3 SPRY domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPRYD3 mRNA PMID:35307453 13939165 PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of PRKAA1 protein PMID:35307453 13939165 PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased phosphorylation of and results in increased activity of PRKAA1 protein PMID:15967841 13939165 PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKAA1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAA1 mRNA PMID:33592257|PMID:34416349 13939165 PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKAA1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAA1 mRNA PMID:33592257|PMID:34416349 13939256 MOCS3 molybdenum cofactor synthesis 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MOCS3 mRNA PMID:35307453 13939397 LONRF2 LON peptidase N-terminal domain and ring finger 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LONRF2 mRNA PMID:35307453 13939474 ACOX2 acyl-CoA oxidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACOX2 mRNA PMID:35307453 13939729 FAM110B family with sequence similarity 110 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM110B mRNA PMID:35307453 13939729 FAM110B family with sequence similarity 110 member B gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FAM110B mRNA PMID:39265697 13939765 TCF23 transcription factor 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCF23 mRNA PMID:35307453 13939780 PLA2G6 phospholipase A2 group VI gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLA2G6 mRNA PMID:35307453 13939886 RPL13A ribosomal protein L13a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL13A mRNA PMID:39265697 13939886 RPL13A ribosomal protein L13a gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of RPL13A mRNA PMID:28069986 13940017 LARP4 La ribonucleoprotein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LARP4 mRNA PMID:35307453 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RIPK3 mRNA PMID:35307453 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 protein] PMID:35665993 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of RIPK3 mRNA; tetrabromobisphenol A results in increased expression of RIPK3 protein PMID:35665993 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 protein] PMID:35665993 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of RIPK3 mRNA; Cadmium Chloride results in increased expression of RIPK3 protein PMID:33626375 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of RIPK3 mRNA; fumonisin B1 results in increased expression of RIPK3 protein PMID:38705344 13940123 RIPK3 receptor interacting serine/threonine kinase 3 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 protein] PMID:38705344 13940164 MYEF2 myelin expression factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYEF2 mRNA PMID:35307453 13940247 SETD9 SET domain containing 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SETD9 mRNA PMID:35307453 13940303 TCEA3 transcription elongation factor A3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCEA3 mRNA PMID:35307453 13940339 ZBTB21 zinc finger and BTB domain containing 21 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBTB21 protein PMID:37257635 13940349 LAX1 lymphocyte transmembrane adaptor 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of LAX1 mRNA PMID:34389318 13940839 CCT7 chaperonin containing TCP1 subunit 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT7 mRNA PMID:35307453 13940884 CD3E CD3 epsilon subunit of T-cell receptor complex gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CD3E mRNA PMID:34389318 13940898 MED15 mediator complex subunit 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED15 mRNA PMID:35307453 13941100 TG thyroglobulin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TG mRNA PMID:35307453 13941211 TUBB tubulin beta class I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in increased expression of TUBB3 mRNA PMID:35307453 13941211 TUBB tubulin beta class I gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250715 CTD MESH:C000628730 graphene oxide results in increased expression of TUBB3 mRNA PMID:39265697 13941219 MPST mercaptopyruvate sulfurtransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MPST mRNA PMID:35307453 13941229 CYP3A39 cytochrome P450 3A39 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CYP3A39 mRNA PMID:34389318 13941229 CYP3A39 cytochrome P450 3A39 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in increased expression of CYP3A39 mRNA] PMID:36615853 13941229 CYP3A39 cytochrome P450 3A39 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of CYP3A39 mRNA PMID:36615853 13941229 CYP3A39 cytochrome P450 3A39 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in increased expression of CYP3A39 mRNA] PMID:36615853 13941337 MRPS18B mitochondrial ribosomal protein S18B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS18B mRNA PMID:35307453 13941512 VLDLR very low density lipoprotein receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of VLDLR mRNA; deoxynivalenol results in decreased expression of VLDLR protein PMID:38403181 13941549 ZGRF1 zinc finger GRF-type containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZGRF1 mRNA PMID:35307453 13941592 RGS16 regulator of G protein signaling 16 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of RGS16 mRNA PMID:25455459 13941689 SLC25A19 solute carrier family 25 member 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A19 mRNA PMID:35307453 13941762 HYOU1 hypoxia up-regulated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of HYOU1 mRNA; deoxynivalenol results in decreased expression of HYOU1 protein PMID:38403181 13941762 HYOU1 hypoxia up-regulated 1 gene CHEBI:35456 cadmium dichloride decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D019256 HYOU1 results in decreased susceptibility to Cadmium Chloride PMID:17464326 13941762 HYOU1 hypoxia up-regulated 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of HYOU1 mRNA PMID:35839969 13941875 TRAPPC5 trafficking protein particle complex subunit 5 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of TRAPPC5 mRNA PMID:28069986 13941889 ATP5PB ATP synthase peripheral stalk-membrane subunit b gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of ATP5PB mRNA PMID:38432436 13942012 ASB9 ankyrin repeat and SOCS box containing 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB9 mRNA PMID:35307453 13942080 PELI2 pellino E3 ubiquitin protein ligase family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PELI2 mRNA PMID:35307453 13942090 DCLK1 doublecortin like kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCLK1 mRNA PMID:35307453 13942090 DCLK1 doublecortin like kinase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of DCLK1 mRNA PMID:39265697 13942236 ITGB4 integrin subunit beta 4 gene CHEBI:25434 bis(2-chloroethyl) sulfide affects expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas affects the expression of ITGB4 protein PMID:9285538 13942570 PRICKLE2 prickle planar cell polarity protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRICKLE2 mRNA PMID:35307453 13942801 REXO4 REX4 homolog, 3'-5' exonuclease gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REXO4 mRNA PMID:35307453 13942872 UBAP1 ubiquitin associated protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBAP1 mRNA PMID:35307453 13942918 ATP7B ATPase copper transporting beta gene CHEBI:17489 3',5'-cyclic AMP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000242 Cyclic AMP inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 13942918 ATP7B ATPase copper transporting beta gene CHEBI:28694 copper atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper binds to ATP7B protein PMID:21084060 13942918 ATP7B ATPase copper transporting beta gene CHEBI:28694 copper atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 Cholera Toxin inhibits the reaction [Copper binds to ATP7B protein]; Colforsin inhibits the reaction [Copper binds to ATP7B protein]; Cyclic AMP inhibits the reaction [Copper binds to ATP7B protein]; PRKACA protein inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 13942918 ATP7B ATPase copper transporting beta gene CHEBI:30052 copper(0) affects binding EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper binds to ATP7B protein PMID:21084060 13942918 ATP7B ATPase copper transporting beta gene CHEBI:30052 copper(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 Cholera Toxin inhibits the reaction [Copper binds to ATP7B protein]; Colforsin inhibits the reaction [Copper binds to ATP7B protein]; Cyclic AMP inhibits the reaction [Copper binds to ATP7B protein]; PRKACA protein inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 13942918 ATP7B ATPase copper transporting beta gene CHEBI:31429 colforsin daropate hydrochloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005576 Colforsin inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 13942990 TMEM39A transmembrane protein 39A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM39A mRNA PMID:35307453 13943227 CDC42EP3 CDC42 effector protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDC42EP3 mRNA PMID:35307453 13943254 CRPPA CDP-L-ribitol pyrophosphorylase A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRPPA mRNA PMID:35307453 13943337 TMEM164 transmembrane protein 164 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM164 mRNA PMID:35307453 13943391 PHKA2 phosphorylase kinase regulatory subunit alpha 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHKA2 mRNA PMID:35307453 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP1A1 mRNA; deoxynivalenol results in decreased expression of CYP1A1 protein PMID:38403181 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYP1A1 mRNA PMID:35307453|PMID:35381244 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C007262 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA] PMID:35381244 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases activity EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA; 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 protein PMID:12970578|PMID:19608276 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 protein] PMID:12970578|PMID:19608276 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CYP1A1 mRNA PMID:34389318 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:16243 quercetin decreases activity EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin results in decreased activity of CYP1A1 protein PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 protein]; Quercetin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein] PMID:12970578|PMID:19608276 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:18227 sterigmatocystin increases expression EXP E RGD:6480464 20191114 CTD MESH:D013241 Sterigmatocystin results in increased expression of CYP1A1 mRNA PMID:20929267 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:254496 7,12-dimethyltetraphene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015127 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein PMID:11042205 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA; Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein PMID:16291828|PMID:16431846 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA] PMID:35381244 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20191114 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of CYP1A1 protein PMID:18636242 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001564 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein PMID:11042205 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein PMID:16291828|PMID:19608276|PMID:22521609 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein]; NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]; Quercetin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein] PMID:19608276|PMID:22521609 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate decreases activity EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in decreased activity of CYP1A1 protein PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in decreased expression of CYP1A1 mRNA PMID:22521609 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein]; epigallocatechin gallate inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; epigallocatechin gallate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] PMID:12970578|PMID:22521609 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:64294 7-ketocholesterol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C003001 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein] PMID:11042205 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of CYP1A1 mRNA PMID:31535366 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:76995 alpha-naphthoflavone decreases activity EXP E RGD:6480464 20191114 CTD MESH:C011512 alpha-naphthoflavone results in decreased activity of CYP1A1 protein PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:76995 alpha-naphthoflavone increases expression EXP E RGD:6480464 20191114 CTD MESH:C011512 alpha-naphthoflavone results in increased expression of CYP1A1 mRNA PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:76995 alpha-naphthoflavone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C011512 alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA] PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:77013 beta-naphthoflavone increases activity EXP E RGD:6480464 20191114 CTD MESH:D019324 beta-Naphthoflavone results in increased activity of CYP1A1 protein PMID:12970578|PMID:19464568 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:77013 beta-naphthoflavone increases expression EXP E RGD:6480464 20191114 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of CYP1A1 mRNA; beta-Naphthoflavone results in increased expression of CYP1A1 protein PMID:12970578|PMID:19464568|PMID:19786062 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:77013 beta-naphthoflavone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019324 epigallocatechin gallate inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; epigallocatechin gallate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] PMID:12970578 13943471 CYP1A1 cytochrome P450 family 1 subfamily A member 1 gene CHEBI:9171 skatole increases oxidation EXP E RGD:6480464 20191114 CTD MESH:D012862 CYP1A1 protein results in increased oxidation of Skatole PMID:30599194 13943610 HMGN3 high mobility group nucleosomal binding domain 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HMGN3 mRNA; deoxynivalenol results in decreased expression of HMGN3 protein PMID:35307453|PMID:38403181 13943610 HMGN3 high mobility group nucleosomal binding domain 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of HMGN3 mRNA PMID:39265697 13943666 LDLR low density lipoprotein receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LDLR mRNA; deoxynivalenol results in decreased expression of LDLR protein PMID:38403181 13943666 LDLR low density lipoprotein receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LDLR mRNA PMID:35307453 13943666 LDLR low density lipoprotein receptor gene CHEBI:177470 Cloprostenol decreases expression EXP E RGD:6480464 20210907 CTD MESH:D003008 Cloprostenol results in decreased expression of LDLR mRNA PMID:15713365 13943666 LDLR low density lipoprotein receptor gene CHEBI:49040 ezetimibe increases expression EXP E RGD:6480464 20191114 CTD MESH:D000069438 Ezetimibe results in increased expression of LDLR mRNA PMID:17130282 13943666 LDLR low density lipoprotein receptor gene CHEBI:49040 ezetimibe multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000069438 Simvastatin promotes the reaction [Ezetimibe results in increased expression of LDLR mRNA] PMID:17130282 13943666 LDLR low density lipoprotein receptor gene CHEBI:9150 simvastatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin results in increased expression of LDLR mRNA PMID:17130282 13943666 LDLR low density lipoprotein receptor gene CHEBI:9150 simvastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin promotes the reaction [Ezetimibe results in increased expression of LDLR mRNA] PMID:17130282 13943703 PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of PPM1D mRNA PMID:37706587 13943703 PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of PPM1D mRNA] PMID:37706587 13943703 PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of PPM1D mRNA] PMID:37706587 13943931 CPXM1 carboxypeptidase X, M14 family member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPXM1 mRNA PMID:35307453 13944055 IFT88 intraflagellar transport 88 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT88 mRNA PMID:35307453 13944102 GEN1 GEN1 Holliday junction 5' flap endonuclease gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of GEN1 mRNA PMID:35307453 13944152 ACOD1 aconitate decarboxylase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACOD1 mRNA PMID:35307453 13944167 PLXND1 plexin D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLXND1 mRNA PMID:35307453 13944240 CREB3L4 cAMP responsive element binding protein 3 like 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CREB3L4 mRNA PMID:35307453 13944350 TMEM9 transmembrane protein 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM9 mRNA PMID:35307453 13944656 CHIC2 cysteine rich hydrophobic domain 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHIC2 mRNA PMID:35307453 13944718 WARS1 tryptophanyl-tRNA synthetase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of WARS1 mRNA PMID:39265697 13944803 GTPBP4 GTP binding protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GTPBP4 mRNA PMID:35307453 13944850 MRPL46 mitochondrial ribosomal protein L46 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL46 mRNA PMID:35307453 13945039 RPS23 ribosomal protein S23 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS23 mRNA PMID:39265697 13945231 MFAP5 microfibril associated protein 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFAP5 mRNA PMID:35307453 13945231 MFAP5 microfibril associated protein 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of MFAP5 mRNA PMID:21852083 13945257 GPR182 G protein-coupled receptor 182 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of GPR182 mRNA PMID:34389318 13945270 FOXO1 forkhead box O1 gene CHEBI:17154 nicotinamide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009536 Niacinamide results in increased expression of FOXO1 mRNA PMID:17851734 13945270 FOXO1 forkhead box O1 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of FOXO1 mRNA PMID:17851734 13945270 FOXO1 forkhead box O1 gene CHEBI:9168 sirolimus affects localization EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus affects the localization of FOXO1 protein PMID:20622751 13945270 FOXO1 forkhead box O1 gene CHEBI:9168 sirolimus increases expression EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus results in increased expression of FOXO1 mRNA; Sirolimus results in increased expression of FOXO1 protein PMID:20622751 13945318 LOC100513296 transmembrane protease serine 11F gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMPRSS11F mRNA PMID:35307453 13945340 PRRT1 proline rich transmembrane protein 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PRRT1 mRNA PMID:34933075 13945647 BCHE butyrylcholinesterase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCHE mRNA PMID:35307453 13945647 BCHE butyrylcholinesterase gene CHEBI:136185 VX nerve agent decreases activity EXP E RGD:6480464 20250401 CTD MESH:C009680 VX-agent results in decreased activity of BCHE protein PMID:38768837 13945647 BCHE butyrylcholinesterase gene CHEBI:17941 diisopropyl fluorophosphate decreases activity EXP E RGD:6480464 20191114 CTD MESH:D007531 Isoflurophate results in decreased activity of BCHE protein PMID:4631366 13945647 BCHE butyrylcholinesterase gene CHEBI:196010 Butyrylcholine increases hydrolysis EXP E RGD:6480464 20231003 CTD MESH:C017100 BCHE protein results in increased hydrolysis of butyrylcholine PMID:4631366 13945647 BCHE butyrylcholinesterase gene CHEBI:27827 paraoxon decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010261 Paraoxon results in decreased activity of BCHE protein PMID:4631366 13945647 BCHE butyrylcholinesterase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of BCHE mRNA PMID:21852083 13945647 BCHE butyrylcholinesterase gene CHEBI:34690 dichlorvos decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004006 Dichlorvos results in decreased activity of BCHE protein PMID:4631366 13945647 BCHE butyrylcholinesterase gene CHEBI:41055 butyrylthiocholine increases hydrolysis EXP E RGD:6480464 20191114 CTD MESH:D002092 BCHE protein results in increased hydrolysis of Butyrylthiocholine PMID:22407886 13945671 SNX17 sorting nexin 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNX17 protein PMID:37257635 13945709 SHANK2 SH3 and multiple ankyrin repeat domains 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHANK2 mRNA PMID:35307453 13945745 ZFTA zinc finger translocation associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFTA mRNA PMID:35307453 13945923 TMEM212 transmembrane protein 212 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM212 mRNA PMID:35307453 13945931 COX7C cytochrome c oxidase subunit 7C gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX7C mRNA PMID:39265697 13945943 ABCD4 ATP binding cassette subfamily D member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCD4 mRNA PMID:35307453 13945966 CLDN9 claudin 9 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CLDN9 mRNA PMID:39265697 13945984 TMEM176A transmembrane protein 176A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM176A mRNA PMID:35307453 13946013 ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENTPD1 mRNA PMID:35307453 13946013 ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of ENTPD1 mRNA PMID:21852083 13946043 PM20D1 peptidase M20 domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PM20D1 mRNA PMID:35307453 13946100 SOX5 SRY-box transcription factor 5 gene CHEBI:10033 warfarin decreases expression EXP E RGD:6480464 20230905 CTD MESH:D014859 Warfarin results in decreased expression of SOX5 mRNA PMID:34520801 13946100 SOX5 SRY-box transcription factor 5 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D014859 Ammonium Chloride inhibits the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]]; LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA]]; LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]]; SOX5 protein affects the reaction [Warfarin results in decreased expression of SOX9 mRNA]; SOX5 protein inhibits the reaction [Warfarin promotes the reaction [SOX9 protein binds to RUNX2 promoter]]; SOX5 protein inhibits the reaction [Warfarin results in decreased expression of and affects the localization of SOX9 protein]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 protein]; SOX5 protein promotes the reaction [Warfarin promotes the reaction [SOX9 protein binds to LRP6 promoter]]; SOX5 protein promotes the reaction [Warfarin results in increased expression of LRP6 protein]; Warfarin promotes the reaction [SOX5 protein binds to SOX9 promoter]; Warfarin results in decreased expression of and affects the localization of SOX5 protein PMID:34520801 13946100 SOX5 SRY-box transcription factor 5 gene CHEBI:31206 ammonium chloride multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D000643 Ammonium Chloride inhibits the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]] PMID:34520801 13946375 EYA1 EYA transcriptional coactivator and phosphatase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EYA1 mRNA PMID:35307453 13946603 PDLIM7 PDZ and LIM domain 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDLIM7 mRNA PMID:35307453 13946857 WDR31 WD repeat domain 31 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR31 mRNA PMID:35307453 13946945 CPAMD8 C3 and PZP like alpha-2-macroglobulin domain containing 8 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CPAMD8 mRNA PMID:34933075 13947011 SASS6 SAS-6 centriolar assembly protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of SASS6 mRNA; deoxynivalenol results in increased expression of SASS6 protein PMID:38403181 13947170 PHLDA2 pleckstrin homology like domain family A member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PHLDA2 mRNA PMID:35307453 13947314 HSPG2 heparan sulfate proteoglycan 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSPG2 mRNA; deoxynivalenol results in decreased expression of HSPG2 protein PMID:38403181 13947441 ELK3 ETS transcription factor ELK3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELK3 mRNA PMID:35307453 13947453 N4BP2L2 NEDD4 binding protein 2 like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of N4BP2L2 mRNA PMID:35307453 13947487 PLCL1 phospholipase C like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLCL1 mRNA PMID:35307453 13947534 WDR4 WD repeat domain 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR4 mRNA PMID:35307453 13947571 DNAH12 dynein axonemal heavy chain 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH12 mRNA PMID:35307453 13947706 GPR137B G protein-coupled receptor 137B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR137B mRNA PMID:35307453 13948182 CLDN1 claudin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20210706 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLDN1 mRNA; deoxynivalenol results in decreased expression of CLDN1 protein PMID:32783910|PMID:35381244|PMID:36596350|PMID:37120089|PMID:37442268 13948182 CLDN1 claudin 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; [deoxynivalenol co-treated with Lipopolysaccharides] results in decreased expression of CLDN1 mRNA; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] PMID:32877744|PMID:35381244|PMID:37120089|PMID:37442268 13948182 CLDN1 claudin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20210706 CTD MESH:D015025 Zearalenone results in decreased expression of CLDN1 protein PMID:32783910 13948182 CLDN1 claudin 1 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of CLDN1 protein PMID:37659622 13948182 CLDN1 claudin 1 gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of CLDN1 mRNA; Hydrogen Peroxide results in decreased expression of CLDN1 protein PMID:38438008 13948182 CLDN1 claudin 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 protein]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 protein] PMID:38438008 13948182 CLDN1 claudin 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of CLDN1 mRNA; Lipopolysaccharides results in decreased expression of CLDN1 protein PMID:22092031|PMID:32877744|PMID:37271275 13948182 CLDN1 claudin 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 [deoxynivalenol co-treated with Lipopolysaccharides] results in decreased expression of CLDN1 mRNA; [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA] PMID:32877744|PMID:37271275 13948182 CLDN1 claudin 1 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin results in increased expression of CLDN1 protein PMID:37120089 13948182 CLDN1 claudin 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] PMID:37120089 13948182 CLDN1 claudin 1 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C026166 [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 protein]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA] PMID:37271275|PMID:38438008 13948182 CLDN1 claudin 1 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN1 mRNA] PMID:37999554 13948182 CLDN1 claudin 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 mRNA]; Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein] PMID:36584959 13948182 CLDN1 claudin 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of CLDN1 mRNA PMID:18988085 13948182 CLDN1 claudin 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] PMID:37442268 13948182 CLDN1 claudin 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of CLDN1 mRNA; Glyphosate results in decreased expression of CLDN1 protein PMID:31677563|PMID:36584959 13948182 CLDN1 claudin 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 mRNA]; Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein] PMID:36584959 13948182 CLDN1 claudin 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of CLDN1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of CLDN1 protein] PMID:37955343 13948182 CLDN1 claudin 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] PMID:35381244 13948182 CLDN1 claudin 1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of CLDN1 protein PMID:36754226 13948182 CLDN1 claudin 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of CLDN1 protein]; Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of CLDN1 protein] PMID:36754226 13948182 CLDN1 claudin 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of CLDN1 mRNA; bisphenol A results in decreased expression of CLDN1 protein PMID:37108405|PMID:37999554 13948182 CLDN1 claudin 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN1 mRNA]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of CLDN1 protein] PMID:37108405|PMID:37999554 13948182 CLDN1 claudin 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in decreased expression of CLDN1 protein PMID:36615853 13948182 CLDN1 claudin 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] PMID:37442268 13948182 CLDN1 claudin 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in decreased expression of CLDN1 mRNA; fumonisin B1 results in decreased expression of CLDN1 protein PMID:31557363|PMID:37955343 13948182 CLDN1 claudin 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of CLDN1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of CLDN1 protein] PMID:37955343 13948182 CLDN1 claudin 1 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of CLDN1 protein] PMID:36754226 13948182 CLDN1 claudin 1 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of CLDN1 protein] PMID:37108405 13948182 CLDN1 claudin 1 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 protein] PMID:39305878 13948182 CLDN1 claudin 1 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in decreased expression of CLDN1 protein PMID:26338884 13948182 CLDN1 claudin 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C093642 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 protein]; SB 203580 inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA] PMID:37271275|PMID:38438008 13948182 CLDN1 claudin 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D020123 Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of CLDN1 protein] PMID:36754226 13948182 CLDN1 claudin 1 gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased expression of CLDN1 mRNA; T-2 Toxin results in decreased expression of CLDN1 protein PMID:39305878 13948182 CLDN1 claudin 1 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of CLDN1 protein] PMID:39305878 13948182 CLDN1 claudin 1 gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in decreased expression of CLDN1 mRNA; Troglitazone results in decreased expression of CLDN1 protein PMID:36596350 13948201 OPRD1 opioid receptor delta 1 gene CHEBI:32595 barium(0) affects transport EXP E RGD:6480464 20191114 CTD MESH:D001464 OPRD1 protein affects the transport of Barium PMID:12031848 13948201 OPRD1 opioid receptor delta 1 gene CHEBI:32595 barium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001464 Enkephalin, D-Penicillamine (2,5)- inhibits the reaction [OPRD1 protein results in increased transport of Barium] PMID:12031848 13948201 OPRD1 opioid receptor delta 1 gene CHEBI:73356 DPDPE multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020881 Enkephalin, D-Penicillamine (2,5)- inhibits the reaction [OPRD1 protein results in increased transport of Barium] PMID:12031848 13948259 UTP20 UTP20 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP20 mRNA PMID:35307453 13948360 INMT indolethylamine N-methyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of INMT mRNA PMID:35307453 13948372 S100A9 S100 calcium binding protein A9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A9 mRNA PMID:35307453 13948372 S100A9 S100 calcium binding protein A9 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of S100A9 mRNA PMID:34933075 13948387 ARF6 ADP ribosylation factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARF6 mRNA PMID:35307453 13948399 COL9A2 collagen type IX alpha 2 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL9A2 mRNA PMID:35307453 13948622 FBLIM1 filamin binding LIM protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FBLIM1 mRNA PMID:35307453 13948688 TMEM255A transmembrane protein 255A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM255A mRNA PMID:35307453 13948710 CFAP299 cilia and flagella associated protein 299 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP299 mRNA PMID:35307453 13948756 TMEM125 transmembrane protein 125 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM125 mRNA PMID:35307453 13948817 UCP2 uncoupling protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UCP2 mRNA PMID:35307453 13948817 UCP2 uncoupling protein 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of UCP2 mRNA] PMID:39151877 13948817 UCP2 uncoupling protein 2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of UCP2 mRNA PMID:39151877 13948817 UCP2 uncoupling protein 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of UCP2 mRNA] PMID:39151877 13948828 SERF2 small EDRK-rich factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERF2 mRNA PMID:35307453 13949127 ACOX1 acyl-CoA oxidase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACOX1 mRNA PMID:34416349 13949127 ACOX1 acyl-CoA oxidase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACOX1 mRNA PMID:34416349 13949127 ACOX1 acyl-CoA oxidase 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of ACOX1 mRNA PMID:16896063|PMID:17437637 13949127 ACOX1 acyl-CoA oxidase 1 gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of ACOX1 mRNA PMID:31360149 13949185 STAT4 signal transducer and activator of transcription 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of STAT4 mRNA PMID:39265697 13949232 DOP1B DOP1 leucine zipper like protein B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DOP1B mRNA PMID:35307453 13949357 KDM2B lysine demethylase 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KDM2B mRNA PMID:35307453 13949535 SULF1 sulfatase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULF1 mRNA PMID:35307453 13949633 ZNF516 zinc finger protein 516 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF516 mRNA PMID:35307453 13949696 CDK2 cyclin dependent kinase 2 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of CDK2 protein PMID:34811946 13949696 CDK2 cyclin dependent kinase 2 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein affects the reaction [Paraquat results in increased expression of CDK2 protein] PMID:34811946 13949742 ZFAND4 zinc finger AN1-type containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFAND4 mRNA PMID:35307453 13949772 DNAI3 dynein axonemal intermediate chain 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAI3 mRNA PMID:35307453 13949838 CDC42EP1 CDC42 effector protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDC42EP1 mRNA PMID:35307453 13949850 AKT2 AKT serine/threonine kinase 2 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of AKT2 protein PMID:38432436 13949850 AKT2 AKT serine/threonine kinase 2 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of AKT2 mRNA PMID:31535366 13949904 EMC4 ER membrane protein complex subunit 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of EMC4 protein PMID:37257635 13949914 PURB purine rich element binding protein B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PURB mRNA PMID:35307453 13949933 TBC1D9 TBC1 domain family member 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBC1D9 mRNA PMID:35307453 13949976 PBK PDZ binding kinase gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of PBK mRNA PMID:35307453 13949976 PBK PDZ binding kinase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PBK mRNA] PMID:21852083 13950093 ZXDC ZXD family zinc finger C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZXDC mRNA PMID:35307453 13950207 MKS1 MKS transition zone complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MKS1 mRNA PMID:35307453 13950249 DENND2D DENN domain containing 2D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DENND2D mRNA PMID:35307453 13950311 CRISPLD2 cysteine rich secretory protein LCCL domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRISPLD2 mRNA PMID:35307453 13950311 CRISPLD2 cysteine rich secretory protein LCCL domain containing 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CRISPLD2 mRNA PMID:21852083 13950330 C3H16orf96 chromosome 3 C16orf96 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C3H16ORF96 mRNA PMID:35307453 13950379 SPATA18 spermatogenesis associated 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPATA18 mRNA PMID:35307453 13950626 PPP1R16A protein phosphatase 1 regulatory subunit 16A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPT mRNA PMID:35307453 13950626 PPP1R16A protein phosphatase 1 regulatory subunit 16A gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in increased activity of GPT protein] PMID:37999554 13950626 PPP1R16A protein phosphatase 1 regulatory subunit 16A gene CHEBI:33216 bisphenol A increases activity EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased activity of GPT protein PMID:37999554 13950626 PPP1R16A protein phosphatase 1 regulatory subunit 16A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in increased activity of GPT protein] PMID:37999554 13950626 PPP1R16A protein phosphatase 1 regulatory subunit 16A gene CHEBI:64163 diquat increases activity EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in increased activity of GPT protein PMID:38567716 13950894 EFNA5 ephrin A5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFNA5 mRNA PMID:35307453 13950910 DLG2 discs large MAGUK scaffold protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DLG2 mRNA PMID:35307453 13950910 DLG2 discs large MAGUK scaffold protein 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of DLG2 mRNA PMID:34933075 13950910 DLG2 discs large MAGUK scaffold protein 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DLG2 mRNA PMID:39265697 13951052 FNBP4 formin binding protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of FNBP4 mRNA; deoxynivalenol results in increased expression of FNBP4 protein PMID:38403181 13951187 MRPL18 mitochondrial ribosomal protein L18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL18 mRNA PMID:35307453 13951300 AGPS alkylglycerone phosphate synthase gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of AGPS mRNA PMID:28069986 13951332 BCL3 BCL3 transcription coactivator gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of BCL3 mRNA PMID:37706587 13951332 BCL3 BCL3 transcription coactivator gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL3 mRNA] PMID:37706587 13951332 BCL3 BCL3 transcription coactivator gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL3 mRNA] PMID:37706587 13951510 SLC25A48 solute carrier family 25 member 48 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SLC25A48 mRNA PMID:34933075 13951571 GRID2 glutamate ionotropic receptor delta type subunit 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GRID2 mRNA PMID:34933075 13951601 CCR6 C-C motif chemokine receptor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CCR6 mRNA PMID:23326479 13951640 RGS8 regulator of G protein signaling 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RGS8 mRNA PMID:35307453 13951690 MSI2 musashi RNA binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MSI2 mRNA PMID:35307453 13951690 MSI2 musashi RNA binding protein 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MSI2 mRNA] PMID:21852083 13951749 EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of EZH2 mRNA PMID:26988607 13951806 ADAMTS15 ADAM metallopeptidase with thrombospondin type 1 motif 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTS15 mRNA PMID:35307453 13952036 AKAP17A A-kinase anchoring protein 17A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP17B mRNA PMID:35307453 13952138 CAPS calcyphosine gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPS mRNA PMID:35307453 13952205 MYO15B myosin XVB gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO15B mRNA PMID:35307453 13952279 RIPK2 receptor interacting serine/threonine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIPK2 mRNA PMID:35307453 13952366 ABCA4 ATP binding cassette subfamily A member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCA4 mRNA PMID:35307453 13952499 C1S complement C1s gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of C1S mRNA PMID:22497863 13952578 FBXO4 F-box protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FBXO4 mRNA PMID:35307453 13952675 MAP2 microtubule associated protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP2 mRNA PMID:35307453 13952949 CEBPD CCAAT enhancer binding protein delta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEBPD mRNA PMID:35307453 13952949 CEBPD CCAAT enhancer binding protein delta gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CEBPD mRNA PMID:39265697 13952949 CEBPD CCAAT enhancer binding protein delta gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CEBPD mRNA PMID:21852083 13953062 GLRX3 glutaredoxin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GLRX3 mRNA PMID:35307453 13953237 ALPK1 alpha kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALPK1 mRNA PMID:35307453 13953255 NLRC3 NLR family CARD domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NLRC3 mRNA PMID:35307453 13953255 NLRC3 NLR family CARD domain containing 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NLRC3 mRNA PMID:34933075 13953314 IL34 interleukin 34 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL34 mRNA PMID:35307453 13953591 SLC9C1 solute carrier family 9 member C1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC9C1 mRNA PMID:35307453 13953661 KLF6 KLF transcription factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLF6 mRNA PMID:35307453 13953669 ARID5A AT-rich interaction domain 5A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARID5A mRNA PMID:35307453 13953722 NAMPT nicotinamide phosphoribosyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAMPT mRNA PMID:35307453 13953809 GLCCI1 glucocorticoid induced 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLCCI1 mRNA PMID:35307453 13953979 RRP7A ribosomal RNA processing 7 homolog A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRP7A mRNA PMID:35307453 13953997 BMPR1B bone morphogenetic protein receptor type 1B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BMPR1B mRNA PMID:35307453 13954110 PLA2G4E phospholipase A2 group IVE gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLA2G4E mRNA PMID:35307453 13954144 TAOK3 TAO kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TAOK3 mRNA PMID:35307453 13954199 ARHGAP28 Rho GTPase activating protein 28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARHGAP28 mRNA; deoxynivalenol results in increased expression of ARHGAP28 protein PMID:35307453|PMID:38403181 13954283 CTH cystathionine gamma-lyase gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CTH mRNA PMID:39265697 13954283 CTH cystathionine gamma-lyase gene CHEBI:16236 ethanol increases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased activity of CTH protein PMID:16792574 13954283 CTH cystathionine gamma-lyase gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of CTH protein PMID:16792574 13954283 CTH cystathionine gamma-lyase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of CTH protein PMID:16792574 13954377 NRSN1 neurensin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRSN1 mRNA PMID:35307453 13954556 ZNF704 zinc finger protein 704 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF704 mRNA PMID:35307453 13954569 RPL31 ribosomal protein L31 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL31 mRNA PMID:39265697 13954605 DTNB dystrobrevin beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DTNB mRNA PMID:35307453 13954699 SFXN2 sideroflexin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SFXN2 mRNA PMID:35307453 13954847 SLITRK2 SLIT and NTRK like family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLITRK2 mRNA PMID:35307453 13954900 OXCT1 3-oxoacid CoA-transferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OXCT1 mRNA PMID:35307453 13954964 KIF19 kinesin family member 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF19 mRNA PMID:35307453 13955038 YARS2 tyrosyl-tRNA synthetase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YARS2 mRNA PMID:35307453 13955051 STAM signal transducing adaptor molecule gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STAM mRNA PMID:35307453 13955160 IL9R interleukin 9 receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL9R mRNA PMID:35307453 13955274 LIPA lipase A, lysosomal acid type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LIPA mRNA PMID:35307453 13955299 KITLG KIT ligand gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KITLG mRNA PMID:35307453 13955299 KITLG KIT ligand gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of KITLG mRNA PMID:39265697 13955321 ATM ATM serine/threonine kinase gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of ATM protein PMID:38104654 13955321 ATM ATM serine/threonine kinase gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 ATM protein promotes the reaction [deoxynivalenol results in increased phosphorylation of CHEK2 protein]; Caffeine inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATM protein] PMID:38104654 13955321 ATM ATM serine/threonine kinase gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20240806 CTD MESH:D002110 Caffeine inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATM protein] PMID:38104654 13955480 CYC1 cytochrome c1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYC1 mRNA PMID:35307453 13955511 TMEM151A transmembrane protein 151A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM151A mRNA PMID:35307453 13955517 SLC8B1 solute carrier family 8 member B1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC8B1 mRNA PMID:35307453 13955517 SLC8B1 solute carrier family 8 member B1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SLC8B1 mRNA] PMID:39151877 13955517 SLC8B1 solute carrier family 8 member B1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SLC8B1 mRNA PMID:39151877 13955517 SLC8B1 solute carrier family 8 member B1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SLC8B1 mRNA] PMID:39151877 13955555 KIAA1549 KIAA1549 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIAA1549 mRNA PMID:35307453 13955605 BMP8B bone morphogenetic protein 8b gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMP8B mRNA PMID:35307453 13955656 KATNAL2 katanin catalytic subunit A1 like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KATNAL2 mRNA PMID:35307453 13955682 AGPAT4 1-acylglycerol-3-phosphate O-acyltransferase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AGPAT4 mRNA PMID:35307453 13955872 UBE2C ubiquitin conjugating enzyme E2 C gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of UBE2C mRNA PMID:21852083 13955889 NFAT5 nuclear factor of activated T cells 5 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of NFAT5 mRNA PMID:21391292 13955985 DZANK1 double zinc ribbon and ankyrin repeat domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DZANK1 mRNA PMID:35307453 13956042 LOC100516084 cytoplasmic tRNA 2-thiolation protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTU1 mRNA PMID:35307453 13956140 GNRHR2 gonadotropin releasing hormone receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNRHR2 mRNA PMID:35307453 13956236 FOXO4 forkhead box O4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXO4 mRNA PMID:35307453 13956337 CILP2 cartilage intermediate layer protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CILP2 mRNA PMID:35307453 13956384 SEMA7A semaphorin 7A (JohnMiltonHagen blood group) gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SEMA7A mRNA PMID:39265697 13956414 CLHC1 clathrin heavy chain linker domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLHC1 mRNA PMID:35307453 13956479 PROM2 prominin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PROM2 mRNA PMID:35307453 13956671 PHKG2 phosphorylase kinase catalytic subunit gamma 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PHKG2 mRNA PMID:35307453 13956727 SGTB small glutamine rich tetratricopeptide repeat co-chaperone beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SGTB mRNA PMID:35307453 13956781 MFN1 mitofusin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFN1 protein PMID:32302720 13956781 MFN1 mitofusin 1 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 protein] PMID:35839969 13956781 MFN1 mitofusin 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of MFN1 mRNA] PMID:36584959 13956781 MFN1 mitofusin 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN1 protein PMID:33493553|PMID:33592257 13956781 MFN1 mitofusin 1 gene CHEBI:25442 mycotoxin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in decreased expression of MFN1 mRNA; Mycotoxins results in decreased expression of MFN1 protein PMID:39137830 13956781 MFN1 mitofusin 1 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of MFN1 mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of MFN1 protein] PMID:39137830 13956781 MFN1 mitofusin 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of MFN1 mRNA PMID:36584959 13956781 MFN1 mitofusin 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of MFN1 mRNA] PMID:36584959 13956781 MFN1 mitofusin 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN1 protein PMID:33493553|PMID:33592257 13956781 MFN1 mitofusin 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of MFN1 mRNA; monobutyl phthalate results in decreased expression of MFN1 protein PMID:35839969 13956781 MFN1 mitofusin 1 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 protein] PMID:35839969 13956884 STK17A serine/threonine kinase 17a gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STK17A mRNA PMID:35307453 13956957 RNF186 ring finger protein 186 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RNF186 mRNA PMID:34933075 13956991 SLC7A1 solute carrier family 7 member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC7A1 mRNA PMID:35307453 13956991 SLC7A1 solute carrier family 7 member 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in increased expression of SLC7A1 mRNA PMID:32710935 13956991 SLC7A1 solute carrier family 7 member 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in decreased expression of SLC7A1 mRNA PMID:33443779 13957040 EXD3 exonuclease 3'-5' domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EXD3 mRNA PMID:35307453 13957064 YIF1A Yip1 interacting factor homolog A, membrane trafficking protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YIF1A mRNA PMID:35307453 13957089 LPL lipoprotein lipase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] PMID:21852083 13957283 LSG1 large 60S subunit nuclear export GTPase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LSG1 mRNA PMID:35307453 13957389 BUB1B BUB1 mitotic checkpoint serine/threonine kinase B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BUB1B mRNA PMID:35307453 13957473 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PYROXD2 mRNA PMID:35307453 13957641 SUSD2 sushi domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUSD2 mRNA PMID:35307453 13957734 RCN2 reticulocalbin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RCN2 mRNA PMID:35307453 13957825 ESRP2 epithelial splicing regulatory protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ESRP2 mRNA PMID:35307453 13958022 GPR119 G protein-coupled receptor 119 gene CHEBI:64243 monosodium L-glutamate affects expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate affects the expression of GPR119 mRNA PMID:31360149 13958022 GPR119 G protein-coupled receptor 119 gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 Dietary Fats affects the reaction [Sodium Glutamate affects the expression of GPR119 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of GPR119 mRNA] PMID:31360149 13958158 KLF11 KLF transcription factor 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLF11 mRNA PMID:35307453 13958192 KLF10 KLF transcription factor 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLF10 mRNA PMID:35307453 13958304 TSPAN12 tetraspanin 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN12 mRNA PMID:35307453 13958347 EML2 EMAP like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EML2 mRNA PMID:35307453 13958420 G6PD glucose-6-phosphate dehydrogenase gene CHEBI:34905 paraquat affects activity EXP E RGD:6480464 20191114 CTD MESH:D010269 Paraquat affects the activity of G6PD protein PMID:11814328 13958481 IL4I1 interleukin 4 induced 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IL4I1 mRNA PMID:35307453 13958536 ST3GAL3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST3GAL3 mRNA PMID:35307453 13958588 ERP27 endoplasmic reticulum protein 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERP27 mRNA PMID:35307453 13958588 ERP27 endoplasmic reticulum protein 27 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ERP27 mRNA PMID:39265697 13958698 TMEM59 transmembrane protein 59 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM59 mRNA PMID:35307453 13958725 ARFGAP1 ADP ribosylation factor GTPase activating protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARFGAP1 mRNA PMID:35307453 13958766 ENKUR enkurin, TRPC channel interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENKUR mRNA PMID:35307453 13958796 SERPINI1 serpin family I member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERPINI1 mRNA PMID:35307453 13958910 BGN biglycan gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BGN mRNA PMID:35307453 13958926 NGF nerve growth factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NGF mRNA PMID:35307453 13958956 METRNL meteorin like, glial cell differentiation regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of METRNL mRNA PMID:35307453 13958956 METRNL meteorin like, glial cell differentiation regulator gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of METRNL mRNA PMID:39265697 13958985 GAA alpha glucosidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAA mRNA PMID:35307453 13959074 MELTF melanotransferrin gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of MELTF mRNA PMID:35307453 13959150 UAP1L1 UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UAP1L1 mRNA PMID:35307453 13959177 PHF7 PHD finger protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHF7 mRNA PMID:35307453 13959317 ZCCHC8 zinc finger CCHC-type containing 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZCCHC8 mRNA PMID:35307453 13959347 REM2 RRAD and GEM like GTPase 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of REM2 mRNA PMID:39265697 13959489 EXOSC10 exosome component 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC10 mRNA PMID:35307453 13959537 MIR100 microRNA mir-100 gene CHEBI:16796 melatonin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in decreased expression of MIR100 mRNA PMID:38848930 13959537 MIR100 microRNA mir-100 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of MIR100 mRNA; [Melatonin co-treated with bisphenol A] results in increased expression of MIR100 mRNA; Melatonin results in decreased expression of and results in decreased phosphorylation of MIR100 protein PMID:38848930 13959537 MIR100 microRNA mir-100 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of MIR100 mRNA PMID:38848930 13959537 MIR100 microRNA mir-100 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in increased expression of MIR100 mRNA PMID:38848930 13959537 MIR100 microRNA mir-100 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of MIR100 mRNA; [Melatonin co-treated with bisphenol A] results in increased expression of MIR100 mRNA PMID:38848930 13959540 GSR glutathione-disulfide reductase gene CHEBI:10022 deoxynivalenol decreases activity EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased activity of GSR protein PMID:29109043 13959540 GSR glutathione-disulfide reductase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSR mRNA PMID:35307453 13959540 GSR glutathione-disulfide reductase gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]; Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]] PMID:29109043 13959540 GSR glutathione-disulfide reductase gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]; Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]] PMID:29109043 13959540 GSR glutathione-disulfide reductase gene CHEBI:16236 ethanol increases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased activity of GSR protein PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of GSR mRNA PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSR protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSR mRNA PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GSR mRNA] PMID:39151877 13959540 GSR glutathione-disulfide reductase gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of GSR mRNA PMID:39151877 13959540 GSR glutathione-disulfide reductase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GSR mRNA] PMID:39151877 13959540 GSR glutathione-disulfide reductase gene CHEBI:27470 folic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D005492 Folic Acid deficiency results in increased activity of GSR protein PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:27470 folic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D005492 Folic Acid deficiency results in increased expression of GSR mRNA PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSR protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSR mRNA PMID:16792574 13959540 GSR glutathione-disulfide reductase gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]] PMID:29109043 13959540 GSR glutathione-disulfide reductase gene CHEBI:34905 paraquat affects activity EXP E RGD:6480464 20191114 CTD MESH:D010269 Paraquat affects the activity of GSR protein PMID:11814328 13959540 GSR glutathione-disulfide reductase gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]] PMID:29109043 13959585 DSCC1 DNA replication and sister chromatid cohesion 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DSCC1 mRNA PMID:35307453 13959693 DNAJC15 DnaJ heat shock protein family (Hsp40) member C15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC15 mRNA PMID:35307453 13959710 TICAM2 toll like receptor adaptor molecule 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TICAM2 mRNA PMID:35307453 13959832 GCHFR GTP cyclohydrolase I feedback regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCHFR mRNA PMID:35307453 13959839 CLU clusterin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLU mRNA PMID:35307453 13959839 CLU clusterin gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of CLU mRNA PMID:28069986 13959839 CLU clusterin gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CLU mRNA PMID:18988085 13959839 CLU clusterin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol promotes the reaction [Dietary Fats results in increased expression of CLU mRNA] PMID:21852083 13960009 CSTF2 cleavage stimulation factor subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSTF2 mRNA PMID:35307453 13960040 NSA2 NSA2 ribosome biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NSA2 mRNA PMID:35307453 13960175 PAQR5 progestin and adipoQ receptor family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAQR5 mRNA PMID:35307453 13960263 MEST mesoderm specific transcript gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MEST mRNA PMID:39265697 13960385 TLN2 talin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TLN2 mRNA PMID:35307453 13960701 CXCL14 C-X-C motif chemokine ligand 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CXCL14 mRNA PMID:35307453 13960701 CXCL14 C-X-C motif chemokine ligand 14 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CXCL14 mRNA PMID:34933075 13960701 CXCL14 C-X-C motif chemokine ligand 14 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CXCL14 mRNA PMID:39265697 13960701 CXCL14 C-X-C motif chemokine ligand 14 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CXCL14 mRNA PMID:34389318 13960878 ABCA7 ATP binding cassette subfamily A member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCA7 mRNA PMID:35307453 13960993 CUTC cutC copper transporter gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CUTC mRNA PMID:35307453 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20221206 CTD MESH:C007262 deoxynivalenol results in increased expression of NFKB1 mRNA PMID:35314294 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:15379 dioxygen affects localization EXP E RGD:6480464 20191114 CTD MESH:D010100 Oxygen deficiency affects the localization of NFKB1 protein PMID:9728040 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of NFKB1 mRNA] PMID:38154151 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFKB1 mRNA PMID:33592257|PMID:34416349 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of NFKB1 mRNA PMID:31677563|PMID:35388968 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of NFKB1 mRNA PMID:38154151 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of NFKB1 mRNA] PMID:38154151 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFKB1 mRNA PMID:33592257|PMID:34416349 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of NFKB1 mRNA; fumonisin B1 results in increased expression of NFKB1 protein PMID:32198028 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of NFKB1 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of NFKB1 protein] PMID:32198028 13961142 NFKB1 nuclear factor kappa B subunit 1 gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of NFKB1 mRNA PMID:29421334 13961167 KLK7 kallikrein related peptidase 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLK7 mRNA PMID:35307453 13961258 EGFR epidermal growth factor receptor gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of EGFR mRNA PMID:37706587 13961258 EGFR epidermal growth factor receptor gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of EGFR mRNA] PMID:37706587 13961258 EGFR epidermal growth factor receptor gene CHEBI:16336 hyaluronic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006820 EGFR protein affects the chemical synthesis of and affects the localization of Hyaluronic Acid PMID:21520325 13961258 EGFR epidermal growth factor receptor gene CHEBI:17026 progesterone affects chemical synthesis EXP E RGD:6480464 20191114 CTD MESH:D011374 EGFR protein affects the chemical synthesis of Progesterone PMID:21520325 13961258 EGFR epidermal growth factor receptor gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of EGFR mRNA] PMID:37706587 13961335 TESK2 testis associated actin remodelling kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TESK2 mRNA PMID:35307453 13961418 LOC100512977 KDEL motif-containing protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EXPH5 mRNA PMID:35307453 13961607 SNRPN small nuclear ribonucleoprotein polypeptide N gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNRPN mRNA PMID:35307453 13961838 EHD1 EH domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EHD1 mRNA PMID:35307453 13961886 SHMT1 serine hydroxymethyltransferase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SHMT1 mRNA] PMID:21852083 13961994 XPO5 exportin 5 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of XPO5 mRNA; bisphenol A results in decreased expression of XPO5 protein PMID:31266599 13961994 XPO5 exportin 5 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with bisphenol A] results in decreased expression of XPO5 mRNA; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with bisphenol A] results in decreased expression of XPO5 protein PMID:31266599 13961994 XPO5 exportin 5 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of XPO5 protein PMID:31266599 13961994 XPO5 exportin 5 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrabromobisphenol A] results in decreased expression of XPO5 mRNA; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrabromobisphenol A] results in decreased expression of XPO5 protein PMID:31266599 13961994 XPO5 exportin 5 gene CHEBI:35004 Tetrachlorobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in decreased expression of XPO5 mRNA; tetrachlorodian results in decreased expression of XPO5 protein PMID:31266599 13961994 XPO5 exportin 5 gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrachlorodian] results in decreased expression of XPO5 mRNA; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrachlorodian] results in decreased expression of XPO5 protein PMID:31266599 13962072 NDUFS2 NADH:ubiquinone oxidoreductase core subunit S2 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of NDUFS2 mRNA PMID:38432436 13962094 ACAT2 acetyl-CoA acetyltransferase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACAT2 mRNA PMID:35307453 13962107 AKAP11 A-kinase anchoring protein 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP11 mRNA PMID:35307453 13962166 OAF out at first homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OAF mRNA PMID:35307453 13962403 MVD mevalonate diphosphate decarboxylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MVD mRNA PMID:35307453 13962421 TBC1D2 TBC1 domain family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBC1D2 mRNA PMID:35307453 13962552 ACBD3 acyl-CoA binding domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACBD3 mRNA PMID:35307453 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of HSD17B1 mRNA PMID:28069986 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:16422 androst-4-ene-3,17-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000735 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Androstenedione] results in increased activity of HSD17B1 protein PMID:16151981 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl decreases activity EXP E RGD:6480464 20191114 CTD MESH:C014024 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of HSD17B1 protein PMID:16151981 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014024 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Androstenedione] results in increased activity of HSD17B1 protein PMID:16151981 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases activity EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of HSD17B1 protein PMID:16151981 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:5692 hexachlorobenzene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene results in decreased expression of HSD17B1 protein PMID:21296658 13962593 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of HSD17B1 protein PMID:21871953 13962642 HSPB1 heat shock protein family B (small) member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPB1 mRNA PMID:35307453 13962642 HSPB1 heat shock protein family B (small) member 1 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased expression of HSP27 protein PMID:12915104 13962647 SLA-8 MHC class I antigen 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-8 mRNA PMID:35307453 13962647 SLA-8 MHC class I antigen 8 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250527 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of HLA-A mRNA; [Dietary Fats co-treated with Resveratrol] results in decreased expression of HLA-B mRNA; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of HLA-B mRNA] PMID:21852083 13962721 PSMB2 proteasome 20S subunit beta 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMB2 mRNA PMID:35307453 13962801 SARS1 seryl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SARS1 mRNA PMID:35307453 13962838 NRP1 neuropilin 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NRP1 mRNA PMID:39265697 13962925 ADAM11 ADAM metallopeptidase domain 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM11 mRNA PMID:35307453 13963117 DCTN4 dynactin subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCTN4 mRNA PMID:35307453 13963117 DCTN4 dynactin subunit 4 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA]; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA] PMID:34811946 13963117 DCTN4 dynactin subunit 4 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA] PMID:34811946 13963117 DCTN4 dynactin subunit 4 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA] PMID:34811946 13963222 RPGRIP1L RPGRIP1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RPGRIP1L mRNA PMID:35307453 13963339 CDC42BPA CDC42 binding protein kinase alpha gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CDC42BPA mRNA PMID:21852083 13963409 RPS26 ribosomal protein S26 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS26 mRNA PMID:39265697 13963561 ERI3 ERI1 exoribonuclease family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERI3 mRNA PMID:35307453 13963634 PRSS27 serine protease 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRSS27 mRNA PMID:35307453 13963846 RALB RAS like proto-oncogene B gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of RALB mRNA PMID:34389318 13963878 ZBTB33 zinc finger and BTB domain containing 33 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBTB33 mRNA PMID:35307453 13963919 GPATCH4 G-patch domain containing 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPATCH4 mRNA PMID:35307453 13963971 SLC44A3 solute carrier family 44 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC44A3 mRNA PMID:35307453 13964011 MOGAT2 monoacylglycerol O-acyltransferase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MOGAT2 mRNA PMID:35307453 13964249 KIAA2012 KIAA2012 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIAA2012 mRNA PMID:35307453 13964683 BBS1 Bardet-Biedl syndrome 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BBS1 mRNA PMID:35307453 13964748 CFAP95 cilia and flagella associated protein 95 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP95 mRNA PMID:35307453 13964818 ALDH1L2 aldehyde dehydrogenase 1 family member L2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH1L2 mRNA PMID:35307453 13964845 SDC1 syndecan 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SDC1 mRNA PMID:35307453 13964845 SDC1 syndecan 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of SDC1 protein PMID:37257635 13964859 PLN phospholamban gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PLN mRNA] PMID:39151877 13964859 PLN phospholamban gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of PLN mRNA PMID:39151877 13964859 PLN phospholamban gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PLN mRNA] PMID:39151877 13964865 RGS14 regulator of G protein signaling 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS14 mRNA PMID:35307453 13964865 RGS14 regulator of G protein signaling 14 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RGS14 mRNA PMID:39265697 13964892 SH2D3A SH2 domain containing 3A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH2D3A mRNA PMID:35307453 13964972 MYH7B myosin heavy chain 7B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYH7B mRNA PMID:35307453 13965036 RAB38 RAB38, member RAS oncogene family gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of RAB38 mRNA] PMID:39151877 13965036 RAB38 RAB38, member RAS oncogene family gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of RAB38 mRNA PMID:39151877 13965036 RAB38 RAB38, member RAS oncogene family gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of RAB38 mRNA] PMID:39151877 13965036 RAB38 RAB38, member RAS oncogene family gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of RAB38 mRNA PMID:21852083 13965100 LYZ lysozyme gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LYZ mRNA PMID:35307453 13965115 URB2 URB2 ribosome biogenesis homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of URB2 mRNA PMID:35307453 13965129 PDLIM1 PDZ and LIM domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDLIM1 mRNA PMID:35307453 13965199 GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNPTAB mRNA PMID:35307453 13965268 H2BC21 H2B clustered histone 21 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H2BC21 mRNA PMID:35307453 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:17933 calcidiol increases hydroxylation EXP E RGD:6480464 20210209 CTD MESH:D002112 CYP2D6 protein results in increased hydroxylation of Calcifediol PMID:11880238 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:223316 (+)-artemisinin increases expression EXP E RGD:6480464 20241001 CTD MESH:C031327 artemisinin results in increased expression of CYP2D6 mRNA PMID:24176340 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:27300 vitamin D increases hydroxylation EXP E RGD:6480464 20210209 CTD MESH:D014807 CYP2D6 protein results in increased hydroxylation of Vitamin D PMID:11880238 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:31186 alfacalcidol increases hydroxylation EXP E RGD:6480464 20210209 CTD MESH:C008088 CYP2D6 protein results in increased hydroxylation of alfacalcidol PMID:11880238 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:6358 lactucin increases expression EXP E RGD:6480464 20241001 CTD MESH:C516715 lactucin results in increased expression of CYP2D6 mRNA PMID:24176340 13965298 CYP2D6 cytochrome P450 family 2 subfamily D member 6 gene CHEBI:9055 scoparone increases expression EXP E RGD:6480464 20241001 CTD MESH:C018145 scoparone results in increased expression of CYP2D6 mRNA PMID:24176340 13965737 EPHA7 EPH receptor A7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPHA7 mRNA PMID:35307453 13965793 PLSCR4 phospholipid scramblase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLSCR4 mRNA PMID:35307453 13965880 ANO5 anoctamin 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANO5 mRNA PMID:35307453 13965915 NEMP1 nuclear envelope integral membrane protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NEMP1 mRNA PMID:35307453 13965986 ARSA arylsulfatase A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARSA mRNA PMID:35307453 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:18291 manganese atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008345 Manganese inhibits the reaction [Calcium results in increased activity of OGDH protein] PMID:20800605 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:22984 calcium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of OGDH protein PMID:20800605 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 Manganese inhibits the reaction [Calcium results in increased activity of OGDH protein] PMID:20800605 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:29320 calcium(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of OGDH protein PMID:20800605 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 Manganese inhibits the reaction [Calcium results in increased activity of OGDH protein] PMID:20800605 13966093 OGDH oxoglutarate dehydrogenase gene CHEBI:35154 manganese(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008345 Manganese inhibits the reaction [Calcium results in increased activity of OGDH protein] PMID:20800605 13966178 VPS9D1 VPS9 domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VPS9D1 mRNA PMID:35307453 13966324 CCR5 C-C motif chemokine receptor 5 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCR5 mRNA PMID:21505051 13966324 CCR5 C-C motif chemokine receptor 5 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 epostane promotes the reaction [Dinoprost results in increased expression of CCR5 mRNA] PMID:21505051 13966324 CCR5 C-C motif chemokine receptor 5 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of CCR5 mRNA PMID:27617619 13966324 CCR5 C-C motif chemokine receptor 5 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of CCR5 mRNA PMID:18790026 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of STAR mRNA PMID:38848930 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:177470 Cloprostenol decreases expression EXP E RGD:6480464 20210907 CTD MESH:D003008 Cloprostenol results in decreased expression of STAR mRNA; Cloprostenol results in decreased expression of STAR protein PMID:15713365 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in increased expression of STAR mRNA PMID:38848930 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of STAR mRNA PMID:29544186|PMID:38848930 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with fisetin] results in decreased expression of STAR mRNA; fisetin promotes the reaction [bisphenol A results in decreased expression of STAR mRNA] PMID:29544186 13966336 STAR steroidogenic acute regulatory protein gene CHEBI:42567 fisetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017875 [bisphenol A co-treated with fisetin] results in decreased expression of STAR mRNA; fisetin promotes the reaction [bisphenol A results in decreased expression of STAR mRNA] PMID:29544186 13966347 MRTFA myocardin related transcription factor A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRTFA mRNA PMID:35307453 13966425 CNN3 calponin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CNN3 mRNA PMID:35307453 13966448 ZC3H15 zinc finger CCCH-type containing 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZC3H15 mRNA PMID:35307453 13966564 PSMC2 proteasome 26S subunit, ATPase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMC2 mRNA PMID:35307453 13966638 SIRT1 sirtuin 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20230704 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of SIRT1 protein PMID:36549457 13966638 SIRT1 sirtuin 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D008070 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein] PMID:36549457 13966638 SIRT1 sirtuin 1 gene CHEBI:17154 nicotinamide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009536 Niacinamide results in decreased expression of SIRT1 mRNA PMID:17851734 13966638 SIRT1 sirtuin 1 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of SIRT1 mRNA; Resveratrol results in increased expression of SIRT1 protein PMID:17037214|PMID:17851734|PMID:23065251 13966638 SIRT1 sirtuin 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C059514 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein] PMID:36549457 13966638 SIRT1 sirtuin 1 gene CHEBI:90369 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C550547 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]] PMID:36549457 13966748 APEX2 apurinic/apyrimidinic endodeoxyribonuclease 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of APEX2 mRNA PMID:35307453 13966809 TBC1D7 TBC1 domain family member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of TBC1D7 mRNA PMID:35307453 13966938 SLIT3 slit guidance ligand 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLIT3 mRNA; deoxynivalenol results in decreased expression of SLIT3 protein PMID:38403181 13966938 SLIT3 slit guidance ligand 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SLIT3 mRNA PMID:34933075 13966984 DNAJC17 DnaJ heat shock protein family (Hsp40) member C17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC17 mRNA PMID:35307453 13967072 TRPV4 transient receptor potential cation channel subfamily V member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPV4 mRNA PMID:35307453 13967299 CDH6 cadherin 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDH6 mRNA PMID:35307453 13967344 HAUS1 HAUS augmin like complex subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HAUS1 mRNA PMID:35307453 13967454 LRRC51 leucine rich repeat containing 51 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC51 mRNA PMID:35307453 13967466 TMEM11 transmembrane protein 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM11 mRNA PMID:35307453 13967501 MARS1 methionyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MARS1 mRNA PMID:35307453 13967576 EPS8L2 EPS8 signaling adaptor L2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EPS8L2 mRNA PMID:35307453 13967629 ST8SIA1 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST8SIA1 mRNA PMID:35307453 13967731 CDON cell adhesion associated, oncogene regulated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDON mRNA PMID:35307453 13967864 KLHDC3 kelch domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHDC3 mRNA PMID:35307453 13967910 OACYL O-acyltransferase like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of OACYL mRNA PMID:35307453 13968041 ZNF436 zinc finger protein 436 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of ZNF436 mRNA PMID:34389318 13968062 RUFY1 RUN and FYVE domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUFY1 mRNA PMID:35307453 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone affects the expression of KEAP1 protein PMID:31760079 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone results in decreased expression of KEAP1 mRNA PMID:31760079 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in increased expression of KEAP1 mRNA] PMID:37999554 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of KEAP1 mRNA PMID:35388968 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of KEAP1 mRNA PMID:37999554 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in increased expression of KEAP1 mRNA] PMID:37999554 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:4948 Evodiamine decreases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in decreased expression of KEAP1 protein PMID:39305878 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of KEAP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of KEAP1 protein] PMID:39305878 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased expression of KEAP1 protein PMID:39305878 13968169 KEAP1 kelch like ECH associated protein 1 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of KEAP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of KEAP1 protein] PMID:39305878 13968195 LOC100524373 platelet factor 4 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20250715 CTD MESH:D009151 Mustard Gas results in increased expression of PF4 mRNA PMID:18988085 13968196 CFH complement factor H gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFH mRNA PMID:35307453 13968197 MEIS2 Meis homeobox 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MEIS2 mRNA PMID:35307453 13968197 MEIS2 Meis homeobox 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MEIS2 mRNA PMID:39265697 13968246 GOLIM4 golgi integral membrane protein 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of GOLIM4 mRNA; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of GOLIM4 mRNA] PMID:21852083 13968397 LGALS12 galectin 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LGALS12 mRNA PMID:35307453 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PMAIP1 mRNA PMID:35307453 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PMAIP1 mRNA] PMID:39151877 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMAIP1 mRNA PMID:33891997 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of PMAIP1 mRNA PMID:39151877 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PMAIP1 mRNA] PMID:39151877 13968458 PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMAIP1 mRNA PMID:33891997 13968509 PLBD2 phospholipase B domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLBD2 mRNA PMID:35307453 13968565 MTRF1L mitochondrial translation release factor 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTRF1L mRNA PMID:35307453 13968859 TCERG1 transcription elongation regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TCERG1 mRNA PMID:35307453 13968905 ACSM3 acyl-CoA synthetase medium chain family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACSM3 mRNA PMID:35307453 13968935 TRPT1 tRNA phosphotransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPT1 mRNA PMID:35307453 13968935 TRPT1 tRNA phosphotransferase 1 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of TRPT1 mRNA PMID:28069986 13969080 PDK1 pyruvate dehydrogenase kinase 1 gene CHEBI:170007 nirmatrelvir increases phosphorylation EXP E RGD:6480464 20250401 CTD MESH:C000718217 nirmatrelvir results in increased phosphorylation of PDK1 protein PMID:38772495 13969080 PDK1 pyruvate dehydrogenase kinase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDK1 mRNA PMID:34416349 13969080 PDK1 pyruvate dehydrogenase kinase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDK1 mRNA PMID:34416349 13969080 PDK1 pyruvate dehydrogenase kinase 1 gene CHEBI:4357 deguelin multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C107676 deguelin results in increased expression of and results in increased phosphorylation of PDK1 protein PMID:37353039 13969165 ZNF428 zinc finger protein 428 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF428 mRNA; deoxynivalenol results in decreased expression of ZNF428 protein PMID:35307453|PMID:37257635 13969182 TICRR TOPBP1 interacting checkpoint and replication regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TICRR mRNA PMID:35307453 13969423 CYBA cytochrome b-245 alpha chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYBA mRNA PMID:35307453 13969502 PTGER3 prostaglandin E receptor 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of PTGER3 mRNA PMID:33626375 13969559 PRLR prolactin receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRLR mRNA PMID:35307453 13969559 PRLR prolactin receptor gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of PRLR protein alternative form PMID:18492821 13969760 TLCD1 TLC domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TLCD1 mRNA PMID:35307453 13970081 LRP2BP LRP2 binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRP2BP mRNA PMID:35307453 13970153 DNAH11 dynein axonemal heavy chain 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH11 mRNA PMID:35307453 13970309 SLC9A1 solute carrier family 9 member A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC9A1 protein PMID:37257635 13970309 SLC9A1 solute carrier family 9 member A1 gene CHEBI:28179 benzamide decreases activity EXP E RGD:6480464 20191114 CTD MESH:C037689 benzamide analog results in decreased activity of SLC9A1 protein PMID:17724433 13970366 F3 coagulation factor III, tissue factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of F3 mRNA PMID:37257635 13970366 F3 coagulation factor III, tissue factor gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of F3 mRNA; Estradiol affects the expression of F3 protein PMID:15964915 13970366 F3 coagulation factor III, tissue factor gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of F3 protein PMID:15964915 13970443 IKZF2 IKAROS family zinc finger 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IKZF2 mRNA PMID:35307453 13970601 LRRC42 leucine rich repeat containing 42 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC42 mRNA PMID:35307453 13970636 RSL1D1 ribosomal L1 domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RSL1D1 mRNA PMID:35307453 13970706 SPEN spen family transcriptional repressor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SPEN mRNA PMID:21852083 13970725 E2F2 E2F transcription factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of E2F2 mRNA PMID:35307453 13970741 STIP1 stress induced phosphoprotein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STIP1 mRNA PMID:35307453 13970893 MFSD2A MFSD2 lysolipid transporter A, lysophospholipid gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MFSD2A mRNA PMID:35307453 13970893 MFSD2A MFSD2 lysolipid transporter A, lysophospholipid gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MFSD2A mRNA PMID:39265697 13970989 LRRC47 leucine rich repeat containing 47 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC47 mRNA PMID:35307453 13971001 MCCC2 methylcrotonyl-CoA carboxylase subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MCCC2 mRNA PMID:35307453 13971068 SYNCRIP synaptotagmin binding cytoplasmic RNA interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SYNCRIP mRNA PMID:35307453 13971267 DYNC2H1 dynein cytoplasmic 2 heavy chain 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of DYNC2H1 mRNA PMID:21852083 13971844 CLSTN2 calsyntenin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CLSTN2 mRNA PMID:35307453 13971865 F2RL2 coagulation factor II thrombin receptor like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of F2RL2 mRNA PMID:35307453 13971923 MRPS11 mitochondrial ribosomal protein S11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS11 mRNA PMID:35307453 13971939 FERMT1 FERM domain containing kindlin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FERMT1 mRNA PMID:35307453 13971939 FERMT1 FERM domain containing kindlin 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FERMT1 mRNA PMID:39265697 13971977 COL4A1 collagen type IV alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL4A1 mRNA PMID:35307453 13971977 COL4A1 collagen type IV alpha 1 chain gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL4A1 mRNA PMID:34416349 13971977 COL4A1 collagen type IV alpha 1 chain gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL4A1 mRNA PMID:34416349 13972038 TLR10 toll like receptor 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TLR10 mRNA PMID:35307453 13972086 LOC100519808 TRPM8 channel-associated factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCAF1 mRNA; deoxynivalenol results in decreased expression of TCAF1 protein PMID:38403181 13972196 RBIS ribosomal biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBIS mRNA PMID:35307453 13972209 AGA aspartylglucosaminidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGA mRNA PMID:35307453 13972249 KCNIP1 potassium voltage-gated channel interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNIP1 mRNA PMID:35307453 13972281 ATP2B4 ATPase plasma membrane Ca2+ transporting 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP2B4 mRNA PMID:35307453 13972330 PARVB parvin beta gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PARVB mRNA] PMID:21852083 13972400 CHN1 chimerin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHN2 mRNA PMID:35307453 13972400 CHN1 chimerin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHN1 mRNA PMID:35307453 13972605 CLCN5 chloride voltage-gated channel 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLCN5 mRNA PMID:35307453 13972635 TYRO3 TYRO3 protein tyrosine kinase gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of TYRO3 mRNA PMID:18988085 13972635 TYRO3 TYRO3 protein tyrosine kinase gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of TYRO3 mRNA PMID:18790026 13972663 SPINK4 serine peptidase inhibitor Kazal type 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPINK4 mRNA PMID:35307453 13972686 CRYL1 crystallin lambda 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRYL1 mRNA PMID:35307453 13972842 GMDS GDP-mannose 4,6-dehydratase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GMDS mRNA PMID:35307453 13972880 AP1S2 adaptor related protein complex 1 subunit sigma 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AP1S2 mRNA PMID:35307453 13972954 PPIG peptidylprolyl isomerase G gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPIG mRNA PMID:35307453 13972997 PAX9 paired box 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAX9 mRNA PMID:35307453 13973167 KIFC2 kinesin family member C2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIFC2 mRNA PMID:35307453 13973208 SCN4A sodium voltage-gated channel alpha subunit 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SCN4A mRNA PMID:34933075 13973321 CCNYL1 cyclin Y like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCNYL1 mRNA PMID:35307453 13973343 ADA2 adenosine deaminase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADA2 mRNA PMID:35307453 13973357 WNT10B Wnt family member 10B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of WNT10B protein PMID:37257635 13973683 AVPR1A vasopressin receptor 1A gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of AVPR1A mRNA PMID:34933075 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of EIF2A protein PMID:37442268 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 GSK2656157 inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2A protein]; Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2A protein] PMID:37442268 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:131923 salubrinal increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C496827 salubrinal results in increased phosphorylation of EIF2A protein PMID:17464326 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:139047 GSK2656157 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C000597302 GSK2656157 inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2A protein] PMID:37442268 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:16170 mercury(0) increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury results in increased phosphorylation of EIF2A protein PMID:16759985 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:22977 cadmium atom increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased phosphorylation of EIF2A protein PMID:16759985 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2A protein PMID:33891997 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:25195 mercury atom increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008628 Mercury results in increased phosphorylation of EIF2A protein PMID:16759985 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2A protein] PMID:37442268 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:31823 mercury dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased phosphorylation of EIF2A protein PMID:16759985 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of EIF2A protein PMID:16759985|PMID:17464326 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2A protein PMID:33891997 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2A protein] PMID:37442268 13973733 EIF2A eukaryotic translation initiation factor 2A gene CHEBI:50842 norflurazon increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased phosphorylation of EIF2A protein PMID:38432436 13973857 EXTL1 exostosin like glycosyltransferase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of EXTL1 mRNA PMID:34933075 13973872 RHEBL1 RHEB like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHEBL1 mRNA PMID:35307453 13973926 PVR PVR cell adhesion molecule gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PVR mRNA PMID:39265697 13974012 SPTLC3 serine palmitoyltransferase long chain base subunit 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPTLC3 mRNA PMID:35307453 13974303 CYBRD1 cytochrome b reductase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYBRD1 mRNA PMID:35307453 13974332 HNF4A hepatocyte nuclear factor 4 alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HNF4A mRNA PMID:35307453 13974372 SGO1 shugoshin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SGO1 mRNA PMID:35307453 13974410 MIR21 microRNA mir-21 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of MIR21 mRNA PMID:38848930 13974410 MIR21 microRNA mir-21 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MIR21 mRNA; [Melatonin co-treated with bisphenol A] results in decreased expression of MIR21 mRNA PMID:38848930 13974410 MIR21 microRNA mir-21 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in increased expression of MIR21 mRNA PMID:38848930 13974410 MIR21 microRNA mir-21 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MIR21 mRNA PMID:38848930 13974410 MIR21 microRNA mir-21 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of MIR21 mRNA PMID:38848930 13974410 MIR21 microRNA mir-21 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MIR21 mRNA; [Melatonin co-treated with bisphenol A] results in decreased expression of MIR21 mRNA PMID:38848930 13974586 CNOT10 CCR4-NOT transcription complex subunit 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CNOT10 mRNA PMID:35307453 13974679 KDM5C lysine demethylase 5C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KDM5C mRNA PMID:35307453 13974679 KDM5C lysine demethylase 5C gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of KDM5C mRNA PMID:34389318 13974745 CCT8 chaperonin containing TCP1 subunit 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT8 mRNA PMID:35307453 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKT1 mRNA; deoxynivalenol results in decreased expression of AKT1 protein PMID:16099139|PMID:32229166 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:10022 deoxynivalenol decreases phosphorylation EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased phosphorylation of AKT1 protein PMID:32229166|PMID:37120089 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of AKT1 protein] PMID:37120089 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:138236 oridonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C011959 oridonin results in decreased expression of and results in decreased phosphorylation of AKT1 protein PMID:38972361 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D008070 [Flavones co-treated with Lipopolysaccharides] results in increased phosphorylation of AKT1 protein PMID:31669396 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:16469 17beta-estradiol increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased phosphorylation of AKT1 protein PMID:17348974 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of AKT1 protein] PMID:37120089 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:170007 nirmatrelvir multiple interactions EXP E RGD:6480464 20250401 CTD MESH:C000718217 nirmatrelvir results in increased expression of and results in increased phosphorylation of AKT1 protein PMID:38772495 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AKT1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased phosphorylation of AKT1 protein PMID:33493553 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:24043 flavones multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D047309 [Flavones co-treated with Lipopolysaccharides] results in increased phosphorylation of AKT1 protein PMID:31669396 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased phosphorylation of AKT1 protein PMID:39486568 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in decreased expression of AKT1 protein PMID:12760830 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:29678 sodium arsenite increases degradation EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased degradation of AKT1 protein PMID:16239170 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017947 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of AKT1 protein]; sodium arsenite results in decreased expression of and results in increased phosphorylation of AKT1 protein; Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] PMID:16239170 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:3093 bifenthrin affects phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin affects the phosphorylation of AKT1 protein PMID:33901951 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:31767 lead diacetate increases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in increased expression of AKT1 mRNA PMID:29273543 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:32234 titanium dioxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased phosphorylation of AKT1 protein PMID:23380242 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of AKT1 mRNA; tetrabromobisphenol A results in decreased expression of AKT1 protein PMID:35665993 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:34440 4-nonylphenol affects phosphorylation EXP E RGD:6480464 20240604 CTD MESH:C041594 4-nonylphenol affects the phosphorylation of AKT1 protein PMID:38246476 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AKT1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased phosphorylation of AKT1 protein PMID:33493553 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:35549 perfluorooctanoic acid decreases phosphorylation EXP E RGD:6480464 20240604 CTD MESH:C023036 perfluorooctanoic acid results in decreased phosphorylation of AKT1 protein PMID:38145882 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:39329 etoxazole affects phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole affects the phosphorylation of AKT1 protein PMID:31744678 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of AKT1 protein]; pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of AKT1 protein]; SB 203580 affects the reaction [etoxazole affects the phosphorylation of AKT1 protein]; U 0126 affects the reaction [etoxazole affects the phosphorylation of AKT1 protein] PMID:31744678 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:39483 sodium dichromate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C016104 sodium bichromate results in decreased expression of AKT1 protein PMID:12760830 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:4357 deguelin multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C107676 deguelin results in increased expression of and results in increased phosphorylation of AKT1 protein PMID:37353039 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:50091 S-nitrosoglutathione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D026422 AKT1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein] PMID:11514583 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of AKT1 protein PMID:38432436 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:52289 wortmannin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009687 Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] PMID:16239170 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] PMID:16239170|PMID:31744678 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of AKT1 protein PMID:16239170 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of AKT1 protein] PMID:16239170 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased phosphorylation of AKT1 protein PMID:39486568 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:7719 ochratoxin A decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased phosphorylation of AKT1 protein PMID:30287338 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:8772 raloxifene decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in decreased phosphorylation of AKT1 protein PMID:17348974 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of AKT1 protein] PMID:31744678 13974772 AKT1 AKT serine/threonine kinase 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 SB 203580 affects the reaction [etoxazole affects the phosphorylation of AKT1 protein] PMID:31744678 13974773 SLC2A13 solute carrier family 2 member 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC2A13 mRNA PMID:35307453 13974834 PIGX phosphatidylinositol glycan anchor biosynthesis class X gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PIGX mRNA PMID:35307453 13974874 FAM81A family with sequence similarity 81 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM81A mRNA PMID:35307453 13974953 ZNF296 zinc finger protein 296 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF296 mRNA PMID:35307453 13975052 SLC4A3 solute carrier family 4 member 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SLC4A3 mRNA PMID:39265697 13975221 TMPRSS5 transmembrane serine protease 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMPRSS5 mRNA PMID:35307453 13975473 CYP2C49 cytochrome P450 2C49 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CYP2C49 mRNA PMID:34389318 13975473 CYP2C49 cytochrome P450 2C49 gene CHEBI:2533 alachlor decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:C000188 CYP2C49 protein results in decreased susceptibility to alachlor PMID:16315095 13975473 CYP2C49 cytochrome P450 2C49 gene CHEBI:50842 norflurazon multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008677 CYP2C49 protein results in increased metabolism of and results in decreased susceptibility to norflurazone PMID:16315095 13975473 CYP2C49 cytochrome P450 2C49 gene CHEBI:63956 isoxaben decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:C057467 CYP2C49 protein results in decreased susceptibility to isoxaben PMID:16315095 13975473 CYP2C49 cytochrome P450 2C49 gene CHEBI:81981 chlorotoluron decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:C007033 CYP2C49 protein results in decreased susceptibility to chlortoluron PMID:16315095 13975504 AQP11 aquaporin 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP11 mRNA PMID:35307453 13975510 MMP17 matrix metallopeptidase 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP17 mRNA PMID:35307453 13975525 BACE1 beta-secretase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BACE1 mRNA PMID:35307453 13975579 PIK3CD phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3CD mRNA PMID:35307453 13975675 INSRR insulin receptor related receptor gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of INSRR mRNA PMID:39265697 13975755 FER1L5 fer-1 like family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FER1L5 mRNA PMID:35307453 13975819 TPGS2 tubulin polyglutamylase complex subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPGS2 mRNA PMID:35307453 13975856 WDR81 WD repeat domain 81 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR81 mRNA PMID:35307453 13975896 CDH2 cadherin 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CDH2 mRNA PMID:39265697 13975896 CDH2 cadherin 2 gene CHEBI:27915 melamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in decreased expression of CDH2 protein PMID:30055240 13975986 GFRA1 GDNF family receptor alpha 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GFRA1 mRNA PMID:35307453 13976016 RMND5A required for meiotic nuclear division 5 homolog A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RMND5A mRNA PMID:35307453 13976253 WBP1L WW domain binding protein 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WBP1L mRNA PMID:35307453 13976401 THOC6 THO complex subunit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THOC6 mRNA PMID:35307453 13976475 P2RY2 purinergic receptor P2Y2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of P2RY2 mRNA PMID:35307453 13976493 CANT1 calcium activated nucleotidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CANT1 mRNA PMID:35307453 13976603 FGG fibrinogen gamma chain gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FGG mRNA PMID:34389318 13976645 CXCL12 C-X-C motif chemokine ligand 12 gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of CXCL12 mRNA PMID:31744678 13976730 PARP8 poly(ADP-ribose) polymerase family member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PARP8 mRNA PMID:35307453 13976806 SPN sialophorin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPN mRNA PMID:35307453 13976834 EPYC epiphycan gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of EPYC mRNA PMID:34933075 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:17489 3',5'-cyclic AMP increases abundance EXP E RGD:6480464 20191114 CTD MESH:D000242 GNRH1 protein results in increased abundance of Cyclic AMP PMID:15833593 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:17489 3',5'-cyclic AMP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000242 [Cobalt binds to GNRH1 protein] which results in increased abundance of Cyclic AMP PMID:15833593 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:27638 cobalt atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D003035 Cobalt binds to GNRH1 protein PMID:15833593 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:27638 cobalt atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003035 [Cobalt binds to GNRH1 protein] which results in increased abundance of Cyclic AMP; [Cobalt binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:15833593 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:28112 nickel atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D009532 Nickel binds to GNRH1 protein PMID:16892001 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:28112 nickel atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009532 [Nickel binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:28694 copper atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper binds to GNRH1 protein PMID:16892001 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:28694 copper atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 [Copper binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:30052 copper(0) affects binding EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper binds to GNRH1 protein PMID:16892001 13976848 GNRH1 gonadotropin releasing hormone 1 gene CHEBI:30052 copper(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 [Copper binds to GNRH1 protein] which results in increased secretion of LHB protein PMID:16892001 13976868 SCARF2 scavenger receptor class F member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCARF2 mRNA PMID:35307453 13976902 P2RX5 purinergic receptor P2X 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P2RX5 mRNA PMID:35307453 13976992 CHL1 cell adhesion molecule L1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHL1 mRNA PMID:35307453 13977176 GOLT1B golgi transport 1B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GOLT1B mRNA PMID:35307453 13977465 COLEC12 collectin subfamily member 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COLEC12 mRNA PMID:35307453 13977482 EGR2 early growth response 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EGR2 mRNA PMID:35307453 13977493 RHOU ras homolog family member U gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of RHOU mRNA PMID:21852083 13977508 MPV17L MPV17 mitochondrial inner membrane protein like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPV17L mRNA PMID:35307453 13977616 ITM2A integral membrane protein 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITM2A mRNA PMID:35307453 13977844 CDRT4 CMT1A duplicated region transcript 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CDRT4 mRNA PMID:34933075 13977934 HSD17B6 hydroxysteroid 17-beta dehydrogenase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSD17B6 mRNA PMID:35307453 13977947 FLRT3 fibronectin leucine rich transmembrane protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FLRT3 mRNA PMID:35307453 13977963 CABYR calcium binding tyrosine phosphorylation regulated gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of CABYR mRNA PMID:35307453 13978120 ARHGAP24 Rho GTPase activating protein 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGAP24 mRNA PMID:35307453 13978120 ARHGAP24 Rho GTPase activating protein 24 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ARHGAP24 mRNA PMID:39265697 13978269 LDLRAP1 low density lipoprotein receptor adaptor protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LDLRAP1 mRNA; deoxynivalenol results in decreased expression of LDLRAP1 protein PMID:38403181 13978286 MAOB monoamine oxidase B gene CHEBI:233581 asoxime chloride decreases activity EXP E RGD:6480464 20250408 CTD MESH:C022870 asoxime chloride results in decreased activity of MAOB protein PMID:21195145 13978286 MAOB monoamine oxidase B gene CHEBI:23924 enzyme inhibitor decreases activity EXP E RGD:6480464 20210608 CTD MESH:D004791 Enzyme Inhibitors results in decreased activity of MAOB protein PMID:33359020 13978286 MAOB monoamine oxidase B gene CHEBI:7930 Pargyline decreases activity EXP E RGD:6480464 20210608 CTD MESH:D010293 Pargyline analog results in decreased activity of MAOB protein PMID:33359020 13978286 MAOB monoamine oxidase B gene CHEBI:8354 pralidoxime decreases activity EXP E RGD:6480464 20191114 CTD MESH:C028797 pralidoxime results in decreased activity of MAOB protein PMID:21195145 13978286 MAOB monoamine oxidase B gene CHEBI:8863 Riluzole decreases activity EXP E RGD:6480464 20210608 CTD MESH:D019782 Riluzole analog results in decreased activity of MAOB protein PMID:33359020 13978320 ACO1 aconitase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACO1 mRNA PMID:35307453 13978320 ACO1 aconitase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ACO1 mRNA PMID:39265697 13978320 ACO1 aconitase 1 gene CHEBI:34905 paraquat decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010269 Paraquat results in decreased activity of ACO1 protein PMID:11814328 13978320 ACO1 aconitase 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of ACO1 mRNA PMID:17363680 13978391 HCAR2 hydroxycarboxylic acid receptor 2 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of HCAR2 mRNA PMID:35307453 13978522 EFHC1 EF-hand domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFHC1 mRNA PMID:35307453 13978587 EIF3J eukaryotic translation initiation factor 3 subunit J gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF3J mRNA; deoxynivalenol results in increased expression of EIF3J protein PMID:35307453|PMID:38403181 13978692 HSD17B14 hydroxysteroid 17-beta dehydrogenase 14 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of HSD17B14 mRNA PMID:28069986 13978856 CPED1 cadherin like and PC-esterase domain containing 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CPED1 mRNA PMID:34933075 13979142 IST1 IST1 factor associated with ESCRT-III gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IST1 mRNA PMID:35307453 13979177 CDK18 cyclin dependent kinase 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDK18 mRNA PMID:35307453 13979233 MRPL41 mitochondrial ribosomal protein L41 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL41 mRNA PMID:35307453 13979359 ADGRF4 adhesion G protein-coupled receptor F4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRF4 mRNA PMID:35307453 13979422 MRPS30 mitochondrial ribosomal protein S30 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS30 mRNA PMID:35307453 13979489 HEXD hexosaminidase D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HEXD mRNA PMID:35307453 13979537 CORO2A coronin 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CORO2A mRNA PMID:35307453 13979565 SGK2 serum/glucocorticoid regulated kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SGK2 mRNA PMID:35307453 13979565 SGK2 serum/glucocorticoid regulated kinase 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SGK2 mRNA PMID:34933075 13979822 RBM14 RNA binding motif protein 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM14 mRNA PMID:35307453 13980010 GADD45B growth arrest and DNA damage inducible beta gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of GADD45B mRNA PMID:37706587 13980010 GADD45B growth arrest and DNA damage inducible beta gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of GADD45B mRNA] PMID:37706587 13980010 GADD45B growth arrest and DNA damage inducible beta gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of GADD45B mRNA] PMID:37706587 13980024 GNAI2 G protein subunit alpha i2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of GNAI2 mRNA PMID:25455459 13980048 SAMD15 sterile alpha motif domain containing 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAMD15 mRNA PMID:35307453 13980136 NFYC nuclear transcription factor Y subunit gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NFYC mRNA PMID:35307453 13980251 VNN1 vanin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VNN1 mRNA PMID:35307453 13980328 PPRC1 PPARG related coactivator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPRC1 mRNA PMID:35307453 13980328 PPRC1 PPARG related coactivator 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PPRC1 mRNA PMID:27617619 13980370 PPCS phosphopantothenoylcysteine synthetase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPCS mRNA PMID:35307453 13980419 SH2D6 SH2 domain containing 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH2D6 mRNA PMID:35307453 13980621 EIF4E eukaryotic translation initiation factor 4E gene CHEBI:10022 deoxynivalenol decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased phosphorylation of EIF4E protein PMID:16099139 13980621 EIF4E eukaryotic translation initiation factor 4E gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4E mRNA; deoxynivalenol results in increased expression of EIF4E protein PMID:35307453|PMID:38403181 13980648 TTC12 tetratricopeptide repeat domain 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC12 mRNA PMID:35307453 13980814 BNIP3 BCL2 interacting protein 3 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of BNIP3 mRNA] PMID:39151877 13980814 BNIP3 BCL2 interacting protein 3 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of BNIP3 mRNA PMID:39151877 13980814 BNIP3 BCL2 interacting protein 3 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of BNIP3 mRNA] PMID:39151877 13980875 IL7 interleukin 7 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL7 mRNA PMID:33592257 13980875 IL7 interleukin 7 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL7 mRNA PMID:33592257 13980897 CDCP2 CUB domain containing protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDCP2 mRNA PMID:35307453 13980907 MYOM2 myomesin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYOM2 mRNA PMID:35307453 13981040 CCNE1 cyclin E1 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of CCNE1 mRNA PMID:37706587 13981040 CCNE1 cyclin E1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CCNE1 mRNA] PMID:37706587 13981040 CCNE1 cyclin E1 gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of CCNE1 mRNA PMID:33901951 13981040 CCNE1 cyclin E1 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CCNE1 mRNA] PMID:37706587 13981040 CCNE1 cyclin E1 gene CHEBI:39329 etoxazole decreases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in decreased expression of CCNE1 mRNA PMID:31744678 13981040 CCNE1 cyclin E1 gene CHEBI:6078 ivermectin decreases expression EXP E RGD:6480464 20201103 CTD MESH:D007559 Ivermectin results in decreased expression of CCNE1 mRNA PMID:31400776 13981124 PEBP4 phosphatidylethanolamine binding protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PEBP4 mRNA PMID:35307453 13981658 IVL involucrin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IVL mRNA PMID:39265697 13981669 DTX4 deltex E3 ubiquitin ligase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DTX4 mRNA PMID:35307453 13981850 NEDD9 neural precursor cell expressed, developmentally down-regulated 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NEDD9 mRNA PMID:35307453 13981875 ACSL4 acyl-CoA synthetase long chain family member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACSL4 mRNA PMID:35307453 13982068 FANCB FA complementation group B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FANCB mRNA PMID:35307453 13982157 REXO2 RNA exonuclease 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REXO2 mRNA PMID:35307453 13982306 TOB1 transducer of ERBB2, 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TOB1 mRNA PMID:35307453 13982454 RORC RAR related orphan receptor C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RORC mRNA PMID:35307453 13982502 HRH2 histamine receptor H2 gene CHEBI:18295 histamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006632 [Histamine affects the activity of HRH2 protein] which affects the secretion of Chlorides PMID:12665126 13982566 PIK3R6 phosphoinositide-3-kinase regulatory subunit 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3R6 mRNA PMID:35307453 13982668 BTBD2 BTB domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of BTBD2 mRNA; deoxynivalenol results in decreased expression of BTBD2 protein PMID:38403181 13982780 ECH1 enoyl-CoA hydratase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ECH1 mRNA PMID:35307453 13982814 IGSF9B immunoglobulin superfamily member 9B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGSF9B mRNA PMID:35307453 13982814 IGSF9B immunoglobulin superfamily member 9B gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IGSF9B mRNA PMID:34933075 13982910 SH3TC2 SH3 domain and tetratricopeptide repeats 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3TC2 mRNA PMID:35307453 13982940 PDLIM5 PDZ and LIM domain 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDLIM5 mRNA PMID:35307453 13983052 FAXDC2 fatty acid hydroxylase domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAXDC2 mRNA PMID:35307453 13983217 CFL1 cofilin 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of CFL1 mRNA PMID:35839969 13983522 BTG2 BTG anti-proliferation factor 2 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of BTG2 mRNA PMID:34389318 13983696 ADARB1 adenosine deaminase RNA specific B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADARB1 mRNA PMID:35307453 13983745 CDKL2 cyclin dependent kinase like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDKL2 mRNA PMID:35307453 13983784 TRPM4 transient receptor potential cation channel subfamily M member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPM4 mRNA PMID:35307453 13983845 MS4A7 membrane spanning 4-domains A7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MS4A7 mRNA PMID:35307453 13983943 METTL27 methyltransferase like 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of METTL27 mRNA PMID:35307453 13984048 ARMC9 armadillo repeat containing 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARMC9 mRNA PMID:35307453 13984100 CORIN corin, serine peptidase gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CORIN mRNA PMID:39265697 13984340 TP53INP1 tumor protein p53 inducible nuclear protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TP53INP1 mRNA PMID:35307453 13984371 LTBP1 latent transforming growth factor beta binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LTBP1 mRNA; deoxynivalenol results in decreased expression of LTBP1 protein PMID:38403181 13984414 STING1 stimulator of interferon response cGAMP interactor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STING1 mRNA PMID:35307453 13984451 RND2 Rho family GTPase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RND2 mRNA PMID:35307453 13984474 TGFBR2 transforming growth factor beta receptor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TGFBR2 mRNA PMID:35307453 13984474 TGFBR2 transforming growth factor beta receptor 2 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of TGFBR2 mRNA PMID:33626375 13984496 FAM186B family with sequence similarity 186 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM186B mRNA PMID:35307453 13984535 FAM107B family with sequence similarity 107 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM107B mRNA PMID:35307453 13984625 PLIN2 perilipin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLIN2 mRNA PMID:35307453 13984625 PLIN2 perilipin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of PLIN2 mRNA; deoxynivalenol results in increased expression of PLIN2 protein PMID:38403181 13984625 PLIN2 perilipin 2 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 protein] PMID:31535366 13984625 PLIN2 perilipin 2 gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of PLIN2 mRNA; Malathion results in decreased expression of PLIN2 protein PMID:31535366 13984625 PLIN2 perilipin 2 gene CHEBI:6651 malathion multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008294 Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 protein] PMID:31535366 13984694 ADAMTS20 ADAM metallopeptidase with thrombospondin type 1 motif 20 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of ADAMTS20 mRNA PMID:34933075 13984772 BPI bactericidal permeability increasing protein gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of BPI mRNA PMID:34389318 13984917 SESN2 sestrin 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SESN2 mRNA] PMID:39151877 13984917 SESN2 sestrin 2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SESN2 mRNA PMID:39151877 13984917 SESN2 sestrin 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SESN2 mRNA] PMID:39151877 13985013 CTDSPL CTD small phosphatase like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTDSPL mRNA PMID:35307453 13985345 OSBPL9 oxysterol binding protein like 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OSBPL9 mRNA PMID:35307453 13985465 ZFR zinc finger RNA binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZFR mRNA PMID:35307453 13985505 LOC100511937 phosphatidylinositol 3-kinase regulatory subunit gamma gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20210525 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of PIK3R3 mRNA PMID:21852083 13985558 SMIM24 small integral membrane protein 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMIM24 mRNA PMID:35307453 13985595 TADA2A transcriptional adaptor 2A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TADA2A mRNA PMID:35307453 13985653 TRIM11 tripartite motif containing 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM11 mRNA PMID:35307453 13985704 SLA-DOB MHC class II, DO beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HLA-DOB mRNA PMID:35307453 13985852 CYP26A1 cytochrome P450 family 26 subfamily A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP26A1 mRNA PMID:35307453 13985927 IZUMO4 IZUMO family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IZUMO4 mRNA PMID:35307453 13985980 ARAP3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARAP3 mRNA PMID:35307453 13986036 ALDOA aldolase, fructose-bisphosphate A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ALDOA mRNA PMID:35307453 13986123 DNAJC27 DnaJ heat shock protein family (Hsp40) member C27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC27 mRNA PMID:35307453 13986205 ENPP4 ectonucleotide pyrophosphatase/phosphodiesterase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENPP4 mRNA PMID:35307453 13986317 LIN7A lin-7 homolog A, crumbs cell polarity complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LIN7A mRNA PMID:35307453 13986341 F2 coagulation factor II, thrombin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of F2 mRNA PMID:35307453 13986341 F2 coagulation factor II, thrombin gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of F2 mRNA PMID:39265697 13986550 SYMPK symplekin scaffold protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SYMPK mRNA PMID:35307453 13986591 METTL5 methyltransferase 5, N6-adenosine gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL5 mRNA PMID:35307453 13986774 EXOSC2 exosome component 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC2 mRNA PMID:35307453 13986866 RAB9A RAB9A, member RAS oncogene family gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RAB9A mRNA PMID:39265697 13986926 SH2B2 SH2B adaptor protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SH2B2 mRNA PMID:35307453 13986982 IL20RA interleukin 20 receptor subunit alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL20RA mRNA PMID:35307453 13987059 CHST3 carbohydrate sulfotransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHST3 mRNA PMID:35307453 13987258 MRM3 mitochondrial rRNA methyltransferase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRM3 mRNA PMID:35307453 13987295 TRIM29 tripartite motif containing 29 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIM29 mRNA PMID:35307453 13987295 TRIM29 tripartite motif containing 29 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TRIM29 mRNA PMID:34933075 13987331 SERTAD4 SERTA domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERTAD4 mRNA PMID:35307453 13987386 TMEM131 transmembrane protein 131 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM131 mRNA PMID:35307453 13987449 MT-2B metallothionein-2A gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MT-2B mRNA PMID:39265697 13987476 COX11 cytochrome c oxidase copper chaperone COX11 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of COX11 mRNA PMID:21852083 13987522 CDC42EP5 CDC42 effector protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDC42EP5 mRNA PMID:35307453 13987553 ENPEP glutamyl aminopeptidase gene CHEBI:2624 amastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016977 amastatin inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame] PMID:8141778 13987553 ENPEP glutamyl aminopeptidase gene CHEBI:2877 aspartame increases hydrolysis EXP E RGD:6480464 20191114 CTD MESH:D001218 ENPEP protein results in increased hydrolysis of Aspartame PMID:8141778 13987553 ENPEP glutamyl aminopeptidase gene CHEBI:2877 aspartame multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001218 1,10-phenanthroline inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame]; amastatin inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame]; Calcium Chloride promotes the reaction [ENPEP protein results in increased hydrolysis of Aspartame] PMID:8141778 13987553 ENPEP glutamyl aminopeptidase gene CHEBI:3312 calcium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002122 Calcium Chloride promotes the reaction [ENPEP protein results in increased hydrolysis of Aspartame] PMID:8141778 13987553 ENPEP glutamyl aminopeptidase gene CHEBI:44975 1,10-phenanthroline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025205 1,10-phenanthroline inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame] PMID:8141778 13987624 ARPP21 cAMP regulated phosphoprotein 21 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARPP21 mRNA PMID:35307453 13987624 ARPP21 cAMP regulated phosphoprotein 21 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ARPP21 mRNA] PMID:21852083 13987681 CORO1B coronin 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CORO1B mRNA PMID:35307453 13987696 TIMM50 translocase of inner mitochondrial membrane 50 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TIMM50 mRNA PMID:35307453 13987740 ADAMTS3 ADAM metallopeptidase with thrombospondin type 1 motif 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADAMTS3 mRNA PMID:34933075 13987766 ZSCAN10 zinc finger and SCAN domain containing 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZSCAN10 mRNA PMID:35307453 13988066 ZNF618 zinc finger protein 618 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF618 mRNA PMID:35307453 13988091 CAPN1 calpain 1 gene CHEBI:15379 dioxygen increases activity EXP E RGD:6480464 20191114 CTD MESH:D010100 Oxygen deficiency results in increased activity of CAPN1 protein PMID:9728040 13988091 CAPN1 calpain 1 gene CHEBI:15379 dioxygen increases expression EXP E RGD:6480464 20191114 CTD MESH:D010100 Oxygen deficiency results in increased expression of CAPN1 mRNA PMID:9728040 13988091 CAPN1 calpain 1 gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of CAPN1 mRNA] PMID:9728040 13988091 CAPN1 calpain 1 gene CHEBI:16480 nitric oxide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009569 Nitric Oxide results in decreased expression of CAPN1 mRNA PMID:9728040 13988091 CAPN1 calpain 1 gene CHEBI:27666 actinomycin D multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003609 Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of CAPN1 mRNA] PMID:9728040 13988091 CAPN1 calpain 1 gene CHEBI:33101 nitrogen dioxide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009585 Nitrogen Dioxide results in decreased expression of CAPN1 mRNA PMID:9728040 13988138 PDGFRB platelet derived growth factor receptor beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDGFRB mRNA; deoxynivalenol results in decreased expression of PDGFRB protein PMID:35307453|PMID:38403181 13988249 DUS3L dihydrouridine synthase 3 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUS3L mRNA PMID:35307453 13988276 SYTL4 synaptotagmin like 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SYTL4 mRNA PMID:21852083 13988324 EHD4 EH domain containing 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EHD4 mRNA PMID:35307453 13988335 SLC3A2 solute carrier family 3 member 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SLC3A2 mRNA PMID:39265697 13988496 ALDH1L1 aldehyde dehydrogenase 1 family member L1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH1L1 mRNA PMID:35307453 13988665 SCNN1B sodium channel epithelial 1 subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCNN1B mRNA PMID:35307453 13988711 MT-CO3 mitochondrially encoded cytochrome c oxidase III gene CHEBI:6651 malathion affects expression EXP E RGD:6480464 20191114 CTD MESH:D008294 Malathion affects the expression of COX3 mRNA PMID:17454254 13988747 HPX hemopexin gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of HPX mRNA PMID:34389318 13988795 NUP88 nucleoporin 88 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUP88 mRNA PMID:35307453 13988827 RNF214 ring finger protein 214 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RNF214 mRNA PMID:35307453 13988887 GLRX glutaredoxin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of GLRX mRNA PMID:39265697 13988887 GLRX glutaredoxin gene CHEBI:22977 cadmium atom decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in decreased activity of GLRX protein PMID:16785314 13988887 GLRX glutaredoxin gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 GLRX protein inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; IDH2 protein inhibits the reaction [Cadmium results in decreased activity of GLRX protein]; oxalomalic acid promotes the reaction [Cadmium results in decreased activity of GLRX protein] PMID:16785314 13988887 GLRX glutaredoxin gene CHEBI:30926 3-oxalomalic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C015407 oxalomalic acid promotes the reaction [Cadmium Chloride results in decreased activity of GLRX protein]; oxalomalic acid promotes the reaction [Cadmium results in decreased activity of GLRX protein] PMID:16785314 13988887 GLRX glutaredoxin gene CHEBI:35456 cadmium dichloride decreases activity EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased activity of GLRX protein PMID:16785314 13988887 GLRX glutaredoxin gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 GLRX protein inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; IDH2 protein inhibits the reaction [Cadmium Chloride results in decreased activity of GLRX protein]; oxalomalic acid promotes the reaction [Cadmium Chloride results in decreased activity of GLRX protein] PMID:16785314 13989199 SYTL1 synaptotagmin like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYTL1 mRNA PMID:35307453 13989249 GPR137 G protein-coupled receptor 137 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR137 mRNA PMID:35307453 13989417 PPP2R5A protein phosphatase 2 regulatory subunit B'alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP2R5A mRNA PMID:35307453 13989529 MID1 midline 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MID1 mRNA PMID:35307453 13989570 IL11RA interleukin 11 receptor subunit alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL11RA mRNA PMID:35307453 13989755 TOMM6 translocase of outer mitochondrial membrane 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230411 CTD MESH:C007262 deoxynivalenol results in increased expression of TOMM6 mRNA PMID:35307453 13989759 MUC13 mucin 13, cell surface associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MUC13 mRNA PMID:35307453 13989774 CRIM1 cysteine rich transmembrane BMP regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRIM1 mRNA; deoxynivalenol results in decreased expression of CRIM1 protein PMID:38403181 13989802 PRKCD protein kinase C delta gene CHEBI:29678 sodium arsenite increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased phosphorylation of PRKCD protein PMID:15089098 13989802 PRKCD protein kinase C delta gene CHEBI:37537 phorbol 13-acetate 12-myristate increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCD protein PMID:15089098 13989858 KPTN kaptin, actin binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KPTN mRNA PMID:35307453 13989957 IL22RA1 interleukin 22 receptor subunit alpha 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL22RA1 mRNA PMID:35307453 13989957 IL22RA1 interleukin 22 receptor subunit alpha 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IL22RA1 mRNA PMID:34933075 13989957 IL22RA1 interleukin 22 receptor subunit alpha 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IL22RA1 mRNA PMID:39265697 13990006 H6PD hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of H6PD mRNA PMID:35307453 13990156 KTI12 KTI12 chromatin associated homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KTI12 mRNA PMID:35307453 13990166 ZNF862 zinc finger protein 862 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF862 mRNA PMID:35307453 13990200 ARF4 ADP ribosylation factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARF4 mRNA PMID:35307453 13990213 PTGR1 prostaglandin reductase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGR1 mRNA PMID:35307453 13990380 ADAM12 ADAM metallopeptidase domain 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM12 mRNA PMID:35307453 13990728 ZNF385A zinc finger protein 385A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF385A mRNA PMID:35307453 13990779 SERPINB8 serpin family B member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERPINB8 mRNA PMID:35307453 13990817 FJX1 four-jointed box kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FJX1 mRNA PMID:35307453 13990851 EIF2B3 eukaryotic translation initiation factor 2B subunit gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2B3 mRNA PMID:35307453 13990873 PCTP phosphatidylcholine transfer protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCTP mRNA PMID:35307453 13990873 PCTP phosphatidylcholine transfer protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PCTP mRNA PMID:39265697 13990906 NAGS N-acetylglutamate synthase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAGS mRNA PMID:35307453 13990963 NUP205 nucleoporin 205 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUP205 mRNA PMID:35307453 13991029 H2BC19 H2B clustered histone 19 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of H2BC19 mRNA; graphene oxide results in decreased expression of H2BC20 mRNA PMID:39265697 13991106 TRPM5 transient receptor potential cation channel subfamily M member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPM5 mRNA PMID:35307453 13991144 THA1 threonine aldolase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of THA1 mRNA PMID:35307453 13991270 ACOT13 acyl-CoA thioesterase 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACOT13 mRNA PMID:35307453 13991376 TOP2A DNA topoisomerase II alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TOP2A mRNA PMID:35307453 13991376 TOP2A DNA topoisomerase II alpha gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of TOP2A mRNA PMID:21852083 13991584 WFDC1 WAP four-disulfide core domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WFDC1 mRNA PMID:35307453 13991584 WFDC1 WAP four-disulfide core domain 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of WFDC1 mRNA PMID:39265697 13991584 WFDC1 WAP four-disulfide core domain 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of WFDC1 mRNA PMID:28069986 13991690 CIP2A cellular inhibitor of PP2A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CIP2A mRNA PMID:35307453 13991790 CACNA1E calcium voltage-gated channel subunit alpha1 E gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CACNA1E mRNA PMID:34933075 13991860 CROCC2 ciliary rootlet coiled-coil, rootletin family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CROCC2 mRNA PMID:35307453 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCLC mRNA PMID:35307453 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone affects the expression of GCLC protein PMID:31760079 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone results in increased expression of GCLC mRNA PMID:31760079 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of GCLC mRNA PMID:39265697 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:16236 ethanol increases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased activity of GCLC protein PMID:16792574 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of GCLC mRNA PMID:16792574 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GCLC protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GCLC mRNA PMID:16792574 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GCLC mRNA] PMID:39151877 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in increased expression of GCLC mRNA] PMID:37999554 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCLC mRNA PMID:33493553 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of GCLC mRNA PMID:39151877 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GCLC mRNA] PMID:39151877 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GCLC protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GCLC mRNA PMID:16792574 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:27584 aldosterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D000450 Aldosterone results in increased expression of GCLC protein PMID:24512358 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Buthionine Sulfoximine inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein]]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein] PMID:20732396 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:28714 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases activity EXP E RGD:6480464 20191114 CTD MESH:D019328 Buthionine Sulfoximine results in decreased activity of GCLC protein PMID:20732396 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:28714 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019328 Buthionine Sulfoximine inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein]] PMID:20732396 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:30621 diarsenic trioxide increases activity EXP E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased activity of GCLC protein PMID:18801422 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:30621 diarsenic trioxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of GCLC mRNA PMID:18801422 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of GCLC mRNA PMID:37999554 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in increased expression of GCLC mRNA] PMID:37999554 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:34247 2,6-di-tert-butyl-4-methylphenol increases expression EXP E RGD:6480464 20191114 CTD MESH:D002084 Butylated Hydroxytoluene results in increased expression of GCLC mRNA PMID:9535746 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCLC mRNA PMID:33493553 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:47807 sulforaphane increases activity EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased activity of GCLC protein PMID:20732396 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of GCLC mRNA PMID:18547363 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 Buthionine Sulfoximine inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein]]; ochratoxin A inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein] PMID:18547363|PMID:20732396 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:49900 arsenous acid increases activity EXP E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased activity of GCLC protein PMID:18801422 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:49900 arsenous acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of GCLC mRNA PMID:18801422 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of GCLC mRNA PMID:18547363 13991983 GCLC glutamate-cysteine ligase catalytic subunit gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA] PMID:18547363 13992179 DDX47 DEAD-box helicase 47 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX47 mRNA PMID:35307453 13992195 TNNI1 troponin I1, slow skeletal type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNNI1 mRNA PMID:35307453 13992195 TNNI1 troponin I1, slow skeletal type gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TNNI1 mRNA PMID:34933075 13992286 FMNL3 formin like 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FMNL3 mRNA PMID:35307453 13992400 EIF4G1 eukaryotic translation initiation factor 4 gamma 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4G1 mRNA PMID:35307453 13992498 MORN4 MORN repeat containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MORN4 mRNA PMID:35307453 13992577 MIR744 microRNA mir-744 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20201006 CTD MESH:D015025 Zearalenone results in increased expression of MIR744 mRNA PMID:32439583 13992580 UPK3A uroplakin 3A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UPK3A mRNA PMID:35307453 13992710 GIMD1 GIMAP family P-loop NTPase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GIMD1 mRNA PMID:35307453 13992830 SLC29A3 solute carrier family 29 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC29A3 mRNA PMID:35307453 13992843 SLC37A4 solute carrier family 37 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC37A4 mRNA PMID:35307453 13993177 SLC5A4 solute carrier family 5 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC5A4 mRNA PMID:35307453 13993290 RAD51B RAD51 paralog B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAD51B mRNA PMID:35307453 13993421 SCNN1A sodium channel epithelial 1 subunit alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCNN1A mRNA PMID:35307453 13993445 ACSS1 acyl-CoA synthetase short chain family member 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ACSS1 mRNA] PMID:39151877 13993445 ACSS1 acyl-CoA synthetase short chain family member 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of ACSS1 mRNA PMID:39151877 13993445 ACSS1 acyl-CoA synthetase short chain family member 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ACSS1 mRNA] PMID:39151877 13993588 SNX24 sorting nexin 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNX24 mRNA PMID:35307453 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TIMP2 mRNA PMID:35307453 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of TIMP2 mRNA PMID:28069986 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 protein PMID:34416349 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of TIMP2 protein PMID:39486568 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 protein PMID:34416349 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of TIMP2 protein PMID:39486568 13993651 TIMP2 TIMP metallopeptidase inhibitor 2 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of TIMP2 mRNA PMID:14994279 13993672 HAVCR1 hepatitis A virus cellular receptor 1 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20231003 CTD MESH:D005839 Gentamicins results in increased expression of HAVCR1 mRNA PMID:28372472 13993672 HAVCR1 hepatitis A virus cellular receptor 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of HAVCR1 mRNA PMID:33905761 13993672 HAVCR1 hepatitis A virus cellular receptor 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of HAVCR1 mRNA PMID:33905761 13993750 MTUS1 microtubule associated scaffold protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTUS1 mRNA PMID:35307453 13993750 MTUS1 microtubule associated scaffold protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MTUS1 mRNA PMID:39265697 13993989 KAT8 lysine acetyltransferase 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KAT8 mRNA PMID:35307453 13994006 ZNF24 zinc finger protein 24 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of ZNF24 mRNA PMID:34389318 13994024 PCED1A PC-esterase domain containing 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCED1A mRNA PMID:35307453 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of MYD88 mRNA; Lipopolysaccharides results in increased expression of MYD88 protein PMID:28528741 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] PMID:28528741 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of MYD88 mRNA] PMID:38154151 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of MYD88 mRNA PMID:38154151 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of MYD88 mRNA] PMID:38154151 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of MYD88 protein PMID:34811946 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:34905 paraquat increases response to substance EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein results in increased susceptibility to Paraquat PMID:34811946 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein]]; [MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 protein; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 protein; MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]; MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]; MYD88 protein affects the reaction [Paraquat results in decreased expression of BCL2 protein]; MYD88 protein affects the reaction [Paraquat results in decreased expression of BCL2L1 mRNA]; MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein]; MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]; MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein]; MYD88 protein affects the reaction [Paraquat results in decreased phosphorylation of MTOR protein]; MYD88 protein affects the reaction [Paraquat results in increased activity of and results in increased cleavage of CASP3 protein]; MYD88 protein affects the reaction [Paraquat results in increased expression of CASP3 mRNA]; MYD88 protein affects the reaction [Paraquat results in increased expression of CDK2 protein]; MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]; MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]; MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]; MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein]; Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]; Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]; Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]; Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]] PMID:34811946 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA]; 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L protein]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]]; 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of PARP1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein]] PMID:34811946 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] PMID:28528741 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of MYD88 mRNA PMID:29421334 13994040 MYD88 MYD88 innate immune signal transduction adaptor gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of DCTN4 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of FIS1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of DNM1L mRNA]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in increased expression of FIS1 mRNA]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of SQSTM1 protein]]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]] PMID:34811946 13994193 SIRPA signal regulatory protein alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIRPA mRNA PMID:35307453 13994193 SIRPA signal regulatory protein alpha gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides affects the expression of SIRPA mRNA PMID:21645290 13994299 RHOF ras homolog family member F, filopodia associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHOF mRNA PMID:35307453 13994418 ZNF800 zinc finger protein 800 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF800 mRNA PMID:35307453 13994465 PRAP1 proline rich acidic protein 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of PRAP1 mRNA PMID:34389318 13994510 CLDN2 claudin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLDN2 mRNA PMID:35307453 13994648 CTNNB1 catenin beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTNNB1 protein PMID:30690062 13994648 CTNNB1 catenin beta 1 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of CTNNB1 protein PMID:37659622 13994648 CTNNB1 catenin beta 1 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA] PMID:30481989 13994648 CTNNB1 catenin beta 1 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA] PMID:30481989 13994648 CTNNB1 catenin beta 1 gene CHEBI:3441 carvedilol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in decreased expression of CTNNB1 mRNA PMID:16824628 13994648 CTNNB1 catenin beta 1 gene CHEBI:3441 carvedilol increases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in increased expression of CTNNB1 protein PMID:16824628 13994648 CTNNB1 catenin beta 1 gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA] PMID:30481989 13994648 CTNNB1 catenin beta 1 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA] PMID:30481989 13994648 CTNNB1 catenin beta 1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA] PMID:30481989 13994713 CLEC4F C-type lectin domain family 4 member F gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLEC4F mRNA PMID:35307453 13994723 GK glycerol kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GK mRNA PMID:35307453 13994825 EIF2B2 eukaryotic translation initiation factor 2B subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2B2 mRNA PMID:35307453 13994938 NEURL1 neuralized E3 ubiquitin protein ligase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEURL1 mRNA PMID:35307453 13994938 NEURL1 neuralized E3 ubiquitin protein ligase 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of NEURL1 mRNA PMID:34389318 13994981 DLC1 DLC1 Rho GTPase activating protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DLC1 mRNA PMID:35307453 13995064 SAL1 salivary lipocalin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SAL1 mRNA PMID:39265697 13995064 SAL1 salivary lipocalin gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SAL1 mRNA PMID:34389318 13995096 ATXN2 ataxin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATXN2 mRNA PMID:35307453 13995670 GABRG3 gamma-aminobutyric acid type A receptor subunit gamma3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GABRG3 mRNA PMID:35307453 13995684 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADAMTS6 mRNA PMID:35307453 13995684 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ADAMTS6 mRNA PMID:39265697 13995712 ADGB androglobin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of ADGB mRNA PMID:21852083 13995779 RNH1 ribonuclease/angiogenin inhibitor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RNH1 mRNA PMID:35307453 13995893 RPL35A ribosomal protein L35a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL35A mRNA PMID:39265697 13995989 UQCRC2 ubiquinol-cytochrome c reductase core protein 2 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of UQCRC2 mRNA PMID:38432436 13996018 DNAH5 dynein axonemal heavy chain 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH5 mRNA PMID:35307453 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MKI67 mRNA PMID:35307453 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate affects the expression of MKI67 mRNA] PMID:39151877 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:23414 copper(II) sulfate affects expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate affects the expression of MKI67 mRNA PMID:39151877 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate affects the expression of MKI67 mRNA] PMID:39151877 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased expression of MKI67 protein PMID:34811946 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein]]; MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein] PMID:34811946 13996106 MKI67 marker of proliferation Ki-67 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of MKI67 protein]] PMID:34811946 13996301 ELL elongation factor for RNA polymerase II gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELL mRNA PMID:35307453 13996321 DPM1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DPM1 mRNA PMID:35307453 13996417 NRL neural retina leucine zipper gene CHEBI:15367 all-trans-retinoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D014212 Tretinoin results in increased expression of NRL protein PMID:16854989 13996475 UBASH3B ubiquitin associated and SH3 domain containing B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBASH3B mRNA PMID:35307453 13996506 EXOSC8 exosome component 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC8 mRNA PMID:35307453 13996581 ADGRL1 adhesion G protein-coupled receptor L1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRL1 mRNA PMID:35307453 13996716 NPHP1 nephrocystin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPHP1 mRNA PMID:35307453 13996745 TANC2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TANC2 mRNA PMID:35307453 13996871 RASGRP1 RAS guanyl releasing protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASGRP1 mRNA PMID:35307453 13996871 RASGRP1 RAS guanyl releasing protein 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RASGRP1 mRNA PMID:34933075 13996871 RASGRP1 RAS guanyl releasing protein 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of RASGRP1 mRNA PMID:39265697 13996918 IQGAP1 IQ motif containing GTPase activating protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IQGAP1 mRNA PMID:35307453 13997029 COX4I1 cytochrome c oxidase subunit 4I1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COX4 mRNA PMID:34416349 13997029 COX4I1 cytochrome c oxidase subunit 4I1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COX4 mRNA PMID:34416349 13997397 KIRREL1 kirre like nephrin family adhesion molecule 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIRREL1 mRNA PMID:35307453 13997432 ANXA1 annexin A1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ANXA1 mRNA PMID:18988085 13997449 ADCY4 adenylate cyclase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADCY4 mRNA PMID:35307453 13997589 GEMIN5 gem nuclear organelle associated protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GEMIN5 mRNA PMID:35307453 13997696 EPCIP exosomal polycystin 1 interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPCIP mRNA PMID:35307453 13998194 TRPV2 transient receptor potential cation channel subfamily V member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRPV2 mRNA PMID:35307453 13998224 TMSB15B thymosin beta 15B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMSB15B mRNA PMID:35307453 13998257 BRIX1 biogenesis of ribosomes BRX1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BRIX1 mRNA PMID:35307453 13998315 RPF2 ribosome production factor 2 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPF2 mRNA PMID:35307453 13998416 FUCA1 alpha-L-fucosidase 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of FUCA1 mRNA PMID:28069986 13998429 CALCOCO1 calcium binding and coiled-coil domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALCOCO1 mRNA PMID:35307453 13998429 CALCOCO1 calcium binding and coiled-coil domain 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CALCOCO1 mRNA PMID:34389318 13998465 MAPK6 mitogen-activated protein kinase 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAPK6 mRNA PMID:35307453 13998465 MAPK6 mitogen-activated protein kinase 6 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased expression of MAPK6 protein PMID:12760830 13998502 MPLKIP M-phase specific PLK1 interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPLKIP mRNA PMID:35307453 13998636 AATF apoptosis antagonizing transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AATF mRNA PMID:35307453 13998732 CFAP99 cilia and flagella associated protein 99 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP99 mRNA PMID:35307453 13998772 LOC100627175 GRAM domain containing 2-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRAMD2A mRNA PMID:35307453 13998826 RUNDC3B RUN domain containing 3B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUNDC3B mRNA PMID:35307453 13998900 DEGS2 delta 4-desaturase, sphingolipid 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DEGS2 mRNA PMID:35307453 13998900 DEGS2 delta 4-desaturase, sphingolipid 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of DEGS2 mRNA PMID:34933075 13998923 PRTG protogenin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRTG mRNA PMID:35307453 13998950 PIK3R5 phosphoinositide-3-kinase regulatory subunit 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3R5 mRNA PMID:35307453 13999079 EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EIF4EBP2 mRNA PMID:35307453 13999103 GALNS galactosamine (N-acetyl)-6-sulfatase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNS mRNA PMID:35307453 13999214 FAM83A family with sequence similarity 83 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM83A mRNA PMID:35307453 13999222 SIGIRR single Ig and TIR domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIGIRR mRNA PMID:35307453 13999394 SLC2A7 solute carrier family 2 member 7 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SLC2A7 mRNA PMID:34933075 13999452 ZBTB18 zinc finger and BTB domain containing 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBTB18 mRNA PMID:35307453 13999522 CNTRL centriolin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CNTRL mRNA PMID:35307453 13999589 CTSZ cathepsin Z gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSZ mRNA PMID:35307453 13999658 SNX16 sorting nexin 16 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of SNX16 mRNA; deoxynivalenol results in increased expression of SNX16 protein PMID:38403181 13999754 SMC1A structural maintenance of chromosomes 1A gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of SMC1A mRNA PMID:35839969 13999991 PAQR6 progestin and adipoQ receptor family member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAQR6 mRNA PMID:35307453 14000091 ECE1 endothelin converting enzyme 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ECE1 mRNA PMID:35307453 14000113 RHOBTB1 Rho related BTB domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHOBTB1 mRNA PMID:35307453 14000221 C9H11orf97 chromosome 9 C11orf97 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C9H11ORF97 mRNA PMID:35307453 14000240 CEP20 centrosomal protein 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEP20 mRNA PMID:35307453 14000280 RAD51 RAD51 recombinase gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in increased expression of RAD51 protein PMID:32454083 14000400 PLA2G1B phospholipase A2 group IB gene CHEBI:15365 acetylsalicylic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001241 Aspirin promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] PMID:10706128 14000400 PLA2G1B phospholipase A2 group IB gene CHEBI:15551 prostaglandin E2 increases chemical synthesis EXP E RGD:6480464 20191114 CTD MESH:D015232 PLA2G1B protein results in increased chemical synthesis of Dinoprostone PMID:10706128 14000400 PLA2G1B phospholipase A2 group IB gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [epostane co-treated with Dinoprost] results in increased expression of PLA2G1B mRNA PMID:20739670 14000400 PLA2G1B phospholipase A2 group IB gene CHEBI:6736 melittin increases activity EXP E RGD:6480464 20191114 CTD MESH:D008555 Melitten results in increased activity of PLA2G1B protein PMID:9092818 14000400 PLA2G1B phospholipase A2 group IB gene CHEBI:9352 sulindac multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013467 Sulindac promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] PMID:10706128 14000413 KIAA1671 KIAA1671 ortholog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIAA1671 mRNA PMID:35307453 14000434 KCNQ5 potassium voltage-gated channel subfamily Q member 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KCNQ5 mRNA PMID:35307453 14000510 CAVIN2 caveolae associated protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CAVIN2 mRNA PMID:35307453 14000510 CAVIN2 caveolae associated protein 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CAVIN2 mRNA PMID:21852083 14000791 RYR1 ryanodine receptor 1 gene CHEBI:133663 thymol sulfate(1-) increases activity EXP E RGD:6480464 20191114 CTD MESH:D013943 Thymol results in increased activity of RYR1 protein PMID:17641978 14000791 RYR1 ryanodine receptor 1 gene CHEBI:22984 calcium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of RYR1 protein PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein]] which results in decreased secretion of Calcium; Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein] PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:27607 thymol increases activity EXP E RGD:6480464 20191114 CTD MESH:D013943 Thymol results in increased activity of RYR1 protein PMID:17641978 14000791 RYR1 ryanodine receptor 1 gene CHEBI:27732 caffeine increases activity EXP E RGD:6480464 20191114 CTD MESH:D002110 Caffeine results in increased activity of RYR1 protein; Caffeine results in increased activity of RYR1 protein mutant form PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002110 Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein mutant form]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein] PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:29320 calcium(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of RYR1 protein PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein]] which results in decreased secretion of Calcium; Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein] PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:33324 strontium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D013324 Strontium results in increased activity of RYR1 protein PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:33324 strontium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013324 Dantrolene inhibits the reaction [Strontium promotes the reaction [Ryanodine binds to RYR1 protein]]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein] PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:3440 carvacrol increases activity EXP E RGD:6480464 20191114 CTD MESH:C073316 carvacrol results in increased activity of RYR1 protein PMID:17641978 14000791 RYR1 ryanodine receptor 1 gene CHEBI:4317 dantrolene decreases activity EXP E RGD:6480464 20191114 CTD MESH:D003620 Dantrolene results in decreased activity of RYR1 protein PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:4317 dantrolene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003620 5'-adenylyl (beta,gamma-methylene)diphosphonate affects the reaction [Dantrolene results in decreased activity of RYR1 protein]; [Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein]] which results in decreased secretion of Calcium; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein mutant form]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein]; Dantrolene inhibits the reaction [Calcium results in increased activity of RYR1 protein]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein mutant form]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Strontium promotes the reaction [Ryanodine binds to RYR1 protein]] PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:8925 ryanodine affects binding EXP E RGD:6480464 20191114 CTD MESH:D012433 Ryanodine binds to RYR1 protein; Ryanodine binds to RYR1 protein mutant form PMID:11278295 14000791 RYR1 ryanodine receptor 1 gene CHEBI:8925 ryanodine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012433 5'-adenylyl (beta,gamma-methylene)diphosphonate affects the reaction [Ryanodine binds to RYR1 protein]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein mutant form]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Strontium promotes the reaction [Ryanodine binds to RYR1 protein]]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein] PMID:11278295 14000900 ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ST8SIA4 mRNA PMID:35307453 14001031 LGMN legumain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LGMN mRNA PMID:35307453 14001064 STX1A syntaxin 1A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STX1A mRNA PMID:35307453 14001092 RPS6KA1 ribosomal protein S6 kinase A1 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in decreased expression of RPS6KA1 protein PMID:12760830 14001092 RPS6KA1 ribosomal protein S6 kinase A1 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of RPS6KA1 protein]; U 0126 promotes the reaction [Ivermectin results in decreased phosphorylation of RPS6KA1 protein] PMID:31400776 14001092 RPS6KA1 ribosomal protein S6 kinase A1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of RPS6KA1 protein] PMID:31400776 14001172 HSPBP1 HSPA (Hsp70) binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPBP1 mRNA PMID:35307453 14001190 CTNNA1 catenin alpha 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CTNNA1 mRNA PMID:21852083 14001297 DDIT4L DNA damage inducible transcript 4 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDIT4L mRNA PMID:35307453 14001331 PDE10A phosphodiesterase 10A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDE10A mRNA PMID:35307453 14001331 PDE10A phosphodiesterase 10A gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PDE10A mRNA PMID:34933075 14001362 RPUSD2 RNA pseudouridine synthase domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPUSD2 mRNA PMID:35307453 14001432 AASDHPPT aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of AASDHPPT mRNA; deoxynivalenol results in increased expression of AASDHPPT protein PMID:38403181 14001448 ASIC2 acid sensing ion channel subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASIC2 mRNA PMID:35307453 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:16796 melatonin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in decreased expression of AIF1 mRNA PMID:38848930 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of AIF1 mRNA; [Melatonin co-treated with bisphenol A] results in increased expression of AIF1 mRNA PMID:38848930 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of AIF1 mRNA PMID:18988085 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in decreased expression of AIF1 mRNA PMID:38848930 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of AIF1 mRNA PMID:38848930 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in increased expression of AIF1 mRNA PMID:38848930 14001508 AIF1 allograft inflammatory factor 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in increased expression of AIF1 mRNA; [Melatonin co-treated with bisphenol A] results in increased expression of AIF1 mRNA PMID:38848930 14001556 AKAP3 A-kinase anchoring protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP3 mRNA PMID:35307453 14001667 KANSL1L KAT8 regulatory NSL complex subunit 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KANSL1L mRNA PMID:35307453 14001699 ATG9A autophagy related 9A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATG9A mRNA PMID:35307453 14001799 DBN1 drebrin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DBN1 mRNA PMID:35307453 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of STAT3 mRNA PMID:23326479 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:22977 cadmium atom increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased phosphorylation of STAT3 protein PMID:21783819 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 SB 203580 inhibits the reaction [Cadmium results in increased phosphorylation of STAT3 protein] PMID:21783819 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of STAT3 protein] PMID:30923867 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:7719 ochratoxin A increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased phosphorylation of STAT3 protein PMID:30923867 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of STAT3 protein]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in increased expression of H2AX protein] PMID:30923867 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:77732 cadmium nitrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in decreased expression of STAT3 mRNA PMID:29421334 14001826 STAT3 signal transducer and activator of transcription 3 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C093642 SB 203580 inhibits the reaction [Cadmium results in increased phosphorylation of STAT3 protein] PMID:21783819 14001950 TRMT10A tRNA methyltransferase 10A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT10A mRNA PMID:35307453 14002127 MAP7D2 MAP7 domain containing 2 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of MAP7D2 mRNA PMID:35839969 14002267 CDKAL1 CDK5 regulatory subunit associated protein 1 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDKAL1 mRNA PMID:35307453 14002267 CDKAL1 CDK5 regulatory subunit associated protein 1 like 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CDKAL1 mRNA PMID:21852083 14002390 SLC5A2 solute carrier family 5 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC5A2 mRNA PMID:35307453 14002530 DARS1 aspartyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DARS1 mRNA PMID:35307453 14002530 DARS1 aspartyl-tRNA synthetase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of DARS1 mRNA PMID:21852083 14002575 DRC3 dynein regulatory complex subunit 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DRC3 mRNA PMID:35307453 14002749 SEC23A SEC23 homolog A, COPII coat complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC23A mRNA PMID:35307453 14002811 WDR12 WD repeat domain 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR12 mRNA PMID:35307453 14002832 RYR2 ryanodine receptor 2 gene CHEBI:8925 ryanodine affects binding EXP E RGD:6480464 20191114 CTD MESH:D012433 Ryanodine binds to RYR2 protein PMID:11278295 14002943 LAPTM5 lysosomal protein transmembrane 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAPTM5 mRNA PMID:35307453 14003119 ABCC9 ATP binding cassette subfamily C member 9 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ABCC9 mRNA PMID:34933075 14003353 H3C6 H3 clustered histone 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of H3C6 mRNA PMID:39265697 14003443 PTMA prothymosin alpha gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of PTMA mRNA PMID:14994279 14003514 EFEMP2 EGF containing fibulin extracellular matrix protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFEMP2 mRNA PMID:35307453 14003532 SLCO2B1 solute carrier organic anion transporter family member 2B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLCO2B1 mRNA PMID:35307453 14003694 PCLO piccolo presynaptic cytomatrix protein gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PCLO mRNA PMID:39265697 14003738 ENSA endosulfine alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ENSA mRNA PMID:35307453 14003758 GTF2F1 general transcription factor IIF subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GTF2F1 mRNA PMID:35307453 14003889 PPP1R14B protein phosphatase 1 regulatory inhibitor subunit 14B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R14B mRNA PMID:35307453 14004011 PCP4L1 Purkinje cell protein 4 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCP4L1 mRNA PMID:35307453 14004348 UPK3BL2 uroplakin 3B like 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of UPK3BL2 mRNA PMID:39265697 14004481 TMEM33 transmembrane protein 33 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of TMEM33 mRNA PMID:34389318 14004590 JADE2 jade family PHD finger 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JADE2 mRNA PMID:35307453 14004590 JADE2 jade family PHD finger 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of JADE2 mRNA PMID:34933075 14004708 BBOF1 basal body orientation factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BBOF1 mRNA PMID:35307453 14004824 PTEN phosphatase and tensin homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTEN mRNA PMID:35307453 14004824 PTEN phosphatase and tensin homolog gene CHEBI:138236 oridonin decreases expression EXP E RGD:6480464 20250311 CTD MESH:C011959 oridonin results in decreased expression of PTEN protein PMID:38972361 14004824 PTEN phosphatase and tensin homolog gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN protein] PMID:35665993 14004824 PTEN phosphatase and tensin homolog gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of PTEN mRNA; tetrabromobisphenol A results in increased expression of PTEN protein PMID:35665993 14004824 PTEN phosphatase and tensin homolog gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN protein] PMID:35665993 14004824 PTEN phosphatase and tensin homolog gene CHEBI:34440 4-nonylphenol increases expression EXP E RGD:6480464 20240604 CTD MESH:C041594 4-nonylphenol results in increased expression of PTEN protein PMID:38246476 14004824 PTEN phosphatase and tensin homolog gene CHEBI:4357 deguelin multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C107676 deguelin results in increased expression of and results in increased phosphorylation of PTEN protein PMID:37353039 14004945 GALNT18 polypeptide N-acetylgalactosaminyltransferase 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT18 mRNA PMID:35307453 14004975 GJB5 gap junction protein beta 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GJB5 mRNA PMID:35307453 14004989 INHCA inhibitor of carbonic anhydrase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of INHCA mRNA PMID:35307453 14004989 INHCA inhibitor of carbonic anhydrase gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of PICA mRNA PMID:18988085 14005014 SERPING1 serpin family G member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERPING1 mRNA PMID:35307453 14005136 NEK2 NIMA related kinase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of NEK2 mRNA PMID:21852083 14005153 COX17 cytochrome c oxidase copper chaperone COX17 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX17 mRNA PMID:39265697 14005153 COX17 cytochrome c oxidase copper chaperone COX17 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in decreased expression of COX17 mRNA PMID:22585802 14005165 C1H15orf48 chromosome 1 C15orf48 homolog gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of C15ORF48 mRNA PMID:39265697 14005235 MRPS18A mitochondrial ribosomal protein S18A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS18A mRNA PMID:35307453 14005476 KIT KIT proto-oncogene, receptor tyrosine kinase gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of KIT mRNA PMID:26386189 14005635 EFR3A EFR3 homolog A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EFR3A mRNA PMID:35307453 14005679 RUNX3 RUNX family transcription factor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RUNX3 mRNA PMID:39265697 14005698 RAE1 ribonucleic acid export 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAE1 mRNA PMID:35307453 14005993 TCEA2 transcription elongation factor A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCEA2 mRNA PMID:35307453 14006067 TTC1 tetratricopeptide repeat domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTC1 mRNA PMID:35307453 14006545 VPS50 VPS50 subunit of EARP/GARPII complex gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VPS50 mRNA PMID:35307453 14006786 CALR3 calreticulin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALR3 mRNA PMID:35307453 14006804 IQCG IQ motif containing G gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQCG mRNA PMID:35307453 14006822 TBCC tubulin folding cofactor C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBCC mRNA PMID:35307453 14006837 GAS2L1 growth arrest specific 2 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAS2L1 mRNA PMID:35307453 14006860 MIR1343 microRNA mir-1343 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20250401 CTD MESH:D015025 Zearalenone results in increased expression of MIR1343 mRNA PMID:32439583 14006985 LIPE lipase E, hormone sensitive type gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LIPE mRNA PMID:35307453 14007033 LTV1 LTV1 ribosome biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LTV1 mRNA PMID:35307453 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAPK1 protein modified form PMID:26988607 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:10022 deoxynivalenol increases activity EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased activity of MAPK1 protein PMID:19674540 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol analog results in increased phosphorylation of MAPK1 protein; deoxynivalenol results in increased phosphorylation of MAPK1 protein PMID:22859312 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:135697 sarpogrelate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C064294 sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein] PMID:11426759 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of MAPK1 protein PMID:20406653 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of MAPK1 protein] PMID:20406653 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:16240 hydrogen peroxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein PMID:11325585|PMID:21798251 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] PMID:21798251 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:16412 lipopolysaccharide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased phosphorylation of MAPK1 protein PMID:28528741 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] PMID:28528741 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK1 mRNA PMID:32423882 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:17688 (S)-nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK1 protein PMID:32423882 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK1 mRNA PMID:32423882 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:18723 nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK1 protein PMID:32423882 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:207229 dihydroartemisinin decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C039060 artenimol results in decreased phosphorylation of MAPK1 protein PMID:29309768 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein PMID:10356984 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:27915 melamine increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in increased phosphorylation of MAPK1 protein PMID:30055240 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:2825 aristolochic acid A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in increased phosphorylation of and results in increased activity of MAPK1 protein; U 0126 inhibits the reaction [aristolochic acid I results in increased phosphorylation of and results in increased activity of MAPK1 protein] PMID:21658425 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:28790 serotonin increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D012701 Serotonin results in increased phosphorylation of MAPK1 protein PMID:11426759 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:28790 serotonin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012701 sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein] PMID:11426759 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:3093 bifenthrin increases phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased phosphorylation of MAPK1 protein PMID:33901951 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:32234 titanium dioxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased phosphorylation of MAPK1 protein PMID:23380242 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK1 protein PMID:20406653 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein PMID:11325585 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:38221 fumonisin B1 increases phosphorylation EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in increased phosphorylation of MAPK1 protein PMID:31557363 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:39329 etoxazole increases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased phosphorylation of MAPK1 protein PMID:31744678 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with etoxazole] results in increased phosphorylation of MAPK1 protein; [pyrazolanthrone co-treated with etoxazole] results in increased phosphorylation of MAPK1 protein; SB 203580 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK1 protein] PMID:31744678 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:48843 disodium selenite increases expression EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite results in increased expression of MAPK1 protein PMID:17342738 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:5078 flavonol increases expression EXP E RGD:6480464 20191114 CTD MESH:C041477 3-hydroxyflavone results in increased expression of MAPK1 protein PMID:21126572 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of MAPK1 protein PMID:38432436 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of MAPK1 protein]; U 0126 promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK1 protein] PMID:31400776 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C085911 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with etoxazole] results in increased phosphorylation of MAPK1 protein PMID:31744678 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:68889 hydroxytyrosol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C005975 3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] PMID:21798251 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:7719 ochratoxin A increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased phosphorylation of MAPK1 protein PMID:28699257 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] PMID:28528741 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK1 protein] PMID:17065204 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 [pyrazolanthrone co-treated with etoxazole] results in increased phosphorylation of MAPK1 protein; pyrazolanthrone inhibits the reaction [Ivermectin results in decreased phosphorylation of MAPK1 protein] PMID:31400776|PMID:31744678 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 SB 203580 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK1 protein] PMID:31744678 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:9753 troglitazone increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in increased phosphorylation of MAPK1 protein PMID:17065204 14007049 MAPK1 mitogen-activated protein kinase 1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK1 protein] PMID:17065204 14007236 ANXA8 annexin A8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in increased expression of ANXA8 mRNA PMID:35307453 14007236 ANXA8 annexin A8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20250325 CTD MESH:D015025 Zearalenone results in increased expression of ANXA8 mRNA PMID:34933075 14007236 ANXA8 annexin A8 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ANXA8 mRNA PMID:39265697 14007236 ANXA8 annexin A8 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20250325 CTD MESH:D000431 Ethanol results in increased expression of ANXA8 mRNA PMID:28069986 14007258 DTD2 D-aminoacyl-tRNA deacylase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DTD2 mRNA PMID:35307453 14007274 SPTBN5 spectrin beta, non-erythrocytic 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPTBN5 mRNA PMID:35307453 14007350 THBS1 thrombospondin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THBS1 mRNA; deoxynivalenol results in increased expression of THBS1 protein PMID:35307453|PMID:37257635 14007350 THBS1 thrombospondin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of THBS1 mRNA PMID:25455459 14007500 NHS NHS actin remodeling regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NHS mRNA PMID:35307453 14007559 TTK TTK protein kinase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate affects the expression of TTK mRNA] PMID:39151877 14007559 TTK TTK protein kinase gene CHEBI:23414 copper(II) sulfate affects expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate affects the expression of TTK mRNA PMID:39151877 14007559 TTK TTK protein kinase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate affects the expression of TTK mRNA] PMID:39151877 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:1296 20-hydroxycholesterol increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C025813 CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol PMID:10882719 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:17703 26-hydroxycholesterol increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C076996 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol PMID:10882719 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of CYP7A1 mRNA PMID:21391292 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:34310 (24S)-24-hydroxycholesterol increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C044563 CYP7A1 protein results in increased metabolism of 24-hydroxycholesterol PMID:11013305 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:42977 25-hydroxycholesterol increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C007997 CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol PMID:10882719 14007685 CYP7A1 cytochrome P450 family 7 subfamily A member 1 gene CHEBI:76591 (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C076996 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol PMID:10882719 14007710 ATP6V0C ATPase H+ transporting V0 subunit c gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP6V0C mRNA PMID:35307453 14007717 STPG2 sperm tail PG-rich repeat containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STPG2 mRNA PMID:35307453 14007733 RBL2 RB transcriptional corepressor like 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of RBL2 mRNA PMID:34389318 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VCAM1 mRNA PMID:35307453 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 mRNA; 3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein PMID:19608276|PMID:20406653 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 mRNA]; CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 mRNA] PMID:19608276|PMID:20406653 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 mRNA]; Quercetin inhibits the reaction [Linoleic Acid results in increased expression of VCAM1 mRNA] PMID:15051824|PMID:19608276 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:17351 linoleic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased expression of VCAM1 mRNA PMID:15051824|PMID:18155686 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 [Linoleic Acid co-treated with Polychlorinated Biphenyls] results in increased expression of VCAM1 protein; Linoleic Acid promotes the reaction [Polychlorinated Biphenyls results in increased expression of VCAM1 mRNA]; prolinedithiocarbamate inhibits the reaction [Linoleic Acid results in increased expression of VCAM1 mRNA]; Quercetin inhibits the reaction [Linoleic Acid results in increased expression of VCAM1 mRNA] PMID:15051824|PMID:18155686 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of VCAM1 mRNA PMID:18988085 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:27432 alpha-linolenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017962 alpha-Linolenic Acid inhibits the reaction [Polychlorinated Biphenyls results in increased expression of VCAM1 mRNA]; alpha-Linolenic Acid inhibits the reaction [Polychlorinated Biphenyls results in increased expression of VCAM1 protein] PMID:18155686 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:2781 apocynin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056165 acetovanillone inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:30187 aluminium oxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D000537 Aluminum Oxide results in increased expression of VCAM1 mRNA; Aluminum Oxide results in increased expression of VCAM1 protein PMID:18456438 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:32234 titanium dioxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased expression of VCAM1 mRNA; titanium dioxide results in increased expression of VCAM1 protein PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:32234 titanium dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009495 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; acetovanillone inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; prolinedithiocarbamate inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA]; SB 203580 inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein PMID:20406653|PMID:22521609|PMID:24709675 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]; CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]; CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]; NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA] PMID:20406653|PMID:22521609|PMID:24709675 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases expression EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein PMID:16797888 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in decreased expression of VCAM1 mRNA PMID:22521609 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]; epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:22521609|PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:50992 1,3-thiazolidine-2,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C089946 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA] PMID:15226458 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C093642 SB 203580 inhibits the reaction [titanium dioxide results in increased expression of VCAM1 mRNA] PMID:23380242 14007778 VCAM1 vascular cell adhesion molecule 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus inhibits the reaction [Zymosan analog results in increased expression of VCAM1 protein] PMID:16797888 14007864 PTPN12 protein tyrosine phosphatase non-receptor type 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPN12 mRNA PMID:35307453 14007939 TEKT1 tektin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TEKT1 mRNA PMID:35307453 14007963 BEND6 BEN domain containing 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BEND6 mRNA PMID:35307453 14008028 CPA1 carboxypeptidase A1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CPA1 mRNA PMID:34933075 14008028 CPA1 carboxypeptidase A1 gene CHEBI:27363 zinc atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of CPA1 protein PMID:17093223 14008028 CPA1 carboxypeptidase A1 gene CHEBI:30185 zinc(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of CPA1 protein PMID:17093223 14008028 CPA1 carboxypeptidase A1 gene CHEBI:36560 zinc oxide increases activity EXP E RGD:6480464 20191114 CTD MESH:D015034 Zinc Oxide results in increased activity of CPA1 protein PMID:17093223 14008134 PLXDC1 plexin domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLXDC1 mRNA; deoxynivalenol results in decreased expression of PLXDC1 protein PMID:38403181 14008134 PLXDC1 plexin domain containing 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PLXDC1 mRNA PMID:34933075 14008156 RPS21 ribosomal protein S21 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS21 mRNA PMID:39265697 14008284 ESR1 estrogen receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ESR1 mRNA PMID:35307453 14008284 ESR1 estrogen receptor 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of ESR1 mRNA PMID:22484360 14008284 ESR1 estrogen receptor 1 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of ESR1 protein PMID:15653758|PMID:16680078 14008284 ESR1 estrogen receptor 1 gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in decreased expression of ESR1 protein; Estradiol results in decreased expression of ESR1 protein alternative form PMID:16431846|PMID:17348974 14008284 ESR1 estrogen receptor 1 gene CHEBI:28088 genistein decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019833 Genistein results in decreased expression of ESR1 protein PMID:22443950 14008284 ESR1 estrogen receptor 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ESR1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of ESR1 protein PMID:16431846 14008284 ESR1 estrogen receptor 1 gene CHEBI:28197 daidzein increases expression EXP E RGD:6480464 20191114 CTD MESH:C004742 daidzein results in increased expression of ESR1 mRNA PMID:19617652 14008284 ESR1 estrogen receptor 1 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C543008 bisphenol S results in decreased expression of ESR1 mRNA PMID:28352085 14008284 ESR1 estrogen receptor 1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C543008 bisphenol S results in increased expression of ESR1 protein PMID:28352085 14008284 ESR1 estrogen receptor 1 gene CHEBI:41774 tamoxifen affects binding EXP E RGD:6480464 20191114 CTD MESH:D013629 Tamoxifen metabolite binds to ESR1 protein PMID:16790557 14008284 ESR1 estrogen receptor 1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased expression of ESR1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased expression of ESR1 protein PMID:24956591 14008284 ESR1 estrogen receptor 1 gene CHEBI:8772 raloxifene affects binding EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride metabolite binds to ESR1 protein PMID:16790557 14008284 ESR1 estrogen receptor 1 gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of ESR1 protein PMID:15653758|PMID:16680078 14008284 ESR1 estrogen receptor 1 gene CHEBI:8772 raloxifene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in decreased expression of ESR1 protein alternative form PMID:17348974 14008386 DNALI1 dynein axonemal light intermediate chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNALI1 mRNA PMID:35307453 14008478 KLHL14 kelch like family member 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHL14 mRNA PMID:35307453 14008531 MCCD1 mitochondrial coiled-coil domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MCCD1 mRNA PMID:35307453 14008550 SRPX2 sushi repeat containing protein X-linked 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SRPX2 mRNA PMID:39265697 14008631 SCD5 stearoyl-CoA desaturase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCD5 mRNA PMID:35307453 14008700 JMJD8 jumonji domain containing 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JMJD8 mRNA PMID:35307453 14008789 GALNT11 polypeptide N-acetylgalactosaminyltransferase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT11 mRNA PMID:35307453 14008826 RAB6A RAB6A, member RAS oncogene family gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAB6A mRNA PMID:35307453 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:27363 zinc atom decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in decreased expression of SLC39A10 mRNA PMID:16804107 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC39A10 mRNA PMID:16804107 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:30185 zinc(0) decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in decreased expression of SLC39A10 mRNA PMID:16804107 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC39A10 mRNA PMID:16804107 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:35176 zinc sulfate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in decreased expression of SLC39A10 mRNA PMID:16804107 14009021 SLC39A10 solute carrier family 39 member 10 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of SLC39A10 mRNA PMID:16804107 14009150 RASA1 RAS p21 protein activator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RASA1 mRNA PMID:35307453 14009190 CCDC103 coiled-coil domain containing 103 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC103 mRNA PMID:35307453 14009198 RGCC regulator of cell cycle gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RGCC mRNA PMID:39265697 14009375 BNC1 basonuclin zinc finger protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BNC1 mRNA PMID:35307453 14009444 C2H11orf86 chromosome 2 C11orf86 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C2H11ORF86 mRNA PMID:35307453 14009460 RFT1 RFT1 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RFT1 mRNA PMID:35307453 14009541 RLBP1 retinaldehyde binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RLBP1 mRNA PMID:35307453 14009678 EMP3 epithelial membrane protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EMP3 mRNA PMID:35307453 14009678 EMP3 epithelial membrane protein 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of EMP3 mRNA PMID:39265697 14009735 ENKD1 enkurin domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENKD1 mRNA PMID:35307453 14009800 USP6NL USP6 N-terminal like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of USP6NL mRNA PMID:35307453 14009968 COX6B2 cytochrome c oxidase subunit 6B2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of COX6B2 mRNA] PMID:39151877 14009968 COX6B2 cytochrome c oxidase subunit 6B2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of COX6B2 mRNA PMID:39151877 14009968 COX6B2 cytochrome c oxidase subunit 6B2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of COX6B2 mRNA] PMID:39151877 14010053 CFAP58 cilia and flagella associated protein 58 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP58 mRNA PMID:35307453 14010075 AMH anti-Mullerian hormone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AMH mRNA PMID:35307453 14010075 AMH anti-Mullerian hormone gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of AMH mRNA PMID:32423882 14010075 AMH anti-Mullerian hormone gene CHEBI:17688 (S)-nicotine decreases secretion EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased secretion of AMH protein PMID:32423882 14010075 AMH anti-Mullerian hormone gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of AMH mRNA PMID:32423882 14010075 AMH anti-Mullerian hormone gene CHEBI:18723 nicotine decreases secretion EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased secretion of AMH protein PMID:32423882 14010075 AMH anti-Mullerian hormone gene CHEBI:31767 lead diacetate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of AMH mRNA PMID:29273543 14010075 AMH anti-Mullerian hormone gene CHEBI:31767 lead diacetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of and results in decreased secretion of AMH protein PMID:29273543 14010100 CCDC74B coiled-coil domain containing 74B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC74B mRNA PMID:35307453 14010117 SLC2A11 solute carrier family 2 member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC2A11 mRNA PMID:35307453 14010117 SLC2A11 solute carrier family 2 member 11 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SLC2A11 mRNA PMID:39265697 14010215 HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20210803 CTD MESH:D002994 Clofibrate results in increased expression of HMGCS2 mRNA PMID:17363680 14010293 CNPY3 canopy FGF signaling regulator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNPY3 mRNA PMID:35307453 14010317 HES4 hes family bHLH transcription factor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HES4 mRNA PMID:35307453 14010412 MTHFD1 methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTHFD1 mRNA; deoxynivalenol results in decreased expression of MTHFD1 protein PMID:38403181 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSTA1 mRNA PMID:35307453 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20250715 CTD MESH:D015025 Zearalenone results in decreased expression of GSTA1 mRNA PMID:34933075 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250715 CTD MESH:C000628730 graphene oxide results in decreased expression of GSTA1 mRNA PMID:39265697 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20250715 CTD MESH:D000431 Ethanol results in increased expression of GSTA1 mRNA PMID:16792574 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20250715 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSTA1 mRNA PMID:16792574 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20250715 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in increased expression of GSTA2 mRNA; Glutathione inhibits the reaction [Paraquat results in decreased expression of GSTA1 mRNA] PMID:36615853 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:27470 folic acid increases expression EXP E RGD:6480464 20250715 CTD MESH:D005492 Folic Acid deficiency results in increased expression of GSTA1 mRNA PMID:16792574 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20250715 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSTA1 mRNA PMID:16792574 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20250715 CTD MESH:D010269 Paraquat results in decreased expression of GSTA1 mRNA PMID:36615853 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20250715 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in increased expression of GSTA2 mRNA; Glutathione inhibits the reaction [Paraquat results in decreased expression of GSTA1 mRNA] PMID:36615853 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20250715 CTD MESH:C016766 sulforaphane results in increased expression of GSTA1 mRNA PMID:18547363 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20250715 CTD MESH:C016766 ochratoxin A inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA] PMID:18547363 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20250715 CTD MESH:D008294 Malathion results in decreased expression of GSTA1 mRNA PMID:31535366 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20250715 CTD MESH:C025589 ochratoxin A results in decreased expression of GSTA1 mRNA PMID:18547363 14010548 LOC106504562 glutathione S-transferase alpha M14 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20250715 CTD MESH:C025589 ochratoxin A inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA] PMID:18547363 14010557 CDH23 cadherin related 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH23 mRNA PMID:35307453 14010709 MYOF myoferlin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYOF mRNA PMID:35307453 14010939 SDE2 SDE2 telomere maintenance homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDE2 mRNA PMID:35307453 14011019 FMOD fibromodulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMOD mRNA PMID:35307453 14011036 METTL2A methyltransferase 2A, tRNA N3-cytidine gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL2A mRNA PMID:35307453 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:17234 glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 SLC2A1 protein results in increased transport of Glucose PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:17276 phloretin increases expression EXP E RGD:6480464 20191114 CTD MESH:D010693 Phloretin results in increased expression of SLC2A1 mRNA; Phloretin results in increased expression of SLC2A1 protein PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:17276 phloretin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010693 Phloretin promotes the reaction [Cyclosporine results in increased expression of SLC2A1 mRNA]; Phloretin promotes the reaction [Cyclosporine results in increased expression of SLC2A1 protein] PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:17634 D-glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 SLC2A1 protein results in increased transport of Glucose PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:2639 amiloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000584 Amiloride promotes the reaction [Cyclosporine results in increased expression of SLC2A1 mRNA] PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of SLC2A1 protein PMID:21575630 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:4031 cyclosporin A decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D016572 SLC2A1 protein results in decreased susceptibility to Cyclosporine PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:4031 cyclosporin A increases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in increased expression of SLC2A1 mRNA; Cyclosporine results in increased expression of SLC2A1 protein PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Amiloride promotes the reaction [Cyclosporine results in increased expression of SLC2A1 mRNA]; Phloretin promotes the reaction [Cyclosporine results in increased expression of SLC2A1 mRNA]; Phloretin promotes the reaction [Cyclosporine results in increased expression of SLC2A1 protein] PMID:12081571 14011054 SLC2A1 solute carrier family 2 member 1 gene CHEBI:42758 aldehydo-D-glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 SLC2A1 protein results in increased transport of Glucose PMID:12081571 14011139 ESPN espin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ESPN mRNA PMID:35307453 14011169 POLR3E RNA polymerase III subunit E gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR3E mRNA PMID:35307453 14011210 NOL10 nucleolar protein 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOL10 mRNA PMID:35307453 14011235 MNS1 meiosis specific nuclear structural 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MNS1 mRNA PMID:35307453 14011288 PRDX6 peroxiredoxin 6 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PRDX6 mRNA] PMID:39151877 14011288 PRDX6 peroxiredoxin 6 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of PRDX6 mRNA PMID:39151877 14011288 PRDX6 peroxiredoxin 6 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PRDX6 mRNA] PMID:39151877 14011297 ZBTB46 zinc finger and BTB domain containing 46 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBTB46 mRNA PMID:35307453 14011312 C6H1orf210 chromosome 6 C1orf210 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C6H1ORF210 mRNA PMID:35307453 14011486 KRI1 KRI1 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KRI1 mRNA PMID:35307453 14011578 PAK6 p21 (RAC1) activated kinase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAK6 mRNA PMID:35307453 14011578 PAK6 p21 (RAC1) activated kinase 6 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of PAK6 mRNA PMID:34933075 14011620 DNAI4 dynein axonemal intermediate chain 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAI4 mRNA PMID:35307453 14011640 FREM1 FRAS1 related extracellular matrix 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FREM1 mRNA PMID:35307453 14011738 VIL1 villin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VIL1 mRNA PMID:35307453 14011785 CS citrate synthase gene CHEBI:8863 Riluzole decreases activity EXP E RGD:6480464 20210608 CTD MESH:D019782 Riluzole analog results in decreased activity of CS protein PMID:33359020 14011851 AMMECR1L AMMECR1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AMMECR1L mRNA PMID:35307453 14012190 NAB2 NGFI-A binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAB2 mRNA PMID:35307453 14012233 TYSND1 trypsin like peroxisomal matrix peptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TYSND1 mRNA; deoxynivalenol results in decreased expression of TYSND1 protein PMID:35307453|PMID:37257635 14012246 SMN1 survival of motor neuron 1, telomeric gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMN1 mRNA PMID:35307453 14012266 DRC12 dynein regulatory complex subunit 12 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DRC12 mRNA PMID:35307453 14012390 FAM161A FAM161 centrosomal protein A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM161A mRNA PMID:35307453 14012509 PDE5A phosphodiesterase 5A gene CHEBI:16356 3',5'-cyclic GMP increases degradation EXP E RGD:6480464 20191114 CTD MESH:D006152 PDE5 protein results in increased degradation of Cyclic GMP PMID:18669600 14012552 RGS12 regulator of G protein signaling 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS12 mRNA PMID:35307453 14012577 PLEKHG4 pleckstrin homology and RhoGEF domain containing G4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHG4 mRNA PMID:35307453 14012750 MATN1 matrilin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MATN1 mRNA PMID:35307453 14012872 CXCL11 C-X-C motif chemokine ligand 11 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CXCL11 mRNA PMID:34389318 14012872 CXCL11 C-X-C motif chemokine ligand 11 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of CXCL11 mRNA PMID:22497863 14012892 AQP3 aquaporin 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in decreased expression of AQP3 mRNA PMID:32710935 14012974 ZSWIM7 zinc finger SWIM-type containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZSWIM7 mRNA PMID:35307453 14013004 FAM3C FAM3 metabolism regulating signaling molecule C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM3C mRNA PMID:35307453 14013095 GAS1 growth arrest specific 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GAS1 mRNA] PMID:21852083 14013219 CCL14 C-C motif chemokine ligand 14 gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of CCL14 mRNA PMID:33901951 14013226 USH1G USH1 protein network component sans gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of USH1G mRNA PMID:35307453 14013617 MGST1 microsomal glutathione S-transferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MGST1 mRNA PMID:35307453 14013677 CDC25B cell division cycle 25B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDC25B mRNA PMID:35307453 14013769 COL11A2 collagen type XI alpha 2 chain gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COL11A2 mRNA PMID:35307453 14013864 HDAC1 histone deacetylase 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of HDAC1 mRNA; ochratoxin A results in increased expression of HDAC1 protein PMID:29080797 14013864 HDAC1 histone deacetylase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 mRNA]; Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 protein] PMID:29080797 14013864 HDAC1 histone deacetylase 1 gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C496932 Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 mRNA]; Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 protein] PMID:29080797 14013963 TP53 tumor protein p53 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA; Acetylcysteine promotes the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]; deoxynivalenol results in decreased expression of and results in decreased phosphorylation of TP53 protein; fumonisin B1 inhibits the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA] PMID:29109043|PMID:38104654 14013963 TP53 tumor protein p53 gene CHEBI:10033 warfarin increases expression EXP E RGD:6480464 20191114 CTD MESH:D014859 Warfarin results in increased expression of TP53 mRNA PMID:29358327 14013963 TP53 tumor protein p53 gene CHEBI:10033 warfarin increases response to substance EXP E RGD:6480464 20191114 CTD MESH:D014859 TP53 protein results in increased susceptibility to Warfarin PMID:29358327 14013963 TP53 tumor protein p53 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 mRNA; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 protein; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of CDKN1A protein; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of EP300 protein; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 mRNA; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 protein; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of SNAI2 protein; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 protein]; SNAI2 protein promotes the reaction [TP53 protein results in increased susceptibility to Warfarin]; Warfarin promotes the reaction [TP53 protein binds to SNAI2 promoter]; Warfarin results in increased expression of and results in decreased acetylation of TP53 protein PMID:29358327 14013963 TP53 tumor protein p53 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of TP53 mRNA PMID:29109043 14013963 TP53 tumor protein p53 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA]]; Acetylcysteine promotes the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]; fumonisin B1 inhibits the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA] PMID:29109043 14013963 TP53 tumor protein p53 gene CHEBI:16796 melatonin decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin results in decreased expression of TP53 mRNA PMID:31535366 14013963 TP53 tumor protein p53 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin inhibits the reaction [Malathion results in increased expression of TP53 mRNA] PMID:31535366 14013963 TP53 tumor protein p53 gene CHEBI:17026 progesterone decreases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 TP53 protein results in decreased secretion of Progesterone PMID:22151798 14013963 TP53 tumor protein p53 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 [TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone PMID:22151798 14013963 TP53 tumor protein p53 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TP53 protein PMID:9302645 14013963 TP53 tumor protein p53 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of and results in increased acetylation of TP53 protein PMID:23065251 14013963 TP53 tumor protein p53 gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of TP53 PMID:12712633|PMID:20603111 14013963 TP53 tumor protein p53 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 mangostin inhibits the reaction [Cisplatin results in increased expression of TP53] PMID:20603111 14013963 TP53 tumor protein p53 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA]]; Acetylcysteine promotes the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]] PMID:29109043 14013963 TP53 tumor protein p53 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased expression of TP53 PMID:13129816 14013963 TP53 tumor protein p53 gene CHEBI:30621 diarsenic trioxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of TP53 PMID:13129816 14013963 TP53 tumor protein p53 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of TP53 protein PMID:28819136 14013963 TP53 tumor protein p53 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein]]; Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein] PMID:34811946 14013963 TP53 tumor protein p53 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of TP53 mRNA PMID:29109043 14013963 TP53 tumor protein p53 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA]]; fumonisin B1 inhibits the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA] PMID:29109043 14013963 TP53 tumor protein p53 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the phosphorylation of TP53 protein]] PMID:34811946 14013963 TP53 tumor protein p53 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000082 Acetaminophen results in decreased expression of TP53 protein PMID:16330492 14013963 TP53 tumor protein p53 gene CHEBI:49900 arsenous acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of TP53 PMID:13129816 14013963 TP53 tumor protein p53 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of TP53 mRNA PMID:31535366 14013963 TP53 tumor protein p53 gene CHEBI:6651 malathion multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008294 Melatonin inhibits the reaction [Malathion results in increased expression of TP53 mRNA] PMID:31535366 14013963 TP53 tumor protein p53 gene CHEBI:67547 alpha-mangostin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C021053 mangostin inhibits the reaction [Cisplatin results in increased expression of TP53] PMID:20603111 14013963 TP53 tumor protein p53 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of TP53 protein PMID:28710020|PMID:32454083 14013963 TP53 tumor protein p53 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TP53 protein] PMID:28710020 14014130 CBR4 carbonyl reductase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBR4 mRNA PMID:35307453 14014130 CBR4 carbonyl reductase 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CBR4 mRNA PMID:39265697 14014302 ABCB6 ATP binding cassette subfamily B member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCB6 mRNA PMID:35307453 14014459 SPRTN SprT-like N-terminal domain gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPRTN mRNA PMID:35307453 14014475 MYLK myosin light chain kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYLK mRNA PMID:35307453 14014475 MYLK myosin light chain kinase gene CHEBI:22984 calcium atom affects uptake EXP E RGD:6480464 20191114 CTD MESH:D002118 MYLK protein affects the uptake of Calcium PMID:9506478 14014475 MYLK myosin light chain kinase gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [ML 7 results in decreased activity of MYLK protein] which results in decreased uptake of Calcium; [ML 9 results in decreased activity of MYLK protein] which results in decreased uptake of Calcium PMID:9506478 14014475 MYLK myosin light chain kinase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of MYLK mRNA PMID:21852083 14014475 MYLK myosin light chain kinase gene CHEBI:29320 calcium(0) affects uptake EXP E RGD:6480464 20191114 CTD MESH:D002118 MYLK protein affects the uptake of Calcium PMID:9506478 14014475 MYLK myosin light chain kinase gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [ML 7 results in decreased activity of MYLK protein] which results in decreased uptake of Calcium; [ML 9 results in decreased activity of MYLK protein] which results in decreased uptake of Calcium PMID:9506478 14014475 MYLK myosin light chain kinase gene CHEBI:78761 ML-7 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070571 [ML 7 results in decreased activity of MYLK protein] which results in decreased uptake of Calcium PMID:9506478 14014661 LRRC59 leucine rich repeat containing 59 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC59 mRNA PMID:35307453 14014689 REPS1 RALBP1 associated Eps domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REPS1 mRNA PMID:35307453 14014924 DCUN1D1 defective in cullin neddylation 1 domain containing 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DCUN1D1 mRNA PMID:34389318 14014973 MPP7 MAGUK p55 scaffold protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MPP7 mRNA PMID:35307453 14015111 ADAMTS8 ADAM metallopeptidase with thrombospondin type 1 motif 8 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ADAMTS8 mRNA PMID:28069986 14015124 CLEC4G C-type lectin domain family 4 member G gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLEC4G mRNA PMID:35307453 14015124 CLEC4G C-type lectin domain family 4 member G gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CLEC4G mRNA PMID:34933075 14015196 PANK1 pantothenate kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PANK1 mRNA PMID:35307453 14015249 RELL2 RELT like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RELL2 mRNA PMID:35307453 14015280 TGFB3 transforming growth factor beta 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGFB3 mRNA PMID:35307453 14015310 ESM1 endothelial cell specific molecule 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ESM1 mRNA PMID:35307453 14015310 ESM1 endothelial cell specific molecule 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ESM1 mRNA PMID:39265697 14015674 GALNT12 polypeptide N-acetylgalactosaminyltransferase 12 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of GALNT12 mRNA PMID:35307453 14015674 GALNT12 polypeptide N-acetylgalactosaminyltransferase 12 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone affects the expression of GALNT12 mRNA PMID:34933075 14015773 C6H19orf12 chromosome 6 C19orf12 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C6H19ORF12 mRNA PMID:35307453 14015817 ENO2 enolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENO2 mRNA PMID:35307453 14015899 SF3A1 splicing factor 3a subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SF3A1 mRNA PMID:35307453 14015922 SLC25A35 solute carrier family 25 member 35 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A35 mRNA PMID:35307453 14016043 CPN1 carboxypeptidase N subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPN1 mRNA PMID:35307453 14016244 NPR1 natriuretic peptide receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPR1 mRNA PMID:35307453 14016270 PLD1 phospholipase D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLD1 mRNA PMID:35307453 14016425 NAGA alpha-N-acetylgalactosaminidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAGA mRNA; deoxynivalenol results in decreased expression of NAGA protein PMID:35307453|PMID:38403181 14016624 DLG4 discs large MAGUK scaffold protein 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of DLG4 mRNA PMID:34933075 14016674 TRMT61A tRNA methyltransferase 61A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT61A mRNA PMID:35307453 14016676 VWA1 von Willebrand factor A domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VWA1 mRNA PMID:35307453 14016709 BNIP5 BCL2 interacting protein 5 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BNIP5 mRNA PMID:39265697 14016792 ALDOC aldolase, fructose-bisphosphate C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDOC mRNA PMID:35307453 14017018 FAM20A FAM20A golgi associated secretory pathway pseudokinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM20A mRNA PMID:35307453 14017175 RCAN1 regulator of calcineurin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RCAN1 mRNA PMID:35307453 14017175 RCAN1 regulator of calcineurin 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of RCAN1 mRNA] PMID:39151877 14017175 RCAN1 regulator of calcineurin 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of RCAN1 mRNA PMID:39151877 14017175 RCAN1 regulator of calcineurin 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of RCAN1 mRNA] PMID:39151877 14017175 RCAN1 regulator of calcineurin 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20200331 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RCAN1 mRNA PMID:21852083 14017212 FCER1A Fc epsilon receptor Ia gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of FCER1A mRNA PMID:21852083 14017360 VGF VGF nerve growth factor inducible gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VGF mRNA PMID:35307453 14017365 UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of UBA52 mRNA PMID:39265697 14017390 GARS1 glycyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GARS1 mRNA PMID:35307453 14017390 GARS1 glycyl-tRNA synthetase 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GARS1 mRNA] PMID:39151877 14017390 GARS1 glycyl-tRNA synthetase 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of GARS1 mRNA PMID:39151877 14017390 GARS1 glycyl-tRNA synthetase 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GARS1 mRNA] PMID:39151877 14017493 MGAM2 maltase-glucoamylase 2 (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MGAM2 mRNA PMID:35307453 14017553 PSMD10 proteasome 26S subunit, non-ATPase 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD10 mRNA PMID:35307453 14017567 NEIL1 nei like DNA glycosylase 1 gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of NEIL1 mRNA PMID:30923867 14017567 NEIL1 nei like DNA glycosylase 1 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA] PMID:30923867 14017567 NEIL1 nei like DNA glycosylase 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of NEIL1 mRNA PMID:30923867 14017567 NEIL1 nei like DNA glycosylase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA] PMID:30923867 14017605 TMEM8B transmembrane protein 8B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM8B mRNA PMID:35307453 14017701 LGALS8 galectin 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LGALS8 mRNA PMID:35307453 14017802 CBL Cbl proto-oncogene gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CBL mRNA; deoxynivalenol results in increased expression of CBL protein PMID:35307453|PMID:38403181 14018019 ANKS1A ankyrin repeat and sterile alpha motif domain containing 1A gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ANKS1A mRNA PMID:34389318 14018078 AARS2 alanyl-tRNA synthetase 2, mitochondrial gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AARS2 mRNA PMID:35307453 14018181 FAM221A family with sequence similarity 221 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM221A mRNA PMID:35307453 14018211 ITGAL integrin subunit alpha L gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGAL mRNA PMID:35307453 14018336 TPM1 tropomyosin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPM1 mRNA; deoxynivalenol results in decreased expression of TPM1 protein PMID:38403181 14018443 SLC1A7 solute carrier family 1 member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC1A7 mRNA PMID:35307453 14018514 TVP23A trans-golgi network vesicle protein 23 homolog A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TVP23A mRNA PMID:35307453 14018743 APITD1 apoptosis-inducing, TAF9-like domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CENPS mRNA PMID:35307453 14018743 APITD1 apoptosis-inducing, TAF9-like domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CENPS mRNA PMID:35307453 14018791 PALM2AKAP2 PALM2-AKAP2 fusion gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PALM2AKAP2 mRNA PMID:35307453 14018791 PALM2AKAP2 PALM2-AKAP2 fusion gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PALM2AKAP2 mRNA] PMID:21852083 14018806 TOM1L2 target of myb1 like 2 membrane trafficking protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TOM1L2 mRNA PMID:35307453 14018891 PREX1 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PREX1 mRNA PMID:35307453 14019134 BMP7 bone morphogenetic protein 7 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BMP7 mRNA PMID:39265697 14019329 PCOLCE2 procollagen C-endopeptidase enhancer 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PCOLCE2 mRNA PMID:39265697 14019358 TFRC transferrin receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFRC mRNA PMID:35307453 14019445 ATG14 autophagy related 14 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of ATG14 mRNA PMID:35839969 14019459 PRKCB protein kinase C beta gene CHEBI:37537 phorbol 13-acetate 12-myristate decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCB protein PMID:15089098 14019642 PSMD6 proteasome 26S subunit, non-ATPase 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD6 mRNA PMID:35307453 14019821 STX1B syntaxin 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STX1B mRNA PMID:35307453 14019838 SLC27A2 solute carrier family 27 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC27A2 mRNA PMID:35307453 14019955 USP54 ubiquitin specific peptidase 54 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of USP54 mRNA PMID:35307453 14020178 CCN2 cellular communication network factor 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCN2 mRNA PMID:27617619 14020199 BLOC1S2 biogenesis of lysosomal organelles complex 1 subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BLOC1S2 mRNA PMID:35307453 14020259 MPI mannose phosphate isomerase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPI mRNA PMID:35307453 14020433 CHP2 calcineurin like EF-hand protein 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CHP2 mRNA PMID:34933075 14020451 CCL5 C-C motif chemokine ligand 5 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCL5 mRNA PMID:18988085 14020555 SEC61G SEC61 translocon subunit gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC61G mRNA PMID:35307453 14020626 TCEANC transcription elongation factor A N-terminal and central domain containing gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TCEANC mRNA PMID:39265697 14020766 WNT9B Wnt family member 9B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WNT9B mRNA PMID:35307453 14020890 PEG10 paternally expressed 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PEG10 mRNA PMID:35307453 14020915 VPS72 vacuolar protein sorting 72 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VPS72 mRNA PMID:35307453 14021082 NHERF2 NHERF family PDZ scaffold protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in decreased expression of NHERF2 mRNA PMID:35307453 14021154 RFC1 replication factor C subunit 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of RFC1 mRNA PMID:34389318 14021250 TMEM200C transmembrane protein 200C gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TMEM200C mRNA PMID:34933075 14021257 PRSS22 serine protease 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS22 mRNA PMID:35307453 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:15553 prostaglandin F2alpha increases secretion EXP E RGD:6480464 20191114 CTD MESH:D015237 GHRL protein results in increased secretion of Dinoprost PMID:19528263 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Dinoprost] PMID:19528263 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:16581 pregnenolone decreases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D011284 GHRL protein results in decreased metabolism of Pregnenolone PMID:22341706 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:17026 progesterone decreases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 GHRL protein results in decreased secretion of Progesterone PMID:19528263 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:17026 progesterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 GHRL protein results in increased secretion of Progesterone PMID:17904772 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 Aminoglutethimide promotes the reaction [GHRL protein results in decreased secretion of Progesterone]; GHRL protein results in decreased chemical synthesis of and results in decreased secretion of Progesterone; STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone] PMID:19528263|PMID:22341706 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:2654 aminoglutethimide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000616 Aminoglutethimide promotes the reaction [GHRL protein results in decreased secretion of Progesterone] PMID:22341706 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:7872 oxytocin increases secretion EXP E RGD:6480464 20191114 CTD MESH:D010121 GHRL protein results in increased secretion of Oxytocin PMID:19528263 14021273 GHRL ghrelin and obestatin prepropeptide gene CHEBI:7872 oxytocin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010121 STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Oxytocin] PMID:19528263 14021347 EAF2 ELL associated factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EAF2 mRNA PMID:35307453 14021365 OCLN occludin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of OCLN mRNA; deoxynivalenol results in decreased expression of OCLN protein PMID:25701311|PMID:33817499|PMID:35307453|PMID:35381244|PMID:36596350|PMID:37120089|PMID:37442268 14021365 OCLN occludin gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein]; Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein] PMID:32877744|PMID:35381244|PMID:37120089|PMID:37442268 14021365 OCLN occludin gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of OCLN protein PMID:37659622 14021365 OCLN occludin gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of OCLN protein] PMID:37659622 14021365 OCLN occludin gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of OCLN mRNA; Hydrogen Peroxide results in decreased expression of OCLN protein PMID:38438008 14021365 OCLN occludin gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein] PMID:38438008 14021365 OCLN occludin gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of OCLN mRNA; Lipopolysaccharides results in decreased expression of OCLN protein PMID:32877744|PMID:37271275 14021365 OCLN occludin gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA] PMID:32877744|PMID:37271275 14021365 OCLN occludin gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] PMID:37120089 14021365 OCLN occludin gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in decreased expression of OCLN protein] PMID:36615853 14021365 OCLN occludin gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C026166 [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA] PMID:37271275|PMID:38438008 14021365 OCLN occludin gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of OCLN mRNA PMID:32423882 14021365 OCLN occludin gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of OCLN mRNA PMID:32423882 14021365 OCLN occludin gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] PMID:37442268 14021365 OCLN occludin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of OCLN mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of OCLN protein] PMID:37955343 14021365 OCLN occludin gene CHEBI:27915 melamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in decreased expression of OCLN protein PMID:30055240 14021365 OCLN occludin gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein] PMID:35381244 14021365 OCLN occludin gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of OCLN protein PMID:36754226 14021365 OCLN occludin gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of OCLN protein] PMID:36754226 14021365 OCLN occludin gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of OCLN protein PMID:37108405 14021365 OCLN occludin gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of OCLN protein] PMID:37108405 14021365 OCLN occludin gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in decreased expression of OCLN protein PMID:36615853 14021365 OCLN occludin gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in decreased expression of OCLN protein] PMID:36615853 14021365 OCLN occludin gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] PMID:37442268 14021365 OCLN occludin gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in decreased expression of OCLN mRNA; fumonisin B1 results in decreased expression of OCLN protein PMID:31557363|PMID:37955343 14021365 OCLN occludin gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of OCLN mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of OCLN protein] PMID:37955343 14021365 OCLN occludin gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of OCLN protein] PMID:36754226 14021365 OCLN occludin gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of OCLN protein] PMID:37108405 14021365 OCLN occludin gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN protein] PMID:39305878 14021365 OCLN occludin gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in increased expression of OCLN protein PMID:26338884 14021365 OCLN occludin gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C093642 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein]; SB 203580 inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA] PMID:37271275|PMID:38438008 14021365 OCLN occludin gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of OCLN protein] PMID:37659622 14021365 OCLN occludin gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased expression of OCLN mRNA; T-2 Toxin results in decreased expression of OCLN protein PMID:39305878 14021365 OCLN occludin gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN protein]]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of OCLN protein] PMID:39305878 14021365 OCLN occludin gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in increased expression of OCLN mRNA PMID:36596350 14021468 RHBDL1 rhomboid like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHBDL1 mRNA PMID:35307453 14021549 SOX6 SRY-box transcription factor 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SOX6 mRNA PMID:35307453 14021932 ZMYND10 zinc finger MYND-type containing 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZMYND10 mRNA PMID:35307453 14022045 NDRG1 N-myc downstream regulated 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDRG1 mRNA PMID:39265697 14022065 ATP6V1G2 ATPase H+ transporting V1 subunit G2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP6V1G2 mRNA PMID:35307453 14022065 ATP6V1G2 ATPase H+ transporting V1 subunit G2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of ATP6V1G2 mRNA PMID:21852083 14022084 WDR64 WD repeat domain 64 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR64 mRNA PMID:35307453 14022184 PRSS8 serine protease 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS8 mRNA PMID:35307453 14022255 SHISA8 shisa family member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SHISA8 mRNA PMID:35307453 14022302 TMEM132C transmembrane protein 132C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM132C mRNA PMID:35307453 14022507 C18H7orf57 chromosome 18 C7orf57 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C18H7ORF57 mRNA PMID:35307453 14022553 IFFO2 intermediate filament family orphan 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IFFO2 mRNA PMID:35307453 14022569 TWF2 twinfilin actin binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TWF2 mRNA PMID:35307453 14022642 CCDC146 coiled-coil domain containing 146 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC146 mRNA PMID:35307453 14022794 SPOCK1 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone affects the expression of SPOCK1 mRNA PMID:34933075 14022817 AP1S3 adaptor related protein complex 1 subunit sigma 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AP1S3 mRNA PMID:35307453 14022833 YARS1 tyrosyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YARS1 mRNA PMID:35307453 14022857 NRGN neurogranin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRGN mRNA PMID:35307453 14022857 NRGN neurogranin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NRGN mRNA PMID:39265697 14022877 RASIP1 Ras interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASIP1 mRNA PMID:35307453 14022893 TNXB tenascin XB gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of TNXB mRNA PMID:18988085 14022993 PCK1 phosphoenolpyruvate carboxykinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCK1 mRNA PMID:35307453 14022993 PCK1 phosphoenolpyruvate carboxykinase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PCK1 mRNA PMID:39265697 14022993 PCK1 phosphoenolpyruvate carboxykinase 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of PCK1 mRNA; ochratoxin A results in decreased expression of PCK1 protein PMID:3753873 14023064 CAPS2 calcyphosine 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPS2 mRNA PMID:35307453 14023138 TLE2 TLE family member 2, transcriptional corepressor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TLE2 mRNA PMID:35307453 14023138 TLE2 TLE family member 2, transcriptional corepressor gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TLE2 mRNA PMID:39265697 14023177 MAP3K7CL MAP3K7 C-terminal like gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of MAP3K7CL mRNA PMID:34933075 14023286 CRELD2 cysteine rich with EGF like domains 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRELD2 mRNA PMID:35307453 14023348 DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC12 mRNA PMID:35307453 14023348 DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DNAJC12 mRNA PMID:39265697 14023381 ACTB actin beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of ACTB mRNA PMID:26417708 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased expression of BAX protein PMID:38104654 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C007262 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of BAX protein PMID:38763499 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of BAX protein PMID:39265697 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:146195 3-acetyldeoxynivalenol increases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased expression of BAX protein PMID:37659622 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of BAX mRNA] PMID:35839969 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:15866 2-deoxy-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003847 [Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein] PMID:25087994 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of BAX mRNA PMID:37706587|PMID:38438008 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA] PMID:37706587|PMID:38438008 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [[Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein] PMID:25087994 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20200714 CTD MESH:D008070 Lipopolysaccharides results in increased expression of BAX protein PMID:31669396 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D008070 Flavones inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein] PMID:31669396 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX protein] PMID:35665993 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA] PMID:38438008 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 [Betaine co-treated with Glyphosate] results in increased expression of BAX mRNA PMID:36584959 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20191114 CTD MESH:D005839 Gentamicins results in increased expression of BAX protein modified form PMID:16569831 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20191114 CTD MESH:C039060 artenimol results in increased expression of BAX mRNA PMID:29309768 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased expression of BAX protein PMID:19135140 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAX protein]; Selenium inhibits the reaction [Cadmium results in increased expression of BAX protein] PMID:19135140|PMID:33493553 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:24043 flavones multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D047309 Flavones inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein] PMID:31669396 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of BAX protein PMID:38763499 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of BAX protein PMID:11781163 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in increased expression of BAX protein] PMID:19135140 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:2762 antimycin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000968 [Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein] PMID:25087994 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of BAX mRNA PMID:36584959 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 [Betaine co-treated with Glyphosate] results in increased expression of BAX mRNA PMID:36584959 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of BAX protein PMID:23065251 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of BAX protein] PMID:37955343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27899 cisplatin affects localization EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin affects the localization of BAX protein PMID:16316343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Bezafibrate inhibits the reaction [Cisplatin affects the localization of BAX protein] PMID:16316343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAX protein] PMID:19135140|PMID:33905761 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of BAX protein PMID:36754226 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of BAX protein PMID:11781163 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of BAX mRNA; bisphenol A results in increased expression of BAX protein PMID:37108405|PMID:38845341 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of BAX protein]; ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of BAX mRNA] PMID:37108405|PMID:38845341 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of BAX mRNA; tetrabromobisphenol A results in increased expression of BAX protein PMID:35665993 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX protein] PMID:35665993 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine affects the localization of BAX protein] PMID:19523970 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in increased expression of BAX mRNA PMID:34399389|PMID:38565334 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of BAX mRNA PMID:28803810 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of BAX mRNA] PMID:28803810 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of BAX protein PMID:26607349 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX protein; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein] PMID:26607349|PMID:33493553 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in increased expression of BAX protein] PMID:19135140 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of BAX mRNA PMID:17437637 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA] PMID:37706587 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20211012 CTD MESH:C056933 fumonisin B1 results in increased expression of BAX mRNA; fumonisin B1 results in increased expression of BAX protein PMID:33905761|PMID:36397609|PMID:37955343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of BAX protein] PMID:33905761|PMID:36397609|PMID:37955343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of BAX mRNA] PMID:28803810 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of BAX protein PMID:31744678 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:4027 cyclophosphamide increases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in increased expression of BAX mRNA PMID:37980972 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in increased expression of BAX mRNA] PMID:37980972 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:4031 cyclosporin A affects localization EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine affects the localization of BAX protein PMID:19523970 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine affects the localization of BAX protein] PMID:19523970 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate inhibits the reaction [Cisplatin affects the localization of BAX protein] PMID:16316343 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:48843 disodium selenite affects expression EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite affects the expression of BAX mRNA PMID:17342738 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAX protein] PMID:26607349|PMID:37108405 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of BAX mRNA PMID:31535366 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20211012 CTD MESH:C025589 ochratoxin A results in increased expression of BAX mRNA; ochratoxin A results in increased expression of BAX protein PMID:33905761|PMID:36397609 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA] PMID:33905761|PMID:36397609 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20241105 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of BAX mRNA] PMID:38845341 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in increased expression of BAX mRNA] PMID:37980972 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of BAX mRNA PMID:35839969 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of BAX mRNA] PMID:35839969 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA] PMID:33905761 14023413 BAX BCL2 associated X, apoptosis regulator gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA] PMID:38438008 14023426 PRM2 protamine 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of PRM2 mRNA PMID:25455459 14023517 DCDC2 doublecortin domain containing 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DCDC2 mRNA PMID:39265697 14023531 ABCC3 ATP binding cassette subfamily C member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCC3 mRNA; deoxynivalenol results in decreased expression of ABCC3 protein PMID:38403181 14023640 CACNG6 calcium voltage-gated channel auxiliary subunit gamma 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CACNG6 mRNA PMID:35307453 14023700 SLC22A5 solute carrier family 22 member 5 gene CHEBI:16347 (R)-carnitine increases uptake EXP E RGD:6480464 20191114 CTD MESH:D002331 SLC22A5 protein results in increased uptake of Carnitine PMID:16826461 14023700 SLC22A5 solute carrier family 22 member 5 gene CHEBI:165622 CAR(3:0(Me2)) decreases activity EXP E RGD:6480464 20201208 CTD MESH:C054040 pivaloylcarnitine results in decreased activity of SLC22A5 protein PMID:16826461 14023700 SLC22A5 solute carrier family 22 member 5 gene CHEBI:57589 O-acetyl-L-carnitine increases uptake EXP E RGD:6480464 20191114 CTD MESH:D000108 SLC22A5 protein results in increased uptake of Acetylcarnitine PMID:16826461 14023817 TMEM156 transmembrane protein 156 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM156 mRNA PMID:35307453 14023869 CDYL chromodomain Y like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDYL mRNA PMID:35307453 14024130 TFR2 transferrin receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFR2 mRNA PMID:35307453 14024130 TFR2 transferrin receptor 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TFR2 mRNA PMID:39265697 14024343 TRMT1L tRNA methyltransferase 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT1L mRNA PMID:35307453 14024367 ADGRL2 adhesion G protein-coupled receptor L2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRL2 mRNA PMID:35307453 14024523 GLOD5 glyoxalase domain containing 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLOD5 mRNA PMID:35307453 14024531 VRK2 VRK serine/threonine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VRK2 mRNA PMID:35307453 14024559 GRB7 growth factor receptor bound protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRB7 mRNA PMID:35307453 14024625 STOX1 storkhead box 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STOX1 mRNA PMID:35307453 14024625 STOX1 storkhead box 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of STOX1 mRNA] PMID:39151877 14024625 STOX1 storkhead box 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of STOX1 mRNA PMID:39151877 14024625 STOX1 storkhead box 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of STOX1 mRNA] PMID:39151877 14024638 METTL3 methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL3 mRNA PMID:35307453 14024689 DUSP1 dual specificity phosphatase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP1 mRNA; deoxynivalenol results in increased expression of DUSP1 protein PMID:35307453|PMID:38403181 14024689 DUSP1 dual specificity phosphatase 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of DUSP1 mRNA PMID:34389318 14024689 DUSP1 dual specificity phosphatase 1 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of DUSP1 mRNA PMID:37706587 14024689 DUSP1 dual specificity phosphatase 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DUSP1 mRNA] PMID:37706587 14024689 DUSP1 dual specificity phosphatase 1 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DUSP1 mRNA] PMID:37706587 14024785 LRRC56 leucine rich repeat containing 56 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC56 mRNA PMID:35307453 14024815 DNAJC24 DnaJ heat shock protein family (Hsp40) member C24 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC24 mRNA PMID:35307453 14024943 FAIM2 Fas apoptotic inhibitory molecule 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAIM2 mRNA PMID:35307453 14024960 PDCD4 programmed cell death 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDCD4 mRNA PMID:35307453 14024960 PDCD4 programmed cell death 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PDCD4 mRNA PMID:39265697 14025049 DOCK8 dedicator of cytokinesis 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DOCK8 mRNA PMID:35307453 14025119 CDCA8 cell division cycle associated 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDCA8 mRNA PMID:35307453 14025134 SLC39A2 solute carrier family 39 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC39A2 mRNA PMID:35307453 14025215 NEK11 NIMA related kinase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEK11 mRNA PMID:35307453 14025247 SLC1A1 solute carrier family 1 member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC1A1 mRNA PMID:35307453 14025247 SLC1A1 solute carrier family 1 member 1 gene CHEBI:33709 amino acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D000596 Amino Acids results in increased expression of SLC1A1 mRNA; Amino Acids results in increased expression of SLC1A1 protein PMID:26338884 14025247 SLC1A1 solute carrier family 1 member 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in decreased expression of SLC1A1 mRNA PMID:33443779 14025264 NR1D1 nuclear receptor subfamily 1 group D member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NR1D1 mRNA PMID:35307453 14025447 AHCTF1 AT-hook containing transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AHCTF1 mRNA PMID:35307453 14025494 SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides affects the expression of SMARCA4 mRNA PMID:21645290 14025586 PPP2CB protein phosphatase 2 catalytic subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP2CB mRNA PMID:35307453 14025684 NAV1 neuron navigator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAV1 mRNA PMID:35307453 14025781 MGAT3 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MGAT3 mRNA PMID:39265697 14025880 PLCH2 phospholipase C eta 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLCH2 mRNA PMID:35307453 14025967 PCSK6 proprotein convertase subtilisin/kexin type 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCSK6 mRNA PMID:35307453 14026012 MYO5B myosin VB gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO5B mRNA PMID:35307453 14026215 CCAR1 cell division cycle and apoptosis regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCAR1 mRNA PMID:35307453 14026473 RRAS2 RAS related 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRAS2 mRNA PMID:35307453 14026645 KAT14 lysine acetyltransferase 14 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of KAT14 mRNA PMID:35839969 14026698 MYL9 myosin light chain 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYL9 mRNA; deoxynivalenol results in decreased expression of MYL9 protein PMID:35307453|PMID:38403181 14026698 MYL9 myosin light chain 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of MYL12A mRNA PMID:35307453 14026698 MYL9 myosin light chain 9 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MYL9 mRNA PMID:39265697 14026698 MYL9 myosin light chain 9 gene CHEBI:15422 ATP decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D000255 Adenosine Triphosphate results in decreased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:15422 ATP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000255 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Adenosine Triphosphate promotes the reaction [calyculin A results in increased phosphorylation of MYL9 protein]]; Adenosine Triphosphate promotes the reaction [calyculin A results in increased phosphorylation of MYL9 protein] PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:16335 adenosine decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D000241 Adenosine results in decreased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:16335 adenosine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000241 8-phenyltheophylline inhibits the reaction [Adenosine results in decreased phosphorylation of MYL9 protein] PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Calcium co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Calcium co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:41791 calyculin A increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C059041 calyculin A results in increased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:41791 calyculin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059041 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Adenosine Triphosphate promotes the reaction [calyculin A results in increased phosphorylation of MYL9 protein]]; Adenosine Triphosphate promotes the reaction [calyculin A results in increased phosphorylation of MYL9 protein] PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:60888 BAPTA multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025603 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Adenosine Triphosphate promotes the reaction [calyculin A results in increased phosphorylation of MYL9 protein]]; [Calcium co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased phosphorylation of MYL9 protein PMID:10942722 14026698 MYL9 myosin light chain 9 gene CHEBI:78761 ML-7 decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C070571 ML 7 results in decreased phosphorylation of MYL9 protein PMID:10942722 14026723 SUPT6H SPT6 homolog, histone chaperone and transcription elongation factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SUPT6H mRNA PMID:35307453 14026882 ZNF79 zinc finger protein 79 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ZNF79 mRNA PMID:34389318 14027027 RPAP3 RNA polymerase II associated protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPAP3 mRNA PMID:35307453 14027146 KIF20A kinesin family member 20A gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of KIF20A mRNA PMID:34389318 14027195 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAA15 mRNA PMID:35307453 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GAPDH mRNA PMID:35307453 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of GAPDH mRNA PMID:18988085 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Paraquat results in decreased activity of GAPDH protein] PMID:17055214 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:32139 sodium hydrogencarbonate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017693 [Sodium Bicarbonate co-treated with Calcium Chloride] results in increased activity of GAPDH protein PMID:26582256 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:3312 calcium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002122 [Sodium Bicarbonate co-treated with Calcium Chloride] results in increased activity of GAPDH protein PMID:26582256 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:34905 paraquat decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010269 Paraquat results in decreased activity of GAPDH protein PMID:11814328|PMID:17055214 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010269 Selenium inhibits the reaction [Paraquat results in decreased activity of GAPDH protein] PMID:17055214 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Paraquat results in decreased activity of GAPDH protein] PMID:17055214 14027225 GAPDH glyceraldehyde-3-phosphate dehydrogenase gene CHEBI:75249 potassium chromate decreases activity EXP E RGD:6480464 20191114 CTD MESH:C027373 potassium chromate(VI) results in decreased activity of GAPDH protein PMID:26582256 14027338 ARID3B AT-rich interaction domain 3B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARID3B mRNA PMID:35307453 14027357 NR1I2 nuclear receptor subfamily 1 group I member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR1I2 mRNA PMID:35307453 14027538 ZC3H12D zinc finger CCCH-type containing 12D gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of ZC3H12D mRNA PMID:35307453 14027555 EREG epiregulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EREG mRNA PMID:35307453 14027580 SPEF1 sperm flagellar 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SPEF1 mRNA PMID:39265697 14027591 VDAC2 voltage dependent anion channel 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VDAC2 mRNA PMID:35307453 14027609 LAMA3 laminin subunit alpha 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of LAMA3 mRNA PMID:37257635 14027609 LAMA3 laminin subunit alpha 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of LAMA3 mRNA PMID:39265697 14027736 MT3 metallothionein 3 gene CHEBI:18421 superoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013481 MT3 protein binds to and affects the metabolism of Superoxides PMID:12680700 14027736 MT3 metallothionein 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of MT3 mRNA PMID:18988085 14027736 MT3 metallothionein 3 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 MT3 protein binds to and affects the abundance of Zinc PMID:12405537 14027736 MT3 metallothionein 3 gene CHEBI:29191 hydroxyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017665 MT3 protein binds to and affects the metabolism of Hydroxyl Radical PMID:12680700 14027736 MT3 metallothionein 3 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 MT3 protein binds to and affects the abundance of Zinc PMID:12405537 14027744 GPAT2 glycerol-3-phosphate acyltransferase 2, mitochondrial gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPAT2 mRNA PMID:35307453 14027814 CBX6 chromobox 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBX6 mRNA PMID:35307453 14027826 TMEM140 transmembrane protein 140 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM140 mRNA PMID:35307453 14027854 TNFSF9 TNF superfamily member 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNFSF9 mRNA PMID:35307453 14027866 APOH apolipoprotein H gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of APOH mRNA PMID:34389318 14027935 BECN1 beclin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of BECN1 mRNA; deoxynivalenol results in increased expression of BECN1 protein PMID:35381244|PMID:37120089 14027935 BECN1 beclin 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of BECN1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA] PMID:35381244|PMID:37120089 14027935 BECN1 beclin 1 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of BECN1 protein PMID:37659622 14027935 BECN1 beclin 1 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin results in increased expression of BECN1 protein PMID:37120089 14027935 BECN1 beclin 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of BECN1 protein] PMID:37120089 14027935 BECN1 beclin 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA] PMID:35381244 14027935 BECN1 beclin 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of BECN1 mRNA PMID:28819136 14027935 BECN1 beclin 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA; Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]] PMID:34811946 14027935 BECN1 beclin 1 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of BECN1 protein PMID:28803810 14027935 BECN1 beclin 1 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of BECN1 protein] PMID:28803810 14027935 BECN1 beclin 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]]; 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of BECN1 protein] PMID:28803810|PMID:34811946 14027935 BECN1 beclin 1 gene CHEBI:50842 norflurazon increases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased expression of BECN1 protein PMID:38432436 14027935 BECN1 beclin 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of BECN1 protein PMID:30287338 14027935 BECN1 beclin 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein] PMID:30287338 14027935 BECN1 beclin 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of BECN1 mRNA]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the expression of BECN1 protein]] PMID:34811946 14028047 H2BC5 H2B clustered histone 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of H2BC5 mRNA PMID:35307453 14028053 MRPL40 mitochondrial ribosomal protein L40 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL40 mRNA PMID:35307453 14028084 GNG5 G protein subunit gamma 5 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of GNG5 mRNA PMID:39265697 14028103 GLT6D1 glycosyltransferase 6 domain containing 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GLT6D1 mRNA PMID:34933075 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:104872 rolipram decreases activity EXP E RGD:6480464 20191114 CTD MESH:D020889 Rolipram results in decreased activity of ADCYAP1 protein alternative form PMID:16847435 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein; Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein] PMID:28506824 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein; Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein] PMID:28506824 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein] PMID:28506824 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein] PMID:28506824 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:31429 colforsin daropate hydrochloride decreases activity EXP E RGD:6480464 20191114 CTD MESH:D005576 Colforsin results in decreased activity of ADCYAP1 protein alternative form PMID:16847435 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of ADCYAP1 protein PMID:29569701 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:3374 capsaicin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002211 Capsaicin inhibits the reaction [ADCYAP1 protein alternative form results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] PMID:14662737 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:90630 omega-conotoxin GVIA multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020866 omega-Conotoxin GVIA inhibits the reaction [ADCYAP1 protein alternative form results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] PMID:14662737 14028124 ADCYAP1 adenylate cyclase activating polypeptide 1 gene CHEBI:91215 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C095284 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [ADCYAP1 protein alternative form results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] PMID:14662737 14028181 PDE6C phosphodiesterase 6C gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PDE6C mRNA PMID:39265697 14028181 PDE6C phosphodiesterase 6C gene CHEBI:16356 3',5'-cyclic GMP increases degradation EXP E RGD:6480464 20191114 CTD MESH:D006152 PDE6C protein results in increased degradation of Cyclic GMP PMID:18669600 14028346 PTGER4 prostaglandin E receptor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGER4 mRNA PMID:35307453 14028445 MAVS mitochondrial antiviral signaling protein gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of MAVS mRNA; Mycotoxins results in increased expression of MAVS protein PMID:39137830 14028445 MAVS mitochondrial antiviral signaling protein gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of MAVS mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of MAVS protein] PMID:39137830 14028468 MCOLN3 mucolipin TRP cation channel 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MCOLN3 mRNA PMID:35307453 14028486 SLC36A2 solute carrier family 36 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC36A2 mRNA PMID:35307453 14028514 SLC50A1 solute carrier family 50 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC50A1 mRNA PMID:35307453 14028643 AK1 adenylate kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AK1 mRNA PMID:35307453 14028770 MRPL1 mitochondrial ribosomal protein L1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL1 mRNA PMID:35307453 14028891 COL14A1 collagen type XIV alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL14A1 mRNA; deoxynivalenol results in decreased expression of COL14A1 protein PMID:35307453|PMID:38403181 14028891 COL14A1 collagen type XIV alpha 1 chain gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of COL14A1 mRNA PMID:21852083 14028969 FOXN1 forkhead box N1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXN1 mRNA PMID:35307453 14028999 CLXN calaxin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLXN mRNA PMID:35307453 14029082 BMI1 BMI1 proto-oncogene, polycomb ring finger gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMI1 protein PMID:30690062 14029165 CYP27A1 cytochrome P450 family 27 subfamily A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP27A1 mRNA PMID:35307453 14029265 HCFC1 host cell factor C1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HCFC1 mRNA PMID:35307453 14029299 ST3GAL1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST3GAL1 mRNA PMID:35307453 14029407 RPL22L1 ribosomal protein L22 like 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL22L1 mRNA PMID:39265697 14029431 APLP2 amyloid beta precursor like protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APLP2 mRNA PMID:35307453 14029458 LRRC25 leucine rich repeat containing 25 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC25 mRNA PMID:35307453 14029705 MIOX myo-inositol oxygenase gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of MIOX mRNA PMID:28069986 14029807 MAFF MAF bZIP transcription factor F gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAFF mRNA PMID:35307453 14030086 PHLDA1 pleckstrin homology like domain family A member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PHLDA1 mRNA PMID:35307453 14030120 FADS3 fatty acid desaturase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FADS3 mRNA PMID:35307453 14030196 ZNF365 zinc finger protein 365 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF365 mRNA PMID:35307453 14030335 CASTOR1 cytosolic arginine sensor for mTORC1 subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CASTOR1 mRNA PMID:35307453 14030368 DUSP14 dual specificity phosphatase 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP14 mRNA PMID:35307453 14030381 HRH1 histamine receptor H1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HRH1 mRNA PMID:35307453 14030381 HRH1 histamine receptor H1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of HRH1 mRNA PMID:39265697 14030589 PNRC2 proline rich nuclear receptor coactivator 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PNRC2 mRNA PMID:39265697 14030600 TAMALIN trafficking regulator and scaffold protein tamalin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TAMALIN mRNA PMID:35307453 14030621 PIR pirin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIR mRNA PMID:35307453 14030646 FAH fumarylacetoacetate hydrolase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAH mRNA PMID:35307453 14030666 SLC18A3 solute carrier family 18 member A3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of SLC18A3 protein PMID:29558425|PMID:29577965 14030881 DCAF4 DDB1 and CUL4 associated factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCAF4 mRNA PMID:35307453 14030945 PPP1R8 protein phosphatase 1 regulatory subunit 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R8 mRNA PMID:35307453 14031249 DRD3 dopamine receptor D3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DRD3 mRNA PMID:35307453 14031273 ARID1B AT-rich interaction domain 1B gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of ARID1B mRNA PMID:21852083 14031352 EPO erythropoietin gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 [Cisplatin co-treated with EPO protein] results in increased cleavage of CASP3 protein PMID:21497595 14031361 STEAP1 STEAP family member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STEAP1 mRNA PMID:35307453 14031372 CALM1 calmodulin 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CALM1 mRNA PMID:39265697 14031391 PTN pleiotrophin gene CHEBI:18376 dermatan sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D003871 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein PMID:14699094 14031391 PTN pleiotrophin gene CHEBI:37397 chondroitin sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D002809 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein PMID:14699094 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:6076 itraconazole multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017964 Itraconazole inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] PMID:21056966 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:64482 phosphatidylcholine increases export EXP E RGD:6480464 20191114 CTD MESH:D010713 ABCB4 protein results in increased export of Phosphatidylcholines PMID:21056966 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:64482 phosphatidylcholine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010713 Itraconazole inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines]; Verapamil inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] PMID:21056966 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:77733 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014700 Verapamil inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] PMID:21056966 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:94366 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017964 Itraconazole inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] PMID:21056966 14031420 ABCB4 ATP binding cassette subfamily B member 4 gene CHEBI:9948 verapamil multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014700 Verapamil inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] PMID:21056966 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIMP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIMP1 protein PMID:34416349 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TIMP1 mRNA PMID:18988085 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased expression of TIMP1 protein PMID:39486568 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of TIMP1 mRNA PMID:21391292 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIMP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIMP1 protein PMID:34416349 14031561 TIMP1 TIMP metallopeptidase inhibitor 1 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased expression of TIMP1 protein PMID:39486568 14031697 CD164L2 CD164 molecule like 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CD164L2 mRNA PMID:39265697 14031769 PPP1R10 protein phosphatase 1 regulatory subunit 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R10 mRNA PMID:35307453 14031873 NR4A1 nuclear receptor subfamily 4, group A, member 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20250401 CTD MESH:D000641 Ammonia results in increased expression of NR4A1 mRNA PMID:34389318 14031887 EDN3 endothelin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EDN3 mRNA PMID:35307453 14031977 RASEF RAS and EF-hand domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASEF mRNA PMID:35307453 14032128 AP4S1 adaptor related protein complex 4 subunit sigma 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AP4S1 mRNA PMID:35307453 14032220 NMRK1 nicotinamide riboside kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NMRK1 mRNA PMID:35307453 14032275 CDH18 cadherin 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH18 mRNA PMID:35307453 14032394 EFHD1 EF-hand domain family member D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFHD1 mRNA PMID:35307453 14032407 ACADM acyl-CoA dehydrogenase medium chain gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADM mRNA PMID:34416349 14032407 ACADM acyl-CoA dehydrogenase medium chain gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADM mRNA PMID:34416349 14032423 RAB15 RAB15, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB15 mRNA PMID:35307453 14032449 H2AC19 H2A clustered histone 19 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H2AC19 mRNA PMID:35307453 14032472 AQP6 aquaporin 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP6 mRNA PMID:35307453 14032485 DPP4 dipeptidyl peptidase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPP4 mRNA PMID:35307453 14032537 CPT1A carnitine palmitoyltransferase 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPT1A mRNA PMID:35307453 14032537 CPT1A carnitine palmitoyltransferase 1A gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CPT1A mRNA PMID:34389318 14032537 CPT1A carnitine palmitoyltransferase 1A gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPT1A mRNA PMID:34416349 14032537 CPT1A carnitine palmitoyltransferase 1A gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPT1A mRNA PMID:34416349 14032537 CPT1A carnitine palmitoyltransferase 1A gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of CPT1A mRNA PMID:16896063|PMID:17363680 14032601 MFSD1 major facilitator superfamily domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFSD1 mRNA PMID:35307453 14032625 ZNF462 zinc finger protein 462 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of ZNF462 mRNA PMID:21852083 14032859 PATL1 PAT1 homolog 1, processing body mRNA decay factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PATL1 mRNA PMID:35307453 14032893 GALE UDP-galactose-4-epimerase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GALE mRNA PMID:35307453 14032954 CAPN8 calpain 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPN8 mRNA PMID:35307453 14033043 SFTA2 surfactant associated 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SFTA2 mRNA PMID:35307453 14033404 MRPS31 mitochondrial ribosomal protein S31 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS31 mRNA PMID:35307453 14033439 GGA2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GGA2 mRNA PMID:35307453 14033567 TMEM134 transmembrane protein 134 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM134 mRNA PMID:35307453 14033619 S100A12 S100 calcium binding protein A12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S100A12 mRNA PMID:35307453 14033619 S100A12 S100 calcium binding protein A12 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of S100A12 mRNA PMID:34933075 14033642 CACNA1H calcium voltage-gated channel subunit alpha1 H gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CACNA1H mRNA PMID:34933075 14033695 RPS20 ribosomal protein S20 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS20 mRNA PMID:39265697 14033741 DSG2 desmoglein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DSG2 mRNA PMID:35307453 14033760 WDR43 WD repeat domain 43 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR43 mRNA PMID:35307453 14033782 FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FCGR1A mRNA PMID:35307453 14033782 FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of FCGR1A mRNA PMID:34389318 14033949 LRRC75A leucine rich repeat containing 75A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC75A mRNA PMID:35307453 14034078 CARS2 cysteinyl-tRNA synthetase 2, mitochondrial gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CARS2 mRNA PMID:35307453 14034157 RPS27 ribosomal protein S27 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS27 mRNA PMID:39265697 14034180 ASB15 ankyrin repeat and SOCS box containing 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB15 mRNA PMID:35307453 14034259 HPS3 HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HPS3 mRNA PMID:35307453 14034383 PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 gene CHEBI:22984 calcium atom decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in decreased phosphorylation of PDHA1 protein modified form PMID:16489745 14034383 PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 gene CHEBI:22984 calcium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of PDHA1 protein PMID:16489745 14034383 PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 gene CHEBI:29320 calcium(0) decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in decreased phosphorylation of PDHA1 protein modified form PMID:16489745 14034383 PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 gene CHEBI:29320 calcium(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of PDHA1 protein PMID:16489745 14034439 TLR3 toll like receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TLR3 mRNA; deoxynivalenol results in decreased expression of TLR3 protein PMID:38403181 14034439 TLR3 toll like receptor 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of TLR3 mRNA PMID:25455459 14034439 TLR3 toll like receptor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TLR3 mRNA PMID:39265697 14034449 AZIN1 antizyme inhibitor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AZIN1 mRNA PMID:35307453 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine promotes the reaction [monobutyl phthalate results in decreased expression of POU5F1 mRNA] PMID:39127149 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of POU5F1 mRNA; bisphenol A results in decreased expression of POU5F1 protein PMID:28819136 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:4027 cyclophosphamide decreases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in decreased expression of POU5F1 mRNA PMID:37980972 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of POU5F1 mRNA] PMID:37980972 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of POU5F1 mRNA] PMID:37980972 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in decreased expression of POU5F1 mRNA PMID:39127149 14034556 POU5F1 POU class 5 homeobox 1 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C028577 Glycine promotes the reaction [monobutyl phthalate results in decreased expression of POU5F1 mRNA] PMID:39127149 14034574 HIVEP1 HIVEP zinc finger 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HIVEP1 mRNA PMID:35307453 14034736 CD163 CD163 molecule gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of CD163 mRNA PMID:22497863 14034944 TK2 thymidine kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TK2 mRNA PMID:35307453 14035129 FOSL2 FOS like 2, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOSL2 mRNA PMID:35307453 14035151 CCN1 cellular communication network factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCN1 mRNA PMID:35307453 14035151 CCN1 cellular communication network factor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCN1 mRNA PMID:27617619 14035380 RBM27 RNA binding motif protein 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM27 mRNA PMID:35307453 14035411 BST1 bone marrow stromal cell antigen 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BST1 mRNA PMID:35307453 14035505 CCDC88B coiled-coil domain containing 88B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC88B mRNA PMID:35307453 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPP1 mRNA PMID:35307453 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in decreased expression of SPP1 protein PMID:15713688 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA] PMID:30481989 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SPP1 mRNA PMID:18988085 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SPP1 mRNA PMID:21852083 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA] PMID:30481989 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA] PMID:30481989 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20211012 CTD MESH:C056933 fumonisin B1 results in increased expression of SPP1 mRNA PMID:33905761 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of SPP1 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of SPP1 mRNA] PMID:33905761 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA] PMID:30481989 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of SPP1 mRNA PMID:38432436 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20211012 CTD MESH:C025589 ochratoxin A results in increased expression of SPP1 mRNA PMID:33905761 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of SPP1 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of SPP1 mRNA] PMID:33905761 14035682 SPP1 secreted phosphoprotein 1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA] PMID:30481989 14035738 CCDC198 coiled-coil domain containing 198 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC198 mRNA PMID:35307453 14035796 MAFG MAF bZIP transcription factor G gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAFG mRNA PMID:35307453 14035839 CRABP1 cellular retinoic acid binding protein 1 gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone affects the expression of CRABP1 protein PMID:11833939 14035952 BCLAF1 BCL2 associated transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BCLAF1 mRNA PMID:35307453 14036006 THUMPD1 THUMP domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THUMPD1 mRNA; deoxynivalenol results in increased expression of THUMPD1 protein PMID:35307453|PMID:38403181 14036260 NAALAD2 N-acetylated alpha-linked acidic dipeptidase 2 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of NAALAD2 mRNA PMID:28069986 14036334 H2AJ H2A.J histone gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of H2AJ mRNA PMID:39265697 14036405 S1PR5 sphingosine-1-phosphate receptor 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of S1PR5 mRNA PMID:35307453 14036484 DUSP26 dual specificity phosphatase 26 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DUSP26 mRNA PMID:35307453 14036659 PRR7 proline rich 7, synaptic gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRR7 mRNA PMID:35307453 14037166 ACAA2 acetyl-CoA acyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACAA2 mRNA PMID:35307453 14037257 CDCA2 cell division cycle associated 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDCA2 mRNA PMID:35307453 14037583 LOC100624218 MORN repeat-containing protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MORN1 mRNA PMID:35307453 14037694 COX7A2 cytochrome c oxidase subunit 7A2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX7A2 mRNA PMID:39265697 14037894 SERPINB7 serpin family B member 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERPINB7 mRNA PMID:35307453 14037973 FEZF1 FEZ family zinc finger 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FEZF1 mRNA PMID:35307453 14038048 ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENTPD2 mRNA PMID:35307453 14038049 ACYP2 acylphosphatase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACYP2 mRNA PMID:35307453 14038221 RGS20 regulator of G protein signaling 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RGS20 mRNA PMID:35307453 14038230 TTC13 tetratricopeptide repeat domain 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC13 mRNA PMID:35307453 14038555 NIPAL3 NIPA like domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NIPAL3 mRNA PMID:35307453 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of NOS2 mRNA PMID:25701311 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of NOS2 mRNA PMID:23727178 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of NOS2 mRNA PMID:23727178 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in decreased expression of INOS mRNA] PMID:36281498 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein] PMID:21375526 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides affects the expression of NOS2 mRNA; Lipopolysaccharides affects the expression of NOS2 protein PMID:12893242 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] PMID:20825639 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NOS2 protein PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of NOS2 protein] PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NOS2 protein PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of NOS2 protein] PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOS2 protein PMID:33592257|PMID:34416349 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased expression of NOS2 mRNA] PMID:35134483 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of NOS2 mRNA PMID:35388968 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of NOS2 protein PMID:20825639 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] PMID:20825639 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of INOS mRNA] PMID:36281498 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of NOS2 mRNA; Cadmium Chloride results in increased expression of NOS2 protein PMID:33626375 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOS2 protein PMID:33592257|PMID:34416349 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NOS2 protein PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of NOS2 protein] PMID:16949779 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:4670 dobutamine affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D004280 NOS2 protein affects the susceptibility to Dobutamine PMID:20141602 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of INOS mRNA PMID:36281498 14038749 NOS2 nitric oxide synthase 2 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of INOS mRNA]; Taurine inhibits the reaction [ochratoxin A results in decreased expression of INOS mRNA] PMID:36281498 14038799 SURF2 surfeit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SURF2 mRNA PMID:35307453 14039044 HSPB6 heat shock protein family B (small) member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSPB6 mRNA PMID:35307453 14039133 PGM2 phosphoglucomutase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of PGM2 mRNA; deoxynivalenol results in increased expression of PGM2 protein PMID:38403181 14039183 IL2 interleukin 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IL2 mRNA; [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IL2 mRNA PMID:18296887|PMID:38763499 14039183 IL2 interleukin 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IL2 mRNA PMID:34933075 14039183 IL2 interleukin 2 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IL2 mRNA PMID:18296887 14039183 IL2 interleukin 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL2 mRNA PMID:33592257 14039183 IL2 interleukin 2 gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IL2 mRNA PMID:38763499 14039183 IL2 interleukin 2 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of IL2 mRNA PMID:33626375 14039183 IL2 interleukin 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL2 mRNA PMID:33592257 14039183 IL2 interleukin 2 gene CHEBI:7719 ochratoxin A decreases secretion EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased secretion of IL2 protein PMID:28699257 14039555 PTPRC protein tyrosine phosphatase receptor type C gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of PTPRC mRNA PMID:34389318 14039629 KCNH3 potassium voltage-gated channel subfamily H member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNH3 mRNA PMID:35307453 14039654 TTLL9 tubulin tyrosine ligase like 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTLL9 mRNA PMID:35307453 14039673 WAPL WAPL cohesin release factor gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of WAPL mRNA PMID:34389318 14039784 ZWILCH zwilch kinetochore protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZWILCH mRNA PMID:35307453 14039818 EP300 E1A binding protein p300 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of EP300 protein PMID:29358327 14039992 CORO6 coronin 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CORO6 mRNA PMID:35307453 14040083 USP19 ubiquitin specific peptidase 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of USP19 mRNA PMID:35307453 14040177 DDX46 DEAD-box helicase 46 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX46 mRNA PMID:35307453 14040383 IRF7 interferon regulatory factor 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of IRF7 mRNA; deoxynivalenol results in decreased expression of IRF7 protein PMID:38403181 14040383 IRF7 interferon regulatory factor 7 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IRF7 mRNA] PMID:27079946 14040540 UGT1A6 UDP glucuronosyltransferase 1 family, polypeptide A6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of UGT1A6 mRNA PMID:35307453 14040567 SYNPO2L synaptopodin 2 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SYNPO2L mRNA PMID:35307453 14040583 HYAL4 hyaluronidase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HYAL4 mRNA PMID:35307453 14040609 SH2D2A SH2 domain containing 2A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SH2D2A mRNA PMID:35307453 14040722 MTF2 metal response element binding transcription factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTF2 mRNA PMID:35307453 14040834 OSR2 odd-skipped related transciption factor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of OSR2 mRNA PMID:34933075 14040853 PTPRU protein tyrosine phosphatase receptor type U gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPRU mRNA PMID:35307453 14040853 PTPRU protein tyrosine phosphatase receptor type U gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PTPRU mRNA PMID:39265697 14040924 CD209 CD209 molecule gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CD209 mRNA PMID:34933075 14041279 ENPP3 ectonucleotide pyrophosphatase/phosphodiesterase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENPP3 mRNA PMID:35307453 14041438 SORD sorbitol dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SORD mRNA PMID:35307453 14041438 SORD sorbitol dehydrogenase gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of SORD mRNA PMID:31535366 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IDH2 mRNA; deoxynivalenol results in decreased expression of IDH2 protein PMID:35307453 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005978 Glutathione inhibits the reaction [Cadmium Chloride results in decreased activity of IDH2 protein]; Glutathione inhibits the reaction [Cadmium results in decreased activity of IDH2 protein] PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:18320 1,4-dithiothreitol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol inhibits the reaction [Cadmium Chloride results in decreased activity of IDH2 protein]; Dithiothreitol inhibits the reaction [Cadmium results in decreased activity of IDH2 protein] PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:22977 cadmium atom affects binding EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium binds to IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:22977 cadmium atom affects folding EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium affects the folding of IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:22977 cadmium atom decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in decreased activity of IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:22977 cadmium atom decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D002104 IDH2 protein results in decreased susceptibility to Cadmium PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [oxalomalic acid results in decreased activity of IDH2 protein] which results in increased susceptibility to Cadmium; Dithiothreitol inhibits the reaction [Cadmium results in decreased activity of IDH2 protein]; Glutathione inhibits the reaction [Cadmium results in decreased activity of IDH2 protein]; IDH2 protein inhibits the reaction [Cadmium results in decreased activity of GLRX protein] PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of IDH2 mRNA PMID:21852083 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:30926 3-oxalomalic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:C015407 oxalomalic acid results in decreased activity of IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:30926 3-oxalomalic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C015407 [oxalomalic acid results in decreased activity of IDH2 protein] which results in increased susceptibility to Cadmium; [oxalomalic acid results in decreased activity of IDH2 protein] which results in increased susceptibility to Cadmium Chloride PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:35456 cadmium dichloride affects binding EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride binds to IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:35456 cadmium dichloride affects folding EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride affects the folding of IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:35456 cadmium dichloride decreases activity EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased activity of IDH2 protein PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:35456 cadmium dichloride decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D019256 IDH2 protein results in decreased susceptibility to Cadmium Chloride PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [oxalomalic acid results in decreased activity of IDH2 protein] which results in increased susceptibility to Cadmium Chloride; Dithiothreitol inhibits the reaction [Cadmium Chloride results in decreased activity of IDH2 protein]; Glutathione inhibits the reaction [Cadmium Chloride results in decreased activity of IDH2 protein]; IDH2 protein inhibits the reaction [Cadmium Chloride results in decreased activity of GLRX protein] PMID:16785314 14041463 IDH2 isocitrate dehydrogenase (NADP(+)) 2 gene CHEBI:42106 L-1,4-dithiothreitol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol inhibits the reaction [Cadmium Chloride results in decreased activity of IDH2 protein]; Dithiothreitol inhibits the reaction [Cadmium results in decreased activity of IDH2 protein] PMID:16785314 14041486 BLVRB biliverdin reductase B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BLVRB mRNA PMID:35307453 14041514 INTS12 integrator complex subunit 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INTS12 mRNA PMID:35307453 14041581 AMPH amphiphysin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AMPH mRNA PMID:35307453 14041729 ZNF277 zinc finger protein 277 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF277 mRNA PMID:35307453 14041751 ZP3 zona pellucida glycoprotein 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of ZP3 mRNA PMID:26386189 14041751 ZP3 zona pellucida glycoprotein 3 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of ZP3 mRNA] PMID:26386189 14041751 ZP3 zona pellucida glycoprotein 3 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of ZP3 mRNA] PMID:26386189 14041896 BUB1 BUB1 mitotic checkpoint serine/threonine kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BUB1 mRNA PMID:35307453 14041896 BUB1 BUB1 mitotic checkpoint serine/threonine kinase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 [Quercetin co-treated with Copper Sulfate] results in increased expression of BUB1 mRNA PMID:39151877 14041896 BUB1 BUB1 mitotic checkpoint serine/threonine kinase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 [Quercetin co-treated with Copper Sulfate] results in increased expression of BUB1 mRNA PMID:39151877 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ERO1A mRNA PMID:35307453 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of ERO1A mRNA] PMID:39151877 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERO1A mRNA PMID:33891997 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of ERO1A mRNA PMID:39151877 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of ERO1A mRNA] PMID:39151877 14041929 ERO1A endoplasmic reticulum oxidoreductase 1 alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERO1A mRNA PMID:33891997 14041988 PERM1 PPARGC1 and ESRR induced regulator, muscle 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PERM1 mRNA PMID:35307453 14042125 ABHD1 abhydrolase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABHD1 mRNA PMID:35307453 14042221 IL23R interleukin 23 receptor gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IL23R mRNA PMID:34933075 14042450 HLX H2.0 like homeobox gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HLX mRNA PMID:35307453 14042521 SNCB synuclein beta gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SNCB mRNA PMID:39265697 14042587 ELFN2 extracellular leucine rich repeat and fibronectin type III domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELFN2 mRNA PMID:35307453 14042628 F12 coagulation factor XII gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of F12 mRNA PMID:35307453 14042628 F12 coagulation factor XII gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of F12 mRNA PMID:34389318 14042693 PDK4 pyruvate dehydrogenase kinase 4 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PDK4 mRNA] PMID:39151877 14042693 PDK4 pyruvate dehydrogenase kinase 4 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of PDK4 mRNA PMID:39151877 14042693 PDK4 pyruvate dehydrogenase kinase 4 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PDK4 mRNA] PMID:39151877 14042757 DCX doublecortin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DCX mRNA PMID:35307453 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230502 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPARG mRNA; deoxynivalenol results in decreased expression of PPARG protein PMID:36596350 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPARG mRNA PMID:35307453 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 [Rosiglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein; [Troglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein; PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; T 0070907 inhibits the reaction [[Rosiglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein]; T 0070907 inhibits the reaction [[Troglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein] PMID:36596350 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein] PMID:15051824 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein] PMID:31535366 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:17154 nicotinamide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009536 Niacinamide results in increased expression of PPARG mRNA PMID:17851734 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA] PMID:30481989 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:17351 linoleic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased activity of PPARG protein PMID:15051824 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 PPARG protein promotes the reaction [Linoleic Acid results in increased activity of RELA protein]; PPARG protein promotes the reaction [Linoleic Acid results in increased expression of IL6 protein]; Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]; Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein] PMID:14519784|PMID:15051824 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of PPARG mRNA PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]; Zinc results in increased expression of and results in increased activity of PPARG protein PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of PPARG mRNA; Resveratrol results in decreased expression of PPARG protein PMID:17851734|PMID:21575630 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein] PMID:21739664 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA] PMID:30481989 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of PPARG mRNA PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]; Zinc results in increased expression of and results in increased activity of PPARG protein PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein] PMID:15051824 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C019273 bisphenol A diglycidyl ether binds to and results in decreased activity of PPARG protein; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Troglitazone results in increased activity of PPARG protein] PMID:14506076|PMID:14519784|PMID:30481989 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20191114 CTD MESH:D003907 Dexamethasone results in increased expression of PPARG PMID:19852296 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA; bisphenol A diglycidyl ether inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA] PMID:30481989 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:50992 1,3-thiazolidine-2,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C089946 2,4-thiazolidinedione binds to and results in increased activity of PPARG protein PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of PPARG mRNA; Malathion results in decreased expression of PPARG protein PMID:31535366 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:6651 malathion multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008294 Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein] PMID:31535366 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:75261 arotinoid acid decreases expression EXP E RGD:6480464 20191114 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of PPARG mRNA PMID:15583048 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:8228 pioglitazone increases activity EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone results in increased activity of PPARG protein PMID:17065204 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060836 Troglitazone inhibits the reaction [Pioglitazone results in increased activity of PPARG protein] PMID:17065204 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA] PMID:14519784 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in decreased expression of PPARG mRNA; Troglitazone results in decreased expression of PPARG protein PMID:36596350 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:9753 troglitazone increases activity EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in increased activity of PPARG protein PMID:14506076 14042986 PPARG peroxisome proliferator activated receptor gamma gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 [Troglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein; bisphenol A diglycidyl ether inhibits the reaction [Troglitazone results in increased activity of PPARG protein]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]]; PPARG protein affects the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]]; T 0070907 inhibits the reaction [[Troglitazone co-treated with deoxynivalenol] results in decreased expression of PPARG protein]; Troglitazone inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA] PMID:14506076|PMID:17065204|PMID:30481989|PMID:36596350 14043058 NFKBIB NFKB inhibitor beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NFKBIB mRNA PMID:35307453 14043072 LMAN2L lectin, mannose binding 2 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMAN2L mRNA PMID:35307453 14043101 INS insulin gene CHEBI:134261 alpha-(methylamino)isobutyric acid increases uptake EXP E RGD:6480464 20191114 CTD MESH:C017911 INS protein results in increased uptake of 2-(methylamino)isobutyric acid PMID:1928324 14043101 INS insulin gene CHEBI:134261 alpha-(methylamino)isobutyric acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017911 Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in increased uptake of 2-(methylamino)isobutyric acid]]; oxophenylarsine inhibits the reaction [INS protein results in increased uptake of 2-(methylamino)isobutyric acid] PMID:1928324 14043101 INS insulin gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of INS protein PMID:9185964 14043101 INS insulin gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of INS protein] PMID:9185964 14043101 INS insulin gene CHEBI:16422 androst-4-ene-3,17-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000735 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; [LHB protein co-treated with INS protein] results in increased abundance of Androstenedione; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione] PMID:11889176 14043101 INS insulin gene CHEBI:17234 glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein results in increased transport of Glucose PMID:8048502 14043101 INS insulin gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein promotes the reaction [AZ 002 results in increased uptake of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] PMID:20622751|PMID:8048502|PMID:8699633 14043101 INS insulin gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013739 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; [LHB protein co-treated with INS protein] results in increased abundance of Testosterone; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone] PMID:11889176 14043101 INS insulin gene CHEBI:17634 D-glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein results in increased transport of Glucose PMID:8048502 14043101 INS insulin gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein promotes the reaction [AZ 002 results in increased uptake of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] PMID:20622751|PMID:8048502|PMID:8699633 14043101 INS insulin gene CHEBI:27485 prostaglandin J2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C037112 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; 9-deoxy-delta-9-prostaglandin D2 inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA] PMID:11889176 14043101 INS insulin gene CHEBI:28073 chromium atom decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002857 Chromium results in decreased expression of INS protein PMID:7628956 14043101 INS insulin gene CHEBI:42758 aldehydo-D-glucose increases transport EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein results in increased transport of Glucose PMID:8048502 14043101 INS insulin gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 INS protein promotes the reaction [AZ 002 results in increased uptake of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] PMID:20622751|PMID:8048502|PMID:8699633 14043101 INS insulin gene CHEBI:50369 tris(picolinato)chromium decreases expression EXP E RGD:6480464 20191114 CTD MESH:C079689 chromium tripicolinate results in decreased expression of INS protein PMID:7628956 14043101 INS insulin gene CHEBI:64198 dimercaprol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004112 Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in increased uptake of 2-(methylamino)isobutyric acid]] PMID:1928324 14043101 INS insulin gene CHEBI:75253 phenylarsine oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C029341 Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in increased uptake of 2-(methylamino)isobutyric acid]]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased uptake of 2-(methylamino)isobutyric acid] PMID:1928324|PMID:8048502 14043101 INS insulin gene CHEBI:9168 sirolimus decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus results in decreased expression of INS mRNA; Sirolimus results in decreased expression of INS protein PMID:20622751 14043101 INS insulin gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] PMID:20622751 14043101 INS insulin gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Androstenedione]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased abundance of Testosterone]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 mRNA]; Troglitazone inhibits the reaction [[LHB protein co-treated with INS protein] results in increased expression of CYP17A1 protein modified form] PMID:11889176 14043135 PLCD3 phospholipase C delta 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLCD3 mRNA PMID:35307453 14043181 MFSD3 major facilitator superfamily domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFSD3 mRNA PMID:35307453 14043218 CLPSL2 colipase like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLPSL2 mRNA PMID:35307453 14043276 AKT3 AKT serine/threonine kinase 3 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of AKT3 protein PMID:38432436 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDKN1A mRNA; deoxynivalenol results in decreased expression of CDKN1A protein PMID:38104654 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDKN1A mRNA PMID:35307453 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of CDKN1A protein PMID:29358327 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CDKN1A mRNA PMID:27617619 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of CDKN1A protein PMID:28819136 14043378 CDKN1A cyclin dependent kinase inhibitor 1A gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000082 Acetaminophen results in decreased expression of CDKN1A protein PMID:16330492 14043408 TOX thymocyte selection associated high mobility group box gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOX mRNA PMID:35307453 14043494 ADGRV1 adhesion G protein-coupled receptor V1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRV1 mRNA PMID:35307453 14043606 LCN2 lipocalin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LCN2 mRNA PMID:35307453 14043606 LCN2 lipocalin 2 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of LCN2 mRNA PMID:38705344 14043606 LCN2 lipocalin 2 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of LCN2 mRNA; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of LCN2 mRNA] PMID:33905761|PMID:38705344 14043606 LCN2 lipocalin 2 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 [fumonisin B1 co-treated with ochratoxin A] results in increased expression of LCN2 mRNA PMID:33905761 14043922 CEP170 centrosomal protein 170 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEP170 mRNA PMID:35307453 14044060 GZMK granzyme K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GZMK mRNA PMID:35307453 14044069 AEN apoptosis enhancing nuclease gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AEN mRNA PMID:35307453 14044077 CMTM7 CKLF like MARVEL transmembrane domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CMTM7 mRNA PMID:35307453 14044185 DES desmin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DES mRNA PMID:39265697 14044217 TMEM248 transmembrane protein 248 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM248 mRNA PMID:35307453 14044243 RBBP8NL RBBP8 N-terminal like gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RBBP8NL mRNA PMID:34933075 14044419 CTSB cathepsin B gene CHEBI:17026 progesterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased expression of CTSB mRNA PMID:20107207 14044419 CTSB cathepsin B gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of CTSB mRNA PMID:16291828 14044419 CTSB cathepsin B gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CTSB mRNA PMID:16291828 14044419 CTSB cathepsin B gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of CTSB mRNA PMID:16896063 14044626 REG3G regenerating islet-derived 3 gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REG3G mRNA PMID:35307453 14044757 SAP18 Sin3A associated protein 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SAP18 mRNA PMID:35307453 14044801 ZNHIT6 zinc finger HIT-type containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNHIT6 mRNA PMID:35307453 14044858 GCFC2 GC-rich sequence DNA-binding factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GCFC2 mRNA PMID:35307453 14044917 AKIRIN2 akirin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AKIRIN2 mRNA PMID:35307453 14044932 SLC7A4 solute carrier family 7 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC7A4 mRNA PMID:35307453 14044932 SLC7A4 solute carrier family 7 member 4 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of SLC7A4 mRNA PMID:28069986 14045003 RGS9 regulator of G protein signaling 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS9 mRNA PMID:35307453 14045078 TES testin LIM domain protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TES mRNA PMID:35307453 14045293 SH3YL1 SH3 and SYLF domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3YL1 mRNA PMID:35307453 14045384 RHBDD2 rhomboid domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHBDD2 mRNA PMID:35307453 14045548 GSTA4 glutathione S-transferase alpha 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSTA4 mRNA PMID:35307453 14045563 SOD1 superoxide dismutase 1 gene CHEBI:10022 deoxynivalenol increases activity EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased activity of SOD1 protein PMID:37442268 14045563 SOD1 superoxide dismutase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased expression of SOD1 protein PMID:38104654 14045563 SOD1 superoxide dismutase 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Selenium analog inhibits the reaction [deoxynivalenol results in increased activity of SOD1 protein] PMID:37442268 14045563 SOD1 superoxide dismutase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of SOD1 mRNA PMID:23727178 14045563 SOD1 superoxide dismutase 1 gene CHEBI:144353 diethyldithiocarbamic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004050 Ditiocarb results in decreased activity of SOD1 protein PMID:11861319 14045563 SOD1 superoxide dismutase 1 gene CHEBI:144353 diethyldithiocarbamic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004050 SOD1 protein affects the susceptibility to [Ditiocarb co-treated with 6-anilino-5,8-quinolinedione] PMID:11861319 14045563 SOD1 superoxide dismutase 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA PMID:29129240 14045563 SOD1 superoxide dismutase 1 gene CHEBI:16236 ethanol decreases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased activity of SOD1 protein PMID:16792574 14045563 SOD1 superoxide dismutase 1 gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in decreased activity of SOD1 protein PMID:16792574 14045563 SOD1 superoxide dismutase 1 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 [sodium arsenite results in increased activity of SOD1 protein] which results in increased abundance of Hydrogen Peroxide PMID:12530527 14045563 SOD1 superoxide dismutase 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20230704 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of SOD1 mRNA PMID:36549457 14045563 SOD1 superoxide dismutase 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D008070 Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD1 mRNA] PMID:36549457 14045563 SOD1 superoxide dismutase 1 gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA PMID:29129240 14045563 SOD1 superoxide dismutase 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA PMID:29129240 14045563 SOD1 superoxide dismutase 1 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased expression of SOD1 mRNA PMID:37207789 14045563 SOD1 superoxide dismutase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOD1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOD1 mRNA; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of SOD1 mRNA] PMID:33493553|PMID:34416349|PMID:37207789 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA] PMID:32280687 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27470 folic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:D005492 Folic Acid deficiency results in decreased activity of SOD1 protein PMID:16792574 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA; [Ethanol co-treated with Folic Acid deficiency] results in decreased activity of SOD1 protein PMID:16792574|PMID:29129240 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased activity of SOD1 protein] PMID:37442268 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27584 aldosterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D000450 Aldosterone results in increased expression of SOD1 protein PMID:24512358 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27744 glyphosate decreases activity EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased activity of SOD1 protein PMID:35388968 14045563 SOD1 superoxide dismutase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of SOD1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of SOD1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD1 mRNA] PMID:36549457|PMID:37955343 14045563 SOD1 superoxide dismutase 1 gene CHEBI:29678 sodium arsenite increases activity EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased activity of SOD1 protein PMID:12530527 14045563 SOD1 superoxide dismutase 1 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017947 [sodium arsenite results in increased activity of SOD1 protein] which results in increased abundance of Hydrogen Peroxide PMID:12530527 14045563 SOD1 superoxide dismutase 1 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA] PMID:32280687 14045563 SOD1 superoxide dismutase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of SOD1 mRNA PMID:29129240 14045563 SOD1 superoxide dismutase 1 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in decreased expression of SOD1 mRNA PMID:34399389|PMID:38565334 14045563 SOD1 superoxide dismutase 1 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of SOD1 mRNA PMID:36615853 14045563 SOD1 superoxide dismutase 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA]; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 protein; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA] PMID:34811946 14045563 SOD1 superoxide dismutase 1 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D019287 Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA] PMID:32280687 14045563 SOD1 superoxide dismutase 1 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SOD1 mRNA PMID:33626375 14045563 SOD1 superoxide dismutase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOD1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOD1 mRNA PMID:33493553|PMID:34416349 14045563 SOD1 superoxide dismutase 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased activity of SOD1 protein] PMID:37442268 14045563 SOD1 superoxide dismutase 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of SOD1 mRNA PMID:17437637 14045563 SOD1 superoxide dismutase 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240604 CTD MESH:C056933 fumonisin B1 results in decreased expression of SOD1 mRNA; fumonisin B1 results in decreased expression of SOD1 protein PMID:37955343 14045563 SOD1 superoxide dismutase 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of SOD1 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of SOD1 protein] PMID:37955343 14045563 SOD1 superoxide dismutase 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA] PMID:34811946 14045563 SOD1 superoxide dismutase 1 gene CHEBI:4027 cyclophosphamide decreases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in decreased expression of SOD1 mRNA PMID:37980972 14045563 SOD1 superoxide dismutase 1 gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of SOD1 mRNA] PMID:37980972 14045563 SOD1 superoxide dismutase 1 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in decreased expression of SOD1 mRNA PMID:32280687|PMID:38567716 14045563 SOD1 superoxide dismutase 1 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA]; [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA]; Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of SOD1 mRNA] PMID:32280687|PMID:38567716 14045563 SOD1 superoxide dismutase 1 gene CHEBI:7719 ochratoxin A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased activity of SOD1 protein PMID:18547704 14045563 SOD1 superoxide dismutase 1 gene CHEBI:78677 6-anilino-5,8-quinolinedione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041715 SOD1 protein affects the susceptibility to [Ditiocarb co-treated with 6-anilino-5,8-quinolinedione] PMID:11861319 14045563 SOD1 superoxide dismutase 1 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of SOD1 mRNA] PMID:37207789 14045563 SOD1 superoxide dismutase 1 gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of SOD1 mRNA] PMID:37980972 14045563 SOD1 superoxide dismutase 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of SOD1 mRNA] PMID:34811946 14045624 CCL24 C-C motif chemokine ligand 24 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL24 mRNA PMID:34416349 14045624 CCL24 C-C motif chemokine ligand 24 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL24 mRNA PMID:34416349 14045661 NOX1 NADPH oxidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOX1 mRNA PMID:35307453 14045661 NOX1 NADPH oxidase 1 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of NOX1 mRNA] PMID:37999554 14045661 NOX1 NADPH oxidase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of NOX1 mRNA PMID:37999554 14045661 NOX1 NADPH oxidase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of NOX1 mRNA] PMID:37999554 14045709 MYH3 myosin heavy chain 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYH3 mRNA PMID:35307453 14045921 ST3GAL5 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST3GAL5 mRNA PMID:35307453 14045981 GLT8D2 glycosyltransferase 8 domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLT8D2 mRNA PMID:35307453 14046212 KATNIP katanin interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KATNIP mRNA PMID:35307453 14046285 TMC1 transmembrane channel like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMC1 mRNA PMID:35307453 14046333 CCL19 C-C motif chemokine ligand 19 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCL19 mRNA PMID:18988085 14046346 DDX21 DExD-box helicase 21 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX21 mRNA PMID:35307453 14046594 ERAP2 endoplasmic reticulum aminopeptidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERAP2 mRNA PMID:35307453 14046729 POLI DNA polymerase iota gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of POLI mRNA PMID:39265697 14046846 DYNC1I1 dynein cytoplasmic 1 intermediate chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNC1I1 mRNA PMID:35307453 14046960 RLIM ring finger protein, LIM domain interacting gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RLIM mRNA PMID:35307453 14047051 NKX2-2 NK2 homeobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NKX2-2 mRNA PMID:35307453 14047160 ZNF598 zinc finger protein 598, E3 ubiquitin ligase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF598 mRNA PMID:35307453 14047280 GATA6 GATA binding protein 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GATA6 mRNA PMID:35307453 14047306 CEP72 centrosomal protein 72 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP72 mRNA PMID:35307453 14047361 MYPOP Myb related transcription factor, partner of profilin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYPOP mRNA PMID:35307453 14047372 PYROXD1 pyridine nucleotide-disulphide oxidoreductase domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PYROXD1 mRNA PMID:35307453 14047424 STX10 syntaxin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STX10 mRNA PMID:35307453 14047441 DAD1 defender against cell death 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of DAD1 mRNA PMID:14994279 14047448 CYSRT1 cysteine rich tail 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYSRT1 mRNA PMID:35307453 14047481 CTSH cathepsin H gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSH mRNA PMID:35307453 14047686 FOXA2 forkhead box A2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOXA2 mRNA PMID:35307453 14047786 OSMR oncostatin M receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OSMR mRNA PMID:35307453 14047858 ANP32E acidic nuclear phosphoprotein 32 family member E gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of ANP32E protein PMID:37257635 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of DICER1 mRNA; bisphenol A results in decreased expression of DICER1 protein PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in decreased expression of DICER1 protein]; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with bisphenol A] results in decreased expression of DICER1 mRNA PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of DICER1 mRNA; tetrabromobisphenol A results in decreased expression of DICER1 protein PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrabromobisphenol A] results in decreased expression of DICER1 mRNA; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrabromobisphenol A] results in decreased expression of DICER1 protein PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:35004 Tetrachlorobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in decreased expression of DICER1 mRNA PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:35004 Tetrachlorobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in increased expression of DICER1 protein PMID:31266599 14047912 DICER1 dicer 1, ribonuclease III gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrachlorodian] results in decreased expression of DICER1 mRNA; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrachlorodian] results in increased expression of DICER1 protein PMID:31266599 14048037 KCNIP2 potassium voltage-gated channel interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNIP2 mRNA PMID:35307453 14048072 PPP1R12A protein phosphatase 1 regulatory subunit 12A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R12A mRNA PMID:35307453 14048173 BMPER BMP binding endothelial regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BMPER mRNA PMID:35307453 14048348 DDX50 DExD-box helicase 50 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX50 mRNA PMID:35307453 14048391 ASRGL1 asparaginase and isoaspartyl peptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASRGL1 mRNA PMID:35307453 14048391 ASRGL1 asparaginase and isoaspartyl peptidase 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ASRGL1 mRNA PMID:34389318 14048406 CIB2 calcium and integrin binding family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CIB2 mRNA PMID:35307453 14048414 SLC25A30 solute carrier family 25 member 30 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SLC25A30 mRNA PMID:39265697 14048438 UROC1 urocanate hydratase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UROC1 mRNA PMID:35307453 14048634 NEFH neurofilament heavy chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEFH mRNA PMID:35307453 14048634 NEFH neurofilament heavy chain gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of NEFH mRNA PMID:35839969 14048673 HK2 hexokinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HK2 mRNA PMID:35307453 14048673 HK2 hexokinase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of HK2 mRNA] PMID:39151877 14048673 HK2 hexokinase 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HK2 mRNA PMID:34416349 14048673 HK2 hexokinase 2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of HK2 mRNA PMID:39151877 14048673 HK2 hexokinase 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of HK2 mRNA] PMID:39151877 14048673 HK2 hexokinase 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HK2 mRNA PMID:34416349 14048673 HK2 hexokinase 2 gene CHEBI:4670 dobutamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004280 Dobutamine results in decreased expression of HK2 protein PMID:19944370 14048695 COX5B mitochondrial cytochrome c oxidase subunit Vb gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX5B mRNA; graphene oxide results in decreased expression of COX5B protein PMID:39265697 14048703 PPBP pro-platelet basic protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPBP mRNA PMID:35307453 14048703 PPBP pro-platelet basic protein gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PPBP mRNA PMID:21852083 14048722 PRRT3 proline rich transmembrane protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRRT3 mRNA PMID:35307453 14048761 HSPA6 heat shock protein family A (Hsp70) member 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA6 mRNA PMID:35307453 14048761 HSPA6 heat shock protein family A (Hsp70) member 6 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20250401 CTD MESH:D002104 Cadmium results in increased expression of HSP70 protein PMID:12915104|PMID:16759985 14048761 HSPA6 heat shock protein family A (Hsp70) member 6 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20250401 CTD MESH:D019287 Zinc Sulfate results in increased expression of HSP70 mRNA PMID:23274768 14048761 HSPA6 heat shock protein family A (Hsp70) member 6 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20250401 CTD MESH:D019256 Cadmium Chloride results in increased expression of HSP70 protein PMID:16759985 14048761 HSPA6 heat shock protein family A (Hsp70) member 6 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20250401 CTD MESH:D002738 Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of HSP70 protein] PMID:17727805 14048775 CPM carboxypeptidase M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CPM mRNA PMID:35307453 14048794 TNS1 tensin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TNS1 mRNA PMID:34933075 14048832 HTR2B 5-hydroxytryptamine receptor 2B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HTR2B mRNA PMID:35307453 14048849 C17H20orf173 chromosome 17 C20orf173 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C17H20ORF173 mRNA PMID:35307453 14048916 ISCU iron-sulfur cluster assembly enzyme gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ISCU mRNA; deoxynivalenol results in decreased expression of ISCU protein PMID:38403181 14048925 IQCD IQ motif containing D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQCD mRNA PMID:35307453 14048970 AMN1 antagonist of mitotic exit network 1 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AMN1 mRNA PMID:35307453 14049014 ACSM2B acyl-CoA synthetase medium chain family member 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACSM2B mRNA PMID:35307453 14049297 LTBP3 latent transforming growth factor beta binding protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LTBP3 mRNA PMID:35307453 14049354 TNIP3 TNFAIP3 interacting protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNIP3 mRNA PMID:35307453 14049390 PIGR polymeric immunoglobulin receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIGR mRNA PMID:35307453 14049434 SLC43A2 solute carrier family 43 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC43A2 mRNA PMID:35307453 14049518 SUOX sulfite oxidase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SUOX mRNA PMID:35307453 14049537 SLC6A6 solute carrier family 6 member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC6A6 mRNA PMID:35307453 14049592 SETDB1 SET domain bifurcated histone lysine methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of SETDB1 mRNA PMID:26988607 14049648 PKNOX2 PBX/knotted 1 homeobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKNOX2 mRNA PMID:35307453 14049682 GSS glutathione synthetase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GSS mRNA PMID:35307453 14049682 GSS glutathione synthetase gene CHEBI:16236 ethanol increases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased activity of GSS protein PMID:16792574 14049682 GSS glutathione synthetase gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of GSS mRNA PMID:16792574 14049682 GSS glutathione synthetase gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSS protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSS mRNA PMID:16792574 14049682 GSS glutathione synthetase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSS protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSS mRNA PMID:16792574 14049797 NRP2 neuropilin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRP2 mRNA PMID:35307453 14049797 NRP2 neuropilin 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of NRP2 mRNA PMID:39265697 14049829 TMEM98 transmembrane protein 98 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of TMEM98 mRNA PMID:28069986 14049847 SLC9B1 solute carrier family 9 member B1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC9B1 mRNA PMID:35307453 14049869 RAB2B RAB2B, member RAS oncogene family gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAB2B mRNA PMID:35307453 14049884 ERC2 ELKS/RAB6-interacting/CAST family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ERC2 mRNA PMID:35307453 14050448 TEX10 testis expressed 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TEX10 mRNA PMID:35307453 14050467 PRXL2B peroxiredoxin like 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRXL2B mRNA PMID:35307453 14050467 PRXL2B peroxiredoxin like 2B gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PRXL2B mRNA PMID:39265697 14050487 SP110 SP110 nuclear body protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of SP110 mRNA; deoxynivalenol results in decreased expression of SP110 protein PMID:38403181 14050649 ZBP1 Z-DNA binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBP1 mRNA PMID:35307453 14050710 FYN FYN proto-oncogene, Src family tyrosine kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FYN mRNA PMID:35307453 14050758 MFF mitochondrial fission factor gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MFF mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MFF protein PMID:33493553 14050758 MFF mitochondrial fission factor gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MFF mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MFF protein PMID:33493553 14050836 KMT2A lysine methyltransferase 2A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KMT2A mRNA PMID:35307453 14050902 FUBP1 far upstream element binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FUBP1 mRNA PMID:35307453 14051022 DNAAF9 dynein axonemal assembly factor 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAAF9 mRNA PMID:35307453 14051071 ZNF783 zinc finger protein 783 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF783 mRNA PMID:35307453 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTGS2 mRNA PMID:35307453 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of PTGS2 mRNA PMID:23727178 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of PTGS2 mRNA PMID:23727178 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:15365 acetylsalicylic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001241 Aspirin promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] PMID:10706128 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005998 [Folic Acid co-treated with Glycine] results in increased expression of PTGS2 PMID:14662146 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:15551 prostaglandin E2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015232 [Polychlorinated Biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; alpha-Linolenic Acid inhibits the reaction [[Polychlorinated Biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Linoleic Acid promotes the reaction [[Polychlorinated Biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Polychlorinated Biphenyls promotes the reaction [[Linoleic Acid results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Resveratrol inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] PMID:18155686|PMID:20825639 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [epostane co-treated with Dinoprost] results in increased expression of PTGS2 mRNA PMID:20739670 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in decreased expression of PTGS2 mRNA] PMID:36281498 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16112 chlorogenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002726 Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] PMID:27861533 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PTGS2 mRNA] PMID:39151877 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of PTGS2 mRNA PMID:26180592|PMID:27861533 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] PMID:26180592|PMID:27861533 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of PTGS2 mRNA PMID:21705055 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Fulvestrant inhibits the reaction [Estradiol results in increased expression of PTGS2 mRNA] PMID:21705055 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of PTGS2 protein PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of PTGS2 protein] PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17351 linoleic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased expression of PTGS2 mRNA PMID:18155686 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid promotes the reaction [[Polychlorinated Biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Linoleic Acid promotes the reaction [Polychlorinated Biphenyls results in increased expression of PTGS2 mRNA]; Linoleic Acid promotes the reaction [Polychlorinated Biphenyls results in increased expression of PTGS2 protein]; Polychlorinated Biphenyls promotes the reaction [[Linoleic Acid results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; prolinedithiocarbamate inhibits the reaction [[Linoleic Acid co-treated with Polychlorinated Biphenyls] results in increased expression of PTGS2 mRNA]; prolinedithiocarbamate inhibits the reaction [Linoleic Acid results in increased expression of PTGS2 mRNA] PMID:18155686 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:174984 3',4',5'-Trimethoxyflavone multiple interactions EXP E RGD:6480464 20210706 CTD MESH:C441202 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] PMID:26180592 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of PTGS2 protein PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of PTGS2 protein] PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:18388 apigenin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D047310 Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] PMID:26180592 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:22977 cadmium atom decreases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in decreased expression of PTGS2 mRNA PMID:37207789 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PTGS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PTGS2 protein; ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTGS2 mRNA] PMID:33592257|PMID:37207789 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] PMID:35134483 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of PTGS2 mRNA PMID:39151877 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of PTGS2 mRNA] PMID:39151877 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:27432 alpha-linolenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017962 alpha-Linolenic Acid inhibits the reaction [[Polychlorinated Biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; alpha-Linolenic Acid inhibits the reaction [Polychlorinated Biphenyls results in increased expression of PTGS2 mRNA]; alpha-Linolenic Acid inhibits the reaction [Polychlorinated Biphenyls results in increased expression of PTGS2 protein] PMID:18155686 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [Folic Acid co-treated with Glycine] results in increased expression of PTGS2 PMID:14662146 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of PTGS2 protein PMID:20825639 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of PTGS2 mRNA; Resveratrol inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] PMID:20825639|PMID:21852083 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of PTGS2 mRNA] PMID:36281498 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:3077 betamethasone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001623 Betamethasone results in decreased expression of PTGS2 protein PMID:11698254 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:31638 fulvestrant multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070081 Fulvestrant inhibits the reaction [Estradiol results in increased expression of PTGS2 mRNA] PMID:21705055 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20241105 CTD MESH:C006780 bisphenol A results in decreased expression of PTGS2 mRNA PMID:38845341 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20241105 CTD MESH:C006780 ursodoxicoltaurine inhibits the reaction [bisphenol A results in decreased expression of PTGS2 mRNA] PMID:38845341 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of PTGS2 mRNA PMID:38565334 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of PTGS2 mRNA; Cadmium Chloride results in increased expression of PTGS2 protein PMID:33626375 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PTGS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PTGS2 protein PMID:33592257 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of PTGS2 protein PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 Kangen-karyu inhibits the reaction [Glucose results in increased expression of PTGS2 protein] PMID:16949779 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 mRNA] PMID:18845708 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of PTGS2 mRNA PMID:36281498 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of PTGS2 mRNA]; Taurine inhibits the reaction [ochratoxin A results in decreased expression of PTGS2 mRNA] PMID:36281498 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:8062 phenethyl caffeate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C055494 caffeic acid phenethyl ester inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 protein] PMID:18845708 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in decreased expression of PTGS2 mRNA]; ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTGS2 mRNA] PMID:37207789|PMID:38845341 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 protein PMID:18845708 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 caffeic acid phenethyl ester inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of PTGS2 mRNA] PMID:18845708 14051082 PTGS2 prostaglandin-endoperoxide synthase 2 gene CHEBI:9352 sulindac multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013467 Sulindac promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] PMID:10706128 14051156 EXTL2 exostosin like glycosyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EXTL2 mRNA PMID:35307453 14051226 SMTN smoothelin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMTN mRNA PMID:35307453 14051251 NTNG2 netrin G2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NTNG2 mRNA PMID:35307453 14051263 PELP1 proline, glutamate and leucine rich protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PELP1 mRNA PMID:35307453 14051357 ANAPC10 anaphase promoting complex subunit 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANAPC10 mRNA PMID:35307453 14051433 SINHCAF SIN3-HDAC complex associated factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SINHCAF mRNA PMID:35307453 14051461 VWA3A von Willebrand factor A domain containing 3A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VWA3A mRNA PMID:35307453 14051510 EEF1A1 eukaryotic translation elongation factor 1 alpha 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EEF1A1 mRNA] PMID:21852083 14051568 CARTPT CART prepropeptide gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of CARTPT protein PMID:29577965 14051568 CARTPT CART prepropeptide gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of CARTPT protein PMID:29558425|PMID:29569701|PMID:29888781|PMID:38069115 14051578 PACRG parkin coregulated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PACRG mRNA PMID:35307453 14051588 NR1I3 nuclear receptor subfamily 1 group I member 3 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in increased expression of NR1I3 mRNA] PMID:36615853 14051588 NR1I3 nuclear receptor subfamily 1 group I member 3 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of NR1I3 mRNA PMID:36615853 14051588 NR1I3 nuclear receptor subfamily 1 group I member 3 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in increased expression of NR1I3 mRNA] PMID:36615853 14051617 EIF4A3 eukaryotic translation initiation factor 4A3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4A3 mRNA PMID:35307453 14051748 DDX1 DEAD-box helicase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX1 mRNA PMID:35307453 14051810 CXCL2 chemokine (C-X-C motif) ligand 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CXCL2 mRNA PMID:35307453 14051810 CXCL2 chemokine (C-X-C motif) ligand 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CXCL2 mRNA PMID:39265697 14051810 CXCL2 chemokine (C-X-C motif) ligand 2 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20210803 CTD MESH:D015237 Dinoprost results in increased expression of CXCL2 mRNA PMID:21505051 14051810 CXCL2 chemokine (C-X-C motif) ligand 2 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D015237 [Dinoprost co-treated with epostane] results in increased expression of CXCL2 mRNA PMID:21505051 14051810 CXCL2 chemokine (C-X-C motif) ligand 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20210803 CTD MESH:D009151 Mustard Gas results in increased expression of CXCL2 mRNA PMID:18988085 14051818 AHR aryl hydrocarbon receptor gene CHEBI:10022 deoxynivalenol affects localization EXP E RGD:6480464 20240430 CTD MESH:C007262 deoxynivalenol affects the localization of AHR protein PMID:35381244 14051818 AHR aryl hydrocarbon receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240430 CTD MESH:C007262 deoxynivalenol results in increased expression of AHR mRNA PMID:35381244 14051818 AHR aryl hydrocarbon receptor gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C007262 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol affects the localization of AHR protein]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR mRNA] PMID:35381244 14051818 AHR aryl hydrocarbon receptor gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl affects the localization of and results in increased activity of AHR protein; [alpha-naphthoflavone co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased activity of AHR protein; epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl affects the localization of and results in increased activity of AHR protein]; epigallocatechin gallate inhibits the reaction [[alpha-naphthoflavone co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased activity of AHR protein]; Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl affects the localization of and results in increased activity of AHR protein] PMID:12970578 14051818 AHR aryl hydrocarbon receptor gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl affects the localization of and results in increased activity of AHR protein] PMID:12970578 14051818 AHR aryl hydrocarbon receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects localization EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the localization of AHR protein PMID:16431846 14051818 AHR aryl hydrocarbon receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of AHR mRNA PMID:16431846 14051818 AHR aryl hydrocarbon receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of AHR protein PMID:16552988 14051818 AHR aryl hydrocarbon receptor gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ARNT mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol affects the localization of AHR protein]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR mRNA] PMID:35381244 14051818 AHR aryl hydrocarbon receptor gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases activity EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of AHR protein PMID:22521609 14051818 AHR aryl hydrocarbon receptor gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AHR protein PMID:16552988 14051818 AHR aryl hydrocarbon receptor gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of AHR protein] PMID:22521609 14051818 AHR aryl hydrocarbon receptor gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl affects the localization of and results in increased activity of AHR protein]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of AHR protein]; epigallocatechin gallate inhibits the reaction [[alpha-naphthoflavone co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased activity of AHR protein]; epigallocatechin gallate inhibits the reaction [alpha-naphthoflavone results in increased activity of AHR protein] PMID:12970578|PMID:22521609 14051818 AHR aryl hydrocarbon receptor gene CHEBI:76995 alpha-naphthoflavone increases activity EXP E RGD:6480464 20191114 CTD MESH:C011512 alpha-naphthoflavone results in increased activity of AHR protein PMID:12970578 14051818 AHR aryl hydrocarbon receptor gene CHEBI:76995 alpha-naphthoflavone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C011512 [alpha-naphthoflavone co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased activity of AHR protein; epigallocatechin gallate inhibits the reaction [[alpha-naphthoflavone co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased activity of AHR protein]; epigallocatechin gallate inhibits the reaction [alpha-naphthoflavone results in increased activity of AHR protein] PMID:12970578 14051870 RFX1 regulatory factor X1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RFX1 mRNA PMID:35307453 14051906 CD40LG CD40 ligand gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of CD40LG protein PMID:15964915 14051932 SLC23A1 solute carrier family 23 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC23A1 mRNA PMID:35307453 14051970 VAMP9 vesicle associated membrane protein 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of VAMP9 mRNA PMID:35307453 14052144 EPHX1 epoxide hydrolase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPHX1 mRNA PMID:35307453 14052161 SLC17A4 solute carrier family 17 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC17A4 mRNA PMID:35307453 14052217 HSPB8 heat shock protein family B (small) member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPB8 mRNA PMID:35307453 14052417 NELFA negative elongation factor complex member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NELFA mRNA PMID:35307453 14052488 KDM4B lysine demethylase 4B gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of KDM4B mRNA PMID:39265697 14052537 EXOC6B exocyst complex component 6B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOC6B mRNA PMID:35307453 14052564 ZBED9 zinc finger BED-type containing 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231205 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBED9 mRNA PMID:35307453 14052650 RAB27B RAB27B, member RAS oncogene family gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of RAB27B mRNA PMID:21852083 14052681 DUSP11 dual specificity phosphatase 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP11 mRNA; deoxynivalenol results in increased expression of DUSP11 protein PMID:38403181 14052723 LZTS3 leucine zipper tumor suppressor family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LZTS3 mRNA PMID:35307453 14052743 ATP13A3 ATPase 13A3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP13A3 mRNA PMID:35307453 14052877 GGT1 gamma-glutamyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of GGT1 mRNA PMID:35307453 14052877 GGT1 gamma-glutamyltransferase 1 gene CHEBI:30621 diarsenic trioxide increases activity EXP E RGD:6480464 20250715 CTD MESH:C006632 Arsenic Trioxide results in increased activity of GGT1 protein PMID:18801422 14052877 GGT1 gamma-glutamyltransferase 1 gene CHEBI:30621 diarsenic trioxide increases expression EXP E RGD:6480464 20250715 CTD MESH:C006632 Arsenic Trioxide results in increased expression of GGT1 mRNA PMID:18801422 14052877 GGT1 gamma-glutamyltransferase 1 gene CHEBI:49900 arsenous acid increases activity EXP E RGD:6480464 20250715 CTD MESH:C032793 Arsenic Trioxide results in increased activity of GGT1 protein PMID:18801422 14052877 GGT1 gamma-glutamyltransferase 1 gene CHEBI:49900 arsenous acid increases expression EXP E RGD:6480464 20250715 CTD MESH:C032793 Arsenic Trioxide results in increased expression of GGT1 mRNA PMID:18801422 14052914 SLC1A2 solute carrier family 1 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC1A2 mRNA PMID:35307453 14053032 B4GAT1 beta-1,4-glucuronyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of B4GAT1 mRNA; deoxynivalenol results in decreased expression of B4GAT1 protein PMID:38403181 14053111 EEF2 eukaryotic translation elongation factor 2 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of EEF2 mRNA PMID:28069986 14053133 PGGHG protein-glucosylgalactosylhydroxylysine glucosidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PGGHG mRNA PMID:35307453 14053209 PTPN21 protein tyrosine phosphatase non-receptor type 21 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN21 mRNA PMID:35307453 14053256 YIPF1 Yip1 domain family member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YIPF1 mRNA PMID:35307453 14053408 CSNK2B casein kinase 2 beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSNK2B mRNA PMID:35307453 14053428 SDAD1 SDA1 domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDAD1 mRNA PMID:35307453 14053547 ERP29 endoplasmic reticulum protein 29 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERP29 mRNA PMID:35307453 14053670 DMC1 DNA meiotic recombinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DMC1 mRNA PMID:35307453 14053692 ACKR3 atypical chemokine receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACKR3 mRNA PMID:35307453 14053706 ANO9 anoctamin 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANO9 mRNA PMID:35307453 14053732 ADRM1 ADRM1 26S proteasome ubiquitin receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADRM1 mRNA PMID:35307453 14053752 CCDC160 coiled-coil domain containing 160 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC160 mRNA PMID:35307453 14053971 KLHL13 kelch like family member 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHL13 mRNA PMID:35307453 14054063 MET MET proto-oncogene, receptor tyrosine kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MET mRNA PMID:35307453 14054137 GPR15 G protein-coupled receptor 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPR15 mRNA PMID:35307453 14054182 BIRC6 baculoviral IAP repeat containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BIRC6 mRNA PMID:35307453 14054182 BIRC6 baculoviral IAP repeat containing 6 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of BIRC6 mRNA PMID:18988085 14054346 PLA2G4D phospholipase A2 group IVD gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLA2G4D mRNA PMID:35307453 14054467 SLC3A1 solute carrier family 3 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC3A1 mRNA PMID:35307453 14054467 SLC3A1 solute carrier family 3 member 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SLC3A1 mRNA PMID:39265697 14054578 HDC histidine decarboxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HDC mRNA PMID:35307453 14054636 DUOX1 dual oxidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUOX1 mRNA PMID:35307453 14054673 GCH1 GTP cyclohydrolase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GCH1 mRNA PMID:35307453 14054689 MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTHFD2 mRNA; deoxynivalenol results in decreased expression of MTHFD2 protein PMID:38403181 14054752 NPM1 nucleophosmin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NPM1 mRNA PMID:35307453 14054752 NPM1 nucleophosmin 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of NPM1 mRNA PMID:14994279 14054839 CCDC69 coiled-coil domain containing 69 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC69 mRNA PMID:35307453 14054868 LOC100517372 cytochrome b561 domain-containing protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYB561D2 mRNA PMID:35307453 14054973 SRGN serglycin gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of SRGN mRNA PMID:28069986 14055064 CAPN2 calpain 2 gene CHEBI:28869 menadione increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased cleavage of CAPN2 protein PMID:16920763 14055064 CAPN2 calpain 2 gene CHEBI:28869 menadione increases expression EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased expression of CAPN2 protein PMID:16920763 14055064 CAPN2 calpain 2 gene CHEBI:64090 tert-butyl hydroperoxide increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased cleavage of CAPN2 protein PMID:16920763 14055064 CAPN2 calpain 2 gene CHEBI:64090 tert-butyl hydroperoxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of CAPN2 protein PMID:16920763 14055212 CDH16 cadherin 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH16 mRNA PMID:35307453 14055238 NRBP2 nuclear receptor binding protein 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NRBP2 mRNA PMID:34933075 14055387 COX7A1 cytochrome c oxidase subunit 7A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COX7A1 mRNA PMID:35307453 14055387 COX7A1 cytochrome c oxidase subunit 7A1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX7A1 mRNA PMID:39265697 14055387 COX7A1 cytochrome c oxidase subunit 7A1 gene CHEBI:16796 melatonin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in decreased expression of COX7A1 mRNA PMID:38848930 14055387 COX7A1 cytochrome c oxidase subunit 7A1 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in decreased expression of COX7A1 mRNA PMID:38848930 14055387 COX7A1 cytochrome c oxidase subunit 7A1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in increased expression of COX7A1 mRNA PMID:38848930 14055434 LGALS3 galectin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LGALS3 mRNA PMID:35307453 14055467 FCF1 FCF1 rRNA-processing protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FCF1 mRNA PMID:35307453 14055490 HPN hepsin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HPN mRNA PMID:35307453 14055518 GSC2 goosecoid homeobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSC2 mRNA PMID:35307453 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCLM mRNA PMID:35307453 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone affects the expression of GCLM mRNA; Zearalenone affects the expression of GCLM protein PMID:31760079 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone results in increased expression of GCLM mRNA PMID:31760079 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GCLM mRNA] PMID:39151877 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in increased expression of GCLM mRNA PMID:36615853 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in increased expression of GCLM mRNA] PMID:37999554 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCLM mRNA PMID:33493553 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of GCLM mRNA PMID:39151877 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of GCLM mRNA] PMID:39151877 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of GCLM mRNA PMID:31677563|PMID:35388968 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of GCLM mRNA PMID:37999554 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in increased expression of GCLM mRNA] PMID:37999554 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in increased expression of GCLM mRNA PMID:36615853 14055570 GCLM glutamate-cysteine ligase modifier subunit gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCLM mRNA PMID:33493553 14055627 MFN2 mitofusin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFN2 mRNA; deoxynivalenol results in decreased expression of MFN2 protein PMID:32302720|PMID:35307453 14055627 MFN2 mitofusin 2 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 protein] PMID:35839969 14055627 MFN2 mitofusin 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN2 protein PMID:33493553|PMID:33592257 14055627 MFN2 mitofusin 2 gene CHEBI:25442 mycotoxin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in decreased expression of MFN2 mRNA; Mycotoxins results in decreased expression of MFN2 protein PMID:39137830 14055627 MFN2 mitofusin 2 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of MFN2 mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of MFN2 protein] PMID:39137830 14055627 MFN2 mitofusin 2 gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of MFN2 protein] PMID:23347876 14055627 MFN2 mitofusin 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MFN2 protein PMID:33493553|PMID:33592257 14055627 MFN2 mitofusin 2 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of MFN2 mRNA PMID:38705344 14055627 MFN2 mitofusin 2 gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in decreased expression of MFN2 protein PMID:23347876 14055627 MFN2 mitofusin 2 gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of MFN2 protein] PMID:23347876 14055627 MFN2 mitofusin 2 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of MFN2 mRNA; monobutyl phthalate results in decreased expression of MFN2 protein PMID:35839969 14055627 MFN2 mitofusin 2 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 protein] PMID:35839969 14055892 HSPA14 heat shock protein family A (Hsp70) member 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA14 mRNA PMID:35307453 14055892 HSPA14 heat shock protein family A (Hsp70) member 14 gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20220614 CTD MESH:D008070 Lipopolysaccharides affects the expression of HSPA14 mRNA PMID:21645290 14055946 CASTOR2 cytosolic arginine sensor for mTORC1 subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CASTOR2 mRNA PMID:35307453 14056086 ASF1A anti-silencing function 1A histone chaperone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ASF1A mRNA PMID:35307453 14056086 ASF1A anti-silencing function 1A histone chaperone gene CHEBI:15428 glycine increases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in increased expression of ASF1A mRNA PMID:39127149 14056086 ASF1A anti-silencing function 1A histone chaperone gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in decreased expression of ASF1A mRNA PMID:39127149 14056301 TNN tenascin N gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNN mRNA PMID:35307453 14056384 AIMP2 aminoacyl tRNA synthetase complex interacting multifunctional protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AIMP2 mRNA PMID:35307453 14056549 MAT2B methionine adenosyltransferase 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAT2B mRNA PMID:35307453 14056565 SNED1 sushi, nidogen and EGF like domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNED1 mRNA PMID:35307453 14056565 SNED1 sushi, nidogen and EGF like domains 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SNED1 mRNA PMID:34933075 14056650 TTI2 TELO2 interacting protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTI2 mRNA PMID:35307453 14056741 CEP250 centrosomal protein 250 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP250 mRNA PMID:35307453 14056856 THSD4 thrombospondin type 1 domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of THSD4 mRNA; deoxynivalenol results in decreased expression of THSD4 protein PMID:38403181 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] PMID:23688591|PMID:30708112 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CCL2 mRNA; Zearalenone results in increased expression of CCL2 protein PMID:23688591|PMID:29758222 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CCL2 mRNA PMID:39265697 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA PMID:19265715|PMID:21130106 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases secretion EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased secretion of CCL2 protein PMID:19265715 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 [2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; [2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]; [2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; [2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]; Acetylcysteine inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]]; sulforaphane inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; Tretinoin promotes the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein] PMID:19265715|PMID:21130106 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014212 Tretinoin promotes the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein] PMID:21130106 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCL2 mRNA PMID:21505051 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [Dinoprost co-treated with epostane] results in increased expression of CCL2 mRNA PMID:21505051 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] PMID:30708112 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL2 mRNA PMID:34416349 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCL2 mRNA PMID:18988085|PMID:27617619 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:2781 apocynin decreases expression EXP E RGD:6480464 20191114 CTD MESH:C056165 acetovanillone results in decreased expression of CCL2 mRNA PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:2781 apocynin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056165 acetovanillone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] PMID:21852083 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA PMID:19265715 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA] PMID:19265715 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of CCL2 mRNA PMID:22533443 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:32234 titanium dioxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased expression of CCL2 mRNA PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:32234 titanium dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009495 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; acetovanillone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; prolinedithiocarbamate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein PMID:19265715|PMID:22521609 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]; NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA] PMID:19265715|PMID:22521609 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL2 mRNA PMID:34416349 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in decreased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 metabolite results in increased expression of CCL2 mRNA; fumonisin B1 results in increased expression of CCL2 mRNA PMID:30708112 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] PMID:23688591|PMID:30708112 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA] PMID:21130106 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:4806 (-)-epigallocatechin 3-gallate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in decreased expression of CCL2 mRNA PMID:22521609 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]; epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA]; epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; HMOX1 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] PMID:20580034|PMID:22521609|PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:50985 sodium borohydride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025364 sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]] PMID:21130106 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:65329 LY294002 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CCL2 mRNA PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of CCL2 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA PMID:23688591 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:76995 alpha-naphthoflavone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C011512 alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA] PMID:19265715 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of CCL2 mRNA PMID:21176401|PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] PMID:19265715|PMID:23380242 14056892 CCL2 chemokine (C-C motif) ligand 2 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C093642 SB 203580 inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] PMID:19265715|PMID:23380242 14056985 UBQLN1 ubiquilin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBQLN1 mRNA PMID:35307453 14057022 TAP1 transporter 1, ATP binding cassette subfamily B member gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of TAP1 mRNA PMID:22497863 14057044 PPP1R3B protein phosphatase 1 regulatory subunit 3B gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PPP1R3B mRNA PMID:21852083 14057092 ADRA1B adrenoceptor alpha 1B gene CHEBI:8093 phenylephrine increases activity EXP E RGD:6480464 20191114 CTD MESH:D010656 Phenylephrine results in increased activity of ADRA1B protein PMID:19376108 14057153 RUVBL2 RuvB like AAA ATPase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUVBL2 mRNA PMID:35307453 14057266 THNSL2 threonine synthase like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THNSL2 mRNA PMID:35307453 14057338 COQ8A coenzyme Q8A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COQ8A mRNA PMID:35307453 14057338 COQ8A coenzyme Q8A gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COQ8A mRNA PMID:39265697 14057368 TMEM138 transmembrane protein 138 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM138 mRNA PMID:35307453 14057442 ELMOD3 ELMO domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ELMOD3 mRNA PMID:35307453 14057482 MPP2 MAGUK p55 scaffold protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPP2 mRNA PMID:35307453 14057524 SPATA6L spermatogenesis associated 6 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPATA6L mRNA PMID:35307453 14057707 NFATC1 nuclear factor of activated T cells 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NFATC1 mRNA PMID:35307453 14057736 PTCD2 pentatricopeptide repeat domain 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTCD2 mRNA PMID:35307453 14057859 AZIN2 antizyme inhibitor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AZIN2 mRNA PMID:35307453 14057902 E2F8 E2F transcription factor 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of E2F8 mRNA PMID:35307453 14057928 RAPGEF3 Rap guanine nucleotide exchange factor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAPGEF3 mRNA PMID:35307453 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GJA1 mRNA PMID:35307453 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of GJA1 mRNA PMID:26386189 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GJA1 mRNA] PMID:21852083 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:27915 melamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C011907 melamine results in decreased expression of GJA1 protein PMID:30055240 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20210504 CTD MESH:D004317 Doxorubicin results in decreased expression of GJA1 protein PMID:32877659 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in increased expression of GJA1 mRNA; Chlorpyrifos results in increased expression of GJA1 protein PMID:38565334 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:38940 sunitinib decreases expression EXP E RGD:6480464 20210504 CTD MESH:C473478 Sunitinib results in decreased expression of GJA1 protein PMID:32877659 14058191 GJA1 gap junction protein alpha 1 gene CHEBI:5132 flutamide affects expression EXP E RGD:6480464 20191114 CTD MESH:D005485 Flutamide affects the expression of GJA1 mRNA PMID:20961722 14058197 CADPS calcium dependent secretion activator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CADPS mRNA PMID:35307453 14058358 EVPL envoplakin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EVPL mRNA PMID:35307453 14058384 ODC1 ornithine decarboxylase 1 gene CHEBI:6980 monocrotaline increases activity EXP E RGD:6480464 20230307 CTD MESH:D016686 Monocrotaline results in increased activity of ODC1 protein PMID:9812344 14058384 ODC1 ornithine decarboxylase 1 gene CHEBI:6980 monocrotaline increases expression EXP E RGD:6480464 20230307 CTD MESH:D016686 Monocrotaline results in increased expression of ODC1 mRNA PMID:9812344 14058405 ART3 ADP-ribosyltransferase 3 (inactive) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ART3 mRNA PMID:35307453 14058508 MYO5C myosin VC gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO5C mRNA PMID:35307453 14058592 PHF21B PHD finger protein 21B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHF21B mRNA PMID:35307453 14058631 TJP3 tight junction protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TJP3 mRNA PMID:35307453 14058631 TJP3 tight junction protein 3 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of TJP3 protein PMID:37659622 14058631 TJP3 tight junction protein 3 gene CHEBI:33709 amino acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000596 Amino Acids inhibits the reaction [Diquat results in decreased expression of TJP3 protein] PMID:26338884 14058631 TJP3 tight junction protein 3 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in decreased expression of TJP3 protein PMID:26338884 14058631 TJP3 tight junction protein 3 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004178 Amino Acids inhibits the reaction [Diquat results in decreased expression of TJP3 protein] PMID:26338884 14058742 SLAMF9 SLAM family member 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLAMF9 mRNA PMID:35307453 14059097 RGS3 regulator of G protein signaling 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS3 mRNA PMID:35307453 14059170 COQ10A coenzyme Q10A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COQ10A mRNA PMID:35307453 14059238 NCKIPSD NCK interacting protein with SH3 domain gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NCKIPSD mRNA PMID:35307453 14059317 SCRN3 secernin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of SCRN3 mRNA; deoxynivalenol results in increased expression of SCRN3 protein PMID:38403181 14059424 LYPD3 LY6/PLAUR domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LYPD3 mRNA PMID:35307453 14059501 MDK midkine gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MDK mRNA PMID:35307453 14059501 MDK midkine gene CHEBI:18376 dermatan sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D003871 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein PMID:14699094 14059501 MDK midkine gene CHEBI:37397 chondroitin sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D002809 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein PMID:14699094 14059522 GPC3 glypican 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPC3 mRNA PMID:35307453 14059582 IFT27 intraflagellar transport 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT27 mRNA PMID:35307453 14059819 SOX2 SRY-box transcription factor 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of SOX2 mRNA PMID:28819136 14059819 SOX2 SRY-box transcription factor 2 gene CHEBI:4027 cyclophosphamide decreases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in decreased expression of SOX2 mRNA PMID:37980972 14059819 SOX2 SRY-box transcription factor 2 gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of SOX2 mRNA] PMID:37980972 14059819 SOX2 SRY-box transcription factor 2 gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of SOX2 mRNA] PMID:37980972 14059858 VIPR2 vasoactive intestinal peptide receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VIPR2 mRNA PMID:35307453 14059929 UBAC2 UBA domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBAC2 mRNA PMID:35307453 14059945 NAA20 N-alpha-acetyltransferase 20, NatB catalytic subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAA20 mRNA PMID:35307453 14059964 SLA-3 MHC class I antigen 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-3 mRNA PMID:35307453 14060036 AKAP8L A-kinase anchoring protein 8 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AKAP8L mRNA PMID:35307453 14060172 KIAA0319 KIAA0319 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIAA0319 mRNA PMID:35307453 14060207 DENR density regulated re-initiation and release factor gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DENR mRNA PMID:33592257 14060207 DENR density regulated re-initiation and release factor gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DENR mRNA PMID:33592257 14060267 KNTC1 kinetochore associated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KNTC1 mRNA PMID:35307453 14060443 CIT citron rho-interacting serine/threonine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CIT mRNA PMID:35307453 14060590 PDK2 pyruvate dehydrogenase kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDK2 mRNA PMID:35307453 14060646 WRAP73 WD repeat containing, antisense to TP73 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WRAP73 mRNA PMID:35307453 14060678 ARHGAP20 Rho GTPase activating protein 20 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ARHGAP20 mRNA PMID:34933075 14060697 C9H1orf116 chromosome 9 C1orf116 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of C9H1ORF116 mRNA PMID:35307453 14060863 TBKBP1 TBK1 binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TBKBP1 mRNA PMID:35307453 14060957 CFD complement factor D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFD mRNA PMID:35307453 14061030 VAV3 vav guanine nucleotide exchange factor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VAV3 mRNA PMID:35307453 14061030 VAV3 vav guanine nucleotide exchange factor 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of VAV3 mRNA PMID:18988085 14061030 VAV3 vav guanine nucleotide exchange factor 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of VAV3 mRNA PMID:21852083 14061030 VAV3 vav guanine nucleotide exchange factor 3 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of VAV3 mRNA PMID:18790026 14061091 LGALS3BP galectin 3 binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LGALS3BP mRNA PMID:35307453 14061200 A4GALT alpha 1,4-galactosyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of A4GALT mRNA PMID:35307453 14061238 HAUS4 HAUS augmin like complex subunit 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HAUS4 mRNA PMID:35307453 14061419 AMOT angiomotin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AMOT mRNA PMID:35307453 14061457 CNR1 cannabinoid receptor 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CNR1 mRNA] PMID:39151877 14061457 CNR1 cannabinoid receptor 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of CNR1 mRNA PMID:39151877 14061457 CNR1 cannabinoid receptor 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CNR1 mRNA] PMID:39151877 14061495 GC GC vitamin D binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GC mRNA PMID:35307453 14061593 XXYLT1 xyloside xylosyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of XXYLT1 mRNA PMID:35307453 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA] PMID:17656051 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA] PMID:17656051 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:16598 DDE decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in decreased expression of CYP11A1 mRNA PMID:11226075 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:16598 DDE multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene inhibits the reaction [Cholera Toxin results in increased expression of CYP11A1 mRNA] PMID:11226075 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of CYP11A1 mRNA PMID:38848930 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:3000 beauvericin increases expression EXP E RGD:6480464 20191114 CTD MESH:C004456 beauvericin results in increased expression of CYP11A1 mRNA PMID:27474255 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of CYP11A1 mRNA PMID:29544186 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with fisetin] results in decreased expression of CYP11A1 mRNA; fisetin promotes the reaction [bisphenol A results in decreased expression of CYP11A1 mRNA] PMID:29544186 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl decreases activity EXP E RGD:6480464 20191114 CTD MESH:C014024 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CYP11A1 protein PMID:16151981 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases activity EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP11A1 protein PMID:16151981 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:42567 fisetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017875 [bisphenol A co-treated with fisetin] results in decreased expression of CYP11A1 mRNA; fisetin promotes the reaction [bisphenol A results in decreased expression of CYP11A1 mRNA] PMID:29544186 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:47136 pentachlorobenzene increases expression EXP E RGD:6480464 20191114 CTD MESH:C003060 pentachlorobenzene results in increased expression of CYP11A1 protein PMID:21296658 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:5692 hexachlorobenzene increases expression EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene results in increased expression of CYP11A1 protein PMID:21296658 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:64983 alternariol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C005197 alternariol results in decreased expression of CYP11A1 protein PMID:19429235 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:6842 methoxychlor increases expression EXP E RGD:6480464 20191114 CTD MESH:D008731 Methoxychlor results in increased expression of CYP11A1 mRNA PMID:11226075 14061611 CYP11A1 cytochrome P450 family 11 subfamily A member 1 gene CHEBI:6842 methoxychlor multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008731 Methoxychlor promotes the reaction [Cholera Toxin results in increased expression of CYP11A1 mRNA] PMID:11226075 14061830 CCDC162 chromosome 1 C6orf183 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC162P mRNA PMID:35307453 14061909 C3 complement C3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C3 mRNA PMID:35307453 14061909 C3 complement C3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of C3 mRNA PMID:34933075 14061909 C3 complement C3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of C3 mRNA PMID:39265697 14061909 C3 complement C3 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of C3 mRNA PMID:18988085 14061972 DPP10 dipeptidyl peptidase like 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPP10 mRNA PMID:35307453 14062109 TMEM205 transmembrane protein 205 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM205 mRNA PMID:35307453 14062292 ARRB2 arrestin beta 2 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of ARRB2 mRNA PMID:21391292 14062335 TINAGL1 tubulointerstitial nephritis antigen like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TINAGL1 mRNA; deoxynivalenol results in decreased expression of TINAGL1 protein PMID:38403181 14062335 TINAGL1 tubulointerstitial nephritis antigen like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TINAGL1 mRNA PMID:35307453 14062514 VPS37D VPS37D subunit of ESCRT-I gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VPS37D mRNA PMID:35307453 14062514 VPS37D VPS37D subunit of ESCRT-I gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of VPS37D mRNA PMID:39265697 14062613 SMAD6 SMAD family member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMAD6 mRNA PMID:35307453 14062613 SMAD6 SMAD family member 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SMAD6 mRNA PMID:39265697 14062661 WWTR1 WW domain containing transcription regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WWTR1 mRNA PMID:35307453 14062737 UBC ubiquitin C gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of UBC mRNA] PMID:39151877 14062737 UBC ubiquitin C gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of UBC mRNA PMID:39151877 14062737 UBC ubiquitin C gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of UBC mRNA] PMID:39151877 14062766 PRKAG1 protein kinase AMP-activated non-catalytic subunit gamma 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAG1 mRNA PMID:34416349 14062766 PRKAG1 protein kinase AMP-activated non-catalytic subunit gamma 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAG1 mRNA PMID:34416349 14062956 MST1 macrophage stimulating 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MST1 mRNA PMID:35307453 14063204 MLYCD malonyl-CoA decarboxylase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MLYCD mRNA] PMID:39151877 14063204 MLYCD malonyl-CoA decarboxylase gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of MLYCD mRNA PMID:39151877 14063204 MLYCD malonyl-CoA decarboxylase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MLYCD mRNA] PMID:39151877 14063217 CNTNAP1 contactin associated protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNTNAP1 mRNA PMID:35307453 14063377 FGD3 FYVE, RhoGEF and PH domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGD3 mRNA PMID:35307453 14063413 MYH10 myosin heavy chain 10 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYH10 mRNA] PMID:21852083 14063460 ARL4D ADP ribosylation factor like GTPase 4D gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARL4D mRNA PMID:35307453 14063466 VWF von Willebrand factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VWF mRNA PMID:35307453 14063466 VWF von Willebrand factor gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20200114 CTD MESH:D010100 [[sodium percarbonate co-treated with calcium peroxide] results in increased abundance of Oxygen] which results in increased expression of VWF protein PMID:26053405 14063466 VWF von Willebrand factor gene CHEBI:48233 calcium peroxide multiple interactions EXP E RGD:6480464 20200114 CTD MESH:C403632 [[sodium percarbonate co-treated with calcium peroxide] results in increased abundance of Oxygen] which results in increased expression of VWF protein PMID:26053405 14063620 TPM3 tropomyosin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TPM3 mRNA; deoxynivalenol results in increased expression of TPM3 protein PMID:35307453|PMID:37257635 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP1LC3B mRNA PMID:26988607 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 deoxynivalenol inhibits the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein]; deoxynivalenol results in increased expression of and results in increased lipidation of MAP1LC3B protein; MAP1LC3B protein affects the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Melatonin affects the reaction [deoxynivalenol results in increased expression of and results in increased lipidation of MAP1LC3B protein] PMID:32877744|PMID:37120089 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:16412 lipopolysaccharide increases lipidation EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in increased lipidation of MAP1LC3B protein PMID:32877744 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 deoxynivalenol inhibits the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein]; MAP1LC3B protein affects the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of OCLN protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] PMID:32877744 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin affects the reaction [deoxynivalenol results in increased expression of and results in increased lipidation of MAP1LC3B protein] PMID:37120089 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:22689 bafilomycin A1 increases lipidation EXP E RGD:6480464 20230704 CTD MESH:C040929 bafilomycin A1 results in increased lipidation of MAP1LC3B protein PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:22689 bafilomycin A1 multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C040929 bafilomycin A1 inhibits the reaction [Benzo(a)pyrene results in decreased lipidation of MAP1LC3B protein] PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:29865 benzo[a]pyrene decreases lipidation EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased lipidation of MAP1LC3B protein PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 bafilomycin A1 inhibits the reaction [Benzo(a)pyrene results in decreased lipidation of MAP1LC3B protein]; Benzo(a)pyrene promotes the reaction [3-methyladenine results in decreased lipidation of MAP1LC3B protein]; Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased lipidation of MAP1LC3B protein] PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of MAP1LC3B protein PMID:31266599 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of MAP1LC3B protein PMID:31266599 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrabromobisphenol A] results in increased expression of MAP1LC3B protein PMID:31266599 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]]; Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]; Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]] PMID:34811946 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:35004 Tetrachlorobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in increased expression of MAP1LC3B protein PMID:31266599 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with tetrachlorodian] results in increased expression of MAP1LC3B protein PMID:31266599 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of MAP1LC3B mRNA PMID:38705344 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of MAP1LC3B mRNA]; fumonisin B1 results in increased lipidation of and results in increased localization of MAP1LC3B protein PMID:38705344 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:38635 3-methyladenine decreases lipidation EXP E RGD:6480464 20230704 CTD MESH:C025946 3-methyladenine results in decreased lipidation of MAP1LC3B protein PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C025946 3-methyladenine affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]]; Benzo(a)pyrene promotes the reaction [3-methyladenine results in decreased lipidation of MAP1LC3B protein] PMID:34811946|PMID:36754226 14063717 MAP1LC3B microtubule associated protein 1 light chain 3 beta gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D020123 Sirolimus affects the reaction [Paraquat affects the reaction [MYD88 protein affects the lipidation of MAP1LC3B protein]]; Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased lipidation of MAP1LC3B protein] PMID:34811946|PMID:36754226 14063891 GGT7 gamma-glutamyltransferase 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GGT7 mRNA PMID:35307453 14063964 TRIB1 tribbles pseudokinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIB1 mRNA PMID:35307453 14064122 DAAM1 dishevelled associated activator of morphogenesis 1 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of DAAM1 mRNA; Chlorpyrifos results in decreased expression of DAAM1 protein PMID:38565334 14064185 MPND MPN domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MPND mRNA PMID:35307453 14064303 SPAG1 sperm associated antigen 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPAG1 mRNA PMID:35307453 14064370 HNMT histamine N-methyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HNMT mRNA PMID:35307453 14064380 APOF apolipoprotein F gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APOF mRNA PMID:35307453 14064436 SULF2 sulfatase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULF2 mRNA PMID:35307453 14064469 SEMA5B semaphorin 5B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA5B mRNA PMID:35307453 14064566 CTSL cathepsin L gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSL mRNA PMID:35307453 14064566 CTSL cathepsin L gene CHEBI:17026 progesterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased expression of CTSL mRNA PMID:20107207 14064683 FGFR4 fibroblast growth factor receptor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGFR4 mRNA PMID:35307453 14064874 GTPBP10 GTP binding protein 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in increased expression of GTPBP10 mRNA PMID:35307453 14065017 NPC1L1 NPC1 like intracellular cholesterol transporter 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPC1L1 mRNA PMID:35307453 14065017 NPC1L1 NPC1 like intracellular cholesterol transporter 1 gene CHEBI:49040 ezetimibe increases expression EXP E RGD:6480464 20191114 CTD MESH:D000069438 Ezetimibe results in increased expression of NPC1L1 mRNA PMID:17130282 14065017 NPC1L1 NPC1 like intracellular cholesterol transporter 1 gene CHEBI:49040 ezetimibe multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000069438 Simvastatin promotes the reaction [Ezetimibe results in increased expression of NPC1L1 mRNA] PMID:17130282 14065017 NPC1L1 NPC1 like intracellular cholesterol transporter 1 gene CHEBI:9150 simvastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin promotes the reaction [Ezetimibe results in increased expression of NPC1L1 mRNA] PMID:17130282 14065040 BOP1 BOP1 ribosomal biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BOP1 mRNA PMID:35307453 14065120 IQCK IQ motif containing K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQCK mRNA PMID:35307453 14065216 H2AC17 H2A clustered histone 17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H2AC12 mRNA PMID:35307453 14065248 NOP9 NOP9 nucleolar protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOP9 mRNA PMID:35307453 14065263 NBL1 NBL1, DAN family BMP antagonist gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NBL1 mRNA PMID:35307453 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SOCS3 mRNA PMID:35307453 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SOCS3 mRNA PMID:39265697 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of SOCS3 mRNA PMID:37706587 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of SOCS3 mRNA] PMID:37706587 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of SOCS3 mRNA] PMID:37706587 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 mRNA]; Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 protein] PMID:30923867 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of SOCS3 mRNA; ochratoxin A results in increased expression of SOCS3 protein PMID:30923867 14065282 SOCS3 suppressor of cytokine signaling 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 mRNA]; Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 protein] PMID:30923867 14065379 FHL1 four and a half LIM domains 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FHL1 mRNA PMID:35307453 14065440 PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3C2B mRNA PMID:35307453 14065577 NBEA neurobeachin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of NBEA mRNA PMID:21852083 14065817 BAZ1A bromodomain adjacent to zinc finger domain 1A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BAZ1A mRNA PMID:35307453 14065925 REPS2 RALBP1 associated Eps domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of REPS2 mRNA PMID:35307453 14065972 DIO1 iodothyronine deiodinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DIO1 mRNA PMID:35307453 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased expression of RPS6KB1 mRNA PMID:32229166 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:10022 deoxynivalenol decreases phosphorylation EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased phosphorylation of RPS6KB1 protein PMID:32229166 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:3093 bifenthrin affects phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin affects the phosphorylation of RPS6KB1 protein PMID:33901951 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:39329 etoxazole affects phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole affects the phosphorylation of RPS6KB1 protein PMID:31744678 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein]; pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein]; SB 203580 affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein]; U 0126 affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein] PMID:31744678 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:50842 norflurazon decreases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased phosphorylation of RPS6KB1 protein PMID:38432436 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein] PMID:31744678 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein] PMID:31744678 14065987 RPS6KB1 ribosomal protein S6 kinase B1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 SB 203580 affects the reaction [etoxazole affects the phosphorylation of RPS6KB1 protein] PMID:31744678 14066090 ACSS3 acyl-CoA synthetase short chain family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACSS3 mRNA PMID:35307453 14066090 ACSS3 acyl-CoA synthetase short chain family member 3 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate results in decreased expression of ACSS3 mRNA] PMID:39151877 14066090 ACSS3 acyl-CoA synthetase short chain family member 3 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of ACSS3 mRNA PMID:39151877 14066090 ACSS3 acyl-CoA synthetase short chain family member 3 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate results in decreased expression of ACSS3 mRNA] PMID:39151877 14066200 COL5A1 collagen type V alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL5A1 mRNA; deoxynivalenol results in decreased expression of COL5A1 protein PMID:38403181 14066200 COL5A1 collagen type V alpha 1 chain gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of COL5A1 mRNA PMID:39265697 14066381 ICA1L islet cell autoantigen 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ICA1L mRNA PMID:35307453 14066421 RIOK2 RIO kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIOK2 mRNA PMID:35307453 14066435 PPCDC phosphopantothenoylcysteine decarboxylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPCDC mRNA PMID:35307453 14066505 STK3 serine/threonine kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STK3 mRNA PMID:35307453 14066555 FXR1 FMR1 autosomal homolog 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FXR1 mRNA PMID:35307453 14066676 LOC100154105 kelch repeat and BTB domain-containing protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KBTBD6 mRNA PMID:35307453 14066729 NGRN neugrin, neurite outgrowth associated gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NGRN mRNA PMID:35307453 14066808 PAPPA pappalysin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAPPA mRNA PMID:35307453 14066808 PAPPA pappalysin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PAPPA mRNA PMID:34933075 14066948 PDLIM2 PDZ and LIM domain 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDLIM2 mRNA PMID:35307453 14066962 CFAP44 cilia and flagella associated protein 44 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP44 mRNA PMID:35307453 14066962 CFAP44 cilia and flagella associated protein 44 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CFAP44 mRNA PMID:39265697 14067152 GPCPD1 glycerophosphocholine phosphodiesterase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPCPD1 mRNA PMID:35307453 14067152 GPCPD1 glycerophosphocholine phosphodiesterase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of GPCPD1 mRNA PMID:39265697 14067185 MPHOSPH10 M-phase phosphoprotein 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MPHOSPH10 mRNA PMID:35307453 14067407 GPATCH11 G-patch domain containing 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPATCH11 mRNA PMID:35307453 14067432 MDM4 MDM4 regulator of p53 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MDM4 mRNA PMID:35307453 14067509 C7H14orf119 chromosome 7 C14orf119 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C7H14ORF119 mRNA PMID:35307453 14067632 F5 coagulation factor V gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of F5 mRNA PMID:35307453 14067865 FNIP1 folliculin interacting protein 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FNIP1 mRNA PMID:34389318 14067952 DYRK3 dual specificity tyrosine phosphorylation regulated kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DYRK3 mRNA PMID:35307453 14067959 NTRK3 neurotrophic receptor tyrosine kinase 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NTRK3 mRNA PMID:34933075 14068071 DLST dihydrolipoamide S-succinyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DLST mRNA PMID:35307453 14068090 RNASE4 ribonuclease A family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNASE4 mRNA PMID:35307453 14068202 RAB3IP RAB3A interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAB3IP mRNA PMID:35307453 14068312 DOCK2 dedicator of cytokinesis 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DOCK2 mRNA PMID:35307453 14068312 DOCK2 dedicator of cytokinesis 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DOCK2 mRNA PMID:34389318 14068452 TFDP2 transcription factor Dp-2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFDP2 mRNA PMID:35307453 14068529 MARCKSL1 MARCKS like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MARCKSL1 mRNA PMID:35307453 14068529 MARCKSL1 MARCKS like 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of MARCKSL1 mRNA PMID:21852083 14068541 KIF1A kinesin family member 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF1A mRNA PMID:35307453 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP1A1 mRNA PMID:35307453 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:27584 aldosterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D000450 Aldosterone results in increased expression of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:28544 digitoxin decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004074 Digitoxin results in decreased activity of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:4551 digoxin decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004077 Digoxin results in decreased activity of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:472805 ouabain decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010042 Ouabain results in decreased activity of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:50095 bucladesine increases expression EXP E RGD:6480464 20191114 CTD MESH:D003994 Bucladesine results in increased expression of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:59030 oleandrin decreases activity EXP E RGD:6480464 20191114 CTD MESH:C021065 oleandrin results in decreased activity of ATP1A1 protein PMID:28438630 14068809 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 gene CHEBI:88046 cylindrospermopsin increases expression EXP E RGD:6480464 20210608 CTD MESH:C089595 cylindrospermopsin results in increased expression of ATP1A1 mRNA PMID:33689780 14068854 LOC100739508 glutathione S-transferase P-like gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20210803 CTD MESH:D005978 GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione] PMID:14573868 14068854 LOC100739508 glutathione S-transferase P-like gene CHEBI:34718 1-chloro-2,4-dinitrobenzene affects metabolic processing EXP E RGD:6480464 20210803 CTD MESH:D004137 GSTP1 protein affects the metabolism of Dinitrochlorobenzene PMID:14573868 14068854 LOC100739508 glutathione S-transferase P-like gene CHEBI:62825 monobromobimane decreases activity EXP E RGD:6480464 20210803 CTD MESH:C028381 monobromobimane results in decreased activity of GSTP1 protein PMID:14573868 14068854 LOC100739508 glutathione S-transferase P-like gene CHEBI:62825 monobromobimane multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C028381 GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione] PMID:14573868 14068877 ARX aristaless related homeobox gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARX mRNA PMID:35307453 14068887 PIGK phosphatidylinositol glycan anchor biosynthesis class K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIGK mRNA PMID:35307453 14068964 ASF1B anti-silencing function 1B histone chaperone gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASF1B mRNA PMID:35307453 14068964 ASF1B anti-silencing function 1B histone chaperone gene CHEBI:15428 glycine increases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in increased expression of ASF1B mRNA PMID:39127149 14068964 ASF1B anti-silencing function 1B histone chaperone gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in decreased expression of ASF1B mRNA PMID:39127149 14069133 GAP43 growth associated protein 43 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAP43 mRNA PMID:35307453 14069151 ADAMTS10 ADAM metallopeptidase with thrombospondin type 1 motif 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTS10 mRNA PMID:35307453 14069277 THBD thrombomodulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THBD mRNA PMID:35307453 14069464 NR3C2 nuclear receptor subfamily 3 group C member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR3C2 mRNA PMID:35307453 14069556 DDX49 DEAD-box helicase 49 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX49 mRNA PMID:35307453 14069576 NDEL1 nudE neurodevelopment protein 1 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NDEL1 mRNA PMID:35307453 14069707 SPX spexin hormone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPX mRNA PMID:35307453 14069801 TCTN1 tectonic family member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCTN1 mRNA PMID:35307453 14069834 FABP1 fatty acid binding protein 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of FABP1 mRNA PMID:17363680 14069878 DYDC2 DPY30 domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYDC2 mRNA PMID:35307453 14070026 SCEL sciellin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCEL mRNA PMID:35307453 14070082 HYLS1 HYLS1 centriolar and ciliogenesis associated gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HYLS1 mRNA PMID:35307453 14070152 SMKR1 small lysine rich protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMKR1 mRNA PMID:35307453 14070406 DDX39A DExD-box helicase 39A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX39A mRNA PMID:35307453 14070421 EPHX2 epoxide hydrolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPHX2 mRNA PMID:35307453 14070481 SCN1B sodium voltage-gated channel beta subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCN1B mRNA PMID:35307453 14070586 SPATA20 spermatogenesis associated 20 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPATA20 mRNA PMID:35307453 14070613 ATF7IP2 activating transcription factor 7 interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATF7IP2 mRNA PMID:35307453 14070613 ATF7IP2 activating transcription factor 7 interacting protein 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATF7IP2 mRNA PMID:39265697 14070789 HOXB3 homeobox B3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB3 mRNA PMID:35307453 14070870 MXRA8 matrix remodeling associated 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MXRA8 mRNA PMID:35307453 14071053 CYP2G2 cytochrome P450 family 2 subfamily G member 2 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C025589 ochratoxin A results in decreased expression of CYP2A6 mRNA PMID:14994279 14071053 CYP2G2 cytochrome P450 family 2 subfamily G member 2 gene CHEBI:9171 skatole increases abundance EXP E RGD:6480464 20250311 CTD MESH:D012862 CYP2A6 gene polymorphism results in increased abundance of Skatole PMID:15265071 14071053 CYP2G2 cytochrome P450 family 2 subfamily G member 2 gene CHEBI:9171 skatole increases metabolic processing EXP E RGD:6480464 20250311 CTD MESH:D012862 CYP2A6 protein results in increased metabolism of Skatole PMID:10828259|PMID:15265071 14071216 SPSB3 splA/ryanodine receptor domain and SOCS box containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPSB3 mRNA PMID:35307453 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of DNMT3A mRNA PMID:26988607 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA PMID:28445388 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:15428 glycine increases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in increased expression of DNMT3A mRNA PMID:39127149 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA PMID:28445388 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA PMID:28445388 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA PMID:28445388 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of DNMT3A mRNA PMID:28445388|PMID:28819136 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA] PMID:28445388 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of DNMT3A mRNA PMID:29080797|PMID:30923867 14071308 DNMT3A DNA methyltransferase 3 alpha gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in increased expression of DNMT3A mRNA PMID:39127149 14071470 GATA3 GATA binding protein 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of GATA3 mRNA] PMID:21852083 14071644 P4HA1 prolyl 4-hydroxylase subunit alpha 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of P4HA1 mRNA PMID:34389318 14071726 SQLE squalene epoxidase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SQLE mRNA PMID:35307453 14071794 STMN4 stathmin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STMN4 mRNA PMID:35307453 14071935 KCND2 potassium voltage-gated channel subfamily D member 2 gene CHEBI:26216 potassium atom increases transport EXP E RGD:6480464 20191114 CTD MESH:D011188 KCND2 protein results in increased transport of Potassium PMID:17242957 14071973 MKX mohawk homeobox gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MKX mRNA PMID:35307453 14072098 CFAP54 cilia and flagella associated protein 54 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP54 mRNA PMID:35307453 14072243 HYKK hydroxylysine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HYKK mRNA PMID:35307453 14072269 TPI1 triosephosphate isomerase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TPI1 mRNA PMID:35307453 14072353 PICALM phosphatidylinositol binding clathrin assembly protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PICALM mRNA PMID:35307453 14072444 CYRIB CYFIP related Rac1 interactor B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYRIB mRNA PMID:35307453 14072596 OLFM2 olfactomedin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OLFM2 mRNA PMID:35307453 14072618 NOCT nocturnin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOCT mRNA PMID:35307453 14072665 SIAE sialic acid acetylesterase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIAE mRNA PMID:35307453 14072870 MAP2K2 mitogen-activated protein kinase kinase 2 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of MAP2K2 mRNA PMID:35839969 14072885 RPL37 ribosomal protein L37 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL37 mRNA PMID:39265697 14072894 SLC30A1 solute carrier family 30 member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC30A1 mRNA PMID:35307453 14072894 SLC30A1 solute carrier family 30 member 1 gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC30A1 mRNA; Zinc results in increased expression of SLC30A1 protein PMID:18061429 14072894 SLC30A1 solute carrier family 30 member 1 gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC30A1 mRNA; Zinc results in increased expression of SLC30A1 protein PMID:18061429 14072894 SLC30A1 solute carrier family 30 member 1 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of SLC30A1 mRNA PMID:25895165 14073095 ZBTB22 zinc finger and BTB domain containing 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBTB22 mRNA PMID:35307453 14073181 TRIM28 tripartite motif containing 28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM28 mRNA PMID:35307453 14073262 CATSPER1 cation channel sperm associated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CATSPER1 mRNA PMID:35307453 14073293 KRT8 keratin 8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of KRT8 mRNA PMID:34933075 14073368 NPR3 natriuretic peptide receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPR3 mRNA PMID:35307453 14073424 ZNF84 zinc finger protein 84 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF84 mRNA PMID:35307453 14073573 CSTPP1 centriolar satellite-associated tubulin polyglutamylase complex regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSTPP1 mRNA PMID:35307453 14073604 ABT1 activator of basal transcription 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABT1 mRNA PMID:35307453 14073748 VDAC1 voltage dependent anion channel 1 gene CHEBI:50842 norflurazon increases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased expression of VDAC1 protein PMID:38432436 14073748 VDAC1 voltage dependent anion channel 1 gene CHEBI:88522 Monobutylphthalate affects localization EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate affects the localization of VDAC1 protein PMID:35839969 14073775 PKM pyruvate kinase M1/2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PKM mRNA PMID:35307453 14073955 PLK3 polo like kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLK3 mRNA PMID:35307453 14073955 PLK3 polo like kinase 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PLK3 mRNA PMID:39265697 14074166 CLBA1 clathrin binding box of aftiphilin containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLBA1 mRNA PMID:35307453 14074185 DROSHA drosha ribonuclease III gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of DROSHA protein PMID:31266599 14074185 DROSHA drosha ribonuclease III gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in decreased expression of DROSHA protein]; [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline co-treated with bisphenol A] results in increased expression of DROSHA mRNA; bisphenol A inhibits the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of DROSHA protein] PMID:31266599 14074185 DROSHA drosha ribonuclease III gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of DROSHA mRNA PMID:31266599 14074223 PPID peptidylprolyl isomerase D gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPID mRNA; deoxynivalenol results in increased expression of PPID protein PMID:35307453|PMID:38403181 14074326 SLC25A42 solute carrier family 25 member 42 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A42 mRNA PMID:35307453 14074352 NOC3L NOC3 like DNA replication regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOC3L mRNA PMID:35307453 14074381 SLC19A3 solute carrier family 19 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC19A3 mRNA PMID:35307453 14074628 SORBS2 sorbin and SH3 domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SORBS2 mRNA PMID:35307453 14074726 TREH trehalase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TREH mRNA PMID:39265697 14074838 PRMT1 protein arginine methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRMT1 mRNA PMID:35307453 14074971 MYO1G myosin IG gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO1G mRNA PMID:35307453 14075234 PRKAB2 protein kinase AMP-activated non-catalytic subunit beta 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRKAB2 mRNA PMID:35307453 14075283 SLC16A5 solute carrier family 16 member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A5 mRNA PMID:35307453 14075328 HAX1 HCLS1 associated protein X-1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HAX1 mRNA PMID:35307453 14075424 CRYBA1 crystallin beta A1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CRYBA1 mRNA PMID:21852083 14075498 KRT18 keratin 18 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of KRT18 mRNA PMID:34933075 14075531 PXDN peroxidasin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of PXDN mRNA; deoxynivalenol results in decreased expression of PXDN protein PMID:38403181 14075581 PRDX5 peroxiredoxin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRDX5 mRNA PMID:35307453 14075643 CASP6 caspase 6 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of CASP6 mRNA PMID:21645290 14075643 CASP6 caspase 6 gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine results in increased expression of CASP6 mRNA] PMID:19523970 14075643 CASP6 caspase 6 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of CASP6 mRNA PMID:28803810 14075643 CASP6 caspase 6 gene CHEBI:4031 cyclosporin A increases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in increased expression of CASP6 mRNA PMID:19523970 14075643 CASP6 caspase 6 gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine results in increased expression of CASP6 mRNA] PMID:19523970 14075681 ARHGDIG Rho GDP dissociation inhibitor gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARHGDIG mRNA PMID:35307453 14075755 DRD1 dopamine receptor D1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DRD1 mRNA PMID:35307453 14075855 CCDC33 coiled-coil domain containing 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC33 mRNA PMID:35307453 14075885 SIL1 SIL1 nucleotide exchange factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIL1 mRNA PMID:35307453 14075913 CRYZ crystallin zeta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRYZ mRNA PMID:35307453 14075978 PIERCE1 piercer of microtubule wall 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIERCE1 mRNA PMID:35307453 14076138 RPA3 replication protein A3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RPA3 mRNA PMID:35307453 14076138 RPA3 replication protein A3 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of RPA3 mRNA PMID:35839969 14076146 TMEM35B transmembrane protein 35B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM35B mRNA PMID:35307453 14076303 GNL3 G protein nucleolar 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GNL3 mRNA PMID:35307453 14076408 ATP5MK ATP synthase membrane subunit k gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATP5MK mRNA PMID:39265697 14076463 DLGAP2 DLG associated protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DLGAP2 mRNA PMID:35307453 14076526 MSRB2 methionine sulfoxide reductase B2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MSRB2 mRNA PMID:35307453 14076668 SDHB succinate dehydrogenase complex iron sulfur subunit B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDHB mRNA PMID:35307453 14076668 SDHB succinate dehydrogenase complex iron sulfur subunit B gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SDHB mRNA PMID:34416349 14076668 SDHB succinate dehydrogenase complex iron sulfur subunit B gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SDHB mRNA PMID:34416349 14076678 HDAC9 histone deacetylase 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HDAC9 mRNA PMID:35307453 14076878 SUN2 Sad1 and UNC84 domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUN2 mRNA PMID:35307453 14076996 PLBD1 phospholipase B domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLBD1 mRNA PMID:35307453 14077100 EXOSC4 exosome component 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC4 mRNA PMID:35307453 14077363 SCARA3 scavenger receptor class A member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCARA3 mRNA PMID:35307453 14077503 MTG1 mitochondrial ribosome associated GTPase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTG1 mRNA PMID:35307453 14077554 S100A2 S100 calcium binding protein A2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of S100A2 mRNA PMID:39265697 14077567 LRP6 LDL receptor related protein 6 gene CHEBI:10033 warfarin increases expression EXP E RGD:6480464 20230905 CTD MESH:D014859 Warfarin results in increased expression of LRP6 mRNA; Warfarin results in increased expression of LRP6 protein PMID:34520801 14077567 LRP6 LDL receptor related protein 6 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D014859 LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA]]; LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]]; LRP6 protein affects the reaction [Warfarin results in increased expression of BMP2 mRNA]; LRP6 protein affects the reaction [Warfarin results in increased expression of RUNX2 mRNA]; SOX5 protein promotes the reaction [Warfarin promotes the reaction [SOX9 protein binds to LRP6 promoter]]; SOX5 protein promotes the reaction [Warfarin results in increased expression of LRP6 protein]; Warfarin promotes the reaction [SOX9 protein binds to LRP6 promoter] PMID:34520801 14077594 ODAD2 outer dynein arm docking complex subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of ODAD2 mRNA PMID:35307453 14077651 MEP1B meprin A subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEP1B mRNA PMID:35307453 14077783 TNFSF15 TNF superfamily member 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFSF15 mRNA PMID:35307453 14078227 PPM1K protein phosphatase, Mg2+/Mn2+ dependent 1K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPM1K mRNA PMID:35307453 14078304 DIO2 iodothyronine deiodinase 2 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of DIO2 mRNA PMID:16896063 14078678 COPE COPI coat complex subunit epsilon gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COPE mRNA PMID:35307453 14078692 KCNH7 potassium voltage-gated channel subfamily H member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNH7 mRNA PMID:35307453 14078759 RASA3 RAS p21 protein activator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASA3 mRNA PMID:35307453 14078794 EGR3 early growth response 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EGR3 mRNA PMID:35307453 14078944 LTC4S leukotriene C4 synthase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LTC4S mRNA PMID:35307453 14078944 LTC4S leukotriene C4 synthase gene CHEBI:2825 aristolochic acid A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in decreased expression of LTC4S protein PMID:21658425 14079086 ZDHHC8 zinc finger DHHC-type palmitoyltransferase 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZDHHC8 mRNA PMID:35307453 14079135 TPGS1 tubulin polyglutamylase complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPGS1 mRNA PMID:35307453 14079154 PLSCR3 phospholipid scramblase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLSCR3 mRNA PMID:35307453 14079235 NOPCHAP1 NOP protein chaperone 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOPCHAP1 mRNA PMID:35307453 14079272 CCN3 cellular communication network factor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCN3 mRNA PMID:35307453 14079272 CCN3 cellular communication network factor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CCN3 mRNA PMID:39265697 14079307 C2H5orf63 chromosome 2 C5orf63 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C2H5ORF63 mRNA PMID:35307453 14079373 NOTCH4 notch receptor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOTCH4 mRNA PMID:35307453 14079432 CRY2 cryptochrome circadian regulator 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRY2 mRNA PMID:35307453 14079458 MBNL3 muscleblind like splicing regulator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MBNL3 mRNA PMID:35307453 14079557 TLE1 TLE family member 1, transcriptional corepressor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TLE1 mRNA PMID:35307453 14079557 TLE1 TLE family member 1, transcriptional corepressor gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of TLE1 mRNA PMID:39265697 14079742 DCT dopachrome tautomerase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DCT mRNA PMID:35307453 14079759 SNRPD1 small nuclear ribonucleoprotein D1 polypeptide gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPD1 mRNA PMID:35307453 14079777 CLDN6 claudin 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CLDN6 mRNA PMID:35307453 14079787 RAP1B RAP1B, member of RAS oncogene family gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAP1B mRNA PMID:35307453 14079802 CCDC24 coiled-coil domain containing 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC24 mRNA PMID:35307453 14079820 DEPTOR DEP domain containing MTOR interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DEPTOR mRNA PMID:35307453 14079820 DEPTOR DEP domain containing MTOR interacting protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DEPTOR mRNA PMID:39265697 14079936 MSMO1 methylsterol monooxygenase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MSMO1 mRNA PMID:35307453 14080078 SLC30A2 solute carrier family 30 member 2 gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC30A2 protein PMID:18061429 14080078 SLC30A2 solute carrier family 30 member 2 gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of SLC30A2 protein PMID:18061429 14080126 MYO9A myosin IXA gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO9A mRNA PMID:35307453 14080209 ARHGEF10L Rho guanine nucleotide exchange factor 10 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF10L mRNA PMID:35307453 14080299 MVK mevalonate kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MVK mRNA PMID:35307453 14080350 TRIOBP TRIO and F-actin binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIOBP mRNA PMID:35307453 14080449 PCDH15 protocadherin related 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCDH15 mRNA PMID:35307453 14080582 GGT6 gamma-glutamyltransferase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GGT6 mRNA PMID:35307453 14080700 GRB10 growth factor receptor bound protein 10 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of GRB10 mRNA PMID:25455459 14080700 GRB10 growth factor receptor bound protein 10 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of GRB10 mRNA PMID:39265697 14080755 LRP8 LDL receptor related protein 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRP8 mRNA PMID:35307453 14080866 CCT5 chaperonin containing TCP1 subunit 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT5 mRNA PMID:35307453 14080978 ZDHHC24 zinc finger DHHC-type containing 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZDHHC24 mRNA PMID:35307453 14080985 VSTM4 V-set and transmembrane domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of VSTM4 mRNA; deoxynivalenol results in decreased expression of VSTM4 protein PMID:38403181 14081082 NLE1 notchless homolog 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NLE1 mRNA PMID:35307453 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20220927 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCL2 mRNA; deoxynivalenol results in decreased expression of BCL2 protein PMID:25701311|PMID:29109043|PMID:37120089|PMID:38104654 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20220927 CTD MESH:C007262 [Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]; Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]; Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]] PMID:29109043|PMID:37120089|PMID:38763499 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220927 CTD MESH:D015025 Zearalenone results in decreased expression of BCL2 mRNA PMID:29109043 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D015025 [Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone] results in increased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]; fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]; Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]; Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]; Zearalenone inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]] PMID:29109043 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BCL2 protein PMID:39265697 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:15422 ATP increases expression EXP E RGD:6480464 20220927 CTD MESH:D000255 Adenosine Triphosphate results in increased expression of BCL2 protein PMID:17997382 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:15422 ATP multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D000255 tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased expression of BCL2 protein] PMID:17997382 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of BCL2 mRNA PMID:37706587|PMID:38438008 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA] PMID:37706587|PMID:38438008 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20220927 CTD MESH:D008070 Lipopolysaccharides results in increased expression of BCL2 mRNA PMID:21645290 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D009569 Nitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein PMID:16039061 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20220927 CTD MESH:D008550 Melatonin results in increased expression of BCL2 mRNA PMID:31535366|PMID:38848930 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [Malathion results in decreased expression of BCL2 mRNA] PMID:31535366|PMID:37120089 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA] PMID:38438008 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20220927 CTD MESH:D009538 Nicotine results in decreased expression of BCL2 mRNA PMID:32423882 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20220927 CTD MESH:D009538 Nicotine results in decreased expression of BCL2 mRNA PMID:32423882 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:207229 dihydroartemisinin decreases expression EXP E RGD:6480464 20220927 CTD MESH:C039060 artenimol results in decreased expression of BCL2 mRNA PMID:29309768 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:22977 cadmium atom decreases expression EXP E RGD:6480464 20220927 CTD MESH:D002104 Cadmium results in decreased expression of BCL2 protein PMID:19135140 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20220927 CTD MESH:D002104 Cadmium results in increased expression of BCL2 mRNA; Cadmium results in increased expression of BCL2 protein PMID:11781163 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]; Selenium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] PMID:19135140|PMID:33493553 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of BCL2 protein PMID:38763499 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20220927 CTD MESH:D009151 Mustard Gas results in decreased expression of BCL2 protein PMID:9302645 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20220927 CTD MESH:D015032 Zinc results in increased expression of BCL2 protein PMID:11781163 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] PMID:19135140 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D000111 [Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with fumonisin B1] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone] results in increased expression of BCL2 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]] PMID:19135140|PMID:29109043|PMID:33905761 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of BCL2 protein PMID:36754226 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20220927 CTD MESH:D015032 Zinc results in increased expression of BCL2 protein PMID:11781163 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:30926 3-oxalomalic acid decreases expression EXP E RGD:6480464 20220927 CTD MESH:C015407 oxalomalic acid results in decreased expression of BCL2 protein PMID:16785314 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220927 CTD MESH:C006780 bisphenol A results in decreased expression of BCL2 mRNA; bisphenol A results in decreased expression of BCL2 protein PMID:28819136|PMID:37108405|PMID:38848930 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20241105 CTD MESH:C006780 bisphenol A results in increased expression of BCL2 mRNA PMID:38845341 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]; ursodoxicoltaurine promotes the reaction [bisphenol A results in increased expression of BCL2 mRNA] PMID:37108405|PMID:38845341 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of BCL2 mRNA; tetrabromobisphenol A results in decreased expression of BCL2 protein PMID:35665993 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in decreased expression of BCL2 mRNA PMID:34399389|PMID:38565334 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased expression of BCL2 protein PMID:34811946 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein affects the reaction [Paraquat results in decreased expression of BCL2 protein] PMID:34811946 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20220927 CTD MESH:D019256 Cadmium Chloride results in decreased expression of BCL2 protein PMID:26607349 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20220927 CTD MESH:D019256 Cadmium Chloride results in increased expression of BCL2 protein PMID:23575899 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 protein; Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] PMID:26607349|PMID:33493553 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] PMID:19135140 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA] PMID:37706587 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20220927 CTD MESH:C056933 fumonisin B1 results in decreased expression of BCL2 mRNA; fumonisin B1 results in decreased expression of BCL2 protein PMID:33905761|PMID:36397609 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20220927 CTD MESH:C056933 [Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with fumonisin B1] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein; [fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]; fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein]; fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]; Zearalenone inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]] PMID:29109043|PMID:33905761|PMID:36397609 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:4027 cyclophosphamide decreases expression EXP E RGD:6480464 20240109 CTD MESH:D003520 Cyclophosphamide results in decreased expression of BCL2 mRNA PMID:37980972 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA] PMID:37980972 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20220927 CTD MESH:D001629 Bezafibrate results in increased expression of BCL2 PMID:16316343 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein] PMID:26607349|PMID:37108405 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20220927 CTD MESH:D008294 Malathion results in decreased expression of BCL2 mRNA PMID:31535366 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:6651 malathion multiple interactions EXP E RGD:6480464 20220927 CTD MESH:D008294 Melatonin inhibits the reaction [Malathion results in decreased expression of BCL2 mRNA] PMID:31535366 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:7719 ochratoxin A affects expression EXP E RGD:6480464 20220927 CTD MESH:C025589 ochratoxin A affects the expression of BCL2 mRNA PMID:28528741 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20220927 CTD MESH:C025589 ochratoxin A results in decreased expression of BCL2 mRNA; ochratoxin A results in decreased expression of BCL2 protein PMID:29080797|PMID:33905761|PMID:36397609 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20220927 CTD MESH:C025589 [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; TLR4 protein affects the reaction [ochratoxin A affects the expression of BCL2 mRNA] PMID:28528741|PMID:33905761|PMID:36397609 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20241105 CTD MESH:C031655 ursodoxicoltaurine promotes the reaction [bisphenol A results in increased expression of BCL2 mRNA] PMID:38845341 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 Panobinostat inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA] PMID:37980972 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20220927 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA] PMID:33905761 14081103 BCL2 BCL2 apoptosis regulator gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA] PMID:38438008 14081125 CDH1 cadherin 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of CDH1 mRNA PMID:35839969 14081151 ELF3 E74 like ETS transcription factor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ELF3 mRNA PMID:39265697 14081170 BPHL biphenyl hydrolase like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BPHL mRNA PMID:35307453 14081214 ALPK3 alpha kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ALPK3 mRNA PMID:35307453 14081298 C9H11orf42 chromosome 9 C11orf42 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C9H11ORF42 mRNA PMID:35307453 14081590 ERO1B endoplasmic reticulum oxidoreductase 1 beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERO1B mRNA PMID:35307453 14081611 FGB fibrinogen beta chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGB mRNA PMID:35307453 14081611 FGB fibrinogen beta chain gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FGB mRNA PMID:34389318 14082056 TPP1 tripeptidyl peptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPP1 mRNA PMID:35307453 14082164 TRMT1 tRNA methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT1 mRNA PMID:35307453 14082247 PTRH2 peptidyl-tRNA hydrolase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTRH2 mRNA PMID:35307453 14082263 ARL6IP4 ADP ribosylation factor like GTPase 6 interacting protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARL6IP4 mRNA PMID:35307453 14082287 CFAP61 cilia and flagella associated protein 61 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP61 mRNA PMID:35307453 14082364 PHC3 polyhomeotic homolog 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PHC3 mRNA PMID:35307453 14082611 PUS1 pseudouridine synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PUS1 mRNA PMID:35307453 14082697 FGF7 fibroblast growth factor 7 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20220517 CTD MESH:D004958 Estradiol results in increased expression of FGF7 mRNA PMID:15271478 14082697 FGF7 fibroblast growth factor 7 gene CHEBI:77006 17beta-estradiol 3-benzoate affects expression EXP E RGD:6480464 20220517 CTD MESH:C074283 estradiol 3-benzoate affects the expression of FGF7 mRNA PMID:15976484 14082741 KCNAB1 potassium voltage-gated channel subfamily A regulatory beta subunit 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of KCNAB1 mRNA PMID:34389318 14082779 CHST11 carbohydrate sulfotransferase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHST11 mRNA PMID:35307453 14082819 ZCCHC24 zinc finger CCHC-type containing 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZCCHC24 mRNA PMID:35307453 14082879 NEXN nexilin F-actin binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NEXN mRNA PMID:35307453 14083024 PRPF40A pre-mRNA processing factor 40 homolog A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRPF40A mRNA PMID:35307453 14083196 DHX58 DExH-box helicase 58 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DHX58 mRNA; deoxynivalenol results in decreased expression of DHX58 protein PMID:35307453|PMID:38403181 14083302 METAP2 methionyl aminopeptidase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of METAP2 mRNA; deoxynivalenol results in increased expression of METAP2 protein PMID:38403181 14083412 PNLIP pancreatic lipase gene CHEBI:25710 organophosphorus compound decreases activity EXP E RGD:6480464 20191114 CTD MESH:D009943 Organophosphorus Compounds results in decreased activity of PNLIP protein PMID:16449251 14083412 PNLIP pancreatic lipase gene CHEBI:30816 vanillic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:D014641 Vanillic Acid results in decreased activity of PNLIP protein PMID:23738459 14083412 PNLIP pancreatic lipase gene CHEBI:6146 kuwanone G decreases activity EXP E RGD:6480464 20240109 CTD MESH:C095194 kuwanon G results in decreased activity of PNLIP protein PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:6146 kuwanone G multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C095194 kuwanon G inhibits the reaction [PNLIP protein results in increased hydrolysis of 4-methylumbelliferyl oleate] PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:67410 p-hydroxybenzyl alcohol decreases activity EXP E RGD:6480464 20191114 CTD MESH:C018966 4-hydroxybenzyl alcohol results in decreased activity of PNLIP protein PMID:30273962 14083412 PNLIP pancreatic lipase gene CHEBI:7005 morusin decreases activity EXP E RGD:6480464 20240109 CTD MESH:C057451 morusin results in decreased activity of PNLIP protein PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:75092 morin decreases activity EXP E RGD:6480464 20240109 CTD MESH:C008548 morin results in decreased activity of PNLIP protein PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:9020 Sanggenon C multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C477157 sanggenone C binds to and results in decreased activity of PNLIP protein; sanggenone C inhibits the reaction [PNLIP protein results in increased hydrolysis of 4-methylumbelliferyl oleate] PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:9021 Sanggenon D decreases activity EXP E RGD:6480464 20240109 CTD MESH:C000630879 sanggenon D results in decreased activity of PNLIP protein PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:9021 Sanggenon D multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C000630879 sanggenon D inhibits the reaction [PNLIP protein results in increased hydrolysis of 4-methylumbelliferyl oleate] PMID:30032067 14083412 PNLIP pancreatic lipase gene CHEBI:94686 orlistat decreases activity EXP E RGD:6480464 20191114 CTD MESH:C055122 Orlistat results in decreased activity of PNLIP protein PMID:21438711 14083497 COL4A3 collagen type IV alpha 3 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL4A3 mRNA PMID:35307453 14083497 COL4A3 collagen type IV alpha 3 chain gene CHEBI:85102 KT 5823 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 results in decreased expression of COL4A3 mRNA PMID:21307347 14083497 COL4A3 collagen type IV alpha 3 chain gene CHEBI:85102 KT 5823 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 inhibits the reaction [NOC 18 results in increased expression of COL4A3 mRNA] PMID:21307347 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC15A1 mRNA PMID:35307453 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of SLC15A1 mRNA PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:33216 bisphenol A decreases methylation EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased methylation of SLC15A1 promoter PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter] PMID:28445388 14083577 SLC15A1 solute carrier family 15 member 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in increased expression of SLC15A1 mRNA PMID:33443779 14083614 GZMM granzyme M gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GZMM mRNA PMID:35307453 14083689 ROMO1 reactive oxygen species modulator 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ROMO1 mRNA PMID:39265697 14083963 TMPRSS6 transmembrane serine protease 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMPRSS6 mRNA PMID:35307453 14084009 BCL2L15 BCL2 like 15 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of BCL2L15 mRNA PMID:39265697 14084096 CBX1 chromobox 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBX1 mRNA PMID:35307453 14084134 EIF2B5 eukaryotic translation initiation factor 2B subunit epsilon gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2B5 mRNA PMID:35307453 14084154 CDH4 cadherin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDH4 mRNA PMID:35307453 14084177 RPA2 replication protein A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RPA2 mRNA PMID:35307453 14084177 RPA2 replication protein A2 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in increased expression of RPA2 protein PMID:32454083 14084190 TNNI2 troponin I2, fast skeletal type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNNI2 mRNA PMID:35307453 14084363 APBB2 amyloid beta precursor protein binding family B member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APBB2 mRNA PMID:35307453 14084426 CA5B carbonic anhydrase 5B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CA5B mRNA PMID:35307453 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP2 mRNA PMID:35307453 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:16469 17beta-estradiol affects secretion EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the secretion of MMP2 protein PMID:15653758 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 protein PMID:34416349 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of MMP2 protein] PMID:23890407 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased expression of MMP2 protein PMID:39486568 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:28748 doxorubicin increases activity EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased activity of MMP2 protein PMID:19782292 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased expression of MMP2 mRNA PMID:19782292 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 protein PMID:34416349 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased expression of MMP2 protein PMID:39486568 14084489 MMP2 matrix metallopeptidase 2 gene CHEBI:8772 raloxifene affects secretion EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the secretion of MMP2 protein PMID:15653758 14084723 PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PPP1R1B mRNA PMID:39265697 14084777 SLC44A2 solute carrier family 44 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC44A2 mRNA PMID:35307453 14084858 NMNAT1 nicotinamide nucleotide adenylyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NMNAT1 mRNA PMID:35307453 14085134 ZNF331 zinc finger protein 331 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF331 mRNA PMID:35307453 14085306 MCU mitochondrial calcium uniporter gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MCU mRNA PMID:35307453 14085339 CALR calreticulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALR mRNA PMID:35307453 14085339 CALR calreticulin gene CHEBI:53016 sulfamethoxazole hydroxylamine increases expression EXP E RGD:6480464 20191114 CTD MESH:C059873 sulfamethoxazole hydroxylamine results in increased expression of CALR protein PMID:16005169 14085339 CALR calreticulin gene CHEBI:64090 tert-butyl hydroperoxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of CALR protein PMID:16005169 14085354 EMD emerin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EMD mRNA PMID:35307453 14085424 MGST3 microsomal glutathione S-transferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MGST3 mRNA PMID:35307453 14085424 MGST3 microsomal glutathione S-transferase 3 gene CHEBI:2825 aristolochic acid A increases expression EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in increased expression of MGST3 protein PMID:21658425 14085424 MGST3 microsomal glutathione S-transferase 3 gene CHEBI:2825 aristolochic acid A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C000228 U 0126 inhibits the reaction [aristolochic acid I results in increased expression of MGST3 protein] PMID:21658425 14085510 COL4A6 collagen type IV alpha 6 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL4A6 mRNA PMID:35307453 14085558 ATP1A2 ATPase Na+/K+ transporting subunit alpha 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ATP1A2 mRNA PMID:34933075 14085646 BEX1 brain expressed, X-linked 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX2 mRNA] PMID:21852083 14085653 ABCC13 ATP binding cassette subfamily C member 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABCC13 mRNA PMID:35307453 14085846 RPS6 ribosomal protein S6 gene CHEBI:3093 bifenthrin increases phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased phosphorylation of RPS6 protein PMID:33901951 14085846 RPS6 ribosomal protein S6 gene CHEBI:39329 etoxazole affects phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole affects the phosphorylation of RPS6 protein PMID:31744678 14085846 RPS6 ribosomal protein S6 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of RPS6 protein]; pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of RPS6 protein]; SB 203580 affects the reaction [etoxazole affects the phosphorylation of RPS6 protein]; U 0126 affects the reaction [etoxazole affects the phosphorylation of RPS6 protein] PMID:31744678 14085846 RPS6 ribosomal protein S6 gene CHEBI:52289 wortmannin decreases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C009687 Wortmannin results in decreased phosphorylation of RPS6 protein PMID:31400776 14085846 RPS6 ribosomal protein S6 gene CHEBI:52289 wortmannin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C009687 Wortmannin promotes the reaction [Ivermectin results in decreased phosphorylation of RPS6 protein] PMID:31400776 14085846 RPS6 ribosomal protein S6 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 Wortmannin promotes the reaction [Ivermectin results in decreased phosphorylation of RPS6 protein] PMID:31400776 14085846 RPS6 ribosomal protein S6 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole affects the phosphorylation of RPS6 protein] PMID:31744678 14085846 RPS6 ribosomal protein S6 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone affects the reaction [etoxazole affects the phosphorylation of RPS6 protein] PMID:31744678 14085846 RPS6 ribosomal protein S6 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 SB 203580 affects the reaction [etoxazole affects the phosphorylation of RPS6 protein] PMID:31744678 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein] PMID:32877744 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:15379 dioxygen increases degradation EXP E RGD:6480464 20191114 CTD MESH:D010100 Oxygen deficiency results in increased degradation of NFKBIA protein PMID:9728040 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:15379 dioxygen increases expression EXP E RGD:6480464 20191114 CTD MESH:D010100 Oxygen deficiency results in increased expression of NFKBIA mRNA PMID:9728040 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:15553 prostaglandin F2alpha increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased phosphorylation of NFKBIA protein PMID:21505051 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of NFKBIA mRNA PMID:37706587 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of NFKBIA mRNA] PMID:37706587 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of NFKBIA protein PMID:32877744 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein] PMID:32877744 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:17245 carbon monoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002248 NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] PMID:11880364 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFKBIA mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of and results in increased ubiquitination of NFKBIA protein PMID:33592257 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of and results in increased phosphorylation of NFKBIA protein PMID:35388968 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:27881 resveratrol decreases degradation EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased degradation of NFKBIA protein PMID:20825639 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:32234 titanium dioxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C009495 titanium dioxide results in increased phosphorylation of NFKBIA protein PMID:23380242 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFKBIA mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of and results in increased ubiquitination of NFKBIA protein PMID:33592257 14085975 NFKBIA NFKB inhibitor alpha gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of NFKBIA mRNA] PMID:37706587 14085989 ID4 inhibitor of DNA binding 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ID4 mRNA PMID:35307453 14086078 ZFP36L2 ZFP36 ring finger protein like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFP36L2 mRNA PMID:37120089 14086078 ZFP36L2 ZFP36 ring finger protein like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZFP36L2 mRNA PMID:35307453 14086078 ZFP36L2 ZFP36 ring finger protein like 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ZFP36L2 mRNA] PMID:37120089 14086078 ZFP36L2 ZFP36 ring finger protein like 2 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ZFP36L2 mRNA] PMID:37120089 14086168 POLR1H RNA polymerase I subunit H gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of POLR1H mRNA PMID:39265697 14086206 FAM89B family with sequence similarity 89 member B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM89B mRNA PMID:35307453 14086212 HMGN2 high mobility group nucleosomal binding domain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HMGN2 mRNA PMID:35307453 14086212 HMGN2 high mobility group nucleosomal binding domain 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of HMGN2 protein PMID:37257635 14086244 TOX4 TOX high mobility group box family member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOX4 mRNA PMID:35307453 14086271 SLC25A6 solute carrier family 25 member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A6 mRNA PMID:35307453 14086272 CREBRF CREB3 regulatory factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CREBRF mRNA PMID:35307453 14086373 LOC100152566 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCNT2 mRNA PMID:35307453 14086503 GNL3L G protein nucleolar 3 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GNL3L mRNA PMID:35307453 14086544 FIBCD1 fibrinogen C domain containing 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of FIBCD1 mRNA PMID:34933075 14086608 H2BC15 H2B clustered histone 15 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of H2BC15 mRNA PMID:39265697 14086627 NEUROD1 neuronal differentiation 1 gene CHEBI:9168 sirolimus decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus results in decreased expression of NEUROD1 mRNA PMID:20622751 14086633 GIP gastric inhibitory polypeptide gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GIP mRNA PMID:35307453 14086710 TNS4 tensin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNS4 mRNA PMID:35307453 14086727 LOC100519098 sterile alpha motif domain-containing protein 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SAMD9 mRNA PMID:35307453 14086823 CD109 CD109 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD109 mRNA PMID:35307453 14086823 CD109 CD109 molecule gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of CD109 mRNA PMID:28069986 14086984 SHISA4 shisa family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHISA4 mRNA PMID:35307453 14087008 STAMBPL1 STAM binding protein like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STAMBPL1 mRNA PMID:35307453 14087045 ETS1 ETS proto-oncogene 1, transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ETS1 mRNA PMID:35307453 14087089 ANPEP alanyl aminopeptidase, membrane gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANPEP mRNA PMID:35307453 14087089 ANPEP alanyl aminopeptidase, membrane gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ANPEP mRNA PMID:18988085 14087089 ANPEP alanyl aminopeptidase, membrane gene CHEBI:44975 1,10-phenanthroline decreases activity EXP E RGD:6480464 20191114 CTD MESH:C025205 1,10-phenanthroline results in decreased activity of ANPEP protein PMID:17109655 14087089 ANPEP alanyl aminopeptidase, membrane gene CHEBI:44975 1,10-phenanthroline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025205 Edetic Acid promotes the reaction [1,10-phenanthroline results in decreased activity of ANPEP protein] PMID:17109655 14087089 ANPEP alanyl aminopeptidase, membrane gene CHEBI:4735 ethylenediaminetetraacetic acid multiple interactions EXP E RGD:6480464 20230207 CTD MESH:D004492 Edetic Acid promotes the reaction [1,10-phenanthroline results in decreased activity of ANPEP protein] PMID:17109655 14087235 SLC16A11 solute carrier family 16 member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A11 mRNA PMID:35307453 14087437 FARSB phenylalanyl-tRNA synthetase subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FARSB mRNA PMID:35307453 14087684 CELSR2 cadherin EGF LAG seven-pass G-type receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CELSR2 mRNA PMID:35307453 14087728 CETN4 centrin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of CETN4 mRNA PMID:35307453 14087751 GPNMB glycoprotein nmb gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPNMB mRNA PMID:35307453 14087783 CFAP418 cilia and flagella associated protein 418 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP418 mRNA PMID:35307453 14087793 EML6 EMAP like 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EML6 mRNA PMID:35307453 14087854 DSE dermatan sulfate epimerase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DSE mRNA PMID:35307453 14087908 SLC49A3 solute carrier family 49 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC49A3 mRNA PMID:35307453 14087975 NDUFA9 NADH:ubiquinone oxidoreductase subunit A9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NDUFA9 mRNA PMID:35307453 14088029 PPP1R14A protein phosphatase 1 regulatory inhibitor subunit 14A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP1R14A mRNA PMID:35307453 14088043 ANK3 ankyrin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANK3 mRNA PMID:35307453 14088118 UQCRB ubiquinol-cytochrome c reductase binding protein gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 [Betaine co-treated with Glyphosate] results in decreased expression of UQCRB mRNA PMID:36584959 14088118 UQCRB ubiquinol-cytochrome c reductase binding protein gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 [Betaine co-treated with Glyphosate] results in decreased expression of UQCRB mRNA PMID:36584959 14088118 UQCRB ubiquinol-cytochrome c reductase binding protein gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of UQCRB mRNA PMID:38432436 14088145 FAM177A1 family with sequence similarity 177 member A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM177A1 mRNA; deoxynivalenol results in decreased expression of FAM177A1 protein PMID:38403181 14088145 FAM177A1 family with sequence similarity 177 member A1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of FAM177A1 mRNA PMID:34389318 14088245 FAM222A family with sequence similarity 222 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM222A mRNA PMID:35307453 14088386 CEACAM16 CEA cell adhesion molecule 16, tectorial membrane component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEACAM16 mRNA PMID:35307453 14088398 CHRNA9 cholinergic receptor nicotinic alpha 9 subunit gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein] PMID:28235547 14088398 CHRNA9 cholinergic receptor nicotinic alpha 9 subunit gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein] PMID:28235547 14088398 CHRNA9 cholinergic receptor nicotinic alpha 9 subunit gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein] PMID:28235547 14088398 CHRNA9 cholinergic receptor nicotinic alpha 9 subunit gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein] PMID:28235547 14088420 FBLN5 fibulin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBLN5 mRNA PMID:35307453 14088463 IKBKB inhibitor of nuclear factor kappa B kinase subunit beta gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IKBKB mRNA PMID:33592257 14088463 IKBKB inhibitor of nuclear factor kappa B kinase subunit beta gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IKBKB mRNA PMID:33592257 14088566 SH3BGRL SH3 domain binding glutamate rich protein like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3BGRL mRNA PMID:35307453 14088566 SH3BGRL SH3 domain binding glutamate rich protein like gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SH3BGRL mRNA PMID:21852083 14088611 BHLHE40 basic helix-loop-helix family member e40 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BHLHE40 mRNA PMID:35307453 14088720 NDRG4 NDRG family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NDRG4 mRNA PMID:35307453 14088720 NDRG4 NDRG family member 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NDRG4 mRNA PMID:34933075 14088765 CD244 CD244 molecule gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CD244 mRNA PMID:34933075 14088785 AQP5 aquaporin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP5 mRNA PMID:35307453 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:16240 hydrogen peroxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein PMID:11325585 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] PMID:17383151 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] PMID:17383151 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:31823 mercury dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased phosphorylation of MAPK9 protein PMID:10696784 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of MAPK9 protein PMID:10696784|PMID:17383151 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] PMID:10696784|PMID:17383151 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] PMID:17383151 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein PMID:11325585 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of MAPK9 mRNA PMID:32198028 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK9 mRNA] PMID:32198028 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 pyrazolanthrone promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK9 protein]; U 0126 promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK9 protein] PMID:31400776 14088820 MAPK9 mitogen-activated protein kinase 9 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK9 protein] PMID:31400776 14088917 CATIP ciliogenesis associated TTC17 interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CATIP mRNA PMID:35307453 14089067 ACTA2 actin alpha 2, smooth muscle gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACTA2 mRNA; deoxynivalenol results in decreased expression of ACTA2 protein PMID:38403181 14089194 NANOG Nanog homeobox gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of NANOG mRNA PMID:28819136 14089194 NANOG Nanog homeobox gene CHEBI:4027 cyclophosphamide multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D003520 [Panobinostat co-treated with Cyclophosphamide] results in increased expression of NANOG mRNA PMID:37980972 14089194 NANOG Nanog homeobox gene CHEBI:85990 panobinostat multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C496932 [Panobinostat co-treated with Cyclophosphamide] results in increased expression of NANOG mRNA PMID:37980972 14089250 SORCS1 sortilin related VPS10 domain containing receptor 1 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of SORCS1 mRNA PMID:35307453 14089299 RIMOC1 RAB7A interacting MON1-CCZ1 complex subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIMOC1 mRNA PMID:35307453 14089316 MASTL microtubule associated serine/threonine kinase like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MASTL mRNA PMID:35307453 14089342 TMC8 transmembrane channel like 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMC8 mRNA PMID:35307453 14089488 XYLB xylulokinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of XYLB mRNA PMID:35307453 14089569 PAK4 p21 (RAC1) activated kinase 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20201006 CTD MESH:D015025 Zearalenone results in decreased expression of PAK4 mRNA; Zearalenone results in decreased expression of PAK4 protein PMID:32439583 14089596 SH3RF3 SH3 domain containing ring finger 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3RF3 mRNA PMID:35307453 14089628 EIF3L eukaryotic translation initiation factor 3 subunit L gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of EIF3L mRNA PMID:28069986 14089650 MLLT6 MLLT6, PHD finger containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MLLT6 mRNA PMID:35307453 14089749 NDUFB1 NADH:ubiquinone oxidoreductase subunit B1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDUFB1 mRNA; graphene oxide results in decreased expression of NDUFB1 protein PMID:39265697 14089785 MT-CO1 mitochondrially encoded cytochrome c oxidase I gene CHEBI:3000 beauvericin increases expression EXP E RGD:6480464 20191114 CTD MESH:C004456 beauvericin results in increased expression of COX1 mRNA PMID:27474255 14089785 MT-CO1 mitochondrially encoded cytochrome c oxidase I gene CHEBI:6651 malathion affects expression EXP E RGD:6480464 20191114 CTD MESH:D008294 Malathion affects the expression of COX1 mRNA PMID:17454254 14089801 RASSF10 Ras association domain family member 10 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RASSF10 mRNA PMID:39265697 14089815 DNAJB13 DnaJ heat shock protein family (Hsp40) member B13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJB13 mRNA PMID:35307453 14089839 ITGA11 integrin subunit alpha 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA11 mRNA PMID:38403181 14090294 DCAF8 DDB1 and CUL4 associated factor 8 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of DCAF8 mRNA PMID:34389318 14090400 WFDC2 WAP four-disulfide core domain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WFDC2 mRNA PMID:35307453 14090487 EFNA1 ephrin A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFNA1 mRNA PMID:35307453 14090759 SOX9 SRY-box transcription factor 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SOX9 mRNA PMID:35307453 14090759 SOX9 SRY-box transcription factor 9 gene CHEBI:10033 warfarin decreases expression EXP E RGD:6480464 20230905 CTD MESH:D014859 Warfarin results in decreased expression of SOX9 mRNA PMID:34520801 14090759 SOX9 SRY-box transcription factor 9 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D014859 SOX5 protein affects the reaction [Warfarin results in decreased expression of SOX9 mRNA]; SOX5 protein inhibits the reaction [Warfarin promotes the reaction [SOX9 protein binds to RUNX2 promoter]]; SOX5 protein inhibits the reaction [Warfarin results in decreased expression of and affects the localization of SOX9 protein]; SOX5 protein promotes the reaction [Warfarin promotes the reaction [SOX9 protein binds to LRP6 promoter]]; Warfarin promotes the reaction [SOX5 protein binds to SOX9 promoter]; Warfarin promotes the reaction [SOX9 protein binds to LRP6 promoter]; Warfarin promotes the reaction [SOX9 protein binds to RUNX2 promoter]; Warfarin results in decreased expression of and affects the localization of SOX9 protein PMID:34520801 14090768 FNDC7 fibronectin type III domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FNDC7 mRNA PMID:35307453 14090811 PRKAG3 protein kinase AMP-activated non-catalytic subunit gamma 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRKAG3 mRNA PMID:35307453 14090811 PRKAG3 protein kinase AMP-activated non-catalytic subunit gamma 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PRKAG3 mRNA PMID:34933075 14090811 PRKAG3 protein kinase AMP-activated non-catalytic subunit gamma 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAG3 mRNA PMID:34416349 14090811 PRKAG3 protein kinase AMP-activated non-catalytic subunit gamma 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKAG3 mRNA PMID:34416349 14090844 CH25H cholesterol 25-hydroxylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CH25H mRNA PMID:35307453 14090942 GORAB golgin, RAB6 interacting gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GORAB mRNA PMID:35307453 14090960 TBXAS1 thromboxane A synthase 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TBXAS1 mRNA PMID:18988085 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:17026 progesterone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in decreased expression of FGFR2 mRNA alternative form PMID:15120423 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form PMID:15976484 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of FGFR2 mRNA PMID:18988085 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:29310 dichlorine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in decreased expression of FGFR2 mRNA PMID:22533443 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:77006 17beta-estradiol 3-benzoate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C074283 estradiol 3-benzoate results in decreased expression of FGFR2 mRNA alternative form PMID:15976484 14091017 FGFR2 fibroblast growth factor receptor 2 gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C074283 [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form PMID:15976484 14091083 CD82 CD82 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD82 mRNA PMID:35307453 14091083 CD82 CD82 molecule gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CD82 mRNA PMID:39265697 14091101 SUMF1 sulfatase modifying factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUMF1 mRNA PMID:35307453 14091156 PPM1F protein phosphatase, Mg2+/Mn2+ dependent 1F gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPM1F mRNA PMID:35307453 14091171 HMGN5 high mobility group nucleosome binding domain 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HMGN5 mRNA PMID:35307453 14091182 NREP neuronal regeneration related protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NREP mRNA PMID:35307453 14091182 NREP neuronal regeneration related protein gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of NREP mRNA PMID:34389318 14091182 NREP neuronal regeneration related protein gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NREP mRNA] PMID:21852083 14091350 RNF32 ring finger protein 32 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNF32 mRNA PMID:35307453 14091386 LPP LIM domain containing preferred translocation partner in lipoma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LPP mRNA PMID:35307453 14091422 NPM3 nucleophosmin/nucleoplasmin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NPM3 mRNA PMID:35307453 14091433 YIF1B Yip1 interacting factor homolog B, membrane trafficking protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YIF1B mRNA PMID:35307453 14091676 TLR1 toll like receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TLR1 mRNA PMID:35307453 14091736 TMIGD1 transmembrane and immunoglobulin domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMIGD1 mRNA PMID:35307453 14091923 FRG1 FSHD region gene 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FRG1 mRNA PMID:35307453 14091936 LEKR1 leucine, glutamate and lysine rich 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LEKR1 mRNA PMID:35307453 14091983 MRAS muscle RAS oncogene homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MRAS mRNA PMID:35307453 14092207 PPP1R1A protein phosphatase 1 regulatory inhibitor subunit 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP1R1A mRNA PMID:35307453 14092224 SIGLEC5 sialic acid binding Ig like lectin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIGLEC5 mRNA PMID:35307453 14092509 SPTBN1 spectrin beta, non-erythrocytic 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of SPTBN1 mRNA PMID:35839969 14092575 UNC93A unc-93 homolog A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UNC93A mRNA PMID:35307453 14092645 SPEF2 sperm flagellar 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPEF2 mRNA PMID:35307453 14092701 NPY2R neuropeptide Y receptor Y2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NPY2R mRNA PMID:35307453 14092745 FTH1 ferritin heavy chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FTH1 mRNA PMID:35307453 14092801 VCAN versican gene CHEBI:17224 4-methylumbelliferone decreases expression EXP E RGD:6480464 20210824 CTD MESH:D006923 Hymecromone results in decreased expression of VCAN mRNA; Hymecromone results in decreased expression of VCAN protein PMID:23139787 14092882 SLC35G6 solute carrier family 35 member G6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC35G6 mRNA PMID:35307453 14093023 PODXL2 podocalyxin like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PODXL2 mRNA PMID:35307453 14093063 RCN3 reticulocalbin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RCN3 mRNA PMID:35307453 14093166 TCN2 transcobalamin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCN2 mRNA PMID:35307453 14093234 ZNF541 zinc finger protein 541 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF541 mRNA PMID:35307453 14093278 DNAJC22 DnaJ heat shock protein family (Hsp40) member C22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC22 mRNA PMID:35307453 14093549 NFKB2 nuclear factor kappa B subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NFKB2 mRNA PMID:35307453 14093636 TBX20 T-box transcription factor 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBX20 mRNA PMID:35307453 14093636 TBX20 T-box transcription factor 20 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TBX20 mRNA PMID:34933075 14093660 PTCHD4 patched domain containing 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of PTCHD4 mRNA PMID:21852083 14093702 CDV3 CDV3 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDV3 mRNA PMID:35307453 14093726 SNRPA1 small nuclear ribonucleoprotein polypeptide A' gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPA1 mRNA PMID:35307453 14093813 CDA cytidine deaminase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDA mRNA PMID:35307453 14093893 IL23A interleukin 23 subunit alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL23A mRNA PMID:23326479 14093893 IL23A interleukin 23 subunit alpha gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of IL23A mRNA PMID:27617619 14093943 ANXA2 annexin A2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANXA2 mRNA PMID:35307453 14094210 RSPH4A radial spoke head component 4A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RSPH4A mRNA PMID:35307453 14094226 OBP odorant binding protein gene CHEBI:45113 2-isobutyl-3-methoxypyrazine affects binding EXP E RGD:6480464 20250401 CTD MESH:C034376 2-isobutyl-3-methoxypyrazine binds to OBP protein PMID:10825538 14094414 CFAP206 cilia and flagella associated protein 206 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP206 mRNA PMID:35307453 14094560 PTGES2 prostaglandin E synthase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTGES2 mRNA PMID:35307453 14094650 SNAPC2 small nuclear RNA activating complex polypeptide 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNAPC2 mRNA PMID:35307453 14094669 EBNA1BP2 EBNA1 binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EBNA1BP2 mRNA PMID:35307453 14094682 DUSP8 dual specificity phosphatase 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP8 mRNA PMID:35307453 14094719 GAMT guanidinoacetate N-methyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAMT mRNA PMID:35307453 14094782 DNAH2 dynein axonemal heavy chain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH2 mRNA PMID:35307453 14094874 MRPL55 mitochondrial ribosomal protein L55 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL55 mRNA PMID:35307453 14094909 BTBD10 BTB domain containing 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BTBD10 mRNA PMID:35307453 14094946 TOP3B DNA topoisomerase III beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOP3B mRNA PMID:35307453 14095004 LGR5 leucine rich repeat containing G protein-coupled receptor 5 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of LGR5 mRNA PMID:34933075 14095098 SDS serine dehydratase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SDS mRNA PMID:21852083 14095121 PPT2 palmitoyl-protein thioesterase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPT2 mRNA PMID:35307453 14095147 ADGRE5 adhesion G protein-coupled receptor E5 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of ADGRE5 mRNA PMID:25455459 14095229 RBM42 RNA binding motif protein 42 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM42 mRNA PMID:35307453 14095278 FRRS1 ferric chelate reductase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FRRS1 mRNA PMID:35307453 14095333 ABCE1 ATP binding cassette subfamily E member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABCE1 mRNA; deoxynivalenol results in increased expression of ABCE1 protein PMID:35307453|PMID:38403181 14095530 ARSB arylsulfatase B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARSB mRNA PMID:35307453 14095695 LOXL3 lysyl oxidase like 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LOXL3 mRNA; deoxynivalenol results in decreased expression of LOXL3 protein PMID:38403181 14095757 NEURL1B neuralized E3 ubiquitin protein ligase 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEURL1B mRNA PMID:35307453 14095788 SLC6A12 solute carrier family 6 member 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC6A12 mRNA PMID:35307453 14095788 SLC6A12 solute carrier family 6 member 12 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SLC6A12 mRNA PMID:39265697 14095831 KIAA1210 KIAA1210 ortholog gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of KIAA1210 mRNA PMID:34933075 14095934 BCKDHB branched chain keto acid dehydrogenase E1 subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCKDHB mRNA PMID:35307453 14095967 FSCN2 fascin actin-bundling protein 2, retinal gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FSCN2 mRNA PMID:35307453 14095983 SLC39A4 solute carrier family 39 member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC39A4 mRNA PMID:35307453 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA PMID:28445388 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:15428 glycine increases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in increased expression of DNMT1 mRNA PMID:39127149 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of DNMT1 mRNA] PMID:39127149 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA PMID:28445388 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA PMID:28445388 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA PMID:28445388 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 protein] PMID:29080797|PMID:30923867 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of DNMT1 mRNA; ochratoxin A results in increased expression of DNMT1 protein PMID:29080797|PMID:30923867 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 protein] PMID:29080797|PMID:30923867 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in decreased expression of DNMT1 mRNA PMID:39127149 14096223 DNMT1 DNA methyltransferase 1 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of DNMT1 mRNA] PMID:39127149 14096331 ISG15 ISG15 ubiquitin like modifier gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of ISG15 mRNA] PMID:27079946 14096337 SLC51B SLC51 subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC51B mRNA PMID:35307453 14096392 NDUFAF4 NADH:ubiquinone oxidoreductase complex assembly factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NDUFAF4 mRNA PMID:35307453 14096444 CTBS chitobiase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTBS mRNA PMID:35307453 14096530 AATK apoptosis associated tyrosine kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AATK mRNA PMID:35307453 14096547 CCDC40 coiled-coil domain 40 molecular ruler complex subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC40 mRNA PMID:35307453 14096869 CHAF1B chromatin assembly factor 1 subunit B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHAF1B mRNA PMID:35307453 14096893 EMID1 EMI domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EMID1 mRNA PMID:35307453 14096981 LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LFNG mRNA PMID:35307453 14097045 EIF4A1 eukaryotic translation initiation factor 4A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4A1 mRNA PMID:35307453 14097161 FBXW9 F-box and WD repeat domain containing 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXW9 mRNA PMID:35307453 14097343 SOCS1 suppressor of cytokine signaling 1 gene CHEBI:77732 cadmium nitrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in decreased expression of SOCS1 mRNA PMID:29421334 14097364 CLIP1 CAP-Gly domain containing linker protein 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CLIP1 mRNA PMID:21852083 14097436 PLA2G4A phospholipase A2 group IVA gene CHEBI:28984 aluminium atom affects activity EXP E RGD:6480464 20191114 CTD MESH:D000535 Aluminum affects the activity of PLA2G4A protein PMID:17279785 14097436 PLA2G4A phospholipase A2 group IVA gene CHEBI:33629 aluminium(0) affects activity EXP E RGD:6480464 20191114 CTD MESH:D000535 Aluminum affects the activity of PLA2G4A protein PMID:17279785 14097574 RBMX2 RNA binding motif protein X-linked 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBMX2 mRNA PMID:35307453 14097584 IGF2BP1 insulin like growth factor 2 mRNA binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IGF2BP1 mRNA PMID:35307453 14097607 MMP7 matrix metallopeptidase 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP7 mRNA PMID:35307453 14097607 MMP7 matrix metallopeptidase 7 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MMP7 mRNA PMID:39265697 14097607 MMP7 matrix metallopeptidase 7 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of MMP7 mRNA PMID:22497863 14097657 NTN4 netrin 4 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of NTN4 mRNA PMID:39265697 14097769 TSTD1 thiosulfate sulfurtransferase like domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSTD1 mRNA PMID:35307453 14097769 TSTD1 thiosulfate sulfurtransferase like domain containing 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TSTD1 mRNA PMID:39265697 14097785 POLR3D RNA polymerase III subunit D gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR3D mRNA PMID:35307453 14097850 SRXN1 sulfiredoxin 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA] PMID:39151877 14097850 SRXN1 sulfiredoxin 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SRXN1 mRNA PMID:39151877 14097850 SRXN1 sulfiredoxin 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA] PMID:39151877 14097949 ATP6V1F ATPase H+ transporting V1 subunit F gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP6V1F mRNA PMID:35307453 14097956 MCAM melanoma cell adhesion molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MCAM mRNA PMID:35307453 14098058 ARMC2 armadillo repeat containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARMC2 mRNA PMID:35307453 14098195 ADCK1 aarF domain containing kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADCK1 mRNA PMID:35307453 14098222 IL6 interleukin 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL6 mRNA; deoxynivalenol results in increased expression of IL6 protein PMID:19027837|PMID:19607891|PMID:23326479|PMID:23688591|PMID:24394488|PMID:32783910|PMID:33817499|PMID:35307453|PMID:37120089|PMID:37442268 14098222 IL6 interleukin 6 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IL6 mRNA; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol] results in decreased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; deoxynivalenol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; deoxynivalenol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of IL6 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of IL6 protein] PMID:19027837|PMID:19607891|PMID:23688591|PMID:32783910|PMID:32877744|PMID:33817499|PMID:37120089|PMID:37442268|PMID:38763499 14098222 IL6 interleukin 6 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of IL6 mRNA; Zearalenone results in increased expression of IL6 protein PMID:23688591|PMID:32783910|PMID:34933075 14098222 IL6 interleukin 6 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone] results in decreased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of IL6 protein]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of IL6 protein] PMID:23688591|PMID:32783910 14098222 IL6 interleukin 6 gene CHEBI:114786 sodium disulfite multiple interactions EXP E RGD:6480464 20220906 CTD MESH:C005200 sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA] PMID:33817499 14098222 IL6 interleukin 6 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of IL6 mRNA PMID:39265697 14098222 IL6 interleukin 6 gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of IL6 mRNA PMID:16364719 14098222 IL6 interleukin 6 gene CHEBI:16112 chlorogenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002726 Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] PMID:27861533 14098222 IL6 interleukin 6 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of IL6 mRNA PMID:38438008 14098222 IL6 interleukin 6 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA] PMID:38438008 14098222 IL6 interleukin 6 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [Linoleic Acid results in increased expression of IL6 mRNA] PMID:15051824 14098222 IL6 interleukin 6 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL6 mRNA PMID:26180592|PMID:27861533|PMID:32877744 14098222 IL6 interleukin 6 gene CHEBI:16412 lipopolysaccharide increases secretion EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased secretion of IL6 protein PMID:8724211 14098222 IL6 interleukin 6 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; picolinic acid promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] PMID:26180592|PMID:27861533|PMID:32877744|PMID:8724211 14098222 IL6 interleukin 6 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein] PMID:37120089 14098222 IL6 interleukin 6 gene CHEBI:17351 linoleic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased expression of IL6 mRNA; Linoleic Acid results in increased expression of IL6 protein PMID:14519784|PMID:15051824 14098222 IL6 interleukin 6 gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 2,4-thiazolidinedione inhibits the reaction [Linoleic Acid results in increased expression of IL6 protein]; PPARG protein promotes the reaction [Linoleic Acid results in increased expression of IL6 protein]; Quercetin inhibits the reaction [Linoleic Acid results in increased expression of IL6 mRNA] PMID:14519784|PMID:15051824 14098222 IL6 interleukin 6 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA] PMID:38438008 14098222 IL6 interleukin 6 gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of IL6 mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased secretion of IL6 protein] PMID:38154151 14098222 IL6 interleukin 6 gene CHEBI:18388 apigenin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D047310 Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] PMID:26180592 14098222 IL6 interleukin 6 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL6 mRNA PMID:33592257|PMID:33891997|PMID:34416349 14098222 IL6 interleukin 6 gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IL6 mRNA PMID:38763499 14098222 IL6 interleukin 6 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of IL6 mRNA PMID:12481301 14098222 IL6 interleukin 6 gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of IL6 mRNA; Mycotoxins results in increased expression of IL6 protein PMID:39137830 14098222 IL6 interleukin 6 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of IL6 mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of IL6 protein] PMID:39137830 14098222 IL6 interleukin 6 gene CHEBI:2682 amphotericin B increases expression EXP E RGD:6480464 20191114 CTD MESH:D000666 Amphotericin B results in increased expression of IL6 protein PMID:24105867 14098222 IL6 interleukin 6 gene CHEBI:2682 amphotericin B multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000666 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein] PMID:24105867 14098222 IL6 interleukin 6 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of IL6 protein] PMID:14519784|PMID:15226458 14098222 IL6 interleukin 6 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein] PMID:37442268 14098222 IL6 interleukin 6 gene CHEBI:27744 glyphosate affects secretion EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the secretion of IL6 protein PMID:35388968 14098222 IL6 interleukin 6 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of IL6 mRNA; Glyphosate results in increased expression of IL6 protein PMID:31677563|PMID:35388968|PMID:36584959 14098222 IL6 interleukin 6 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL6 mRNA] PMID:35388968 14098222 IL6 interleukin 6 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA] PMID:37955343 14098222 IL6 interleukin 6 gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20200114 CTD MESH:D020106 Acrylamide results in increased expression of IL6 protein PMID:31302221 14098222 IL6 interleukin 6 gene CHEBI:28747 picolinic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C030614 picolinic acid promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] PMID:8724211 14098222 IL6 interleukin 6 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of IL6 mRNA PMID:22533443 14098222 IL6 interleukin 6 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of IL6 protein] PMID:14519784|PMID:15226458 14098222 IL6 interleukin 6 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of IL6 mRNA PMID:37108405|PMID:38154151 14098222 IL6 interleukin 6 gene CHEBI:33216 bisphenol A increases secretion EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased secretion of IL6 protein PMID:38154151 14098222 IL6 interleukin 6 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of IL6 mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased secretion of IL6 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL6 mRNA] PMID:37108405|PMID:38154151 14098222 IL6 interleukin 6 gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C019273 bisphenol A diglycidyl ether inhibits the reaction [Rosiglitazone promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]; bisphenol A diglycidyl ether inhibits the reaction [Rosiglitazone promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 protein]] PMID:19474210 14098222 IL6 interleukin 6 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of IL6 mRNA PMID:33626375 14098222 IL6 interleukin 6 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL6 mRNA PMID:33592257|PMID:33891997|PMID:34416349 14098222 IL6 interleukin 6 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IL6 mRNA] PMID:27079946 14098222 IL6 interleukin 6 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein] PMID:37442268 14098222 IL6 interleukin 6 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in decreased expression of IL6 mRNA PMID:23688591 14098222 IL6 interleukin 6 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of IL6 mRNA PMID:23688591|PMID:30708112|PMID:37955343|PMID:38705344 14098222 IL6 interleukin 6 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in decreased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA] PMID:23688591|PMID:37955343|PMID:38705344 14098222 IL6 interleukin 6 gene CHEBI:47495 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases expression EXP E RGD:6480464 20191114 CTD MESH:C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of IL6 protein PMID:24105867 14098222 IL6 interleukin 6 gene CHEBI:47495 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein] PMID:24105867 14098222 IL6 interleukin 6 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL6 mRNA] PMID:37108405 14098222 IL6 interleukin 6 gene CHEBI:50992 1,3-thiazolidine-2,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C089946 2,4-thiazolidinedione inhibits the reaction [Linoleic Acid results in increased expression of IL6 protein]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]] PMID:14519784|PMID:15226458 14098222 IL6 interleukin 6 gene CHEBI:7599 Nivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in decreased expression of IL6 mRNA PMID:23688591 14098222 IL6 interleukin 6 gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL6 mRNA PMID:23688591 14098222 IL6 interleukin 6 gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol] results in decreased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in decreased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone] results in decreased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL6 mRNA PMID:23688591 14098222 IL6 interleukin 6 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of IL6 mRNA PMID:28710020 14098222 IL6 interleukin 6 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL6 mRNA] PMID:28710020 14098222 IL6 interleukin 6 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of IL6 mRNA PMID:29421334 14098222 IL6 interleukin 6 gene CHEBI:78782 pyrrolidine dithiocarbamate multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020972 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL6 mRNA] PMID:35388968 14098222 IL6 interleukin 6 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of IL6 protein PMID:14519784 14098222 IL6 interleukin 6 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of IL6 protein] PMID:14519784|PMID:15226458 14098222 IL6 interleukin 6 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of IL6 mRNA PMID:21176401 14098222 IL6 interleukin 6 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA] PMID:38438008 14098290 HTRA3 HtrA serine peptidase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HTRA3 mRNA PMID:35307453 14098402 TMTC4 transmembrane O-mannosyltransferase targeting cadherins 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMTC4 mRNA PMID:35307453 14098439 ATP5MC1 ATP synthase membrane subunit c locus 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP5MC1 mRNA PMID:35307453 14098439 ATP5MC1 ATP synthase membrane subunit c locus 1 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of ATP5MC1 mRNA PMID:38432436 14098539 DGAT1 diacylglycerol O-acyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DGAT1 mRNA PMID:35307453 14098573 LRRFIP1 LRR binding FLII interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRFIP1 mRNA PMID:35307453 14098752 GPR153 G protein-coupled receptor 153 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR153 mRNA PMID:35307453 14098909 MTMR4 myotubularin related protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of MTMR4 protein PMID:37257635 14099138 TSC22D2 TSC22 domain family member 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of TSC22D2 mRNA PMID:21852083 14099299 IL4 interleukin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL4 mRNA PMID:25701311 14099299 IL4 interleukin 4 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of and results in decreased secretion of IL4 protein PMID:23727178 14099299 IL4 interleukin 4 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL4 mRNA PMID:33891997|PMID:34416349 14099299 IL4 interleukin 4 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL4 mRNA PMID:33891997|PMID:34416349 14099299 IL4 interleukin 4 gene CHEBI:6736 melittin decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D008555 IL4 protein results in decreased susceptibility to Melitten PMID:20017192 14099299 IL4 interleukin 4 gene CHEBI:77149 notoginsenoside R1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C072936 notoginsenoside R1 results in decreased expression of IL4 protein PMID:25721049 14099299 IL4 interleukin 4 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of IL4 mRNA PMID:14994279 14099322 GRM4 glutamate metabotropic receptor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRM4 mRNA PMID:35307453 14099392 SPATA16 spermatogenesis associated 16 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPATA16 mRNA PMID:35307453 14099404 RTCB RNA 2',3'-cyclic phosphate and 5'-OH ligase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RTCB mRNA PMID:35307453 14099475 SLA-DOA major histocompatibility complex, class II, DO alpha gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of SLA-DOA mRNA PMID:22497863 14099500 GRHL1 grainyhead like transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GRHL1 mRNA PMID:35307453 14099540 UTP3 UTP3 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP3 mRNA PMID:35307453 14099647 ZNF366 zinc finger protein 366 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF366 mRNA PMID:35307453 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGF18 mRNA PMID:35307453 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of FGF18 mRNA PMID:37706587 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FGF18 mRNA] PMID:37706587 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:18376 dermatan sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D003871 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein PMID:14699094 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:37397 chondroitin sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D002809 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein PMID:14699094 14099704 FGF18 fibroblast growth factor 18 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FGF18 mRNA] PMID:37706587 14099813 EFCAB2 EF-hand calcium binding domain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFCAB2 mRNA PMID:35307453 14100156 PRADC1 protease associated domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRADC1 mRNA PMID:35307453 14100165 ZFR2 zinc finger RNA binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFR2 mRNA PMID:35307453 14100277 FOXR1 forkhead box R1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXR1 mRNA PMID:35307453 14100293 CFL2 cofilin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CFL2 mRNA; deoxynivalenol results in increased expression of CFL2 protein PMID:35307453|PMID:38403181 14100424 PTGES3 prostaglandin E synthase 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of PTGES3 protein PMID:33626375 14100531 ALDH18A1 aldehyde dehydrogenase 18 family member A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH18A1 mRNA; deoxynivalenol results in decreased expression of ALDH18A1 protein PMID:38403181 14100712 SLC16A10 solute carrier family 16 member 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A10 mRNA PMID:35307453 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYP3A29 mRNA PMID:35307453 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:17347 testosterone increases hydroxylation EXP E RGD:6480464 20191114 CTD MESH:D013739 CYP3A29 protein results in increased hydroxylation of Testosterone PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013739 Ketoconazole inhibits the reaction [CYP3A29 protein results in increased hydroxylation of Testosterone]; Troleandomycin inhibits the reaction [CYP3A29 protein results in increased hydroxylation of Testosterone] PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:223316 (+)-artemisinin increases expression EXP E RGD:6480464 20241001 CTD MESH:C031327 artemisinin results in increased expression of CYP3A29 mRNA PMID:24176340 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:34477 6beta-hydroxytestosterone increases chemical synthesis EXP E RGD:6480464 20191114 CTD MESH:C025591 CYP3A29 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:34477 6beta-hydroxytestosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025591 Ketoconazole inhibits the reaction [CYP3A29 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Troleandomycin inhibits the reaction [CYP3A29 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone] PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of CYP3A29 mRNA PMID:22497863 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20241001 CTD MESH:D003907 Dexamethasone results in increased expression of CYP3A29 mRNA PMID:24176340 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:45735 troleandomycin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014217 Troleandomycin inhibits the reaction [CYP3A29 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Troleandomycin inhibits the reaction [CYP3A29 protein results in increased hydroxylation of Testosterone]; Troleandomycin inhibits the reaction [CYP3A29 protein results in increased oxidation of Nifedipine] PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:47519 ketoconazole multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D007654 Ketoconazole inhibits the reaction [CYP3A29 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Ketoconazole inhibits the reaction [CYP3A29 protein results in increased hydroxylation of Testosterone]; Ketoconazole inhibits the reaction [CYP3A29 protein results in increased oxidation of Nifedipine] PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:7565 nifedipine increases oxidation EXP E RGD:6480464 20191114 CTD MESH:D009543 CYP3A29 protein results in increased oxidation of Nifedipine PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:7565 nifedipine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009543 Ketoconazole inhibits the reaction [CYP3A29 protein results in increased oxidation of Nifedipine]; Troleandomycin inhibits the reaction [CYP3A29 protein results in increased oxidation of Nifedipine] PMID:20863320 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20191114 CTD MESH:C014558 flunixin meglumine affects the expression of CYP3A29 mRNA PMID:26366864 14100757 CYP3A29 cytochrome P450 family 3 subfamily A member 29 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20191114 CTD MESH:D005273 Fenbendazole affects the expression of CYP3A29 mRNA PMID:26366864 14100824 CTHRC1 collagen triple helix repeat containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of CTHRC1 mRNA PMID:37257635 14100883 HOXA5 homeobox A5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXA5 mRNA PMID:35307453 14100969 FGF8 fibroblast growth factor 8 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of FGF8 mRNA PMID:37706587 14100969 FGF8 fibroblast growth factor 8 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FGF8 mRNA] PMID:37706587 14100969 FGF8 fibroblast growth factor 8 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of FGF8 mRNA] PMID:37706587 14101011 AQP8 aquaporin 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP8 mRNA PMID:35307453 14101021 RPLP2 ribosomal protein lateral stalk subunit P2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPLP2 mRNA PMID:39265697 14101036 SKIDA1 SKI/DACH domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SKIDA1 mRNA PMID:35307453 14101099 DNAH17 dynein axonemal heavy chain 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH17 mRNA PMID:35307453 14101257 ATP5MC3 ATP synthase membrane subunit c locus 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP5MC3 mRNA PMID:35307453 14101305 PTCH2 patched 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTCH2 mRNA PMID:35307453 14101383 DMAC2 distal membrane arm assembly component 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DMAC2 mRNA PMID:35307453 14101401 YPEL1 yippee like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of YPEL1 mRNA PMID:35307453 14101468 MUTYH mutY DNA glycosylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MUTYH mRNA PMID:35307453 14101504 SLC25A12 solute carrier family 25 member 12 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SLC25A12 mRNA PMID:34389318 14101539 SLC24A1 solute carrier family 24 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC24A1 mRNA PMID:35307453 14101585 OPN4 opsin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OPN4 mRNA PMID:35307453 14101699 FMO2 flavin containing dimethylaniline monoxygenase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMO2 mRNA PMID:35307453 14102062 HEXA hexosaminidase subunit alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HEXA mRNA PMID:35307453 14102092 TBC1D22B TBC1 domain family member 22B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBC1D22B mRNA PMID:35307453 14102141 TCOF1 treacle ribosome biogenesis factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TCOF1 mRNA PMID:35307453 14102395 NGDN neuroguidin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NGDN mRNA PMID:35307453 14102428 RNLS renalase, FAD dependent amine oxidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNLS mRNA PMID:35307453 14102469 KLK1 kallikrein 1 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of KLK1 mRNA PMID:21391292 14102477 UGT2B31 UDP-glucuronosyltransferase 2B31 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of UGT2B11 mRNA PMID:21852083 14102511 HIBCH 3-hydroxyisobutyryl-CoA hydrolase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HIBCH mRNA PMID:35307453 14102595 TOGARAM2 TOG array regulator of axonemal microtubules 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOGARAM2 mRNA PMID:35307453 14102713 UBALD1 UBA like domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBALD1 mRNA PMID:35307453 14102808 BAP1 BRCA1 associated deubiquitinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BAP1 mRNA PMID:35307453 14102857 FREM2 FRAS1 related extracellular matrix 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FREM2 mRNA PMID:35307453 14102960 DNAJA2 DnaJ heat shock protein family (Hsp40) member A2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJA2 mRNA PMID:35307453 14103000 VILL villin like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VILL mRNA PMID:35307453 14103084 CPNE2 copine 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPNE2 mRNA PMID:35307453 14103108 NFIB nuclear factor I B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NFIB mRNA PMID:35307453 14103178 FCGBP Fc gamma binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FCGBP mRNA PMID:35307453 14103217 SBSN suprabasin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SBSN mRNA PMID:35307453 14103307 KYAT1 kynurenine aminotransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KYAT1 mRNA PMID:35307453 14103353 TMEM68 transmembrane protein 68 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM68 mRNA PMID:35307453 14103384 RIPOR3 RIPOR family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RIPOR3 mRNA PMID:35307453 14103384 RIPOR3 RIPOR family member 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RIPOR3 mRNA PMID:34933075 14103420 SMPDL3A sphingomyelin phosphodiesterase acid like 3A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMPDL3A mRNA PMID:35307453 14103444 EMB embigin gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of EMB mRNA PMID:39265697 14103484 CAT catalase gene CHEBI:10022 deoxynivalenol decreases activity EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased activity of CAT protein PMID:37120089 14103484 CAT catalase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAT mRNA; deoxynivalenol results in decreased expression of CAT protein PMID:35307453|PMID:38104654|PMID:38403181 14103484 CAT catalase gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased activity of CAT protein] PMID:37120089 14103484 CAT catalase gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CAT mRNA PMID:23727178 14103484 CAT catalase gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein PMID:29129240 14103484 CAT catalase gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CAT mRNA] PMID:35839969 14103484 CAT catalase gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in decreased expression of CAT mRNA] PMID:36281498 14103484 CAT catalase gene CHEBI:16240 hydrogen peroxide decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D006861 CAT results in decreased susceptibility to Hydrogen Peroxide PMID:18086661 14103484 CAT catalase gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 CAT protein inhibits the reaction [Paraquat results in increased abundance of Hydrogen Peroxide] PMID:11039594 14103484 CAT catalase gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20230704 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of CAT mRNA PMID:36549457 14103484 CAT catalase gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D008070 Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT mRNA] PMID:36549457 14103484 CAT catalase gene CHEBI:16796 melatonin increases activity EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin results in increased activity of CAT protein PMID:37120089 14103484 CAT catalase gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of CAT mRNA PMID:38848930 14103484 CAT catalase gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased activity of CAT protein]; Melatonin inhibits the reaction [Malathion results in decreased expression of CAT mRNA] PMID:31535366|PMID:37120089 14103484 CAT catalase gene CHEBI:17245 carbon monoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002248 CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] PMID:21984542 14103484 CAT catalase gene CHEBI:17368 hypoxanthine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019271 CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; CAT protein results in decreased activity of [Hypoxanthine co-treated with XDH protein] PMID:21984542 14103484 CAT catalase gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein PMID:29129240 14103484 CAT catalase gene CHEBI:17578 toluene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014050 CAT protein inhibits the reaction [Toluene results in increased secretion of Malondialdehyde] PMID:12781212 14103484 CAT catalase gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein; Betaine inhibits the reaction [Glyphosate results in increased expression of CAT mRNA] PMID:29129240|PMID:36584959 14103484 CAT catalase gene CHEBI:22977 cadmium atom affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D002104 CAT affects the susceptibility to Cadmium PMID:18086661 14103484 CAT catalase gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased expression of CAT mRNA PMID:37207789 14103484 CAT catalase gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAT mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CAT mRNA; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of CAT mRNA] PMID:33493553|PMID:34416349|PMID:37207789 14103484 CAT catalase gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of CAT mRNA] PMID:32280687 14103484 CAT catalase gene CHEBI:27417 p-xylene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031286 CAT protein inhibits the reaction [4-xylene results in increased secretion of Malondialdehyde] PMID:12781212 14103484 CAT catalase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein PMID:29129240 14103484 CAT catalase gene CHEBI:27744 glyphosate increases activity EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased activity of CAT protein PMID:31677563 14103484 CAT catalase gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of CAT mRNA PMID:36584959 14103484 CAT catalase gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of CAT mRNA] PMID:36584959 14103484 CAT catalase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C059514 Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT mRNA] PMID:36549457 14103484 CAT catalase gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of CAT mRNA] PMID:36281498 14103484 CAT catalase gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of CAT mRNA] PMID:32280687 14103484 CAT catalase gene CHEBI:32888 gamma-hexachlorocyclohexane decreases activity EXP E RGD:6480464 20191114 CTD MESH:D001556 Hexachlorocyclohexane results in decreased activity of CAT protein PMID:16838206 14103484 CAT catalase gene CHEBI:33216 bisphenol A decreases activity EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased activity of CAT protein PMID:37108405 14103484 CAT catalase gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of CAT mRNA; bisphenol A results in decreased expression of CAT protein PMID:29129240|PMID:38848930 14103484 CAT catalase gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased activity of CAT protein] PMID:29129240|PMID:37108405 14103484 CAT catalase gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in decreased expression of CAT mRNA PMID:34399389|PMID:38565334 14103484 CAT catalase gene CHEBI:34905 paraquat decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D010269 CAT protein results in decreased susceptibility to Paraquat PMID:10752666 14103484 CAT catalase gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein]; [MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein; CAT protein inhibits the reaction [Paraquat results in increased abundance of Hydrogen Peroxide] PMID:11039594|PMID:34811946 14103484 CAT catalase gene CHEBI:3537 cefaloridine decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002509 Cephaloridine results in decreased activity of CAT protein PMID:11039594 14103484 CAT catalase gene CHEBI:35456 cadmium dichloride decreases activity EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased activity of CAT protein PMID:23904328 14103484 CAT catalase gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of CAT mRNA PMID:33626375 14103484 CAT catalase gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAT mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CAT mRNA; CAT inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA] PMID:18086661|PMID:33493553|PMID:34416349 14103484 CAT catalase gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of CAT mRNA PMID:17437637 14103484 CAT catalase gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the activity of CAT protein] PMID:34811946 14103484 CAT catalase gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in decreased activity of CAT protein] PMID:37108405 14103484 CAT catalase gene CHEBI:4948 Evodiamine increases activity EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in increased activity of CAT protein PMID:39305878 14103484 CAT catalase gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine inhibits the reaction [T-2 Toxin results in decreased activity of CAT protein] PMID:39305878 14103484 CAT catalase gene CHEBI:566274 malonaldehyde multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008315 CAT protein inhibits the reaction [4-xylene results in increased secretion of Malondialdehyde]; CAT protein inhibits the reaction [Toluene results in increased secretion of Malondialdehyde] PMID:12781212 14103484 CAT catalase gene CHEBI:64163 diquat affects activity EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat affects the activity of CAT protein PMID:22558963 14103484 CAT catalase gene CHEBI:64163 diquat decreases activity EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in decreased activity of CAT protein PMID:38567716 14103484 CAT catalase gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in decreased expression of CAT mRNA PMID:32280687 14103484 CAT catalase gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Diquat results in decreased activity of CAT protein]; [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of CAT mRNA] PMID:32280687|PMID:38567716 14103484 CAT catalase gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of CAT mRNA PMID:31535366 14103484 CAT catalase gene CHEBI:6651 malathion multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D008294 Melatonin inhibits the reaction [Malathion results in decreased expression of CAT mRNA] PMID:31535366 14103484 CAT catalase gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of CAT mRNA; ochratoxin A results in decreased expression of CAT protein PMID:18547704|PMID:36281498 14103484 CAT catalase gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of CAT mRNA]; Taurine inhibits the reaction [ochratoxin A results in decreased expression of CAT mRNA] PMID:36281498 14103484 CAT catalase gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of CAT mRNA] PMID:37207789 14103484 CAT catalase gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of CAT mRNA PMID:35839969 14103484 CAT catalase gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CAT mRNA] PMID:35839969 14103484 CAT catalase gene CHEBI:9381 T-2 toxin decreases activity EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased activity of CAT protein PMID:39305878 14103484 CAT catalase gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 evodiamine inhibits the reaction [T-2 Toxin results in decreased activity of CAT protein] PMID:39305878 14103529 FAM227A family with sequence similarity 227 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM227A mRNA PMID:35307453 14103570 DNAH6 dynein axonemal heavy chain 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH6 mRNA PMID:35307453 14103744 ATF3 activating transcription factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20221206 CTD MESH:C007262 deoxynivalenol results in increased expression of ATF3 mRNA; deoxynivalenol results in increased expression of ATF3 protein PMID:35307453|PMID:35314294|PMID:37257635 14103744 ATF3 activating transcription factor 3 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ATF3 mRNA PMID:34389318 14103855 RBPJ recombination signal binding protein for immunoglobulin kappa J region gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBPJ mRNA PMID:35307453 14103855 RBPJ recombination signal binding protein for immunoglobulin kappa J region gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of RBPJ mRNA PMID:34389318 14104111 FARSA phenylalanyl-tRNA synthetase subunit alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FARSA mRNA PMID:35307453 14104133 FRMPD1 FERM and PDZ domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FRMPD1 mRNA PMID:35307453 14104177 SNRPB2 small nuclear ribonucleoprotein polypeptide B2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPB2 mRNA PMID:35307453 14104208 RPS28 ribosomal protein S28 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS28 mRNA PMID:39265697 14104344 VASP vasodilator stimulated phosphoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VASP mRNA PMID:35307453 14104455 DHRS3 dehydrogenase/reductase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DHRS3 mRNA PMID:35307453 14104455 DHRS3 dehydrogenase/reductase 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of DHRS3 mRNA PMID:39265697 14104502 ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ST3GAL6 mRNA PMID:34389318 14104857 CASP10 caspase 10 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of CASP10 mRNA PMID:32198028 14104857 CASP10 caspase 10 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP10 mRNA] PMID:32198028 14105010 CSE1L chromosome segregation 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSE1L mRNA PMID:35307453 14105054 ERBB4 erb-b2 receptor tyrosine kinase 4 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ERBB4 mRNA] PMID:39151877 14105054 ERBB4 erb-b2 receptor tyrosine kinase 4 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of ERBB4 mRNA PMID:39151877 14105054 ERBB4 erb-b2 receptor tyrosine kinase 4 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ERBB4 mRNA] PMID:39151877 14105192 ABAT 4-aminobutyrate aminotransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABAT mRNA PMID:35307453 14105211 TRIQK triple QxxK/R motif containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIQK mRNA PMID:35307453 14105284 FANCM FA complementation group M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FANCM mRNA PMID:35307453 14105410 SLC19A1 solute carrier family 19 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC19A1 mRNA PMID:35307453 14105426 FKBP3 FKBP prolyl isomerase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FKBP3 mRNA PMID:35307453 14105481 ME1 malic enzyme 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ME1 mRNA PMID:35307453 14105847 GRN granulin precursor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRN mRNA PMID:35307453 14105864 SLC24A5 solute carrier family 24 member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC24A5 mRNA PMID:35307453 14105864 SLC24A5 solute carrier family 24 member 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SLC24A5 mRNA] PMID:21852083 14106097 RXFP4 relaxin family peptide/INSL5 receptor 4 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of RXFP4 mRNA PMID:39265697 14106128 TNNC1 troponin C1, slow skeletal and cardiac type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNNC1 mRNA PMID:35307453 14106128 TNNC1 troponin C1, slow skeletal and cardiac type gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TNNC1 mRNA PMID:34933075 14106463 MYBPH myosin binding protein H gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYBPH mRNA PMID:35307453 14106484 PLG plasminogen gene CHEBI:2639 amiloride multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D000584 Amiloride inhibits the reaction [[Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [[Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [Asbestos, Serpentine results in increased cleavage of PLG protein] PMID:9853007 14106484 PLG plasminogen gene CHEBI:46666 crocidolite asbestos increases cleavage EXP E RGD:6480464 20201006 CTD MESH:D017638 Asbestos, Crocidolite results in increased cleavage of PLG protein PMID:9853007 14106484 PLG plasminogen gene CHEBI:46666 crocidolite asbestos multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D017638 [Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein; Amiloride inhibits the reaction [[Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of PLG protein] PMID:9853007 14106484 PLG plasminogen gene CHEBI:46680 serpentine asbestos increases cleavage EXP E RGD:6480464 20201006 CTD MESH:D017632 Asbestos, Serpentine results in increased cleavage of PLG protein PMID:9853007 14106484 PLG plasminogen gene CHEBI:46680 serpentine asbestos multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D017632 [Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein; Amiloride inhibits the reaction [[Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [Asbestos, Serpentine results in increased cleavage of PLG protein] PMID:9853007 14106699 ENTREP2 endosomal transmembrane epsin interactor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM189A1 mRNA PMID:35307453 14106719 WDR75 WD repeat domain 75 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR75 mRNA PMID:35307453 14106764 MAK male germ cell associated kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAK mRNA PMID:35307453 14106795 MAPK10 mitogen-activated protein kinase 10 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of MAPK10 mRNA PMID:32198028 14106795 MAPK10 mitogen-activated protein kinase 10 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK10 mRNA] PMID:32198028 14106886 TMED4 transmembrane p24 trafficking protein 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TMED4 mRNA PMID:21852083 14106899 RALGPS1 Ral GEF with PH domain and SH3 binding motif 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RALGPS1 mRNA PMID:35307453 14107050 ADRA1A adrenoceptor alpha 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADRA1A mRNA PMID:35307453 14107233 CCDC71 coiled-coil domain containing 71 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC71 mRNA PMID:35307453 14107327 CPLANE2 ciliogenesis and planar polarity effector complex subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPLANE2 mRNA PMID:35307453 14107465 FABP2 fatty acid binding protein 2 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in increased activity of FABP2 protein] PMID:36615853 14107465 FABP2 fatty acid binding protein 2 gene CHEBI:34905 paraquat increases activity EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased activity of FABP2 protein PMID:36615853 14107465 FABP2 fatty acid binding protein 2 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in increased activity of FABP2 protein] PMID:36615853 14107594 PAPLN papilin, proteoglycan like sulfated glycoprotein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAPLN mRNA PMID:35307453 14107748 ADAM28 ADAM metallopeptidase domain 28 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM28 mRNA PMID:35307453 14107780 SHC3 SHC adaptor protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHC3 mRNA PMID:35307453 14107841 LRFN3 leucine rich repeat and fibronectin type III domain containing 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of LRFN3 mRNA PMID:34933075 14107861 FGGY FGGY carbohydrate kinase domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGGY mRNA PMID:35307453 14107937 MTO1 mitochondrial tRNA translation optimization 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTO1 mRNA PMID:35307453 14108140 CORT cortistatin gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CORT protein PMID:34416349 14108140 CORT cortistatin gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CORT protein PMID:34416349 14108145 PTPRR protein tyrosine phosphatase receptor type R gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PTPRR mRNA] PMID:21852083 14108315 IGSF11 immunoglobulin superfamily member 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGSF11 mRNA PMID:35307453 14108378 PHACTR2 phosphatase and actin regulator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHACTR2 mRNA PMID:35307453 14108481 MAP3K7 mitogen-activated protein kinase kinase kinase 7 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A affects the expression of MAP3K7 protein PMID:29577965 14108532 PIK3IP1 phosphoinositide-3-kinase interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3IP1 mRNA PMID:35307453 14108582 EVA1B eva-1 homolog B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EVA1B mRNA PMID:35307453 14108603 PES1 pescadillo ribosomal biogenesis factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PES1 mRNA PMID:35307453 14108684 CPT1B carnitine palmitoyltransferase 1B gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CPT1B mRNA] PMID:39151877 14108684 CPT1B carnitine palmitoyltransferase 1B gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of CPT1B mRNA PMID:39151877 14108684 CPT1B carnitine palmitoyltransferase 1B gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CPT1B mRNA] PMID:39151877 14108737 IDO1 indoleamine 2,3-dioxygenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IDO1 mRNA PMID:35307453 14109094 TRAF2 TNF receptor associated factor 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF2 protein PMID:33891997 14109094 TRAF2 TNF receptor associated factor 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF2 protein PMID:33891997 14109094 TRAF2 TNF receptor associated factor 2 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of TRAF2 mRNA PMID:32198028 14109106 PPP2CA protein phosphatase 2 catalytic subunit alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP2CA mRNA PMID:35307453 14109106 PPP2CA protein phosphatase 2 catalytic subunit alpha gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of PPP2CA mRNA PMID:36615853 14109198 ARHGAP36 Rho GTPase activating protein 36 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGAP36 mRNA PMID:35307453 14109235 METAP1 methionyl aminopeptidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METAP1 mRNA PMID:35307453 14109415 LEPR leptin receptor gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of LEPR mRNA PMID:33901951 14109415 LEPR leptin receptor gene CHEBI:39329 etoxazole decreases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in decreased expression of LEPR mRNA PMID:31744678 14109459 KDM5A lysine demethylase 5A gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of KDM5A mRNA PMID:34389318 14109765 CRYBG2 crystallin beta-gamma domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRYBG2 mRNA PMID:35307453 14109938 SPATA17 spermatogenesis associated 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPATA17 mRNA PMID:35307453 14110052 PPT1 palmitoyl-protein thioesterase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPT1 mRNA PMID:35307453 14110153 GABRQ gamma-aminobutyric acid type A receptor subunit theta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GABRQ mRNA PMID:35307453 14110256 DERL3 derlin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DERL3 mRNA PMID:35307453 14110281 MAMSTR MEF2 activating motif and SAP domain containing transcriptional regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAMSTR mRNA PMID:35307453 14110345 BCAM basal cell adhesion molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCAM mRNA PMID:35307453 14110345 BCAM basal cell adhesion molecule gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BCAM mRNA PMID:39265697 14110383 CUBN cubilin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CUBN mRNA PMID:35307453 14110570 IQGAP2 IQ motif containing GTPase activating protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQGAP2 mRNA PMID:35307453 14110615 ADSS1 adenylosuccinate synthase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADSS1 mRNA PMID:35307453 14110661 SCN3A sodium voltage-gated channel alpha subunit 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCN3A mRNA PMID:35307453 14110758 SRP72 signal recognition particle 72 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SRP72 mRNA PMID:35307453 14110879 P2RY10 P2Y receptor family member 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of P2RY10 mRNA PMID:35307453 14110894 DYNLT4 dynein light chain Tctex-type 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20241105 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNLT4 mRNA PMID:35307453 14111006 FXYD6 FXYD domain containing ion transport regulator 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FXYD6 mRNA; deoxynivalenol results in decreased expression of FXYD6 protein PMID:35307453|PMID:38403181 14111028 CDC42BPG CDC42 binding protein kinase gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDC42BPG mRNA PMID:35307453 14111115 RAB3B RAB3B, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB3B mRNA PMID:35307453 14111160 SETD2 SET domain containing 2, histone lysine methyltransferase gene CHEBI:15428 glycine increases expression EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine results in increased expression of SETD2 protein PMID:39127149 14111160 SETD2 SET domain containing 2, histone lysine methyltransferase gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of SETD2 protein] PMID:39127149 14111160 SETD2 SET domain containing 2, histone lysine methyltransferase gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20250311 CTD MESH:C028577 monobutyl phthalate results in decreased expression of SETD2 protein PMID:39127149 14111160 SETD2 SET domain containing 2, histone lysine methyltransferase gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of SETD2 protein] PMID:39127149 14111207 SCLT1 sodium channel and clathrin linker 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCLT1 mRNA PMID:35307453 14111254 FABP5 fatty acid binding protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FABP5 mRNA PMID:35307453 14111289 CAMK1 calcium/calmodulin dependent protein kinase I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CAMK1 mRNA PMID:35307453 14111318 MRGPRF MAS related GPR family member F gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MRGPRF mRNA PMID:35307453 14111334 PPL periplakin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPL mRNA PMID:35307453 14111479 GPS1 G protein pathway suppressor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPS1 mRNA PMID:35307453 14111578 CCDC148 coiled-coil domain containing 148 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC148 mRNA PMID:35307453 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MUC1 mRNA PMID:35307453 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MUC1 mRNA PMID:39265697 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MUC1 protein; [Melatonin co-treated with bisphenol A] results in decreased expression of MUC1 mRNA; [Melatonin co-treated with bisphenol A] results in decreased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in decreased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of MUC1 mRNA; bisphenol A results in decreased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of MUC1 protein; [Melatonin co-treated with bisphenol A] results in decreased expression of MUC1 mRNA; [Melatonin co-treated with bisphenol A] results in decreased expression of MUC1 protein PMID:38848930 14111624 MUC1 mucin 1, cell surface associated gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in decreased expression of MUC1 mRNA PMID:31557363 14111739 EPAS1 endothelial PAS domain protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPAS1 mRNA PMID:35307453 14111759 TRIM27 tripartite motif containing 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM27 mRNA PMID:35307453 14111760 EPHB6 EPH receptor B6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPHB6 mRNA PMID:35307453 14111869 PRF1 perforin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRF1 mRNA PMID:35307453 14111876 RAP1A RAP1A, member of RAS oncogene family gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAP1A mRNA PMID:35307453 14111913 SPINT2 serine peptidase inhibitor, Kunitz type 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPINT2 mRNA PMID:35307453 14111954 FES FES proto-oncogene, tyrosine kinase gene CHEBI:49668 gefitinib decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C419708 Gefitinib results in decreased phosphorylation of FES protein PMID:19885553 14111954 FES FES proto-oncogene, tyrosine kinase gene CHEBI:49668 gefitinib multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C419708 Gefitinib inhibits the reaction [FGF2 protein results in increased phosphorylation of FES protein]; Gefitinib inhibits the reaction [VEGFA protein results in increased phosphorylation of FES protein] PMID:19885553 14112124 ASB14 ankyrin repeat and SOCS box containing 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB14 mRNA PMID:35307453 14112219 RBM7 RNA binding motif protein 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM7 mRNA PMID:35307453 14112316 DPY19L3 dpy-19 like C-mannosyltransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPY19L3 mRNA PMID:35307453 14112368 PDSS2 decaprenyl diphosphate synthase subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDSS2 mRNA PMID:35307453 14112392 COL28A1 collagen type XXVIII alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL28A1 mRNA PMID:35307453 14112549 ARG1 arginase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARG1 mRNA PMID:35307453|PMID:37257635 14112549 ARG1 arginase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARG1 mRNA PMID:34416349 14112549 ARG1 arginase 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ARG1 mRNA PMID:18988085 14112549 ARG1 arginase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARG1 mRNA PMID:34416349 14112635 LOC100525798 nucleosome assembly protein 1-like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAP1L2 mRNA PMID:35307453 14112645 GJC1 gap junction protein gamma 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GJC1 mRNA PMID:35307453 14112694 DENND2A DENN domain containing 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DENND2A mRNA PMID:35307453 14112859 CFAP45 cilia and flagella associated protein 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP45 mRNA PMID:35307453 14113178 USH1C USH1 protein network component harmonin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of USH1C mRNA PMID:35307453 14113224 TSPAN32 tetraspanin 32 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN32 mRNA PMID:35307453 14113405 USP18 ubiquitin specific peptidase 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of USP18 mRNA PMID:35307453 14113541 LDLRAD4 low density lipoprotein receptor class A domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LDLRAD4 mRNA PMID:35307453 14113627 CTSD cathepsin D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSD mRNA PMID:35307453 14113654 IGFBP2 insulin like growth factor binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFBP2 mRNA PMID:35307453 14113654 IGFBP2 insulin like growth factor binding protein 2 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of IGFBP2 mRNA PMID:14994279 14113786 TBCB tubulin folding cofactor B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBCB mRNA PMID:35307453 14113829 TIPARP TCDD inducible poly(ADP-ribose) polymerase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TIPARP mRNA PMID:35307453 14113840 LDHC lactate dehydrogenase C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LDHC mRNA PMID:35307453 14113881 SUSD3 sushi domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUSD3 mRNA PMID:35307453 14113914 DCAF13 DDB1 and CUL4 associated factor 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCAF13 mRNA PMID:35307453 14113948 CCDC110 coiled-coil domain containing 110 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC110 mRNA PMID:35307453 14113990 GDPD2 glycerophosphodiester phosphodiesterase domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GDPD2 mRNA PMID:35307453 14114032 PGAM5 PGAM family member 5, mitochondrial serine/threonine protein phosphatase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGAM5 mRNA PMID:35307453 14114119 CASP2 caspase 2 gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of CASP2 PMID:12712633 14114175 COQ9 coenzyme Q9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COQ9 mRNA PMID:35307453 14114189 NME5 NME/NM23 family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NME5 mRNA PMID:35307453 14114222 HAUS5 HAUS augmin like complex subunit 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HAUS5 mRNA PMID:35307453 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:132103 sodium perchlorate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031068 sodium perchlorate inhibits the reaction [SLC5A5 protein alternative form results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] PMID:12586784 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of SLC5A5 mRNA PMID:16291828 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:33167 sodium iodide increases uptake EXP E RGD:6480464 20191114 CTD MESH:D012974 SLC5A5 protein alternative form results in increased uptake of Sodium Iodide; SLC5A5 protein results in increased uptake of Sodium Iodide PMID:12586784 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:33167 sodium iodide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012974 sodium perchlorate inhibits the reaction [SLC5A5 protein alternative form results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] PMID:12586784 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP E RGD:6480464 20191114 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SLC5A5 mRNA PMID:16291828 14114255 SLC5A5 solute carrier family 5 member 5 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of SLC5A5 mRNA PMID:16896063 14114404 KCND3 potassium voltage-gated channel subfamily D member 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of KCND3 mRNA PMID:34933075 14114417 DZIP1 DAZ interacting zinc finger protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DZIP1 mRNA PMID:35307453 14114563 FAM184B family with sequence similarity 184 member B gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of FAM184B mRNA PMID:34933075 14114585 LRRC10B leucine rich repeat containing 10B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC10B mRNA PMID:35307453 14114602 EVC2 EvC ciliary complex subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EVC2 mRNA PMID:35307453 14114654 WDR1 WD repeat domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR1 mRNA PMID:35307453 14114673 DHODH dihydroorotate dehydrogenase (quinone) gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DHODH mRNA PMID:35307453 14114744 ZFYVE27 zinc finger FYVE-type containing 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFYVE27 mRNA PMID:35307453 14114861 TMEM65 transmembrane protein 65 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM65 mRNA PMID:35307453 14114897 AGPAT1 1-acylglycerol-3-phosphate O-acyltransferase 1 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of AGPAT1 mRNA PMID:28069986 14114911 ADGRD1 adhesion G protein-coupled receptor D1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ADGRD1 mRNA] PMID:21852083 14114960 UPP1 uridine phosphorylase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UPP1 mRNA PMID:35307453 14115042 PLPP7 phospholipid phosphatase 7 (inactive) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLPP7 mRNA PMID:35307453 14115072 TGM2 transglutaminase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGM2 mRNA PMID:35307453 14115072 TGM2 transglutaminase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TGM2 mRNA PMID:34933075 14115072 TGM2 transglutaminase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of TGM2 mRNA] PMID:39151877 14115072 TGM2 transglutaminase 2 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of TGM2 mRNA PMID:39151877 14115072 TGM2 transglutaminase 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of TGM2 mRNA] PMID:39151877 14115093 EIF3I eukaryotic translation initiation factor 3 subunit I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF3I mRNA PMID:35307453 14115108 JAKMIP2 janus kinase and microtubule interacting protein 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of JAKMIP2 mRNA PMID:34933075 14115236 RPS29 ribosomal protein S29 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS29 mRNA PMID:39265697 14115279 GGPS1 geranylgeranyl diphosphate synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GGPS1 mRNA; deoxynivalenol results in increased expression of GGPS1 protein PMID:35307453|PMID:38403181 14115354 HEPH hephaestin gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of HEPH mRNA PMID:34933075 14115397 P2RY12 purinergic receptor P2Y12 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of P2RY12 mRNA PMID:21852083 14115425 SCLY selenocysteine lyase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCLY mRNA PMID:35307453 14115449 CEP131 centrosomal protein 131 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP131 mRNA PMID:35307453 14115511 WNT6 Wnt family member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WNT6 mRNA PMID:35307453 14115550 IL17A interleukin 17A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL17A mRNA; deoxynivalenol results in increased expression of IL17A protein PMID:23326479|PMID:27915442 14115550 IL17A interleukin 17A gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein; deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL17A mRNA]; fumonisin B1 inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein] PMID:27915442|PMID:30708112 14115550 IL17A interleukin 17A gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein; fumonisin B1 inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein] PMID:30708112 14115550 IL17A interleukin 17A gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL17A mRNA PMID:33592257 14115550 IL17A interleukin 17A gene CHEBI:3084 bethanechol increases expression EXP E RGD:6480464 20230704 CTD MESH:D018723 Bethanechol results in increased expression of IL17A mRNA PMID:29380034 14115550 IL17A interleukin 17A gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of IL17A mRNA PMID:37108405 14115550 IL17A interleukin 17A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL17A mRNA] PMID:37108405 14115550 IL17A interleukin 17A gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL17A mRNA PMID:33592257 14115550 IL17A interleukin 17A gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein] PMID:30708112 14115550 IL17A interleukin 17A gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL17A mRNA] PMID:37108405 14115550 IL17A interleukin 17A gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL17A mRNA PMID:27915442 14115550 IL17A interleukin 17A gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL17A mRNA] PMID:27915442 14115675 TXNDC16 thioredoxin domain containing 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TXNDC16 mRNA PMID:35307453 14115858 PI15 peptidase inhibitor 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PI15 mRNA PMID:35307453 14115868 KIF27 kinesin family member 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF27 mRNA PMID:35307453 14115923 ALB albumin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALB protein PMID:19477247 14115923 ALB albumin gene CHEBI:132446 perfluorobutanesulfonic acid affects binding EXP E RGD:6480464 20240604 CTD MESH:C539348 perfluorobutanesulfonic acid binds to ALB protein PMID:38518100 14115923 ALB albumin gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of ALB mRNA PMID:34389318 14115923 ALB albumin gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of ALB protein PMID:19477247 14115923 ALB albumin gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of ALB protein] PMID:37999554 14115923 ALB albumin gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of ALB protein PMID:37999554 14115923 ALB albumin gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of ALB protein] PMID:37999554 14115923 ALB albumin gene CHEBI:35549 perfluorooctanoic acid affects binding EXP E RGD:6480464 20240604 CTD MESH:C023036 perfluorooctanoic acid binds to ALB protein PMID:38518100 14115923 ALB albumin gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of ALB mRNA PMID:16896063 14115923 ALB albumin gene CHEBI:39426 perfluorobutyric acid affects binding EXP E RGD:6480464 20240604 CTD MESH:C033094 perfluorobutyric acid binds to ALB protein PMID:38518100 14115923 ALB albumin gene CHEBI:83492 perfluorohexanoic acid affects binding EXP E RGD:6480464 20240604 CTD MESH:C479228 perfluorohexanoic acid binds to ALB protein PMID:38518100 14115923 ALB albumin gene CHEBI:88046 cylindrospermopsin decreases uptake EXP E RGD:6480464 20210608 CTD MESH:C089595 cylindrospermopsin results in decreased uptake of ALB protein PMID:33689780 14115946 NUDT14 nudix hydrolase 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUDT14 mRNA PMID:35307453 14115967 CERKL ceramide kinase like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CERKL mRNA PMID:35307453 14115989 TRAPPC8 trafficking protein particle complex subunit 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRAPPC8 mRNA PMID:35307453 14116058 PDE6B phosphodiesterase 6B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDE6B mRNA PMID:35307453 14116191 AREG amphiregulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AREG mRNA PMID:35307453 14116202 FZD5 frizzled class receptor 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FZD5 mRNA PMID:35307453 14116211 HABP2 hyaluronan binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HABP2 mRNA PMID:35307453 14116313 GARIN1A golgi associated RAB2 interactor 1A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GARIN1A mRNA PMID:35307453 14116415 TNFRSF11A TNF receptor superfamily member 11a gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFRSF11A mRNA PMID:35307453 14116489 KCNJ2 potassium inwardly rectifying channel subfamily J member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNJ2 mRNA PMID:35307453 14116599 SF3B4 splicing factor 3b subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SF3B4 mRNA PMID:35307453 14116679 GPD1 glycerol-3-phosphate dehydrogenase 1 gene CHEBI:15367 all-trans-retinoic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:D014212 Tretinoin results in decreased activity of GPD1 protein PMID:15583048 14116679 GPD1 glycerol-3-phosphate dehydrogenase 1 gene CHEBI:34839 methoprene increases activity EXP E RGD:6480464 20191114 CTD MESH:D008726 Methoprene results in increased activity of GPD1 protein PMID:15583048 14116679 GPD1 glycerol-3-phosphate dehydrogenase 1 gene CHEBI:75261 arotinoid acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased activity of GPD1 protein PMID:15583048 14116805 DNAJC18 DnaJ heat shock protein family (Hsp40) member C18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC18 mRNA PMID:35307453 14116898 RPL12 ribosomal protein L12 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL12 mRNA PMID:39265697 14116944 P2RX1 purinergic receptor P2X 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P2RX1 mRNA PMID:35307453 14116991 MICOS10 mitochondrial contact site and cristae organizing system subunit 10 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MICOS10 mRNA PMID:39265697 14116999 COL6A2 collagen type VI alpha 2 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL6A2 mRNA PMID:35307453 14117000 DSC2 desmocollin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DSC2 mRNA PMID:35307453 14117037 CHMP2B charged multivesicular body protein 2B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHMP2B mRNA PMID:35307453 14117101 GANC glucosidase alpha, neutral C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GANC mRNA PMID:35307453 14117158 OPRM1 opioid receptor mu 1 gene CHEBI:26216 potassium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011188 Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]; OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]; OPRM1 protein affects the reaction [Potassium results in increased transport of Barium] PMID:12031848 14117158 OPRM1 opioid receptor mu 1 gene CHEBI:272 (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020875 Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]; omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]] PMID:12031848 14117158 OPRM1 opioid receptor mu 1 gene CHEBI:32595 barium(0) affects transport EXP E RGD:6480464 20191114 CTD MESH:D001464 OPRM1 protein affects the transport of Barium PMID:12031848 14117158 OPRM1 opioid receptor mu 1 gene CHEBI:32595 barium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001464 Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]; omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]]; OPRM1 protein affects the reaction [Potassium results in increased transport of Barium] PMID:12031848 14117158 OPRM1 opioid receptor mu 1 gene CHEBI:90630 omega-conotoxin GVIA multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020866 omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]] PMID:12031848 14117383 AQP7 aquaporin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AQP7 mRNA PMID:35307453 14117533 U2AF1 U2 small nuclear RNA auxiliary factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of U2AF1 mRNA PMID:35307453 14117565 SCNN1G sodium channel epithelial 1 subunit gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCNN1G mRNA PMID:35307453 14117565 SCNN1G sodium channel epithelial 1 subunit gamma gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SCNN1G mRNA PMID:34933075 14117565 SCNN1G sodium channel epithelial 1 subunit gamma gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SCNN1G mRNA PMID:39265697 14117582 ESRRA estrogen related receptor alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ESRRA mRNA PMID:35307453 14117633 ABHD2 abhydrolase domain containing 2, acylglycerol lipase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABHD2 mRNA PMID:35307453 14117649 NEK6 NIMA related kinase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEK6 mRNA PMID:35307453 14117726 SCIN scinderin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCIN mRNA PMID:35307453 14117726 SCIN scinderin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SCIN mRNA PMID:39265697 14117861 SEMA4C semaphorin 4C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA4C mRNA PMID:35307453 14117923 DIP2A disco interacting protein 2 homolog A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DIP2A mRNA PMID:35307453 14117924 LOC100624785 tubulin beta-2A chain gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TUBB2B mRNA PMID:35307453 14117932 XAB2 XPA binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of XAB2 mRNA PMID:35307453 14117955 RTCA RNA 3'-terminal phosphate cyclase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RTCA mRNA PMID:35307453 14118067 COL12A1 collagen type XII alpha 1 chain gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COL12A1 mRNA PMID:35307453 14118067 COL12A1 collagen type XII alpha 1 chain gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of COL12A1 mRNA PMID:39265697 14118218 WDR3 WD repeat domain 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR3 mRNA PMID:35307453 14118387 TIGD4 tigger transposable element derived 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TIGD4 mRNA PMID:35307453 14118392 PTPN3 protein tyrosine phosphatase non-receptor type 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN3 mRNA PMID:35307453 14118457 CREB1 cAMP responsive element binding protein 1 gene CHEBI:31429 colforsin daropate hydrochloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D005576 Colforsin results in increased phosphorylation of CREB1 protein PMID:17680988 14118457 CREB1 cAMP responsive element binding protein 1 gene CHEBI:31429 colforsin daropate hydrochloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005576 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein] PMID:17680988 14118457 CREB1 cAMP responsive element binding protein 1 gene CHEBI:47495 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Brimonidine Tartrate results in increased phosphorylation of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein] PMID:17680988 14118457 CREB1 cAMP responsive element binding protein 1 gene CHEBI:51157 brimonidine tartrate increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D000068438 Brimonidine Tartrate results in increased phosphorylation of CREB1 protein PMID:17680988 14118457 CREB1 cAMP responsive element binding protein 1 gene CHEBI:51157 brimonidine tartrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000068438 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Brimonidine Tartrate results in increased phosphorylation of CREB1 protein] PMID:17680988 14118524 WNT5B Wnt family member 5B gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of WNT5B mRNA PMID:28069986 14118729 KCTD12 potassium channel tetramerization domain containing 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KCTD12 mRNA PMID:35307453 14118762 DACT1 dishevelled binding antagonist of beta catenin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DACT1 mRNA PMID:35307453 14118762 DACT1 dishevelled binding antagonist of beta catenin 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DACT1 mRNA] PMID:21852083 14118904 TNS3 tensin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNS3 mRNA PMID:35307453 14119020 LAMC3 laminin subunit gamma 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of LAMC3 mRNA PMID:34933075 14119157 WDR38 WD repeat domain 38 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR38 mRNA PMID:35307453 14119175 GALNT1 polypeptide N-acetylgalactosaminyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GALNT1 mRNA PMID:35307453 14119230 HOXB8 homeobox B8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB8 mRNA PMID:35307453|PMID:37257635 14119243 SH3PXD2A SH3 and PX domains 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH3PXD2A mRNA PMID:35307453 14119525 NADK2 NAD kinase 2, mitochondrial gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NADK2 mRNA PMID:35307453 14119629 ADGRA1 adhesion G protein-coupled receptor A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRA1 mRNA PMID:35307453 14119659 FFAR1 free fatty acid receptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in increased expression of FFAR1 mRNA PMID:35307453 14119659 FFAR1 free fatty acid receptor 1 gene CHEBI:26710 sodium chloride multiple interactions EXP E RGD:6480464 20250401 CTD MESH:D012965 Dietary Fats affects the reaction [Sodium Chloride affects the expression of FFAR1 mRNA]; Sodium Chloride affects the reaction [Dietary Fats affects the expression of FFAR1 mRNA] PMID:31360149 14119659 FFAR1 free fatty acid receptor 1 gene CHEBI:64243 monosodium L-glutamate affects expression EXP E RGD:6480464 20250401 CTD MESH:D012970 Sodium Glutamate affects the expression of FFAR1 mRNA PMID:31360149 14119723 SLC4A1AP solute carrier family 4 member 1 adaptor protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC4A1AP mRNA PMID:35307453 14120006 CYP3A22 cytochrome P450 family 3 subfamily A member 22 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CYP3A22 mRNA PMID:39265697 14120006 CYP3A22 cytochrome P450 family 3 subfamily A member 22 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20191114 CTD MESH:C014558 flunixin meglumine affects the expression of CYP3A22 mRNA PMID:26366864 14120006 CYP3A22 cytochrome P450 family 3 subfamily A member 22 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20191114 CTD MESH:D005273 Fenbendazole affects the expression of CYP3A22 mRNA PMID:26366864 14120048 DYRK4 dual specificity tyrosine phosphorylation regulated kinase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYRK4 mRNA PMID:35307453 14120129 CTSC cathepsin C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTSC mRNA PMID:35307453 14120144 TRIM9 tripartite motif containing 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM9 mRNA PMID:35307453 14120458 MBTPS1 membrane bound transcription factor peptidase, site 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of MBTPS1 mRNA PMID:21852083 14120497 ADCY6 adenylate cyclase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADCY6 mRNA PMID:35307453 14120610 SBF2 SET binding factor 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SBF2 mRNA PMID:21852083 14120663 GAB2 GRB2 associated binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GAB2 mRNA PMID:35307453 14120680 UBE2V2 ubiquitin conjugating enzyme E2 V2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBE2V2 protein PMID:37257635 14120680 UBE2V2 ubiquitin conjugating enzyme E2 V2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBE2V2 mRNA PMID:35307453 14120741 TRIM46 tripartite motif containing 46 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIM46 mRNA PMID:35307453 14120741 TRIM46 tripartite motif containing 46 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TRIM46 mRNA PMID:39265697 14120804 SEZ6L seizure related 6 homolog like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEZ6L mRNA PMID:35307453 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAPK8 mRNA; deoxynivalenol results in increased expression of MAPK8 protein PMID:35307453|PMID:38403181 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of MAPK8 protein PMID:38608924 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:16240 hydrogen peroxide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein PMID:11325585|PMID:18086661 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK8 mRNA PMID:32423882 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:17688 (S)-nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK8 protein PMID:32423882 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of MAPK8 mRNA PMID:32423882 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:18723 nicotine decreases phosphorylation EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased phosphorylation of MAPK8 protein PMID:32423882 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] PMID:17383151 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK8 protein PMID:10356984 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:28869 menadione increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased phosphorylation of MAPK8 protein PMID:18086661 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] PMID:17383151 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:3093 bifenthrin increases phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased phosphorylation of MAPK8 protein PMID:33901951 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:31823 mercury dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased phosphorylation of MAPK8 protein PMID:10696784 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of MAPK8 protein PMID:10696784|PMID:17383151|PMID:17464326|PMID:18086661 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]; Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]; XBP1 affects the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] PMID:10696784|PMID:17383151|PMID:18086661 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] PMID:17383151 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of MAPK8 mRNA; fumonisin B1 results in increased expression of MAPK8 protein PMID:32198028 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK8 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK8 protein] PMID:32198028 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:39329 etoxazole increases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased phosphorylation of MAPK8 protein PMID:31744678 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:39329 etoxazole multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C508136 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole results in increased phosphorylation of MAPK8 protein]; [SB 203580 co-treated with etoxazole] results in increased phosphorylation of MAPK8 protein; pyrazolanthrone inhibits the reaction [etoxazole results in increased phosphorylation of MAPK8 protein]; U 0126 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK8 protein] PMID:31744678 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:6078 ivermectin multiple interactions EXP E RGD:6480464 20201103 CTD MESH:D007559 pyrazolanthrone promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK8 protein]; U 0126 promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK8 protein] PMID:31400776 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [etoxazole results in increased phosphorylation of MAPK8 protein] PMID:31744678 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of MAPK8 mRNA PMID:29421334 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [etoxazole results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone promotes the reaction [Ivermectin results in decreased phosphorylation of MAPK8 protein] PMID:31400776|PMID:31744678 14121138 MAPK8 mitogen-activated protein kinase 8 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20201103 CTD MESH:C093642 [SB 203580 co-treated with etoxazole] results in increased phosphorylation of MAPK8 protein PMID:31744678 14121196 PLCD1 phospholipase C delta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLCD1 mRNA PMID:35307453 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGFB1 mRNA; deoxynivalenol results in decreased expression of TGFB1 protein PMID:18329193|PMID:37442268 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of TGFB1 mRNA PMID:23326479 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]; Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TGFB1 protein]; TGFB1 protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]] PMID:32877744|PMID:37442268 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of TGFB1 mRNA PMID:32877744 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]; TGFB1 protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in decreased expression of TGFB1 mRNA]] PMID:32877744 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TGFB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TGFB1 protein PMID:34416349 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TGFB1 protein] PMID:37442268 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:2814 arecoline increases expression EXP E RGD:6480464 20191114 CTD MESH:D001115 Arecoline results in increased expression of TGFB1 mRNA PMID:26908192 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:2814 arecoline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001115 Arecoline results in increased secretion of and results in increased activity of TGFB1 protein; pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of TGFB1 mRNA] PMID:26908192 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the expression of TGFB1 protein PMID:39486568 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of TGFB1 mRNA; Cadmium Chloride results in increased expression of TGFB1 protein PMID:33626375 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TGFB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TGFB1 protein; Cadmium Chloride results in increased expression of and results in increased cleavage of TGFB1 protein PMID:33626375|PMID:34416349 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of TGFB1 protein] PMID:37442268 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane inhibits the reaction [ochratoxin A results in increased expression of TGFB1 mRNA] PMID:28710020 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the expression of TGFB1 protein PMID:39486568 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of TGFB1 mRNA PMID:28710020 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of TGFB1 mRNA] PMID:28710020 14121243 TGFB1 transforming growth factor beta 1 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of TGFB1 mRNA] PMID:26908192 14121291 NRTN neurturin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRTN mRNA PMID:35307453 14121291 NRTN neurturin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NRTN mRNA PMID:39265697 14121298 GUCY2D guanylate cyclase 2D, retinal gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GUCY2D mRNA PMID:35307453 14121386 CNTN5 contactin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNTN5 mRNA PMID:35307453 14121437 ZC3H12B zinc finger CCCH-type containing 12B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZC3H12B mRNA PMID:35307453 14121452 GPX3 glutathione peroxidase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPX3 mRNA PMID:25701311|PMID:35307453 14121452 GPX3 glutathione peroxidase 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of GPX3 mRNA PMID:39265697 14121524 MAP3K3 mitogen-activated protein kinase kinase kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP3K3 mRNA PMID:35307453 14121557 ELL2 elongation factor for RNA polymerase II 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELL2 mRNA PMID:35307453 14121590 CCDC13 coiled-coil domain containing 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC13 mRNA PMID:35307453 14121671 SFRP2 secreted frizzled related protein 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SFRP2 mRNA PMID:34389318 14121698 GTPBP2 GTP binding protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of GTPBP2 mRNA; deoxynivalenol results in decreased expression of GTPBP2 protein PMID:38403181 14121739 KRT6A keratin 6A gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of KRT6A mRNA PMID:34933075 14121739 KRT6A keratin 6A gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of KRT6A mRNA PMID:39265697 14121739 KRT6A keratin 6A gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20220405 CTD MESH:D000431 Ethanol results in increased expression of KRT6A mRNA PMID:28069986 14121768 VASH2 vasohibin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VASH2 mRNA PMID:35307453 14121887 AOX1 aldehyde oxidase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of AOX1 mRNA PMID:39265697 14121974 SESN1 sestrin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SESN1 mRNA PMID:35307453 14122012 RCOR2 REST corepressor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RCOR2 mRNA PMID:35307453 14122115 EIF2S2 eukaryotic translation initiation factor 2 subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2S2 mRNA PMID:35307453 14122145 C3H16orf89 chromosome 3 C16orf89 homolog gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20230307 CTD MESH:D015025 Zearalenone results in increased expression of C3H16ORF89 mRNA PMID:34933075 14122203 PRSS12 serine protease 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRSS12 mRNA PMID:35307453 14122333 IL1R1 interleukin 1 receptor type 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of IL1R1 mRNA PMID:18988085 14122333 IL1R1 interleukin 1 receptor type 1 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of IL1R1 mRNA PMID:22533443 14122430 METTL16 methyltransferase 16, RNA N6-adenosine gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL16 mRNA PMID:35307453 14122518 PLIN1 perilipin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLIN1 mRNA PMID:35307453 14122518 PLIN1 perilipin 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of PLIN1 protein PMID:31266599 14122518 PLIN1 perilipin 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in increased expression of PLIN1 protein PMID:31266599 14122518 PLIN1 perilipin 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of PLIN1 protein PMID:31266599 14122518 PLIN1 perilipin 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [tetrabromobisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in increased expression of PLIN1 protein PMID:31266599 14122518 PLIN1 perilipin 1 gene CHEBI:35004 Tetrachlorobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in increased expression of PLIN1 protein PMID:31266599 14122518 PLIN1 perilipin 1 gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 [tetrachlorodian co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in increased expression of PLIN1 protein PMID:31266599 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPARGC1A mRNA; deoxynivalenol results in decreased expression of PPARGC1A protein PMID:35307453 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PPARGC1A mRNA] PMID:39151877 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARGC1A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARGC1A protein PMID:33592257 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of PPARGC1A mRNA PMID:39151877 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PPARGC1A mRNA] PMID:39151877 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of PPARGC1A protein PMID:21739664 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARGC1A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARGC1A protein PMID:33592257 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in decreased expression of PPARGC1A mRNA PMID:38705344 14122644 PPARGC1A PPARG coactivator 1 alpha gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in decreased expression of PPARGC1A mRNA] PMID:38705344 14122782 TMSB4X thymosin beta 4 X-linked gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250715 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of TMSB4Y mRNA PMID:21852083 14123005 OTUD1 OTU deubiquitinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTUD1 mRNA PMID:35307453 14123011 NMNAT2 nicotinamide nucleotide adenylyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NMNAT2 mRNA PMID:35307453 14123156 SLC7A8 solute carrier family 7 member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC7A8 mRNA PMID:35307453 14123156 SLC7A8 solute carrier family 7 member 8 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SLC7A8 mRNA PMID:34389318 14123237 TMEM207 transmembrane protein 207 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM207 mRNA PMID:35307453 14123316 EHBP1L1 EH domain binding protein 1 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EHBP1L1 mRNA PMID:35307453 14123475 GXYLT1 glucoside xylosyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GXYLT1 mRNA PMID:35307453 14123538 FCN2 ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of FCN2 mRNA PMID:35307453 14123538 FCN2 ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of FCNB mRNA PMID:18988085 14123621 SLC46A3 solute carrier family 46 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC46A3 mRNA PMID:35307453 14123621 SLC46A3 solute carrier family 46 member 3 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SLC46A3 mRNA PMID:34389318 14123708 TMED8 transmembrane p24 trafficking protein family member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of TMED8 mRNA; deoxynivalenol results in increased expression of TMED8 protein PMID:38403181 14123765 RALGPS2 Ral GEF with PH domain and SH3 binding motif 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RALGPS2 mRNA PMID:35307453 14123924 ANKRD37 ankyrin repeat domain 37 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ANKRD37 mRNA PMID:39265697 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of AQP1 mRNA PMID:39265697 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:15377 water increases transport EXP E RGD:6480464 20191114 CTD MESH:D014867 AQP1 protein results in increased transport of Water PMID:16534851 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:15377 water multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014867 Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water] PMID:16534851 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:29375 diprotium oxide increases transport EXP E RGD:6480464 20191114 CTD MESH:D014867 AQP1 protein results in increased transport of Water PMID:16534851 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:29375 diprotium oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014867 Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water] PMID:16534851 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:31823 mercury dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water] PMID:16534851 14123985 AQP1 aquaporin 1 (Colton blood group) gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of AQP1 mRNA PMID:20576581 14123999 JAKMIP3 Janus kinase and microtubule interacting protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JAKMIP3 mRNA PMID:35307453 14124055 DYNC2I2 dynein 2 intermediate chain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNC2I2 mRNA PMID:35307453 14124106 SOX13 SRY-box transcription factor 13 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SOX13 mRNA PMID:21852083 14124142 PHTF1 putative homeodomain transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHTF1 mRNA PMID:35307453 14124206 TARS1 threonyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TARS1 mRNA PMID:35307453 14124289 ITGBL1 integrin subunit beta like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGBL1 mRNA PMID:35307453 14124402 RDH12 retinol dehydrogenase 12 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RDH12 mRNA PMID:34933075 14124419 SLA-DQB1 SLA-DQ beta1 domain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DQB1 mRNA PMID:35307453 14124439 CSGALNACT1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSGALNACT1 mRNA PMID:35307453 14124498 PARL presenilin associated rhomboid like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PARL mRNA PMID:35307453 14124533 SRGAP3 SLIT-ROBO Rho GTPase activating protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SRGAP3 mRNA PMID:35307453 14124579 LMNTD1 lamin tail domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LMNTD1 mRNA PMID:35307453 14124682 KIF7 kinesin family member 7 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of KIF7 mRNA PMID:21852083 14124761 TBX1 T-box transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TBX1 mRNA PMID:35307453 14124800 CCDC88A coiled-coil domain containing 88A gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of CCDC88A mRNA] PMID:21852083 14124903 ELK1 ETS transcription factor ELK1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220405 CTD MESH:D015025 Zearalenone results in decreased expression of ELK1 mRNA; Zearalenone results in decreased expression of ELK1 protein PMID:32439583 14125002 ZNF185 zinc finger protein 185 with LIM domain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF185 mRNA PMID:35307453 14125099 NDUFB8 NADH:ubiquinone oxidoreductase subunit B8 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFB8 mRNA PMID:34416349 14125099 NDUFB8 NADH:ubiquinone oxidoreductase subunit B8 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFB8 mRNA PMID:34416349 14125113 TGFBR3 transforming growth factor beta receptor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TGFBR3 mRNA PMID:39265697 14125144 KCNJ5 potassium inwardly rectifying channel subfamily J member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNJ5 mRNA PMID:35307453 14125201 CCT6A chaperonin containing TCP1 subunit 6A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCT6A mRNA PMID:35307453 14125229 GPSM1 G protein signaling modulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPSM1 mRNA PMID:35307453 14125231 LURAP1 leucine rich adaptor protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LURAP1 mRNA PMID:35307453 14125237 VANGL2 VANGL planar cell polarity protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VANGL2 mRNA PMID:35307453 14125252 NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of NDUFS3 mRNA PMID:38432436 14125422 AKAP14 A-kinase anchoring protein 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP14 mRNA PMID:35307453 14125435 TMEM94 transmembrane protein 94 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM94 mRNA PMID:35307453 14125523 RGL2 ral guanine nucleotide dissociation stimulator like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGL2 mRNA PMID:35307453 14125691 IFITM3 interferon induced transmembrane protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFITM3 mRNA PMID:35307453 14125695 TCF4 transcription factor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCF4 mRNA PMID:35307453 14125887 PYGM glycogen phosphorylase, muscle associated gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PYGM mRNA PMID:35307453 14125887 PYGM glycogen phosphorylase, muscle associated gene CHEBI:4670 dobutamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004280 Dobutamine results in decreased expression of PYGM protein PMID:19944370 14125911 REX1BD required for excision 1-B domain containing gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REX1BD mRNA PMID:35307453 14125990 DAGLA diacylglycerol lipase alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DAGLA mRNA PMID:35307453 14126015 ANGPT4 angiopoietin 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ANGPT4 mRNA PMID:34933075 14126028 GBX1 gastrulation brain homeobox 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GBX1 mRNA PMID:35307453 14126034 CLDN8 claudin 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLDN8 mRNA PMID:35307453|PMID:37257635 14126074 RARS1 arginyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RARS1 mRNA PMID:35307453 14126311 GRB14 growth factor receptor bound protein 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRB14 mRNA PMID:35307453 14126492 POLE DNA polymerase epsilon, catalytic subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POLE mRNA PMID:35307453 14126884 MAP3K14 mitogen-activated protein kinase kinase kinase 14 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of MAP3K14 mRNA PMID:32198028 14126926 DPP7 dipeptidyl peptidase 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPP7 mRNA PMID:35307453 14127072 RHOQ ras homolog family member Q gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHOQ mRNA PMID:35307453 14127196 MAN2A2 mannosidase alpha class 2A member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAN2A2 mRNA PMID:35307453 14127546 BRCA1 BRCA1 DNA repair associated gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in increased expression of BRCA1 protein PMID:32454083 14127683 MECOM MDS1 and EVI1 complex locus gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MECOM mRNA PMID:35307453 14127773 FEM1A fem-1 homolog A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FEM1A mRNA PMID:35307453 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCNA protein PMID:30690062 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA protein] PMID:36584959 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PCNA protein PMID:9302645 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of PCNA mRNA; Glyphosate results in increased expression of PCNA protein PMID:36584959 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA protein] PMID:36584959 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of PCNA protein PMID:36754226 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of PCNA protein PMID:33901951 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:6078 ivermectin decreases expression EXP E RGD:6480464 20201103 CTD MESH:D007559 Ivermectin results in decreased expression of PCNA mRNA; Ivermectin results in decreased expression of PCNA protein PMID:31400776 14127840 PCNA proliferating cell nuclear antigen gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20201006 CTD MESH:C025589 ochratoxin A results in decreased expression of PCNA protein PMID:32454083 14128033 NOD1 nucleotide binding oligomerization domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOD1 mRNA; deoxynivalenol results in decreased expression of NOD1 protein PMID:35307453|PMID:37257635 14128079 ANKRD1 ankyrin repeat domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANKRD1 mRNA PMID:35307453 14128117 MRPS22 mitochondrial ribosomal protein S22 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS22 mRNA PMID:35307453 14128154 KREMEN1 kringle containing transmembrane protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KREMEN1 mRNA PMID:35307453 14128312 CREG1 cellular repressor of E1A stimulated genes 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CREG1 mRNA PMID:35307453 14128383 CSF2 colony stimulating factor 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CSF2 mRNA PMID:39265697 14128383 CSF2 colony stimulating factor 2 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005998 [Folic Acid co-treated with Glycine] results in decreased expression of CSF2 mRNA PMID:14662146 14128383 CSF2 colony stimulating factor 2 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [Folic Acid co-treated with Glycine] results in decreased expression of CSF2 mRNA PMID:14662146 14128391 KIF11 kinesin family member 11 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 [Quercetin co-treated with Copper Sulfate] results in increased expression of KIF11 mRNA PMID:39151877 14128391 KIF11 kinesin family member 11 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 [Quercetin co-treated with Copper Sulfate] results in increased expression of KIF11 mRNA PMID:39151877 14128391 KIF11 kinesin family member 11 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KIF11 mRNA] PMID:21852083 14128460 THRA thyroid hormone receptor alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THRA mRNA PMID:35307453 14128460 THRA thyroid hormone receptor alpha gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of THRA mRNA PMID:16896063 14128484 HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HERPUD1 mRNA PMID:35307453 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL6A1 mRNA PMID:38403181 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of COL6A1 protein PMID:31266599 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A inhibits the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of COL6A1 protein] PMID:31266599 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of COL6A1 protein PMID:31266599 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [tetrabromobisphenol A results in increased expression of COL6A1 protein]; tetrabromobisphenol A inhibits the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of COL6A1 protein] PMID:31266599 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:35004 Tetrachlorobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in increased expression of COL6A1 protein PMID:31266599 14128523 LOC100623720 collagen alpha-1(VI) chain gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [tetrachlorodian results in increased expression of COL6A1 protein]; tetrachlorodian inhibits the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of COL6A1 protein] PMID:31266599 14128570 CCDC59 coiled-coil domain containing 59 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC59 mRNA PMID:35307453 14128578 PGLYRP2 peptidoglycan recognition protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PGLYRP2 mRNA PMID:35307453 14128684 NDC80 NDC80 kinetochore complex component gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20200331 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NDC80 mRNA] PMID:21852083 14128714 ALDH1A3 aldehyde dehydrogenase 1 family member A3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ALDH1A3 mRNA PMID:34933075 14128732 COL1A2 collagen type I alpha 2 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL1A2 mRNA; deoxynivalenol results in decreased expression of COL1A2 protein PMID:35307453|PMID:38403181 14128732 COL1A2 collagen type I alpha 2 chain gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL1A2 mRNA] PMID:21852083 14129055 EPHA4 EPH receptor A4 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of EPHA4 mRNA PMID:18988085 14129144 GAS6 growth arrest specific 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAS6 mRNA PMID:35307453 14129162 ADAM22 ADAM metallopeptidase domain 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM22 mRNA PMID:35307453 14129162 ADAM22 ADAM metallopeptidase domain 22 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADAM22 mRNA PMID:34933075 14129314 CFAP43 cilia and flagella associated protein 43 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP43 mRNA PMID:35307453 14129475 SLC12A4 solute carrier family 12 member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC12A4 mRNA PMID:35307453 14129475 SLC12A4 solute carrier family 12 member 4 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SLC12A4 mRNA PMID:39265697 14129545 NSRP1 nuclear speckle splicing regulatory protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NSRP1 mRNA PMID:35307453 14129631 LOC100620238 zinc finger protein 454 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZFP2 mRNA PMID:35307453 14129694 FNIP2 folliculin interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FNIP2 mRNA PMID:35307453 14129786 PCYOX1L prenylcysteine oxidase 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCYOX1L mRNA PMID:35307453 14129821 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BPNT1 mRNA PMID:35307453 14129866 PPP1R12B protein phosphatase 1 regulatory subunit 12B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP1R12B mRNA PMID:35307453 14130082 HMGCL 3-hydroxy-3-methylglutaryl-CoA lyase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HMGCL mRNA PMID:35307453 14130109 MMP1 matrix metallopeptidase 1 gene CHEBI:28748 doxorubicin increases activity EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased activity of MMP1 protein PMID:19782292 14130109 MMP1 matrix metallopeptidase 1 gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased expression of MMP1 mRNA PMID:19782292 14130158 CTPS1 CTP synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTPS1 mRNA PMID:35307453 14130271 C4A complement C4A (Rodgers blood group) gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20250325 CTD MESH:D015025 Zearalenone results in decreased expression of C4A mRNA PMID:34933075 14130271 C4A complement C4A (Rodgers blood group) gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20250401 CTD MESH:D009151 Mustard Gas results in increased expression of C4 mRNA PMID:18988085 14130381 WDR33 WD repeat domain 33 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR33 mRNA PMID:35307453 14130478 MCL1 MCL1 apoptosis regulator, BCL2 family member gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of MCL1 mRNA PMID:21645290 14130490 IKZF4 IKAROS family zinc finger 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IKZF4 mRNA PMID:35307453 14130553 MMP13 matrix metallopeptidase 13 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MMP13 mRNA PMID:39265697 14130553 MMP13 matrix metallopeptidase 13 gene CHEBI:27881 resveratrol decreases activity EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased activity of MMP13 protein PMID:20825639 14130553 MMP13 matrix metallopeptidase 13 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of MMP13 mRNA PMID:20825639 14130600 RASGRF1 Ras protein specific guanine nucleotide releasing factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASGRF1 mRNA PMID:35307453 14130684 KCNJ11 potassium inwardly rectifying channel subfamily J member 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KCNJ11 mRNA PMID:35307453 14130786 GTSF1 gametocyte specific factor 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of GTSF1 mRNA PMID:34933075 14130830 MYZAP myocardial zonula adherens protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYZAP mRNA PMID:35307453 14130830 MYZAP myocardial zonula adherens protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MYZAP mRNA PMID:39265697 14131250 CCDC116 coiled-coil domain containing 116 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC116 mRNA PMID:35307453 14131295 CARNS1 carnosine synthase 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CARNS1 mRNA PMID:34389318 14131315 NOL11 nucleolar protein 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOL11 mRNA PMID:35307453 14131389 TAF9 TATA-box binding protein associated factor 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TAF9 mRNA PMID:35307453 14131455 ZNF219 zinc finger protein 219 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF219 mRNA PMID:35307453 14131472 ACADSB acyl-CoA dehydrogenase short/branched chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACADSB mRNA PMID:35307453 14131488 PSP-I porcine seminal protein I gene CHEBI:27363 zinc atom affects folding EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc affects the folding of PSP-I protein PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc promotes the reaction [PSP-I protein binds to Heparin] PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:28304 heparin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006493 zinc chloride promotes the reaction [PSP-I protein binds to Heparin]; Zinc promotes the reaction [PSP-I protein binds to Heparin] PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:30185 zinc(0) affects folding EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc affects the folding of PSP-I protein PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc promotes the reaction [PSP-I protein binds to Heparin] PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:49976 zinc dichloride affects folding EXP E RGD:6480464 20191114 CTD MESH:C016837 zinc chloride affects the folding of PSP-I protein PMID:16819821 14131488 PSP-I porcine seminal protein I gene CHEBI:49976 zinc dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016837 zinc chloride promotes the reaction [PSP-I protein binds to Heparin] PMID:16819821 14131548 KLHL7 kelch like family member 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLHL7 mRNA PMID:35307453 14131608 PANX2 pannexin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PANX2 mRNA PMID:35307453 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NLRP3 mRNA PMID:35307453 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]] PMID:32877744 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of NLRP3 mRNA; Zearalenone results in increased expression of NLRP3 protein PMID:30270565 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 protein; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of NLRP3 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 protein] PMID:30270565 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein] PMID:36281498 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20210309 CTD MESH:D008070 Lipopolysaccharides results in increased expression of NLRP3 mRNA; Lipopolysaccharides results in increased expression of NLRP3 protein PMID:32877744|PMID:37271275 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA] PMID:32877744|PMID:37271275 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C026166 [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA] PMID:37271275 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 protein PMID:33592257|PMID:34416349 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased expression of NLRP3 protein] PMID:35134483 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein] PMID:36281498 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D016264 Dextran Sulfate results in increased expression of NLRP3 mRNA; Dextran Sulfate results in increased expression of NLRP3 protein PMID:30270565 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016264 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 protein; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of NLRP3 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 protein] PMID:30270565 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 protein PMID:33592257|PMID:34416349 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:4948 Evodiamine increases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in increased expression of NLRP3 mRNA PMID:39305878 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 protein] PMID:39305878 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of NLRP3 protein PMID:36281498 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein]; Taurine inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein] PMID:36281498 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C093642 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA] PMID:37271275 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of NLRP3 mRNA; T-2 Toxin results in increased expression of NLRP3 protein PMID:39305878 14131615 NLRP3 NLR family pyrin domain containing 3 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of NLRP3 protein] PMID:39305878 14131639 CREB3L1 cAMP responsive element binding protein 3 like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CREB3L1 mRNA PMID:35307453 14131639 CREB3L1 cAMP responsive element binding protein 3 like 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CREB3L1 mRNA PMID:39265697 14131745 TBC1D25 TBC1 domain family member 25 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TBC1D25 mRNA PMID:35307453 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of IGF1R mRNA PMID:37706587 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of IGF1R mRNA] PMID:37706587 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA] PMID:30481989 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA] PMID:30481989 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in decreased expression of IGF1R mRNA PMID:32710935 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of IGF1R mRNA] PMID:37706587 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA] PMID:30481989 14131810 IGF1R insulin like growth factor 1 receptor gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA] PMID:30481989 14131905 FRMD4B FERM domain containing 4B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FRMD4B mRNA PMID:35307453 14132061 SLC16A2 solute carrier family 16 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A2 mRNA PMID:35307453 14132097 GTF2B general transcription factor IIB gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GTF2B mRNA PMID:35307453 14132145 PLEKHG1 pleckstrin homology and RhoGEF domain containing G1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PLEKHG1 mRNA PMID:39265697 14132166 DNAJB14 DnaJ heat shock protein family (Hsp40) member B14 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of DNAJB14 mRNA PMID:21852083 14132190 LRRC71 leucine rich repeat containing 71 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC71 mRNA PMID:35307453 14132309 NAAA N-acylethanolamine acid amidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAAA mRNA PMID:35307453 14132324 SUSD1 sushi domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUSD1 mRNA PMID:35307453 14132441 PHB1 prohibitin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230801 CTD MESH:C007262 deoxynivalenol results in increased expression of PHB1 mRNA PMID:35307453 14132606 PAK3 p21 (RAC1) activated kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAK3 mRNA PMID:35307453 14132606 PAK3 p21 (RAC1) activated kinase 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PAK3 mRNA PMID:21852083 14132672 LMO7 LIM domain 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LMO7 mRNA PMID:35307453 14132810 FANK1 fibronectin type III and ankyrin repeat domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FANK1 mRNA PMID:35307453 14132907 APP amyloid beta precursor protein gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of APP mRNA PMID:28069986 14132977 PKHD1L1 PKHD1 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKHD1L1 mRNA PMID:35307453 14133167 CFAP210 cilia and flagella associated protein 210 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP210 mRNA PMID:35307453 14133200 TMEM143 transmembrane protein 143 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM143 mRNA PMID:35307453 14133228 ALDH3A1 aldehyde dehydrogenase 3 family member A1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ALDH3A1 mRNA PMID:34933075 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 protein] PMID:36309173 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CASP1 mRNA; Zearalenone results in increased expression of CASP1 protein PMID:30270565 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 protein; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 mRNA] PMID:30270565 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in increased expression of and results in increased cleavage of CASP1 protein] PMID:36281498 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CASP1 mRNA] PMID:39151877 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 protein PMID:33592257|PMID:34416349 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of CASP1 mRNA PMID:39151877 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CASP1 mRNA] PMID:39151877 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of and results in increased cleavage of CASP1 protein] PMID:36281498 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D016264 Dextran Sulfate results in increased expression of CASP1 mRNA; Dextran Sulfate results in increased expression of CASP1 protein PMID:30270565 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016264 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 protein; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 mRNA] PMID:30270565 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of CASP1 mRNA PMID:22497863 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 protein PMID:33592257|PMID:34416349 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C056933 N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 protein] PMID:36309173 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:4948 Evodiamine increases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in increased expression of CASP1 mRNA PMID:39305878 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 protein] PMID:39305878 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of and results in increased cleavage of CASP1 protein]; ochratoxin A results in increased expression of and results in increased cleavage of CASP1 protein; Taurine inhibits the reaction [ochratoxin A results in increased expression of and results in increased cleavage of CASP1 protein] PMID:36281498 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of CASP1 mRNA; T-2 Toxin results in increased expression of CASP1 protein PMID:39305878 14133292 CASP1 caspase 1, apoptosis-related cysteine peptidase gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 protein]]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CASP1 protein] PMID:39305878 14133390 HMGB2 high mobility group box 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HMGB2 mRNA PMID:35307453 14133515 MORN2 MORN repeat containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MORN2 mRNA PMID:35307453 14133515 MORN2 MORN repeat containing 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MORN2 mRNA PMID:39265697 14133566 NUDT2 nudix hydrolase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUDT2 mRNA PMID:35307453 14133633 MEGF8 multiple EGF like domains 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEGF8 mRNA PMID:35307453 14133746 NOXA1 NADPH oxidase activator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOXA1 mRNA PMID:35307453 14133764 OTUB1 OTU deubiquitinase, ubiquitin aldehyde binding 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTUB1 mRNA PMID:35307453 14133824 HELLS helicase, lymphoid specific gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HELLS mRNA PMID:35307453 14133865 CCDC152 coiled-coil domain containing 152 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CCDC152 mRNA PMID:39265697 14133973 CXCR4 C-X-C motif chemokine receptor 4 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CXCR4 mRNA PMID:18988085 14133977 KBTBD8 kelch repeat and BTB domain containing 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KBTBD8 mRNA PMID:35307453 14134112 SLC38A1 solute carrier family 38 member 1 gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides affects the expression of SLC38A1 mRNA PMID:21645290 14134132 ADAMTSL2 ADAMTS like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTSL2 mRNA PMID:35307453 14134172 CASP3 caspase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in decreased expression of CASP3 protein PMID:38104654 14134172 CASP3 caspase 3 gene CHEBI:10022 deoxynivalenol increases activity EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased activity of CASP3 protein PMID:20937367|PMID:24394488 14134172 CASP3 caspase 3 gene CHEBI:10022 deoxynivalenol increases cleavage EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased cleavage of CASP3 protein PMID:38608924 14134172 CASP3 caspase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CASP3 mRNA; deoxynivalenol results in increased expression of CASP3 protein PMID:29109043|PMID:35307453|PMID:35314294 14134172 CASP3 caspase 3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein]; [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CASP3 protein; [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; MAP1LC3B protein affects the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein]; Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein] PMID:29109043|PMID:32877744|PMID:38763499 14134172 CASP3 caspase 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CASP3 mRNA PMID:29109043 14134172 CASP3 caspase 3 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Acetylcysteine co-treated with Zearalenone] results in decreased expression of CASP3 protein; [fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein] PMID:29109043 14134172 CASP3 caspase 3 gene CHEBI:131146 dihydroouabain decreases cleavage EXP E RGD:6480464 20211207 CTD MESH:C000977 dihydroouabain results in decreased cleavage of CASP3 protein PMID:28438630 14134172 CASP3 caspase 3 gene CHEBI:132889 graphene oxide increases cleavage EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased cleavage of CASP3 protein PMID:39265697 14134172 CASP3 caspase 3 gene CHEBI:146195 3-acetyldeoxynivalenol increases cleavage EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased cleavage of CASP3 protein PMID:37659622 14134172 CASP3 caspase 3 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased cleavage of CASP3 protein] PMID:37659622 14134172 CASP3 caspase 3 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of and results in increased activity of CASP3 protein]; Glycine inhibits the reaction [monobutyl phthalate results in increased expression of CASP3 mRNA] PMID:35839969 14134172 CASP3 caspase 3 gene CHEBI:15553 prostaglandin F2alpha increases activity EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased activity of CASP3 protein PMID:20739670 14134172 CASP3 caspase 3 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CASP3 mRNA PMID:20739670 14134172 CASP3 caspase 3 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [epostane co-treated with Dinoprost] results in increased activity of CASP3 protein; Dinoprost promotes the reaction [epostane results in increased expression of CASP3 mRNA]; epostane promotes the reaction [Dinoprost results in increased expression of CASP3 mRNA] PMID:20739670 14134172 CASP3 caspase 3 gene CHEBI:16240 hydrogen peroxide increases activity EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased activity of CASP3 protein PMID:15191356 14134172 CASP3 caspase 3 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of CASP3 mRNA PMID:37706587|PMID:38438008 14134172 CASP3 caspase 3 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] PMID:15191356|PMID:37706587|PMID:38438008 14134172 CASP3 caspase 3 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of CASP3 protein] PMID:39151877 14134172 CASP3 caspase 3 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20200714 CTD MESH:D008070 Lipopolysaccharides results in increased expression of CASP3 protein PMID:31669396|PMID:32877744 14134172 CASP3 caspase 3 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D008070 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein]; [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein; Flavones inhibits the reaction [Lipopolysaccharides results in increased expression of CASP3 protein]; MAP1LC3B protein affects the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CASP3 protein] PMID:31669396|PMID:32877744 14134172 CASP3 caspase 3 gene CHEBI:16796 melatonin decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin results in decreased expression of CASP3 mRNA PMID:31535366|PMID:38848930 14134172 CASP3 caspase 3 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 protein] PMID:35665993 14134172 CASP3 caspase 3 gene CHEBI:16990 bilirubin IXalpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001663 Bilirubin inhibits the reaction [Excitatory Amino Acid Agents results in increased activity of CASP3 protein] PMID:16371440 14134172 CASP3 caspase 3 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [Troglitazone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CASP3 mRNA PMID:30481989 14134172 CASP3 caspase 3 gene CHEBI:17351 linoleic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased activity of CASP3 protein PMID:10617950 14134172 CASP3 caspase 3 gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]; Zinc Acetate inhibits the reaction [Linoleic Acid results in increased activity of CASP3 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950 14134172 CASP3 caspase 3 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] PMID:38438008 14134172 CASP3 caspase 3 gene CHEBI:17578 toluene affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D014050 CASP3 protein affects the susceptibility to Toluene PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:17578 toluene increases activity EXP E RGD:6480464 20191114 CTD MESH:D014050 Toluene results in increased activity of CASP3 protein PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:17578 toluene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014050 aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Toluene results in increased activity of CASP3 protein] PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of CASP3 mRNA] PMID:36584959 14134172 CASP3 caspase 3 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20231003 CTD MESH:D005839 Gentamicins results in increased expression of CASP3 mRNA PMID:28372472 14134172 CASP3 caspase 3 gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20191114 CTD MESH:C039060 artenimol results in increased expression of CASP3 mRNA PMID:29309768 14134172 CASP3 caspase 3 gene CHEBI:22977 cadmium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased activity of CASP3 protein PMID:19135140 14134172 CASP3 caspase 3 gene CHEBI:22977 cadmium atom increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased cleavage of CASP3 protein PMID:16785314 14134172 CASP3 caspase 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of and results in increased cleavage of CASP3 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP3 protein]; oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of CASP3 protein]; Selenium inhibits the reaction [Cadmium results in increased activity of CASP3 protein] PMID:16785314|PMID:19135140|PMID:33493553|PMID:33891997|PMID:34416349 14134172 CASP3 caspase 3 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of CASP3 protein PMID:39151877 14134172 CASP3 caspase 3 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of CASP3 protein] PMID:39151877 14134172 CASP3 caspase 3 gene CHEBI:24043 flavones multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D047309 Flavones inhibits the reaction [Lipopolysaccharides results in increased expression of CASP3 protein] PMID:31669396 14134172 CASP3 caspase 3 gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CASP3 protein PMID:38763499 14134172 CASP3 caspase 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CASP3 mRNA PMID:18988085 14134172 CASP3 caspase 3 gene CHEBI:27417 p-xylene affects response to substance EXP E RGD:6480464 20191114 CTD MESH:C031286 CASP3 protein affects the susceptibility to 4-xylene PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:27417 p-xylene increases activity EXP E RGD:6480464 20191114 CTD MESH:C031286 4-xylene results in increased activity of CASP3 protein PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:27417 p-xylene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031286 aspartyl-glutamyl-valyl-aspartal inhibits the reaction [4-xylene results in increased activity of CASP3 protein] PMID:14705839 14134172 CASP3 caspase 3 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Selenium inhibits the reaction [Cadmium results in increased activity of CASP3 protein] PMID:17383151|PMID:19135140 14134172 CASP3 caspase 3 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of CASP3 mRNA PMID:36584959 14134172 CASP3 caspase 3 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of CASP3 mRNA] PMID:36584959 14134172 CASP3 caspase 3 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in decreased expression of CASP3 mRNA PMID:38848930 14134172 CASP3 caspase 3 gene CHEBI:27881 resveratrol increases cleavage EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased cleavage of CASP3 protein PMID:23065251 14134172 CASP3 caspase 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in increased cleavage of CASP3 protein] PMID:37955343 14134172 CASP3 caspase 3 gene CHEBI:27889 lead(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D007854 Lead results in increased expression of CASP3 PMID:20390873 14134172 CASP3 caspase 3 gene CHEBI:27899 cisplatin increases activity EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased activity of CASP3 protein PMID:20435919 14134172 CASP3 caspase 3 gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of CASP3 PMID:12712633 14134172 CASP3 caspase 3 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 [Cisplatin co-treated with EPO protein] results in increased cleavage of CASP3 protein; Bezafibrate inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]; Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein PMID:16316343|PMID:20435919|PMID:21497595 14134172 CASP3 caspase 3 gene CHEBI:2825 aristolochic acid A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C000228 aristolochic acid I results in increased cleavage of and results in increased activity of CASP3 protein; MK-886 inhibits the reaction [aristolochic acid I results in increased cleavage of and results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [aristolochic acid I results in increased cleavage of and results in increased activity of CASP3 protein] PMID:21658425 14134172 CASP3 caspase 3 gene CHEBI:28544 digitoxin decreases cleavage EXP E RGD:6480464 20191114 CTD MESH:D004074 Digitoxin results in decreased cleavage of CASP3 protein PMID:28438630 14134172 CASP3 caspase 3 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 [Acetylcysteine co-treated with Zearalenone] results in decreased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]] PMID:17383151|PMID:19135140|PMID:29109043|PMID:33905761 14134172 CASP3 caspase 3 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [Troglitazone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CASP3 mRNA PMID:30481989 14134172 CASP3 caspase 3 gene CHEBI:30621 diarsenic trioxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of CASP3 PMID:13129816 14134172 CASP3 caspase 3 gene CHEBI:30926 3-oxalomalic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C015407 oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of CASP3 protein] PMID:16785314 14134172 CASP3 caspase 3 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of CASP3 mRNA; bisphenol A results in increased expression of CASP3 protein PMID:29544186|PMID:37108405|PMID:38845341|PMID:38848930 14134172 CASP3 caspase 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with fisetin] results in increased expression of CASP3 mRNA; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of CASP3 mRNA] PMID:29544186|PMID:37108405|PMID:38845341 14134172 CASP3 caspase 3 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of CASP3 mRNA; tetrabromobisphenol A results in increased expression of CASP3 protein PMID:35665993 14134172 CASP3 caspase 3 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 protein] PMID:35665993 14134172 CASP3 caspase 3 gene CHEBI:34631 chlorpyrifos increases cleavage EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in increased cleavage of CASP3 mRNA PMID:38565334 14134172 CASP3 caspase 3 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in increased expression of CASP3 mRNA PMID:34399389 14134172 CASP3 caspase 3 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in increased expression of CASP3 mRNA PMID:34811946 14134172 CASP3 caspase 3 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein affects the reaction [Paraquat results in increased activity of and results in increased cleavage of CASP3 protein]; MYD88 protein affects the reaction [Paraquat results in increased expression of CASP3 mRNA]; Paraquat results in increased activity of and results in increased cleavage of CASP3 protein PMID:34811946 14134172 CASP3 caspase 3 gene CHEBI:35176 zinc sulfate increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased cleavage of CASP3 protein PMID:28803810 14134172 CASP3 caspase 3 gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of CASP3 mRNA PMID:28803810 14134172 CASP3 caspase 3 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP3 protein] PMID:28803810 14134172 CASP3 caspase 3 gene CHEBI:35456 cadmium dichloride increases activity EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased activity of CASP3 protein PMID:17383151 14134172 CASP3 caspase 3 gene CHEBI:35456 cadmium dichloride increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased cleavage of CASP3 protein PMID:16785314 14134172 CASP3 caspase 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of CASP3 protein PMID:26607349 14134172 CASP3 caspase 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of and results in increased cleavage of CASP3 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; Selenium inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein] PMID:16785314|PMID:17383151|PMID:26607349|PMID:33493553|PMID:33891997|PMID:34416349 14134172 CASP3 caspase 3 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002738 Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein] PMID:30287338 14134172 CASP3 caspase 3 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Selenium inhibits the reaction [Cadmium results in increased activity of CASP3 protein] PMID:17383151|PMID:19135140 14134172 CASP3 caspase 3 gene CHEBI:3697 cilastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015377 Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein] PMID:20435919 14134172 CASP3 caspase 3 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] PMID:37706587 14134172 CASP3 caspase 3 gene CHEBI:38221 fumonisin B1 increases cleavage EXP E RGD:6480464 20240604 CTD MESH:C056933 fumonisin B1 results in increased cleavage of CASP3 protein PMID:37955343 14134172 CASP3 caspase 3 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of CASP3 mRNA; fumonisin B1 results in increased expression of CASP3 protein; fumonisin B1 results in increased expression of CASP3 protein modified form PMID:32198028|PMID:33905761|PMID:36397609 14134172 CASP3 caspase 3 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP3 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP3 protein]; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form; [fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]]; deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [fumonisin B1 results in increased cleavage of CASP3 protein]; Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA] PMID:29109043|PMID:32198028|PMID:33905761|PMID:36397609|PMID:37955343 14134172 CASP3 caspase 3 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP3 protein]; 3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein] PMID:28803810|PMID:30287338 14134172 CASP3 caspase 3 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20220308 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form] PMID:34637808 14134172 CASP3 caspase 3 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [Troglitazone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CASP3 mRNA PMID:30481989 14134172 CASP3 caspase 3 gene CHEBI:42567 fisetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017875 [bisphenol A co-treated with fisetin] results in increased expression of CASP3 mRNA PMID:29544186 14134172 CASP3 caspase 3 gene CHEBI:472805 ouabain decreases cleavage EXP E RGD:6480464 20191114 CTD MESH:D010042 Ouabain results in decreased cleavage of CASP3 protein PMID:28438630 14134172 CASP3 caspase 3 gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein] PMID:16316343 14134172 CASP3 caspase 3 gene CHEBI:48843 disodium selenite decreases expression EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite results in decreased expression of CASP3 protein PMID:17342738 14134172 CASP3 caspase 3 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP3 protein] PMID:15191356|PMID:26607349|PMID:37108405 14134172 CASP3 caspase 3 gene CHEBI:49900 arsenous acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of CASP3 PMID:13129816 14134172 CASP3 caspase 3 gene CHEBI:5078 flavonol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C041477 3-hydroxyflavone results in decreased expression of CASP3 protein PMID:21126572 14134172 CASP3 caspase 3 gene CHEBI:50834 cadmium selenide decreases activity EXP E RGD:6480464 20191114 CTD MESH:C058667 cadmium selenide results in decreased activity of CASP3 protein PMID:18632727 14134172 CASP3 caspase 3 gene CHEBI:59030 oleandrin decreases cleavage EXP E RGD:6480464 20191114 CTD MESH:C021065 oleandrin results in decreased cleavage of CASP3 protein PMID:28438630 14134172 CASP3 caspase 3 gene CHEBI:61057 tacrolimus hydrate increases activity EXP E RGD:6480464 20191114 CTD MESH:D016559 Tacrolimus results in increased activity of CASP3 protein PMID:14675044 14134172 CASP3 caspase 3 gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [Linoleic Acid results in increased activity of CASP3 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950 14134172 CASP3 caspase 3 gene CHEBI:64090 tert-butyl hydroperoxide increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased cleavage of CASP3 protein PMID:16005169 14134172 CASP3 caspase 3 gene CHEBI:75390 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060893 MK-886 inhibits the reaction [aristolochic acid I results in increased cleavage of and results in increased activity of CASP3 protein] PMID:21658425 14134172 CASP3 caspase 3 gene CHEBI:7719 ochratoxin A increases cleavage EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased cleavage of CASP3 protein PMID:30287338|PMID:36397609 14134172 CASP3 caspase 3 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20211012 CTD MESH:C025589 ochratoxin A results in increased expression of CASP3 mRNA; ochratoxin A results in increased expression of CASP3 protein; ochratoxin A results in increased expression of CASP3 protein modified form PMID:33905761|PMID:36397609 14134172 CASP3 caspase 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein] PMID:30287338|PMID:33905761|PMID:36397609 14134172 CASP3 caspase 3 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20241105 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of CASP3 mRNA] PMID:38845341 14134172 CASP3 caspase 3 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950 14134172 CASP3 caspase 3 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of CASP3 mRNA PMID:35839969 14134172 CASP3 caspase 3 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of and results in increased activity of CASP3 protein]; Glycine inhibits the reaction [monobutyl phthalate results in increased expression of CASP3 mRNA]; monobutyl phthalate results in increased expression of and results in increased activity of CASP3 protein PMID:35839969 14134172 CASP3 caspase 3 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C432165 pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein] PMID:33905761 14134172 CASP3 caspase 3 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] PMID:38438008 14134172 CASP3 caspase 3 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased cleavage of CASP3 protein] PMID:37659622 14134172 CASP3 caspase 3 gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in increased expression of CASP3 protein modified form PMID:34637808 14134172 CASP3 caspase 3 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20220308 CTD MESH:D013605 4-phenylbutyric acid inhibits the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form] PMID:34637808 14134172 CASP3 caspase 3 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 [Troglitazone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CASP3 mRNA PMID:30481989 14134172 CASP3 caspase 3 gene CHEBI:9786 Tylophorine decreases cleavage EXP E RGD:6480464 20191114 CTD MESH:C004218 tylophorine results in decreased cleavage of CASP3 protein PMID:28438630 14134229 HLF HLF transcription factor, PAR bZIP family member gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HLF mRNA PMID:35307453 14134245 IFNB1 interferon beta 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IFNB1 mRNA PMID:24394488 14134245 IFNB1 interferon beta 1 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IFNB1 mRNA] PMID:27079946 14134245 IFNB1 interferon beta 1 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of IFNB1 mRNA PMID:29421334 14134248 CTNNBL1 catenin beta like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTNNBL1 mRNA PMID:35307453 14134317 LYRM2 LYR motif containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LYRM2 mRNA PMID:35307453 14134324 PEG3 paternally expressed 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PEG3 mRNA PMID:21852083 14134356 PDZK1 PDZ domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDZK1 mRNA PMID:35307453 14134380 ZNF367 zinc finger protein 367 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF367 mRNA PMID:35307453 14134431 HYCC1 hyccin PI4KA lipid kinase complex subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of HYCC1 mRNA PMID:35307453 14134478 YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of YWHAE mRNA PMID:18988085 14134499 FAF2 Fas associated factor family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAF2 mRNA PMID:35307453 14134597 STK39 serine/threonine kinase 39 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STK39 mRNA PMID:35307453 14134619 PCK2 phosphoenolpyruvate carboxykinase 2, mitochondrial gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCK2 mRNA; deoxynivalenol results in decreased expression of PCK2 protein PMID:35307453|PMID:38403181 14134639 CIDEA cell death inducing DFFA like effector a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CIDEA mRNA PMID:39265697 14134661 HNF4G hepatocyte nuclear factor 4 gamma gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of HNF4G mRNA PMID:34389318 14134841 PDCD6IP programmed cell death 6 interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDCD6IP mRNA PMID:35307453 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSTO1 mRNA PMID:34416349 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of GSTO1 mRNA PMID:36584959 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 [epigallocatechin gallate co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of GSTO1 mRNA PMID:22521609 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of GSTO1 mRNA PMID:33626375 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSTO1 mRNA PMID:34416349 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate increases expression EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate results in increased expression of GSTO1 mRNA PMID:22521609 14134880 GSTO1 glutathione S-transferase omega 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 [epigallocatechin gallate co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of GSTO1 mRNA; NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of GSTO1 mRNA] PMID:22521609 14135126 FBLN7 fibulin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBLN7 mRNA PMID:35307453 14135203 GORASP2 golgi reassembly stacking protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GORASP2 mRNA PMID:35307453 14135229 ACO2 aconitase 2 gene CHEBI:18300 maleic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:C030272 maleic acid results in decreased activity of ACO2 protein PMID:25119790 14135229 ACO2 aconitase 2 gene CHEBI:18300 maleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C030272 Curcumin inhibits the reaction [maleic acid results in decreased activity of ACO2 protein] PMID:25119790 14135229 ACO2 aconitase 2 gene CHEBI:3962 curcumin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003474 Curcumin inhibits the reaction [maleic acid results in decreased activity of ACO2 protein] PMID:25119790 14135251 ATP2B3 ATPase plasma membrane Ca2+ transporting 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP2B3 mRNA PMID:35307453 14135338 NKX2-8 NK2 homeobox 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NKX2-8 mRNA PMID:35307453 14135426 PIWIL3 piwi like RNA-mediated gene silencing 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of PIWIL3 mRNA PMID:21852083 14135587 RASL11A RAS like family 11 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASL11A mRNA PMID:35307453 14135826 STK32B serine/threonine kinase 32B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of STK32B mRNA PMID:35307453 14135921 PDZD7 PDZ domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDZD7 mRNA PMID:35307453 14135943 BLM BLM RecQ like helicase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BLM mRNA PMID:35307453 14136023 ATG3 autophagy related 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATG3 mRNA PMID:35307453 14136087 TGM5 transglutaminase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGM5 mRNA PMID:35307453 14136104 ZNF750 zinc finger protein 750 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of ZNF750 mRNA PMID:34933075 14136135 CRSP3 mediator complex subunit 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALCB mRNA PMID:35307453 14136174 RGS4 regulator of G protein signaling 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RGS4 mRNA PMID:39265697 14136242 IGFBP4 insulin like growth factor binding protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFBP4 mRNA PMID:35307453 14136254 TRMT13 tRNA methyltransferase 13 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT13 mRNA PMID:35307453 14136374 RNF19B ring finger protein 19B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RNF19B mRNA PMID:35307453 14136488 PDZD2 PDZ domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDZD2 mRNA PMID:35307453 14136488 PDZD2 PDZ domain containing 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PDZD2 mRNA] PMID:21852083 14136541 SELENOM selenoprotein M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SELENOM mRNA PMID:35307453 14136612 ABLIM1 actin binding LIM protein 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of ABLIM1 mRNA PMID:21852083 14136788 CREB3L2 cAMP responsive element binding protein 3 like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CREB3L2 mRNA PMID:35307453 14136804 PHGDH phosphoglycerate dehydrogenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHGDH mRNA PMID:35307453 14136849 PMP22 peripheral myelin protein 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PMP22 mRNA PMID:35307453 14136943 IYD iodotyrosine deiodinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IYD mRNA PMID:35307453 14137058 HYI hydroxypyruvate isomerase (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HYI mRNA PMID:35307453 14137093 TRMU tRNA mitochondrial 2-thiouridylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMU mRNA PMID:35307453 14137120 PSMC6 proteasome 26S subunit, ATPase 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMC6 mRNA PMID:35307453 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMO1 mRNA PMID:35307453 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of FMO1 mRNA PMID:25455459|PMID:34933075 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:16269 N,N-dimethylaniline increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:C015157 FMO1 protein results in increased metabolism of N,N-dimethylaniline PMID:6439199 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:17141 cysteamine increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D003543 FMO1 protein results in increased metabolism of Cysteamine PMID:6439199 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:3647 chlorpromazine increases oxidation EXP E RGD:6480464 20191114 CTD MESH:D002746 FMO1 protein results in increased oxidation of Chlorpromazine PMID:6439199 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:47499 imipramine increases oxidation EXP E RGD:6480464 20191114 CTD MESH:D007099 FMO1 protein results in increased oxidation of Imipramine PMID:6439199 14137184 FMO1 flavin containing dimethylaniline monoxygenase 1 gene CHEBI:50673 methimazole increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D008713 FMO1 protein results in increased metabolism of Methimazole PMID:6439199 14137222 HEXB hexosaminidase subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HEXB mRNA PMID:35307453 14137284 CAPRIN2 caprin family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPRIN2 mRNA PMID:35307453 14137359 PRCP prolylcarboxypeptidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRCP mRNA PMID:35307453 14137651 SAMD13 sterile alpha motif domain containing 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAMD13 mRNA PMID:35307453 14137705 CCL16 C-C motif chemokine ligand 16 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CCL16 mRNA PMID:34389318 14137825 SERPINF1 serpin family F member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERPINF1 mRNA PMID:35307453 14137956 FLT4 fms related receptor tyrosine kinase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FLT4 mRNA PMID:35307453 14138095 EPHB3 EPH receptor B3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EPHB3 mRNA PMID:35307453 14138124 WDR74 WD repeat domain 74 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR74 mRNA PMID:35307453 14138275 CFB complement factor B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFB mRNA PMID:35307453 14138275 CFB complement factor B gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CFB mRNA PMID:39265697 14138275 CFB complement factor B gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of BF mRNA PMID:18988085 14138302 H2BC18 H2B clustered histone 18 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of H2BC18 mRNA PMID:39265697 14138328 ZNF275 zinc finger protein 275 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ZNF275 mRNA PMID:34933075 14138399 FSCN1 fascin actin-bundling protein 1 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of FSCN1 mRNA; Chlorpyrifos results in decreased expression of FSCN1 protein PMID:38565334 14138456 LMTK3 lemur tyrosine kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMTK3 mRNA PMID:35307453 14138498 COG8 component of oligomeric golgi complex 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COG8 mRNA PMID:35307453 14138523 RNF223 ring finger protein 223 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNF223 mRNA PMID:35307453 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of AGO2 protein PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in decreased expression of AGO2 protein PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of AGO2 protein PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C020806 [tetrabromobisphenol A co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in decreased expression of AGO2 protein PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:35004 Tetrachlorobisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in decreased expression of AGO2 protein PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:35004 Tetrachlorobisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C041181 tetrachlorodian results in increased expression of AGO2 mRNA PMID:31266599 14138598 AGO2 argonaute RISC catalytic component 2 gene CHEBI:35004 Tetrachlorobisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C041181 [tetrachlorodian co-treated with 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline] results in decreased expression of AGO2 protein PMID:31266599 14138755 PDE4C phosphodiesterase 4C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDE4C mRNA PMID:35307453 14138843 ABI2 abl interactor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABI2 mRNA PMID:35307453 14139064 FBXO25 F-box protein 25 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXO25 mRNA PMID:35307453 14139186 BEST2 bestrophin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BEST2 mRNA PMID:35307453 14139300 MIR125A microRNA mir-125a gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 Sodium Selenite inhibits the reaction [Cadmium results in decreased expression of MIR125A mRNA] PMID:26607349 14139300 MIR125A microRNA mir-125a gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased expression of MIR125A mRNA PMID:26607349 14139300 MIR125A microRNA mir-125a gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein; [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein; [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein; [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein; Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of BAK1 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]] PMID:26607349 14139300 MIR125A microRNA mir-125a gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]; Sodium Selenite inhibits the reaction [Cadmium results in decreased expression of MIR125A mRNA]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP9 protein] PMID:26607349 14139332 OGA O-GlcNAcase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OGA mRNA PMID:35307453 14139357 KLF15 KLF transcription factor 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLF15 mRNA PMID:35307453 14139357 KLF15 KLF transcription factor 15 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of KLF15 mRNA PMID:39265697 14139375 SSBP4 single stranded DNA binding protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SSBP4 mRNA PMID:35307453 14139642 AGXT2 alanine--glyoxylate aminotransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGXT2 mRNA PMID:35307453 14139724 COL4A2 collagen type IV alpha 2 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL4A2 mRNA; deoxynivalenol results in decreased expression of COL4A2 protein PMID:38403181 14139724 COL4A2 collagen type IV alpha 2 chain gene CHEBI:85102 KT 5823 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 results in decreased expression of COL4A2 protein PMID:21307347 14139724 COL4A2 collagen type IV alpha 2 chain gene CHEBI:85102 KT 5823 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 inhibits the reaction [NOC 18 results in increased expression of COL4A2 protein] PMID:21307347 14139781 ZBTB40 zinc finger and BTB domain containing 40 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZBTB40 mRNA PMID:35307453 14139804 SUSD6 sushi domain containing 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUSD6 mRNA PMID:35307453 14139845 LRRC46 leucine rich repeat containing 46 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC46 mRNA PMID:35307453 14139945 NKD2 NKD inhibitor of WNT signaling pathway 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NKD2 mRNA PMID:35307453 14139964 SEPTIN5 septin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEPTIN5 mRNA PMID:35307453 14139995 CSNK1A1 casein kinase 1 alpha 1 gene CHEBI:65373 ageladine A affects activity EXP E RGD:6480464 20191114 CTD MESH:C482289 Ageladine A affects the activity of CSNK1A1 protein PMID:21413800 14139995 CSNK1A1 casein kinase 1 alpha 1 gene CHEBI:65373 ageladine A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C482289 Ageladine A analog results in decreased activity of CSNK1A1 protein PMID:21413800 14140034 A1CF APOBEC1 complementation factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of A1CF mRNA PMID:35307453 14140071 PLEK2 pleckstrin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLEK2 mRNA PMID:35307453 14140071 PLEK2 pleckstrin 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PLEK2 mRNA PMID:39265697 14140114 TPPP3 tubulin polymerization promoting protein family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPPP3 mRNA PMID:35307453 14140192 BAIAP3 BAI1 associated protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BAIAP3 mRNA PMID:35307453 14140192 BAIAP3 BAI1 associated protein 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of BAIAP3 mRNA PMID:34933075 14140276 ATRIP ATR interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in increased expression of ATRIP mRNA PMID:35307453 14140276 ATRIP ATR interacting protein gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20250325 CTD MESH:C028577 monobutyl phthalate results in increased expression of ATRIP mRNA PMID:35839969 14140366 PGLYRP3 peptidoglycan recognition protein 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of PGLYRP3 mRNA PMID:34933075 14140428 PODNL1 podocan like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PODNL1 mRNA PMID:35307453 14140574 RARB retinoic acid receptor beta gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of RARB mRNA PMID:33901951 14140617 IQCA1 IQ motif containing with AAA domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQCA1 mRNA PMID:35307453 14140725 GPR19 G protein-coupled receptor 19 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPR19 mRNA PMID:35307453 14140874 CDK15 cyclin dependent kinase 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDK15 mRNA PMID:35307453 14141026 A2M alpha-2-macroglobulin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of A2M mRNA PMID:35307453 14141097 KCNH8 potassium voltage-gated channel subfamily H member 8 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KCNH8 mRNA] PMID:21852083 14141117 SBSPON somatomedin B and thrombospondin type 1 domain containing gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SBSPON mRNA PMID:34933075 14141117 SBSPON somatomedin B and thrombospondin type 1 domain containing gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SBSPON mRNA PMID:39265697 14141149 DUOXA2 dual oxidase maturation factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DUOXA2 mRNA PMID:35307453 14141196 EIF2S3 eukaryotic translation initiation factor 2 subunit gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2S3 mRNA PMID:35307453 14141218 DMTN dematin actin binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DMTN mRNA PMID:35307453 14141267 KLF2 KLF transcription factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLF2 mRNA PMID:35307453 14141393 IER3 immediate early response 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IER3 mRNA PMID:35307453 14141569 ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased activity of ATP2A2 protein PMID:17784851 14141671 ABCC2 ATP binding cassette subfamily C member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABCC2 mRNA PMID:35307453 14141764 ILDR2 immunoglobulin like domain containing receptor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ILDR2 mRNA PMID:35307453 14141796 CPSF6 cleavage and polyadenylation specific factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CPSF6 mRNA PMID:35307453 14141852 MNAT1 MNAT1 component of CDK activating kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MNAT1 mRNA PMID:35307453 14141885 HVCN1 hydrogen voltage gated channel 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HVCN1 mRNA PMID:35307453 14141983 EFCAB5 EF-hand calcium binding domain 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EFCAB5 mRNA PMID:35307453 14142011 ATP4B ATPase H+/K+ transporting subunit beta gene CHEBI:77543 ebselen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C042986 ebselen results in decreased activity of [ATP4A protein binds to ATP4B protein] PMID:7590103 14142133 RRBP1 ribosome binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRBP1 mRNA PMID:35307453 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:135361 methscopolamine affects binding EXP E RGD:6480464 20191114 CTD MESH:D019832 N-Methylscopolamine binds to CHRM2 protein PMID:12757728 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:135361 methscopolamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019832 [N-Methylscopolamine binds to CHRM2 protein] affects the reaction [1,3-bis(4-(phthalimidomethoxyiminomethyl)pyridinium-1-yl)propane binds to CHRM2 protein]; brucine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein]; Strychnine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] PMID:12757728|PMID:16362429 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:28973 strychnine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013331 Strychnine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] PMID:12757728 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:3193 brucine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C083806 brucine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] PMID:12757728 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:73452 methoctramine tetrahydrochloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C054938 methoctramine inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM2 protein] PMID:8744975 14142286 CHRM2 cholinergic receptor muscarinic 2 gene CHEBI:7851 Oxotremorine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010095 [Oxotremorine binds to CHRM2 protein] affects the reaction [1,3-bis(4-(phthalimidomethoxyiminomethyl)pyridinium-1-yl)propane binds to CHRM2 protein] PMID:16362429 14142359 ACTA1 actin alpha 1, skeletal muscle gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ACTA1 mRNA PMID:35307453 14142523 GALC galactosylceramidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALC mRNA PMID:35307453 14142630 TCTA T cell leukemia translocation altered gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCTA mRNA PMID:35307453 14142630 TCTA T cell leukemia translocation altered gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TCTA mRNA PMID:39265697 14142646 FXYD3 FXYD domain containing ion transport regulator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FXYD3 mRNA PMID:35307453 14142646 FXYD3 FXYD domain containing ion transport regulator 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FXYD3 mRNA PMID:39265697 14142646 FXYD3 FXYD domain containing ion transport regulator 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of FXYD3 mRNA PMID:18988085 14142791 CCL25 C-C motif chemokine ligand 25 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCL25 mRNA PMID:35307453 14142812 ALOX12 arachidonate 12-lipoxygenase, 12S type gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ALOX12 mRNA PMID:39265697 14142812 ALOX12 arachidonate 12-lipoxygenase, 12S type gene CHEBI:29310 dichlorine decreases expression EXP E RGD:6480464 20210810 CTD MESH:D002713 Chlorine results in decreased expression of ALOX12 mRNA PMID:22533443 14142872 CCDC183 coiled-coil domain containing 183 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC183 mRNA PMID:35307453 14142939 NUDT19 nudix hydrolase 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUDT19 mRNA PMID:35307453 14143041 ESF1 ESF1 nucleolar pre-rRNA processing protein homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ESF1 mRNA PMID:35307453 14143091 SGF29 SAGA complex associated factor 29 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SGF29 mRNA PMID:35307453 14143126 MMP23 matrix metallopeptidase 23 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP23B mRNA PMID:35307453 14143181 DDX27 DEAD-box helicase 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX27 mRNA PMID:35307453 14143231 LRRC49 leucine rich repeat containing 49 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC49 mRNA PMID:35307453 14143278 REV3L REV3 like, DNA directed polymerase zeta catalytic subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of REV3L mRNA PMID:35307453 14143343 EFR3B EFR3 homolog B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFR3B mRNA PMID:35307453 14143411 ADPRS ADP-ribosylserine hydrolase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADPRS mRNA PMID:35307453 14143428 MSMB microseminoprotein beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MSMB mRNA PMID:35307453 14143474 LSAMP limbic system associated membrane protein gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of LSAMP mRNA] PMID:21852083 14143671 RIT1 Ras like without CAAX 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIT1 mRNA PMID:35307453 14143803 AKAP7 A-kinase anchoring protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP7 mRNA PMID:35307453 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTOR mRNA PMID:26988607|PMID:32229166 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:10022 deoxynivalenol decreases phosphorylation EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased phosphorylation of MTOR protein PMID:32229166|PMID:37120089 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of MTOR protein] PMID:37120089 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:146195 3-acetyldeoxynivalenol increases phosphorylation EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased phosphorylation of MTOR protein PMID:37659622 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased phosphorylation of MTOR protein] PMID:37659622 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:15866 2-deoxy-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003847 [Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein; Quercetin promotes the reaction [[Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein] PMID:25087994 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin promotes the reaction [[Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein] PMID:25087994 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:16796 melatonin decreases phosphorylation EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin results in decreased phosphorylation of MTOR protein PMID:37120089 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of MTOR protein] PMID:37120089 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:2762 antimycin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000968 [Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein; Quercetin promotes the reaction [[Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein] PMID:25087994 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of MTOR protein PMID:21739664 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:31767 lead diacetate increases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in increased expression of MTOR mRNA PMID:29273543 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:34905 paraquat decreases phosphorylation EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased phosphorylation of MTOR protein PMID:34811946 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein affects the reaction [Paraquat results in decreased phosphorylation of MTOR protein] PMID:34811946 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:7719 ochratoxin A decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased phosphorylation of MTOR protein PMID:30287338 14143837 MTOR mechanistic target of rapamycin kinase gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased phosphorylation of MTOR protein] PMID:37659622 14144081 NR4A2 nuclear receptor subfamily 4 group A member 2 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of NR4A2 mRNA PMID:34389318 14144171 ATAD5 ATPase family AAA domain containing 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATAD5 mRNA PMID:35307453 14144340 TOMM20 translocase of outer mitochondrial membrane 20 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased expression of TOMM20 protein PMID:34811946 14144340 TOMM20 translocase of outer mitochondrial membrane 20 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein]]; MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein] PMID:34811946 14144340 TOMM20 translocase of outer mitochondrial membrane 20 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of TOMM20 protein]] PMID:34811946 14144350 NABP1 nucleic acid binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NABP1 mRNA PMID:35307453 14144350 NABP1 nucleic acid binding protein 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of NABP1 mRNA PMID:35839969 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SREBF1 mRNA PMID:35307453 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of SREBF1 mRNA PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of SREBF1 mRNA PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of SREBF1 mRNA PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] PMID:25827716 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:49040 ezetimibe multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000069438 [Ezetimibe co-treated with Simvastatin] results in increased expression of SREBF1 mRNA PMID:17130282 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of SREBF1 mRNA PMID:31360149 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 mRNA] PMID:31360149 14144399 SREBF1 sterol regulatory element binding transcription factor 1 gene CHEBI:9150 simvastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019821 [Ezetimibe co-treated with Simvastatin] results in increased expression of SREBF1 mRNA PMID:17130282 14144518 MAPK8IP2 mitogen-activated protein kinase 8 interacting protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAPK8IP2 mRNA PMID:35307453 14144539 KLHDC8A kelch domain containing 8A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHDC8A mRNA PMID:35307453 14144577 NUP42 nucleoporin 42 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUP42 mRNA PMID:35307453 14144613 SLAMF7 SLAM family member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLAMF7 mRNA PMID:35307453 14144627 TIMM17A translocase of inner mitochondrial membrane 17A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TIMM17A mRNA PMID:35307453 14144877 PDE4D phosphodiesterase 4D gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PDE4D mRNA PMID:21852083 14145028 ARSK arylsulfatase family member K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARSK mRNA PMID:35307453 14145028 ARSK arylsulfatase family member K gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ARSK mRNA PMID:28069986 14145114 FAM98C family with sequence similarity 98 member C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM98C mRNA PMID:35307453 14145176 SLC52A3 solute carrier family 52 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC52A3 mRNA PMID:35307453 14145343 OSCP1 organic solute carrier partner 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OSCP1 mRNA PMID:35307453 14145475 CAPG capping actin protein, gelsolin like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CAPG mRNA PMID:35307453 14145641 CTTNBP2NL CTTNBP2 N-terminal like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CTTNBP2NL mRNA; deoxynivalenol results in increased expression of CTTNBP2NL protein PMID:35307453|PMID:38403181 14145712 DYNC2I1 dynein 2 intermediate chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNC2I1 mRNA PMID:35307453 14145778 DNAJC11 DnaJ heat shock protein family (Hsp40) member C11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC11 mRNA PMID:35307453 14145806 IL22 interleukin 22 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL22 mRNA PMID:23326479|PMID:27915442|PMID:35307453 14145806 IL22 interleukin 22 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL22 mRNA] PMID:27915442 14145806 IL22 interleukin 22 gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL22 mRNA PMID:27915442 14145806 IL22 interleukin 22 gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL22 mRNA] PMID:27915442 14145843 ETV4 ETS variant transcription factor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ETV4 mRNA PMID:35307453 14145937 NR4A3 nuclear receptor subfamily 4 group A member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NR4A3 mRNA PMID:35307453 14145937 NR4A3 nuclear receptor subfamily 4 group A member 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of NR4A3 mRNA PMID:18988085 14145937 NR4A3 nuclear receptor subfamily 4 group A member 3 gene CHEBI:9150 simvastatin decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin results in decreased expression of NR4A3 mRNA PMID:16005304 14146129 CLDN7 claudin 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CLDN7 mRNA PMID:35307453 14146197 MRC1 mannose receptor C-type 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRC1 mRNA PMID:34416349 14146197 MRC1 mannose receptor C-type 1 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of MRC1 mRNA PMID:22497863 14146197 MRC1 mannose receptor C-type 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRC1 mRNA PMID:34416349 14146388 GPIHBP1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPIHBP1 mRNA PMID:35307453 14146464 ORAI1 ORAI calcium release-activated calcium modulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ORAI1 mRNA PMID:35307453 14146516 ATP8A1 ATPase phospholipid transporting 8A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP8A1 mRNA PMID:35307453 14146612 CHRNB2 cholinergic receptor nicotinic beta 2 subunit gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein] PMID:28235547 14146612 CHRNB2 cholinergic receptor nicotinic beta 2 subunit gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein] PMID:28235547 14146612 CHRNB2 cholinergic receptor nicotinic beta 2 subunit gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein] PMID:28235547 14146612 CHRNB2 cholinergic receptor nicotinic beta 2 subunit gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein] PMID:28235547 14146686 MGARP mitochondria localized glutamic acid rich protein gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MGARP mRNA] PMID:39151877 14146686 MGARP mitochondria localized glutamic acid rich protein gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of MGARP mRNA PMID:39151877 14146686 MGARP mitochondria localized glutamic acid rich protein gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MGARP mRNA] PMID:39151877 14146699 GNPTG N-acetylglucosamine-1-phosphate transferase subunit gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNPTG mRNA PMID:35307453 14146900 CXCL9 C-X-C motif chemokine ligand 9 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CXCL9 mRNA PMID:34389318 14146900 CXCL9 C-X-C motif chemokine ligand 9 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CXCL9 mRNA PMID:34416349 14146900 CXCL9 C-X-C motif chemokine ligand 9 gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of CXCL9 mRNA PMID:22497863 14146900 CXCL9 C-X-C motif chemokine ligand 9 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CXCL9 mRNA PMID:34416349 14146918 IRX3 iroquois homeobox 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IRX3 mRNA PMID:34933075 14147348 TRAFD1 TRAF-type zinc finger domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRAFD1 mRNA PMID:35307453 14147364 MED27 mediator complex subunit 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED27 mRNA PMID:35307453 14147397 ITGB5 integrin subunit beta 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGB5 mRNA PMID:38403181 14147397 ITGB5 integrin subunit beta 5 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of ITGB5 mRNA PMID:25455459 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of MAPK14 protein PMID:38438008 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK14 protein] PMID:38438008 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20231031 CTD MESH:D008070 Lipopolysaccharides results in increased expression of MAPK14 mRNA PMID:37271275 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008070 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA] PMID:37271275 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C026166 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK14 protein]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA] PMID:37271275|PMID:38438008 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:50842 norflurazon increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased phosphorylation of MAPK14 protein PMID:38432436 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of MAPK14 mRNA PMID:29421334 14147421 MAPK14 mitogen-activated protein kinase 14 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C093642 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA] PMID:37271275 14147529 AFP alpha fetoprotein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AFP mRNA PMID:35307453 14147728 TRMT9B tRNA methyltransferase 9B (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRMT9B mRNA PMID:35307453 14147791 RPL6 ribosomal protein L6 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL6 mRNA PMID:21852083 14147884 NMNAT3 nicotinamide nucleotide adenylyltransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NMNAT3 mRNA PMID:35307453 14147955 HP haptoglobin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HP mRNA PMID:35307453 14147970 PMEL premelanosome protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PMEL mRNA PMID:35307453 14147970 PMEL premelanosome protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PMEL mRNA PMID:39265697 14148081 HHAT hedgehog acyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HHAT mRNA PMID:35307453 14148097 ATP6V1A ATPase H+ transporting V1 subunit A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP6V1A mRNA PMID:35307453 14148169 SPRY2 sprouty RTK signaling antagonist 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPRY2 protein PMID:37257635 14148180 DEPP1 DEPP autophagy regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DEPP1 mRNA PMID:35307453 14148223 WDR89 WD repeat domain 89 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR89 mRNA PMID:35307453 14148244 HAL histidine ammonia-lyase gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of HAL mRNA PMID:35307453 14148458 AMPD3 adenosine monophosphate deaminase 3 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of AMPD3 mRNA PMID:35839969 14148659 GLS2 glutaminase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLS2 mRNA PMID:35307453 14148697 TMEM35A transmembrane protein 35A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM35A mRNA PMID:35307453 14148825 NDUFV1 NADH:ubiquinone oxidoreductase core subunit V1 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of NDUFV1 mRNA PMID:38432436 14148873 SKIL SKI like proto-oncogene gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SKIL mRNA PMID:35307453 14148888 RLN2 relaxin 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of RLN2 mRNA PMID:37257635 14148930 LRTM2 leucine rich repeats and transmembrane domains 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of LRTM2 mRNA PMID:34933075 14148996 SMAP2 small ArfGAP2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMAP2 mRNA PMID:35307453 14149029 SLA-DMA SLA-DM alpha chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DMA mRNA PMID:35307453 14149029 SLA-DMA SLA-DM alpha chain gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of SLA-DMA mRNA PMID:22497863 14149139 CD44 CD44 molecule gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CD44 mRNA PMID:35307453 14149139 CD44 CD44 molecule gene CHEBI:17224 4-methylumbelliferone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006923 Hymecromone results in decreased expression of CD44 mRNA PMID:23139787 14149314 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DYRK2 mRNA PMID:35307453 14149398 VEGFD vascular endothelial growth factor D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VEGFD mRNA PMID:35307453 14149409 ENO1 enolase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ENO1 mRNA PMID:35307453 14149516 LOC100513346 mitochondrial import inner membrane translocase subunit TIM16 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of PAM16 mRNA PMID:28069986 14149593 MOGAT1 monoacylglycerol O-acyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MOGAT1 mRNA PMID:35307453 14149629 NCF4 neutrophil cytosolic factor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NCF4 mRNA PMID:35307453 14149629 NCF4 neutrophil cytosolic factor 4 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of NCF4 mRNA PMID:21645290 14149675 MAP1A microtubule associated protein 1A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP1A mRNA PMID:35307453 14149690 MME membrane metalloendopeptidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MME mRNA PMID:35307453 14149744 ACADL acyl-CoA dehydrogenase long chain gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ACADL mRNA PMID:28069986 14149762 RXRA retinoid X receptor alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RXRA mRNA PMID:35307453 14149762 RXRA retinoid X receptor alpha gene CHEBI:75261 arotinoid acid decreases expression EXP E RGD:6480464 20191114 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of RXRA mRNA PMID:15583048 14149931 IQUB IQ motif and ubiquitin domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQUB mRNA PMID:35307453 14150045 ATOX1 antioxidant 1 copper chaperone gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATOX1 mRNA PMID:39265697 14150045 ATOX1 antioxidant 1 copper chaperone gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased expression of ATOX1 mRNA PMID:22585802 14150054 UNC119 unc-119 lipid binding chaperone gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UNC119 mRNA PMID:35307453 14150097 UGT8 UDP glycosyltransferase 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UGT8 mRNA PMID:35307453 14150179 MREG melanoregulin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MREG mRNA PMID:35307453 14150191 NR2F6 nuclear receptor subfamily 2 group F member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR2F6 mRNA PMID:35307453 14150271 FAM91A1 family with sequence similarity 91 member A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM91A1 mRNA PMID:35307453 14150353 PPM1H protein phosphatase, Mg2+/Mn2+ dependent 1H gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPM1H mRNA PMID:35307453 14150400 KIAA0825 KIAA0825 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIAA0825 mRNA PMID:35307453 14150565 RAD9B RAD9 checkpoint clamp component B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAD9B mRNA PMID:35307453 14150646 SNAPC1 small nuclear RNA activating complex polypeptide 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNAPC1 mRNA PMID:35307453 14150680 KIF23 kinesin family member 23 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIF23 mRNA PMID:35307453 14150809 CGRRF1 cell growth regulator with ring finger domain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CGRRF1 mRNA PMID:35307453 14150859 MMP28 matrix metallopeptidase 28 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP28 mRNA PMID:35307453 14150880 IFT140 intraflagellar transport 140 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT140 mRNA PMID:35307453 14150928 GLIPR2 GLI pathogenesis related 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLIPR2 mRNA; deoxynivalenol results in decreased expression of GLIPR2 protein PMID:35307453|PMID:38403181 14151013 RPS16 ribosomal protein S16 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS16 mRNA PMID:39265697 14151026 CD300A CD300a molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD300A mRNA PMID:35307453 14151078 UNC13A unc-13 homolog A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UNC13A mRNA PMID:35307453 14151164 H2AC18 H2A clustered histone 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H2AC18 mRNA PMID:35307453 14151175 SLC6A9 solute carrier family 6 member 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC6A9 mRNA PMID:35307453 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HIF1A mRNA PMID:35307453 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIF1A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIF1A protein PMID:33493553 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019833 Genistein inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; Genistein inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased expression of HIF1A mRNA; sodium arsenite results in increased expression of HIF1A protein PMID:15089098 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017947 bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA]; Go 6976 inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA] PMID:15089098 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIF1A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIF1A protein PMID:33493553 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:41072 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070515 bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA] PMID:15089098 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:4356 desferrioxamine B increases expression EXP E RGD:6480464 20191114 CTD MESH:D003676 Deferoxamine results in increased expression of HIF1A protein PMID:11514583|PMID:15089098 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:50091 S-nitrosoglutathione increases expression EXP E RGD:6480464 20191114 CTD MESH:D026422 S-Nitrosoglutathione results in increased expression of HIF1A protein PMID:11514583 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:50091 S-nitrosoglutathione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D026422 2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; AKT1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; Genistein inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; PIK3R1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; Wortmannin inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein] PMID:11514583 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:51913 Goe 6976 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C081021 Go 6976 inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA] PMID:15089098 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:52289 wortmannin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009687 Wortmannin inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; Wortmannin inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:64215 2,3-dimethoxynaphthalene-1,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C063002 2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; 2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14151254 HIF1A hypoxia inducible factor 1 subunit alpha gene CHEBI:75253 phenylarsine oxide increases expression EXP E RGD:6480464 20191114 CTD MESH:C029341 oxophenylarsine results in increased expression of HIF1A protein PMID:11514583 14151394 C4H8orf88 chromosome 4 C8orf88 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C4H8ORF88 mRNA PMID:35307453 14151445 PYM1 PYM homolog 1, exon junction complex associated factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PYM1 mRNA PMID:35307453 14151475 PRR14 proline rich 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRR14 mRNA PMID:35307453 14151573 ADGRB2 adhesion G protein-coupled receptor B2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRB2 mRNA PMID:35307453 14151636 ZNF622 zinc finger protein 622 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF622 mRNA; deoxynivalenol results in increased expression of ZNF622 protein PMID:35307453|PMID:38403181 14151650 CD36 CD36 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230502 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD36 mRNA PMID:36596350 14151650 CD36 CD36 molecule gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA]; T 0070907 inhibits the reaction [Rosiglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA]]; T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA] PMID:36596350 14151650 CD36 CD36 molecule gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20230502 CTD MESH:C057693 Troglitazone results in increased expression of CD36 mRNA PMID:36596350 14151650 CD36 CD36 molecule gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C057693 T 0070907 inhibits the reaction [Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA]]; Troglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CD36 mRNA] PMID:36596350 14151800 NIPAL2 NIPA like domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NIPAL2 mRNA PMID:35307453 14151928 PDZK1IP1 PDZK1 interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDZK1IP1 mRNA PMID:35307453 14151928 PDZK1IP1 PDZK1 interacting protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PDZK1IP1 mRNA PMID:39265697 14152000 PRRC1 proline rich coiled-coil 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRRC1 mRNA PMID:35307453 14152215 NKRF NFKB repressing factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NKRF mRNA PMID:35307453 14152215 NKRF NFKB repressing factor gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of NKRF mRNA PMID:33626375 14152262 COMT catechol-O-methyltransferase gene CHEBI:15414 S-adenosyl-L-methionine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012436 [S-Adenosylmethionine analog co-treated with COMT protein] results in increased methylation of catechol PMID:20196537 14152262 COMT catechol-O-methyltransferase gene CHEBI:16112 chlorogenic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002726 Chlorogenic Acid results in decreased activity of COMT protein PMID:27270453 14152262 COMT catechol-O-methyltransferase gene CHEBI:17226 rosmarinic acid decreases activity EXP E RGD:6480464 20240206 CTD MESH:C041376 Rosmarinic Acid results in decreased activity of COMT protein PMID:27270453 14152262 COMT catechol-O-methyltransferase gene CHEBI:18135 catechol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C034221 [S-Adenosylmethionine analog co-treated with COMT protein] results in increased methylation of catechol PMID:20196537 14152262 COMT catechol-O-methyltransferase gene CHEBI:45453 sinefungin decreases activity EXP E RGD:6480464 20191114 CTD MESH:C006235 sinefungin results in decreased activity of COMT protein PMID:26577531 14152262 COMT catechol-O-methyltransferase gene CHEBI:67040 S-adenosyl-L-methioninate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012436 [S-Adenosylmethionine analog co-treated with COMT protein] results in increased methylation of catechol PMID:20196537 14152262 COMT catechol-O-methyltransferase gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases activity EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased activity of COMT protein PMID:22750137 14152289 ELP5 elongator acetyltransferase complex subunit 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELP5 mRNA PMID:35307453 14152352 IFN-OMEGA-6 interferon omega 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFN-OMEGA-6 mRNA PMID:35307453 14152361 ZYX zyxin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZYX mRNA PMID:35307453 14152412 GABRB3 gamma-aminobutyric acid type A receptor subunit beta3 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of GABRB3 mRNA PMID:28069986 14152442 RPS17 ribosomal protein S17 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS17 mRNA PMID:39265697 14152650 GUSB glucuronidase beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GUSB mRNA PMID:35307453 14152742 CCL21 C-C motif chemokine ligand 21 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCL21 mRNA PMID:35307453 14152742 CCL21 C-C motif chemokine ligand 21 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CCL21 mRNA PMID:34933075 14152954 TIMM10B translocase of inner mitochondrial membrane 10B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TIMM10B mRNA PMID:35307453 14152961 TGIF1 TGFB induced factor homeobox 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TGIF1 mRNA PMID:35307453 14153013 CD28 CD28 molecule gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CD28 mRNA PMID:21852083 14153067 SOAT2 sterol O-acyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SOAT2 mRNA PMID:35307453 14153109 PEAR1 platelet endothelial aggregation receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PEAR1 mRNA PMID:35307453 14153211 MMP11 matrix metallopeptidase 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP11 mRNA PMID:35307453 14153406 MED20 mediator complex subunit 20 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED20 mRNA PMID:35307453 14153544 MGP matrix Gla protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MGP mRNA PMID:35307453 14153544 MGP matrix Gla protein gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of MGP mRNA PMID:34933075 14153575 TP53I13 tumor protein p53 inducible protein 13 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TP53I13 mRNA PMID:35307453 14153605 CCDC9B coiled-coil domain containing 9B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC9B mRNA PMID:35307453 14153624 MRPS14 mitochondrial ribosomal protein S14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS14 mRNA PMID:35307453 14153699 BRWD1 bromodomain and WD repeat domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of BRWD1 mRNA; deoxynivalenol results in increased expression of BRWD1 protein PMID:38403181 14153838 EIF6 eukaryotic translation initiation factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF6 mRNA PMID:35307453 14153872 CASC3 CASC3 exon junction complex subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CASC3 mRNA PMID:35307453 14153962 STPG1 sperm tail PG-rich repeat containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STPG1 mRNA PMID:35307453 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADIPOQ mRNA PMID:35307453 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:16469 17beta-estradiol increases secretion EXP E RGD:6480464 20191114 CTD MESH:D004958 ADIPOQ protein results in increased secretion of Estradiol PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Benzo(a)pyrene inhibits the reaction [ADIPOQ protein results in increased secretion of Estradiol]; bisphenol A promotes the reaction [ADIPOQ protein results in increased secretion of Estradiol]; Estradiol results in increased expression of and results in increased secretion of ADIPOQ protein; halowax 1051 inhibits the reaction [ADIPOQ protein results in increased secretion of Estradiol]; Hexachlorobenzene inhibits the reaction [ADIPOQ protein results in increased secretion of Estradiol] PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:17347 testosterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D013739 ADIPOQ protein results in increased secretion of Testosterone PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013739 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [ADIPOQ protein results in increased secretion of Testosterone]; bisphenol A inhibits the reaction [ADIPOQ protein results in increased secretion of Testosterone]; halowax 1051 promotes the reaction [ADIPOQ protein results in increased secretion of Testosterone]; Testosterone results in decreased expression of and results in decreased secretion of ADIPOQ protein PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001564 Benzo(a)pyrene inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein]; Benzo(a)pyrene inhibits the reaction [ADIPOQ protein results in increased secretion of Estradiol]; Benzo(a)pyrene results in decreased expression of and results in decreased secretion of ADIPOQ protein PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein]; bisphenol A inhibits the reaction [ADIPOQ protein results in increased secretion of Testosterone]; bisphenol A promotes the reaction [ADIPOQ protein results in increased secretion of Estradiol]; bisphenol A results in increased expression of and results in increased secretion of ADIPOQ protein PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:5692 hexachlorobenzene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006581 Hexachlorobenzene inhibits the reaction [ADIPOQ protein results in increased secretion of Estradiol]; Hexachlorobenzene results in decreased expression of and results in decreased secretion of ADIPOQ protein PMID:28284726 14153993 ADIPOQ adiponectin, C1Q and collagen domain containing gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [ADIPOQ protein results in increased expression of CYP19A1 protein]; 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [ADIPOQ protein results in increased secretion of Testosterone]; 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of ADIPOQ protein PMID:28284726 14154293 RBM19 RNA binding motif protein 19 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM19 mRNA PMID:35307453 14154350 EIF3B eukaryotic translation initiation factor 3 subunit B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF3B mRNA PMID:35307453 14154583 CHORDC1 cysteine and histidine rich domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHORDC1 mRNA; deoxynivalenol results in increased expression of CHORDC1 protein PMID:35307453|PMID:38403181 14154597 CCNB1 cyclin B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCNB1 protein PMID:38104654 14154597 CCNB1 cyclin B1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CCNB1 protein]; pifithrin inhibits the reaction [deoxynivalenol results in decreased expression of CCNB1 protein] PMID:38104654 14154597 CCNB1 cyclin B1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of CCNB1 mRNA; Zearalenone results in decreased expression of CCNB1 protein PMID:29758222 14154597 CCNB1 cyclin B1 gene CHEBI:229924 pifithrin-alpha hydrobromide multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C121565 pifithrin inhibits the reaction [deoxynivalenol results in decreased expression of CCNB1 protein] PMID:38104654 14154597 CCNB1 cyclin B1 gene CHEBI:23414 copper(II) sulfate increases secretion EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased secretion of CCNB1 protein PMID:24521407 14154597 CCNB1 cyclin B1 gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20240806 CTD MESH:D002110 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CCNB1 protein] PMID:38104654 14154597 CCNB1 cyclin B1 gene CHEBI:27889 lead(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D007854 Lead results in increased expression of CCNB1 PMID:20390873 14154597 CCNB1 cyclin B1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of CCNB1 mRNA PMID:21391292 14154597 CCNB1 cyclin B1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of CCNB1 protein PMID:36754226 14154614 FZD1 frizzled class receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FZD1 mRNA PMID:35307453 14154620 ADPRHL1 ADP-ribosylhydrolase like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADPRHL1 mRNA PMID:35307453 14154692 TYMS thymidylate synthetase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TYMS mRNA PMID:35307453 14154710 TRIP10 thyroid hormone receptor interactor 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIP10 mRNA PMID:35307453 14154730 RPN1 ribophorin I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPN1 mRNA PMID:35307453 14154771 ZNF511 zinc finger protein 511 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF511 protein PMID:37257635 14155059 RAD17 RAD17 checkpoint clamp loader component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAD17 mRNA PMID:35307453 14155163 CNOT4 CCR4-NOT transcription complex subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CNOT4 mRNA PMID:35307453 14155282 MYO10 myosin X gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of MYO10 mRNA PMID:21852083 14155282 MYO10 myosin X gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of MYO10 mRNA; Chlorpyrifos results in decreased expression of MYO10 protein PMID:38565334 14155327 RGMA repulsive guidance molecule BMP co-receptor a gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGMA mRNA PMID:35307453 14155425 C2H11orf68 chromosome 2 C11orf68 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of C2H11ORF68 mRNA PMID:35307453 14155528 DIRAS3 DIRAS family GTPase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DIRAS3 mRNA PMID:35307453 14155528 DIRAS3 DIRAS family GTPase 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of DIRAS3 mRNA PMID:39265697 14155543 SERINC3 serine incorporator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERINC3 mRNA PMID:35307453 14155681 BCL2L1 BCL2 like 1 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BCL2L1 mRNA PMID:30481989 14155681 BCL2L1 BCL2 like 1 gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of BCL2L1 protein PMID:11781163 14155681 BCL2L1 BCL2 like 1 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BCL2L1 mRNA PMID:30481989 14155681 BCL2L1 BCL2 like 1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of BCL2L1 protein PMID:36754226 14155681 BCL2L1 BCL2 like 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of BCL2L1 protein]; Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2L1 protein] PMID:36754226 14155681 BCL2L1 BCL2 like 1 gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of BCL2L1 protein PMID:11781163 14155681 BCL2L1 BCL2 like 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of BCL2L1 mRNA; bisphenol A results in decreased expression of BCL2L1 protein PMID:28819136|PMID:37108405 14155681 BCL2L1 BCL2 like 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of BCL2L1 protein] PMID:37108405 14155681 BCL2L1 BCL2 like 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased expression of BCL2L1 mRNA PMID:34811946 14155681 BCL2L1 BCL2 like 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 MYD88 protein affects the reaction [Paraquat results in decreased expression of BCL2L1 mRNA] PMID:34811946 14155681 BCL2L1 BCL2 like 1 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of BCL2L1 mRNA PMID:17437637 14155681 BCL2L1 BCL2 like 1 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid promotes the reaction [Benzo(a)pyrene results in decreased expression of BCL2L1 protein] PMID:36754226 14155681 BCL2L1 BCL2 like 1 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BCL2L1 mRNA PMID:30481989 14155681 BCL2L1 BCL2 like 1 gene CHEBI:48843 disodium selenite affects expression EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite affects the expression of BCL2L1 mRNA PMID:17342738 14155681 BCL2L1 BCL2 like 1 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite affects the reaction [bisphenol A results in decreased expression of BCL2L1 protein] PMID:37108405 14155681 BCL2L1 BCL2 like 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D020123 Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2L1 protein] PMID:36754226 14155723 MYCN MYCN proto-oncogene, bHLH transcription factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYCN mRNA] PMID:21852083 14155766 PLAC9 placenta associated 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLAC9 mRNA PMID:35307453 14155872 EXOSC3 exosome component 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC3 mRNA PMID:35307453 14156024 JPH2 junctophilin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JPH2 mRNA PMID:35307453 14156086 COL15A1 collagen type XV alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL15A1 mRNA; deoxynivalenol results in decreased expression of COL15A1 protein PMID:38403181 14156131 ISLR2 immunoglobulin superfamily containing leucine rich repeat 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ISLR2 mRNA PMID:35307453 14156131 ISLR2 immunoglobulin superfamily containing leucine rich repeat 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ISLR2 mRNA PMID:34933075 14156163 JADE1 jade family PHD finger 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JADE1 mRNA PMID:35307453 14156509 SLC12A1 solute carrier family 12 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC12A1 mRNA PMID:35307453 14156640 SORCS2 sortilin related VPS10 domain containing receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SORCS2 mRNA PMID:35307453 14156640 SORCS2 sortilin related VPS10 domain containing receptor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SORCS2 mRNA PMID:34933075 14156640 SORCS2 sortilin related VPS10 domain containing receptor 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SORCS2 mRNA PMID:34389318 14156746 SYT5 synaptotagmin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYT5 mRNA PMID:35307453 14156818 PKIA cAMP-dependent protein kinase inhibitor alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKIA mRNA PMID:35307453 14156845 SLTM SAFB like transcription modulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLTM mRNA PMID:35307453 14156899 THBS3 thrombospondin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of THBS3 mRNA; deoxynivalenol results in decreased expression of THBS3 protein PMID:38403181 14156997 S1PR1 sphingosine-1-phosphate receptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of S1PR1 mRNA PMID:35307453 14157231 PRG4 proteoglycan 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRG4 mRNA PMID:35307453 14157345 CDCA5 cell division cycle associated 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDCA5 mRNA PMID:35307453 14157409 LY96 lymphocyte antigen 96 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LY96 mRNA PMID:35307453 14157424 SUFU SUFU negative regulator of hedgehog signaling gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SUFU mRNA PMID:35307453 14157592 CST3 cystatin C gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone affects the expression of CST3 mRNA PMID:20107207 14157628 TOMM40 translocase of outer mitochondrial membrane 40 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOMM40 mRNA PMID:35307453 14157647 TRPV5 transient receptor potential cation channel subfamily V member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRPV5 mRNA PMID:35307453 14157809 EPCAM epithelial cell adhesion molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPCAM mRNA PMID:35307453 14157809 EPCAM epithelial cell adhesion molecule gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EPCAM mRNA] PMID:21852083 14157822 RIMS2 regulating synaptic membrane exocytosis 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIMS2 mRNA PMID:35307453 14157937 SLC28A2 solute carrier family 28 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC28A2 mRNA PMID:35307453 14158247 CLSPN claspin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLSPN mRNA PMID:35307453 14158294 GMPR guanosine monophosphate reductase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GMPR mRNA PMID:35307453 14158406 CAPN13 calpain 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPN13 mRNA PMID:35307453 14158452 C7H6orf226 chromosome 7 C6orf226 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C7H6ORF226 mRNA PMID:35307453 14158689 PINK1 PTEN induced kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PINK1 mRNA PMID:35307453 14158689 PINK1 PTEN induced kinase 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of PINK1 mRNA; fumonisin B1 results in increased expression of PINK1 protein PMID:38705344 14158689 PINK1 PTEN induced kinase 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of PINK1 mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of PINK1 protein] PMID:38705344 14158883 H1-0 H1.0 linker histone gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H1-0 mRNA PMID:35307453 14158893 HNRNPU heterogeneous nuclear ribonucleoprotein U gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HNRNPU mRNA PMID:35307453 14158923 CCR9 C-C motif chemokine receptor 9 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CCR9 mRNA PMID:21852083 14158940 UBE3A ubiquitin protein ligase E3A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBE3A mRNA PMID:35307453 14159081 NCAPG2 non-SMC condensin II complex subunit G2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NCAPG2 mRNA PMID:35307453 14159197 CTSV cathepsin V gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CTSV mRNA] PMID:21852083 14159255 HAUS2 HAUS augmin like complex subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HAUS2 mRNA PMID:35307453 14159461 CRELD1 cysteine rich with EGF like domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRELD1 mRNA PMID:35307453 14159492 EFCAB3 EF-hand calcium binding domain 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFCAB3 mRNA PMID:35307453 14159604 CCNK cyclin K gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCNK mRNA PMID:35307453 14159625 ITGA7 integrin subunit alpha 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA7 mRNA PMID:35307453 14159862 MRS2 magnesium transporter MRS2 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of MRS2 mRNA PMID:35839969 14159882 MAPK7 mitogen-activated protein kinase 7 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of MAPK7 mRNA PMID:35839969 14159942 ALDH5A1 aldehyde dehydrogenase 5 family member A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH5A1 mRNA PMID:35307453 14159956 ADD3 adducin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADD3 mRNA; deoxynivalenol results in decreased expression of ADD3 protein PMID:38403181 14160052 ABL2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABL2 mRNA PMID:35307453 14160104 CRYAB crystallin alpha B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRYAB mRNA PMID:35307453 14160104 CRYAB crystallin alpha B gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of CRYAB mRNA PMID:14994279 14160151 PADI1 peptidyl arginine deiminase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PADI1 mRNA PMID:35307453 14160433 GRM5 glutamate metabotropic receptor 5 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of GRM5 mRNA PMID:18790026 14160467 QPCT glutaminyl-peptide cyclotransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of QPCT mRNA PMID:35307453 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHUK mRNA PMID:37120089 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CHUK mRNA] PMID:37120089 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CHUK mRNA] PMID:37120089 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of CHUK mRNA PMID:32198028 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:4948 Evodiamine decreases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in decreased expression of CHUK protein PMID:39305878 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CHUK protein] PMID:39305878 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of CHUK protein PMID:39305878 14160578 CHUK component of inhibitor of nuclear factor kappa B kinase complex gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of CHUK protein] PMID:39305878 14160596 MYNN myoneurin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYNN mRNA PMID:35307453 14160849 TLR4 toll like receptor 4 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of TLR4 mRNA; Lipopolysaccharides results in increased expression of TLR4 protein PMID:15998543|PMID:28528741 14160849 TLR4 toll like receptor 4 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] PMID:28528741 14160849 TLR4 toll like receptor 4 gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of TLR4 mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased expression of TLR4 protein] PMID:38154151 14160849 TLR4 toll like receptor 4 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TLR4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TLR4 protein PMID:34416349 14160849 TLR4 toll like receptor 4 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TLR4 mRNA PMID:18988085 14160849 TLR4 toll like receptor 4 gene CHEBI:28640 lipoteichoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C009900 lipoteichoic acid results in increased expression of TLR4 mRNA PMID:15998543 14160849 TLR4 toll like receptor 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of TLR4 mRNA; bisphenol A results in increased expression of TLR4 protein PMID:38154151 14160849 TLR4 toll like receptor 4 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of TLR4 mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased expression of TLR4 protein] PMID:38154151 14160849 TLR4 toll like receptor 4 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TLR4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TLR4 protein PMID:34416349 14160849 TLR4 toll like receptor 4 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [ochratoxin A affects the expression of BCL2 mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] PMID:28528741 14160849 TLR4 toll like receptor 4 gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of TLR4 mRNA PMID:29421334 14160936 RAD52 RAD52 homolog, DNA repair protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAD52 mRNA PMID:35307453 14161060 SOD2 superoxide dismutase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of SOD2 mRNA PMID:37120089 14161060 SOD2 superoxide dismutase 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of SOD2 mRNA] PMID:37120089 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16236 ethanol increases activity EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased activity of SOD2 protein PMID:16792574 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of SOD2 protein PMID:16792574 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate results in decreased expression of SOD2 mRNA] PMID:39151877 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20201103 CTD MESH:D008550 Melatonin results in increased expression of SOD2 mRNA PMID:31535366 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of SOD2 mRNA] PMID:37120089 14161060 SOD2 superoxide dismutase 2 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] affects the expression of SOD2 mRNA PMID:36615853 14161060 SOD2 superoxide dismutase 2 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of SOD2 mRNA] PMID:37999554 14161060 SOD2 superoxide dismutase 2 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of SOD2 mRNA] PMID:36584959 14161060 SOD2 superoxide dismutase 2 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased expression of SOD2 mRNA PMID:37207789 14161060 SOD2 superoxide dismutase 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOD2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOD2 mRNA; ursodoxicoltaurine affects the reaction [Cadmium results in increased expression of SOD2 mRNA] PMID:33493553|PMID:34416349|PMID:37207789 14161060 SOD2 superoxide dismutase 2 gene CHEBI:22984 calcium atom decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in decreased phosphorylation of SOD2 protein modified form PMID:16489745 14161060 SOD2 superoxide dismutase 2 gene CHEBI:22984 calcium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of SOD2 protein PMID:16489745 14161060 SOD2 superoxide dismutase 2 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of SOD2 mRNA PMID:39151877 14161060 SOD2 superoxide dismutase 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate results in decreased expression of SOD2 mRNA] PMID:39151877 14161060 SOD2 superoxide dismutase 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SOD2 mRNA PMID:18988085 14161060 SOD2 superoxide dismutase 2 gene CHEBI:27470 folic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D005492 Folic Acid deficiency results in increased activity of SOD2 protein; Folic Acid results in increased activity of SOD2 protein PMID:16792574|PMID:22889112 14161060 SOD2 superoxide dismutase 2 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of SOD2 protein PMID:16792574 14161060 SOD2 superoxide dismutase 2 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of SOD2 mRNA PMID:36584959 14161060 SOD2 superoxide dismutase 2 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of SOD2 mRNA] PMID:36584959 14161060 SOD2 superoxide dismutase 2 gene CHEBI:28869 menadione decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D024483 SOD2 results in decreased susceptibility to Vitamin K 3 PMID:18086661 14161060 SOD2 superoxide dismutase 2 gene CHEBI:28869 menadione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024483 SOD2 inhibits the reaction [Vitamin K 3 results in increased activity of ATF6 protein] PMID:18086661 14161060 SOD2 superoxide dismutase 2 gene CHEBI:29320 calcium(0) decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in decreased phosphorylation of SOD2 protein modified form PMID:16489745 14161060 SOD2 superoxide dismutase 2 gene CHEBI:29320 calcium(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium results in increased activity of SOD2 protein PMID:16489745 14161060 SOD2 superoxide dismutase 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of SOD2 mRNA PMID:37999554 14161060 SOD2 superoxide dismutase 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of SOD2 mRNA] PMID:37999554 14161060 SOD2 superoxide dismutase 2 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20231205 CTD MESH:D004390 Chlorpyrifos results in decreased expression of SOD2 mRNA PMID:34399389|PMID:38565334 14161060 SOD2 superoxide dismutase 2 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] affects the expression of SOD2 mRNA PMID:36615853 14161060 SOD2 superoxide dismutase 2 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SOD2 mRNA PMID:33626375 14161060 SOD2 superoxide dismutase 2 gene CHEBI:35456 cadmium dichloride decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D019256 SOD2 results in decreased susceptibility to Cadmium Chloride PMID:18086661 14161060 SOD2 superoxide dismutase 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOD2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOD2 mRNA; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA]; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; SOD2 inhibits the reaction [Cadmium Chloride results in increased splicing of XBP1 mRNA] PMID:18086661|PMID:33493553|PMID:34416349 14161060 SOD2 superoxide dismutase 2 gene CHEBI:6651 malathion increases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in increased expression of SOD2 mRNA PMID:31535366 14161060 SOD2 superoxide dismutase 2 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine affects the reaction [Cadmium results in increased expression of SOD2 mRNA] PMID:37207789 14161077 TNFRSF1A TNF receptor superfamily member 1A gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFRSF1A mRNA PMID:33592257 14161077 TNFRSF1A TNF receptor superfamily member 1A gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of TNFRSF1A mRNA; Cadmium Chloride results in increased expression of TNFRSF1A protein PMID:33626375 14161077 TNFRSF1A TNF receptor superfamily member 1A gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFRSF1A mRNA PMID:33592257 14161199 NRG1 neuregulin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NRG1 mRNA PMID:35307453 14161295 HSD17B7 hydroxysteroid 17-beta dehydrogenase 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSD17B7 mRNA PMID:35307453 14161319 REEP2 receptor accessory protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of REEP2 mRNA PMID:35307453 14161339 FGA fibrinogen alpha chain gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FGA mRNA PMID:34389318 14161426 THOC1 THO complex subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THOC1 mRNA PMID:35307453 14161721 PTPRH protein tyrosine phosphatase receptor type H gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPRH mRNA PMID:35307453 14161755 IL21 interleukin 21 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL21 mRNA PMID:23326479 14161767 ASTN1 astrotactin 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ASTN1 mRNA PMID:34933075 14161817 SLC16A3 solute carrier family 16 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A3 mRNA; deoxynivalenol results in decreased expression of SLC16A3 protein PMID:38403181 14161817 SLC16A3 solute carrier family 16 member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC16A3 mRNA PMID:35307453 14161851 ABCC5 ATP binding cassette subfamily C member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCC5 mRNA PMID:35307453 14161991 PFKM phosphofructokinase, muscle gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PFKM mRNA PMID:35307453 14162081 MR1 major histocompatibility complex, class I-related gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MR1 mRNA PMID:35307453 14162101 PRDM6 PR/SET domain 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRDM6 mRNA PMID:35307453 14162200 IGFALS insulin like growth factor binding protein acid labile subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGFALS mRNA PMID:35307453 14162209 APLF aprataxin and PNKP like factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APLF mRNA PMID:35307453 14162260 OFD1 OFD1 centriole and centriolar satellite protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OFD1 mRNA PMID:35307453 14162452 SVEP1 sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SVEP1 mRNA PMID:35307453 14162564 MDN1 midasin AAA ATPase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MDN1 mRNA PMID:35307453 14162816 ADHFE1 alcohol dehydrogenase iron containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADHFE1 mRNA PMID:35307453 14162942 MMP16 matrix metallopeptidase 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMP16 mRNA PMID:35307453 14162956 SMPDL3B sphingomyelin phosphodiesterase acid like 3B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMPDL3B mRNA PMID:35307453 14162956 SMPDL3B sphingomyelin phosphodiesterase acid like 3B gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SMPDL3B mRNA PMID:39265697 14163212 AKAP5 A-kinase anchoring protein 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKAP5 mRNA PMID:35307453 14163336 ZNF668 zinc finger protein 668 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF668 mRNA PMID:35307453 14163497 TNS2 tensin 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TNS2 mRNA PMID:34933075 14163607 FSIP1 fibrous sheath interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FSIP1 mRNA PMID:35307453 14163711 CFAP92 cilia and flagella associated protein 92 (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP92 mRNA PMID:35307453 14163982 EGR1 early growth response 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EGR1 mRNA PMID:35307453 14163982 EGR1 early growth response 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of EGR1 mRNA PMID:34389318 14163982 EGR1 early growth response 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of EGR1 mRNA PMID:18988085|PMID:27617619 14163982 EGR1 early growth response 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of EGR1 mRNA] PMID:21852083 14163982 EGR1 early growth response 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of EGR1 mRNA PMID:7564105 14164037 MAIP1 matrix AAA peptidase interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAIP1 mRNA PMID:35307453 14164065 TFPT TCF3 fusion partner gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TFPT mRNA PMID:35307453 14164114 UBL5 ubiquitin like 5 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of UBL5 mRNA PMID:39265697 14164211 ASPN asporin gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ASPN mRNA PMID:34933075 14164235 MYO15A myosin XVA gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO15A mRNA PMID:35307453 14164303 TDO2 tryptophan 2,3-dioxygenase gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20191114 CTD MESH:D004178 Diquat results in increased expression of TDO2 mRNA PMID:22558963 14164333 ST6GALNAC6 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST6GALNAC6 mRNA PMID:35307453 14164418 COL8A1 collagen type VIII alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL8A1 mRNA PMID:38403181 14164441 CYP2U1 cytochrome P450 family 2 subfamily U member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP2U1 mRNA PMID:35307453 14164489 APOB apolipoprotein B gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of APOB mRNA PMID:34389318 14164566 MAPK15 mitogen-activated protein kinase 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAPK15 mRNA PMID:35307453 14164593 ZNF674 zinc finger protein 674 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ZNF674 mRNA PMID:39265697 14164613 IGF2 insulin like growth factor 2 gene CHEBI:9168 sirolimus decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus results in decreased expression of IGF2 mRNA; Sirolimus results in decreased expression of IGF2 protein PMID:20622751 14164674 DXO decapping exoribonuclease gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DXO mRNA PMID:35307453 14164718 SAMD4A sterile alpha motif domain containing 4A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SAMD4A mRNA PMID:35307453 14164804 NAT8 N-acetyltransferase 8 (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAT8 mRNA PMID:35307453 14164879 SOST sclerostin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SOST mRNA PMID:39265697 14165012 SERPINE2 serpin family E member 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SERPINE2 mRNA PMID:39265697 14165072 FOXRED2 FAD dependent oxidoreductase domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOXRED2 mRNA PMID:35307453 14165089 RSPH14 radial spoke head 14 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RSPH14 mRNA PMID:35307453 14165172 BNIP1 BCL2 interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BNIP1 mRNA PMID:35307453 14165198 SELENOS selenoprotein S gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SELENOS mRNA PMID:35307453 14165198 SELENOS selenoprotein S gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SELENOS mRNA] PMID:39151877 14165198 SELENOS selenoprotein S gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of SELENOS mRNA PMID:39151877 14165198 SELENOS selenoprotein S gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of SELENOS mRNA] PMID:39151877 14165295 WDR90 WD repeat domain 90 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR90 mRNA PMID:35307453 14165401 FSTL1 follistatin like 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FSTL1 mRNA] PMID:21852083 14165438 EDN2 endothelin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EDN2 mRNA PMID:35307453 14165448 PINX1 PIN2 (TERF1) interacting telomerase inhibitor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PINX1 mRNA PMID:35307453 14165471 AGRN agrin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGRN mRNA PMID:35307453 14165573 LOC110255331 acyl-coenzyme A thioesterase 1-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACOT4 mRNA PMID:35307453 14165588 QRSL1 glutaminyl-tRNA amidotransferase subunit QRSL1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of QRSL1 mRNA PMID:35307453 14165773 SKA1 spindle and kinetochore associated complex subunit 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SKA1 mRNA PMID:35307453 14165773 SKA1 spindle and kinetochore associated complex subunit 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of SKA1 mRNA PMID:35839969 14165811 DLGAP5 DLG associated protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DLGAP5 mRNA PMID:35307453 14165933 CYSTM1 cysteine rich transmembrane module containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYSTM1 mRNA PMID:35307453 14165963 TSPOAP1 TSPO associated protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPOAP1 mRNA PMID:35307453 14166155 PTPN18 protein tyrosine phosphatase non-receptor type 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN18 mRNA PMID:35307453 14166176 ITGA6 integrin subunit alpha 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ITGA6 mRNA PMID:35307453 14166176 ITGA6 integrin subunit alpha 6 gene CHEBI:25434 bis(2-chloroethyl) sulfide affects expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas affects the expression of ITGA6 protein PMID:9285538 14166205 CD59 CD59 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD59 mRNA PMID:35307453 14166239 GZMA granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of GZMA mRNA PMID:34389318 14166328 TPM4 tropomyosin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TPM4 mRNA PMID:35307453 14166385 LONRF3 LON peptidase N-terminal domain and ring finger 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LONRF3 mRNA PMID:35307453 14166423 SYNGAP1 synaptic Ras GTPase activating protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYNGAP1 mRNA PMID:35307453 14166481 TEX12 testis expressed 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TEX12 mRNA PMID:35307453 14166591 ZBTB7C zinc finger and BTB domain containing 7C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZBTB7C mRNA PMID:35307453 14166612 PLEKHF2 pleckstrin homology and FYVE domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHF2 mRNA PMID:35307453 14166770 WNT9A Wnt family member 9A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WNT9A mRNA PMID:35307453 14166940 MAP9 microtubule associated protein 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP9 mRNA PMID:35307453 14167067 CHI3L1 chitinase 3 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHI3L1 mRNA PMID:35307453 14167067 CHI3L1 chitinase 3 like 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CHI3L1 mRNA PMID:21852083 14167086 SEC24A SEC24 homolog A, COPII coat complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC24A mRNA PMID:35307453 14167149 ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKS1B mRNA PMID:35307453 14167238 BAMBI BMP and activin membrane bound inhibitor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BAMBI mRNA PMID:35307453 14167245 DCPS decapping enzyme, scavenger gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCPS mRNA PMID:35307453 14167294 ERRFI1 ERBB receptor feedback inhibitor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ERRFI1 mRNA PMID:35307453 14167294 ERRFI1 ERBB receptor feedback inhibitor 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of ERRFI1 mRNA PMID:21852083 14167302 HSH2D hematopoietic SH2 domain containing gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSH2D mRNA PMID:35307453 14167442 HERC6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HERC6 mRNA PMID:35307453 14167594 CENPM centromere protein M gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CENPM mRNA PMID:35307453 14167631 ACAP3 ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of ACAP3 protein PMID:37257635 14167667 ZNF597 zinc finger protein 597 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF597 mRNA PMID:35307453 14167761 ITIH5 inter-alpha-trypsin inhibitor heavy chain 5 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ITIH5 mRNA PMID:28069986 14167807 FOLH1B folate hydrolase 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOLH1B mRNA PMID:35307453 14167879 ZNF652 zinc finger protein 652 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF652 mRNA PMID:35307453 14168004 NME7 NME/NM23 family member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NME7 mRNA PMID:35307453 14168111 GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GUCY1A1 mRNA PMID:35307453 14168111 GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1 gene CHEBI:142433 cinaciguat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C480588 BAY 58-2667 inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1A1 protein] PMID:19466990 14168111 GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1 gene CHEBI:91215 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one increases degradation EXP E RGD:6480464 20191114 CTD MESH:C095284 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1A1 protein PMID:19466990 14168111 GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1 gene CHEBI:91215 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C095284 BAY 58-2667 inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1A1 protein] PMID:19466990 14168217 RGS9BP regulator of G protein signaling 9 binding protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS9BP mRNA PMID:35307453 14168271 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HMGCS1 mRNA PMID:35307453 14168318 CCR1 C-C motif chemokine receptor 1 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCR1 mRNA PMID:21505051 14168318 CCR1 C-C motif chemokine receptor 1 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 epostane promotes the reaction [Dinoprost results in increased expression of CCR1 mRNA] PMID:21505051 14168318 CCR1 C-C motif chemokine receptor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CCR1 mRNA PMID:18988085 14168318 CCR1 C-C motif chemokine receptor 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of CCR1 mRNA PMID:18790026|PMID:21391292 14168318 CCR1 C-C motif chemokine receptor 1 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of CCR1 mRNA PMID:22533443 14168355 OTOF otoferlin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTOF mRNA PMID:35307453 14168430 SELENBP1 selenium binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SELENBP1 mRNA PMID:35307453 14168430 SELENBP1 selenium binding protein 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SELENBP1 mRNA PMID:34933075 14168430 SELENBP1 selenium binding protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SELENBP1 mRNA PMID:39265697 14168473 SLC22A18 solute carrier family 22 member 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC22A18 mRNA PMID:35307453 14168675 GLIS2 GLIS family zinc finger 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLIS2 mRNA PMID:35307453 14168709 ALKBH4 alkB homolog 4, lysine demethylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ALKBH4 mRNA PMID:35307453 14168727 ST8SIA2 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ST8SIA2 mRNA PMID:34933075 14168748 CERS4 ceramide synthase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CERS4 mRNA PMID:35307453 14168775 TGM3 transglutaminase 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TGM3 mRNA PMID:39265697 14168872 TTR transthyretin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTR mRNA PMID:35307453 14168872 TTR transthyretin gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of TTR mRNA PMID:16896063 14168958 IFN-ALPHA-8 interferon-alpha-8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFN-ALPHA-8 mRNA PMID:35307453 14168964 PGA5 pepsinogen 5, group I (pepsinogen A) gene CHEBI:7989 pepstatin A decreases activity EXP E RGD:6480464 20250325 CTD MESH:C031375 pepstatin analog results in decreased activity of PGA5 protein PMID:1478780 14168998 CFAP70 cilia and flagella associated protein 70 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP70 mRNA PMID:35307453 14169037 ETFDH electron transfer flavoprotein dehydrogenase gene CHEBI:16389 ubiquinones affects binding EXP E RGD:6480464 20191114 CTD MESH:D014451 Ubiquinone binds to ETFDH protein PMID:17050691 14169073 UBE2V1 ubiquitin conjugating enzyme E2 V1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBE2V1 mRNA PMID:35307453 14169110 NHP2 NHP2 ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NHP2 mRNA PMID:35307453 14169226 TAL1 TAL bHLH transcription factor 1, erythroid differentiation factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TAL1 mRNA PMID:35307453 14169329 LY49 killer cell lectin-like receptor subfamily A, member 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250401 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of KLRA1 mRNA PMID:21852083 14169422 ACSF2 acyl-CoA synthetase family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACSF2 mRNA PMID:35307453 14169805 HOXA10 homeobox A10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXA10 mRNA PMID:35307453 14169805 HOXA10 homeobox A10 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of HOXA10 mRNA PMID:34933075 14169805 HOXA10 homeobox A10 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of HOXA10 mRNA PMID:21705055 14169805 HOXA10 homeobox A10 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol promotes the reaction [Progesterone results in increased expression of HOXA10 mRNA]; Fulvestrant inhibits the reaction [Estradiol results in increased expression of HOXA10 mRNA] PMID:21705055 14169805 HOXA10 homeobox A10 gene CHEBI:17026 progesterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased expression of HOXA10 mRNA PMID:21705055 14169805 HOXA10 homeobox A10 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 Estradiol promotes the reaction [Progesterone results in increased expression of HOXA10 mRNA] PMID:21705055 14169805 HOXA10 homeobox A10 gene CHEBI:31638 fulvestrant decreases expression EXP E RGD:6480464 20191114 CTD MESH:C070081 Fulvestrant results in decreased expression of HOXA10 mRNA PMID:21705055 14169805 HOXA10 homeobox A10 gene CHEBI:31638 fulvestrant multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070081 Fulvestrant inhibits the reaction [Estradiol results in increased expression of HOXA10 mRNA] PMID:21705055 14169879 NICOL1 NELL2 interacting cell ontogeny regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230801 CTD MESH:C007262 deoxynivalenol results in decreased expression of NICOL1 mRNA PMID:35307453 14169895 SULT1A3 sulfotransferase family 1A member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULT1A3 mRNA PMID:35307453 14169895 SULT1A3 sulfotransferase family 1A member 3 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20250325 CTD MESH:C014558 flunixin meglumine affects the expression of SULT1A1 mRNA PMID:26366864 14169895 SULT1A3 sulfotransferase family 1A member 3 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20250325 CTD MESH:D005273 Fenbendazole affects the expression of SULT1A1 mRNA PMID:26366864 14169912 LARP6 La ribonucleoprotein 6, translational regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LARP6 mRNA PMID:35307453 14169919 NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUS1 mRNA PMID:35307453 14170127 MYBPC1 myosin binding protein C1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYBPC1 mRNA PMID:35307453 14170191 RPL30 ribosomal protein L30 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL30 mRNA PMID:39265697 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20221206 CTD MESH:D015025 Zearalenone results in decreased expression of NFE2L2 mRNA; Zearalenone results in decreased expression of NFE2L2 protein PMID:35489465 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone results in increased expression of NFE2L2 mRNA; Zearalenone results in increased expression of NFE2L2 protein PMID:31760079 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D015025 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 protein]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 protein] PMID:35489465 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:141524 ochratoxin B decreases activity EXP E RGD:6480464 20191114 CTD MESH:C045354 ochratoxin B results in decreased activity of NFE2L2 protein PMID:18547704 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:16494 lipoic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of NFE2L2 mRNA] PMID:36584959 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:180664 4-hydroxy-TEMPO multiple interactions EXP E RGD:6480464 20211109 CTD MESH:C001803 tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFE2L2 mRNA PMID:34416349 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:26267 proanthocyanidin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D044945 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 protein]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NQO1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of NFE2L2 protein] PMID:35489465 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA] PMID:32280687 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:27584 aldosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000450 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; acetovanillone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Aldosterone results in increased expression of and results in increased activity of NFE2L2 protein; diphenyleneiodonium inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Eplerenone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Ro 32-0432 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; W 7 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of NFE2L2 mRNA; Glyphosate results in increased expression of NFE2L2 protein PMID:31677563|PMID:35388968|PMID:36584959 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of NFE2L2 mRNA]; Glyphosate results in increased expression of and affects the localization of NFE2L2 protein PMID:35388968|PMID:36584959 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:2781 apocynin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056165 acetovanillone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NFE2L2 protein] PMID:37955343 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of NFE2L2 protein PMID:36754226 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA] PMID:32280687 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:30314 (R)-lipoic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:31547 eplerenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C414690 Eplerenone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C023035 NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]; NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA] PMID:22521609 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D019287 Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA] PMID:32280687 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of NFE2L2 mRNA; Cadmium Chloride results in decreased expression of NFE2L2 protein PMID:33626375 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NFE2L2 mRNA PMID:34416349 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240604 CTD MESH:C056933 fumonisin B1 results in decreased expression of NFE2L2 protein PMID:37955343 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C056933 Resveratrol inhibits the reaction [fumonisin B1 results in decreased expression of NFE2L2 protein] PMID:37955343 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:47807 sulforaphane affects localization EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane affects the localization of NFE2L2 protein PMID:18547363|PMID:19913604 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:47807 sulforaphane increases activity EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased activity of NFE2L2 protein PMID:18547363 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of NFE2L2 mRNA PMID:28710020 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of NQO1 protein]; ochratoxin A inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforaphane results in increased expression of NFE2L2 mRNA]; sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein PMID:18547363|PMID:21130106|PMID:28710020 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of GSTO1 mRNA]; NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of NQO1 mRNA] PMID:22521609 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:4948 Evodiamine increases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in increased expression of NFE2L2 mRNA PMID:39305878 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide affects the reaction [evodiamine affects the reaction [T-2 Toxin affects the localization of NFE2L2 protein]]; evodiamine affects the reaction [T-2 Toxin affects the localization of NFE2L2 protein]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of NFE2L2 mRNA] PMID:39305878 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in decreased expression of NFE2L2 mRNA PMID:32280687 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA]; Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA] PMID:32280687 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:7719 ochratoxin A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased activity of NFE2L2 protein PMID:18547363|PMID:18547704 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of NFE2L2 mRNA PMID:18547363|PMID:28710020 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TP53 protein]; ochratoxin A inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforaphane results in increased expression of NFE2L2 mRNA] PMID:18547363|PMID:28710020 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:77986 dibenziodolium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007517 diphenyleneiodonium inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] PMID:24512358 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:9381 T-2 toxin affects localization EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin affects the localization of NFE2L2 protein PMID:39305878 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in decreased expression of NFE2L2 mRNA PMID:39305878 14170248 NFE2L2 NFE2 like bZIP transcription factor 2 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide affects the reaction [evodiamine affects the reaction [T-2 Toxin affects the localization of NFE2L2 protein]]; evodiamine affects the reaction [T-2 Toxin affects the localization of NFE2L2 protein]; evodiamine inhibits the reaction [T-2 Toxin results in decreased expression of NFE2L2 mRNA] PMID:39305878 14170429 PPP1R14D protein phosphatase 1 regulatory inhibitor subunit 14D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP1R14D mRNA PMID:35307453 14170457 ORAI2 ORAI calcium release-activated calcium modulator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ORAI2 mRNA PMID:35307453 14170564 ABRAXAS2 abraxas 2, BRISC complex subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABRAXAS2 mRNA PMID:35307453 14170598 R3HCC1L R3H domain and coiled-coil containing 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of R3HCC1L mRNA PMID:35307453 14170639 SERPINE3 serpin family E member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERPINE3 mRNA PMID:35307453 14170800 ALKBH8 alkB homolog 8, tRNA methyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ALKBH8 mRNA PMID:35307453 14170830 DEPDC1 DEP domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DEPDC1 mRNA PMID:35307453 14171046 DIPK1B divergent protein kinase domain 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DIPK1B mRNA PMID:35307453 14171050 TSPAN1 tetraspanin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN1 mRNA PMID:35307453 14171050 TSPAN1 tetraspanin 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TSPAN1 mRNA PMID:39265697 14171072 ANTXR1 ANTXR cell adhesion molecule 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANTXR1 mRNA PMID:35307453 14171094 SLA-DRB1 MHC class II histocompatibility antigen SLA-DRB1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DRB1 mRNA PMID:35307453 14171108 ABCB10 ATP binding cassette subfamily B member 10 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ABCB10 mRNA] PMID:39151877 14171108 ABCB10 ATP binding cassette subfamily B member 10 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of ABCB10 mRNA PMID:39151877 14171108 ABCB10 ATP binding cassette subfamily B member 10 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of ABCB10 mRNA] PMID:39151877 14171147 GAS2 growth arrest specific 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAS2 mRNA PMID:35307453 14171251 SLC17A8 solute carrier family 17 member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC17A8 mRNA PMID:35307453 14171272 COX7A2L cytochrome c oxidase subunit 7A2 like gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of COX7A2L mRNA] PMID:35665993 14171272 COX7A2L cytochrome c oxidase subunit 7A2 like gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of COX7A2L mRNA PMID:35665993 14171272 COX7A2L cytochrome c oxidase subunit 7A2 like gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of COX7A2L mRNA] PMID:35665993 14171430 FOXH1 forkhead box H1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXH1 mRNA PMID:35307453 14171449 TAC1 tachykinin precursor 1 gene CHEBI:16480 nitric oxide increases abundance EXP E RGD:6480464 20191114 CTD MESH:D009569 TAC1 protein results in increased abundance of Nitric Oxide PMID:12672649 14171449 TAC1 tachykinin precursor 1 gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020106 Acrylamide results in increased expression of TAC1 protein modified form PMID:30222996 14171449 TAC1 tachykinin precursor 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of TAC1 protein PMID:29558425|PMID:29569701|PMID:29888781|PMID:38069115 14171449 TAC1 tachykinin precursor 1 gene CHEBI:3374 capsaicin increases secretion EXP E RGD:6480464 20191114 CTD MESH:D002211 Capsaicin results in increased secretion of TAC1 protein PMID:10766449 14171449 TAC1 tachykinin precursor 1 gene CHEBI:9774 tubocurarine affects activity EXP E RGD:6480464 20191114 CTD MESH:D014403 Tubocurarine affects the activity of TAC1 protein PMID:11877319 14171471 GORASP1 golgi reassembly stacking protein 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of GORASP1 mRNA PMID:34389318 14171512 DAO D-amino acid oxidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DAO mRNA PMID:35307453 14171512 DAO D-amino acid oxidase gene CHEBI:113455 sodium benzoate decreases activity EXP E RGD:6480464 20191114 CTD MESH:D020160 Sodium Benzoate results in decreased activity of DAO protein PMID:20952482 14171512 DAO D-amino acid oxidase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate results in decreased expression of DAO mRNA] PMID:39151877 14171512 DAO D-amino acid oxidase gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of DAO mRNA PMID:39151877 14171512 DAO D-amino acid oxidase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate results in decreased expression of DAO mRNA] PMID:39151877 14171512 DAO D-amino acid oxidase gene CHEBI:3647 chlorpromazine decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002746 Chlorpromazine results in decreased activity of DAO protein PMID:18615285 14171512 DAO D-amino acid oxidase gene CHEBI:74739 5-methyl-pyrazole-3-carboxylic acid decreases activity EXP E RGD:6480464 20191114 CTD MESH:C005210 5-methylpyrazole-3-carboxylic acid results in decreased activity of DAO protein PMID:20952482 14171588 CDH5 cadherin 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDH5 mRNA PMID:35307453 14171588 CDH5 cadherin 5 gene CHEBI:3441 carvedilol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in decreased expression of CDH5 mRNA PMID:16824628 14171588 CDH5 cadherin 5 gene CHEBI:3441 carvedilol increases expression EXP E RGD:6480464 20191114 CTD MESH:C043211 Carvedilol results in increased expression of CDH5 protein PMID:16824628 14171612 FOSL1 FOS like 1, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOSL1 mRNA; deoxynivalenol results in increased expression of FOSL1 protein PMID:35307453|PMID:37257635|PMID:38403181 14171620 COL9A3 collagen type IX alpha 3 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL9A3 mRNA PMID:35307453 14171704 FRMPD4 FERM and PDZ domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FRMPD4 mRNA PMID:35307453 14171704 FRMPD4 FERM and PDZ domain containing 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of FRMPD4 mRNA PMID:34933075 14171775 MAP1B microtubule associated protein 1B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP1B mRNA PMID:35307453 14171789 SLC12A5 solute carrier family 12 member 5 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of SLC12A5 mRNA PMID:35307453 14171858 CCNG2 cyclin G2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCNG2 mRNA PMID:35307453 14171912 TRAK2 trafficking kinesin protein 2 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of TRAK2 mRNA PMID:34389318 14172086 TNFSF13 TNF superfamily member 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNFSF13 mRNA PMID:35307453 14172106 FGFR3 fibroblast growth factor receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FGFR3 mRNA PMID:35307453 14172238 PLA2G3 phospholipase A2 group III gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLA2G3 mRNA PMID:35307453 14172350 CDC45 cell division cycle 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDC45 mRNA PMID:35307453 14172461 WEE1 WEE1 G2 checkpoint kinase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of WEE1 mRNA PMID:21852083 14172526 MXD3 MAX dimerization protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MXD3 mRNA PMID:35307453 14172576 TM4SF5 transmembrane 4 L six family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TM4SF5 mRNA PMID:35307453 14172585 CDH7 cadherin 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDH7 mRNA PMID:35307453 14172663 AIFM2 apoptosis inducing factor mitochondria associated 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of AIFM2 mRNA PMID:25455459 14172763 LAMA4 laminin subunit alpha 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAMA4 mRNA PMID:38403181 14172830 DAB2 DAB adaptor protein 2 gene CHEBI:88046 cylindrospermopsin decreases expression EXP E RGD:6480464 20220419 CTD MESH:C089595 cylindrospermopsin results in decreased expression of DAB2 mRNA PMID:33689780 14172981 CORO1C coronin 1C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CORO1C mRNA PMID:35307453 14173134 CTC1 CST telomere replication complex component 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTC1 mRNA PMID:35307453 14173161 SCUBE2 signal peptide, CUB domain and EGF like domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCUBE2 mRNA PMID:35307453 14173282 AMCF-II alveolar macrophage-derived chemotactic factor-II gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20250715 CTD MESH:D009151 Mustard Gas results in increased expression of CXCL5 mRNA PMID:18988085 14173290 TUFT1 tuftelin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TUFT1 mRNA PMID:35307453 14173308 TTLL1 TTL family tubulin polyglutamylase complex subunit L1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTLL1 mRNA PMID:35307453 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STAT1 mRNA PMID:35307453 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:15553 prostaglandin F2alpha increases secretion EXP E RGD:6480464 20191114 CTD MESH:D015237 STAT1 protein results in increased secretion of Dinoprost PMID:19528263 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Dinoprost] PMID:19528263 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone] PMID:19528263 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:22977 cadmium atom increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased phosphorylation of STAT1 protein PMID:21783819 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 SB 203580 inhibits the reaction [Cadmium results in increased phosphorylation of STAT1 protein] PMID:21783819 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:7872 oxytocin increases secretion EXP E RGD:6480464 20191114 CTD MESH:D010121 STAT1 protein results in increased secretion of Oxytocin PMID:19528263 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:7872 oxytocin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010121 STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Oxytocin] PMID:19528263 14173345 STAT1 signal transducer and activator of transcription 1 gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C093642 SB 203580 inhibits the reaction [Cadmium results in increased phosphorylation of STAT1 protein] PMID:21783819 14173599 PLRG1 pleiotropic regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLRG1 mRNA PMID:35307453 14173631 RBPMS RNA binding protein, mRNA processing factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBPMS mRNA PMID:35307453 14173839 CHRDL1 chordin like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHRDL1 mRNA PMID:35307453 14174034 ANO3 anoctamin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANO3 mRNA PMID:35307453 14174077 KIF9 kinesin family member 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF9 mRNA PMID:35307453 14174134 ARNTL2 aryl hydrocarbon receptor nuclear translocator like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of ARNTL2 mRNA PMID:35307453 14174233 OPRL1 opioid related nociceptin receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OPRL1 mRNA PMID:35307453 14174233 OPRL1 opioid related nociceptin receptor 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of OPRL1 mRNA PMID:39265697 14174339 DNAJC3 DnaJ heat shock protein family (Hsp40) member C3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC3 mRNA PMID:35307453 14174356 GAREM2 GRB2 associated regulator of MAPK1 subtype 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAREM2 mRNA PMID:35307453 14174457 THEM6 thioesterase superfamily member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THEM6 mRNA PMID:35307453 14174499 NR2F2 nuclear receptor subfamily 2 group F member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR2F2 mRNA PMID:35307453 14174499 NR2F2 nuclear receptor subfamily 2 group F member 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of NR2F2 mRNA PMID:18988085 14174685 SMNDC1 survival motor neuron domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMNDC1 mRNA PMID:35307453 14174717 SLC12A2 solute carrier family 12 member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC12A2 mRNA PMID:35307453 14174762 KLF5 KLF transcription factor 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLF5 mRNA PMID:37120089 14174762 KLF5 KLF transcription factor 5 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of KLF5 mRNA] PMID:37120089 14174762 KLF5 KLF transcription factor 5 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of KLF5 mRNA] PMID:37120089 14174837 NCF1 neutrophil cytosolic factor 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of NCF1 mRNA PMID:21645290 14174856 GRHPR glyoxylate and hydroxypyruvate reductase gene CHEBI:16412 lipopolysaccharide affects expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides affects the expression of GRHPR mRNA PMID:21645290 14174884 NPPB natriuretic peptide B gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of NPPB mRNA PMID:27617619 14174891 INHBB inhibin subunit beta B gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of INHBB mRNA PMID:32423882 14174891 INHBB inhibin subunit beta B gene CHEBI:17688 (S)-nicotine decreases secretion EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased secretion of INHBB protein PMID:32423882 14174891 INHBB inhibin subunit beta B gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of INHBB mRNA PMID:32423882 14174891 INHBB inhibin subunit beta B gene CHEBI:18723 nicotine decreases secretion EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased secretion of INHBB protein PMID:32423882 14174891 INHBB inhibin subunit beta B gene CHEBI:31767 lead diacetate decreases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of INHBB mRNA PMID:29273543 14174891 INHBB inhibin subunit beta B gene CHEBI:31767 lead diacetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of and results in decreased secretion of [INHBB protein binds to INHA protein]; lead acetate results in decreased expression of and results in decreased secretion of INHBB protein PMID:29273543 14174896 GPR4 G protein-coupled receptor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPR4 mRNA PMID:35307453 14174992 MED10 mediator complex subunit 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED10 mRNA PMID:35307453 14175024 CCL8 chemokine (C-C motif) ligand 8 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCL8 mRNA PMID:21505051 14175024 CCL8 chemokine (C-C motif) ligand 8 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [Dinoprost co-treated with epostane] results in increased expression of CCL8 mRNA PMID:21505051 14175024 CCL8 chemokine (C-C motif) ligand 8 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CCL8 mRNA PMID:21852083 14175110 ZNF395 zinc finger protein 395 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ZNF395 mRNA PMID:39265697 14175252 NUSAP1 nucleolar and spindle associated protein 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NUSAP1 mRNA] PMID:21852083 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:17688 (S)-nicotine increases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in increased expression of MMP9 mRNA PMID:32423882 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:18723 nicotine increases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in increased expression of MMP9 mRNA PMID:32423882 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 protein PMID:34416349 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of MMP9 mRNA PMID:12481301 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the expression of MMP9 protein PMID:39486568 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:28748 doxorubicin increases activity EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased activity of MMP9 protein PMID:19782292 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased expression of MMP9 mRNA PMID:19782292 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20211109 CTD MESH:C008745 4,4'-bisphenol F results in increased expression of MMP9 mRNA PMID:34019995 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 protein PMID:34416349 14175280 MMP9 matrix metallopeptidase 9 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the expression of MMP9 protein PMID:39486568 14175654 ZC3H18 zinc finger CCCH-type containing 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZC3H18 mRNA PMID:35307453 14175723 VDR vitamin D receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VDR mRNA PMID:35307453 14175769 GLMN glomulin, FKBP associated protein gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of GLMN mRNA PMID:14994279 14175855 SF3B3 splicing factor 3b subunit 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SF3B3 mRNA PMID:35307453 14175897 VAMP1 vesicle associated membrane protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VAMP1 mRNA PMID:35307453 14175944 CISH cytokine inducible SH2 containing protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CISH mRNA PMID:35307453 14176034 AHSG alpha 2-HS glycoprotein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AHSG mRNA PMID:35307453 14176169 ABCF1 ATP binding cassette subfamily F member 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of ABCF1 mRNA PMID:25455459 14176204 IMPDH2 inosine monophosphate dehydrogenase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of QRICH1 mRNA PMID:35307453 14176294 NBEAL2 neurobeachin like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NBEAL2 mRNA PMID:35307453 14176434 UBR5 ubiquitin protein ligase E3 component n-recognin 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBR5 mRNA PMID:35307453 14176738 NFE2L1 NFE2 like bZIP transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NFE2L1 mRNA PMID:35307453 14176738 NFE2L1 NFE2 like bZIP transcription factor 1 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in decreased expression of NFE2L1 mRNA PMID:38705344 14176738 NFE2L1 NFE2 like bZIP transcription factor 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in decreased expression of NFE2L1 mRNA] PMID:38705344 14176791 TPX2 TPX2 microtubule nucleation factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TPX2 mRNA PMID:35307453 14176791 TPX2 TPX2 microtubule nucleation factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of TPX2 mRNA PMID:21852083 14176866 SCAP SREBF chaperone gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCAP mRNA PMID:35307453 14176941 OLFML2A olfactomedin like 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OLFML2A mRNA PMID:35307453 14176956 SEMA6A semaphorin 6A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA6A mRNA PMID:35307453 14177130 SIRT2 sirtuin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SIRT2 mRNA PMID:35307453 14177176 OPRK1 opioid receptor kappa 1 gene CHEBI:32595 barium(0) affects transport EXP E RGD:6480464 20191114 CTD MESH:D001464 OPRK1 protein affects the transport of Barium PMID:12031848 14177176 OPRK1 opioid receptor kappa 1 gene CHEBI:32595 barium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001464 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [OPRK1 protein results in increased transport of Barium] PMID:12031848 14177176 OPRK1 opioid receptor kappa 1 gene CHEBI:73358 U50488 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019900 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [OPRK1 protein results in increased transport of Barium] PMID:12031848 14177202 GJB3 gap junction protein beta 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GJB3 mRNA PMID:35307453 14177270 PLAU plasminogen activator, urokinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of PLAU mRNA PMID:37257635 14177270 PLAU plasminogen activator, urokinase gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PLAU mRNA PMID:39265697 14177270 PLAU plasminogen activator, urokinase gene CHEBI:17026 progesterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone results in increased expression of PLAU mRNA PMID:23103014 14177270 PLAU plasminogen activator, urokinase gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PLAU mRNA PMID:18988085 14177270 PLAU plasminogen activator, urokinase gene CHEBI:2639 amiloride multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D000584 Amiloride inhibits the reaction [[Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein]; Amiloride inhibits the reaction [[Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein] PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46666 crocidolite asbestos increases activity EXP E RGD:6480464 20201006 CTD MESH:D017638 Asbestos, Crocidolite results in increased activity of PLAU protein PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46666 crocidolite asbestos increases expression EXP E RGD:6480464 20201006 CTD MESH:D017638 Asbestos, Crocidolite results in increased expression of PLAU mRNA PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46666 crocidolite asbestos multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D017638 [Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein; Amiloride inhibits the reaction [[Asbestos, Crocidolite results in increased activity of PLAU protein] which results in increased cleavage of PLG protein] PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46680 serpentine asbestos increases activity EXP E RGD:6480464 20201006 CTD MESH:D017632 Asbestos, Serpentine results in increased activity of PLAU protein PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46680 serpentine asbestos increases expression EXP E RGD:6480464 20201006 CTD MESH:D017632 Asbestos, Serpentine results in increased expression of PLAU mRNA PMID:9853007 14177270 PLAU plasminogen activator, urokinase gene CHEBI:46680 serpentine asbestos multiple interactions EXP E RGD:6480464 20201006 CTD MESH:D017632 [Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein; Amiloride inhibits the reaction [[Asbestos, Serpentine results in increased activity of PLAU protein] which results in increased cleavage of PLG protein] PMID:9853007 14177391 GLRB glycine receptor beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLRB mRNA PMID:35307453 14177478 MLEC malectin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MLEC mRNA PMID:35307453 14177550 HNRNPL heterogeneous nuclear ribonucleoprotein L gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HNRNPL mRNA PMID:35307453 14177573 ZNF22 zinc finger protein 22 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF22 mRNA PMID:35307453 14177623 CHST1 carbohydrate sulfotransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHST1 mRNA PMID:35307453 14177651 UBE2U ubiquitin conjugating enzyme E2 U gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBE2U mRNA PMID:35307453 14177651 UBE2U ubiquitin conjugating enzyme E2 U gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of UBE2U mRNA PMID:21852083 14178073 STAT5B signal transducer and activator of transcription 5B gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of STAT5B mRNA PMID:25455459 14178112 TRANK1 tetratricopeptide repeat and ankyrin repeat containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRANK1 mRNA PMID:35307453 14178203 SEMA3C semaphorin 3C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEMA3C mRNA PMID:35307453 14178257 IFNG interferon gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFNG mRNA PMID:18329193 14178257 IFNG interferon gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IFNG mRNA PMID:25701311 14178257 IFNG interferon gamma gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IFNG mRNA; [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IFNG mRNA PMID:18296887|PMID:38763499 14178257 IFNG interferon gamma gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IFNG mRNA PMID:34933075 14178257 IFNG interferon gamma gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IFNG mRNA; Zearalenone results in decreased expression of and results in decreased secretion of IFNG protein; Zearalenone results in increased expression of and results in increased secretion of IFNG protein PMID:18296887|PMID:23727178 14178257 IFNG interferon gamma gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IFNG mRNA PMID:15998543 14178257 IFNG interferon gamma gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 Glutathione inhibits the reaction [Paraquat results in increased expression of IFNG mRNA] PMID:36615853 14178257 IFNG interferon gamma gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFNG mRNA PMID:33592257|PMID:33891997 14178257 IFNG interferon gamma gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of IFNG mRNA PMID:38763499 14178257 IFNG interferon gamma gene CHEBI:28640 lipoteichoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C009900 lipoteichoic acid results in increased expression of IFNG mRNA PMID:15998543 14178257 IFNG interferon gamma gene CHEBI:3084 bethanechol increases expression EXP E RGD:6480464 20230704 CTD MESH:D018723 Bethanechol results in increased expression of IFNG mRNA PMID:29380034 14178257 IFNG interferon gamma gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of IFNG mRNA PMID:37108405|PMID:38154151 14178257 IFNG interferon gamma gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IFNG mRNA] PMID:37108405 14178257 IFNG interferon gamma gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of IFNG mRNA PMID:36615853 14178257 IFNG interferon gamma gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 Glutathione inhibits the reaction [Paraquat results in increased expression of IFNG mRNA] PMID:36615853 14178257 IFNG interferon gamma gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFNG mRNA PMID:33592257|PMID:33891997 14178257 IFNG interferon gamma gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IFNG mRNA] PMID:27079946 14178257 IFNG interferon gamma gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 metabolite results in decreased expression of IFNG protein PMID:30708112 14178257 IFNG interferon gamma gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IFNG mRNA] PMID:37108405 14178257 IFNG interferon gamma gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of IFNG mRNA PMID:21176401 14178337 GSK3B glycogen synthase kinase 3 beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of GSK3B protein PMID:30690062 14178393 THAP2 THAP domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of THAP2 mRNA PMID:35307453 14178530 MAP4K2 mitogen-activated protein kinase kinase kinase kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP4K2 mRNA PMID:35307453 14178605 SECTM1 secreted and transmembrane 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SECTM1 mRNA PMID:35307453 14178616 DPF1 double PHD fingers 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DPF1 mRNA PMID:35307453 14178735 ADAP2 ArfGAP with dual PH domains 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAP2 mRNA PMID:35307453 14178856 GRIN1 glutamate ionotropic receptor NMDA type subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRIN1 mRNA PMID:35307453 14178929 PSAT1 phosphoserine aminotransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSAT1 mRNA PMID:35307453 14178929 PSAT1 phosphoserine aminotransferase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PSAT1 mRNA] PMID:21852083 14179008 APOBEC3B apolipoprotein B mRNA editing enzyme catalytic subunit 3B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APOBEC3B mRNA PMID:35307453 14179025 DIMT1 DIM1 rRNA methyltransferase and ribosome maturation factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DIMT1 mRNA PMID:35307453 14179260 RAB36 RAB36, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB36 mRNA PMID:35307453 14179532 COX6C COX6C protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of COX6C mRNA PMID:39265697 14179543 TACC1 transforming acidic coiled-coil containing protein 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of TACC1 mRNA PMID:34933075 14179629 APOLD1 apolipoprotein L domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APOLD1 mRNA PMID:35307453 14179744 NEK10 NIMA related kinase 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEK10 mRNA PMID:35307453 14179902 KAT2B lysine acetyltransferase 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KAT2B mRNA PMID:35307453 14179902 KAT2B lysine acetyltransferase 2B gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of KAT2B mRNA PMID:21391292 14179952 RAP2B RAP2B, member of RAS oncogene family gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAP2B mRNA PMID:35307453 14179972 FAM124A family with sequence similarity 124 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM124A mRNA PMID:35307453 14180095 ADGRA2 adhesion G protein-coupled receptor A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRA2 mRNA PMID:35307453 14180123 SH3KBP1 SH3 domain containing kinase binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SH3KBP1 mRNA PMID:35307453 14180224 GADD45G growth arrest and DNA damage inducible gamma gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GADD45G mRNA PMID:35307453 14180224 GADD45G growth arrest and DNA damage inducible gamma gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of GADD45G mRNA PMID:37706587 14180224 GADD45G growth arrest and DNA damage inducible gamma gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of GADD45G mRNA] PMID:37706587 14180224 GADD45G growth arrest and DNA damage inducible gamma gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of GADD45G mRNA] PMID:37706587 14180343 HOXD1 homeobox D1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HOXD1 mRNA PMID:35307453 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOS3 mRNA PMID:35307453 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:135755 sulprostone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016767 sulprostone inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA] PMID:10525081 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of NOS3 mRNA PMID:16364719 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:141046 16,16-dimethylprostaglandin E2 increases expression EXP E RGD:6480464 20191114 CTD MESH:D015064 16,16-Dimethylprostaglandin E2 results in increased expression of NOS3 mRNA PMID:10525081 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:141046 16,16-dimethylprostaglandin E2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015064 16,16-Dimethylprostaglandin E2 inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA] PMID:10525081 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:149906 Tanshinone I multiple interactions EXP E RGD:6480464 20200602 CTD MESH:C021751 tanshinone inhibits the reaction [AGT protein results in decreased expression of NOS3 mRNA]; tanshinone inhibits the reaction [AGT protein results in decreased expression of NOS3 protein] PMID:17717927 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:15555 prostaglandin D2 increases expression EXP E RGD:6480464 20191114 CTD MESH:D015230 Prostaglandin D2 results in increased expression of NOS3 mRNA PMID:10644584 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:15555 prostaglandin D2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015230 BW A868C inhibits the reaction [Prostaglandin D2 results in increased expression of NOS3 mRNA]; Prostaglandin D2 inhibits the reaction [BW A868C results in decreased expression of NOS3 mRNA] PMID:10644584 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:15866 2-deoxy-D-glucose decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003847 Deoxyglucose results in decreased expression of NOS3 mRNA PMID:11382920 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of NOS3 mRNA PMID:15653758 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in decreased expression of NOS3 mRNA PMID:16680078 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16469 17beta-estradiol increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased phosphorylation of NOS3 protein PMID:16680078|PMID:17618301 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased phosphorylation of and results in increased activity of NOS3 protein; Fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of NOS3 protein] PMID:15967841|PMID:17618301 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16480 nitric oxide decreases activity EXP E RGD:6480464 20191114 CTD MESH:D009569 Nitric Oxide results in decreased activity of NOS3 protein PMID:10823391|PMID:8810647 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] PMID:8810647 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:176744 11-deoxyprostaglandin E1 multiple interactions EXP E RGD:6480464 20210803 CTD MESH:C034008 11-deoxyprostaglandin E1 inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA] PMID:10525081 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:185642 BW A868C decreases expression EXP E RGD:6480464 20220104 CTD MESH:C058848 BW A868C results in decreased expression of NOS3 mRNA PMID:10644584 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:185642 BW A868C multiple interactions EXP E RGD:6480464 20220104 CTD MESH:C058848 BW A868C inhibits the reaction [Prostaglandin D2 results in increased expression of NOS3 mRNA]; Prostaglandin D2 inhibits the reaction [BW A868C results in decreased expression of NOS3 mRNA] PMID:10644584 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:209558 Calphostin C multiple interactions EXP E RGD:6480464 20231219 CTD MESH:C058819 calphostin C inhibits the reaction [Clofibrate results in increased expression of NOS3 protein] PMID:17105827 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [embelin results in increased uptake of Calcium] which results in increased activity of NOS3 protein PMID:20144727 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:24757 hypochlorous acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006997 Hypochlorous Acid inhibits the reaction [NOS3 protein binds to NOS3 protein] PMID:17762155 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:28201 rotenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D012402 Rotenone results in increased expression of NOS3 mRNA PMID:11382920 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [embelin results in increased uptake of Calcium] which results in increased activity of NOS3 protein PMID:20144727 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in decreased expression of NOS3 protein PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:29678 sodium arsenite increases degradation EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased degradation of NOS3 protein PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017947 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of NOS3 protein]; sodium arsenite results in increased phosphorylation of and results in decreased activity of NOS3 protein; Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein] PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:30060 potassium hexacyanoferrate(3-) decreases activity EXP E RGD:6480464 20191114 CTD MESH:C028033 potassium ferricyanide results in decreased activity of NOS3 protein PMID:8810647 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:31638 fulvestrant multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070081 Fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of NOS3 protein]; Fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased phosphorylation of NOS3 protein] PMID:17618301 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of NOS3 protein PMID:17105827 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002994 calphostin C inhibits the reaction [Clofibrate results in increased expression of NOS3 protein] PMID:17105827 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:40050 amprenavir decreases expression EXP E RGD:6480464 20191114 CTD MESH:C095108 amprenavir results in decreased expression of NOS3 mRNA PMID:16123675 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in decreased expression of NOS3 protein PMID:12695417 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:42017 2,4-dinitrophenol increases expression EXP E RGD:6480464 20191114 CTD MESH:D019297 2,4-Dinitrophenol results in increased expression of NOS3 mRNA PMID:11382920 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:45409 ritonavir decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019438 Ritonavir results in decreased expression of NOS3 mRNA; Ritonavir results in decreased expression of NOS3 protein PMID:15681703|PMID:16123675|PMID:22037733 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:45409 ritonavir multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019438 Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA]; Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 protein]; Ritonavir results in decreased expression of and results in decreased activity of NOS3 protein PMID:15681703|PMID:22037733 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:4778 embelin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C010945 [embelin results in increased uptake of Calcium] which results in increased activity of NOS3 protein PMID:20144727 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:52289 wortmannin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009687 Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein] PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:5855 ibuprofen decreases expression EXP E RGD:6480464 20191114 CTD MESH:D007052 Ibuprofen results in decreased expression of NOS3 mRNA PMID:10525081|PMID:10644584 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:5855 ibuprofen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D007052 11-deoxy-16-phenoxy-17,18,19,20-tetranorprostaglandin E1 inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA]; 11-deoxyprostaglandin E1 inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA]; 16,16-Dimethylprostaglandin E2 inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA]; sulprostone inhibits the reaction [Ibuprofen results in decreased expression of NOS3 mRNA] PMID:10525081 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:63621 saquinavir decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019258 Saquinavir results in decreased expression of NOS3 mRNA PMID:16123675 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:65329 LY294002 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein] PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:73468 masoprocol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009637 Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA]; Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 protein] PMID:22037733 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NOS3 protein PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of NOS3 protein] PMID:16239170 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:75253 phenylarsine oxide affects localization EXP E RGD:6480464 20191114 CTD MESH:C029341 oxophenylarsine affects the localization of NOS3 protein PMID:9546377 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:75253 phenylarsine oxide decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C029341 oxophenylarsine results in decreased phosphorylation of NOS3 protein PMID:9546377 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of NOS3 mRNA PMID:15653758 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:8772 raloxifene decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in decreased expression of NOS3 protein PMID:16680078 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:8772 raloxifene increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in increased phosphorylation of NOS3 protein PMID:16680078|PMID:17618301 14180349 NOS3 nitric oxide synthase 3 gene CHEBI:8772 raloxifene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020849 Fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased phosphorylation of NOS3 protein] PMID:17618301 14180395 SLC20A1 solute carrier family 20 member 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SLC20A1 mRNA PMID:21852083 14180436 KANK1 KN motif and ankyrin repeat domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of KANK1 protein PMID:37257635 14180656 MSRB3 methionine sulfoxide reductase B3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MSRB3 mRNA PMID:35307453 14180748 BMF Bcl2 modifying factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMF mRNA PMID:35307453 14180816 KLHL17 kelch like family member 17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLHL17 mRNA PMID:35307453 14180972 PRSS2 serine protease 2 gene CHEBI:27363 zinc atom increases activity EXP E RGD:6480464 20250715 CTD MESH:D015032 Zinc results in increased activity of PRSS1 protein PMID:17093223 14180972 PRSS2 serine protease 2 gene CHEBI:30185 zinc(0) increases activity EXP E RGD:6480464 20250715 CTD MESH:D015032 Zinc results in increased activity of PRSS1 protein PMID:17093223 14180972 PRSS2 serine protease 2 gene CHEBI:36560 zinc oxide increases activity EXP E RGD:6480464 20250715 CTD MESH:D015034 Zinc Oxide results in increased activity of PRSS1 protein PMID:17093223 14180985 SSPO SCO-spondin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SSPOP mRNA PMID:35307453 14180985 SSPO SCO-spondin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SSPO mRNA PMID:39265697 14181210 EIF2B4 eukaryotic translation initiation factor 2B subunit delta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2B4 mRNA PMID:35307453 14181226 MKNK2 MAPK interacting serine/threonine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MKNK2 mRNA PMID:35307453 14181226 MKNK2 MAPK interacting serine/threonine kinase 2 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of MKNK2 mRNA PMID:28069986 14181259 IDO2 indoleamine 2,3-dioxygenase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IDO2 mRNA PMID:35307453 14181317 BAK1 BCL2 antagonist/killer 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAK1 mRNA PMID:33493553 14181317 BAK1 BCL2 antagonist/killer 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of BAK1 protein PMID:26607349 14181317 BAK1 BCL2 antagonist/killer 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAK1 mRNA; MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAK1 protein] PMID:26607349|PMID:33493553 14181317 BAK1 BCL2 antagonist/killer 1 gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of BAK1 protein PMID:31744678 14181317 BAK1 BCL2 antagonist/killer 1 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAK1 protein] PMID:26607349 14181340 ELF5 E74 like ETS transcription factor 5 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone affects the expression of ELF5 mRNA PMID:34933075 14181399 SGPL1 sphingosine-1-phosphate lyase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SGPL1 mRNA PMID:35307453 14181469 RSAD1 radical S-adenosyl methionine domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RSAD1 mRNA PMID:35307453 14181486 LIN37 lin-37 DREAM MuvB core complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LIN37 mRNA PMID:35307453 14181585 TMEM107 transmembrane protein 107 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM107 mRNA PMID:35307453 14181661 TNF tumor necrosis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of TNF mRNA; deoxynivalenol results in increased expression of TNF protein PMID:19027837|PMID:23326479|PMID:23688591|PMID:24394488|PMID:32783910|PMID:35314294|PMID:37120089 14181661 TNF tumor necrosis factor gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of TNF mRNA; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF protein; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [Zearalenone co-treated with deoxynivalenol] results in decreased expression of TNF mRNA; deoxynivalenol promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; deoxynivalenol promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of TNF protein]; lipopolysaccharide, Escherichia coli O111 B4 promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of TNF protein] PMID:18296887|PMID:19027837|PMID:19607891|PMID:23688591|PMID:30708112|PMID:32783910|PMID:32877744|PMID:37120089|PMID:38763499 14181661 TNF tumor necrosis factor gene CHEBI:10106 zearalenone decreases secretion EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased secretion of TNF protein PMID:21763767 14181661 TNF tumor necrosis factor gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of TNF mRNA; Zearalenone results in increased expression of TNF protein PMID:23688591|PMID:32783910|PMID:34933075 14181661 TNF tumor necrosis factor gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [Zearalenone co-treated with deoxynivalenol] results in decreased expression of TNF mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of TNF protein]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of TNF protein]; Zearalenone results in decreased expression of and results in decreased secretion of TNF protein; Zearalenone results in increased expression of and results in increased secretion of TNF protein PMID:18296887|PMID:23688591|PMID:23727178|PMID:32783910 14181661 TNF tumor necrosis factor gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of TNF mRNA PMID:16364719 14181661 TNF tumor necrosis factor gene CHEBI:15422 ATP increases expression EXP E RGD:6480464 20191114 CTD MESH:D000255 Adenosine Triphosphate results in increased expression of TNF protein PMID:17997382 14181661 TNF tumor necrosis factor gene CHEBI:15422 ATP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000255 tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased expression of TNF protein] PMID:17997382 14181661 TNF tumor necrosis factor gene CHEBI:16112 chlorogenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002726 Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] PMID:27861533 14181661 TNF tumor necrosis factor gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of TNF mRNA PMID:22083491|PMID:38438008 14181661 TNF tumor necrosis factor gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF protein]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF mRNA] PMID:38438008 14181661 TNF tumor necrosis factor gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of TNF mRNA; Lipopolysaccharides results in increased expression of TNF protein PMID:21948611|PMID:26180592|PMID:27861533|PMID:28528741|PMID:32877744|PMID:9185964 14181661 TNF tumor necrosis factor gene CHEBI:16412 lipopolysaccharide increases secretion EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased secretion of TNF protein PMID:12406900 14181661 TNF tumor necrosis factor gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF protein; [laminaran co-treated with fucoidan co-treated with Minerals] promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; GH1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; MAP1LC3B protein affects the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; picolinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] PMID:21948611|PMID:26180592|PMID:27861533|PMID:28528741|PMID:30708112|PMID:32877744|PMID:9185964 14181661 TNF tumor necrosis factor gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of TNF protein] PMID:37120089 14181661 TNF tumor necrosis factor gene CHEBI:17245 carbon monoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002248 NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] PMID:11880364 14181661 TNF tumor necrosis factor gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]; Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]; TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950 14181661 TNF tumor necrosis factor gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF mRNA] PMID:38438008 14181661 TNF tumor necrosis factor gene CHEBI:174984 3',4',5'-Trimethoxyflavone multiple interactions EXP E RGD:6480464 20210706 CTD MESH:C441202 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] PMID:26180592 14181661 TNF tumor necrosis factor gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of TNF mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased secretion of TNF protein] PMID:38154151 14181661 TNF tumor necrosis factor gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNF mRNA PMID:33891997|PMID:34416349 14181661 TNF tumor necrosis factor gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA] PMID:35134483 14181661 TNF tumor necrosis factor gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in decreased expression of TNF mRNA PMID:38763499 14181661 TNF tumor necrosis factor gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TNF mRNA PMID:12481301 14181661 TNF tumor necrosis factor gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of TNF mRNA; Mycotoxins results in increased expression of TNF protein PMID:39137830 14181661 TNF tumor necrosis factor gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of TNF mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of TNF protein] PMID:39137830 14181661 TNF tumor necrosis factor gene CHEBI:26523 reactive oxygen species increases abundance EXP E RGD:6480464 20191114 CTD MESH:D017382 TNF protein results in increased abundance of Reactive Oxygen Species PMID:10975995 14181661 TNF tumor necrosis factor gene CHEBI:26523 reactive oxygen species multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D017382 Disulfiram inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] PMID:10975995 14181661 TNF tumor necrosis factor gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [2,4-thiazolidinedione co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [ciprofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Fenofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Troglitazone co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of TNF mRNA]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458|PMID:32280687 14181661 TNF tumor necrosis factor gene CHEBI:27744 glyphosate affects secretion EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the secretion of TNF protein PMID:35388968 14181661 TNF tumor necrosis factor gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of TNF protein PMID:36584959 14181661 TNF tumor necrosis factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of TNF mRNA] PMID:37955343 14181661 TNF tumor necrosis factor gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of TNF mRNA PMID:20435919 14181661 TNF tumor necrosis factor gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019833 Genistein inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14181661 TNF tumor necrosis factor gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20200114 CTD MESH:D020106 Acrylamide results in increased expression of TNF protein PMID:31302221 14181661 TNF tumor necrosis factor gene CHEBI:28747 picolinic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C030614 picolinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] PMID:9185964 14181661 TNF tumor necrosis factor gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in decreased expression of TNF mRNA PMID:15810080 14181661 TNF tumor necrosis factor gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015032 [2,4-thiazolidinedione co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [ciprofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Fenofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Troglitazone co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of TNF mRNA]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458|PMID:32280687 14181661 TNF tumor necrosis factor gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of TNF mRNA; bisphenol A results in increased expression of TNF protein PMID:29558425|PMID:37108405|PMID:38154151 14181661 TNF tumor necrosis factor gene CHEBI:33216 bisphenol A increases secretion EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased secretion of TNF protein PMID:38154151 14181661 TNF tumor necrosis factor gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of TNF mRNA]; Glutamine inhibits the reaction [bisphenol A results in increased secretion of TNF protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of TNF mRNA] PMID:37108405|PMID:38154151 14181661 TNF tumor necrosis factor gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C019273 bisphenol A diglycidyl ether inhibits the reaction [Rosiglitazone promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]]; bisphenol A diglycidyl ether inhibits the reaction [Rosiglitazone promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; bisphenol A diglycidyl ether inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of TNF mRNA]; bisphenol A diglycidyl ether inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of TNF protein] PMID:17217567|PMID:19474210 14181661 TNF tumor necrosis factor gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D019287 Zinc Sulfate inhibits the reaction [Diquat results in increased expression of TNF mRNA] PMID:32280687 14181661 TNF tumor necrosis factor gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of TNF mRNA; Cadmium Chloride results in increased expression of TNF protein PMID:33626375 14181661 TNF tumor necrosis factor gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNF mRNA PMID:33891997|PMID:34416349 14181661 TNF tumor necrosis factor gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of TNF mRNA PMID:17437637 14181661 TNF tumor necrosis factor gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of TNF mRNA; fumonisin B1 results in increased expression of TNF protein PMID:23688591|PMID:30708112|PMID:32198028|PMID:37955343|PMID:38705344 14181661 TNF tumor necrosis factor gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF protein; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of TNF mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of TNF protein]; Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of TNF mRNA] PMID:23688591|PMID:30708112|PMID:37955343|PMID:38705344 14181661 TNF tumor necrosis factor gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of TNF mRNA PMID:31744678 14181661 TNF tumor necrosis factor gene CHEBI:4659 disulfiram multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004221 Disulfiram inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] PMID:10975995 14181661 TNF tumor necrosis factor gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; HMOX1 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] PMID:20580034 14181661 TNF tumor necrosis factor gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of TNF mRNA] PMID:37108405 14181661 TNF tumor necrosis factor gene CHEBI:5001 fenofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011345 [Fenofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein] PMID:15226458 14181661 TNF tumor necrosis factor gene CHEBI:50867 ciprofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C019304 [ciprofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein] PMID:15226458 14181661 TNF tumor necrosis factor gene CHEBI:50992 1,3-thiazolidine-2,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C089946 [2,4-thiazolidinedione co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]] PMID:15226458 14181661 TNF tumor necrosis factor gene CHEBI:5181 fucoidan multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007789 [laminaran co-treated with fucoidan co-treated with Minerals] promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] PMID:21948611 14181661 TNF tumor necrosis factor gene CHEBI:52289 wortmannin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009687 Wortmannin inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14181661 TNF tumor necrosis factor gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950 14181661 TNF tumor necrosis factor gene CHEBI:6364 laminarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008247 [laminaran co-treated with fucoidan co-treated with Minerals] promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] PMID:21948611 14181661 TNF tumor necrosis factor gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in increased expression of TNF mRNA PMID:32280687 14181661 TNF tumor necrosis factor gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of TNF mRNA]; Zinc Sulfate inhibits the reaction [Diquat results in increased expression of TNF mRNA] PMID:32280687 14181661 TNF tumor necrosis factor gene CHEBI:64215 2,3-dimethoxynaphthalene-1,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C063002 2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [TNF protein results in increased expression of HIF1A protein] PMID:11514583 14181661 TNF tumor necrosis factor gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of TNF mRNA PMID:23688591 14181661 TNF tumor necrosis factor gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of TNF mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of TNF mRNA PMID:23688591 14181661 TNF tumor necrosis factor gene CHEBI:7719 ochratoxin A increases secretion EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased secretion of TNF protein PMID:28699257 14181661 TNF tumor necrosis factor gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] PMID:28528741 14181661 TNF tumor necrosis factor gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of TNF mRNA PMID:29421334 14181661 TNF tumor necrosis factor gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases activity EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein PMID:15226458 14181661 TNF tumor necrosis factor gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 [2,4-thiazolidinedione co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [ciprofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Fenofibrate co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Troglitazone co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Zinc co-treated with 2,4-thiazolidinedione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of IL6 mRNA]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Linoleic Acid promotes the reaction [TNF protein results in increased activity of CASP3 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of ANXA5 protein]]]; Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein results in increased activity of CASP3 protein]]; Zinc Acetate promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [TNF protein promotes the reaction [Linoleic Acid results in increased activity of CASP3 protein]]] PMID:10617950|PMID:15226458 14181661 TNF tumor necrosis factor gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of TNF mRNA PMID:21176401 14181661 TNF tumor necrosis factor gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C093642 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF protein] PMID:38438008 14181661 TNF tumor necrosis factor gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 [Troglitazone co-treated with Zinc] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of TNF protein] PMID:15226458 14181788 MDFIC MyoD family inhibitor domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MDFIC mRNA PMID:35307453 14181916 PPP2R5B protein phosphatase 2 regulatory subunit B'beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP2R5B mRNA PMID:35307453 14181934 RPL9 ribosomal protein L9 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL9 mRNA PMID:39265697 14182005 UGDH UDP-glucose 6-dehydrogenase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UGDH mRNA PMID:35307453 14182027 PLOD2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLOD2 mRNA; deoxynivalenol results in decreased expression of PLOD2 protein PMID:35307453|PMID:38403181 14182124 ECD ecdysoneless cell cycle regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ECD mRNA PMID:35307453 14182384 TRMT6 tRNA methyltransferase 6 non-catalytic subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT6 mRNA PMID:35307453 14182449 PHLDA3 pleckstrin homology like domain family A member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHLDA3 mRNA PMID:35307453 14182459 GNG4 G protein subunit gamma 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNG4 mRNA PMID:35307453 14182499 STK11IP serine/threonine kinase 11 interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STK11IP mRNA PMID:35307453 14182665 UPK1B uroplakin 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UPK1B mRNA PMID:35307453 14182665 UPK1B uroplakin 1B gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of UPK1B mRNA PMID:34933075 14182756 LYRM1 LYR motif containing 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of LYRM1 mRNA PMID:39265697 14182805 PGGT1B protein geranylgeranyltransferase type I subunit beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGGT1B mRNA PMID:35307453 14182876 RND3 Rho family GTPase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RND3 mRNA PMID:35307453 14182883 TMEM234 transmembrane protein 234 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM234 mRNA PMID:35307453 14182946 BBS2 Bardet-Biedl syndrome 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BBS2 mRNA PMID:35307453 14183041 ALDH6A1 aldehyde dehydrogenase 6 family member A1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH6A1 mRNA PMID:35307453 14183092 CLCF1 cardiotrophin like cytokine factor 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CLCF1 mRNA PMID:39265697 14183132 PLEKHO1 pleckstrin homology domain containing O1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLEKHO1 mRNA PMID:35307453 14183132 PLEKHO1 pleckstrin homology domain containing O1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of PLEKHO1 mRNA PMID:28069986 14183166 CDT1 chromatin licensing and DNA replication factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDT1 mRNA PMID:35307453 14183252 NSFL1C NSFL1 cofactor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NSFL1C mRNA PMID:35307453 14183272 IRF3 interferon regulatory factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IRF3 mRNA PMID:35307453 14183272 IRF3 interferon regulatory factor 3 gene CHEBI:25442 mycotoxin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in decreased expression of IRF3 mRNA; Mycotoxins results in decreased expression of IRF3 protein PMID:39137830 14183272 IRF3 interferon regulatory factor 3 gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of IRF3 mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of IRF3 protein] PMID:39137830 14183369 FITM2 fat storage inducing transmembrane protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FITM2 mRNA PMID:35307453 14183404 UPRT uracil phosphoribosyltransferase homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UPRT mRNA PMID:35307453 14183512 ACKR2 atypical chemokine receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACKR2 mRNA PMID:35307453 14183556 CACNA1G calcium voltage-gated channel subunit alpha1 G gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CACNA1G mRNA PMID:34933075 14184002 TYROBP transmembrane immune signaling adaptor TYROBP gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of TYROBP mRNA PMID:18790026|PMID:21391292 14184002 TYROBP transmembrane immune signaling adaptor TYROBP gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of TYROBP mRNA PMID:22497863 14184039 MUC2 mucin 2, oligomeric mucus/gel-forming gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200211 CTD MESH:C056933 fumonisin B1 results in increased expression of MUC2 mRNA PMID:31557363 14184256 APOOL apolipoprotein O like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of APOOL mRNA PMID:35307453 14184298 PSMD4 proteasome 26S subunit ubiquitin receptor, non-ATPase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD4 mRNA PMID:35307453 14184346 MIR155 microRNA mir-155 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A] results in increased expression of MIR155 mRNA PMID:38848930 14184346 MIR155 microRNA mir-155 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in increased expression of MIR155 mRNA PMID:38848930 14184346 MIR155 microRNA mir-155 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A] results in increased expression of MIR155 mRNA PMID:38848930 14184499 SRP68 signal recognition particle 68 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SRP68 mRNA PMID:35307453 14184568 VMO1 vitelline membrane outer layer 1 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VMO1 mRNA PMID:35307453 14184568 VMO1 vitelline membrane outer layer 1 homolog gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of VMO1 mRNA PMID:39265697 14184851 POU2F1 POU class 2 homeobox 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POU2F1 mRNA PMID:35307453 14184964 SCARA5 scavenger receptor class A member 5 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SCARA5 mRNA PMID:34933075 14185027 UCP3 uncoupling protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UCP3 mRNA PMID:35307453 14185229 LRRC27 leucine rich repeat containing 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC27 mRNA PMID:35307453 14185345 DGCR2 DiGeorge syndrome critical region gene 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DGCR2 mRNA PMID:35307453 14185367 GCKR glucokinase regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCKR mRNA PMID:35307453 14185474 SAXO2 stabilizer of axonemal microtubules 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAXO2 mRNA PMID:35307453 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA1L mRNA; deoxynivalenol results in increased expression of HSPA1L protein PMID:35307453|PMID:37257635 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of HSPA1L mRNA PMID:37706587 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA1L mRNA] PMID:37706587 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of HSPA1L mRNA PMID:18988085 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20250715 CTD MESH:D004317 Doxorubicin results in increased expression of HSPA1A protein PMID:15810080 14185755 HSPA1L heat shock protein family A (Hsp70) member 1 like gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA1L mRNA] PMID:37706587 14185903 UBR4 ubiquitin protein ligase E3 component n-recognin 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBR4 mRNA PMID:35307453 14186013 SRCIN1 SRC kinase signaling inhibitor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SRCIN1 mRNA PMID:35307453 14186013 SRCIN1 SRC kinase signaling inhibitor 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SRCIN1 mRNA PMID:39265697 14186071 UTP4 UTP4 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP4 mRNA PMID:35307453 14186226 RPS6KC1 ribosomal protein S6 kinase C1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPS6KC1 mRNA PMID:35307453 14186569 GIPR gastric inhibitory polypeptide receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GIPR mRNA PMID:35307453 14186658 ZNF488 zinc finger protein 488 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF488 mRNA PMID:35307453 14186742 FOXN2 forkhead box N2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FOXN2 mRNA PMID:35307453 14186762 LOC100624136 ankyrin repeat domain-containing protein 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC9C2 mRNA PMID:35307453 14186838 CENPF centromere protein F gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CENPF mRNA] PMID:21852083 14187004 PAPSS1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAPSS1 mRNA PMID:35307453 14187004 PAPSS1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PAPSS1 mRNA PMID:21852083 14187075 FAM98A family with sequence similarity 98 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM98A mRNA PMID:35307453 14187104 STRA6 signaling receptor and transporter of retinol STRA6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STRA6 mRNA PMID:35307453 14187140 EIF4A2 eukaryotic translation initiation factor 4A2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4A2 mRNA; deoxynivalenol results in increased expression of EIF4A2 protein PMID:38403181 14187165 CSDC2 cold shock domain containing C2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CSDC2 mRNA PMID:35307453 14187165 CSDC2 cold shock domain containing C2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CSDC2 mRNA PMID:39265697 14187231 ASPH aspartate beta-hydroxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASPH mRNA PMID:35307453 14187322 SMPD1 sphingomyelin phosphodiesterase 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SMPD1 mRNA PMID:39265697 14187349 CASP8 caspase 8 gene CHEBI:15422 ATP increases activity EXP E RGD:6480464 20191114 CTD MESH:D000255 Adenosine Triphosphate results in increased activity of CASP8 protein PMID:17997382 14187349 CASP8 caspase 8 gene CHEBI:15422 ATP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000255 tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased activity of CASP8 protein] PMID:17997382 14187349 CASP8 caspase 8 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 protein] PMID:35665993 14187349 CASP8 caspase 8 gene CHEBI:27899 cisplatin increases activity EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased activity of CASP8 protein PMID:20435919 14187349 CASP8 caspase 8 gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of CASP8 PMID:12712633 14187349 CASP8 caspase 8 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] PMID:20435919 14187349 CASP8 caspase 8 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of CASP8 mRNA PMID:37108405 14187349 CASP8 caspase 8 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP8 mRNA] PMID:37108405 14187349 CASP8 caspase 8 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of CASP8 mRNA; tetrabromobisphenol A results in decreased expression of CASP8 protein PMID:35665993 14187349 CASP8 caspase 8 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 protein] PMID:35665993 14187349 CASP8 caspase 8 gene CHEBI:35176 zinc sulfate increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased cleavage of CASP8 protein PMID:28803810 14187349 CASP8 caspase 8 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP8 protein] PMID:28803810 14187349 CASP8 caspase 8 gene CHEBI:3697 cilastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015377 Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] PMID:20435919 14187349 CASP8 caspase 8 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of CASP8 mRNA PMID:32198028 14187349 CASP8 caspase 8 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C056933 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP8 mRNA] PMID:32198028 14187349 CASP8 caspase 8 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP8 protein] PMID:28803810 14187349 CASP8 caspase 8 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of CASP8 mRNA] PMID:37108405 14187663 GATM glycine amidinotransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GATM mRNA PMID:35307453 14187694 PLXNA3 plexin A3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PLXNA3 mRNA PMID:39265697 14187892 PJA2 praja ring finger ubiquitin ligase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PJA2 mRNA PMID:35307453 14188013 AVIL advillin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AVIL mRNA PMID:35307453 14188013 AVIL advillin gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of AVIL mRNA PMID:35839969 14188085 HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSD17B2 mRNA PMID:35307453 14188085 HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of HSD17B2 mRNA PMID:39265697 14188085 HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of HSD17B2 mRNA PMID:38848930 14188085 HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20250311 CTD MESH:C059514 Resveratrol results in increased expression of HSD17B2 mRNA PMID:38848930 14188085 HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of HSD17B2 mRNA PMID:38848930 14188092 GZMH granzyme H (cathepsin G-like 2, protein h-CCPX) gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250401 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GZMH mRNA] PMID:21852083 14188151 PLXDC2 plexin domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLXDC2 mRNA PMID:35307453 14188176 TAGLN transgelin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TAGLN mRNA; deoxynivalenol results in decreased expression of TAGLN protein PMID:38403181 14188203 KIAA1549L KIAA1549 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIAA1549L mRNA PMID:35307453 14188247 PRPF38A pre-mRNA processing factor 38A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRPF38A mRNA PMID:35307453 14188268 NKAIN2 sodium/potassium transporting ATPase interacting 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NKAIN2 mRNA PMID:35307453 14188322 RND1 Rho family GTPase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RND1 mRNA PMID:35307453 14188322 RND1 Rho family GTPase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RND1 mRNA PMID:39265697 14188379 DMPK DM1 protein kinase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of DMPK mRNA] PMID:39151877 14188379 DMPK DM1 protein kinase gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of DMPK mRNA PMID:39151877 14188379 DMPK DM1 protein kinase gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of DMPK mRNA] PMID:39151877 14188437 LOC100511546 60S ribosomal protein L22 pseudogene gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL22 mRNA PMID:39265697 14188460 GYG2 glycogenin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GYG2 mRNA PMID:35307453 14188540 GEMIN2 gem nuclear organelle associated protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GEMIN2 mRNA PMID:35307453 14188638 MAGI2 membrane associated guanylate kinase, WW and PDZ domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAGI2 mRNA PMID:35307453 14188693 ATXN7L2 ataxin 7 like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATXN7L2 mRNA PMID:35307453 14188731 GALNTL5 polypeptide N-acetylgalactosaminyltransferase like 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNTL5 mRNA PMID:35307453 14188798 NFIX nuclear factor I X gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NFIX mRNA PMID:35307453 14188798 NFIX nuclear factor I X gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of NFIX mRNA PMID:34389318 14188933 LENG1 leukocyte receptor cluster member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LENG1 mRNA PMID:35307453 14189059 SLC19A2 solute carrier family 19 member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC19A2 mRNA PMID:35307453 14189217 GNMT glycine N-methyltransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNMT mRNA PMID:35307453 14189301 SOWAHA sosondowah ankyrin repeat domain family member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SOWAHA mRNA PMID:35307453 14189328 RARRES1 retinoic acid receptor responder 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RARRES1 mRNA PMID:21852083 14189473 ATP8B1 ATPase phospholipid transporting 8B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP8B1 mRNA PMID:35307453 14189571 PTHLH parathyroid hormone like hormone gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PTHLH mRNA PMID:39265697 14189677 KDR kinase insert domain receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KDR mRNA PMID:35307453 14189677 KDR kinase insert domain receptor gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of KDR mRNA] PMID:39151877 14189677 KDR kinase insert domain receptor gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of KDR mRNA PMID:39151877 14189677 KDR kinase insert domain receptor gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of KDR mRNA] PMID:39151877 14189913 HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of HSD11B2 mRNA PMID:35307453 14189946 APBB3 amyloid beta precursor protein binding family B member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of APBB3 mRNA PMID:35307453 14189976 PC pyruvate carboxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PC mRNA PMID:35307453 14189998 TRIM37 tripartite motif containing 37 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIM37 mRNA PMID:35307453 14190049 KLHL25 kelch like family member 25 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KLHL25 mRNA PMID:35307453 14190124 NIP7 nucleolar pre-rRNA processing protein NIP7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NIP7 mRNA PMID:35307453 14190206 GREM1 gremlin 1, DAN family BMP antagonist gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GREM1 mRNA PMID:35307453 14190206 GREM1 gremlin 1, DAN family BMP antagonist gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of GREM1 mRNA PMID:39265697 14190216 PPP1R3C protein phosphatase 1 regulatory subunit 3C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R3C mRNA PMID:35307453 14190230 MUC5B mucin 5B, oligomeric mucus/gel-forming gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of MUC5B mRNA PMID:34933075 14190379 NR2F1 nuclear receptor subfamily 2 group F member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR2F1 mRNA PMID:35307453 14190379 NR2F1 nuclear receptor subfamily 2 group F member 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of NR2F1 mRNA PMID:34933075 14190379 NR2F1 nuclear receptor subfamily 2 group F member 1 gene CHEBI:75261 arotinoid acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NR2F1 mRNA PMID:15583048 14190515 HES7 hes family bHLH transcription factor 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HES7 mRNA PMID:35307453 14190648 TMEM40 transmembrane protein 40 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM40 mRNA PMID:21852083 14190762 NUDCD1 NudC domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUDCD1 mRNA PMID:35307453 14190943 CALCOCO2 calcium binding and coiled-coil domain 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CALCOCO2 mRNA PMID:35307453 14190986 PI4K2B phosphatidylinositol 4-kinase type 2 beta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PI4K2B mRNA PMID:35307453 14191017 BMP2 bone morphogenetic protein 2 gene CHEBI:10033 warfarin increases expression EXP E RGD:6480464 20230905 CTD MESH:D014859 Warfarin results in increased expression of BMP2 mRNA PMID:34520801 14191017 BMP2 bone morphogenetic protein 2 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 mRNA; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 protein; leptomycin B inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA]; LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA]]; LRP6 protein affects the reaction [Warfarin results in increased expression of BMP2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 mRNA]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA] PMID:29358327|PMID:34520801 14191017 BMP2 bone morphogenetic protein 2 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone affects the expression of BMP2 mRNA PMID:34933075 14191017 BMP2 bone morphogenetic protein 2 gene CHEBI:52646 leptomycin B multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C038753 leptomycin B inhibits the reaction [Warfarin results in increased expression of BMP2 mRNA] PMID:34520801 14191029 NXPH3 neurexophilin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NXPH3 mRNA PMID:35307453 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUNX2 mRNA PMID:35307453 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:10033 warfarin increases expression EXP E RGD:6480464 20230905 CTD MESH:D014859 Warfarin results in increased expression of RUNX2 mRNA; Warfarin results in increased expression of RUNX2 protein PMID:34520801 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 mRNA; [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 protein; Ammonium Chloride inhibits the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]]; LRP6 protein affects the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]]; LRP6 protein affects the reaction [Warfarin results in increased expression of RUNX2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 protein]; SOX5 protein inhibits the reaction [Warfarin promotes the reaction [SOX9 protein binds to RUNX2 promoter]]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]; SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 protein]; Warfarin promotes the reaction [SOX9 protein binds to RUNX2 promoter] PMID:29358327|PMID:34520801 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] PMID:30481989 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] PMID:30481989 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:31206 ammonium chloride multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D000643 Ammonium Chloride inhibits the reaction [SOX5 protein inhibits the reaction [Warfarin results in increased expression of RUNX2 mRNA]] PMID:34520801 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] PMID:30481989 14191035 RUNX2 RUNX family transcription factor 2 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] PMID:30481989 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSPA5 mRNA; deoxynivalenol results in decreased expression of HSPA5 protein PMID:35307453|PMID:38403181 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA5 protein PMID:37442268|PMID:38608924 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of HSPA5 protein] PMID:37442268 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:136004 linsidomine increases expression EXP E RGD:6480464 20191114 CTD MESH:C002385 linsidomine results in increased expression of HSPA5 mRNA PMID:18086661 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of HSPA5 protein PMID:37659622 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of HSPA5 protein] PMID:37659622 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:15365 acetylsalicylic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001241 Aspirin inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein] PMID:20665602 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of HSPA5 protein PMID:20665602 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006861 Aspirin inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein]; nimesulide inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein] PMID:20665602 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:18320 1,4-dithiothreitol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol metabolite results in increased expression of HSPA5 protein PMID:17416481 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20210504 CTD MESH:C039060 artenimol results in increased expression of HSPA5 mRNA PMID:32721431 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased expression of HSPA5 mRNA; Cadmium results in increased expression of HSPA5 protein PMID:16759985|PMID:37207789 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA5 protein; Cycloheximide inhibits the reaction [Cadmium results in increased expression of HSPA5 protein]; Dactinomycin inhibits the reaction [Cadmium results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of HSPA5 mRNA] PMID:16759985|PMID:33891997|PMID:37207789 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased expression of HSPA5 mRNA PMID:17464326 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of HSPA5 protein] PMID:37442268 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:27641 cycloheximide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; Cycloheximide inhibits the reaction [Cadmium results in increased expression of HSPA5 protein] PMID:16759985 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:27666 actinomycin D multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003609 Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; Dactinomycin inhibits the reaction [Cadmium results in increased expression of HSPA5 protein] PMID:16759985 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:28869 menadione increases expression EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased expression of HSPA5 mRNA; Vitamin K 3 results in increased expression of HSPA5 protein PMID:16920763|PMID:18086661 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:28869 menadione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024483 PD 150606 inhibits the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] PMID:16920763 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA] PMID:18086661 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:29699 tunicamycin decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D014415 HSPA5 results in decreased susceptibility to Tunicamycin PMID:17464326|PMID:18086661 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:29699 tunicamycin increases expression EXP E RGD:6480464 20191114 CTD MESH:D014415 Tunicamycin results in increased expression of HSPA5 protein PMID:15049342|PMID:16920763|PMID:17416481 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of HSPA5 protein PMID:36754226 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 protein] PMID:36754226 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:3093 bifenthrin increases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased expression of HSPA5 protein PMID:33901951 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:31767 lead diacetate increases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in increased expression of HSPA5 mRNA PMID:17464326 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:31823 mercury dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased expression of HSPA5 mRNA PMID:17464326 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of HSPA5 mRNA; bisphenol A results in increased expression of HSPA5 protein PMID:37108405|PMID:38845341 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA] PMID:37108405|PMID:38845341 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased expression of HSPA5 mRNA PMID:20600546 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35456 cadmium dichloride decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:D019256 HSPA5 results in decreased susceptibility to Cadmium Chloride PMID:17464326|PMID:20600546 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of HSPA5 mRNA; Cadmium Chloride results in increased expression of HSPA5 protein PMID:16759985|PMID:17464326|PMID:18086661|PMID:20576581 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of HSPA5 protein PMID:20600546 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA5 protein; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; CAT inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; SOD2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein] PMID:16759985|PMID:18086661|PMID:33891997 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:35696 cobalt dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:C018021 cobaltous chloride results in increased expression of HSPA5 mRNA PMID:17464326 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of HSPA5 protein] PMID:37442268 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of HSPA5 protein PMID:31744678 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 protein] PMID:36754226 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:42106 L-1,4-dithiothreitol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004229 Dithiothreitol metabolite results in increased expression of HSPA5 protein PMID:17416481 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:44445 nimesulide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C012655 nimesulide inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein] PMID:20665602 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of HSPA5 protein] PMID:37108405 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:49662 indometacin increases expression EXP E RGD:6480464 20191114 CTD MESH:D007213 Indomethacin results in increased expression of HSPA5 mRNA PMID:18799549 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:50842 norflurazon multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased expression of and results in increased phosphorylation of HSPA5 protein PMID:38432436 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:53016 sulfamethoxazole hydroxylamine increases expression EXP E RGD:6480464 20191114 CTD MESH:C059873 sulfamethoxazole hydroxylamine results in increased expression of HSPA5 protein PMID:16005169 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:64090 tert-butyl hydroperoxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of HSPA5 protein PMID:16005169|PMID:16920763 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:64090 tert-butyl hydroperoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020122 PD 150606 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA5 protein] PMID:16920763 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in increased expression of HSPA5 protein PMID:38567716 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 protein PMID:28699257 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA]; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of HSPA5 mRNA] PMID:37207789|PMID:38845341 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in decreased expression of HSPA5 protein] PMID:37659622 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:9381 T-2 toxin decreases expression EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in decreased expression of HSPA5 protein PMID:34637808 14191050 HSPA5 heat shock protein family A (Hsp70) member 5 gene CHEBI:9516 thapsigargin increases expression EXP E RGD:6480464 20191114 CTD MESH:D019284 Thapsigargin results in increased expression of HSPA5 protein PMID:16759985|PMID:16920763|PMID:17416481 14191208 ZNF630 zinc finger protein 630 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF630 mRNA PMID:35307453 14191230 EFCAB12 EF-hand calcium binding domain 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFCAB12 mRNA PMID:35307453 14191230 EFCAB12 EF-hand calcium binding domain 12 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of EFCAB12 mRNA PMID:39265697 14191396 PSMB7 proteasome 20S subunit beta 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMB7 mRNA PMID:35307453 14191442 RING1 ring finger protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RING1 mRNA PMID:35307453 14191569 TNIP2 TNFAIP3 interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNIP2 mRNA PMID:35307453 14191729 KCNK6 potassium two pore domain channel subfamily K member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNK6 mRNA PMID:35307453 14191750 SUMO1 small ubiquitin like modifier 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of SUMO1 mRNA PMID:14994279 14191934 MT-ATP6 mitochondrially encoded ATP synthase membrane subunit 6 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of ATP6 mRNA PMID:38432436 14192087 PRKAR1B protein kinase cAMP-dependent type I regulatory subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRKAR1B mRNA PMID:35307453 14192118 SLC2A4 solute carrier family 2 member 4 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of SLC2A4 protein PMID:21575630 14192118 SLC2A4 solute carrier family 2 member 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of SLC2A4 protein] PMID:21739664 14192118 SLC2A4 solute carrier family 2 member 4 gene CHEBI:41879 dexamethasone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003907 Dexamethasone results in decreased expression of SLC2A4 mRNA; Dexamethasone results in decreased expression of SLC2A4 protein PMID:19852296 14192148 PAK5 p21 (RAC1) activated kinase 5 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of PAK5 mRNA PMID:34933075 14192257 MYRFL myelin regulatory factor like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYRFL mRNA PMID:35307453 14192338 CCNE2 cyclin E2 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of CCNE2 mRNA PMID:35307453 14192613 AMY2 amylase, alpha 2B (pancreatic) gene CHEBI:27363 zinc atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of AMY2B protein PMID:17093223 14192613 AMY2 amylase, alpha 2B (pancreatic) gene CHEBI:30185 zinc(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of AMY2B protein PMID:17093223 14192613 AMY2 amylase, alpha 2B (pancreatic) gene CHEBI:36560 zinc oxide increases activity EXP E RGD:6480464 20191114 CTD MESH:D015034 Zinc Oxide results in increased activity of AMY2B protein PMID:17093223 14192685 SCD stearoyl-CoA desaturase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCD mRNA PMID:35307453 14192685 SCD stearoyl-CoA desaturase gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SCD mRNA PMID:34389318 14192685 SCD stearoyl-CoA desaturase gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of SCD mRNA PMID:17363680 14192717 PHOSPHO1 phosphoethanolamine/phosphocholine phosphatase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHOSPHO1 mRNA PMID:35307453 14192749 SLC7A7 solute carrier family 7 member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC7A7 mRNA PMID:35307453 14192749 SLC7A7 solute carrier family 7 member 7 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in decreased expression of SLC7A7 mRNA PMID:32710935 14192749 SLC7A7 solute carrier family 7 member 7 gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20210706 CTD MESH:C056933 fumonisin B1 results in decreased expression of SLC7A7 mRNA PMID:33443779 14192789 SPINT1 serine peptidase inhibitor, Kunitz type 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPINT1 mRNA PMID:35307453 14192954 NICN1 nicolin 1, tubulin polyglutamylase complex subunit gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NICN1 mRNA PMID:35307453 14193049 CDC25C cell division cycle 25C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDC25C protein PMID:38104654 14193049 CDC25C cell division cycle 25C gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CDC25C protein] PMID:38104654 14193049 CDC25C cell division cycle 25C gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20240806 CTD MESH:D002110 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CDC25C protein] PMID:38104654 14193128 ASPM assembly factor for spindle microtubules gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ASPM mRNA PMID:35307453 14193128 ASPM assembly factor for spindle microtubules gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate affects the expression of ASPM mRNA] PMID:39151877 14193128 ASPM assembly factor for spindle microtubules gene CHEBI:23414 copper(II) sulfate affects expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate affects the expression of ASPM mRNA PMID:39151877 14193128 ASPM assembly factor for spindle microtubules gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate affects the expression of ASPM mRNA] PMID:39151877 14193156 SMCO2 single-pass membrane protein with coiled-coil domains 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMCO2 mRNA PMID:35307453 14193500 FAM180B family with sequence similarity 180 member B gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of FAM180B mRNA PMID:34389318 14193736 POU2F3 POU class 2 homeobox 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POU2F3 mRNA PMID:35307453 14193736 POU2F3 POU class 2 homeobox 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of POU2F3 mRNA PMID:18988085 14193767 NDUFB3 NADH:ubiquinone oxidoreductase subunit B3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDUFB3 mRNA PMID:39265697 14193811 CEP126 centrosomal protein 126 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP126 mRNA PMID:35307453 14193863 TRIM31 tripartite motif containing 31 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM31 protein PMID:37257635 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBP1 mRNA PMID:35307453 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:18291 manganese atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D008345 Manganese results in increased activity of FBP1 protein PMID:12595529 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:25107 magnesium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008274 Magnesium binds to and results in increased activity of FBP1 protein PMID:12595529 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:27363 zinc atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of FBP1 protein PMID:12595529 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:30185 zinc(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased activity of FBP1 protein PMID:12595529 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:30440 thallium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D013793 Thallium results in increased activity of FBP1 protein PMID:12595529 14193884 FBP1 fructose-bisphosphatase 1 gene CHEBI:35154 manganese(0) increases activity EXP E RGD:6480464 20191114 CTD MESH:D008345 Manganese results in increased activity of FBP1 protein PMID:12595529 14193895 SNW1 SNW domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNW1 mRNA PMID:35307453 14194259 RGS22 regulator of G protein signaling 22 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGS22 mRNA PMID:35307453 14194412 GSN gelsolin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSN mRNA PMID:35307453 14194525 SARM1 sterile alpha and TIR motif containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SARM1 mRNA PMID:35307453 14194588 SEMA3B semaphorin 3B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEMA3B mRNA PMID:35307453 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CYP2E1 mRNA PMID:34389318 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:16318 4-nitrocatechol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C001833 2-aminoacetophenone inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]; [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol; Skatole inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol] PMID:30599194 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:16836 4-nitrophenol increases hydroxylation EXP E RGD:6480464 20191114 CTD MESH:C024836 CYP2E1 protein results in increased hydroxylation of 4-nitrophenol PMID:30599194 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:16836 4-nitrophenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C024836 2-aminoacetophenone inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]; 2-aminoacetophenone inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol]; [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol; Skatole inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]; Skatole inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] PMID:30599194 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:17578 toluene increases activity EXP E RGD:6480464 20191114 CTD MESH:D014050 Toluene results in increased activity of CYP2E1 protein PMID:12781212 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:17578 toluene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014050 Disulfiram inhibits the reaction [Toluene results in increased activity of CYP2E1 protein] PMID:12781212 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:27417 p-xylene increases activity EXP E RGD:6480464 20191114 CTD MESH:C031286 4-xylene results in increased activity of CYP2E1 protein PMID:12781212 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:27417 p-xylene multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031286 Disulfiram inhibits the reaction [4-xylene results in increased activity of CYP2E1 protein] PMID:12781212 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:4659 disulfiram multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004221 Disulfiram inhibits the reaction [4-xylene results in increased activity of CYP2E1 protein]; Disulfiram inhibits the reaction [Toluene results in increased activity of CYP2E1 protein] PMID:12781212 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:6358 lactucin increases expression EXP E RGD:6480464 20241001 CTD MESH:C516715 lactucin results in increased expression of CYP2E1 mRNA PMID:24176340 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:76144 flunixin meglumine affects expression EXP E RGD:6480464 20191114 CTD MESH:C014558 flunixin meglumine affects the expression of CYP2E1 mRNA PMID:26366864 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:77092 fenbendazole affects expression EXP E RGD:6480464 20191114 CTD MESH:D005273 Fenbendazole affects the expression of CYP2E1 mRNA PMID:26366864 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:91110 o-aminoacetophenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C055495 2-aminoacetophenone inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]; 2-aminoacetophenone inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] PMID:30599194 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:9171 skatole increases hydroxylation EXP E RGD:6480464 20191114 CTD MESH:D012862 CYP2E1 protein results in increased hydroxylation of Skatole PMID:30599194 14194645 CYP2E1 cytochrome P450 family 2 subfamily E member 1 gene CHEBI:9171 skatole multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012862 Skatole inhibits the reaction [[CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]; Skatole inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] PMID:30599194 14194691 LRRC41 leucine rich repeat containing 41 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC41 mRNA PMID:35307453 14194817 MICU1 mitochondrial calcium uptake 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MICU1 mRNA PMID:35307453 14194858 FRA10AC1 FRA10A associated CGG repeat 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FRA10AC1 mRNA PMID:35307453 14194983 SRP54 signal recognition particle 54 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SRP54 mRNA PMID:35307453 14195148 ESR2 estrogen receptor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ESR2 mRNA PMID:35307453 14195148 ESR2 estrogen receptor 2 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol affects the expression of ESR2 protein PMID:15653758|PMID:16680078 14195148 ESR2 estrogen receptor 2 gene CHEBI:28197 daidzein increases expression EXP E RGD:6480464 20191114 CTD MESH:C004742 daidzein results in increased expression of ESR2 mRNA; daidzein results in increased expression of ESR2 protein PMID:19617652 14195148 ESR2 estrogen receptor 2 gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP E RGD:6480464 20191114 CTD MESH:C016340 o,p'-DDT results in decreased expression of ESR2 protein PMID:18195494 14195148 ESR2 estrogen receptor 2 gene CHEBI:34211 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene decreases expression EXP E RGD:6480464 20191114 CTD MESH:C054919 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in decreased expression of ESR2 protein PMID:18195494 14195148 ESR2 estrogen receptor 2 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C543008 bisphenol S results in decreased expression of ESR2 mRNA PMID:28352085 14195148 ESR2 estrogen receptor 2 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C543008 bisphenol S results in increased expression of ESR2 protein PMID:28352085 14195148 ESR2 estrogen receptor 2 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ESR2 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ESR2 protein PMID:24956591 14195148 ESR2 estrogen receptor 2 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20191114 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased expression of ESR2 mRNA; 2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased expression of ESR2 protein PMID:24956591 14195148 ESR2 estrogen receptor 2 gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of ESR2 protein PMID:15653758|PMID:16680078 14195310 WNT5A Wnt family member 5A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WNT5A mRNA PMID:35307453 14195350 LHPP phospholysine phosphohistidine inorganic pyrophosphate phosphatase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LHPP mRNA PMID:35307453 14195378 ODAD4 outer dynein arm docking complex subunit 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of ODAD4 mRNA PMID:35307453 14195406 PRICKLE1 prickle planar cell polarity protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRICKLE1 mRNA PMID:35307453 14195529 THG1L tRNA-histidine guanylyltransferase 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THG1L mRNA PMID:35307453 14195607 NWD1 NACHT and WD repeat domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NWD1 mRNA PMID:35307453 14195735 NEK5 NIMA related kinase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEK5 mRNA PMID:35307453 14195814 COL5A3 collagen type V alpha 3 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL5A3 mRNA PMID:35307453 14195814 COL5A3 collagen type V alpha 3 chain gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of COL5A3 mRNA PMID:39265697 14195907 DYRK1B dual specificity tyrosine phosphorylation regulated kinase 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYRK1B mRNA PMID:35307453 14195982 LAYN layilin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAYN mRNA PMID:35307453 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:15368 acrolein affects folding EXP E RGD:6480464 20191114 CTD MESH:D000171 Acrolein affects the folding of GOT1 protein PMID:12365456 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:15368 acrolein affects metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D000171 Acrolein affects the metabolism of GOT1 protein PMID:12365456 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:15368 acrolein decreases activity EXP E RGD:6480464 20191114 CTD MESH:D000171 Acrolein results in decreased activity of GOT1 protein PMID:12365456 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:17158 methylglyoxal affects folding EXP E RGD:6480464 20191114 CTD MESH:D011765 Pyruvaldehyde affects the folding of GOT1 protein PMID:12559987 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:17158 methylglyoxal affects glycation EXP E RGD:6480464 20191114 CTD MESH:D011765 Pyruvaldehyde affects the glycation of GOT1 protein PMID:12559987 14196033 GOT1 glutamic-oxaloacetic transaminase 1 gene CHEBI:17158 methylglyoxal decreases activity EXP E RGD:6480464 20191114 CTD MESH:D011765 Pyruvaldehyde results in decreased activity of GOT1 protein PMID:12559987 14196046 LRRC36 leucine rich repeat containing 36 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC36 mRNA PMID:35307453 14196205 WDR97 WD repeat domain 97 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of WDR97 mRNA PMID:34933075 14196258 PGK1 phosphoglycerate kinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGK1 mRNA PMID:35307453 14196258 PGK1 phosphoglycerate kinase 1 gene CHEBI:39282 iodomethane increases alkylation EXP E RGD:6480464 20191114 CTD MESH:C014055 methyl iodide results in increased alkylation of PGK1 protein PMID:6697999 14196290 SLCO4A1 solute carrier organic anion transporter family member 4A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLCO4A1 mRNA PMID:35307453 14196314 ECE2 endothelin converting enzyme 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250325 CTD MESH:C007262 deoxynivalenol results in increased expression of EEF1AKMT4 mRNA PMID:35307453 14196381 CFI complement factor I gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFI mRNA PMID:35307453 14196398 B4GALNT2 beta-1,4-N-acetyl-galactosaminyltransferase 2 (SID blood group) gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of B4GALNT2 mRNA PMID:35307453 14196428 JCAD junctional cadherin 5 associated gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JCAD mRNA PMID:35307453 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAMP2 mRNA PMID:35307453 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of LAMP2 mRNA PMID:26988607 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:22689 bafilomycin A1 multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C040929 bafilomycin A1 inhibits the reaction [Benzo(a)pyrene results in decreased expression of LAMP2 protein] PMID:36754226 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of LAMP2 protein PMID:36754226 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 bafilomycin A1 inhibits the reaction [Benzo(a)pyrene results in decreased expression of LAMP2 protein]; Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of LAMP2 protein] PMID:36754226 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:38635 3-methyladenine decreases expression EXP E RGD:6480464 20230704 CTD MESH:C025946 3-methyladenine results in decreased expression of LAMP2 protein PMID:36754226 14196536 LAMP2 lysosomal associated membrane protein 2 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D020123 Sirolimus inhibits the reaction [Benzo(a)pyrene results in decreased expression of LAMP2 protein] PMID:36754226 14196560 BORCS8 BLOC-1 related complex subunit 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BORCS8 mRNA PMID:35307453 14196682 BBC3 BCL2 binding component 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BBC3 mRNA PMID:35307453 14196682 BBC3 BCL2 binding component 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BBC3 mRNA PMID:33891997 14196682 BBC3 BCL2 binding component 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BBC3 mRNA PMID:33891997 14196699 CSTF2T cleavage stimulation factor subunit 2 tau variant gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSTF2T mRNA PMID:35307453 14196711 HMMR hyaluronan mediated motility receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HMMR mRNA PMID:35307453 14196781 NDUFA1 NADH:ubiquinone oxidoreductase subunit A1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDUFA1 mRNA PMID:39265697 14196788 CSF1 colony stimulating factor 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CSF1 mRNA PMID:39265697 14196922 HBS1L HBS1 like translational GTPase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HBS1L mRNA PMID:35307453 14196958 IL11 interleukin 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of IL11 mRNA; deoxynivalenol results in increased expression of IL11 protein PMID:38403181 14196958 IL11 interleukin 11 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of IL11 mRNA PMID:39265697 14196983 MYO6 myosin VI gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of MYO6 mRNA PMID:21391292 14197162 MMADHC metabolism of cobalamin associated D gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MMADHC mRNA PMID:35307453 14197235 GAR1 GAR1 ribonucleoprotein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GAR1 mRNA PMID:35307453 14197279 ATP6V1C1 ATPase H+ transporting V1 subunit C1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP6V1C1 mRNA PMID:35307453 14197308 ARMH4 armadillo like helical domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARMH4 mRNA PMID:35307453 14197351 MTX1 metaxin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTX1 mRNA PMID:35307453 14197363 TIGIT T cell immunoreceptor with Ig and ITIM domains gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TIGIT mRNA PMID:35307453 14197440 GDPD1 glycerophosphodiester phosphodiesterase domain containing 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GDPD1 mRNA PMID:34933075 14197548 CAMSAP2 calmodulin regulated spectrin associated protein family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CAMSAP2 mRNA PMID:35307453 14197570 SEMA4D semaphorin 4D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA4D mRNA PMID:35307453 14197646 WNK3 WNK lysine deficient protein kinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WNK3 mRNA PMID:35307453 14197740 CNTN3 contactin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNTN3 mRNA PMID:35307453 14197933 DBP D-box binding PAR bZIP transcription factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DBP mRNA PMID:35307453 14197970 MLLT11 MLLT11 transcription factor 7 cofactor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MLLT11 mRNA PMID:35307453 14197970 MLLT11 MLLT11 transcription factor 7 cofactor gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MLLT11 mRNA PMID:39265697 14197970 MLLT11 MLLT11 transcription factor 7 cofactor gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of MLLT11 mRNA] PMID:39151877 14197970 MLLT11 MLLT11 transcription factor 7 cofactor gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of MLLT11 mRNA PMID:39151877 14197970 MLLT11 MLLT11 transcription factor 7 cofactor gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of MLLT11 mRNA] PMID:39151877 14198046 GABRE gamma-aminobutyric acid type A receptor subunit epsilon gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GABRE mRNA PMID:35307453 14198063 ZPR1 ZPR1 zinc finger gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZPR1 mRNA PMID:35307453 14198257 HMGA1 high mobility group AT-hook 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HMGA1 mRNA PMID:35307453 14198310 PTPRT protein tyrosine phosphatase receptor type T gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPRT mRNA PMID:35307453 14198374 RETSAT retinol saturase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RETSAT mRNA PMID:35307453 14198630 ATP2A3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP2A3 mRNA PMID:35307453 14198630 ATP2A3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C020806 tetrabromobisphenol A results in decreased activity of ATP2A3 protein PMID:17784851 14198717 SLC25A24 solute carrier family 25 member 24 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC25A24 mRNA PMID:35307453 14198828 GOLGA7B golgin A7 family member B gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of GOLGA7B mRNA PMID:39265697 14198855 FAM98B family with sequence similarity 98 member B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM98B mRNA PMID:35307453 14198867 STAT6 signal transducer and activator of transcription 6 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of STAT6 mRNA PMID:25455459 14198915 SLC16A1 solute carrier family 16 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC16A1 mRNA PMID:35307453 14198947 GLI1 GLI family zinc finger 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLI1 mRNA PMID:35307453 14199010 ZBTB16 zinc finger and BTB domain containing 16 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ZBTB16 mRNA PMID:34933075 14199027 CPPED1 calcineurin like phosphoesterase domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CPPED1 mRNA PMID:35307453 14199104 FLRT2 fibronectin leucine rich transmembrane protein 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FLRT2 mRNA PMID:39265697 14199122 TCF7L1 transcription factor 7 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCF7L1 mRNA PMID:35307453 14199181 GFM2 GTP dependent ribosome recycling factor mitochondrial 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GFM2 mRNA PMID:35307453 14199248 ARMC1 armadillo repeat containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARMC1 mRNA PMID:35307453 14199259 FBXL6 F-box and leucine rich repeat protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXL6 mRNA PMID:35307453 14199305 ATP5MF ATP synthase membrane subunit f gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATP5MF mRNA PMID:39265697 14199577 FGF10 fibroblast growth factor 10 gene CHEBI:18376 dermatan sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D003871 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein PMID:14699094 14199577 FGF10 fibroblast growth factor 10 gene CHEBI:37397 chondroitin sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D002809 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein PMID:14699094 14199735 DKC1 dyskerin pseudouridine synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DKC1 mRNA PMID:35307453 14199757 MCOLN1 mucolipin TRP cation channel 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MCOLN1 mRNA PMID:35307453 14199785 ZDHHC2 zinc finger DHHC-type palmitoyltransferase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZDHHC2 mRNA PMID:35307453 14199785 ZDHHC2 zinc finger DHHC-type palmitoyltransferase 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol promotes the reaction [Dietary Fats results in increased expression of ZDHHC2 mRNA] PMID:21852083 14199809 SCN3B sodium voltage-gated channel beta subunit 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCN3B mRNA PMID:35307453 14199844 ARL6 ADP ribosylation factor like GTPase 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARL6 mRNA PMID:35307453 14199864 SMARCE1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMARCE1 mRNA PMID:35307453 14199936 ABCC6 ATP binding cassette subfamily C member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCC6 mRNA PMID:35307453 14199996 NRM nurim gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRM mRNA PMID:35307453 14200035 APIP APAF1 interacting protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of APIP mRNA PMID:39265697 14200464 OAS2 2'-5'-oligoadenylate synthetase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OAS2 mRNA PMID:35307453 14200489 TRIM14 tripartite motif containing 14 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIM14 mRNA PMID:35307453 14200648 ANXA7 annexin A7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANXA7 mRNA PMID:35307453 14200671 PMEPA1 prostate transmembrane protein, androgen induced 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of PMEPA1 mRNA PMID:39265697 14200903 CCL4 C-C motif chemokine ligand 4 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CCL4 mRNA PMID:21505051 14200903 CCL4 C-C motif chemokine ligand 4 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [Dinoprost co-treated with epostane] results in increased expression of CCL4 mRNA PMID:21505051 14200903 CCL4 C-C motif chemokine ligand 4 gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of CCL4 mRNA PMID:33901951 14200953 ZFYVE28 zinc finger FYVE-type containing 28 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFYVE28 mRNA PMID:35307453 14201179 SMAD4 SMAD family member 4 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of SMAD4 mRNA PMID:33626375 14201179 SMAD4 SMAD family member 4 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of SMAD4 mRNA PMID:38432436 14201220 CCDC65 coiled-coil domain containing 65 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC65 mRNA PMID:35307453 14201270 RUNX1T1 RUNX1 partner transcriptional co-repressor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RUNX1T1 mRNA PMID:35307453 14201270 RUNX1T1 RUNX1 partner transcriptional co-repressor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RUNX1T1 mRNA PMID:34933075 14201375 SAMD14 sterile alpha motif domain containing 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAMD14 mRNA PMID:35307453 14201393 IL18 interleukin 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of IL18 mRNA PMID:37120089 14201393 IL18 interleukin 18 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C007262 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein] PMID:36309173|PMID:37120089 14201393 IL18 interleukin 18 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of IL18 mRNA PMID:25455459|PMID:30270565 14201393 IL18 interleukin 18 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of IL18 mRNA; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of IL18 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of IL18 mRNA] PMID:30270565 14201393 IL18 interleukin 18 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL18 mRNA] PMID:37120089 14201393 IL18 interleukin 18 gene CHEBI:188567 Belnacasan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C520022 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein] PMID:36309173 14201393 IL18 interleukin 18 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 mRNA PMID:33592257|PMID:34416349 14201393 IL18 interleukin 18 gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased expression of IL18 mRNA] PMID:35134483 14201393 IL18 interleukin 18 gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D016264 Dextran Sulfate results in increased expression of IL18 mRNA PMID:30270565 14201393 IL18 interleukin 18 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016264 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of IL18 mRNA; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of IL18 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of IL18 mRNA] PMID:30270565 14201393 IL18 interleukin 18 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 mRNA PMID:33592257|PMID:34416349 14201393 IL18 interleukin 18 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C056933 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein] PMID:36309173 14201393 IL18 interleukin 18 gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL18 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL18 protein] PMID:39305878 14201393 IL18 interleukin 18 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of IL18 protein PMID:36281498 14201393 IL18 interleukin 18 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of IL18 mRNA PMID:29421334 14201393 IL18 interleukin 18 gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of IL18 mRNA; T-2 Toxin results in increased expression of IL18 protein PMID:39305878 14201393 IL18 interleukin 18 gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL18 mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL18 protein] PMID:39305878 14201411 VARS1 valyl-tRNA synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VARS1 mRNA PMID:35307453 14201510 TMPRSS2 transmembrane serine protease 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMPRSS2 mRNA PMID:35307453 14201629 THSD1 thrombospondin type 1 domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THSD1 mRNA PMID:35307453 14201659 CFAP74 cilia and flagella associated protein 74 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP74 mRNA PMID:35307453 14201913 PRSS36 serine protease 36 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRSS36 mRNA PMID:35307453 14201932 HMOX1 heme oxygenase 1 gene CHEBI:10106 zearalenone affects expression EXP E RGD:6480464 20200519 CTD MESH:D015025 Zearalenone affects the expression of HMOX1 mRNA; Zearalenone affects the expression of HMOX1 protein PMID:31760079 14201932 HMOX1 heme oxygenase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20221206 CTD MESH:D015025 Zearalenone results in decreased expression of HMOX1 mRNA; Zearalenone results in decreased expression of HMOX1 protein PMID:35489465 14201932 HMOX1 heme oxygenase 1 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D015025 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein] PMID:35489465 14201932 HMOX1 heme oxygenase 1 gene CHEBI:17245 carbon monoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002248 [HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide; chromium mesoporphyrin inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide]; tin protoporphyrin IX inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide] PMID:16751286 14201932 HMOX1 heme oxygenase 1 gene CHEBI:17561 L-cysteine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D003545 Cysteine inhibits the reaction [bisphenol A results in decreased expression of HMOX1 mRNA] PMID:37999554 14201932 HMOX1 heme oxygenase 1 gene CHEBI:17627 ferroheme b increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D006418 HMOX1 protein results in increased metabolism of Heme PMID:16751286 14201932 HMOX1 heme oxygenase 1 gene CHEBI:17627 ferroheme b multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006418 [HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide; chromium mesoporphyrin inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide]; tin protoporphyrin IX inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide] PMID:16751286 14201932 HMOX1 heme oxygenase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HMOX1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMOX1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMOX1 protein PMID:33493553|PMID:33592257|PMID:34416349 14201932 HMOX1 heme oxygenase 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of HMOX1 mRNA PMID:18988085 14201932 HMOX1 heme oxygenase 1 gene CHEBI:25942 peroxynitrous acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D030421 Peroxynitrous Acid results in increased expression of HMOX1 protein PMID:16371440 14201932 HMOX1 heme oxygenase 1 gene CHEBI:26267 proanthocyanidin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D044945 [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]]; [Heterocyclic Compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein]]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 mRNA]; Proanthocyanidins inhibits the reaction [Zearalenone results in decreased expression of HMOX1 protein] PMID:35489465 14201932 HMOX1 heme oxygenase 1 gene CHEBI:26355 heme b increases metabolic processing EXP E RGD:6480464 20191114 CTD MESH:D006418 HMOX1 protein results in increased metabolism of Heme PMID:16751286 14201932 HMOX1 heme oxygenase 1 gene CHEBI:26355 heme b multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006418 [HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide; chromium mesoporphyrin inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide]; tin protoporphyrin IX inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide] PMID:16751286 14201932 HMOX1 heme oxygenase 1 gene CHEBI:27584 aldosterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D000450 Aldosterone results in increased expression of HMOX1 protein PMID:24512358 14201932 HMOX1 heme oxygenase 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of HMOX1 mRNA PMID:31677563 14201932 HMOX1 heme oxygenase 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of HMOX1 mRNA PMID:35388968|PMID:36584959 14201932 HMOX1 heme oxygenase 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of and affects the localization of HMOX1 protein PMID:35388968 14201932 HMOX1 heme oxygenase 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of HMOX1 mRNA PMID:21391292 14201932 HMOX1 heme oxygenase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of HMOX1 mRNA PMID:37999554 14201932 HMOX1 heme oxygenase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Cysteine inhibits the reaction [bisphenol A results in decreased expression of HMOX1 mRNA] PMID:37999554 14201932 HMOX1 heme oxygenase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HMOX1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMOX1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMOX1 protein PMID:33493553|PMID:33592257|PMID:34416349 14201932 HMOX1 heme oxygenase 1 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of HMOX1 protein PMID:28710020 14201932 HMOX1 heme oxygenase 1 gene CHEBI:47807 sulforaphane multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C016766 NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein] PMID:28710020 14201932 HMOX1 heme oxygenase 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C045651 HMOX1 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] PMID:20580034 14201933 LRRC4B leucine rich repeat containing 4B gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of LRRC4B mRNA PMID:34933075 14202130 PCLAF PCNA clamp associated factor gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of PCLAF mRNA PMID:35307453 14202130 PCLAF PCNA clamp associated factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of PCLAF mRNA PMID:21852083 14202273 GRPR gastrin releasing peptide receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRPR mRNA PMID:35307453 14202316 LAMB1 laminin subunit beta 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LAMB1 mRNA PMID:35307453 14202316 LAMB1 laminin subunit beta 1 gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of LAMB1 mRNA PMID:32423882 14202316 LAMB1 laminin subunit beta 1 gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20200915 CTD MESH:D009538 Nicotine results in decreased expression of LAMB1 mRNA PMID:32423882 14202369 PNPLA2 patatin like phospholipase domain containing 2 gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of PNPLA2 mRNA PMID:31360149 14202388 TTC38 tetratricopeptide repeat domain 38 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC38 mRNA PMID:35307453 14202420 ADAM15 ADAM metallopeptidase domain 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM15 mRNA PMID:35307453 14202515 RPL24 ribosomal protein L24 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL24 mRNA PMID:39265697 14202613 PID1 phosphotyrosine interaction domain containing 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PID1 mRNA PMID:21852083 14202796 HSPD1 heat shock protein family D (Hsp60) member 1 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002738 Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of HSPD1 protein] PMID:17727805 14202796 HSPD1 heat shock protein family D (Hsp60) member 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of HSPD1 mRNA PMID:14994279 14202999 CCND1 cyclin D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCND1 protein PMID:30690062 14202999 CCND1 cyclin D1 gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of CCND1 protein PMID:37659622 14202999 CCND1 cyclin D1 gene CHEBI:3093 bifenthrin decreases expression EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in decreased expression of CCND1 mRNA PMID:33901951 14202999 CCND1 cyclin D1 gene CHEBI:39329 etoxazole decreases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in decreased expression of CCND1 mRNA PMID:31744678 14202999 CCND1 cyclin D1 gene CHEBI:6078 ivermectin decreases expression EXP E RGD:6480464 20201103 CTD MESH:D007559 Ivermectin results in decreased expression of CCND1 mRNA PMID:31400776 14203008 APOA1 apolipoprotein A1 gene CHEBI:16113 cholesterol increases transport EXP E RGD:6480464 20191114 CTD MESH:D002784 APOA1 protein results in increased transport of Cholesterol PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:16113 cholesterol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002784 24-hydroxycholesterol promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; Fenofibrate inhibits the reaction [APOA1 protein results in increased transport of Cholesterol]; Fenofibrate promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; Pioglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; T0901317 promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; Troglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol] PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:34310 (24S)-24-hydroxycholesterol increases secretion EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol results in increased secretion of APOA1 protein PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:34310 (24S)-24-hydroxycholesterol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol promotes the reaction [APOA1 protein results in increased transport of Cholesterol] PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate results in increased expression of APOA1 mRNA PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:47612 bezafibrate increases secretion EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate results in increased secretion of APOA1 protein PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:5001 fenofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D011345 Fenofibrate results in decreased expression of APOA1 mRNA PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:5001 fenofibrate increases secretion EXP E RGD:6480464 20191114 CTD MESH:D011345 Fenofibrate results in increased secretion of APOA1 protein PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:5001 fenofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011345 Fenofibrate inhibits the reaction [APOA1 protein results in increased transport of Cholesterol]; Fenofibrate promotes the reaction [APOA1 protein results in increased transport of Cholesterol] PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:8228 pioglitazone increases secretion EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone results in increased secretion of APOA1 protein PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol] PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in decreased expression of APOA1 mRNA PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:9753 troglitazone increases secretion EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in increased secretion of APOA1 protein PMID:16530456 14203008 APOA1 apolipoprotein A1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol] PMID:16530456 14203115 TUBB6 tubulin beta 6 class V gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TUBB6 mRNA PMID:35307453 14203205 MEGF6 multiple EGF like domains 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEGF6 mRNA PMID:35307453 14203258 SLC2A8 solute carrier family 2 member 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC2A8 mRNA PMID:35307453 14203277 CEMIP cell migration inducing hyaluronidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEMIP mRNA PMID:35307453 14203321 WDR36 WD repeat domain 36 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR36 mRNA PMID:35307453 14203492 AP3B2 adaptor related protein complex 3 subunit beta 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AP3B2 mRNA PMID:35307453 14203563 INSIG1 insulin induced gene 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INSIG1 mRNA PMID:35307453 14203589 ATP2B2 ATPase plasma membrane Ca2+ transporting 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP2B2 mRNA PMID:35307453 14203774 MEDAG mesenteric estrogen dependent adipogenesis gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MEDAG mRNA] PMID:21852083 14203783 DZIP1L DAZ interacting zinc finger protein 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DZIP1L mRNA PMID:35307453 14203827 ZNF787 zinc finger protein 787 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF787 mRNA PMID:35307453 14203867 TFF3 trefoil factor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFF3 mRNA PMID:30854615 14203867 TFF3 trefoil factor 3 gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in decreased expression of TFF3 protein] PMID:38154151 14203867 TFF3 trefoil factor 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of TFF3 protein PMID:38154151 14203867 TFF3 trefoil factor 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in decreased expression of TFF3 protein] PMID:38154151 14203975 AFMID arylformamidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AFMID mRNA PMID:35307453 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of EIF2AK3 protein PMID:37442268 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 GSK2656157 inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2AK3 protein]; Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2AK3 protein] PMID:37442268 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:139047 GSK2656157 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C000597302 GSK2656157 inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2AK3 protein] PMID:37442268 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 protein] PMID:36584959 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20210504 CTD MESH:C039060 artenimol results in increased expression of EIF2AK3 protein modified form PMID:32721431 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 protein PMID:33891997 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2AK3 protein] PMID:37442268 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of EIF2AK3 mRNA; Glyphosate results in increased expression of EIF2AK3 protein PMID:36584959 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 protein] PMID:36584959 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:33216 bisphenol A increases phosphorylation EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased phosphorylation of EIF2AK3 protein PMID:37108405 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased phosphorylation of EIF2AK3 protein] PMID:37108405 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of EIF2AK3 protein PMID:17464326 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 protein PMID:33891997 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased phosphorylation of EIF2AK3 protein] PMID:37442268 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:39329 etoxazole increases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased phosphorylation of EIF2AK3 protein PMID:31744678 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased phosphorylation of EIF2AK3 protein] PMID:37108405 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:64163 diquat increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in increased phosphorylation of EIF2AK3 protein PMID:38567716 14204083 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 gene CHEBI:9381 T-2 toxin increases phosphorylation EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in increased phosphorylation of EIF2AK3 protein PMID:34637808 14204104 NOLC1 nucleolar and coiled-body phosphoprotein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOLC1 mRNA PMID:35307453 14204137 MRPL47 mitochondrial ribosomal protein L47 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL47 mRNA PMID:35307453 14204442 PER1 period circadian regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PER1 mRNA PMID:35307453 14204503 SMOX spermine oxidase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMOX mRNA PMID:35307453 14204618 GRK4 G protein-coupled receptor kinase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRK4 mRNA PMID:35307453 14204717 C2H11orf98 chromosome 2 C11orf98 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C2H11ORF98 mRNA PMID:35307453 14204946 TENT5B terminal nucleotidyltransferase 5B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TENT5B mRNA PMID:35307453 14204962 PTPRV protein tyrosine phosphatase receptor type V gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPRV mRNA PMID:35307453 14205103 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3CG mRNA PMID:32229166 14205103 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PIK3CG mRNA PMID:33493553 14205103 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of PIK3CG mRNA PMID:21391292 14205103 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of PIK3CG mRNA; tetrabromobisphenol A results in decreased expression of PIK3CG protein PMID:35665993 14205103 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PIK3CG mRNA PMID:33493553 14205390 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NTMT1 mRNA PMID:35307453 14205418 FCGR3A Fc fragment of IgG receptor IIIa gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FCGR3A mRNA PMID:35307453 14205451 TET1 tet methylcytosine dioxygenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TET1 mRNA PMID:35307453 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITPR1 mRNA PMID:35307453 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of ITPR1 protein PMID:37442268 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ITPR1 protein] PMID:37442268 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ITPR1 mRNA PMID:33891997 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ITPR1 protein] PMID:37442268 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ITPR1 mRNA PMID:33891997 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of ITPR1 protein] PMID:37442268 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:50842 norflurazon increases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased expression of ITPR1 protein PMID:38432436 14205466 ITPR1 inositol 1,4,5-trisphosphate receptor type 1 gene CHEBI:88522 Monobutylphthalate affects localization EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate affects the localization of ITPR1 protein PMID:35839969 14205586 PPP4R4 protein phosphatase 4 regulatory subunit 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPP4R4 mRNA PMID:35307453 14205586 PPP4R4 protein phosphatase 4 regulatory subunit 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PPP4R4 mRNA PMID:39265697 14205758 TRAF6 TNF receptor associated factor 6 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF6 mRNA PMID:33592257 14205758 TRAF6 TNF receptor associated factor 6 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF6 mRNA PMID:33592257 14205814 PBXIP1 PBX homeobox interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PBXIP1 mRNA PMID:35307453 14205854 MSH5 mutS homolog 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MSH5 mRNA PMID:35307453 14205895 TFCP2L1 transcription factor CP2 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFCP2L1 mRNA PMID:35307453 14205943 SRD5A2 steroid 5 alpha-reductase 2 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SRD5A2 mRNA PMID:34389318 14205996 PECAM1 platelet and endothelial cell adhesion molecule 1 gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20200114 CTD MESH:D010100 [[sodium percarbonate co-treated with calcium peroxide] results in increased abundance of Oxygen] which results in increased expression of PECAM1 protein PMID:26053405 14205996 PECAM1 platelet and endothelial cell adhesion molecule 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PECAM1 protein] PMID:21375526 14205996 PECAM1 platelet and endothelial cell adhesion molecule 1 gene CHEBI:48233 calcium peroxide multiple interactions EXP E RGD:6480464 20200114 CTD MESH:C403632 [[sodium percarbonate co-treated with calcium peroxide] results in increased abundance of Oxygen] which results in increased expression of PECAM1 protein PMID:26053405 14206348 RIMS4 regulating synaptic membrane exocytosis 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RIMS4 mRNA PMID:35307453 14206409 ETV5 ETS variant transcription factor 5 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of ETV5 mRNA PMID:21852083 14206433 MYORG myogenesis regulating glycosidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYORG mRNA PMID:35307453 14206439 CITED4 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CITED4 mRNA PMID:39265697 14206461 COL3A1 collagen type III alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL3A1 mRNA PMID:38403181 14206461 COL3A1 collagen type III alpha 1 chain gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL3A1 mRNA PMID:34416349 14206461 COL3A1 collagen type III alpha 1 chain gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL3A1 mRNA] PMID:21852083 14206461 COL3A1 collagen type III alpha 1 chain gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL3A1 mRNA PMID:34416349 14206520 MYBPC2 myosin binding protein C2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYBPC2 mRNA PMID:35307453 14206565 NME9 NME/NM23 family member 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NME9 mRNA PMID:35307453 14206623 TARDBP TAR DNA binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TARDBP mRNA PMID:35307453 14206649 ATP6V0A1 ATPase H+ transporting V0 subunit a1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP6V0A1 mRNA PMID:35307453 14206843 CYB5D2 cytochrome b5 domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYB5D2 mRNA PMID:35307453 14207010 SEC13 SEC13 homolog, nuclear pore and COPII coat complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC13 mRNA PMID:35307453 14207059 UPTI plasmin trypsin inhibitor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UPTI mRNA PMID:35307453 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 capsazepine inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; iodoresiniferatoxin inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Ruthenium Red inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium] PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:26708 sodium atom affects activity EXP E RGD:6480464 20191114 CTD MESH:D012964 Sodium affects the activity of TRPV1 protein PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:26708 sodium atom affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D012964 TRPV1 protein affects the susceptibility to Sodium PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:26708 sodium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012964 capsazepine inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; iodoresiniferatoxin inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Ruthenium Red inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium] PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 capsazepine inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; iodoresiniferatoxin inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Ruthenium Red inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]]; Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium] PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:34956 ruthenium red multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012430 Ruthenium Red inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]] PMID:18230619 14207321 TRPV1 transient receptor potential cation channel subfamily V member 1 gene CHEBI:70773 capsazepine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C071423 capsazepine inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]] PMID:18230619 14207342 AGBL4 AGBL carboxypeptidase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGBL4 mRNA PMID:35307453 14207429 NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NDUFV3 mRNA PMID:35307453 14207438 CFAP73 cilia and flagella associated protein 73 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP73 mRNA PMID:35307453 14207531 TMEM72 transmembrane protein 72 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of TMEM72 mRNA PMID:35307453 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of TNFAIP6 mRNA PMID:26386189 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of TNFAIP6 mRNA] PMID:26386189 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:22977 cadmium atom decreases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in decreased expression of TNFAIP6 mRNA PMID:37207789 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D002104 [ursodoxicoltaurine co-treated with Cadmium] results in increased expression of TNFAIP6 mRNA; ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of TNFAIP6 mRNA] PMID:37207789 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of TNFAIP6 mRNA] PMID:26386189 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of TNFAIP6 mRNA PMID:38565334 14207585 TNFAIP6 TNF alpha induced protein 6 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 [ursodoxicoltaurine co-treated with Cadmium] results in increased expression of TNFAIP6 mRNA; ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of TNFAIP6 mRNA] PMID:37207789 14207615 LIG3 DNA ligase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF830 mRNA PMID:35307453 14207895 TMEM266 transmembrane protein 266 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM266 mRNA PMID:35307453 14208051 CDK1 cyclin dependent kinase 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CDK1 protein]; deoxynivalenol results in decreased expression of and results in decreased phosphorylation of CDK1 protein; pifithrin inhibits the reaction [deoxynivalenol results in decreased expression of CDK1 protein] PMID:38104654 14208051 CDK1 cyclin dependent kinase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of CDK1 mRNA; Zearalenone results in decreased expression of CDK1 protein PMID:29758222 14208051 CDK1 cyclin dependent kinase 1 gene CHEBI:229924 pifithrin-alpha hydrobromide multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C121565 pifithrin inhibits the reaction [deoxynivalenol results in decreased expression of CDK1 protein] PMID:38104654 14208051 CDK1 cyclin dependent kinase 1 gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20240806 CTD MESH:D002110 Caffeine inhibits the reaction [deoxynivalenol results in decreased expression of CDK1 protein] PMID:38104654 14208226 BCAR1 BCAR1 scaffold protein, Cas family member gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BCAR1 mRNA PMID:35307453 14208391 DDIT4 DNA damage inducible transcript 4 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of DDIT4 mRNA PMID:25455459 14208466 CRIP2 cysteine rich protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CRIP2 mRNA PMID:35307453 14208549 SF1 splicing factor 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SF1 mRNA PMID:21852083 14208657 TXNIP thioredoxin interacting protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TXNIP mRNA PMID:35307453 14208657 TXNIP thioredoxin interacting protein gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate results in decreased expression of TXNIP mRNA] PMID:39151877 14208657 TXNIP thioredoxin interacting protein gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of TXNIP mRNA PMID:39151877 14208657 TXNIP thioredoxin interacting protein gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate results in decreased expression of TXNIP mRNA] PMID:39151877 14208742 CD27 CD27 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD27 mRNA PMID:35307453 14208766 BMP1 bone morphogenetic protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMP1 mRNA; deoxynivalenol results in decreased expression of BMP1 protein PMID:35307453|PMID:38403181 14208819 TRIB3 tribbles pseudokinase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIB3 mRNA PMID:35307453 14208819 TRIB3 tribbles pseudokinase 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of TRIB3 mRNA PMID:39265697 14208867 STK16 serine/threonine kinase 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STK16 mRNA PMID:35307453 14208880 DLK1 delta like non-canonical Notch ligand 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of DLK1 mRNA PMID:34933075 14209048 CLIC3 chloride intracellular channel 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLIC3 mRNA PMID:35307453 14209048 CLIC3 chloride intracellular channel 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of CLIC3 mRNA PMID:34933075 14209050 WASHC4 WASH complex subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WASHC4 mRNA PMID:35307453 14209087 LNPK lunapark, ER junction formation factor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of LNPK mRNA PMID:21852083 14209127 IL10 interleukin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL10 protein PMID:37442268 14209127 IL10 interleukin 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL10 mRNA PMID:19607891 14209127 IL10 interleukin 10 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL10 mRNA]; Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of IL10 protein] PMID:19027837|PMID:37442268 14209127 IL10 interleukin 10 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IL10 mRNA PMID:34933075 14209127 IL10 interleukin 10 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of IL10 protein PMID:34933075 14209127 IL10 interleukin 10 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of and results in decreased secretion of IL10 protein PMID:23727178 14209127 IL10 interleukin 10 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL10 mRNA PMID:15998543 14209127 IL10 interleukin 10 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in increased expression of IL10 mRNA PMID:36615853 14209127 IL10 interleukin 10 gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in decreased secretion of IL10 protein] PMID:38154151 14209127 IL10 interleukin 10 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL10 mRNA PMID:33592257|PMID:34416349 14209127 IL10 interleukin 10 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of IL10 protein] PMID:37442268 14209127 IL10 interleukin 10 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of IL10 protein PMID:36584959 14209127 IL10 interleukin 10 gene CHEBI:28640 lipoteichoic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:C009900 lipoteichoic acid results in increased expression of IL10 mRNA PMID:15998543 14209127 IL10 interleukin 10 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of IL10 mRNA PMID:37108405 14209127 IL10 interleukin 10 gene CHEBI:33216 bisphenol A decreases secretion EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased secretion of IL10 protein PMID:38154151 14209127 IL10 interleukin 10 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in decreased secretion of IL10 protein]; Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of IL10 mRNA] PMID:37108405|PMID:38154151 14209127 IL10 interleukin 10 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in increased expression of IL10 mRNA PMID:36615853 14209127 IL10 interleukin 10 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of IL10 mRNA PMID:33626375 14209127 IL10 interleukin 10 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL10 mRNA PMID:33592257|PMID:34416349 14209127 IL10 interleukin 10 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in decreased expression of IL10 protein] PMID:37442268 14209127 IL10 interleukin 10 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of IL10 mRNA] PMID:37108405 14209127 IL10 interleukin 10 gene CHEBI:77149 notoginsenoside R1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C072936 notoginsenoside R1 results in decreased expression of IL10 protein PMID:25721049 14209147 SOD3 superoxide dismutase 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SOD3 mRNA PMID:39265697 14209147 SOD3 superoxide dismutase 3 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SOD3 mRNA PMID:34389318 14209161 ERBB2 erb-b2 receptor tyrosine kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERBB2 mRNA PMID:35307453 14209199 POMC proopiomelanocortin gene CHEBI:144353 diethyldithiocarbamic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004050 Ditiocarb promotes the reaction [Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone]] PMID:21466817 14209199 POMC proopiomelanocortin gene CHEBI:17026 progesterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 POMC protein results in increased secretion of Progesterone PMID:22100847 14209199 POMC proopiomelanocortin gene CHEBI:17650 cortisol increases abundance EXP E RGD:6480464 20191114 CTD MESH:D006854 POMC protein alternative form results in increased abundance of Hydrocortisone PMID:1666317 14209199 POMC proopiomelanocortin gene CHEBI:17650 cortisol increases secretion EXP E RGD:6480464 20191114 CTD MESH:D006854 POMC protein results in increased secretion of Hydrocortisone PMID:21466817|PMID:22100847 14209199 POMC proopiomelanocortin gene CHEBI:17650 cortisol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006854 Ditiocarb promotes the reaction [Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone]]; Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone] PMID:21466817 14209199 POMC proopiomelanocortin gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POMC protein PMID:34416349 14209199 POMC proopiomelanocortin gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POMC protein PMID:34416349 14209199 POMC proopiomelanocortin gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D018038 Ditiocarb promotes the reaction [Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone]]; Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone] PMID:21466817 14209242 FNDC4 fibronectin type III domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FNDC4 mRNA PMID:35307453 14209242 FNDC4 fibronectin type III domain containing 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of FNDC4 mRNA PMID:34933075 14209263 TCTN2 tectonic family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCTN2 mRNA PMID:35307453 14209343 IL1A interleukin 1 alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL1A mRNA PMID:23688591|PMID:35307453 14209343 IL1A interleukin 1 alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL1A mRNA; deoxynivalenol results in increased expression of IL1A protein PMID:23326479|PMID:23688591|PMID:27915442|PMID:35314294 14209343 IL1A interleukin 1 alpha gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with fumonisin B1] results in decreased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone] results in decreased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL1A mRNA]; nivalenol promotes the reaction [deoxynivalenol results in increased expression of IL1A mRNA] PMID:23688591|PMID:27915442 14209343 IL1A interleukin 1 alpha gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone] results in decreased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone] results in decreased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL1A mRNA PMID:28528741 14209343 IL1A interleukin 1 alpha gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]] PMID:28528741 14209343 IL1A interleukin 1 alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1A mRNA PMID:33592257 14209343 IL1A interleukin 1 alpha gene CHEBI:29310 dichlorine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in decreased expression of IL1A mRNA PMID:22533443 14209343 IL1A interleukin 1 alpha gene CHEBI:3084 bethanechol increases expression EXP E RGD:6480464 20230704 CTD MESH:D018723 Bethanechol results in increased expression of IL1A mRNA PMID:29380034 14209343 IL1A interleukin 1 alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1A mRNA PMID:33592257 14209343 IL1A interleukin 1 alpha gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in decreased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in decreased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:7599 Nivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in decreased expression of IL1A mRNA PMID:23688591 14209343 IL1A interleukin 1 alpha gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL1A mRNA PMID:23688591|PMID:27915442 14209343 IL1A interleukin 1 alpha gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL1A mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone] results in decreased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL1A mRNA; deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL1A mRNA]; nivalenol promotes the reaction [deoxynivalenol results in increased expression of IL1A mRNA] PMID:23688591|PMID:27915442 14209343 IL1A interleukin 1 alpha gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]] PMID:28528741 14209483 BMP2K BMP2 inducible kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BMP2K mRNA PMID:35307453 14209644 PLEKHG6 pleckstrin homology and RhoGEF domain containing G6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHG6 mRNA PMID:35307453 14209694 FAM13B family with sequence similarity 13 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM13B mRNA PMID:35307453 14209858 SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULT1E1 mRNA PMID:35307453 14209858 SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of SULT1E1 mRNA PMID:18790026 14209933 PTPN14 protein tyrosine phosphatase non-receptor type 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPN14 mRNA PMID:35307453 14209962 PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 gene CHEBI:138236 oridonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C011959 oridonin affects the expression of and results in decreased phosphorylation of PIK3R1 protein PMID:38972361 14209962 PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 gene CHEBI:34440 4-nonylphenol increases expression EXP E RGD:6480464 20240604 CTD MESH:C041594 4-nonylphenol results in increased expression of PIK3R1 protein PMID:38246476 14209962 PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 gene CHEBI:4357 deguelin multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C107676 deguelin results in increased expression of and results in increased phosphorylation of PIK3R1 protein PMID:37353039 14209962 PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 gene CHEBI:50091 S-nitrosoglutathione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D026422 PIK3R1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein] PMID:11514583 14210144 MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP4K4 mRNA PMID:35307453 14210235 DUSP10 dual specificity phosphatase 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DUSP10 mRNA PMID:35307453|PMID:37257635 14210235 DUSP10 dual specificity phosphatase 10 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of DUSP10 mRNA PMID:37706587 14210235 DUSP10 dual specificity phosphatase 10 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DUSP10 mRNA] PMID:37706587 14210235 DUSP10 dual specificity phosphatase 10 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DUSP10 mRNA] PMID:37706587 14210262 INSYN2B inhibitory synaptic factor family member 2B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INSYN2B mRNA PMID:35307453 14210299 PRSS35 serine protease 35 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRSS35 mRNA PMID:35307453 14210306 GPKOW G-patch domain and KOW motifs gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPKOW mRNA PMID:35307453 14210387 LMBRD1 LMBR1 domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMBRD1 mRNA PMID:35307453 14210602 RANBP6 RAN binding protein 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RANBP6 mRNA PMID:35307453 14210629 YOD1 YOD1 deubiquitinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of YOD1 mRNA; deoxynivalenol results in increased expression of YOD1 protein PMID:38403181 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NR1H3 mRNA PMID:35307453 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NR1H3 mRNA PMID:25827716 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 T0901317 promotes the reaction [Glucose results in increased expression of NR1H3 mRNA] PMID:25827716 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NR1H3 mRNA PMID:25827716 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 T0901317 promotes the reaction [Glucose results in increased expression of NR1H3 mRNA] PMID:25827716 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20191114 CTD MESH:D005947 Glucose results in increased expression of NR1H3 mRNA PMID:25827716 14210648 NR1H3 nuclear receptor subfamily 1 group H member 3 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005947 T0901317 promotes the reaction [Glucose results in increased expression of NR1H3 mRNA] PMID:25827716 14210834 CENPK centromere protein K gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CENPK mRNA PMID:35307453 14210993 HSD17B10 hydroxysteroid 17-beta dehydrogenase 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSD17B10 mRNA PMID:35307453 14211010 ARCN1 archain 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARCN1 mRNA PMID:35307453 14211081 HEATR6 HEAT repeat containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HEATR6 mRNA PMID:35307453 14211106 QSOX1 quiescin sulfhydryl oxidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of QSOX1 mRNA PMID:35307453 14211130 DRC1 dynein regulatory complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DRC1 mRNA PMID:35307453 14211160 SFXN5 sideroflexin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SFXN5 mRNA PMID:35307453 14211183 ZFP36L1 ZFP36 ring finger protein like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZFP36L1 mRNA PMID:35307453 14211268 RAB4A RAB4A, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB4A mRNA PMID:35307453 14211295 PDGFRA platelet derived growth factor receptor alpha gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of PDGFRA mRNA PMID:34933075 14211295 PDGFRA platelet derived growth factor receptor alpha gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of PDGFRA mRNA PMID:18988085 14211327 HERC4 HECT and RLD domain containing E3 ubiquitin protein ligase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HERC4 mRNA PMID:35307453 14211425 UQCRQ ubiquinol-cytochrome c reductase complex III subunit VII gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRQ mRNA PMID:34416349 14211425 UQCRQ ubiquinol-cytochrome c reductase complex III subunit VII gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRQ mRNA PMID:34416349 14211425 UQCRQ ubiquinol-cytochrome c reductase complex III subunit VII gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of UQCRQ mRNA PMID:38432436 14211438 HAO2 hydroxyacid oxidase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HAO2 mRNA PMID:35307453 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 protein] PMID:36584959 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSP90B1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSP90B1 protein PMID:33891997 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased expression of HSP90B1 mRNA PMID:17464326 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of HSP90B1 mRNA; Glyphosate results in increased expression of HSP90B1 protein PMID:36584959 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 protein] PMID:36584959 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:28869 menadione increases expression EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased expression of HSP90B1 mRNA; Vitamin K 3 results in increased expression of HSP90B1 protein PMID:16920763|PMID:18086661 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:28869 menadione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024483 PD 150606 inhibits the reaction [Vitamin K 3 results in increased expression of HSP90B1 protein] PMID:16920763 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HSP90B1 mRNA] PMID:18086661 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:29699 tunicamycin increases expression EXP E RGD:6480464 20191114 CTD MESH:D014415 Tunicamycin results in increased expression of HSP90B1 protein PMID:15049342|PMID:17416481 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:31767 lead diacetate increases expression EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in increased expression of HSP90B1 mRNA PMID:17464326 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:31823 mercury dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased expression of HSP90B1 mRNA PMID:17464326 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of HSP90B1 mRNA PMID:17464326|PMID:18086661 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSP90B1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSP90B1 protein; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HSP90B1 mRNA] PMID:18086661|PMID:33891997 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:35696 cobalt dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:C018021 cobaltous chloride results in increased expression of HSP90B1 mRNA PMID:17464326 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:53016 sulfamethoxazole hydroxylamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059873 sulfamethoxazole hydroxylamine results in decreased expression of HSP90B1 protein PMID:16005169 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:64090 tert-butyl hydroperoxide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in decreased expression of HSP90B1 protein PMID:16005169 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:64090 tert-butyl hydroperoxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of HSP90B1 protein PMID:16920763 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:64090 tert-butyl hydroperoxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020122 PD 150606 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSP90B1 protein] PMID:16920763 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of HSP90B1 mRNA PMID:14994279 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of HSP90B1 mRNA PMID:14994279 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:9516 thapsigargin decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019284 Thapsigargin results in decreased expression of HSP90B1 protein PMID:16920763 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:9516 thapsigargin increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019284 Thapsigargin results in increased cleavage of HSP90B1 protein PMID:16920763 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:9516 thapsigargin increases expression EXP E RGD:6480464 20191114 CTD MESH:D019284 Thapsigargin results in increased expression of HSP90B1 protein PMID:16759985|PMID:16920763|PMID:17416481 14211492 HSP90B1 heat shock protein 90 beta family member 1 gene CHEBI:9516 thapsigargin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019284 PD 150606 inhibits the reaction [Thapsigargin results in increased cleavage of HSP90B1 protein] PMID:16920763 14211683 HS6ST1 heparan sulfate 6-O-sulfotransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HS6ST1 mRNA PMID:35307453 14211690 PGC progastricsin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGC mRNA PMID:35307453 14211709 CLEC11A C-type lectin domain containing 11A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLEC11A mRNA PMID:35307453 14211728 GRAMD2B GRAM domain containing 2B gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of GRAMD2B mRNA PMID:35839969 14211762 KCNN4 potassium calcium-activated channel subfamily N member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCNN4 mRNA PMID:35307453 14211775 MAGOH mago homolog, exon junction complex subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAGOH mRNA PMID:35307453 14211838 TSPAN10 tetraspanin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN10 mRNA PMID:35307453 14211891 AIG1 androgen induced 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AIG1 mRNA PMID:35307453 14211960 BROX BRO1 domain and CAAX motif containing gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of BROX mRNA; deoxynivalenol results in increased expression of BROX protein PMID:38403181 14212021 IFT172 intraflagellar transport 172 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT172 mRNA PMID:35307453 14212163 CBX7 chromobox 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBX7 mRNA PMID:35307453 14212181 BCAS3 BCAS3 microtubule associated cell migration factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCAS3 mRNA PMID:35307453 14212181 BCAS3 BCAS3 microtubule associated cell migration factor gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of BCAS3 mRNA PMID:39265697 14212234 JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JMJD6 mRNA; deoxynivalenol results in increased expression of JMJD6 protein PMID:35307453|PMID:38403181 14212246 UMODL1 uromodulin like 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of UMODL1 mRNA PMID:34933075 14212272 TGFB1I1 transforming growth factor beta 1 induced transcript 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TGFB1I1 mRNA PMID:35307453 14212378 USP39 ubiquitin specific peptidase 39 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of USP39 mRNA PMID:35307453 14212439 UTP25 UTP25 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP25 mRNA PMID:35307453 14212509 POU6F2 POU class 6 homeobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of POU6F2 mRNA PMID:35307453 14212621 PCBP3 poly(rC) binding protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PCBP3 mRNA PMID:35307453 14212658 RAB27A RAB27A, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB27A mRNA PMID:35307453 14212756 SLC13A2 solute carrier family 13 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC13A2 mRNA PMID:35307453 14212857 PLPPR3 phospholipid phosphatase related 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLPPR3 mRNA PMID:35307453 14212877 SLF1 SMC5-SMC6 complex localization factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLF1 mRNA PMID:35307453 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:209558 Calphostin C decreases expression EXP E RGD:6480464 20231219 CTD MESH:C058819 calphostin C results in decreased expression of PPARA PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:209558 Calphostin C multiple interactions EXP E RGD:6480464 20231219 CTD MESH:C058819 calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA protein]; calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA]; calphostin C promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of PPARA] PMID:17105827|PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARA mRNA PMID:34416349 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein] PMID:21739664 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:27899 cisplatin decreases activity EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in decreased activity of PPARA protein PMID:16316343 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 [Cisplatin results in decreased activity of PPARA protein] which results in increased abundance of Fatty Acids, Nonesterified; Bezafibrate inhibits the reaction [[Cisplatin results in decreased activity of PPARA protein] which results in increased abundance of Fatty Acids, Nonesterified]; Bezafibrate inhibits the reaction [Cisplatin results in decreased activity of PPARA protein] PMID:16316343 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARA mRNA PMID:34416349 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of PPARA; Clofibrate results in increased expression of PPARA protein PMID:17105827|PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002994 calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA protein]; calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA]; Tetradecanoylphorbol Acetate inhibits the reaction [Clofibrate results in increased expression of PPARA] PMID:17105827|PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:37537 phorbol 13-acetate 12-myristate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in decreased expression of PPARA; Tetradecanoylphorbol Acetate results in decreased expression of PPARA protein PMID:17105827|PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013755 calphostin C promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of PPARA]; Tetradecanoylphorbol Acetate inhibits the reaction [Clofibrate results in increased expression of PPARA] PMID:20568414 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate inhibits the reaction [[Cisplatin results in decreased activity of PPARA protein] which results in increased abundance of Fatty Acids, Nonesterified]; Bezafibrate inhibits the reaction [Cisplatin results in decreased activity of PPARA protein] PMID:16316343 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of PPARA mRNA] PMID:18845708 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of PPARA mRNA PMID:18845708 14213069 PPARA peroxisome proliferator activated receptor alpha gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of PPARA mRNA] PMID:18845708 14213077 DDC dopa decarboxylase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDC mRNA PMID:35307453 14213138 SLC15A2 solute carrier family 15 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC15A2 mRNA PMID:35307453 14213188 OGG1 8-oxoguanine DNA glycosylase gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of OGG1 mRNA PMID:30923867 14213188 OGG1 8-oxoguanine DNA glycosylase gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in decreased expression of OGG1 mRNA] PMID:30923867 14213188 OGG1 8-oxoguanine DNA glycosylase gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of OGG1 mRNA PMID:30923867 14213188 OGG1 8-oxoguanine DNA glycosylase gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of OGG1 mRNA] PMID:30923867 14213201 SRGAP1 SLIT-ROBO Rho GTPase activating protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SRGAP1 mRNA PMID:35307453 14213454 METTL13 methyltransferase 13, eEF1A N-terminus and K55 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL13 mRNA PMID:35307453 14213490 ELP4 elongator acetyltransferase complex subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of ELP4 mRNA; deoxynivalenol results in increased expression of ELP4 protein PMID:38403181 14213513 CHRDL2 chordin like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHRDL2 mRNA PMID:35307453 14213551 RRP9 ribosomal RNA processing 9, U3 small nucleolar RNA binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRP9 mRNA PMID:35307453 14213570 DYNC2LI1 dynein cytoplasmic 2 light intermediate chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DYNC2LI1 mRNA PMID:35307453 14213597 DPEP1 dipeptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DPEP1 mRNA PMID:35307453 14213620 KDELR3 KDEL endoplasmic reticulum protein retention receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of KDELR3 mRNA; deoxynivalenol results in decreased expression of KDELR3 protein PMID:38403181 14213629 GBP1 guanylate binding protein 1, interferon-inducible gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20230321 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of GBP1 mRNA PMID:22497863 14213700 NOTCH3 notch receptor 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NOTCH3 mRNA; deoxynivalenol results in decreased expression of NOTCH3 protein PMID:35307453|PMID:38403181 14213825 RALGDS ral guanine nucleotide dissociation stimulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RALGDS mRNA PMID:35307453 14213895 PPME1 protein phosphatase methylesterase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPME1 mRNA PMID:35307453 14213924 PRKG2 protein kinase cGMP-dependent 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRKG2 mRNA PMID:35307453 14213958 ATG5 autophagy related 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of ATG5 mRNA; deoxynivalenol results in increased expression of ATG5 protein PMID:35381244|PMID:37120089 14213958 ATG5 autophagy related 5 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of ATG5 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein] PMID:35381244|PMID:37120089 14213958 ATG5 autophagy related 5 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of ATG5 protein] PMID:37120089 14213958 ATG5 autophagy related 5 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein] PMID:35381244 14213958 ATG5 autophagy related 5 gene CHEBI:50842 norflurazon increases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in increased expression of ATG5 protein PMID:38432436 14213958 ATG5 autophagy related 5 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of ATG5 protein PMID:28699257|PMID:30287338 14213958 ATG5 autophagy related 5 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein] PMID:30287338 14214033 CHPF chondroitin polymerizing factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHPF mRNA PMID:35307453 14214103 RBM41 RNA binding motif protein 41 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM41 mRNA PMID:35307453 14214124 KIF21A kinesin family member 21A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KIF21A mRNA; deoxynivalenol results in increased expression of KIF21A protein PMID:35307453|PMID:38403181 14214287 C1QTNF1 C1q and TNF related 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C1QTNF1 mRNA; deoxynivalenol results in decreased expression of C1QTNF1 protein PMID:35307453|PMID:38403181 14214313 ENAH ENAH actin regulator gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ENAH mRNA PMID:35307453 14214442 FPGT fucose-1-phosphate guanylyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FPGT mRNA PMID:35307453 14214664 KCNK5 potassium two pore domain channel subfamily K member 5 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of KCNK5 mRNA PMID:34389318 14214988 PKD1 polycystin 1, transient receptor potential channel interacting gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKD1 mRNA PMID:35307453 14215058 ENTPD5 ectonucleoside triphosphate diphosphohydrolase 5 (inactive) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENTPD5 mRNA PMID:35307453 14215179 APLNR apelin receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APLNR mRNA PMID:35307453 14215209 RNF113A ring finger protein 113A gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of RNF113A mRNA] PMID:21852083 14215266 CNGA4 cyclic nucleotide gated channel subunit alpha 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CNGA4 mRNA PMID:35307453 14215292 MOK MOK protein kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MOK mRNA PMID:35307453 14215303 LTBP4 latent transforming growth factor beta binding protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LTBP4 mRNA PMID:35307453 14215375 DDO D-aspartate oxidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDO mRNA PMID:35307453 14215440 FOXJ1 forkhead box J1 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FOXJ1 mRNA PMID:34389318 14215553 TMIE transmembrane inner ear gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMIE mRNA PMID:35307453 14215618 LDHD lactate dehydrogenase D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LDHD mRNA PMID:35307453 14215683 FAM53A family with sequence similarity 53 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM53A mRNA PMID:35307453 14215850 GSTK1 glutathione S-transferase kappa 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GSTK1 mRNA PMID:35307453 14216124 ALDOB aldolase, fructose-bisphosphate B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDOB mRNA PMID:35307453 14216231 IFT46 intraflagellar transport 46 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFT46 mRNA PMID:35307453 14216283 HOPX HOP homeobox gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of HOPX mRNA PMID:39265697 14216378 DDX55 DEAD-box helicase 55 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX55 mRNA PMID:35307453 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:27086 tributylstannane increases expression EXP E RGD:6480464 20191114 CTD MESH:C011559 tributyltin results in increased expression of ABCA1 mRNA PMID:31006824 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:34310 (24S)-24-hydroxycholesterol affects localization EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol affects the localization of ABCA1 protein PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:34310 (24S)-24-hydroxycholesterol increases expression EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol results in increased expression of ABCA1 mRNA PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:5001 fenofibrate affects localization EXP E RGD:6480464 20191114 CTD MESH:D011345 Fenofibrate affects the localization of ABCA1 protein PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:8228 pioglitazone affects localization EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone affects the localization of ABCA1 protein PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:8228 pioglitazone increases expression EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone results in increased expression of ABCA1 mRNA PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:9753 troglitazone affects localization EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone affects the localization of ABCA1 protein PMID:16530456 14216440 ABCA1 ATP binding cassette subfamily A member 1 gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in decreased expression of ABCA1 mRNA PMID:16530456 14216518 ABCA2 ATP binding cassette subfamily A member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCA2 mRNA PMID:35307453 14216531 TSPAN15 tetraspanin 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN15 mRNA PMID:35307453 14216556 FAM120A family with sequence similarity 120 member A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM120A mRNA PMID:35307453 14216613 MANBA mannosidase beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MANBA mRNA PMID:35307453 14216742 TIMM10 translocase of inner mitochondrial membrane 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TIMM10 mRNA PMID:35307453 14216747 TRIB2 tribbles pseudokinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIB2 mRNA PMID:35307453 14216885 TMTC3 transmembrane O-mannosyltransferase targeting cadherins 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMTC3 mRNA PMID:35307453 14216932 C2 complement C2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C2 mRNA PMID:35307453 14216932 C2 complement C2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of C2 mRNA PMID:18988085 14216954 LIPI lipase I gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LIPI mRNA PMID:35307453 14216990 RPL36AL ribosomal protein L36a like gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL36A mRNA; graphene oxide results in decreased expression of RPL36AL mRNA PMID:39265697 14217037 ARF5 ADP ribosylation factor 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARF5 mRNA PMID:35307453 14217095 ADCY5 adenylate cyclase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADCY5 mRNA PMID:35307453 14217095 ADCY5 adenylate cyclase 5 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADCY5 mRNA PMID:34933075 14217214 SLC9A3 solute carrier family 9 member A3 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SLC9A3 mRNA PMID:34389318 14217377 GDF15 growth differentiation factor 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GDF15 mRNA PMID:35307453 14217497 CHEK2 checkpoint kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CHEK2 mRNA PMID:35307453 14217497 CHEK2 checkpoint kinase 2 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20240806 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of CHEK2 protein PMID:38104654 14217497 CHEK2 checkpoint kinase 2 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240806 CTD MESH:C007262 ATM protein promotes the reaction [deoxynivalenol results in increased phosphorylation of CHEK2 protein]; Caffeine inhibits the reaction [deoxynivalenol results in increased phosphorylation of CHEK2 protein] PMID:38104654 14217497 CHEK2 checkpoint kinase 2 gene CHEBI:27732 caffeine multiple interactions EXP E RGD:6480464 20240806 CTD MESH:D002110 Caffeine inhibits the reaction [deoxynivalenol results in increased phosphorylation of CHEK2 protein] PMID:38104654 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JUN mRNA; deoxynivalenol results in increased expression of JUN protein PMID:35307453|PMID:37257635 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:135697 sarpogrelate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C064294 sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein] PMID:11426759 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of JUN mRNA; Hydrogen Peroxide results in increased expression of JUN protein PMID:37706587 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN mRNA]; Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein] PMID:37706587 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN protein PMID:33891997 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:28790 serotonin increases expression EXP E RGD:6480464 20191114 CTD MESH:D012701 Serotonin results in increased expression of JUN mRNA; Serotonin results in increased expression of JUN protein PMID:11426759 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:28790 serotonin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012701 sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein] PMID:11426759 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:31823 mercury dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased expression of JUN mRNA; Mercuric Chloride results in increased expression of JUN protein PMID:10696784 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:31823 mercury dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008627 Mercuric Chloride results in increased phosphorylation of JUN protein PMID:10696784 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of JUN mRNA PMID:7564105 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN protein PMID:33891997 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of JUN mRNA PMID:17437637 14217642 JUN Jun proto-oncogene, AP-1 transcription factor subunit gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN mRNA]; Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein] PMID:37706587 14217744 CHRNA2 cholinergic receptor nicotinic alpha 2 subunit gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein] PMID:28235547 14217744 CHRNA2 cholinergic receptor nicotinic alpha 2 subunit gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein] PMID:28235547 14217744 CHRNA2 cholinergic receptor nicotinic alpha 2 subunit gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein] PMID:28235547 14217744 CHRNA2 cholinergic receptor nicotinic alpha 2 subunit gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein] PMID:28235547 14217808 MYO7B myosin VIIB gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYO7B mRNA PMID:35307453 14218065 RXFP2 relaxin family peptide receptor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RXFP2 mRNA PMID:34933075 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FGF2 mRNA PMID:39265697 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone inhibits the reaction [estrone benzoate results in decreased expression of FGF2 mRNA] PMID:15120423 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:18376 dermatan sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D003871 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein PMID:14699094 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of FGF2 mRNA PMID:27617619 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:37397 chondroitin sulfate affects binding EXP E RGD:6480464 20191114 CTD MESH:D002809 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein PMID:14699094 14218120 FGF2 fibroblast growth factor 2 gene CHEBI:49668 gefitinib multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C419708 Gefitinib inhibits the reaction [FGF2 protein results in increased phosphorylation of FES protein] PMID:19885553 14218190 ARHGEF33 Rho guanine nucleotide exchange factor 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF33 mRNA PMID:35307453 14218270 SDC4 syndecan 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDC4 mRNA PMID:35307453 14218270 SDC4 syndecan 4 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SDC4 mRNA PMID:39265697 14218284 DOK5 docking protein 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DOK5 mRNA PMID:35307453 14218335 RNF25 ring finger protein 25 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RNF25 mRNA PMID:35307453 14218437 ANO1 anoctamin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANO1 mRNA PMID:35307453 14218437 ANO1 anoctamin 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ANO1 mRNA PMID:39265697 14218532 GM2A ganglioside GM2 activator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GM2A mRNA PMID:35307453 14218543 LIG4 DNA ligase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LIG4 mRNA PMID:35307453 14218574 SNUPN snurportin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNUPN mRNA PMID:35307453 14218789 DOK2 docking protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DOK2 mRNA PMID:35307453 14218817 DDR1 discoidin domain receptor tyrosine kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDR1 mRNA PMID:35307453 14218934 MRPS9 mitochondrial ribosomal protein S9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPS9 mRNA PMID:35307453 14219027 ROCK1 Rho associated coiled-coil containing protein kinase 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of ROCK1 mRNA PMID:21645290 14219064 PSMB6 proteasome 20S subunit beta 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMB6 mRNA PMID:35307453 14219114 UNC45B unc-45 myosin chaperone B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UNC45B mRNA PMID:35307453 14219138 APAF1 apoptotic peptidase activating factor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of APAF1 mRNA PMID:34933075 14219138 APAF1 apoptotic peptidase activating factor 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20230404 CTD MESH:C056933 fumonisin B1 results in increased expression of APAF1 mRNA; fumonisin B1 results in increased expression of APAF1 protein PMID:36397609 14219138 APAF1 apoptotic peptidase activating factor 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20230404 CTD MESH:C056933 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 protein] PMID:36397609 14219138 APAF1 apoptotic peptidase activating factor 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230404 CTD MESH:C025589 ochratoxin A results in increased expression of APAF1 mRNA; ochratoxin A results in increased expression of APAF1 protein PMID:36397609 14219138 APAF1 apoptotic peptidase activating factor 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230404 CTD MESH:C025589 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 protein] PMID:36397609 14219330 FADS2 fatty acid desaturase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of FADS2 mRNA; deoxynivalenol results in decreased expression of FADS2 protein PMID:38403181 14219498 ILF3 interleukin enhancer binding factor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ILF3 mRNA PMID:35307453 14219632 WTIP WT1 interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WTIP mRNA PMID:35307453 14219680 GLMP glycosylated lysosomal membrane protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLMP mRNA PMID:35307453 14219722 U2SURP U2 snRNP associated SURP domain containing gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of U2SURP mRNA PMID:35307453 14219828 TARBP2 TARBP2 subunit of RISC loading complex gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TARBP2 mRNA PMID:35307453 14219856 TTC31 tetratricopeptide repeat domain 31 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of TTC31 mRNA PMID:34389318 14219955 MRPL19 mitochondrial ribosomal protein L19 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL19 mRNA PMID:35307453 14219965 MFSD4A major facilitator superfamily domain containing 4A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFSD4A mRNA PMID:35307453 14220008 RPL26 ribosomal protein L26 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL26 mRNA PMID:39265697 14220030 CPA4 carboxypeptidase A4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CPA4 mRNA PMID:35307453 14220186 HOXB6 homeobox B6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB6 mRNA PMID:35307453 14220224 ATP13A4 ATPase 13A4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATP13A4 mRNA PMID:35307453 14220352 GYS1 glycogen synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GYS1 mRNA PMID:35307453 14220352 GYS1 glycogen synthase 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter PMID:29065941 14220352 GYS1 glycogen synthase 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter PMID:29065941 14220352 GYS1 glycogen synthase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter PMID:29065941 14220352 GYS1 glycogen synthase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter PMID:29065941 14220463 MAP3K12 mitogen-activated protein kinase kinase kinase 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP3K12 mRNA PMID:35307453 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA] PMID:30481989 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA] PMID:30481989 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20191114 CTD MESH:D003907 Dexamethasone results in increased expression of CEBPA mRNA PMID:11225715 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA] PMID:30481989 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20191114 CTD MESH:C057693 Troglitazone results in increased expression of CEBPA mRNA PMID:11225715 14220489 CEBPA CCAAT enhancer binding protein alpha gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA] PMID:30481989 14220495 BMP5 bone morphogenetic protein 5 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of BMP5 mRNA PMID:18988085 14220495 BMP5 bone morphogenetic protein 5 gene CHEBI:29224 dibromine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in decreased expression of BMP5 mRNA PMID:18790026 14220743 SAT2 spermidine/spermine N1-acetyltransferase family member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAT2 mRNA PMID:35307453 14220840 ARMC6 armadillo repeat containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARMC6 mRNA PMID:35307453 14220840 ARMC6 armadillo repeat containing 6 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ARMC6 mRNA PMID:39265697 14221034 GCK glucokinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GCK mRNA PMID:35307453 14221177 OTUD7B OTU deubiquitinase 7B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OTUD7B mRNA PMID:35307453 14221326 SEC23B SEC23 homolog B, COPII coat complex component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SEC23B mRNA PMID:35307453 14221569 AIMP1 aminoacyl tRNA synthetase complex interacting multifunctional protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AIMP1 mRNA PMID:35307453 14221850 PDE9A phosphodiesterase 9A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDE9A mRNA PMID:35307453 14221941 GPR162 G protein-coupled receptor 162 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of GPR162 mRNA PMID:35307453 14222010 NYAP2 neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NYAP2 mRNA PMID:35307453 14222209 KLHDC9 kelch domain containing 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHDC9 mRNA PMID:35307453 14222262 CENPE centromere protein E gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CENPE mRNA PMID:21852083 14222359 SSX2IP SSX family member 2 interacting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SSX2IP mRNA PMID:35307453 14222359 SSX2IP SSX family member 2 interacting protein gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SSX2IP mRNA PMID:21852083 14222507 PCYT1A phosphate cytidylyltransferase 1A, choline gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of PCYT1A mRNA PMID:34389318 14222685 VWA7 von Willebrand factor A domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VWA7 mRNA PMID:35307453 14222752 LAMP1 lysosomal associated membrane protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAMP1 mRNA PMID:35307453 14222764 SUV39H2 SUV39H2 histone lysine methyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of SUV39H2 mRNA PMID:26988607 14222820 HK1 hexokinase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HK1 mRNA PMID:35307453 14222868 DNASE2 deoxyribonuclease 2, lysosomal gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNASE2 mRNA PMID:35307453 14222911 PIGW phosphatidylinositol glycan anchor biosynthesis class W gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PIGW mRNA PMID:35307453 14222938 BRSK2 BR serine/threonine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BRSK2 mRNA PMID:35307453 14223040 SLC29A2 solute carrier family 29 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC29A2 mRNA PMID:35307453 14223167 TSFM Ts translation elongation factor, mitochondrial gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TSFM mRNA PMID:35307453 14223177 NTF4 neurotrophin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NTF4 mRNA PMID:35307453 14223207 SLC30A3 solute carrier family 30 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC30A3 mRNA PMID:35307453 14223234 ZRANB1 zinc finger RANBP2-type containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZRANB1 mRNA PMID:35307453 14223260 UPK1A uroplakin 1A gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of UPK1A mRNA PMID:34933075 14223269 DGKA diacylglycerol kinase alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DGKA mRNA PMID:35307453 14223269 DGKA diacylglycerol kinase alpha gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of DGKA mRNA PMID:39265697 14223319 ITGAV integrin subunit alpha V gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGAV mRNA PMID:35307453|PMID:38403181 14223319 ITGAV integrin subunit alpha V gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ITGAV mRNA PMID:39265697 14223319 ITGAV integrin subunit alpha V gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ITGAV mRNA] PMID:21852083 14223319 ITGAV integrin subunit alpha V gene CHEBI:85102 KT 5823 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 inhibits the reaction [NOC 18 results in increased expression of [ITGAV protein binds to ITGB3 protein]] PMID:21307347 14223857 FBXO17 F-box protein 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXO17 mRNA PMID:35307453 14223907 RAI14 retinoic acid induced 14 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of RAI14 mRNA PMID:39265697 14224035 BDH1 3-hydroxybutyrate dehydrogenase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of BDH1 mRNA; deoxynivalenol results in decreased expression of BDH1 protein PMID:38403181 14224231 RHBG Rh family B glycoprotein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHBG mRNA PMID:35307453 14224231 RHBG Rh family B glycoprotein gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of RHBG mRNA PMID:18988085 14224278 APOE apolipoprotein E gene CHEBI:28417 gentamycin C decreases uptake EXP E RGD:6480464 20191114 CTD MESH:C100093 APOE protein results in decreased uptake of gentamicin C PMID:15777622 14224278 APOE apolipoprotein E gene CHEBI:28417 gentamycin C multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C100093 APOE protein inhibits the reaction [gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein]; APOE protein inhibits the reaction [gentamicin C results in decreased expression of SLC5A1 mRNA] PMID:15777622 14224288 CALM3 calmodulin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALM3 mRNA PMID:35307453 14224315 SHMT2 serine hydroxymethyltransferase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHMT2 mRNA; deoxynivalenol results in decreased expression of SHMT2 protein PMID:38403181 14224545 OGT O-linked N-acetylglucosamine (GlcNAc) transferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OGT mRNA PMID:35307453 14224640 P2RX4 purinergic receptor P2X 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P2RX4 mRNA PMID:35307453 14224656 PLPPR2 phospholipid phosphatase related 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLPPR2 mRNA PMID:35307453 14224780 NPHS1 NPHS1 adhesion molecule, nephrin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NPHS1 mRNA PMID:35307453 14224907 TLR2 toll like receptor 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of TLR2 mRNA PMID:25455459 14224907 TLR2 toll like receptor 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TLR2 mRNA PMID:18988085 14224907 TLR2 toll like receptor 2 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of TLR2 mRNA PMID:21391292 14225033 PTGFRN prostaglandin F2 receptor inhibitor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGFRN mRNA PMID:35307453 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP1B1 mRNA; deoxynivalenol results in decreased expression of CYP1B1 protein PMID:38403181 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CYP1B1 mRNA PMID:34389318 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CYP1B1 mRNA] PMID:39151877 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of CYP1B1 mRNA PMID:39151877 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of CYP1B1 mRNA] PMID:39151877 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of CYP1B1 mRNA PMID:31535366 14225127 CYP1B1 cytochrome P450 family 1 subfamily B member 1 gene CHEBI:77013 beta-naphthoflavone increases expression EXP E RGD:6480464 20191114 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of CYP1B1 mRNA PMID:19464568|PMID:19786062 14225202 IWS1 interacts with SUPT6H, CTD assembly factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IWS1 mRNA PMID:35307453 14225268 UHRF1 ubiquitin like with PHD and ring finger domains 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of UHRF1 mRNA] PMID:21852083 14225307 TUBA1B tubulin alpha 1b gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of TUBA1B mRNA] PMID:35839969 14225307 TUBA1B tubulin alpha 1b gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of TUBA1B mRNA PMID:35839969 14225307 TUBA1B tubulin alpha 1b gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of TUBA1B mRNA] PMID:35839969 14225328 KIF5C kinesin family member 5C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF5C mRNA PMID:35307453 14225372 GSPT1 G1 to S phase transition 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GSPT1 mRNA PMID:35307453 14225665 B4GALNT3 beta-1,4-N-acetyl-galactosaminyltransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of B4GALNT3 mRNA PMID:35307453 14225696 DSG3 desmoglein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DSG3 mRNA PMID:35307453 14225696 DSG3 desmoglein 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of DSG3 mRNA PMID:34933075 14225924 ISLR immunoglobulin superfamily containing leucine rich repeat gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ISLR mRNA PMID:35307453 14226011 LOC100623616 arylacetamide deacetylase-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AADAC mRNA PMID:35307453 14226032 DNASE1L2 deoxyribonuclease 1 like 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of DNASE1L2 mRNA PMID:34933075 14226049 GPR176 G protein-coupled receptor 176 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR176 mRNA PMID:35307453 14226076 CCDC141 coiled-coil domain containing 141 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC141 mRNA PMID:35307453 14226193 TIMP3 TIMP metallopeptidase inhibitor 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TIMP3 mRNA] PMID:21852083 14226211 CFTR CF transmembrane conductance regulator gene CHEBI:2639 amiloride increases activity EXP E RGD:6480464 20191114 CTD MESH:D000584 Amiloride results in increased activity of CFTR protein PMID:15246976 14226211 CFTR CF transmembrane conductance regulator gene CHEBI:27881 resveratrol increases activity EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased activity of CFTR protein PMID:24282612 14226211 CFTR CF transmembrane conductance regulator gene CHEBI:31429 colforsin daropate hydrochloride increases activity EXP E RGD:6480464 20191114 CTD MESH:D005576 Colforsin results in increased activity of CFTR protein PMID:15246976 14226277 MAP2K1 mitogen-activated protein kinase kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP2K1 mRNA PMID:37120089 14226277 MAP2K1 mitogen-activated protein kinase kinase 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C007262 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of MAP2K1 mRNA] PMID:37120089 14226277 MAP2K1 mitogen-activated protein kinase kinase 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of MAP2K1 mRNA] PMID:37120089 14226351 SNRPA small nuclear ribonucleoprotein polypeptide A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPA mRNA PMID:35307453 14226359 SH2D4B SH2 domain containing 4B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SH2D4B mRNA PMID:35307453 14226376 AIFM3 apoptosis inducing factor mitochondria associated 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AIFM3 mRNA PMID:35307453 14226425 GRIP2 glutamate receptor interacting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRIP2 mRNA PMID:35307453 14226550 TP53RK TP53 regulating kinase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TP53RK mRNA PMID:35307453 14226570 PTDSS2 phosphatidylserine synthase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTDSS2 mRNA PMID:35307453 14226657 TGFB2 transforming growth factor beta 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TGFB2 mRNA PMID:35307453 14226657 TGFB2 transforming growth factor beta 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TGFB2 mRNA PMID:21852083 14226897 TMEM45B transmembrane protein 45B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM45B mRNA PMID:35307453 14226921 MRPL34 mitochondrial ribosomal protein L34 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MRPL34 mRNA PMID:39265697 14226953 SRRM3 serine/arginine repetitive matrix 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SRRM3 mRNA PMID:35307453 14227063 NUF2 NUF2 component of NDC80 kinetochore complex gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUF2 mRNA PMID:35307453 14227063 NUF2 NUF2 component of NDC80 kinetochore complex gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of NUF2 mRNA] PMID:21852083 14227098 PELI3 pellino E3 ubiquitin protein ligase family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PELI3 mRNA PMID:35307453 14227149 FMO4 flavin containing dimethylaniline monoxygenase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FMO4 mRNA PMID:35307453 14227262 SLC25A34 solute carrier family 25 member 34 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A34 mRNA PMID:35307453 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of IL1B mRNA; deoxynivalenol results in increased expression of IL1B protein PMID:19027837|PMID:23326479|PMID:23688591|PMID:32783910|PMID:37120089 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]; deoxynivalenol promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of IL1B protein]; Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of IL1B protein] PMID:19027837|PMID:23688591|PMID:32783910|PMID:36309173|PMID:37120089 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of IL1B mRNA; Zearalenone results in increased expression of IL1B protein PMID:23688591|PMID:30270565|PMID:32783910|PMID:34933075 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of IL1B protein]; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of IL1B mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; Zearalenone results in decreased expression of and results in decreased secretion of IL1B protein; Zearalenone results in increased expression of and results in increased secretion of IL1B protein PMID:23688591|PMID:23727178|PMID:30270565|PMID:32783910 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:135949 ambrisentan decreases expression EXP E RGD:6480464 20191114 CTD MESH:C467894 ambrisentan results in decreased expression of IL1B mRNA PMID:16364719 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in increased expression of IL1B protein] PMID:36281498 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of IL1B mRNA PMID:38438008 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B protein]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA] PMID:38438008 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20231031 CTD MESH:D008070 Lipopolysaccharides results in increased expression of IL1B mRNA PMID:37271275 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008070 [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] PMID:37271275 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D008550 Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein] PMID:37120089 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C026166 [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] PMID:37271275|PMID:38438008 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased secretion of IL1B protein] PMID:38154151 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:188567 Belnacasan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C520022 belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein] PMID:36309173 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B protein PMID:33592257|PMID:34416349 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:229959 mogroside V increases expression EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V results in increased expression of IL1B mRNA PMID:35134483 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of IL1B mRNA PMID:12481301 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of IL1B mRNA; Mycotoxins results in increased expression of IL1B protein PMID:39137830 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of IL1B mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of IL1B protein] PMID:39137830 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of IL1B mRNA] PMID:32280687 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of IL1B mRNA; Glyphosate results in increased expression of IL1B protein PMID:35388968|PMID:36584959 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:27744 glyphosate increases secretion EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased secretion of IL1B protein PMID:35388968 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL1B mRNA] PMID:35388968 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20240604 CTD MESH:C059514 Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] PMID:37955343 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20200114 CTD MESH:D020106 Acrylamide results in increased expression of IL1B protein PMID:31302221 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of IL1B protein] PMID:36281498 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of IL1B mRNA PMID:21391292 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of IL1B mRNA PMID:22533443 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of IL1B mRNA] PMID:32280687 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of IL1B mRNA; bisphenol A results in increased expression of IL1B protein PMID:29558425|PMID:37108405|PMID:38154151 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:33216 bisphenol A increases secretion EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased secretion of IL1B protein PMID:38154151 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased secretion of IL1B protein]; Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL1B mRNA] PMID:37108405|PMID:38154151 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D016264 Dextran Sulfate results in increased expression of IL1B mRNA PMID:30270565 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016264 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of IL1B mRNA; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of IL1B mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA] PMID:30270565 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of IL1B mRNA PMID:36615853 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D019287 Zinc Sulfate inhibits the reaction [Diquat results in increased expression of IL1B mRNA] PMID:32280687 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of IL1B mRNA PMID:33626375 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B protein PMID:33592257|PMID:34416349 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of IL1B mRNA] PMID:27079946 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of IL1B mRNA PMID:23688591|PMID:37955343|PMID:38705344 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] PMID:23688591|PMID:36309173|PMID:37955343|PMID:38705344 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of IL1B mRNA] PMID:37108405 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:4948 Evodiamine decreases expression EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in decreased expression of IL1B mRNA PMID:39305878 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL1B mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL1B protein] PMID:39305878 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:64163 diquat increases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in increased expression of IL1B mRNA PMID:32280687 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in increased expression of IL1B mRNA]; Zinc Sulfate inhibits the reaction [Diquat results in increased expression of IL1B mRNA] PMID:32280687 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of IL1B mRNA PMID:23688591 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of IL1B mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of IL1B mRNA PMID:23688591 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of IL1B protein PMID:36281498 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of IL1B protein]; Taurine inhibits the reaction [ochratoxin A results in increased expression of IL1B protein] PMID:36281498 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of IL1B mRNA PMID:29421334 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:78782 pyrrolidine dithiocarbamate multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020972 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL1B mRNA] PMID:35388968 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of IL1B mRNA PMID:21176401 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases secretion EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased secretion of IL1B protein PMID:21176401 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:90705 SB 203580 multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C093642 [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B protein] PMID:37271275|PMID:38438008 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of IL1B mRNA; T-2 Toxin results in increased expression of IL1B protein PMID:39305878 14227286 LOC110258578 interleukin-1 beta-like gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL1B mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of IL1B protein] PMID:39305878 14227311 EFHB EF-hand domain family member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFHB mRNA PMID:35307453 14227338 CDK3 cyclin dependent kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDK3 mRNA PMID:35307453 14227365 PI16 peptidase inhibitor 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PI16 mRNA PMID:35307453 14227533 CHRM1 cholinergic receptor muscarinic 1 gene CHEBI:8247 pirenzepine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010890 Pirenzepine inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM1 protein] PMID:8744975 14227565 EPB41L4A erythrocyte membrane protein band 4.1 like 4A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPB41L4A mRNA PMID:35307453 14227603 SI sucrase-isomaltase gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA PMID:28445388 14227603 SI sucrase-isomaltase gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA PMID:28445388 14227603 SI sucrase-isomaltase gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA PMID:28445388 14227603 SI sucrase-isomaltase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA PMID:28445388 14227603 SI sucrase-isomaltase gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of SI mRNA PMID:28445388 14227786 EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of EIF4EBP1 protein modified form PMID:16099139 14227786 EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF4EBP1 mRNA PMID:35307453 14227786 EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 gene CHEBI:8772 raloxifene decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in decreased phosphorylation of EIF4EBP1 protein PMID:17348974 14227849 RBM22 RNA binding motif protein 22 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM22 mRNA PMID:35307453 14227914 SPRED3 sprouty related EVH1 domain containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPRED3 mRNA PMID:35307453 14227948 ARHGAP6 Rho GTPase activating protein 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGAP6 mRNA PMID:35307453 14227977 GRIN3B glutamate ionotropic receptor NMDA type subunit 3B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRIN3B mRNA PMID:35307453 14228039 DHX36 DEAH-box helicase 36 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DHX36 mRNA PMID:35307453 14228248 ANKDD1B ankyrin repeat and death domain containing 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKDD1B mRNA PMID:35307453 14228427 ADRB2 adrenoceptor beta 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADRB2 mRNA PMID:35307453 14228574 PLAAT3 phospholipase A and acyltransferase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLAAT3 mRNA PMID:35307453 14228599 GPR15LG G protein-coupled receptor 15 ligand gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR15LG mRNA PMID:35307453 14228650 TMEM117 transmembrane protein 117 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM117 mRNA PMID:35307453 14228650 TMEM117 transmembrane protein 117 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM117 mRNA PMID:21852083 14228690 GRPEL1 GrpE like 1, mitochondrial gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GRPEL1 mRNA PMID:35307453 14228752 BCL2L11 BCL2 like 11 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL2L11 mRNA PMID:33891997 14228752 BCL2L11 BCL2 like 11 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL2L11 mRNA PMID:33891997 14228827 CEACAM20 CEA cell adhesion molecule 20 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEACAM20 mRNA PMID:35307453 14228915 INHBA inhibin subunit beta A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INHBA mRNA PMID:35307453 14228915 INHBA inhibin subunit beta A gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of INHBA mRNA PMID:25455459 14228915 INHBA inhibin subunit beta A gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of INHBA mRNA PMID:39265697 14228915 INHBA inhibin subunit beta A gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of INHBA mRNA] PMID:21852083 14229013 SERPINB11 serpin family B member 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERPINB11 mRNA PMID:35307453 14229013 SERPINB11 serpin family B member 11 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SERPINB11 mRNA PMID:34933075 14229098 JAK2 Janus kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of JAK2 mRNA PMID:35307453 14229098 JAK2 Janus kinase 2 gene CHEBI:50131 5-aza-2'-deoxycytidine decreases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in decreased phosphorylation of JAK2 protein PMID:30923867 14229098 JAK2 Janus kinase 2 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of JAK2 protein] PMID:30923867 14229098 JAK2 Janus kinase 2 gene CHEBI:7719 ochratoxin A increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased phosphorylation of JAK2 protein PMID:30923867 14229098 JAK2 Janus kinase 2 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of JAK2 protein] PMID:30923867 14229154 KEL Kell metallo-endopeptidase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KEL mRNA PMID:35307453 14229180 RAB11FIP4 RAB11 family interacting protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB11FIP4 mRNA PMID:35307453 14229321 H1-2 H1.2 linker histone, cluster member gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of H1-2 mRNA PMID:35307453 14229384 MAL mal, T cell differentiation protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAL mRNA PMID:35307453 14229475 PNKD PNKD metallo-beta-lactamase domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PNKD mRNA PMID:35307453 14229573 MYL4 myosin light chain 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYL4 mRNA PMID:35307453 14229643 HSPA8 heat shock protein family A (Hsp70) member 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA8 mRNA PMID:35307453 14229643 HSPA8 heat shock protein family A (Hsp70) member 8 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of HSPA8 mRNA] PMID:39151877 14229643 HSPA8 heat shock protein family A (Hsp70) member 8 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of HSPA8 mRNA PMID:39151877 14229643 HSPA8 heat shock protein family A (Hsp70) member 8 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of HSPA8 mRNA] PMID:39151877 14229656 PNCK pregnancy up-regulated nonubiquitous CaM kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PNCK mRNA PMID:35307453 14229656 PNCK pregnancy up-regulated nonubiquitous CaM kinase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PNCK mRNA PMID:39265697 14229673 DBH dopamine beta-hydroxylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DBH mRNA PMID:35307453 14229673 DBH dopamine beta-hydroxylase gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of DBH protein PMID:29888781 14229730 TFF2 trefoil factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of TFF2 mRNA PMID:30854615 14229730 TFF2 trefoil factor 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of TFF2 mRNA PMID:25455459 14229788 FXYD2 FXYD domain containing ion transport regulator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FXYD2 mRNA PMID:35307453 14229812 CEBPZ CCAAT enhancer binding protein zeta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEBPZ mRNA PMID:35307453 14230004 SULT2A1 sulfotransferase family 2A member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SULT2A1 mRNA PMID:35307453 14230004 SULT2A1 sulfotransferase family 2A member 1 gene CHEBI:223316 (+)-artemisinin decreases expression EXP E RGD:6480464 20241001 CTD MESH:C031327 artemisinin results in decreased expression of SULT2A1 mRNA PMID:24333270 14230004 SULT2A1 sulfotransferase family 2A member 1 gene CHEBI:6358 lactucin increases expression EXP E RGD:6480464 20241001 CTD MESH:C516715 lactucin results in increased expression of SULT2A1 mRNA PMID:24333270 14230004 SULT2A1 sulfotransferase family 2A member 1 gene CHEBI:9055 scoparone decreases expression EXP E RGD:6480464 20241001 CTD MESH:C018145 scoparone results in decreased expression of SULT2A1 mRNA PMID:24333270 14230004 SULT2A1 sulfotransferase family 2A member 1 gene CHEBI:9171 skatole decreases expression EXP E RGD:6480464 20241001 CTD MESH:D012862 Skatole results in decreased expression of SULT2A1 mRNA PMID:24333270 14230024 SERINC1 serine incorporator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERINC1 mRNA PMID:35307453 14230086 CALML4 calmodulin like 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CALML4 mRNA PMID:35307453 14230245 TSPYL2 TSPY like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPYL2 mRNA PMID:35307453 14230298 PKP1 plakophilin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKP1 mRNA PMID:35307453 14230321 CHD1 chromodomain helicase DNA binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHD1 mRNA PMID:35307453 14230380 AGT angiotensinogen gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGT mRNA PMID:35307453 14230380 AGT angiotensinogen gene CHEBI:149906 Tanshinone I multiple interactions EXP E RGD:6480464 20200602 CTD MESH:C021751 tanshinone inhibits the reaction [AGT protein results in decreased expression of NOS3 mRNA]; tanshinone inhibits the reaction [AGT protein results in decreased expression of NOS3 protein] PMID:17717927 14230380 AGT angiotensinogen gene CHEBI:16480 nitric oxide affects activity EXP E RGD:6480464 20191114 CTD MESH:D009569 Nitric Oxide affects the activity of AGT protein PMID:21127344 14230380 AGT angiotensinogen gene CHEBI:17026 progesterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D011374 AGT protein results in increased secretion of Progesterone PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:17650 cortisol increases secretion EXP E RGD:6480464 20191114 CTD MESH:D006854 AGT protein results in increased secretion of Hydrocortisone PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:17650 cortisol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D006854 D-Ala(2),MePhe(4),Met(0)-ol-enkephalin promotes the reaction [AGT protein results in increased secretion of Hydrocortisone] PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:27584 aldosterone increases secretion EXP E RGD:6480464 20191114 CTD MESH:D000450 AGT protein results in increased secretion of Aldosterone PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:27584 aldosterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000450 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [AGT protein results in increased secretion of Aldosterone]; Enkephalin, D-Penicillamine (2,5)- inhibits the reaction [AGT protein results in increased secretion of Aldosterone] PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein] PMID:17105827 14230380 AGT angiotensinogen gene CHEBI:4784 enalapril affects activity EXP E RGD:6480464 20191114 CTD MESH:D004656 Enalapril affects the activity of AGT protein PMID:21127344 14230380 AGT angiotensinogen gene CHEBI:49662 indometacin affects activity EXP E RGD:6480464 20191114 CTD MESH:D007213 Indomethacin affects the activity of AGT protein PMID:21127344 14230380 AGT angiotensinogen gene CHEBI:59877 enalaprilat dihydrate decreases activity EXP E RGD:6480464 20191114 CTD MESH:D015773 Enalaprilat results in decreased activity of AGT protein modified form PMID:7890486 14230380 AGT angiotensinogen gene CHEBI:6541 losartan affects activity EXP E RGD:6480464 20191114 CTD MESH:D019808 Losartan affects the activity of AGT protein PMID:21127344 14230380 AGT angiotensinogen gene CHEBI:73356 DPDPE multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020881 Enkephalin, D-Penicillamine (2,5)- inhibits the reaction [AGT protein results in increased secretion of Aldosterone] PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:73358 U50488 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019900 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [AGT protein results in increased secretion of Aldosterone] PMID:22100847 14230380 AGT angiotensinogen gene CHEBI:9927 valsartan decreases activity EXP E RGD:6480464 20191114 CTD MESH:C081489 Valsartan results in decreased activity of AGT protein modified form PMID:7890486 14230468 CPNE4 copine 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CPNE4 mRNA PMID:35307453 14230498 FABP3 fatty acid binding protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FABP3 mRNA PMID:35307453 14230555 LRFN5 leucine rich repeat and fibronectin type III domain containing 5 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of LRFN5 mRNA PMID:34933075 14230635 CKAP2 cytoskeleton associated protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of CKAP2 mRNA; deoxynivalenol results in increased expression of CKAP2 protein PMID:38403181 14230658 SNRPB small nuclear ribonucleoprotein polypeptides B and B1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRPB mRNA PMID:35307453 14230679 NIM1K NIM1 serine/threonine protein kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NIM1K mRNA PMID:35307453 14230760 CD9 CD9 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD9 mRNA PMID:35307453 14230772 ZEB1 zinc finger E-box binding homeobox 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZEB1 mRNA PMID:35307453 14230772 ZEB1 zinc finger E-box binding homeobox 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ZEB1 mRNA PMID:34933075 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VEGFA mRNA PMID:35307453 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of VEGFA protein PMID:39486568 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in increased expression of VEGFA mRNA PMID:15089098 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017947 bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; R 59949 promotes the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; sodium arsenite results in increased expression of and results in increased secretion of VEGFA protein PMID:15089098 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of VEGFA protein PMID:20172683 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:41072 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C070515 bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA] PMID:15089098 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:49668 gefitinib multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C419708 Gefitinib inhibits the reaction [VEGFA protein results in increased phosphorylation of FES protein] PMID:19885553 14230826 VEGFA vascular endothelial growth factor A gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of VEGFA protein PMID:39486568 14230841 CRTAP cartilage associated protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRTAP mRNA PMID:35307453 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP2A19 mRNA PMID:35307453 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:27510 umbelliferone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031477 2-aminoacetophenone inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin]; [CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin; Skatole inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin] PMID:30599194 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:28794 coumarin increases hydroxylation EXP E RGD:6480464 20191114 CTD MESH:C030123 CYP2A19 protein results in increased hydroxylation of coumarin PMID:30599194 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:28794 coumarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C030123 2-aminoacetophenone inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin]; 2-aminoacetophenone inhibits the reaction [CYP2A19 protein results in increased hydroxylation of coumarin]; [CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin; Skatole inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin]; Skatole inhibits the reaction [CYP2A19 protein results in increased hydroxylation of coumarin] PMID:30599194 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:6358 lactucin increases expression EXP E RGD:6480464 20241001 CTD MESH:C516715 lactucin results in increased expression of CYP2A19 mRNA PMID:24176340 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:91110 o-aminoacetophenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C055495 2-aminoacetophenone inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin]; 2-aminoacetophenone inhibits the reaction [CYP2A19 protein results in increased hydroxylation of coumarin] PMID:30599194 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:9171 skatole increases hydroxylation EXP E RGD:6480464 20191114 CTD MESH:D012862 CYP2A19 protein results in increased hydroxylation of Skatole PMID:30599194 14230852 CYP2A19 cytochrome P450 family 2 subfamily A member 19 gene CHEBI:9171 skatole multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012862 Skatole inhibits the reaction [[CYP2A19 protein results in increased hydroxylation of coumarin] which results in increased chemical synthesis of 7-hydroxycoumarin]; Skatole inhibits the reaction [CYP2A19 protein results in increased hydroxylation of coumarin] PMID:30599194 14231010 PRR15L proline rich 15 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRR15L mRNA PMID:35307453 14231031 LAMC2 laminin subunit gamma 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of LAMC2 mRNA PMID:38403181 14231031 LAMC2 laminin subunit gamma 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of LAMC2 protein PMID:9302645 14231177 CAPSL calcyphosine like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPSL mRNA PMID:35307453 14231177 CAPSL calcyphosine like gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CAPSL mRNA PMID:21852083 14231228 MKRN2OS MKRN2 opposite strand gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of MKRN2OS mRNA PMID:39265697 14231339 DAG1 dystroglycan 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DAG1 mRNA PMID:35307453 14231397 ZC3HC1 zinc finger C3HC-type containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZC3HC1 mRNA PMID:35307453 14231437 TMEM141 transmembrane protein 141 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM141 mRNA PMID:35307453 14231468 INPP5A inositol polyphosphate-5-phosphatase A gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of INPP5A mRNA PMID:39265697 14231641 MTAP methylthioadenosine phosphorylase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTAP mRNA PMID:35307453 14231654 TRIP4 thyroid hormone receptor interactor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIP4 mRNA PMID:35307453 14231748 C4H8orf82 chromosome 4 C8orf82 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in increased expression of C4H8ORF82 mRNA PMID:35307453 14231755 SPRY3 sprouty RTK signaling antagonist 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPRY3 mRNA PMID:35307453 14231765 RHBDF1 rhomboid 5 homolog 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RHBDF1 mRNA PMID:35307453 14231822 SPA17 sperm autoantigenic protein 17 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPA17 mRNA PMID:35307453 14231855 GAL galanin and GMAP prepropeptide gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A affects the expression of GAL protein PMID:29577965 14231855 GAL galanin and GMAP prepropeptide gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of GAL protein PMID:29558425|PMID:29569701|PMID:29888781|PMID:38069115 14231896 NEIL3 nei like DNA glycosylase 3 gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of NEIL3 mRNA PMID:30923867 14231896 NEIL3 nei like DNA glycosylase 3 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA] PMID:30923867 14231896 NEIL3 nei like DNA glycosylase 3 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of NEIL3 mRNA PMID:30923867 14231896 NEIL3 nei like DNA glycosylase 3 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA] PMID:30923867 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFAM mRNA PMID:33592257 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of TFAM mRNA PMID:28819136 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFAM mRNA PMID:33592257 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in decreased expression of TFAM mRNA PMID:38705344 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in decreased expression of TFAM mRNA] PMID:38705344 14231974 TFAM transcription factor A, mitochondrial gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of TFAM protein PMID:27993529 14232082 GUCY1B1 guanylate cyclase 1 soluble subunit beta 1 gene CHEBI:142433 cinaciguat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C480588 BAY 58-2667 inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1B1 protein] PMID:19466990 14232082 GUCY1B1 guanylate cyclase 1 soluble subunit beta 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of GUCY1B1 mRNA PMID:18988085 14232082 GUCY1B1 guanylate cyclase 1 soluble subunit beta 1 gene CHEBI:28783 zinc protoporphyrin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017803 zinc protoporphyrin inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1B1 protein] PMID:19466990 14232082 GUCY1B1 guanylate cyclase 1 soluble subunit beta 1 gene CHEBI:91215 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one increases degradation EXP E RGD:6480464 20191114 CTD MESH:C095284 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1B1 protein PMID:19466990 14232082 GUCY1B1 guanylate cyclase 1 soluble subunit beta 1 gene CHEBI:91215 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C095284 BAY 58-2667 inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1B1 protein]; zinc protoporphyrin inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1B1 protein] PMID:19466990 14232263 HAAO 3-hydroxyanthranilate 3,4-dioxygenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HAAO mRNA PMID:35307453 14232535 PRPS1 phosphoribosyl pyrophosphate synthetase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRPS1 mRNA PMID:35307453 14232613 INPP5D inositol polyphosphate-5-phosphatase D gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of INPP5D mRNA PMID:39265697 14232647 FST follistatin gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of FST mRNA PMID:25455459 14232690 PDZRN3 PDZ domain containing ring finger 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PDZRN3 mRNA PMID:35307453 14232707 LOC100512656 retinol dehydrogenase 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RDH16 mRNA PMID:35307453 14232782 CES3 carboxylesterase 3 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CES3 mRNA PMID:39265697 14232782 CES3 carboxylesterase 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of CES3 mRNA PMID:21852083 14232799 DCUN1D5 defective in cullin neddylation 1 domain containing 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCUN1D5 mRNA PMID:35307453 14232864 ITGA3 integrin subunit alpha 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA3 mRNA PMID:38403181 14232864 ITGA3 integrin subunit alpha 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ITGA3 mRNA PMID:35307453 14233047 ARPC5 actin related protein 2/3 complex subunit 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARPC5 mRNA PMID:35307453 14233053 TM4SF1 transmembrane 4 L six family member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TM4SF1 mRNA PMID:35307453 14233205 MMD2 monocyte to macrophage differentiation associated 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MMD2 mRNA] PMID:21852083 14233305 SOX4 SRY-box transcription factor 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of SOX4 mRNA PMID:21852083 14233334 UBR7 ubiquitin protein ligase E3 component n-recognin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UBR7 mRNA PMID:35307453 14233421 COPS6 COP9 signalosome subunit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COPS6 mRNA PMID:35307453 14233592 BLZF1 basic leucine zipper nuclear factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BLZF1 mRNA PMID:35307453 14233712 RRAS RAS related gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRAS mRNA PMID:35307453 14233914 ADAMTSL1 ADAMTS like 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADAMTSL1 mRNA PMID:34933075 14233956 FHOD1 formin homology 2 domain containing 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FHOD1 mRNA PMID:39265697 14234159 SLA-DRA MHC class II DR-alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DRA mRNA PMID:35307453 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin affects the reaction [Copper Sulfate results in decreased expression of HSD3B1 mRNA] PMID:39151877 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:177470 Cloprostenol increases expression EXP E RGD:6480464 20210907 CTD MESH:D003008 Cloprostenol results in increased expression of HSD3B1 mRNA PMID:15713365 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of HSD3B1 mRNA PMID:39151877 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin affects the reaction [Copper Sulfate results in decreased expression of HSD3B1 mRNA] PMID:39151877 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of HSD3B1 mRNA PMID:29544186 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A promotes the reaction [fisetin results in decreased expression of HSD3B1 mRNA]; fisetin promotes the reaction [bisphenol A results in decreased expression of HSD3B1 mRNA] PMID:29544186 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:42567 fisetin decreases expression EXP E RGD:6480464 20191114 CTD MESH:C017875 fisetin results in decreased expression of HSD3B1 mRNA PMID:29544186 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:42567 fisetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C017875 bisphenol A promotes the reaction [fisetin results in decreased expression of HSD3B1 mRNA]; fisetin promotes the reaction [bisphenol A results in decreased expression of HSD3B1 mRNA] PMID:29544186 14234219 HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 gene CHEBI:6358 lactucin increases expression EXP E RGD:6480464 20241001 CTD MESH:C516715 lactucin results in increased expression of HSD3B1 mRNA PMID:24333270 14234252 TAT tyrosine aminotransferase gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TAT mRNA PMID:34933075 14234252 TAT tyrosine aminotransferase gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TAT mRNA PMID:39265697 14234252 TAT tyrosine aminotransferase gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of TAT mRNA PMID:21391292 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:10022 deoxynivalenol increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased phosphorylation of ERN1 protein PMID:38608924 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:146195 3-acetyldeoxynivalenol increases phosphorylation EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased phosphorylation of ERN1 protein PMID:37659622 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased phosphorylation of ERN1 protein] PMID:37659622 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of ERN1 mRNA] PMID:36584959 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERN1 protein PMID:33891997 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of ERN1 mRNA PMID:36584959 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of ERN1 mRNA] PMID:36584959 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:29865 benzo[a]pyrene increases phosphorylation EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased phosphorylation of ERN1 protein PMID:36754226 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of ERN1 protein] PMID:36754226 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ERN1 protein PMID:37108405 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ERN1 protein] PMID:37108405 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERN1 protein PMID:33891997 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of ERN1 protein] PMID:36754226 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ERN1 protein] PMID:37108405 14234278 ERN1 endoplasmic reticulum to nucleus signaling 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased phosphorylation of ERN1 protein] PMID:37659622 14234588 SPAG16 sperm associated antigen 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPAG16 mRNA PMID:35307453 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LTA4H mRNA PMID:35307453 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:27363 zinc atom decreases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in decreased activity of LTA4H protein PMID:21670530 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:27638 cobalt atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D003035 Cobalt results in increased activity of LTA4H protein PMID:21670530 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:30185 zinc(0) decreases activity EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in decreased activity of LTA4H protein PMID:21670530 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:4735 ethylenediaminetetraacetic acid decreases activity EXP E RGD:6480464 20230207 CTD MESH:D004492 Edetic Acid results in decreased activity of LTA4H protein PMID:21670530 14234668 LTA4H leukotriene A4 hydrolase gene CHEBI:7989 pepstatin A decreases activity EXP E RGD:6480464 20191114 CTD MESH:C031375 pepstatin results in decreased activity of LTA4H protein PMID:21670530 14234691 PIK3R2 phosphoinositide-3-kinase regulatory subunit 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIK3R2 mRNA PMID:35307453 14234847 APLN apelin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of APLN mRNA PMID:35307453 14234855 SLC44A5 solute carrier family 44 member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC44A5 mRNA PMID:35307453 14235026 PLEKHD1 pleckstrin homology and coiled-coil domain containing D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHD1 mRNA PMID:35307453 14235094 ERICH6 glutamate rich 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERICH6 mRNA PMID:35307453 14235126 TMTC1 transmembrane O-mannosyltransferase targeting cadherins 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMTC1 mRNA PMID:35307453 14235373 PTGR2 prostaglandin reductase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGR2 mRNA PMID:35307453 14235401 UTP18 UTP18 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP18 mRNA PMID:35307453 14235457 CACNA1I calcium voltage-gated channel subunit alpha1 I gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CACNA1I mRNA PMID:35307453 14235497 C1R complement C1r gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of C1R mRNA PMID:39265697 14235512 GBA1 glucosylceramidase beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230801 CTD MESH:C007262 deoxynivalenol results in decreased expression of GBA1 mRNA PMID:35307453 14235546 SLC1A6 solute carrier family 1 member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC1A6 mRNA PMID:35307453 14235774 CTSO cathepsin O gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSO mRNA PMID:35307453 14235831 IRF8 interferon regulatory factor 8 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of IRF8 mRNA PMID:21391292 14235895 CDK10 cyclin dependent kinase 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDK10 mRNA PMID:35307453 14235930 TPPP tubulin polymerization promoting protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPPP mRNA PMID:35307453 14236154 PSD pleckstrin and Sec7 domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSD mRNA PMID:35307453 14236176 LOC110259107 leucine-rich repeat-containing protein 40-like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC69 mRNA PMID:35307453 14236182 EMP2 epithelial membrane protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EMP2 mRNA PMID:35307453 14236221 GOLGA3 golgin A3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GOLGA3 mRNA PMID:35307453 14236256 PUS3 pseudouridine synthase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PUS3 mRNA PMID:35307453 14236396 AKR1C1 aldo-keto reductase family 1, member C1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250715 CTD MESH:C007262 deoxynivalenol results in decreased expression of AKR1C2 mRNA PMID:35307453 14236396 AKR1C1 aldo-keto reductase family 1, member C1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20250325 CTD MESH:D015025 Zearalenone results in decreased expression of AKR1C1 mRNA PMID:34933075 14236451 PKHD1 PKHD1 ciliary IPT domain containing fibrocystin/polyductin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKHD1 mRNA PMID:35307453 14236581 MAD1L1 mitotic arrest deficient 1 like 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MAD1L1 mRNA PMID:39265697 14236628 UNC13D unc-13 homolog D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of UNC13D mRNA PMID:35307453 14236832 FTL ferritin light chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FTL mRNA PMID:35307453 14236863 TTC29 tetratricopeptide repeat domain 29 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TTC29 mRNA PMID:35307453 14236991 PWP1 PWP1 homolog, endonuclein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PWP1 mRNA PMID:35307453 14237057 SLC9A5 solute carrier family 9 member A5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC9A5 mRNA PMID:35307453 14237057 SLC9A5 solute carrier family 9 member A5 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SLC9A5 mRNA PMID:34933075 14237100 NAV3 neuron navigator 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAV3 mRNA PMID:35307453 14237212 ADAMTSL5 ADAMTS like 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAMTSL5 mRNA PMID:35307453 14237275 ITIH4 inter-alpha-trypsin inhibitor heavy chain 4 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of ITIH4 mRNA PMID:21391292 14237425 SLC35D1 solute carrier family 35 member D1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC35D1 mRNA PMID:35307453 14237551 TSPO translocator protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPO mRNA PMID:35307453 14237604 TSPAN7 tetraspanin 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN7 mRNA PMID:35307453 14237835 DOCK11 dedicator of cytokinesis 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DOCK11 mRNA PMID:35307453 14237931 SYNC syncoilin, intermediate filament protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SYNC mRNA PMID:35307453 14238008 AMIGO1 adhesion molecule with Ig like domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AMIGO1 mRNA PMID:35307453 14238106 MXD1 MAX dimerization protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MXD1 mRNA PMID:35307453 14238151 TSC22D3 TSC22 domain family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSC22D3 mRNA PMID:35307453 14238184 TNC tenascin C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNC mRNA PMID:35307453 14238184 TNC tenascin C gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of TNC mRNA PMID:39265697 14238184 TNC tenascin C gene CHEBI:17224 4-methylumbelliferone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006923 Hymecromone results in decreased expression of TNC mRNA PMID:23139787 14238184 TNC tenascin C gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TNC mRNA PMID:18988085 14238184 TNC tenascin C gene CHEBI:6980 monocrotaline increases expression EXP E RGD:6480464 20191114 CTD MESH:D016686 Monocrotaline results in increased expression of TNC mRNA PMID:9251245 14238184 TNC tenascin C gene CHEBI:6980 monocrotaline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016686 1,3-dimethylthiourea inhibits the reaction [Monocrotaline results in increased expression of TNC mRNA] PMID:9251245 14238330 MFAP3L microfibril associated protein 3 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MFAP3L mRNA PMID:35307453 14238375 FAM162A family with sequence similarity 162 member A gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of FAM162A mRNA PMID:39265697 14238390 EMC2 ER membrane protein complex subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EMC2 mRNA PMID:35307453 14238475 NAT8L N-acetyltransferase 8 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NAT8L mRNA PMID:35307453 14238475 NAT8L N-acetyltransferase 8 like gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of NAT8L mRNA] PMID:39151877 14238475 NAT8L N-acetyltransferase 8 like gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of NAT8L mRNA PMID:39151877 14238475 NAT8L N-acetyltransferase 8 like gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of NAT8L mRNA] PMID:39151877 14238721 CWC27 CWC27 spliceosome associated cyclophilin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CWC27 mRNA PMID:35307453 14238751 MIGA2 mitoguardin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MIGA2 mRNA PMID:35307453 14238772 MTREX Mtr4 exosome RNA helicase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTREX mRNA PMID:35307453 14238820 FUCA2 alpha-L-fucosidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FUCA2 mRNA PMID:35307453 14238926 PLEKHN1 pleckstrin homology domain containing N1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLEKHN1 mRNA PMID:35307453 14238970 ULK1 unc-51 like autophagy activating kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ULK1 mRNA PMID:35307453 14239017 DLEC1 DLEC1 cilia and flagella associated protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DLEC1 mRNA PMID:35307453 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP3K5 mRNA PMID:35307453 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 [Oleanolic Acid co-treated with Hydrogen Peroxide] results in increased expression of MAP3K5 mRNA PMID:37706587 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of MAP3K5 mRNA] PMID:39151877 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of MAP3K5 mRNA PMID:39151877 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of MAP3K5 mRNA] PMID:39151877 14239150 MAP3K5 mitogen-activated protein kinase kinase kinase 5 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 [Oleanolic Acid co-treated with Hydrogen Peroxide] results in increased expression of MAP3K5 mRNA PMID:37706587 14239210 MPZL2 myelin protein zero like 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of MPZL2 mRNA] PMID:21852083 14239237 SLA-DQA1 MHC class II histocompatibility antigen SLA-DQA gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DQA1 mRNA PMID:35307453 14239329 ALOX15B arachidonate 15-lipoxygenase type B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALOX15B mRNA PMID:35307453 14239367 METTL25 methyltransferase like 25 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of METTL25 mRNA PMID:35307453 14239472 CASKIN1 CASK interacting protein 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CASKIN1 mRNA PMID:39265697 14239501 VSIG10 V-set and immunoglobulin domain containing 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VSIG10 mRNA PMID:35307453 14239657 SLC17A2 solute carrier family 17 member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC17A2 mRNA PMID:35307453 14239688 LLPH LLP homolog, long-term synaptic facilitation factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LLPH mRNA PMID:35307453 14239698 LOC100520401 CDGSH iron-sulfur domain-containing protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CISD1 mRNA PMID:35307453 14239718 DGKD diacylglycerol kinase delta gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DGKD mRNA PMID:35307453 14239840 GNAT1 G protein subunit alpha transducin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNAT1 mRNA PMID:35307453 14239951 BMP4 bone morphogenetic protein 4 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of BMP4 mRNA PMID:34389318 14240011 ABCG1 ATP binding cassette subfamily G member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ABCG1 mRNA PMID:35307453 14240079 SAMD11 sterile alpha motif domain containing 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SAMD11 mRNA PMID:35307453 14240270 ATF5 activating transcription factor 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ATF5 mRNA PMID:35307453 14240317 UBA1 ubiquitin like modifier activating enzyme 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBA1 mRNA PMID:35307453 14240363 LYAR Ly1 antibody reactive gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LYAR mRNA PMID:35307453 14240681 PRKD3 protein kinase D3 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of PRKD3 mRNA PMID:28069986 14240773 TSPAN9 tetraspanin 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN9 mRNA; deoxynivalenol results in decreased expression of TSPAN9 protein PMID:35307453|PMID:38403181 14240924 FAM171B family with sequence similarity 171 member B gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FAM171B mRNA PMID:39265697 14240979 TXNDC9 thioredoxin domain containing 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TXNDC9 mRNA PMID:35307453 14241044 NRF1 nuclear respiratory factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRF1 mRNA; deoxynivalenol results in decreased expression of NRF1 protein PMID:35307453 14241044 NRF1 nuclear respiratory factor 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRF1 mRNA PMID:33592257 14241044 NRF1 nuclear respiratory factor 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRF1 mRNA PMID:33592257 14241044 NRF1 nuclear respiratory factor 1 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of NRF1 protein PMID:27993529 14241221 POLR1B RNA polymerase I subunit B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR1B mRNA PMID:35307453 14241291 FASLG Fas ligand gene CHEBI:27899 cisplatin affects localization EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin affects the localization of FASLG protein PMID:20435919 14241291 FASLG Fas ligand gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Cilastatin inhibits the reaction [Cisplatin affects the localization of FASLG protein] PMID:20435919 14241291 FASLG Fas ligand gene CHEBI:3697 cilastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015377 Cilastatin inhibits the reaction [Cisplatin affects the localization of FASLG protein] PMID:20435919 14241418 MYCBPAP MYCBP associated protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYCBPAP mRNA PMID:35307453 14241456 TASP1 taspase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TASP1 mRNA PMID:35307453 14241573 PLK4 polo like kinase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PLK4 mRNA PMID:35307453 14241573 PLK4 polo like kinase 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PLK4 mRNA] PMID:21852083 14241615 FAM227B family with sequence similarity 227 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM227B mRNA PMID:35307453 14241831 NEURL3 neuralized E3 ubiquitin protein ligase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEURL3 mRNA PMID:35307453 14241893 MMD monocyte to macrophage differentiation associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MMD mRNA PMID:35307453 14241929 CACNA2D4 calcium voltage-gated channel auxiliary subunit alpha2delta 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CACNA2D4 mRNA PMID:35307453 14241969 NGFR nerve growth factor receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NGFR mRNA PMID:35307453 14241979 TRAF3IP2 TRAF3 interacting protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRAF3IP2 mRNA PMID:35307453 14242007 TEX2 testis expressed 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TEX2 mRNA PMID:35307453 14242023 LMF2 lipase maturation factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMF2 mRNA PMID:35307453 14242097 MAP2K4 mitogen-activated protein kinase kinase 4 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 [Oleanolic Acid co-treated with Hydrogen Peroxide] results in increased expression of MAP2K4 mRNA PMID:37706587 14242097 MAP2K4 mitogen-activated protein kinase kinase 4 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 [Oleanolic Acid co-treated with Hydrogen Peroxide] results in increased expression of MAP2K4 mRNA PMID:37706587 14242176 TMEM106A transmembrane protein 106A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM106A mRNA PMID:35307453 14242194 ZNF385D zinc finger protein 385D gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF385D mRNA PMID:35307453 14242216 SQOR sulfide quinone oxidoreductase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SQOR mRNA PMID:35307453 14242328 MARCHF3 membrane associated ring-CH-type finger 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MARCHF3 mRNA PMID:35307453 14242569 CST6 cystatin E/M gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CST6 mRNA PMID:35307453 14242576 FANCC FA complementation group C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FANCC mRNA PMID:35307453 14242604 GPATCH1 G-patch domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPATCH1 mRNA PMID:35307453 14242750 ARHGEF19 Rho guanine nucleotide exchange factor 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF19 mRNA PMID:35307453 14242841 GPD1L glycerol-3-phosphate dehydrogenase 1 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPD1L mRNA PMID:35307453 14242917 CREBL2 cAMP responsive element binding protein like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CREBL2 mRNA PMID:35307453 14243170 LOC110260809 rab-like protein 2A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RABL2B mRNA PMID:35307453 14243220 PTGDS prostaglandin D2 synthase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTGDS mRNA PMID:35307453 14243242 CCDC57 coiled-coil domain containing 57 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC57 mRNA PMID:35307453 14243326 CIDEB cell death inducing DFFA like effector b gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CIDEB mRNA PMID:35307453 14243348 PLTP phospholipid transfer protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLTP mRNA PMID:35307453 14243389 SERPINB2 serpin family B member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERPINB2 mRNA PMID:35307453 14243389 SERPINB2 serpin family B member 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of SERPINB2 mRNA PMID:34933075 14243389 SERPINB2 serpin family B member 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SERPINB2 mRNA PMID:39265697 14243389 SERPINB2 serpin family B member 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SERPINB2 mRNA PMID:21852083 14243414 SCFD1 sec1 family domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCFD1 mRNA PMID:35307453 14243506 CFAP276 cilia and flagella associated protein 276 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP276 mRNA PMID:35307453 14243740 EVC EvC ciliary complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EVC mRNA PMID:35307453 14243802 PARVA parvin alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PARVA mRNA PMID:35307453 14243865 AAMDC adipogenesis associated Mth938 domain containing gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AAMDC mRNA PMID:35307453 14243865 AAMDC adipogenesis associated Mth938 domain containing gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of AAMDC mRNA PMID:39265697 14243874 MESP1 mesoderm posterior bHLH transcription factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MESP1 mRNA PMID:35307453 14243886 CELA2A chymotrypsin-like elastase family, member 2A gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250715 CTD MESH:C000628730 graphene oxide results in decreased expression of CELA2A mRNA PMID:39265697 14243944 MRPL35 mitochondrial ribosomal protein L35 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL35 mRNA PMID:35307453 14244093 RHCG Rh family C glycoprotein gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of RHCG mRNA PMID:34933075 14244164 SPACA9 sperm acrosome associated 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPACA9 mRNA PMID:35307453 14244259 CCPG1 cell cycle progression 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCPG1 mRNA PMID:35307453 14244313 CNNM2 cyclin and CBS domain divalent metal cation transport mediator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNNM2 mRNA PMID:35307453 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of CXCL8 protein PMID:26417708 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CXCL8 mRNA; deoxynivalenol results in increased expression of CXCL8 protein PMID:23326479|PMID:23688591|PMID:25701311|PMID:27915442|PMID:33817499|PMID:35307453|PMID:35314294|PMID:37257635|PMID:37442268 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; deoxynivalenol promotes the reaction [nivalenol results in increased expression of CXCL8 mRNA]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA] PMID:23688591|PMID:27915442|PMID:30708112|PMID:33817499|PMID:37442268 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10106 zearalenone decreases secretion EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased secretion of CXCL8 protein PMID:21763767 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CXCL8 mRNA PMID:23688591|PMID:34933075 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA PMID:23688591 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:114786 sodium disulfite multiple interactions EXP E RGD:6480464 20220906 CTD MESH:C005200 sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA] PMID:33817499 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of CXCL8 mRNA PMID:39265697 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:15553 prostaglandin F2alpha increases expression EXP E RGD:6480464 20191114 CTD MESH:D015237 Dinoprost results in increased expression of CXCL8 mRNA PMID:21505051 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 [Dinoprost co-treated with epostane] results in increased expression of CXCL8 mRNA PMID:21505051 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:16112 chlorogenic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002726 Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CXCL8 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA] PMID:27861533 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of CXCL8 mRNA PMID:22083491 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of CXCL8 mRNA PMID:26180592|PMID:27861533 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:16412 lipopolysaccharide increases secretion EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased secretion of CXCL8 protein PMID:15912099 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; [deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CXCL8 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; Lipopolysaccharides results in increased expression of and results in increased secretion of CXCL8 protein PMID:26180592|PMID:27861533|PMID:30708112 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:174984 3',4',5'-Trimethoxyflavone multiple interactions EXP E RGD:6480464 20210706 CTD MESH:C441202 3',4',5'-trimethoxyflavone analog inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA] PMID:26180592 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:18388 apigenin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D047310 Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA] PMID:26180592 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CXCL8 mRNA PMID:33891997 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CXCL8 mRNA PMID:12481301|PMID:18988085|PMID:27617619 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein] PMID:37442268 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of CXCL8 mRNA PMID:35388968 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of CXCL8 mRNA] PMID:35388968 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of CXCL8 mRNA PMID:21391292 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of CXCL8 mRNA PMID:22533443 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:3084 bethanechol increases expression EXP E RGD:6480464 20230704 CTD MESH:D018723 Bethanechol results in increased expression of CXCL8 mRNA PMID:29380034 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of CXCL8 mRNA PMID:33626375 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CXCL8 mRNA PMID:33891997 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein] PMID:37442268 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D013755 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of CXCL8 protein PMID:15912099 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20191114 CTD MESH:C056933 fumonisin B1 results in increased expression of CXCL8 mRNA PMID:23688591|PMID:30708112 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA] PMID:23688591|PMID:30708112 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:63954 ionomycin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015759 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of CXCL8 protein PMID:15912099 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:7599 Nivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C038405 nivalenol results in increased expression of CXCL8 mRNA PMID:23688591|PMID:27915442 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:7599 Nivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C038405 [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone] results in increased expression of CXCL8 mRNA; deoxynivalenol promotes the reaction [nivalenol results in increased expression of CXCL8 mRNA] PMID:23688591|PMID:27915442 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:77732 cadmium nitrate affects expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the expression of CXCL8 mRNA PMID:29421334 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:77732 cadmium nitrate affects secretion EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate affects the secretion of CXCL8 protein PMID:29421334 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:78782 pyrrolidine dithiocarbamate multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020972 pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of CXCL8 mRNA] PMID:35388968 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased expression of CXCL8 mRNA PMID:21176401 14244462 CXCL8 C-X-C motif chemokine ligand 8 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one decreases secretion EXP E RGD:6480464 20191114 CTD MESH:C432165 pyrazolanthrone results in decreased secretion of CXCL8 protein PMID:21176401 14244470 SLIT2 slit guidance ligand 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of SLIT2 mRNA PMID:34389318 14244621 PPOX protoporphyrinogen oxidase gene CHEBI:73172 acifluorfen decreases activity EXP E RGD:6480464 20191114 CTD MESH:C018425 acifluorfen results in decreased activity of PPOX protein PMID:7697001 14244728 SLC37A1 solute carrier family 37 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC37A1 mRNA PMID:35307453 14244779 PIGT phosphatidylinositol glycan anchor biosynthesis class T gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PIGT mRNA PMID:35307453 14244798 MASP2 MBL associated serine protease 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MASP2 mRNA PMID:35307453 14245524 ONECUT2 one cut homeobox 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ONECUT2 mRNA PMID:35307453 14245546 NOS1 nitric oxide synthase 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of NOS1 protein PMID:38069115 14245619 PARPBP PARP1 binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PARPBP mRNA PMID:35307453 14245639 MMP14 matrix metallopeptidase 14 gene CHEBI:16240 hydrogen peroxide increases expression EXP E RGD:6480464 20240604 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of MMP14 mRNA PMID:37706587 14245639 MMP14 matrix metallopeptidase 14 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D006861 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP14 mRNA] PMID:37706587 14245639 MMP14 matrix metallopeptidase 14 gene CHEBI:28748 doxorubicin increases activity EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased activity of MMP14 protein PMID:19782292 14245639 MMP14 matrix metallopeptidase 14 gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20191114 CTD MESH:D004317 Doxorubicin results in increased expression of MMP14 mRNA PMID:19782292 14245639 MMP14 matrix metallopeptidase 14 gene CHEBI:37659 oleanolic acid multiple interactions EXP E RGD:6480464 20240604 CTD MESH:D009828 Oleanolic Acid inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP14 mRNA] PMID:37706587 14245706 XPA XPA, DNA damage recognition and repair factor gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in decreased expression of XPA mRNA PMID:14994279 14245787 SREBF2 sterol regulatory element binding transcription factor 2 gene CHEBI:49040 ezetimibe increases expression EXP E RGD:6480464 20191114 CTD MESH:D000069438 Ezetimibe results in increased expression of SREBF2 mRNA PMID:17130282 14245787 SREBF2 sterol regulatory element binding transcription factor 2 gene CHEBI:49040 ezetimibe multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000069438 Simvastatin promotes the reaction [Ezetimibe results in increased expression of SREBF2 mRNA] PMID:17130282 14245787 SREBF2 sterol regulatory element binding transcription factor 2 gene CHEBI:9150 simvastatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019821 Simvastatin promotes the reaction [Ezetimibe results in increased expression of SREBF2 mRNA] PMID:17130282 14245817 DPF2 double PHD fingers 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DPF2 mRNA PMID:35307453 14245927 MARCHF7 membrane associated ring-CH-type finger 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MARCHF7 mRNA PMID:35307453 14246074 HNRNPH3 heterogeneous nuclear ribonucleoprotein H3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HNRNPH3 mRNA PMID:35307453 14246156 ZFYVE19 zinc finger FYVE-type containing 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZFYVE19 mRNA PMID:35307453 14246185 GPRASP2 G protein-coupled receptor associated sorting protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPRASP2 mRNA PMID:35307453 14246351 TCF7 transcription factor 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TCF7 mRNA PMID:35307453 14246397 MAP1S microtubule associated protein 1S gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP1S mRNA PMID:35307453 14246397 MAP1S microtubule associated protein 1S gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of MAP1S mRNA PMID:28069986 14246413 ZNFX1 zinc finger NFX1-type containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNFX1 mRNA PMID:35307453 14246477 CEP162 centrosomal protein 162 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP162 mRNA PMID:35307453 14246652 GPR75 G protein-coupled receptor 75 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPR75 mRNA PMID:35307453 14246833 CRP C-reactive protein, pentraxin-related gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRP protein PMID:25701311 14246833 CRP C-reactive protein, pentraxin-related gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased expression of CRP protein PMID:21575630 14246896 BEX4 brain expressed X-linked 4 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of BEX4 mRNA] PMID:21852083 14246903 TFPI tissue factor pathway inhibitor gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TFPI mRNA PMID:21852083 14246979 TLR5 toll like receptor 5 gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of TLR5 mRNA PMID:29421334 14246999 SHLD2 shieldin complex subunit 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SHLD2 mRNA PMID:21852083 14247034 MYOM3 myomesin 3 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of MYOM3 mRNA PMID:35307453 14247205 AK8 adenylate kinase 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AK8 mRNA PMID:35307453 14247253 INHA inhibin subunit alpha gene CHEBI:31767 lead diacetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C008261 lead acetate results in decreased expression of and results in decreased secretion of [INHBB protein binds to INHA protein] PMID:29273543 14247357 FTSJ3 FtsJ RNA 2'-O-methyltransferase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FTSJ3 mRNA PMID:35307453 14247572 SEMA3A semaphorin 3A gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of SEMA3A mRNA PMID:35307453 14247615 PAK1IP1 PAK1 interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PAK1IP1 mRNA PMID:35307453 14247764 SERTAD1 SERTA domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SERTAD1 mRNA PMID:35307453 14247971 RSAD2 radical S-adenosyl methionine domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of RSAD2 mRNA; deoxynivalenol results in decreased expression of RSAD2 protein PMID:38403181 14248022 DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNTTIP2 mRNA PMID:35307453 14248033 LOC396867 stefin A8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSTA mRNA PMID:35307453 14248176 TNNT2 troponin T2, cardiac type gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20210504 CTD MESH:D004317 Doxorubicin results in decreased expression of TNNT2 protein PMID:32877659 14248176 TNNT2 troponin T2, cardiac type gene CHEBI:38940 sunitinib decreases expression EXP E RGD:6480464 20210504 CTD MESH:C473478 Sunitinib results in decreased expression of TNNT2 protein PMID:32877659 14248201 RAB40B RAB40B, member RAS oncogene family gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RAB40B mRNA PMID:39265697 14248299 SLC22A7 solute carrier family 22 member 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC22A7 mRNA PMID:35307453 14248299 SLC22A7 solute carrier family 22 member 7 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of SLC22A7 mRNA PMID:34389318 14248319 ZC3H7A zinc finger CCCH-type containing 7A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZC3H7A mRNA PMID:35307453 14248490 REC114 REC114 meiotic recombination protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of REC114 mRNA PMID:35307453 14248545 ADPRM ADP-ribose/CDP-alcohol diphosphatase, manganese dependent gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADPRM mRNA PMID:35307453 14248615 CDIP1 cell death inducing p53 target 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDIP1 mRNA PMID:35307453 14248691 SMAD3 SMAD family member 3 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the phosphorylation of SMAD3 protein PMID:39486568 14248691 SMAD3 SMAD family member 3 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of SMAD3 mRNA PMID:33626375 14248691 SMAD3 SMAD family member 3 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which affects the phosphorylation of SMAD3 protein PMID:39486568 14248787 CTDSP2 CTD small phosphatase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTDSP2 mRNA PMID:35307453 14248812 MAML1 mastermind like transcriptional coactivator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAML1 mRNA PMID:35307453 14248854 PTX3 pentraxin 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of PTX3 mRNA PMID:26386189 14248854 PTX3 pentraxin 3 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of PTX3 mRNA] PMID:26386189 14248854 PTX3 pentraxin 3 gene CHEBI:22977 cadmium atom decreases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in decreased expression of PTX3 mRNA PMID:37207789 14248854 PTX3 pentraxin 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D002104 ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTX3 mRNA] PMID:37207789 14248854 PTX3 pentraxin 3 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Zearalenone results in decreased expression of PTX3 mRNA] PMID:26386189 14248854 PTX3 pentraxin 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20241105 CTD MESH:C006780 bisphenol A results in decreased expression of PTX3 mRNA PMID:38845341 14248854 PTX3 pentraxin 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20241105 CTD MESH:C006780 ursodoxicoltaurine inhibits the reaction [bisphenol A results in decreased expression of PTX3 mRNA] PMID:38845341 14248854 PTX3 pentraxin 3 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [bisphenol A results in decreased expression of PTX3 mRNA]; ursodoxicoltaurine inhibits the reaction [Cadmium results in decreased expression of PTX3 mRNA] PMID:37207789|PMID:38845341 14248901 MYH7 myosin heavy chain 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYH7 mRNA PMID:35307453 14248901 MYH7 myosin heavy chain 7 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of MYH7 mRNA PMID:25455459 14248980 DCP1A decapping mRNA 1A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCP1A mRNA PMID:35307453 14249092 LMOD1 leiomodin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMOD1 mRNA PMID:35307453 14249177 GADD45A growth arrest and DNA damage inducible alpha gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of GADD45A mRNA PMID:18988085 14249229 SMPD5 sphingomyelin phosphodiesterase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMPD5 mRNA PMID:35307453 14249455 NMD3 NMD3 ribosome export adaptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NMD3 mRNA PMID:35307453 14249488 PSMD12 proteasome 26S subunit, non-ATPase 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PSMD12 mRNA PMID:35307453 14249525 KAZALD1 Kazal type serine peptidase inhibitor domain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KAZALD1 mRNA PMID:35307453 14249572 CBX2 chromobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBX2 mRNA PMID:35307453|PMID:37257635 14249797 QTRT2 queuine tRNA-ribosyltransferase accessory subunit 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of QTRT2 mRNA PMID:35307453 14249873 RRP12 ribosomal RNA processing 12 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRP12 mRNA PMID:35307453 14249922 ATL1 atlastin GTPase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATL1 mRNA PMID:35307453 14250089 DMXL2 Dmx like 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DMXL2 mRNA] PMID:21852083 14250202 MORN5 MORN repeat containing 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MORN5 mRNA PMID:35307453 14250274 C5H12orf57 chromosome 5 C12orf57 homolog gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of C12ORF57 mRNA PMID:28069986 14250344 GLS glutaminase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GLS mRNA PMID:35307453 14250488 FBN1 fibrillin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBN1 mRNA PMID:35307453 14250488 FBN1 fibrillin 1 gene CHEBI:17224 4-methylumbelliferone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D006923 Hymecromone results in decreased expression of FBN1 mRNA PMID:23139787 14250488 FBN1 fibrillin 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of FBN1 mRNA] PMID:21852083 14250586 MIX23 mitochondrial matrix import factor 23 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of MIX23 mRNA PMID:35307453 14250773 RASAL2 RAS protein activator like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RASAL2 mRNA PMID:35307453 14250930 ALX3 ALX homeobox 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALX3 mRNA PMID:35307453 14250938 NIPAL4 NIPA like domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NIPAL4 mRNA PMID:35307453 14251091 SH3BP5 SH3 domain binding protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SH3BP5 mRNA PMID:35307453 14251136 SEMA6C semaphorin 6C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEMA6C mRNA PMID:35307453 14251226 CYCS cytochrome c, somatic gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYCS mRNA PMID:35307453 14251226 CYCS cytochrome c, somatic gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CYCS protein; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]; deoxynivalenol results in increased expression of and results in increased localization of CYCS protein; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA] PMID:29109043|PMID:38104654|PMID:38763499 14251226 CYCS cytochrome c, somatic gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of CYCS mRNA PMID:29109043 14251226 CYCS cytochrome c, somatic gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA] PMID:29109043 14251226 CYCS cytochrome c, somatic gene CHEBI:146195 3-acetyldeoxynivalenol increases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased expression of CYCS protein PMID:37659622 14251226 CYCS cytochrome c, somatic gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CYCS protein] PMID:37659622 14251226 CYCS cytochrome c, somatic gene CHEBI:15422 ATP affects localization EXP E RGD:6480464 20191114 CTD MESH:D000255 Adenosine Triphosphate affects the localization of CYCS protein PMID:17997382 14251226 CYCS cytochrome c, somatic gene CHEBI:15422 ATP multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000255 [Calcium co-treated with Phosphates co-treated with Adenosine Triphosphate] affects the localization of CYCS protein; tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate affects the localization of CYCS protein] PMID:16489745|PMID:17997382 14251226 CYCS cytochrome c, somatic gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYCS mRNA PMID:33493553 14251226 CYCS cytochrome c, somatic gene CHEBI:22984 calcium atom affects localization EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium affects the localization of CYCS protein PMID:16489745 14251226 CYCS cytochrome c, somatic gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Calcium co-treated with Phosphates co-treated with Adenosine Triphosphate] affects the localization of CYCS protein PMID:16489745 14251226 CYCS cytochrome c, somatic gene CHEBI:2504 aflatoxin B1 multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D016604 [deoxynivalenol co-treated with Aflatoxin B1] results in increased expression of CYCS protein PMID:38763499 14251226 CYCS cytochrome c, somatic gene CHEBI:27899 cisplatin affects localization EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin affects the localization of CYCS protein PMID:16316343 14251226 CYCS cytochrome c, somatic gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Bezafibrate inhibits the reaction [Cisplatin affects the localization of CYCS protein] PMID:16316343 14251226 CYCS cytochrome c, somatic gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA]] PMID:29109043 14251226 CYCS cytochrome c, somatic gene CHEBI:29320 calcium(0) affects localization EXP E RGD:6480464 20191114 CTD MESH:D002118 Calcium affects the localization of CYCS protein PMID:16489745 14251226 CYCS cytochrome c, somatic gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 [Calcium co-treated with Phosphates co-treated with Adenosine Triphosphate] affects the localization of CYCS protein PMID:16489745 14251226 CYCS cytochrome c, somatic gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine affects the localization of CYCS protein] PMID:23347876 14251226 CYCS cytochrome c, somatic gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of CYCS mRNA PMID:28803810 14251226 CYCS cytochrome c, somatic gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019287 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of CYCS mRNA] PMID:28803810 14251226 CYCS cytochrome c, somatic gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYCS mRNA PMID:33493553 14251226 CYCS cytochrome c, somatic gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C056933 [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA] PMID:29109043|PMID:36397609 14251226 CYCS cytochrome c, somatic gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025946 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased expression of CYCS mRNA] PMID:28803810 14251226 CYCS cytochrome c, somatic gene CHEBI:39329 etoxazole increases expression EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased expression of CYCS protein PMID:31744678 14251226 CYCS cytochrome c, somatic gene CHEBI:4031 cyclosporin A affects localization EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine affects the localization of CYCS protein PMID:23347876 14251226 CYCS cytochrome c, somatic gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine affects the localization of CYCS protein] PMID:23347876 14251226 CYCS cytochrome c, somatic gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate inhibits the reaction [Cisplatin affects the localization of CYCS protein] PMID:16316343 14251226 CYCS cytochrome c, somatic gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230404 CTD MESH:C025589 ochratoxin A results in increased expression of CYCS mRNA PMID:36397609 14251226 CYCS cytochrome c, somatic gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230404 CTD MESH:C025589 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA] PMID:36397609 14251226 CYCS cytochrome c, somatic gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CYCS protein] PMID:37659622 14251261 ANKRD13C ankyrin repeat domain 13C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANKRD13C mRNA PMID:35307453 14251385 MFSD10 major facilitator superfamily domain containing 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFSD10 mRNA PMID:35307453 14251402 WDFY1 WD repeat and FYVE domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDFY1 mRNA PMID:35307453 14251422 RPS5 ribosomal protein S5 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of RPS5 mRNA PMID:14994279 14251508 TXNDC5 thioredoxin domain containing 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TXNDC5 mRNA PMID:35307453 14251553 SHLD1 shieldin complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHLD1 mRNA PMID:35307453 14251652 ARID5B AT-rich interaction domain 5B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ARID5B mRNA PMID:35307453 14251778 SDCBP2 syndecan binding protein 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SDCBP2 mRNA PMID:35307453 14251813 RASA4B RAS p21 protein activator 4B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASA4B mRNA PMID:35307453 14251888 RRP1 ribosomal RNA processing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RRP1 mRNA PMID:35307453 14251967 FBXO41 F-box protein 41 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FBXO41 mRNA PMID:35307453 14252091 CRB2 crumbs cell polarity complex component 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRB2 mRNA PMID:35307453 14252108 SRFBP1 serum response factor binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SRFBP1 mRNA PMID:35307453 14252241 ALPL alkaline phosphatase, biomineralization associated gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALPL mRNA PMID:35307453 14252241 ALPL alkaline phosphatase, biomineralization associated gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] PMID:30481989 14252241 ALPL alkaline phosphatase, biomineralization associated gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] PMID:30481989 14252241 ALPL alkaline phosphatase, biomineralization associated gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] PMID:30481989 14252241 ALPL alkaline phosphatase, biomineralization associated gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] PMID:30481989 14252272 CBARP CACN subunit beta associated regulatory protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CBARP mRNA PMID:35307453 14252302 DNAH1 dynein axonemal heavy chain 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH1 mRNA PMID:35307453 14252391 MAOA monoamine oxidase A gene CHEBI:233581 asoxime chloride decreases activity EXP E RGD:6480464 20250408 CTD MESH:C022870 asoxime chloride results in decreased activity of MAOA protein PMID:21195145 14252391 MAOA monoamine oxidase A gene CHEBI:233584 trimedoxime bromide decreases activity EXP E RGD:6480464 20250408 CTD MESH:D014289 Trimedoxime results in decreased activity of MAOA protein PMID:21195145 14252391 MAOA monoamine oxidase A gene CHEBI:23924 enzyme inhibitor decreases activity EXP E RGD:6480464 20210608 CTD MESH:D004791 Enzyme Inhibitors results in decreased activity of MAOA protein PMID:33359020 14252391 MAOA monoamine oxidase A gene CHEBI:3763 clorgyline decreases activity EXP E RGD:6480464 20210608 CTD MESH:D003010 Clorgyline analog results in decreased activity of MAOA protein PMID:33359020 14252391 MAOA monoamine oxidase A gene CHEBI:8354 pralidoxime decreases activity EXP E RGD:6480464 20191114 CTD MESH:C028797 pralidoxime results in decreased activity of MAOA protein PMID:21195145 14252391 MAOA monoamine oxidase A gene CHEBI:8863 Riluzole decreases activity EXP E RGD:6480464 20210608 CTD MESH:D019782 Riluzole analog results in decreased activity of MAOA protein; Riluzole results in decreased activity of MAOA protein PMID:33359020 14252497 LY6D lymphocyte antigen 6 family member D gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of LY6D mRNA PMID:39265697 14252583 SMAD7 SMAD family member 7 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of SMAD7 mRNA PMID:39265697 14252583 SMAD7 SMAD family member 7 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SMAD7 mRNA; Cadmium Chloride results in decreased expression of SMAD7 protein PMID:33626375 14252652 TPCN1 two pore segment channel 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPCN1 mRNA PMID:35307453 14252724 USP15 ubiquitin specific peptidase 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of USP15 mRNA PMID:35307453 14252803 ZNF281 zinc finger protein 281 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF281 mRNA PMID:35307453 14252897 DNAAF4 dynein axonemal assembly factor 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAAF4 mRNA PMID:35307453 14253073 WDR27 WD repeat domain 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR27 mRNA PMID:35307453 14253123 APOC3 apolipoprotein C3 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of APOC3 mRNA PMID:34389318 14253173 IRF9 interferon regulatory factor 9 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of IRF9 mRNA PMID:39265697 14253254 LHCGR luteinizing hormone/choriogonadotropin receptor gene CHEBI:177470 Cloprostenol decreases expression EXP E RGD:6480464 20210907 CTD MESH:D003008 Cloprostenol results in decreased expression of LHCGR mRNA; Cloprostenol results in decreased expression of LHCGR protein PMID:15713365 14253383 CYP2C33 cytochrome P450 family 2 subfamily C member 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CYP2C33 mRNA PMID:35307453 14253383 CYP2C33 cytochrome P450 family 2 subfamily C member 33 gene CHEBI:223316 (+)-artemisinin increases expression EXP E RGD:6480464 20241001 CTD MESH:C031327 artemisinin results in increased expression of CYP2C33 mRNA PMID:24176340 14253582 AGBL2 AGBL carboxypeptidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGBL2 mRNA PMID:35307453 14253624 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MDGA1 mRNA PMID:35307453 14253645 GPT2 glutamic--pyruvic transaminase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GPT2 mRNA PMID:35307453 14253664 EMC1 ER membrane protein complex subunit 1 gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of EMC1 mRNA PMID:35839969 14253752 LRRC45 leucine rich repeat containing 45 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC45 mRNA PMID:35307453 14253848 AGTRAP angiotensin II receptor associated protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGTRAP mRNA PMID:35307453 14253910 CRIP3 cysteine rich protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRIP3 mRNA PMID:35307453 14254071 HTR2C 5-hydroxytryptamine receptor 2C gene CHEBI:73378 mesulergine affects binding EXP E RGD:6480464 20191114 CTD MESH:C031649 mesulergine binds to HTR2C protein PMID:11927170 14254071 HTR2C 5-hydroxytryptamine receptor 2C gene CHEBI:73378 mesulergine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C031649 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine inhibits the reaction [mesulergine binds to HTR2C protein] PMID:11927170 14254177 DAW1 dynein assembly factor with WD repeats 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DAW1 mRNA PMID:35307453 14254259 COBL cordon-bleu WH2 repeat protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COBL mRNA PMID:35307453 14254309 FGFBP1 fibroblast growth factor binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FGFBP1 mRNA PMID:35307453 14254320 SSUH2 ssu-2 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SSUH2 mRNA PMID:35307453 14254356 SLC27A1 solute carrier family 27 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC27A1 mRNA PMID:35307453 14254450 RAPH1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAPH1 mRNA PMID:35307453 14254536 ID1 inhibitor of DNA binding 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ID1 mRNA PMID:35307453 14254536 ID1 inhibitor of DNA binding 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ID1 mRNA PMID:39265697 14254542 SNAI3 snail family transcriptional repressor 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SNAI3 mRNA PMID:39265697 14254597 TMEM220 transmembrane protein 220 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM220 mRNA PMID:35307453 14254623 ATRN attractin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATRN mRNA PMID:35307453 14254679 RPL23A ribosomal protein L23a gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPL23A mRNA PMID:39265697 14254688 IQANK1 IQ motif and ankyrin repeat containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQANK1 mRNA PMID:35307453 14254705 MAP3K1 mitogen-activated protein kinase kinase kinase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP3K1 mRNA PMID:35307453 14254747 RMDN2 regulator of microtubule dynamics 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RMDN2 mRNA PMID:35307453 14254821 UQCR11 ubiquinol-cytochrome c reductase, complex III subunit XI gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of UQCR11 mRNA PMID:39265697 14254860 BCL6B BCL6B transcription repressor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BCL6B mRNA PMID:35307453 14254922 AK7 adenylate kinase 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AK7 mRNA PMID:35307453 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:2682 amphotericin B increases expression EXP E RGD:6480464 20250715 CTD MESH:D000666 Amphotericin B results in increased expression of PRKACG protein PMID:24105867 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:2682 amphotericin B multiple interactions EXP E RGD:6480464 20250715 CTD MESH:D000666 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein] PMID:24105867 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:27561 oxirane decreases activity EXP E RGD:6480464 20250311 CTD MESH:D005027 Ethylene Oxide results in decreased activity of PRKACA protein PMID:39068997 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:28694 copper atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 PRKACA protein inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20191114 CTD MESH:C017947 sodium arsenite results in decreased expression of PRKACA protein PMID:12760830 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:30052 copper(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003300 PRKACA protein inhibits the reaction [Copper binds to ATP7B protein] PMID:21084060 14255237 PRKACA protein kinase cAMP-activated catalytic subunit alpha gene CHEBI:47495 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP E RGD:6480464 20250715 CTD MESH:C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein] PMID:24105867 14255254 STRC stereocilin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of STRC mRNA PMID:35307453 14255349 LOC102158035 uncharacterized LOC102158035 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of TRAC mRNA] PMID:21852083 14255422 C15H2orf72 chromosome 15 C2orf72 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C15H2ORF72 mRNA PMID:35307453 14255487 NEBL nebulette gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEBL mRNA PMID:35307453 14255601 PCDH10 protocadherin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCDH10 mRNA PMID:35307453 14255610 PCID2 PCI domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PCID2 mRNA PMID:35307453 14255756 SERPINF2 serpin family F member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SERPINF2 mRNA PMID:35307453 14255770 RGS2 regulator of G protein signaling 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RGS2 mRNA PMID:39265697 14255981 PKIG cAMP-dependent protein kinase inhibitor gamma gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PKIG mRNA PMID:35307453 14256027 RBM28 RNA binding motif protein 28 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM28 mRNA PMID:35307453 14256141 RPS25 ribosomal protein S25 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RPS25 mRNA PMID:39265697 14256175 DNAAF1 dynein axonemal assembly factor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAAF1 mRNA PMID:35307453 14256204 ZNHIT3 zinc finger HIT-type containing 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNHIT3 mRNA PMID:35307453 14256228 VIP vasoactive intestinal peptide gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20191114 CTD MESH:D020106 Acrylamide results in increased expression of VIP protein PMID:30222996 14256228 VIP vasoactive intestinal peptide gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of VIP protein PMID:29577965 14256228 VIP vasoactive intestinal peptide gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in increased expression of VIP protein PMID:29558425 14256228 VIP vasoactive intestinal peptide gene CHEBI:90630 omega-conotoxin GVIA multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020866 omega-Conotoxin GVIA inhibits the reaction [VIP protein results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] PMID:14662737 14256284 NUFIP1 nuclear FMR1 interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUFIP1 mRNA PMID:35307453 14256423 CEACAM18 CEA cell adhesion molecule 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEACAM18 mRNA PMID:35307453 14256575 JAK3 Janus kinase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JAK3 mRNA PMID:35307453 14256642 ZNF232 zinc finger protein 232 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF232 mRNA PMID:35307453 14256679 RGS6 regulator of G protein signaling 6 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RGS6 mRNA PMID:34933075 14256731 NRAP nebulin related anchoring protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NRAP mRNA PMID:35307453 14256731 NRAP nebulin related anchoring protein gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NRAP mRNA PMID:39265697 14256925 ZC2HC1C zinc finger C2HC-type containing 1C gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZC2HC1C mRNA PMID:35307453 14257034 MTHFR methylenetetrahydrofolate reductase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTHFR mRNA PMID:35307453 14257034 MTHFR methylenetetrahydrofolate reductase gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA PMID:28445388 14257034 MTHFR methylenetetrahydrofolate reductase gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA PMID:28445388 14257034 MTHFR methylenetetrahydrofolate reductase gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA PMID:28445388 14257034 MTHFR methylenetetrahydrofolate reductase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA PMID:28445388 14257077 RILPL2 Rab interacting lysosomal protein like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RILPL2 mRNA PMID:35307453 14257148 NRBP1 nuclear receptor binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NRBP1 mRNA PMID:35307453 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of MLKL mRNA PMID:39265697 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL protein] PMID:35665993 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of MLKL mRNA; tetrabromobisphenol A results in increased expression of MLKL protein PMID:35665993 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL protein] PMID:35665993 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of MLKL mRNA; Cadmium Chloride results in increased expression of MLKL protein PMID:33626375 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of MLKL mRNA; fumonisin B1 results in increased expression of MLKL protein PMID:38705344 14257240 MLKL mixed lineage kinase domain like pseudokinase gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of MLKL mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of MLKL protein] PMID:38705344 14257338 RIPOR1 RHO family interacting cell polarization regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of RIPOR1 protein PMID:37257635 14257448 RGS17 regulator of G protein signaling 17 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RGS17 mRNA PMID:35307453 14257559 RASSF5 Ras association domain family member 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RASSF5 mRNA PMID:35307453 14257602 PDE12 phosphodiesterase 12 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PDE12 mRNA PMID:35307453 14257609 SLC25A27 solute carrier family 25 member 27 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC25A27 mRNA PMID:35307453 14257609 SLC25A27 solute carrier family 25 member 27 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of SLC25A27 mRNA] PMID:39151877 14257609 SLC25A27 solute carrier family 25 member 27 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of SLC25A27 mRNA PMID:39151877 14257609 SLC25A27 solute carrier family 25 member 27 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of SLC25A27 mRNA] PMID:39151877 14257682 ZNF311 zinc finger protein 311 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF311 mRNA PMID:35307453 14257693 LRPAP1 LDL receptor related protein associated protein 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of LRPAP1 mRNA PMID:35839969 14258156 NME4 NME/NM23 nucleoside diphosphate kinase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NME4 mRNA PMID:35307453 14258182 TOMM7 translocase of outer mitochondrial membrane 7 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of TOMM7 mRNA PMID:39265697 14258420 RPF1 ribosome production factor 1 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RPF1 mRNA PMID:35307453 14258434 ADGRG7 adhesion G protein-coupled receptor G7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADGRG7 mRNA PMID:35307453 14258525 TASOR2 transcription activation suppressor family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TASOR2 mRNA PMID:35307453 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009569 TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] PMID:8810647 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:27568 selenium atom increases activity EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium analog results in increased activity of TXNRD1 protein; Selenium results in increased activity of TXNRD1 protein PMID:17055214|PMID:37442268 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:27568 selenium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium results in increased expression of TXNRD1 mRNA PMID:16908641 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:27568 selenium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Paraquat results in decreased activity of TXNRD1 protein] PMID:17055214 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:27584 aldosterone increases expression EXP E RGD:6480464 20191114 CTD MESH:D000450 Aldosterone results in increased expression of TXNRD1 protein PMID:24512358 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:34905 paraquat decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010269 Paraquat results in decreased activity of TXNRD1 protein PMID:17055214 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010269 Selenium inhibits the reaction [Paraquat results in decreased activity of TXNRD1 protein] PMID:17055214 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:36904 elemental selenium increases activity EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium analog results in increased activity of TXNRD1 protein; Selenium results in increased activity of TXNRD1 protein PMID:17055214|PMID:37442268 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:36904 elemental selenium increases expression EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium results in increased expression of TXNRD1 mRNA PMID:16908641 14258610 TXNRD1 thioredoxin reductase 1 gene CHEBI:36904 elemental selenium multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012643 Selenium inhibits the reaction [Paraquat results in decreased activity of TXNRD1 protein] PMID:17055214 14258643 LIMS2 LIM zinc finger domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LIMS2 mRNA PMID:35307453 14258807 CD4 CD4 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD4 mRNA PMID:35307453 14259044 ADM adrenomedullin gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of ADM mRNA PMID:18988085 14259118 MARCKS myristoylated alanine rich protein kinase C substrate gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MARCKS mRNA; deoxynivalenol results in decreased expression of MARCKS protein PMID:38403181 14259118 MARCKS myristoylated alanine rich protein kinase C substrate gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MARCKS mRNA PMID:35307453 14259124 FZD2 frizzled class receptor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FZD2 mRNA PMID:35307453 14259237 FRAT2 FRAT regulator of WNT signaling pathway 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FRAT2 mRNA PMID:35307453 14259531 MID1IP1 MID1 interacting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MID1IP1 mRNA PMID:35307453 14259614 ANKRD53 ankyrin repeat domain 53 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ANKRD53 mRNA PMID:35307453 14259728 MEOX1 mesenchyme homeobox 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEOX1 mRNA PMID:37257635 14259874 ACBD7 acyl-CoA binding domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACBD7 mRNA PMID:35307453 14259888 ABCB11 ATP binding cassette subfamily B member 11 gene CHEBI:28865 taurocholic acid increases transport EXP E RGD:6480464 20191114 CTD MESH:D013656 ABCB11 protein results in increased transport of Taurocholic Acid PMID:21056966 14259991 TSPAN3 tetraspanin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN3 mRNA PMID:35307453 14260002 DDR2 discoidin domain receptor tyrosine kinase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDR2 mRNA; deoxynivalenol results in decreased expression of DDR2 protein PMID:38403181 14260002 DDR2 discoidin domain receptor tyrosine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDR2 mRNA PMID:35307453 14260106 UTP15 UTP15 small subunit processome component gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UTP15 mRNA PMID:35307453 14260140 CIITA class II major histocompatibility complex transactivator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CIITA mRNA PMID:35307453 14260222 RPL32 ribosomal protein L32 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL32 mRNA PMID:21852083 14260327 METTL1 methyltransferase 1, tRNA methylguanosine gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of METTL1 mRNA; deoxynivalenol results in increased expression of METTL1 protein PMID:38403181 14260337 RASSF4 Ras association domain family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RASSF4 mRNA PMID:35307453 14260384 NDUFA6 NADH:ubiquinone oxidoreductase subunit A6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NDUFA6 mRNA PMID:35307453 14260437 NYAP1 neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NYAP1 mRNA PMID:35307453 14260498 VMA21 vacuolar ATPase assembly factor VMA21 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of VMA21 mRNA PMID:35307453 14260570 TNFRSF11B TNF receptor superfamily member 11b gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20191114 CTD MESH:D004958 Estradiol results in increased expression of TNFRSF11B protein PMID:15713688 14260570 TNFRSF11B TNF receptor superfamily member 11b gene CHEBI:8772 raloxifene increases expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride results in increased expression of TNFRSF11B protein PMID:15713688 14260630 FOXS1 forkhead box S1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FOXS1 mRNA PMID:35307453 14260839 LCN15 lipocalin 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LCN15 mRNA PMID:35307453 14260893 SCNM1 sodium channel modifier 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in increased expression of SCNM1 mRNA PMID:35307453 14260950 WDR18 WD repeat domain 18 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WDR18 mRNA PMID:35307453 14260974 TECTA tectorin alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TECTA mRNA PMID:35307453 14261109 DNAI2 dynein axonemal intermediate chain 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAI2 mRNA PMID:35307453 14261162 CERCAM cerebral endothelial cell adhesion molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CERCAM mRNA PMID:35307453 14261185 ZNF777 zinc finger protein 777 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF777 mRNA PMID:35307453 14261254 IGF1 insulin like growth factor 1 gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol affects the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol]; deoxynivalenol affects the reaction [IGF1 protein results in increased abundance of Estradiol]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA] PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of IGF1 mRNA; Zearalenone results in decreased expression of IGF1 protein PMID:29758222 14261254 IGF1 insulin like growth factor 1 gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone affects the reaction [IGF1 protein results in increased abundance of Estradiol]; Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP11A1 mRNA]; Zearalenone inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased expression of CYP19A1 mRNA]; Zearalenone promotes the reaction [IGF1 protein results in increased abundance of Progesterone] PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:16469 17beta-estradiol increases abundance EXP E RGD:6480464 20191114 CTD MESH:D004958 IGF1 protein results in increased abundance of Estradiol PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D004958 [FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol; deoxynivalenol affects the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Estradiol]; deoxynivalenol affects the reaction [IGF1 protein results in increased abundance of Estradiol]; Zearalenone affects the reaction [IGF1 protein results in increased abundance of Estradiol] PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:17026 progesterone increases abundance EXP E RGD:6480464 20191114 CTD MESH:D011374 IGF1 protein results in increased abundance of Progesterone PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 [FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; Zearalenone promotes the reaction [IGF1 protein results in increased abundance of Progesterone] PMID:17656051 14261254 IGF1 insulin like growth factor 1 gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA] PMID:30481989 14261254 IGF1 insulin like growth factor 1 gene CHEBI:23414 copper(II) sulfate increases secretion EXP E RGD:6480464 20191114 CTD MESH:D019327 Copper Sulfate results in increased secretion of IGF1 protein PMID:24521407 14261254 IGF1 insulin like growth factor 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of IGF1 mRNA PMID:18988085 14261254 IGF1 insulin like growth factor 1 gene CHEBI:27363 zinc atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of IGF1 protein PMID:15387849 14261254 IGF1 insulin like growth factor 1 gene CHEBI:27889 lead(0) increases secretion EXP E RGD:6480464 20191114 CTD MESH:D007854 Lead results in increased secretion of IGF1 protein PMID:20390873 14261254 IGF1 insulin like growth factor 1 gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper results in increased expression of IGF1 mRNA PMID:22367704 14261254 IGF1 insulin like growth factor 1 gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA] PMID:30481989 14261254 IGF1 insulin like growth factor 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of IGF1 mRNA PMID:21391292 14261254 IGF1 insulin like growth factor 1 gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D003300 Copper results in increased expression of IGF1 mRNA PMID:22367704 14261254 IGF1 insulin like growth factor 1 gene CHEBI:30185 zinc(0) increases expression EXP E RGD:6480464 20191114 CTD MESH:D015032 Zinc results in increased expression of IGF1 protein PMID:15387849 14261254 IGF1 insulin like growth factor 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20210406 CTD MESH:C006780 bisphenol A results in decreased expression of IGF1 mRNA PMID:32710935 14261254 IGF1 insulin like growth factor 1 gene CHEBI:36560 zinc oxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D015034 Zinc Oxide results in increased expression of IGF1 mRNA PMID:7899834 14261254 IGF1 insulin like growth factor 1 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA] PMID:30481989 14261254 IGF1 insulin like growth factor 1 gene CHEBI:9753 troglitazone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C057693 Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA] PMID:30481989 14261314 ZSWIM6 zinc finger SWIM-type containing 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZSWIM6 mRNA PMID:35307453 14261723 SLC34A1 solute carrier family 34 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC34A1 mRNA PMID:35307453 14261881 GALNT14 polypeptide N-acetylgalactosaminyltransferase 14 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GALNT14 mRNA PMID:35307453 14261920 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFKFB3 mRNA PMID:35307453 14261920 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFKFB3 mRNA PMID:34416349 14261920 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFKFB3 mRNA PMID:34416349 14262121 LYPD6 LY6/PLAUR domain containing 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LYPD6 mRNA PMID:35307453 14262154 FAM20C FAM20C golgi associated secretory pathway kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM20C mRNA PMID:37257635 14262168 SPARC secreted protein acidic and cysteine rich gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPARC mRNA PMID:35307453 14262168 SPARC secreted protein acidic and cysteine rich gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of SPARC mRNA] PMID:21852083 14262180 CCDC166 coiled-coil domain containing 166 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC166 mRNA PMID:35307453 14262186 HTR1B 5-hydroxytryptamine receptor 1B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HTR1B mRNA PMID:35307453 14262237 DMRTB1 DMRT like family B with proline rich C-terminal 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DMRTB1 mRNA PMID:35307453 14262245 SNAI2 snail family transcriptional repressor 2 gene CHEBI:10033 warfarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014859 [TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of SNAI2 protein; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of BMP2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 mRNA]; SNAI2 protein promotes the reaction [[TP53 protein results in increased susceptibility to Warfarin] which results in increased expression of RUNX2 protein]; SNAI2 protein promotes the reaction [TP53 protein results in increased susceptibility to Warfarin]; Warfarin promotes the reaction [TP53 protein binds to SNAI2 promoter] PMID:29358327 14262273 CDK7 cyclin dependent kinase 7 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CDK7 mRNA PMID:35307453 14262421 CCNB2 cyclin B2 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of CCNB2 mRNA PMID:21391292 14262644 CT55 cancer/testis antigen 55 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CT55 mRNA PMID:35307453 14262661 DAB2IP DAB2 interacting protein gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DAB2IP mRNA PMID:34389318 14262696 SH3BGRL2 SH3 domain binding glutamate rich protein like 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SH3BGRL2 mRNA PMID:21852083 14262716 PGS1 phosphatidylglycerophosphate synthase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PGS1 mRNA PMID:35307453 14262742 RASGRF2 Ras protein specific guanine nucleotide releasing factor 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of RASGRF2 mRNA PMID:34933075 14262810 EBF3 EBF transcription factor 3 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of EBF3 mRNA PMID:25455459 14262978 DNAH10 dynein axonemal heavy chain 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAH10 mRNA PMID:35307453 14263090 RAB19 RAB19, member RAS oncogene family gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAB19 mRNA PMID:35307453 14263146 TBC1D16 TBC1 domain family member 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TBC1D16 mRNA PMID:35307453 14263573 GDF7 growth differentiation factor 7 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GDF7 mRNA PMID:34933075 14263582 GAS7 growth arrest specific 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAS7 mRNA PMID:35307453 14263738 C8H4orf46 chromosome 8 C4orf46 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of C8H4ORF46 mRNA PMID:35307453 14263859 TMEM86A transmembrane protein 86A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM86A mRNA PMID:35307453 14263902 ARHGEF18 Rho/Rac guanine nucleotide exchange factor 18 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF18 mRNA PMID:35307453 14263902 ARHGEF18 Rho/Rac guanine nucleotide exchange factor 18 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ARHGEF18 mRNA PMID:39265697 14264013 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010100 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein] PMID:28235547 14264013 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit gene CHEBI:16526 carbon dioxide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002245 [Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein] PMID:28235547 14264013 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein] PMID:28235547 14264013 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009538 Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein] PMID:28235547 14264092 GAREM1 GRB2 associated regulator of MAPK1 subtype 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAREM1 mRNA PMID:35307453 14264138 MANSC1 MANSC domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MANSC1 mRNA PMID:35307453 14264284 SPCS3 signal peptidase complex subunit 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SPCS3 mRNA PMID:35307453 14264293 HAPLN2 hyaluronan and proteoglycan link protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HAPLN2 mRNA PMID:35307453 14264319 LGR6 leucine rich repeat containing G protein-coupled receptor 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LGR6 mRNA PMID:35307453 14264489 MAN1C1 mannosidase alpha class 1C member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAN1C1 mRNA PMID:35307453 14264505 CAPN6 calpain 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CAPN6 mRNA PMID:35307453 14264526 MRC2 mannose receptor C-type 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MRC2 mRNA PMID:35307453 14264694 SNRNP40 small nuclear ribonucleoprotein U5 subunit 40 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNRNP40 mRNA PMID:35307453 14264713 RTN4R reticulon 4 receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RTN4R mRNA PMID:35307453 14264771 SLN sarcolipin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLN mRNA PMID:35307453 14264862 NTRK2 neurotrophic receptor tyrosine kinase 2 gene CHEBI:64310 crizotinib decreases activity EXP E RGD:6480464 20191114 CTD MESH:C551994 Crizotinib results in decreased activity of NTRK2 protein PMID:21812414 14264921 ITGB8 integrin subunit beta 8 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGB8 mRNA PMID:35307453 14265001 TOPBP1 DNA topoisomerase II binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TOPBP1 mRNA PMID:35307453 14265047 PGLYRP4 peptidoglycan recognition protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PGLYRP4 mRNA PMID:35307453 14265111 ATP6V1B1 ATPase H+ transporting V1 subunit B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP6V1B1 mRNA PMID:35307453 14265169 PAG1 phosphoprotein membrane anchor with glycosphingolipid microdomains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PAG1 mRNA PMID:35307453 14265189 DMGDH dimethylglycine dehydrogenase gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DMGDH mRNA PMID:34389318 14265214 AMDHD2 amidohydrolase domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AMDHD2 mRNA PMID:35307453 14265249 ITM2B integral membrane protein 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITM2B mRNA PMID:35307453 14265589 ARSE arylsulfatase E (chondrodysplasia punctata 1) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARSL mRNA PMID:35307453 14265616 C14H10orf62 chromosome 14 C10orf62 homolog gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230307 CTD MESH:C007262 deoxynivalenol results in decreased expression of C14H10ORF62 mRNA PMID:35307453 14265696 UBA2 ubiquitin like modifier activating enzyme 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UBA2 mRNA PMID:35307453 14265881 CSKMT citrate synthase lysine methyltransferase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSKMT mRNA PMID:35307453 14265894 MYH9 myosin heavy chain 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYH9 mRNA PMID:35307453 14265940 KLHDC7A kelch domain containing 7A gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of KLHDC7A mRNA PMID:34933075 14265968 ATF6 activating transcription factor 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of ATF6 mRNA PMID:38608924 14265968 ATF6 activating transcription factor 6 gene CHEBI:146195 3-acetyldeoxynivalenol increases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in increased expression of ATF6 protein PMID:37659622 14265968 ATF6 activating transcription factor 6 gene CHEBI:146195 3-acetyldeoxynivalenol multiple interactions EXP E RGD:6480464 20240109 CTD MESH:C043247 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 protein] PMID:37659622 14265968 ATF6 activating transcription factor 6 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of ATF6 mRNA] PMID:36584959 14265968 ATF6 activating transcription factor 6 gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased expression of ATF6 mRNA PMID:37207789 14265968 ATF6 activating transcription factor 6 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA] PMID:33891997|PMID:37207789 14265968 ATF6 activating transcription factor 6 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of ATF6 mRNA PMID:36584959 14265968 ATF6 activating transcription factor 6 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of ATF6 mRNA] PMID:36584959 14265968 ATF6 activating transcription factor 6 gene CHEBI:28869 menadione increases activity EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased activity of ATF6 protein PMID:18086661 14265968 ATF6 activating transcription factor 6 gene CHEBI:28869 menadione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024483 SOD2 inhibits the reaction [Vitamin K 3 results in increased activity of ATF6 protein] PMID:18086661 14265968 ATF6 activating transcription factor 6 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ATF6 protein PMID:36754226 14265968 ATF6 activating transcription factor 6 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D001564 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of ATF6 protein] PMID:36754226 14265968 ATF6 activating transcription factor 6 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ATF6 protein PMID:37108405 14265968 ATF6 activating transcription factor 6 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ATF6 protein] PMID:37108405 14265968 ATF6 activating transcription factor 6 gene CHEBI:35456 cadmium dichloride increases cleavage EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased cleavage of ATF6 protein PMID:17464326 14265968 ATF6 activating transcription factor 6 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Cadmium Chloride results in increased cleavage of ATF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein PMID:17464326|PMID:33891997 14265968 ATF6 activating transcription factor 6 gene CHEBI:39329 etoxazole increases cleavage EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased cleavage of ATF6 protein PMID:31744678 14265968 ATF6 activating transcription factor 6 gene CHEBI:41500 4-phenylbutyric acid multiple interactions EXP E RGD:6480464 20230704 CTD MESH:C075773 4-phenylbutyric acid inhibits the reaction [Benzo(a)pyrene results in increased expression of ATF6 protein] PMID:36754226 14265968 ATF6 activating transcription factor 6 gene CHEBI:48843 disodium selenite multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D018038 Sodium Selenite inhibits the reaction [bisphenol A results in increased expression of ATF6 protein] PMID:37108405 14265968 ATF6 activating transcription factor 6 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA] PMID:37207789 14265968 ATF6 activating transcription factor 6 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20240109 CTD MESH:D020123 Sirolimus inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 protein] PMID:37659622 14266045 NCF2 neutrophil cytosolic factor 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NCF2 mRNA PMID:35307453 14266045 NCF2 neutrophil cytosolic factor 2 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of NCF2 mRNA PMID:21645290 14266068 FDFT1 farnesyl-diphosphate farnesyltransferase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of FDFT1 mRNA; deoxynivalenol results in decreased expression of FDFT1 protein PMID:38403181 14266068 FDFT1 farnesyl-diphosphate farnesyltransferase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FDFT1 mRNA PMID:35307453 14266117 GRAMD4 GRAM domain containing 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRAMD4 mRNA PMID:35307453 14266213 HSD17B12 hydroxysteroid 17-beta dehydrogenase 12 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HSD17B12 mRNA] PMID:21852083 14266254 GFOD1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GFOD1 mRNA PMID:35307453 14266295 ATP5ME ATP synthase membrane subunit e gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ATP5ME mRNA PMID:39265697 14266439 LRIG3 leucine rich repeats and immunoglobulin like domains 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRIG3 mRNA PMID:35307453 14266518 MANSC4 MANSC domain containing 4 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of MANSC4 mRNA PMID:35307453 14266558 CRACR2B calcium release activated channel regulator 2B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CRACR2B mRNA PMID:35307453 14266587 EBF4 EBF family member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EBF4 mRNA PMID:35307453 14266638 IL18R1 interleukin 18 receptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IL18R1 mRNA; deoxynivalenol results in increased expression of IL18R1 protein PMID:35307453|PMID:37257635 14266703 CNGB1 cyclic nucleotide gated channel subunit beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNGB1 mRNA PMID:35307453 14266863 ADA adenosine deaminase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADA mRNA PMID:35307453 14266947 DNAI7 dynein axonemal intermediate chain 7 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol affects the expression of DNAI7 mRNA PMID:35307453 14267007 CEL carboxyl ester lipase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEL mRNA PMID:35307453 14267104 KCP kielin cysteine rich BMP regulator gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCP mRNA PMID:35307453 14267164 INTS6 integrator complex subunit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of INTS6 mRNA PMID:35307453 14267248 FAM114A1 family with sequence similarity 114 member A1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM114A1 mRNA PMID:35307453 14267266 GATD3 glutamine amidotransferase class 1 domain containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GATD3 mRNA PMID:35307453 14267311 VPS36 vacuolar protein sorting 36 homolog gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of VPS36 mRNA PMID:34389318 14267350 ZRANB2 zinc finger RANBP2-type containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZRANB2 mRNA; deoxynivalenol results in increased expression of ZRANB2 protein PMID:35307453|PMID:38403181 14267477 PROS1 protein S gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PROS1 mRNA PMID:35307453 14267477 PROS1 protein S gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of PROS1 mRNA PMID:21852083 14267496 NEUROG3 neurogenin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NEUROG3 mRNA PMID:35307453 14267564 DRG1 developmentally regulated GTP binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DRG1 mRNA PMID:35307453 14267700 GNG7 G protein subunit gamma 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GNG7 mRNA PMID:35307453 14267816 NTN1 netrin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NTN1 mRNA PMID:35307453 14267816 NTN1 netrin 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of NTN1 mRNA PMID:38705344 14267816 NTN1 netrin 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C056933 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of NTN1 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of NTN1 mRNA] PMID:33905761|PMID:38705344 14267816 NTN1 netrin 1 gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20211012 CTD MESH:C025589 ochratoxin A results in increased expression of NTN1 mRNA PMID:33905761 14267816 NTN1 netrin 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20211012 CTD MESH:C025589 fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of NTN1 mRNA] PMID:33905761 14268057 MAP1LC3A microtubule associated protein 1 light chain 3 alpha gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MAP1LC3A mRNA PMID:35307453 14268057 MAP1LC3A microtubule associated protein 1 light chain 3 alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP1LC3A mRNA PMID:32229166|PMID:32302720|PMID:35381244 14268057 MAP1LC3A microtubule associated protein 1 light chain 3 alpha gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C007262 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA] PMID:35381244 14268057 MAP1LC3A microtubule associated protein 1 light chain 3 alpha gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C017947 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; AHR protein affects the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3A mRNA] PMID:35381244 14268057 MAP1LC3A microtubule associated protein 1 light chain 3 alpha gene CHEBI:35176 zinc sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D019287 Zinc Sulfate results in increased expression of MAP1LC3A mRNA PMID:28803810 14268267 MPPE1 metallophosphoesterase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MPPE1 mRNA PMID:35307453 14268312 F7 coagulation factor VII gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of F7 mRNA PMID:35307453 14268496 H2AZ2 H2A.Z variant histone 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of H2AZ2 mRNA PMID:35307453 14268511 SLC46A1 solute carrier family 46 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC46A1 mRNA PMID:35307453 14268533 ENDOU endonuclease, poly(U) specific gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENDOU mRNA PMID:35307453 14268670 CWC22 CWC22 spliceosome associated protein homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CWC22 mRNA PMID:35307453 14268729 DUOX2 dual oxidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DUOX2 mRNA PMID:35307453 14268729 DUOX2 dual oxidase 2 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of DUOX2 mRNA PMID:34389318 14268729 DUOX2 dual oxidase 2 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of DUOX2 mRNA] PMID:39151877 14268729 DUOX2 dual oxidase 2 gene CHEBI:17489 3',5'-cyclic AMP increases expression EXP E RGD:6480464 20191114 CTD MESH:D000242 Cyclic AMP results in increased expression of DUOX2 mRNA PMID:10601291 14268729 DUOX2 dual oxidase 2 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of DUOX2 mRNA PMID:39151877 14268729 DUOX2 dual oxidase 2 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of DUOX2 mRNA] PMID:39151877 14268729 DUOX2 dual oxidase 2 gene CHEBI:6651 malathion decreases expression EXP E RGD:6480464 20201103 CTD MESH:D008294 Malathion results in decreased expression of DUOX2 mRNA PMID:31535366 14268729 DUOX2 dual oxidase 2 gene CHEBI:75253 phenylarsine oxide affects folding EXP E RGD:6480464 20191114 CTD MESH:C029341 oxophenylarsine affects the folding of DUOX2 protein PMID:10601291 14268827 ADAM33 ADAM metallopeptidase domain 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ADAM33 mRNA PMID:35307453 14268827 ADAM33 ADAM metallopeptidase domain 33 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADAM33 mRNA PMID:34933075 14268922 GRAMD1B GRAM domain containing 1B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRAMD1B mRNA PMID:35307453 14269009 CXCL10 C-X-C motif chemokine ligand 10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of CXCL10 mRNA PMID:25701311 14269009 CXCL10 C-X-C motif chemokine ligand 10 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of CXCL10 mRNA PMID:34389318 14269009 CXCL10 C-X-C motif chemokine ligand 10 gene CHEBI:3084 bethanechol increases expression EXP E RGD:6480464 20230704 CTD MESH:D018723 Bethanechol results in increased expression of CXCL10 mRNA PMID:29380034 14269117 P2RX7 purinergic receptor P2X 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of P2RX7 mRNA PMID:35307453 14269393 MDM2 MDM2 proto-oncogene gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MDM2 mRNA PMID:35307453 14269428 FAM237B family with sequence similarity 237 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM237B mRNA PMID:35307453 14269494 B3GNT4 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of B3GNT4 mRNA PMID:35307453 14269602 CEP78 centrosomal protein 78 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CEP78 mRNA PMID:35307453 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CLIC5 mRNA PMID:35307453 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of CLIC5 protein PMID:37257635 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:27641 cycloheximide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide results in decreased expression of CLIC5 protein PMID:20576581 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:27641 cycloheximide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of CLIC5 protein] PMID:20576581 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased expression of CLIC5 mRNA; Cadmium Chloride results in decreased expression of CLIC5 protein PMID:20576581 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:35456 cadmium dichloride increases degradation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased degradation of CLIC5 protein PMID:20576581 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 bafilomycin A inhibits the reaction [Cadmium Chloride results in decreased expression of CLIC5 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of CLIC5 protein]; Cycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of CLIC5 protein] PMID:20576581 14269643 CLIC5 chloride intracellular channel 5 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of CLIC5 protein] PMID:20576581 14269715 RAPGEFL1 Rap guanine nucleotide exchange factor like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAPGEFL1 mRNA PMID:35307453 14269715 RAPGEFL1 Rap guanine nucleotide exchange factor like 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of RAPGEFL1 mRNA PMID:39265697 14269796 ZNF575 zinc finger protein 575 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF575 mRNA PMID:35307453 14269855 KCNC1 potassium voltage-gated channel subfamily C member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of KCNC1 mRNA PMID:35307453 14269878 ALOX15 arachidonate 15-lipoxygenase gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of ALOX15 mRNA PMID:33626375 14270126 EFCAB7 EF-hand calcium binding domain 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EFCAB7 mRNA PMID:35307453 14270147 KIF15 kinesin family member 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF15 mRNA PMID:35307453 14270147 KIF15 kinesin family member 15 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of KIF15 mRNA] PMID:21852083 14270259 RERE arginine-glutamic acid dipeptide repeats gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RERE mRNA PMID:35307453 14270471 MORN3 MORN repeat containing 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MORN3 mRNA PMID:35307453 14270519 EPHB2 EPH receptor B2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of EPHB2 mRNA PMID:35307453 14270549 DKK1 dickkopf WNT signaling pathway inhibitor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of DKK1 mRNA PMID:25455459 14270596 GALR1 galanin receptor 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of GALR1 mRNA PMID:34933075 14270632 TECR trans-2,3-enoyl-CoA reductase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TECR mRNA; deoxynivalenol results in decreased expression of TECR protein PMID:35307453|PMID:38403181 14270662 PHF5A PHD finger protein 5A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PHF5A mRNA PMID:35307453 14270675 GLB1 galactosidase beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLB1 mRNA PMID:35307453 14270746 CD83 CD83 molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CD83 mRNA PMID:35307453 14270861 IFN-OMEGA-7 interferon omega 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFN-OMEGA-7 mRNA PMID:35307453 14270888 ZNF532 zinc finger protein 532 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF532 mRNA PMID:35307453 14271000 TSPAN6 tetraspanin 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSPAN6 mRNA PMID:35307453 14271013 MAK16 MAK16 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAK16 mRNA PMID:35307453 14271035 SORL1 sortilin related receptor 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SORL1 mRNA PMID:35307453 14271378 SLC20A2 solute carrier family 20 member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SLC20A2 mRNA PMID:35307453 14271653 CCDC112 coiled-coil domain containing 112 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CCDC112 mRNA PMID:35307453 14271690 GH1 growth hormone 1 gene CHEBI:16199 urea multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D014508 GH1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Urea] PMID:9185964 14271690 GH1 growth hormone 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D008070 GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose]; GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of INS protein]; GH1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Bilirubin]; GH1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Fatty Acids, Nonesterified]; GH1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Urea]; GH1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] PMID:9185964 14271690 GH1 growth hormone 1 gene CHEBI:16990 bilirubin IXalpha multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D001663 GH1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Bilirubin] PMID:9185964 14271690 GH1 growth hormone 1 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D005947 GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose] PMID:9185964 14271690 GH1 growth hormone 1 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D005947 GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose] PMID:9185964 14271690 GH1 growth hormone 1 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20250325 CTD MESH:D005947 GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose] PMID:9185964 14271699 CPSF2 cleavage and polyadenylation specific factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CPSF2 mRNA PMID:35307453 14271733 HAPLN1 hyaluronan and proteoglycan link protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HAPLN1 mRNA PMID:35307453 14271797 DNAAF6 dynein axonemal assembly factor 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAAF6 mRNA PMID:35307453 14271814 RBM8A RNA binding motif protein 8A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBM8A mRNA PMID:35307453 14271933 ANKRD24 ankyrin repeat domain 24 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ANKRD24 mRNA PMID:39265697 14272055 AIFM1 apoptosis inducing factor mitochondria associated 1 gene CHEBI:15428 glycine multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D005998 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of AIFM1 mRNA] PMID:35839969 14272055 AIFM1 apoptosis inducing factor mitochondria associated 1 gene CHEBI:27899 cisplatin affects response to substance EXP E RGD:6480464 20191114 CTD MESH:D002945 AIFM1 protein affects the susceptibility to Cisplatin PMID:15983031 14272055 AIFM1 apoptosis inducing factor mitochondria associated 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in increased expression of AIFM1 mRNA PMID:35839969 14272055 AIFM1 apoptosis inducing factor mitochondria associated 1 gene CHEBI:88522 Monobutylphthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C028577 Glycine inhibits the reaction [monobutyl phthalate results in increased expression of AIFM1 mRNA] PMID:35839969 14272092 WDR86 WD repeat domain 86 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR86 mRNA PMID:35307453 14272249 LRRC32 leucine rich repeat containing 32 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LRRC32 mRNA PMID:35307453 14272270 CFAP184 cilia and flagella associated protein 184 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP184 mRNA PMID:35307453 14272378 CDK6 cyclin dependent kinase 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of CDK6 mRNA; deoxynivalenol results in increased expression of CDK6 protein PMID:38403181 14272378 CDK6 cyclin dependent kinase 6 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of CDK6 mRNA] PMID:21852083 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RELA mRNA PMID:35307453 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:10022 deoxynivalenol multiple interactions EXP E RGD:6480464 20210309 CTD MESH:C007262 [deoxynivalenol co-treated with Lipopolysaccharides] affects the localization of RELA protein; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] PMID:32877744 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases activity EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased activity of RELA protein PMID:21130106 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 [2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of RELA protein] PMID:21130106 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:16240 hydrogen peroxide increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:D006861 Hydrogen Peroxide results in increased phosphorylation of RELA protein PMID:38438008 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20240903 CTD MESH:D006861 theanine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of RELA protein] PMID:38438008 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:16412 lipopolysaccharide increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased phosphorylation of RELA protein PMID:28528741|PMID:32877744 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008070 [deoxynivalenol co-treated with Lipopolysaccharides] affects the localization of RELA protein; [Flavones co-treated with Lipopolysaccharides] results in increased phosphorylation of RELA protein; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] PMID:28528741|PMID:31669396|PMID:32877744 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:17351 linoleic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D019787 Linoleic Acid results in increased activity of RELA protein PMID:14519784 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:17351 linoleic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019787 2,4-thiazolidinedione inhibits the reaction [Linoleic Acid results in increased activity of RELA protein]; PPARG protein promotes the reaction [Linoleic Acid results in increased activity of RELA protein] PMID:14519784 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:17394 N(5)-ethyl-L-glutamine multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C026166 theanine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of RELA protein] PMID:38438008 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:18050 L-glutamine multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D005973 Glutamine inhibits the reaction [bisphenol A results in increased expression of RELA protein] PMID:38154151 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of RELA protein PMID:34416349 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:229959 mogroside V multiple interactions EXP E RGD:6480464 20240409 CTD MESH:C041740 mogroside V inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein] PMID:35134483 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:24043 flavones multiple interactions EXP E RGD:6480464 20200714 CTD MESH:D047309 [Flavones co-treated with Lipopolysaccharides] results in increased phosphorylation of RELA protein PMID:31669396 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:25442 mycotoxin increases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in increased expression of RELA mRNA; Mycotoxins results in increased expression of RELA protein PMID:39137830 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of RELA mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in increased expression of RELA protein] PMID:39137830 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:27744 glyphosate increases phosphorylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased phosphorylation of RELA protein PMID:35388968 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of RELA protein PMID:38154151 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C006780 Glutamine inhibits the reaction [bisphenol A results in increased expression of RELA protein] PMID:38154151 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:35456 cadmium dichloride affects localization EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride affects the localization of RELA protein PMID:23575899 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of RELA protein PMID:34416349 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine inhibits the reaction [SZU-101 results in increased expression of RELA protein] PMID:27079946 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:4948 Evodiamine decreases phosphorylation EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine results in decreased phosphorylation of RELA protein PMID:39305878 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide affects the reaction [evodiamine affects the reaction [T-2 Toxin affects the localization of RELA protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased phosphorylation of RELA protein]]; evodiamine affects the reaction [T-2 Toxin affects the localization of RELA protein]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of RELA mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased phosphorylation of RELA protein] PMID:39305878 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:50992 1,3-thiazolidine-2,4-dione multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C089946 2,4-thiazolidinedione inhibits the reaction [Linoleic Acid results in increased activity of RELA protein] PMID:14519784 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] PMID:28528741 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:77732 cadmium nitrate increases expression EXP E RGD:6480464 20191114 CTD MESH:C035196 cadmium nitrate results in increased expression of RELA mRNA PMID:29421334 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:9381 T-2 toxin affects localization EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin affects the localization of RELA protein PMID:39305878 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of RELA mRNA PMID:39305878 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:9381 T-2 toxin increases phosphorylation EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased phosphorylation of RELA protein PMID:39305878 14272472 RELA RELA proto-oncogene, NF-kB subunit gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide affects the reaction [evodiamine affects the reaction [T-2 Toxin affects the localization of RELA protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [evodiamine inhibits the reaction [T-2 Toxin results in increased phosphorylation of RELA protein]]; evodiamine affects the reaction [T-2 Toxin affects the localization of RELA protein]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of RELA mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased phosphorylation of RELA protein] PMID:39305878 14272892 OSBP oxysterol binding protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of OSBP mRNA PMID:35307453 14272958 CP ceruloplasmin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CP mRNA PMID:35307453 14273208 MIEF2 mitochondrial elongation factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MIEF2 mRNA PMID:35307453 14273330 LGI2 leucine rich repeat LGI family member 2 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of LGI2 mRNA PMID:34933075 14273382 CD47 CD47 molecule gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of CD47 mRNA PMID:28069986 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20230307 CTD MESH:D008550 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 protein] PMID:35665993 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression EXP E RGD:6480464 20230307 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of RIPK1 mRNA; tetrabromobisphenol A results in increased expression of RIPK1 protein PMID:35665993 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C020806 Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 protein] PMID:35665993 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of RIPK1 mRNA; Cadmium Chloride results in increased expression of RIPK1 protein PMID:33626375 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of RIPK1 mRNA; fumonisin B1 results in increased expression of RIPK1 protein PMID:38705344 14273646 RIPK1 receptor interacting serine/threonine kinase 1 gene CHEBI:38221 fumonisin B1 multiple interactions EXP E RGD:6480464 20240903 CTD MESH:C056933 necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 protein] PMID:38705344 14273699 SAFB scaffold attachment factor B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SAFB mRNA PMID:35307453 14273699 SAFB scaffold attachment factor B gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of SAFB mRNA PMID:28069986 14273927 SEPTIN4 septin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEPTIN4 mRNA PMID:35307453 14273956 FHIT fragile histidine triad diadenosine triphosphatase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FHIT mRNA PMID:35307453 14273999 AGER advanced glycosylation end-product specific receptor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGER mRNA PMID:35307453 14273999 AGER advanced glycosylation end-product specific receptor gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20200714 CTD MESH:C056933 fumonisin B1 results in increased expression of AGER mRNA PMID:32198028 14274036 ZNF408 zinc finger protein 408 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF408 mRNA PMID:35307453 14274232 PTPRN protein tyrosine phosphatase receptor type N gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PTPRN mRNA PMID:35307453 14274259 ANKRD29 ankyrin repeat domain 29 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ANKRD29 mRNA PMID:35307453 14274383 FBXL5 F-box and leucine rich repeat protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FBXL5 mRNA PMID:35307453 14274408 LRRC24 leucine rich repeat containing 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC24 mRNA PMID:35307453 14274436 RPL17 ribosomal protein L17 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of RPL17 mRNA PMID:21852083 14274476 ZAN zonadhesin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZAN mRNA PMID:35307453 14274476 ZAN zonadhesin gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of ZAN mRNA PMID:39265697 14274522 CCDC187 coiled-coil domain containing 187 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCDC187 mRNA PMID:35307453 14274790 THRAP3 thyroid hormone receptor associated protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of THRAP3 mRNA PMID:35307453 14274790 THRAP3 thyroid hormone receptor associated protein 3 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of THRAP3 mRNA PMID:21852083 14274816 SLC13A1 solute carrier family 13 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC13A1 mRNA PMID:35307453 14274847 CERK ceramide kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CERK mRNA PMID:35307453 14274886 RRN3 RRN3 homolog, RNA polymerase I transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of RRN3 mRNA; deoxynivalenol results in increased expression of RRN3 protein PMID:38403181 14274913 DACT3 dishevelled binding antagonist of beta catenin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DACT3 mRNA PMID:35307453 14275006 NOP2 NOP2 nucleolar protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NOP2 mRNA PMID:35307453 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15551 prostaglandin E2 increases abundance EXP E RGD:6480464 20191114 CTD MESH:D015232 OXT protein results in increased abundance of Dinoprostone PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15551 prostaglandin E2 increases secretion EXP E RGD:6480464 20191114 CTD MESH:D015232 OXT protein results in increased secretion of Dinoprostone PMID:16997130 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15551 prostaglandin E2 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015232 Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprostone] PMID:16997130 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15553 prostaglandin F2alpha increases abundance EXP E RGD:6480464 20191114 CTD MESH:D015237 OXT protein results in increased abundance of Dinoprost PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15553 prostaglandin F2alpha increases secretion EXP E RGD:6480464 20191114 CTD MESH:D015237 OXT protein results in increased secretion of Dinoprost PMID:16997130 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:15553 prostaglandin F2alpha multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015237 Progesterone inhibits the reaction [OXT protein results in increased abundance of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprost] PMID:16997130|PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011374 Progesterone affects the reaction [OXT protein results in increased abundance of Calcium]; Progesterone inhibits the reaction [OXT protein results in increased abundance of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprostone]; Progesterone inhibits the reaction [OXT protein results in increased transport of Calcium] PMID:16997130|PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:22984 calcium atom increases abundance EXP E RGD:6480464 20191114 CTD MESH:D002118 OXT protein results in increased abundance of Calcium PMID:16997130 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:22984 calcium atom increases transport EXP E RGD:6480464 20191114 CTD MESH:D002118 OXT protein results in increased transport of Calcium PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:22984 calcium atom multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 Progesterone affects the reaction [OXT protein results in increased abundance of Calcium]; Progesterone inhibits the reaction [OXT protein results in increased transport of Calcium] PMID:16997130|PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:29320 calcium(0) increases abundance EXP E RGD:6480464 20191114 CTD MESH:D002118 OXT protein results in increased abundance of Calcium PMID:16997130 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:29320 calcium(0) increases transport EXP E RGD:6480464 20191114 CTD MESH:D002118 OXT protein results in increased transport of Calcium PMID:21370738 14275189 OXT oxytocin/neurophysin I prepropeptide gene CHEBI:29320 calcium(0) multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002118 Progesterone affects the reaction [OXT protein results in increased abundance of Calcium]; Progesterone inhibits the reaction [OXT protein results in increased transport of Calcium] PMID:16997130|PMID:21370738 14275255 HCFC1R1 host cell factor C1 regulator 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HCFC1R1 mRNA PMID:35307453 14275255 HCFC1R1 host cell factor C1 regulator 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of HCFC1R1 mRNA PMID:39265697 14275273 GGCT gamma-glutamylcyclotransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GGCT mRNA PMID:35307453 14275292 RELN reelin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RELN mRNA PMID:35307453 14275370 SPARCL1 SPARC like 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of SPARCL1 mRNA PMID:34933075 14275428 KLF9 KLF transcription factor 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLF9 mRNA PMID:35307453 14275432 FHL2 four and a half LIM domains 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FHL2 mRNA PMID:35307453 14275520 LXN latexin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LXN mRNA PMID:35307453 14275714 ADM2 adrenomedullin 2 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of ADM2 mRNA PMID:39265697 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYC protein PMID:30690062 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MYC mRNA PMID:35307453 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:146195 3-acetyldeoxynivalenol decreases expression EXP E RGD:6480464 20240109 CTD MESH:C043247 3-acetyldeoxynivalenol results in decreased expression of MYC protein PMID:37659622 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:22977 cadmium atom increases expression EXP E RGD:6480464 20191114 CTD MESH:D002104 Cadmium results in increased expression of MYC mRNA PMID:11781163 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of MYC mRNA PMID:27617619 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of MYC PMID:12712633 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002945 Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of MYC] PMID:12712633 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000111 Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of MYC] PMID:12712633 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased expression of MYC mRNA PMID:7564105 14275719 MYC MYC proto-oncogene, bHLH transcription factor gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in increased expression of MYC mRNA PMID:17437637 14275749 MX2 MX dynamin like GTPase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MX2 mRNA PMID:35307453 14275812 CKB creatine kinase B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CKB mRNA PMID:35307453 14275813 DCBLD2 discoidin, CUB and LCCL domain containing 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DCBLD2 mRNA PMID:35307453 14275878 GPRASP1 G protein-coupled receptor associated sorting protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPRASP1 mRNA PMID:35307453 14276056 PALMD palmdelphin gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PALMD mRNA PMID:35307453 14276072 SLA-DMB MHC class II, DM beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLA-DMB mRNA PMID:35307453 14276144 KIF12 kinesin family member 12 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF12 mRNA PMID:35307453 14276287 PPAT phosphoribosyl pyrophosphate amidotransferase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PPAT mRNA PMID:35307453 14276287 PPAT phosphoribosyl pyrophosphate amidotransferase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of PPAT mRNA] PMID:21852083 14276302 VPS37A VPS37A subunit of ESCRT-I gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of VPS37A mRNA PMID:35307453 14276329 RGL3 ral guanine nucleotide dissociation stimulator like 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RGL3 mRNA PMID:35307453 14276356 MRPL10 mitochondrial ribosomal protein L10 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MRPL10 mRNA PMID:35307453 14276370 SORBS1 sorbin and SH3 domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SORBS1 mRNA PMID:35307453 14276548 IL33 interleukin 33 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IL33 mRNA PMID:35307453 14276635 TNFRSF12A TNF receptor superfamily member 12A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TNFRSF12A mRNA PMID:35307453 14276635 TNFRSF12A TNF receptor superfamily member 12A gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of TNFRSF12A mRNA PMID:22533443 14276650 ZSCAN23 zinc finger and SCAN domain containing 23 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ZSCAN23 mRNA PMID:34933075 14276667 MTHFD2L methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTHFD2L mRNA PMID:35307453 14276813 SNAPC3 small nuclear RNA activating complex polypeptide 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SNAPC3 mRNA PMID:35307453 14276841 PPP1R11 protein phosphatase 1 regulatory inhibitor subunit 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPP1R11 mRNA PMID:35307453 14276886 PRNP prion protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PRNP mRNA PMID:35307453 14276886 PRNP prion protein gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of PRNP mRNA PMID:28069986 14277069 HSPA4 heat shock protein family A (Hsp70) member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HSPA4 mRNA PMID:35307453 14277131 KIF24 kinesin family member 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KIF24 mRNA PMID:35307453 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GPX1 mRNA PMID:35307453 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of GPX1 mRNA; Zearalenone results in increased expression of GPX1 protein PMID:23727178|PMID:31760079 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of GPX1 mRNA PMID:39265697 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA PMID:29129240 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] PMID:36281498 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20230704 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of GPX1 mRNA PMID:36549457 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:16796 melatonin increases expression EXP E RGD:6480464 20250311 CTD MESH:D008550 Melatonin results in increased expression of GPX1 mRNA PMID:38848930 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A] results in decreased expression of GPX1 mRNA PMID:38848930 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA PMID:29129240 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA PMID:29129240 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPX1 mRNA PMID:33493553 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA] PMID:32280687 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA PMID:29129240 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:27568 selenium atom increases activity EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog results in increased activity of GPX1 protein PMID:37442268 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:27744 glyphosate decreases activity EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased activity of GPX1 protein PMID:35388968 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of GPX1 mRNA PMID:31677563 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] PMID:36281498 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:29224 dibromine increases expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine results in increased expression of GPX1 mRNA PMID:21391292 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D015032 [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA] PMID:32280687 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191114 CTD MESH:C006780 bisphenol A results in decreased expression of GPX1 mRNA PMID:28819136|PMID:38848930 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA; [Melatonin co-treated with bisphenol A] results in decreased expression of GPX1 mRNA PMID:29129240|PMID:38848930 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA]; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA; [MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 protein; Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA] PMID:34811946 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D019287 Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA] PMID:32280687 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of GPX1 mRNA PMID:33626375 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPX1 mRNA PMID:33493553 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:36904 elemental selenium increases activity EXP E RGD:6480464 20231031 CTD MESH:D012643 Selenium analog results in increased activity of GPX1 protein PMID:37442268 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D002994 Clofibrate results in decreased expression of GPX1 mRNA PMID:17437637 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA] PMID:34811946 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D004178 Diquat results in decreased expression of GPX1 mRNA PMID:32280687|PMID:38567716 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:64163 diquat multiple interactions EXP E RGD:6480464 20210907 CTD MESH:D004178 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA]; [Zinc binds to alpha-hydroxy-gamma-methylmercaptobutyric acid] inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA]; Zinc Sulfate inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA] PMID:32280687|PMID:38567716 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in decreased expression of GPX1 mRNA PMID:36281498 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Taurine inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] PMID:36281498 14277298 GPX1 glutathione peroxidase 1 gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [[MYD88 protein affects the susceptibility to Paraquat] which affects the expression of GPX1 mRNA] PMID:34811946 14277333 FAS Fas cell surface death receptor gene CHEBI:27899 cisplatin increases expression EXP E RGD:6480464 20191114 CTD MESH:D002945 Cisplatin results in increased expression of FAS mRNA PMID:20435919 14277425 BUD31 BUD31 homolog gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BUD31 mRNA PMID:35307453 14277462 UGP2 UDP-glucose pyrophosphorylase 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of UGP2 mRNA PMID:18988085 14277638 EEIG2 EEIG family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in increased expression of EEIG2 mRNA PMID:35307453 14277661 HOXA4 homeobox A4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXA4 mRNA PMID:35307453 14277698 DNAJC28 DnaJ heat shock protein family (Hsp40) member C28 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAJC28 mRNA PMID:35307453 14277710 KHDRBS3 KH RNA binding domain containing, signal transduction associated 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of KHDRBS3 mRNA PMID:34933075 14277931 PDIA3 protein disulfide isomerase family A member 3 gene CHEBI:17616 all-trans-retinyl palmitate increases hydrolysis EXP E RGD:6480464 20191114 CTD MESH:C014794 PDIA3 protein results in increased hydrolysis of retinol palmitate PMID:16798117 14277931 PDIA3 protein disulfide isomerase family A member 3 gene CHEBI:64482 phosphatidylcholine increases hydrolysis EXP E RGD:6480464 20191114 CTD MESH:D010713 PDIA3 protein results in increased hydrolysis of Phosphatidylcholines PMID:16798117 14278000 CDKN1C cyclin dependent kinase inhibitor 1C gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CDKN1C mRNA PMID:39265697 14278022 TRIO trio Rho guanine nucleotide exchange factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRIO mRNA PMID:35307453 14278092 RBMS3 RNA binding motif single stranded interacting protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RBMS3 mRNA PMID:35307453 14278283 CEBPZOS CEBPZ opposite strand gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEBPZOS mRNA PMID:35307453 14278305 NIPAL1 NIPA like domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NIPAL1 mRNA PMID:35307453 14278373 CTSA cathepsin A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CTSA mRNA PMID:35307453 14278402 JSRP1 junctional sarcoplasmic reticulum protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of JSRP1 mRNA PMID:35307453 14278445 SCARB2 scavenger receptor class B member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCARB2 mRNA PMID:35307453 14278445 SCARB2 scavenger receptor class B member 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SCARB2 mRNA PMID:18988085 14278754 RAD23B RAD23 homolog B, nucleotide excision repair protein gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RAD23B mRNA PMID:35307453 14278781 LPCAT3 lysophosphatidylcholine acyltransferase 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LPCAT3 mRNA PMID:35307453 14278798 P2RY6 pyrimidinergic receptor P2Y6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of P2RY6 mRNA PMID:39265697 14278836 LOC102165256 V-type proton ATPase subunit G 1 pseudogene gene CHEBI:17234 glucose decreases expression EXP E RGD:6480464 20211221 CTD MESH:D005947 Glucose results in decreased expression of ATP6V1G1 mRNA PMID:16313995 14278836 LOC102165256 V-type proton ATPase subunit G 1 pseudogene gene CHEBI:17634 D-glucose decreases expression EXP E RGD:6480464 20211221 CTD MESH:D005947 Glucose results in decreased expression of ATP6V1G1 mRNA PMID:16313995 14278836 LOC102165256 V-type proton ATPase subunit G 1 pseudogene gene CHEBI:42758 aldehydo-D-glucose decreases expression EXP E RGD:6480464 20211221 CTD MESH:D005947 Glucose results in decreased expression of ATP6V1G1 mRNA PMID:16313995 14278914 GJB1 gap junction protein beta 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GJB1 mRNA PMID:35307453 14278973 DNAAF11 dynein axonemal assembly factor 11 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230207 CTD MESH:C007262 deoxynivalenol results in decreased expression of DNAAF11 mRNA PMID:35307453 14279017 FIRRM FIGNL1 interacting regulator of recombination and mitosis gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230404 CTD MESH:C007262 deoxynivalenol results in increased expression of FIRRM mRNA PMID:35307453 14279050 NR1D2 nuclear receptor subfamily 1 group D member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NR1D2 mRNA PMID:35307453 14279067 CFAP263 cilia and flagella associated protein 263 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP263 mRNA PMID:35307453 14279135 KCTD19 potassium channel tetramerization domain containing 19 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KCTD19 mRNA PMID:35307453 14279188 PRKAR2B protein kinase cAMP-dependent type II regulatory subunit beta gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRKAR2B mRNA PMID:35307453 14279203 FAM76B family with sequence similarity 76 member B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM76B mRNA PMID:35307453 14279331 CDCA7 cell division cycle associated 7 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of CDCA7 mRNA PMID:21852083 14279353 XCR1 X-C motif chemokine receptor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20191114 CTD MESH:C007262 deoxynivalenol results in increased expression of XCR1 mRNA PMID:23326479 14279498 CNN1 calponin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of CNN1 protein PMID:38403181 14279668 BMP3 bone morphogenetic protein 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BMP3 mRNA PMID:35307453 14279689 IRS1 insulin receptor substrate 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IRS1 mRNA PMID:35307453 14279689 IRS1 insulin receptor substrate 1 gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in increased expression of IRS1 protein PMID:21575630|PMID:21739664 14279689 IRS1 insulin receptor substrate 1 gene CHEBI:41879 dexamethasone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003907 Dexamethasone results in decreased expression of IRS1 mRNA PMID:19852296 14279702 LOC100522421 aldehyde dehydrogenase family 3 member B2-like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALDH3B2 mRNA PMID:35307453 14279756 OTOG otogelin gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of OTOG mRNA PMID:35307453 14279921 FANCD2 FA complementation group D2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FANCD2 mRNA PMID:35307453 14279982 IFT25 intraflagellar transport 25 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IFT25 mRNA PMID:35307453 14280021 BARX2 BARX homeobox 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BARX2 mRNA PMID:35307453 14280043 RECQL4 RecQ like helicase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RECQL4 mRNA PMID:35307453 14280261 PPIA peptidylprolyl isomerase A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPIA mRNA PMID:35307453 14280261 PPIA peptidylprolyl isomerase A gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20191114 CTD MESH:C025589 ochratoxin A results in increased expression of PPIA mRNA PMID:14994279 14280287 DDX56 DEAD-box helicase 56 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DDX56 mRNA PMID:35307453 14280305 FAM81B family with sequence similarity 81 member B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM81B mRNA PMID:35307453 14280319 SLC51A solute carrier family 51 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC51A mRNA PMID:35307453 14280319 SLC51A solute carrier family 51 member A gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:C028577 monobutyl phthalate results in decreased expression of SLC51A mRNA PMID:35839969 14280500 SPDEF SAM pointed domain containing ETS transcription factor gene CHEBI:34745 Estradiol 17beta-cyclopentylpropionate increases expression EXP E RGD:6480464 20191114 CTD MESH:C007630 estradiol 17 beta-cypionate results in increased expression of SPDEF mRNA PMID:22497863 14280546 PNPLA7 patatin like phospholipase domain containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PNPLA7 mRNA PMID:35307453 14280597 RABGEF1 RAB guanine nucleotide exchange factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RABGEF1 mRNA PMID:35307453 14280626 ITGA2 integrin subunit alpha 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of ITGA2 mRNA] PMID:21852083 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRP2 mRNA PMID:35307453 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:16325 lithocholic acid affects expression EXP E RGD:6480464 20191114 CTD MESH:D008095 Lithocholic Acid affects the expression of LRP2 protein PMID:15375181 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:16325 lithocholic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D008095 Lithocholic Acid binds to and results in increased activity of LRP2 protein PMID:15375181 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:16359 cholic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D019826 Cholic Acid results in increased expression of LRP2 protein PMID:15375181 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:16755 chenodeoxycholic acid increases expression EXP E RGD:6480464 20191114 CTD MESH:D002635 Chenodeoxycholic Acid results in increased expression of LRP2 protein PMID:15375181 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:27641 cycloheximide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide results in decreased expression of LRP2 protein PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:27641 cycloheximide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D003513 Cycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein] PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in decreased expression of LRP2 mRNA; Cadmium Chloride results in decreased expression of LRP2 protein PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:35456 cadmium dichloride increases degradation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased degradation of LRP2 protein PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 bafilomycin A inhibits the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]; Cycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein] PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein] PMID:20576581 14280699 LRP2 LDL receptor related protein 2 gene CHEBI:88046 cylindrospermopsin decreases expression EXP E RGD:6480464 20210608 CTD MESH:C089595 cylindrospermopsin results in decreased expression of LRP2 mRNA PMID:33689780 14280787 H2AZ1 H2A.Z variant histone 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230905 CTD MESH:C007262 deoxynivalenol results in increased expression of H2AZ1 mRNA PMID:35307453 14280809 FANCF FA complementation group F gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FANCF mRNA PMID:35307453 14280877 NPC1 NPC intracellular cholesterol transporter 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NPC1 mRNA PMID:35307453 14280907 PRDX2 peroxiredoxin 2 gene CHEBI:68508 diethyl maleate decreases activity EXP E RGD:6480464 20191114 CTD MESH:C014476 diethyl maleate results in decreased activity of PRDX2 protein PMID:19208552 14281004 EIF3M eukaryotic translation initiation factor 3 subunit M gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF3M mRNA PMID:35307453 14281030 ZNF143 zinc finger protein 143 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF143 mRNA PMID:35307453 14281279 PLIN5 perilipin 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLIN5 mRNA PMID:35307453 14281330 MOG myelin oligodendrocyte glycoprotein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MOG mRNA PMID:35307453 14281391 SLPI secretory leukocyte peptidase inhibitor gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLPI mRNA PMID:35307453 14281484 SH2D5 SH2 domain containing 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SH2D5 mRNA PMID:35307453|PMID:37257635 14281507 TSNAXIP1 translin associated factor X interacting protein 1 gene CHEBI:10022 deoxynivalenol affects expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol affects the expression of TSNAXIP1 mRNA PMID:35307453 14281593 UCK2 uridine-cytidine kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of UCK2 mRNA PMID:35307453 14281685 MFSD13A major facilitator superfamily domain containing 13A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MFSD13A mRNA PMID:35307453 14281716 CBS cystathionine beta-synthase gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D000431 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of CBS protein PMID:16792574 14281716 CBS cystathionine beta-synthase gene CHEBI:27470 folic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D005492 Folic Acid deficiency results in increased activity of CBS protein PMID:16792574 14281716 CBS cystathionine beta-synthase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Ethanol co-treated with Folic Acid deficiency] results in increased activity of CBS protein PMID:16792574 14281780 TXN thioredoxin gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of TXN mRNA PMID:18988085 14281816 CELSR3 cadherin EGF LAG seven-pass G-type receptor 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CELSR3 mRNA PMID:35307453 14281862 LRP4 LDL receptor related protein 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRP4 mRNA PMID:35307453 14281904 DNAJC7 DnaJ heat shock protein family (Hsp40) member C7 gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in increased expression of DNAJC7 mRNA PMID:36615853 14281904 DNAJC7 DnaJ heat shock protein family (Hsp40) member C7 gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in increased expression of DNAJC7 mRNA PMID:36615853 14282019 TMUB1 transmembrane and ubiquitin like domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMUB1 protein PMID:37257635 14282026 TMEM126A transmembrane protein 126A gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM126A mRNA PMID:35307453 14282079 SCG5 secretogranin V gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SCG5 mRNA PMID:35307453 14282106 AGMAT agmatinase (putative) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AGMAT mRNA PMID:35307453 14282245 AOX2 aldehyde oxidase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of AOX2 mRNA PMID:35307453 14282294 LMCD1 LIM and cysteine rich domains 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LMCD1 mRNA PMID:35307453 14282294 LMCD1 LIM and cysteine rich domains 1 gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of LMCD1 mRNA PMID:39265697 14282420 ASB13 ankyrin repeat and SOCS box containing 13 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASB13 mRNA PMID:35307453 14282466 ST8SIA5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ST8SIA5 mRNA PMID:35307453 14282525 IGDCC4 immunoglobulin superfamily DCC subclass member 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IGDCC4 mRNA PMID:35307453 14282553 KCNJ16 potassium inwardly rectifying channel subfamily J member 16 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of KCNJ16 mRNA PMID:39265697 14282577 CFAP126 cilia and flagella associated protein 126 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP126 mRNA PMID:35307453 14282649 FAM171A2 family with sequence similarity 171 member A2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM171A2 mRNA PMID:35307453 14282817 PPFIA4 PTPRF interacting protein alpha 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPFIA4 mRNA PMID:35307453 14282899 PLPP3 phospholipid phosphatase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLPP3 mRNA PMID:35307453 14282899 PLPP3 phospholipid phosphatase 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of PLPP3 mRNA PMID:39265697 14282980 XBP1 X-box binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of XBP1 mRNA PMID:35307453|PMID:38608924 14282980 XBP1 X-box binding protein 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of XBP1 mRNA] PMID:36584959 14282980 XBP1 X-box binding protein 1 gene CHEBI:22977 cadmium atom increases splicing EXP E RGD:6480464 20231031 CTD MESH:D002104 Cadmium results in increased splicing of XBP1 mRNA PMID:37207789 14282980 XBP1 X-box binding protein 1 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20211012 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA alternative form; ursodoxicoltaurine inhibits the reaction [Cadmium results in increased splicing of XBP1 mRNA] PMID:33891997|PMID:37207789 14282980 XBP1 X-box binding protein 1 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of XBP1 mRNA PMID:36584959 14282980 XBP1 X-box binding protein 1 gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of XBP1 mRNA] PMID:36584959 14282980 XBP1 X-box binding protein 1 gene CHEBI:28869 menadione increases splicing EXP E RGD:6480464 20191114 CTD MESH:D024483 Vitamin K 3 results in increased splicing of XBP1 mRNA PMID:18086661 14282980 XBP1 X-box binding protein 1 gene CHEBI:35456 cadmium dichloride increases splicing EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased splicing of XBP1 mRNA PMID:17464326|PMID:18086661 14282980 XBP1 X-box binding protein 1 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA alternative form; SOD2 inhibits the reaction [Cadmium Chloride results in increased splicing of XBP1 mRNA]; XBP1 affects the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] PMID:18086661|PMID:33891997 14282980 XBP1 X-box binding protein 1 gene CHEBI:80774 tauroursodeoxycholic acid multiple interactions EXP E RGD:6480464 20231031 CTD MESH:C031655 ursodoxicoltaurine inhibits the reaction [Cadmium results in increased splicing of XBP1 mRNA] PMID:37207789 14282993 HPCAL4 hippocalcin like 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HPCAL4 mRNA PMID:35307453 14283004 ACAN aggrecan gene CHEBI:27881 resveratrol decreases degradation EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol results in decreased degradation of ACAN protein PMID:20825639 14283038 FILIP1L filamin A interacting protein 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FILIP1L mRNA PMID:35307453 14283114 SVOP SV2 related protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SVOP mRNA PMID:35307453 14283256 LRRIQ1 leucine rich repeats and IQ motif containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRIQ1 mRNA PMID:35307453 14283315 MED8 mediator complex subunit 8 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MED8 mRNA PMID:35307453 14283369 NLGN3 neuroligin 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NLGN3 mRNA PMID:35307453 14283678 RIGI RNA sensor RIG-I gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230606 CTD MESH:C007262 deoxynivalenol results in decreased expression of RIGI mRNA PMID:35307453 14283734 FAM111B FAM111 trypsin like peptidase B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FAM111B mRNA PMID:35307453 14283753 MYBPC3 myosin binding protein C3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MYBPC3 mRNA PMID:35307453 14283801 MEIG1 meiosis/spermiogenesis associated 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MEIG1 mRNA PMID:35307453 14283815 GAL3ST3 galactose-3-O-sulfotransferase 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GAL3ST3 mRNA PMID:35307453 14283875 POLR2K RNA polymerase II, I and III subunit K gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of POLR2K mRNA PMID:35307453 14283955 ERMP1 endoplasmic reticulum metallopeptidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ERMP1 mRNA PMID:35307453 14283977 TPM2 tropomyosin 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPM2 mRNA; deoxynivalenol results in decreased expression of TPM2 protein PMID:38403181 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:16856 glutathione multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D005978 [Glutathione co-treated with Paraquat] results in decreased expression of CYP2B6B mRNA PMID:36615853 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:28077 rifampicin increases expression EXP E RGD:6480464 20191114 CTD MESH:D012293 Rifampin results in increased expression of CYP2B6B mRNA PMID:19464568 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20230704 CTD MESH:D010269 Paraquat results in increased expression of CYP2B6B mRNA PMID:36615853 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010269 [Glutathione co-treated with Paraquat] results in decreased expression of CYP2B6B mRNA PMID:36615853 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:6902 metolachlor multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C051786 CYP2B6B protein results in increased metabolism of and results in decreased susceptibility to metolachlor PMID:16315095 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:8069 phenobarbital increases expression EXP E RGD:6480464 20191114 CTD MESH:D010634 Phenobarbital results in increased expression of CYP2B6B protein PMID:15614250 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:81981 chlorotoluron decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:C007033 CYP2B6B protein results in decreased susceptibility to chlortoluron PMID:16315095 14284006 CYP2B6B cytochrome P450 family 2 subfamily B member 6B gene CHEBI:83569 pendimethalin decreases response to substance EXP E RGD:6480464 20191114 CTD MESH:C030856 CYP2B6B protein results in decreased susceptibility to pendimethalin PMID:16315095 14284083 PCYT1B phosphate cytidylyltransferase 1B, choline gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PCYT1B mRNA PMID:35307453 14284121 KRT4 keratin 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KRT4 mRNA PMID:35307453 14284192 TMEM242 transmembrane protein 242 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TMEM242 mRNA PMID:35307453 14284325 ACER1 alkaline ceramidase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ACER1 mRNA PMID:35307453 14284386 GINS4 GINS complex subunit 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GINS4 mRNA PMID:35307453 14284546 RBSN rabenosyn, RAB effector gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RBSN mRNA PMID:35307453 14284650 GRAP GRB2 related adaptor protein gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRAP mRNA PMID:35307453 14284663 TTC27 tetratricopeptide repeat domain 27 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TTC27 mRNA PMID:35307453 14284701 COL2A1 collagen type II alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL2A1 mRNA PMID:35307453 14284842 TRIM65 tripartite motif containing 65 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRIM65 mRNA PMID:35307453 14284947 CSRNP1 cysteine and serine rich nuclear protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSRNP1 mRNA PMID:35307453 14285041 ZNF526 zinc finger protein 526 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ZNF526 mRNA PMID:35307453 14285060 SNX10 sorting nexin 10 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SNX10 mRNA PMID:35307453 14285096 SESN3 sestrin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SESN3 mRNA PMID:35307453 14285157 NAA10 N-alpha-acetyltransferase 10, NatA catalytic subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NAA10 mRNA PMID:35307453 14285192 TMEM52B transmembrane protein 52B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM52B mRNA PMID:35307453 14285279 ADRA2A adrenoceptor alpha 2A gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of ADRA2A mRNA PMID:34933075 14285305 COQ10B coenzyme Q10B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of COQ10B mRNA PMID:35307453 14285319 TPD52L1 TPD52 like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TPD52L1 mRNA PMID:35307453 14285344 TRMT5 tRNA methyltransferase 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TRMT5 mRNA PMID:35307453 14285356 ABCB9 ATP binding cassette subfamily B member 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCB9 mRNA PMID:35307453 14285399 WBP4 WW domain binding protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WBP4 mRNA PMID:35307453 14285457 MX1 MX dynamin like GTPase 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MX1 mRNA PMID:35307453 14285476 ITGA1 integrin subunit alpha 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGA1 mRNA PMID:38403181 14285541 CDK5 cyclin dependent kinase 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDK5 mRNA PMID:35307453 14285650 AASS aminoadipate-semialdehyde synthase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AASS mRNA PMID:35307453 14285714 EXOSC9 exosome component 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EXOSC9 mRNA PMID:35307453 14285736 SFXN1 sideroflexin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SFXN1 mRNA PMID:35307453 14285826 SELP selectin P gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELP mRNA PMID:19608276 14285826 SELP selectin P gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELP mRNA] PMID:19608276 14285826 SELP selectin P gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELP mRNA] PMID:19608276 14285826 SELP selectin P gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of SELP mRNA PMID:21852083 14285826 SELP selectin P gene CHEBI:37537 phorbol 13-acetate 12-myristate increases expression EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased expression of SELP protein PMID:16797888 14285826 SELP selectin P gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20191114 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of SELP protein PMID:15964915 14285826 SELP selectin P gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D020123 Sirolimus inhibits the reaction [Zymosan analog results in increased expression of SELP protein] PMID:16797888 14285842 DRAM2 DNA damage regulated autophagy modulator 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DRAM2 mRNA PMID:35307453 14285995 TMEM171 transmembrane protein 171 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of TMEM171 mRNA PMID:34933075 14286300 SURF6 surfeit 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SURF6 mRNA PMID:35307453 14286470 SHAS2 hyaluronan synthase 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SHAS2 mRNA PMID:35307453 14286470 SHAS2 hyaluronan synthase 2 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in decreased expression of SHAS2 mRNA PMID:26386189 14286470 SHAS2 hyaluronan synthase 2 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SHAS2 mRNA PMID:18988085 14286470 SHAS2 hyaluronan synthase 2 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20240903 CTD MESH:D004390 Chlorpyrifos results in decreased expression of SHAS2 mRNA PMID:38565334 14286589 DNAJC2 DnaJ heat shock protein family (Hsp40) member C2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC2 mRNA PMID:35307453 14286643 DDX60 DExD/H-box helicase 60 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DDX60 mRNA PMID:35307453 14286757 BYSL bystin like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BYSL mRNA PMID:35307453 14286768 GLTPD2 glycolipid transfer protein domain containing 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GLTPD2 mRNA PMID:35307453 14286824 PRPF40B pre-mRNA processing factor 40 homolog B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PRPF40B mRNA PMID:35307453 14286893 LIAT1 ligand of ATE1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230606 CTD MESH:C007262 deoxynivalenol results in decreased expression of LIAT1 mRNA PMID:35307453 14286953 NVL nuclear VCP like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NVL mRNA PMID:35307453 14287068 MTCP1 mature T cell proliferation 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of MTCP1 mRNA PMID:35307453 14287068 MTCP1 mature T cell proliferation 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MTCP1 mRNA] PMID:39151877 14287068 MTCP1 mature T cell proliferation 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of MTCP1 mRNA PMID:39151877 14287068 MTCP1 mature T cell proliferation 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of MTCP1 mRNA] PMID:39151877 14287123 ELF1 E74 like ETS transcription factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ELF1 mRNA PMID:35307453 14287189 FKBP4 FKBP prolyl isomerase 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FKBP4 mRNA PMID:35307453 14287203 LIPG lipase G, endothelial type gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LIPG mRNA PMID:35307453 14287203 LIPG lipase G, endothelial type gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of LIPG mRNA PMID:39265697 14287203 LIPG lipase G, endothelial type gene CHEBI:34310 (24S)-24-hydroxycholesterol decreases expression EXP E RGD:6480464 20191114 CTD MESH:C044563 24-hydroxycholesterol results in decreased expression of LIPG mRNA; 24-hydroxycholesterol results in decreased expression of LIPG protein PMID:15953354 14287203 LIPG lipase G, endothelial type gene CHEBI:47612 bezafibrate decreases expression EXP E RGD:6480464 20191114 CTD MESH:D001629 Bezafibrate results in decreased expression of LIPG mRNA; Bezafibrate results in decreased expression of LIPG protein PMID:15953354 14287203 LIPG lipase G, endothelial type gene CHEBI:8228 pioglitazone decreases expression EXP E RGD:6480464 20191114 CTD MESH:C060836 Pioglitazone results in decreased expression of LIPG mRNA; Pioglitazone results in decreased expression of LIPG protein PMID:15953354 14287251 GNG11 G protein subunit gamma 11 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of GNG11 mRNA PMID:35307453 14287361 BAALC BAALC binder of MAP3K1 and KLF4 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of BAALC mRNA PMID:34933075 14287395 PFKP phosphofructokinase, platelet gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PFKP mRNA PMID:35307453 14287421 FRMD1 FERM domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FRMD1 mRNA PMID:35307453 14287517 TMEM47 transmembrane protein 47 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TMEM47 mRNA PMID:35307453 14287517 TMEM47 transmembrane protein 47 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of TMEM47 mRNA PMID:21852083 14287564 CDX2 caudal type homeobox 2 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D008550 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of CDX2 protein; [Melatonin co-treated with bisphenol A] results in decreased expression of CDX2 protein PMID:38848930 14287564 CDX2 caudal type homeobox 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C059514 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of CDX2 protein PMID:38848930 14287564 CDX2 caudal type homeobox 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20250311 CTD MESH:C006780 bisphenol A results in decreased expression of CDX2 protein PMID:38848930 14287564 CDX2 caudal type homeobox 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20250311 CTD MESH:C006780 [Melatonin co-treated with bisphenol A co-treated with Resveratrol] results in decreased expression of CDX2 protein; [Melatonin co-treated with bisphenol A] results in decreased expression of CDX2 protein PMID:38848930 14287573 IFN-DELTA-9 interferon-delta-9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IFN-DELTA-9 mRNA PMID:35307453 14287598 PALD1 phosphatase domain containing paladin 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PALD1 mRNA PMID:35307453 14287704 WASL WASP like actin nucleation promoting factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of WASL mRNA PMID:35307453 14287743 FN3K fructosamine 3 kinase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FN3K mRNA PMID:35307453 14287940 ASPRV1 aspartic peptidase retroviral like 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ASPRV1 mRNA PMID:35307453 14288023 AVEN apoptosis and caspase activation inhibitor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of AVEN mRNA PMID:35307453 14288033 MAPK1IP1L mitogen-activated protein kinase 1 interacting protein 1 like gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAPK1IP1L mRNA PMID:35307453 14288155 ITGB3 integrin subunit beta 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of ITGB3 mRNA PMID:38403181 14288155 ITGB3 integrin subunit beta 3 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of ITGB3 protein PMID:39486568 14288155 ITGB3 integrin subunit beta 3 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in decreased expression of ITGB3 protein PMID:39486568 14288155 ITGB3 integrin subunit beta 3 gene CHEBI:85102 KT 5823 multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C073601 KT 5823 inhibits the reaction [NOC 18 results in increased expression of [ITGAV protein binds to ITGB3 protein]] PMID:21307347 14288175 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTAR1 mRNA PMID:35307453 14288186 PLXNB1 plexin B1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLXNB1 mRNA PMID:35307453 14288228 BBS9 Bardet-Biedl syndrome 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of BBS9 mRNA PMID:35307453 14288292 ALDH9A1 aldehyde dehydrogenase 9 family member A1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ALDH9A1 mRNA PMID:28069986 14288391 TCP1 t-complex 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TCP1 mRNA PMID:35307453 14288412 NUDT15 nudix hydrolase 15 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NUDT15 mRNA PMID:35307453 14288419 FDPS farnesyl diphosphate synthase gene CHEBI:132889 graphene oxide increases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in increased expression of FDPS mRNA PMID:39265697 14288480 ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ENPP1 mRNA PMID:35307453 14288480 ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ENPP1 mRNA] PMID:21852083 14288573 XPO6 exportin 6 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of XPO6 mRNA PMID:35307453 14288641 ALCAM activated leukocyte cell adhesion molecule gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALCAM mRNA PMID:35307453 14288668 TRARG1 trafficking regulator of GLUT4 (SLC2A4) 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TRARG1 mRNA PMID:35307453 14288780 LOC100625049 isopentenyl-diphosphate Delta-isomerase 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IDI1 mRNA PMID:35307453 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of EIF2S1 mRNA PMID:35307453 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20230606 CTD MESH:D001622 Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 protein] PMID:36584959 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:207229 dihydroartemisinin increases expression EXP E RGD:6480464 20210504 CTD MESH:C039060 artenimol results in increased expression of EIF2S1 protein modified form PMID:32721431 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of EIF2S1 mRNA; Glyphosate results in increased expression of EIF2S1 protein PMID:36584959 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:27744 glyphosate multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C010974 Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 protein] PMID:36584959 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:29865 benzo[a]pyrene increases phosphorylation EXP E RGD:6480464 20230704 CTD MESH:D001564 Benzo(a)pyrene results in increased phosphorylation of EIF2S1 protein PMID:36754226 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:3093 bifenthrin increases phosphorylation EXP E RGD:6480464 20210706 CTD MESH:C099952 bifenthrin results in increased phosphorylation of EIF2S1 protein PMID:33901951 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:35456 cadmium dichloride increases phosphorylation EXP E RGD:6480464 20191114 CTD MESH:D019256 Cadmium Chloride results in increased phosphorylation of EIF2S1 protein PMID:20600546 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:39329 etoxazole increases phosphorylation EXP E RGD:6480464 20201103 CTD MESH:C508136 etoxazole results in increased phosphorylation of EIF2S1 protein PMID:31744678 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:64163 diquat increases phosphorylation EXP E RGD:6480464 20240903 CTD MESH:D004178 Diquat results in increased phosphorylation of EIF2S1 protein PMID:38567716 14288797 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha gene CHEBI:9381 T-2 toxin increases phosphorylation EXP E RGD:6480464 20220308 CTD MESH:D013605 T-2 Toxin results in increased phosphorylation of EIF2S1 protein PMID:34637808 14288925 SMARCA1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMARCA1 mRNA PMID:35307453 14289073 BRF2 BRF2 RNA polymerase III transcription initiation factor subunit gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BRF2 mRNA PMID:35307453 14289108 MRPS6 mitochondrial ribosomal protein S6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of MRPS6 mRNA; deoxynivalenol results in decreased expression of MRPS6 protein PMID:38403181 14289169 ABCA6 ATP binding cassette subfamily A member 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ABCA6 mRNA PMID:35307453 14289254 PSTPIP1 proline-serine-threonine phosphatase interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PSTPIP1 mRNA PMID:35307453 14289320 AK9 adenylate kinase 9 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of AK9 mRNA PMID:35307453 14289394 HNF1A HNF1 homeobox A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HNF1A mRNA PMID:35307453 14289414 FOSB FosB proto-oncogene, AP-1 transcription factor subunit gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of FOSB mRNA PMID:34389318 14289650 MT-ATP8 mitochondrially encoded ATP synthase membrane subunit 8 gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in increased expression of ATP8 mRNA PMID:34933075 14289734 SMIM1 small integral membrane protein 1 (Vel blood group) gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SMIM1 mRNA PMID:35307453 14289734 SMIM1 small integral membrane protein 1 (Vel blood group) gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SMIM1 mRNA PMID:39265697 14289747 RELL1 RELT like 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RELL1 mRNA PMID:35307453 14289839 FILIP1 filamin A interacting protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FILIP1 mRNA PMID:35307453 14289862 RUSC1 RUN and SH3 domain containing 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RUSC1 mRNA PMID:35307453 14289909 NARS2 asparaginyl-tRNA synthetase 2, mitochondrial gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NARS2 mRNA PMID:35307453 14290038 SSBP1 single stranded DNA binding protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SSBP1 mRNA PMID:35307453 14290146 USH2A usherin gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in increased expression of USH2A mRNA PMID:21852083 14290343 TM4SF4 transmembrane 4 L six family member 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TM4SF4 mRNA PMID:35307453 14290439 ZNF362 zinc finger protein 362 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ZNF362 mRNA PMID:35307453 14290469 F10 coagulation factor X gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of F10 mRNA PMID:35307453 14290653 TERF2 telomeric repeat binding factor 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of TERF2 mRNA PMID:35307453 14290667 ING3 inhibitor of growth family member 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ING3 mRNA PMID:35307453 14290686 HNRNPH1 heterogeneous nuclear ribonucleoprotein H1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of HNRNPH1 mRNA PMID:35307453 14290789 MAP4 microtubule associated protein 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MAP4 mRNA PMID:35307453 14290916 RAD54L RAD54 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RAD54L mRNA PMID:35307453 14290949 CFAP100 cilia and flagella associated protein 100 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CFAP100 mRNA PMID:35307453 14291034 MOCOS molybdenum cofactor sulfurase gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MOCOS mRNA PMID:35307453 14291034 MOCOS molybdenum cofactor sulfurase gene CHEBI:83354 benzamidoxime affects reduction EXP E RGD:6480464 20191114 CTD MESH:C053561 MOCOS protein affects the reduction of benzamidoxime PMID:16973608 14291301 NT5C2 5'-nucleotidase, cytosolic II gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NT5C2 mRNA PMID:35307453 14291991 RNF144B ring finger protein 144B gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RNF144B mRNA PMID:35307453 14292031 NUDT16 nudix hydrolase 16 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of NUDT16 mRNA PMID:35307453 14292031 NUDT16 nudix hydrolase 16 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NUDT16 mRNA PMID:39265697 14292114 ATP8B3 ATPase phospholipid transporting 8B3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ATP8B3 mRNA PMID:35307453 14292360 RNF183 ring finger protein 183 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RNF183 mRNA PMID:35307453 14292511 LAS1L LAS1 like ribosome biogenesis factor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LAS1L mRNA PMID:35307453 14292619 PYCARD PYD and CARD domain containing gene CHEBI:10106 zearalenone increases expression EXP E RGD:6480464 20191114 CTD MESH:D015025 Zearalenone results in increased expression of PYCARD mRNA; Zearalenone results in increased expression of PYCARD protein PMID:30270565 14292619 PYCARD PYD and CARD domain containing gene CHEBI:10106 zearalenone multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D015025 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD protein PMID:30270565 14292619 PYCARD PYD and CARD domain containing gene CHEBI:15891 taurine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D013654 Taurine inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein] PMID:36281498 14292619 PYCARD PYD and CARD domain containing gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PYCARD mRNA] PMID:39151877 14292619 PYCARD PYD and CARD domain containing gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of PYCARD mRNA PMID:39151877 14292619 PYCARD PYD and CARD domain containing gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of PYCARD mRNA] PMID:39151877 14292619 PYCARD PYD and CARD domain containing gene CHEBI:28939 N-acetyl-L-cysteine multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D000111 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein] PMID:36281498 14292619 PYCARD PYD and CARD domain containing gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20191114 CTD MESH:D016264 Dextran Sulfate results in increased expression of PYCARD mRNA; Dextran Sulfate results in increased expression of PYCARD protein PMID:30270565 14292619 PYCARD PYD and CARD domain containing gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016264 [Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD protein PMID:30270565 14292619 PYCARD PYD and CARD domain containing gene CHEBI:4948 Evodiamine multiple interactions EXP E RGD:6480464 20250114 CTD MESH:C049639 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of PYCARD mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of PYCARD protein] PMID:39305878 14292619 PYCARD PYD and CARD domain containing gene CHEBI:7719 ochratoxin A increases expression EXP E RGD:6480464 20230502 CTD MESH:C025589 ochratoxin A results in increased expression of PYCARD protein PMID:36281498 14292619 PYCARD PYD and CARD domain containing gene CHEBI:7719 ochratoxin A multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C025589 Acetylcysteine inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein]; Taurine inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein] PMID:36281498 14292619 PYCARD PYD and CARD domain containing gene CHEBI:9381 T-2 toxin increases expression EXP E RGD:6480464 20250114 CTD MESH:D013605 T-2 Toxin results in increased expression of PYCARD mRNA; T-2 Toxin results in increased expression of PYCARD protein PMID:39305878 14292619 PYCARD PYD and CARD domain containing gene CHEBI:9381 T-2 toxin multiple interactions EXP E RGD:6480464 20250114 CTD MESH:D013605 evodiamine inhibits the reaction [T-2 Toxin results in increased expression of PYCARD mRNA]; evodiamine inhibits the reaction [T-2 Toxin results in increased expression of PYCARD protein] PMID:39305878 14292739 ARNT2 aryl hydrocarbon receptor nuclear translocator 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARNT2 mRNA PMID:35307453 14292838 CAPNS1 calpain small subunit 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of CAPNS1 mRNA PMID:18988085 14293055 PPM1G protein phosphatase, Mg2+/Mn2+ dependent 1G gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PPM1G mRNA PMID:35307453 14293122 LPIN1 lipin 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of LPIN1 mRNA PMID:35307453 14293122 LPIN1 lipin 1 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of LPIN1 mRNA] PMID:39151877 14293122 LPIN1 lipin 1 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of LPIN1 mRNA PMID:39151877 14293122 LPIN1 lipin 1 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of LPIN1 mRNA] PMID:39151877 14293223 SELE selectin E gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20191114 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELE mRNA PMID:19608276 14293223 SELE selectin E gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028451 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELE mRNA] PMID:19608276 14293223 SELE selectin E gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011794 Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of SELE mRNA] PMID:19608276 14293223 SELE selectin E gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20191114 CTD MESH:D008070 Lipopolysaccharides results in increased expression of SELE PMID:12224865 14293223 SELE selectin E gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in increased expression of SELE mRNA PMID:18988085 14293223 SELE selectin E gene CHEBI:29310 dichlorine increases expression EXP E RGD:6480464 20191114 CTD MESH:D002713 Chlorine results in increased expression of SELE mRNA PMID:22533443 14293223 SELE selectin E gene CHEBI:30187 aluminium oxide increases expression EXP E RGD:6480464 20191114 CTD MESH:D000537 Aluminum Oxide results in increased expression of SELE mRNA; Aluminum Oxide results in increased expression of SELE protein PMID:18456438 14293223 SELE selectin E gene CHEBI:37537 phorbol 13-acetate 12-myristate increases expression EXP E RGD:6480464 20191114 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased expression of SELE protein PMID:16797888 14293223 SELE selectin E gene CHEBI:62984 zinc acetate multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D019345 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SELE mRNA] PMID:18845708 14293223 SELE selectin E gene CHEBI:6736 melittin increases expression EXP E RGD:6480464 20191114 CTD MESH:D008555 Melitten results in increased expression of SELE mRNA PMID:10769290 14293223 SELE selectin E gene CHEBI:78496 mastoparan increases expression EXP E RGD:6480464 20191114 CTD MESH:C037500 mastoparan results in increased expression of SELE mRNA PMID:10769290 14293223 SELE selectin E gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP E RGD:6480464 20191114 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SELE mRNA PMID:18845708 14293223 SELE selectin E gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C044387 Zinc Acetate inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SELE mRNA] PMID:18845708 14293464 KRT15 keratin 15 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KRT15 mRNA PMID:35307453 14293605 TYW5 tRNA-yW synthesizing protein 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in increased expression of TYW5 mRNA; deoxynivalenol results in increased expression of TYW5 protein PMID:38403181 14293676 CPNE6 copine 6 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of CPNE6 mRNA PMID:39265697 14293760 IP6K3 inositol hexakisphosphate kinase 3 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of IP6K3 mRNA PMID:34933075 14293816 AK4 adenylate kinase 4 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of AK4 mRNA] PMID:39151877 14293816 AK4 adenylate kinase 4 gene CHEBI:23414 copper(II) sulfate increases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in increased expression of AK4 mRNA PMID:39151877 14293816 AK4 adenylate kinase 4 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in increased expression of AK4 mRNA] PMID:39151877 14293898 G6PC3 glucose-6-phosphatase catalytic subunit 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of G6PC3 mRNA PMID:35307453 14293925 LRRC7 leucine rich repeat containing 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of LRRC7 mRNA PMID:35307453 14294084 COMMD6 COMM domain containing 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of COMMD6 mRNA PMID:35307453 14294103 DENND6B DENN domain containing 6B gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DENND6B mRNA PMID:35307453 14294259 SEPTIN3 septin 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SEPTIN3 mRNA PMID:35307453 14294259 SEPTIN3 septin 3 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of SEPTIN3 mRNA PMID:39265697 14294327 TSNARE1 t-SNARE domain containing 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TSNARE1 mRNA PMID:35307453 14294404 RHOC ras homolog family member C gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of RHOC mRNA PMID:35307453 14294487 PTPN2 protein tyrosine phosphatase non-receptor type 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of PTPN2 mRNA PMID:35307453 14294779 KMO kynurenine 3-monooxygenase gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of KMO mRNA] PMID:21852083 14294839 ACHE acetylcholinesterase gene CHEBI:136185 VX nerve agent decreases activity EXP E RGD:6480464 20191114 CTD MESH:C009680 VX-agent results in decreased activity of ACHE protein PMID:20888357|PMID:38768837 14294839 ACHE acetylcholinesterase gene CHEBI:136185 VX nerve agent multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C009680 N,N'-monomethylenebis(pyridiniumaldoxime) inhibits the reaction [VX-agent results in decreased activity of ACHE protein] PMID:20888357 14294839 ACHE acetylcholinesterase gene CHEBI:16325 lithocholic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D008095 Lithocholic Acid results in increased activity of ACHE protein PMID:3697337 14294839 ACHE acetylcholinesterase gene CHEBI:16359 cholic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D019826 Cholic Acid results in increased activity of ACHE protein PMID:3697337 14294839 ACHE acetylcholinesterase gene CHEBI:16755 chenodeoxycholic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D002635 Chenodeoxycholic Acid results in increased activity of ACHE protein PMID:3697337 14294839 ACHE acetylcholinesterase gene CHEBI:233581 asoxime chloride multiple interactions EXP E RGD:6480464 20250408 CTD MESH:C022870 asoxime chloride inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; asoxime chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein] PMID:16021679|PMID:19428926|PMID:20156534|PMID:20971170|PMID:22230262 14294839 ACHE acetylcholinesterase gene CHEBI:27827 paraoxon decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010261 Paraoxon results in decreased activity of ACHE protein PMID:19428926|PMID:20156534|PMID:20971170|PMID:22230262 14294839 ACHE acetylcholinesterase gene CHEBI:27827 paraoxon multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010261 asoxime chloride inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; N,N'-monomethylenebis(pyridiniumaldoxime) inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Paraoxon results in decreased activity of ACHE protein] PMID:19428926|PMID:20156534|PMID:20971170|PMID:22230262 14294839 ACHE acetylcholinesterase gene CHEBI:27953 physostigmine decreases activity EXP E RGD:6480464 20191114 CTD MESH:D010830 Physostigmine results in decreased activity of ACHE protein PMID:21414391 14294839 ACHE acetylcholinesterase gene CHEBI:27953 physostigmine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D010830 Physostigmine inhibits the reaction [Soman results in decreased activity of ACHE protein] PMID:21414391 14294839 ACHE acetylcholinesterase gene CHEBI:28834 deoxycholic acid increases activity EXP E RGD:6480464 20191114 CTD MESH:D003840 Deoxycholic Acid results in increased activity of ACHE protein PMID:3697337 14294839 ACHE acetylcholinesterase gene CHEBI:34682 diazinon decreases activity EXP E RGD:6480464 20191114 CTD MESH:D003976 Diazinon results in decreased activity of ACHE protein PMID:21467751 14294839 ACHE acetylcholinesterase gene CHEBI:34690 dichlorvos decreases activity EXP E RGD:6480464 20191114 CTD MESH:D004006 Dichlorvos results in decreased activity of ACHE protein PMID:21467751 14294839 ACHE acetylcholinesterase gene CHEBI:75701 sarin decreases activity EXP E RGD:6480464 20191114 CTD MESH:D012524 Sarin results in decreased activity of ACHE protein PMID:16021679|PMID:19428926|PMID:20156534|PMID:20888357|PMID:22230262|PMID:22343375 14294839 ACHE acetylcholinesterase gene CHEBI:75701 sarin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012524 asoxime chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]; N,N'-monomethylenebis(pyridiniumaldoxime) inhibits the reaction [Sarin results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein] PMID:16021679|PMID:19428926|PMID:20156534|PMID:20888357|PMID:22230262 14294839 ACHE acetylcholinesterase gene CHEBI:8354 pralidoxime multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C028797 pralidoxime inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [tabun results in decreased activity of ACHE protein] PMID:20370537|PMID:20971170 14294839 ACHE acetylcholinesterase gene CHEBI:8666 Pyridostigmine bromide decreases activity EXP E RGD:6480464 20191114 CTD MESH:D011729 Pyridostigmine Bromide results in decreased activity of ACHE protein PMID:21414391 14294839 ACHE acetylcholinesterase gene CHEBI:8666 Pyridostigmine bromide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D011729 Pyridostigmine Bromide inhibits the reaction [Soman results in decreased activity of ACHE protein] PMID:21414391 14294839 ACHE acetylcholinesterase gene CHEBI:9195 Soman decreases activity EXP E RGD:6480464 20191114 CTD MESH:D012999 Soman results in decreased activity of ACHE protein PMID:21414391 14294839 ACHE acetylcholinesterase gene CHEBI:9195 Soman multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D012999 Physostigmine inhibits the reaction [Soman results in decreased activity of ACHE protein]; Pyridostigmine Bromide inhibits the reaction [Soman results in decreased activity of ACHE protein] PMID:21414391 14294858 YTHDF2 YTH N6-methyladenosine RNA binding protein F2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of YTHDF2 mRNA PMID:35307453 14294868 HSPA2 heat shock protein family A (Hsp70) member 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of HSPA2 mRNA PMID:35307453 14294868 HSPA2 heat shock protein family A (Hsp70) member 2 gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 [Dietary Fats co-treated with Resveratrol] results in decreased expression of HSPA2 mRNA PMID:21852083 14295284 NDUFAF2 NADH:ubiquinone oxidoreductase complex assembly factor 2 gene CHEBI:132889 graphene oxide decreases expression EXP E RGD:6480464 20250708 CTD MESH:C000628730 graphene oxide results in decreased expression of NDUFAF2 mRNA PMID:39265697 14295317 ENO4 enolase 4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ENO4 mRNA PMID:35307453 14295411 CER1 cerberus 1, DAN family BMP antagonist gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CER1 mRNA PMID:35307453 14295452 MTFR1 mitochondrial fission regulator 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of MTFR1 mRNA PMID:35307453 14295598 SPDL1 spindle apparatus coiled-coil protein 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPDL1 mRNA PMID:35307453 14295631 SLA-1 MHC class I antigen 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20231031 CTD MESH:C007262 deoxynivalenol results in increased expression of SLA-1 protein PMID:37257635 14295731 WDR6 WD repeat domain 6 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of WDR6 mRNA PMID:35307453 14295793 CELF3 CUGBP Elav-like family member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CELF3 mRNA PMID:35307453 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC5A1 mRNA; deoxynivalenol results in decreased expression of SLC5A1 protein PMID:35307453 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D002794 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA PMID:28445388 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:17439 cyanocob(III)alamin multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D014805 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA PMID:28445388 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:17750 glycine betaine multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D001622 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA PMID:28445388 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009151 Mustard Gas results in decreased expression of SLC5A1 mRNA PMID:18988085 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D005492 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA PMID:28445388 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:28417 gentamycin C decreases expression EXP E RGD:6480464 20191114 CTD MESH:C100093 gentamicin C results in decreased expression of SLC5A1 mRNA; gentamicin C results in decreased expression of SLC5A1 protein PMID:12927799|PMID:15777622 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:28417 gentamycin C multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C100093 [gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein] which results in decreased uptake of Aminoglycosides; APOE protein inhibits the reaction [gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein]; APOE protein inhibits the reaction [gentamicin C results in decreased expression of SLC5A1 mRNA]; gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein PMID:15777622 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C006780 [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA PMID:28445388 14295883 SLC5A1 solute carrier family 5 member 1 gene CHEBI:7507 neomycin decreases expression EXP E RGD:6480464 20191114 CTD MESH:D009355 Neomycin results in decreased expression of SLC5A1 mRNA; Neomycin results in decreased expression of SLC5A1 protein PMID:12927799 14295938 NACC1 nucleus accumbens associated 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NACC1 mRNA PMID:35307453 14295938 NACC1 nucleus accumbens associated 1 gene CHEBI:16134 ammonia decreases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in decreased expression of NACC1 mRNA PMID:34389318 14296023 CCDC158 coiled-coil domain containing 158 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CCDC158 mRNA PMID:34933075 14296023 CCDC158 coiled-coil domain containing 158 gene CHEBI:16134 ammonia increases expression EXP E RGD:6480464 20220308 CTD MESH:D000641 Ammonia results in increased expression of CCDC158 mRNA PMID:34389318 14296073 ALOX5 arachidonate 5-lipoxygenase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ALOX5 mRNA PMID:35307453 14296073 ALOX5 arachidonate 5-lipoxygenase gene CHEBI:10112 zileuton decreases activity EXP E RGD:6480464 20191114 CTD MESH:C063449 zileuton results in decreased activity of ALOX5 protein PMID:11509739 14296073 ALOX5 arachidonate 5-lipoxygenase gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of ALOX5 mRNA PMID:28069986 14296073 ALOX5 arachidonate 5-lipoxygenase gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of ALOX5 mRNA PMID:33626375 14296147 CDHR5 cadherin related family member 5 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CDHR5 mRNA PMID:35307453 14296177 ADORA2B adenosine A2b receptor gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of ADORA2B mRNA PMID:35307453 14296244 FAM228A family with sequence similarity 228 member A gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of FAM228A mRNA PMID:35307453 14296321 SCN4B sodium voltage-gated channel beta subunit 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SCN4B mRNA PMID:35307453 14296378 SMAD2 SMAD family member 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SMAD2 mRNA PMID:35307453 14296378 SMAD2 SMAD family member 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMAD2 mRNA PMID:34416349 14296378 SMAD2 SMAD family member 2 gene CHEBI:28685 molybdenum atom multiple interactions EXP E RGD:6480464 20250708 CTD MESH:D008982 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased phosphorylation of SMAD2 protein PMID:39486568 14296378 SMAD2 SMAD family member 2 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of SMAD2 mRNA PMID:33626375 14296378 SMAD2 SMAD family member 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20220111 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMAD2 mRNA PMID:34416349 14296378 SMAD2 SMAD family member 2 gene CHEBI:50842 norflurazon decreases expression EXP E RGD:6480464 20240903 CTD MESH:C008677 norflurazone results in decreased expression of SMAD2 mRNA PMID:38432436 14296378 SMAD2 SMAD family member 2 gene CHEBI:75215 sodium molybdate (anhydrous) multiple interactions EXP E RGD:6480464 20250708 CTD MESH:C024687 [sodium molybdate(VI) results in increased abundance of Molybdenum] which results in increased phosphorylation of SMAD2 protein PMID:39486568 14296448 BTAF1 B-TFIID TATA-box binding protein associated factor 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BTAF1 mRNA PMID:35307453 14296496 CYP51A1 cytochrome P450 family 51 subfamily A member 1 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CYP51A1 mRNA PMID:35307453 14296496 CYP51A1 cytochrome P450 family 51 subfamily A member 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in increased expression of CYP51 mRNA PMID:28069986 14296639 DNAJC30 DnaJ heat shock protein family (Hsp40) member C30 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of DNAJC30 mRNA PMID:35307453 14296826 PHEX phosphate regulating endopeptidase X-linked gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PHEX mRNA PMID:35307453 14296891 TMEM102 transmembrane protein 102 gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D011794 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of TMEM102 mRNA] PMID:39151877 14296891 TMEM102 transmembrane protein 102 gene CHEBI:23414 copper(II) sulfate decreases expression EXP E RGD:6480464 20250311 CTD MESH:D019327 Copper Sulfate results in decreased expression of TMEM102 mRNA PMID:39151877 14296891 TMEM102 transmembrane protein 102 gene CHEBI:23414 copper(II) sulfate multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D019327 Quercetin inhibits the reaction [Copper Sulfate results in decreased expression of TMEM102 mRNA] PMID:39151877 14296902 IRAK2 interleukin 1 receptor associated kinase 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of IRAK2 mRNA PMID:35307453 14296919 CABP7 calcium binding protein 7 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CABP7 mRNA PMID:35307453 14297210 PLXNB3 plexin B3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of PLXNB3 mRNA PMID:35307453 14297271 SLC41A3 solute carrier family 41 member 3 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of SLC41A3 mRNA PMID:35307453 14297304 BAG3 BAG cochaperone 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of BAG3 mRNA PMID:35307453 14297312 TNNI3 troponin I3, cardiac type gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of TNNI3 mRNA PMID:35307453 14297312 TNNI3 troponin I3, cardiac type gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of TNNI3 mRNA PMID:28069986 14297414 DMAC2L distal membrane arm assembly component 2 like gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of DMAC2L mRNA PMID:35307453 14297491 CCHCR1 coiled-coil alpha-helical rod protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CCHCR1 mRNA PMID:35307453 14297665 IQCE IQ motif containing E gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of IQCE mRNA PMID:35307453 14297701 ARHGEF25 Rho guanine nucleotide exchange factor 25 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF25 mRNA PMID:35307453 14297734 NTN5 netrin 5 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of NTN5 mRNA PMID:35307453 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C007262 deoxynivalenol results in decreased expression of OPA1 protein PMID:32302720 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPA1 mRNA PMID:33592257 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:25442 mycotoxin decreases expression EXP E RGD:6480464 20250311 CTD MESH:D009183 Mycotoxins results in decreased expression of OPA1 mRNA; Mycotoxins results in decreased expression of OPA1 protein PMID:39137830 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:25442 mycotoxin multiple interactions EXP E RGD:6480464 20250311 CTD MESH:D009183 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of OPA1 mRNA]; 3,5-dicaffeoylquinic acid inhibits the reaction [Mycotoxins results in decreased expression of OPA1 protein] PMID:39137830 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:33234 vitamin E multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D024502 Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of OPA1 protein] PMID:23347876 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:34905 paraquat affects expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat affects the expression of OPA1 protein PMID:34811946 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230905 CTD MESH:D010269 Paraquat results in decreased expression of OPA1 mRNA PMID:34811946 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:34905 paraquat multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D010269 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]]; MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]; MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]] PMID:34811946 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20210504 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPA1 mRNA PMID:33592257 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:38221 fumonisin B1 increases expression EXP E RGD:6480464 20240903 CTD MESH:C056933 fumonisin B1 results in increased expression of OPA1 mRNA PMID:38705344 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:38635 3-methyladenine multiple interactions EXP E RGD:6480464 20230905 CTD MESH:C025946 3-methyladenine affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]] PMID:34811946 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20191114 CTD MESH:D016572 Cyclosporine results in decreased expression of OPA1 protein PMID:23347876 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D016572 Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of OPA1 protein] PMID:23347876 14297845 OPA1 OPA1 mitochondrial dynamin like GTPase gene CHEBI:9168 sirolimus multiple interactions EXP E RGD:6480464 20230905 CTD MESH:D020123 Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat affects the expression of OPA1 protein]]; Sirolimus affects the reaction [MYD88 protein affects the reaction [Paraquat results in decreased expression of OPA1 mRNA]] PMID:34811946 14297890 GRTP1 growth hormone regulated TBC protein 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of GRTP1 mRNA PMID:35307453 14297890 GRTP1 growth hormone regulated TBC protein 1 gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000431 Ethanol results in decreased expression of GRTP1 mRNA PMID:28069986 14297902 RTN4RL2 reticulon 4 receptor like 2 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of RTN4RL2 mRNA PMID:35307453 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20240903 CTD MESH:C007262 deoxynivalenol results in decreased expression of COL1A1 mRNA PMID:38403181 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:17270 glycerol 2-phosphate multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C031463 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA] PMID:30481989 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20191114 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in increased expression of COL1A1 mRNA] PMID:21852083 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:29073 L-ascorbic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D001205 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA] PMID:30481989 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:29224 dibromine affects expression EXP E RGD:6480464 20191114 CTD MESH:D001966 Bromine affects the expression of COL1A1 mRNA PMID:18790026 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:34578 Bisphenol A diglycidyl ether multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C019273 bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA] PMID:30481989 14297975 COL1A1 collagen type I alpha 1 chain gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D003907 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA; bisphenol A diglycidyl ether promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL1A1 mRNA] PMID:30481989 14298057 MT-ND1 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20191114 CTD MESH:C016766 sulforaphane results in increased expression of ND1 protein PMID:27993529 14298099 SPAG9 sperm associated antigen 9 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of SPAG9 mRNA PMID:35307453 14298229 KLHL24 kelch like family member 24 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of KLHL24 mRNA PMID:35307453 14298311 CEP135 centrosomal protein 135 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of CEP135 mRNA PMID:35307453 14298353 TLR7 toll like receptor 7 gene CHEBI:3638 chloroquine multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D002738 Chloroquine affects the localization of and results in decreased activity of TLR7 protein PMID:27079946 14298401 ARHGEF39 Rho guanine nucleotide exchange factor 39 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ARHGEF39 mRNA PMID:35307453 14298550 CSRNP3 cysteine and serine rich nuclear protein 3 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CSRNP3 mRNA PMID:35307453 14298624 ODAD1 outer dynein arm docking complex subunit 1 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in decreased expression of ODAD1 mRNA PMID:35307453 14298708 CNTN4 contactin 4 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20220705 CTD MESH:D015025 Zearalenone results in decreased expression of CNTN4 mRNA PMID:34933075 14298737 CHI3L2 chitinase 3 like 2 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of CHI3L2 mRNA PMID:35307453 15003193 FFAR4 free fatty acid receptor 4 gene CHEBI:10022 deoxynivalenol increases expression EXP E RGD:6480464 20230117 CTD MESH:C007262 deoxynivalenol results in increased expression of FFAR4 mRNA PMID:35307453 15003193 FFAR4 free fatty acid receptor 4 gene CHEBI:64243 monosodium L-glutamate affects expression EXP E RGD:6480464 20200901 CTD MESH:D012970 Sodium Glutamate affects the expression of FFAR4 mRNA PMID:31360149 15003193 FFAR4 free fatty acid receptor 4 gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200901 CTD MESH:D012970 Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR4 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR4 mRNA] PMID:31360149 15039275 SREBP-1 sterol regulatory element binding protein 1 gene CHEBI:75261 arotinoid acid decreases expression EXP E RGD:6480464 20191203 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of SREBP-1 mRNA PMID:15583048 406326261 HOXB4 homeobox B4 gene CHEBI:10022 deoxynivalenol decreases expression EXP E RGD:6480464 20250401 CTD MESH:C007262 deoxynivalenol results in decreased expression of HOXB4 mRNA PMID:35307453